PMID,OWN,STAT,DCOM,LR,IS,VI,IP,DP,TI,PG,FAU,AU,LA,PT,PL,TA,JT,JID,SB,MH,EDAT,MHDA,CRDT,PHST,AID,PST,SO,RN,AB,TT,PMC,OID,GN,GR
276646,NLM,MEDLINE,19780915,20190817,0021-5287 (Print) 0021-5287 (Linking),69,4,1978 Apr,[Platelet-like bodies in urine of patients with leukaemia (author's transl)].,443-7,"['Kono, N', 'Toyama, K', 'Chen, T P', 'Suzawa, N', 'Mizokami, T']","['Kono N', 'Toyama K', 'Chen TP', 'Suzawa N', 'Mizokami T']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Nihon Hinyokika Gakkai Zasshi,Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,2984841R,IM,"['Adult', 'Blood Platelets/*ultrastructure', 'Female', 'Humans', 'Leukemia/*urine', 'Leukemia, Monocytic, Acute/urine', 'Leukemia, Myeloid/urine', 'Leukemia, Myeloid, Acute/urine', 'Male', 'Middle Aged']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.5980/jpnjurol1928.69.4_443 [doi]'],ppublish,Nihon Hinyokika Gakkai Zasshi. 1978 Apr;69(4):443-7. doi: 10.5980/jpnjurol1928.69.4_443.,,,,,,,
276644,NLM,MEDLINE,19780915,20041117,0047-1860 (Print) 0047-1860 (Linking),26,5,1978 May,[Metabolic and functional abnormalities of platelets (author's transl)].,423-8,"['Kuramoto, A', 'Kimura, A', 'Fujimura, K']","['Kuramoto A', 'Kimura A', 'Fujimura K']",['jpn'],['Journal Article'],Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['Blood Glucose/*metabolism', 'Blood Platelet Disorders/blood', 'Blood Platelets/*metabolism', 'Humans', 'Leukemia, Myeloid/blood', 'Superoxide Dismutase/blood']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Rinsho Byori. 1978 May;26(5):423-8.,"['0 (Blood Glucose)', 'EC 1.15.1.1 (Superoxide Dismutase)']",,,,,,
276643,NLM,MEDLINE,19780925,20161017,0098-7484 (Print) 0098-7484 (Linking),240,7,1978 Aug 18,Reversible heart block in acute leukemia.,668-9,"['Maguire, L C', 'Sharlip, I D', 'Spaulding, J T', 'Tewfik, H H']","['Maguire LC', 'Sharlip ID', 'Spaulding JT', 'Tewfik HH']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,JAMA,JAMA,7501160,IM,"['Acute Disease', 'Adult', 'Electrocardiography', 'Follow-Up Studies', 'Heart Block/etiology/pathology/*radiotherapy', 'Heart Conduction System/pathology/radiation effects', 'Humans', 'Leukemia, Erythroblastic, Acute/pathology', 'Lymphoma, Non-Hodgkin/*complications/pathology/radiotherapy', 'Male', 'Neoplasm Metastasis']",1978/08/18 00:00,1978/08/18 00:01,['1978/08/18 00:00'],"['1978/08/18 00:00 [pubmed]', '1978/08/18 00:01 [medline]', '1978/08/18 00:00 [entrez]']",,ppublish,JAMA. 1978 Aug 18;240(7):668-9.,,,,,,,
276632,NLM,MEDLINE,19780929,20190509,0027-8874 (Print) 0027-8874 (Linking),61,1,1978 Jul,A specific chromosome breakpoint associated with mouse plasmacytomas.,255-8,"['Shepard, J S', 'Pettengill, O S', 'Wurster-Hill, D H', 'Sorenson, G D']","['Shepard JS', 'Pettengill OS', 'Wurster-Hill DH', 'Sorenson GD']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', '*Chromosome Aberrations', 'Chromosome Deletion', 'Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/genetics', 'Leukemia, Plasma Cell/genetics', 'Mice', 'Mice, Inbred BALB C', 'Multiple Myeloma/genetics', 'Plasmacytoma/*genetics', 'Sarcoma, Experimental/genetics', 'Translocation, Genetic', 'Trisomy', 'X Chromosome']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1093/jnci/61.1.255 [doi]'],ppublish,J Natl Cancer Inst. 1978 Jul;61(1):255-8. doi: 10.1093/jnci/61.1.255.,,"The chromosomes of uncultured cells of the near-diploid mouse plasmacytoma MOPC-31C were studied. The modal number of chromosomes was 44. The tumor lacked two marker chromosomes, reciprocal translocation [rcp t(12; 15)], that in previous studies were found to be common to 3 other uncultured myelomas and 1 cultured mouse myeloma. Through the formation of two markers, rcp t(6; 15), unique to this tumor, however, the tumor shared with other tumors and their specific markers a common breakpoint in chromosome ""15 at band D3/E. This breakpoint has been found in all mouse plasmacytomas examined with banding thus far and is considered of possible importance in the development of this tumor.",,,,,
276620,NLM,MEDLINE,19780929,20190509,0027-8874 (Print) 0027-8874 (Linking),61,1,1978 Jul,"Immune reactivity of RBL-3, a nonproducer leukemia induced by Rauscher murine leukemia virus in C57BL/6 mice.",107-12,"['Chang, K S']",['Chang KS'],['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', '*Antigens, Viral/administration & dosage', 'Cells, Cultured', 'Female', 'Graft Rejection', '*Histocompatibility Antigens', 'Idoxuridine/pharmacology', 'Leukemia, Experimental/*etiology', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Neoplasm Transplantation', 'Rauscher Virus/*immunology', 'Transplantation, Isogeneic', 'Tumor Virus Infections/etiology', 'Viral Proteins/immunology', 'Virus Replication/drug effects']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1093/jnci/61.1.107 [doi]'],ppublish,J Natl Cancer Inst. 1978 Jul;61(1):107-12. doi: 10.1093/jnci/61.1.107.,"['0 (Antigens, Viral)', '0 (Histocompatibility Antigens)', '0 (Viral Proteins)', 'LGP81V5245 (Idoxuridine)']","A cultured line of RBL-3 leukemia, induced by Rauscher murine leukemia virus (R-MuLV) in C57BL/6 mice, was found to be a virus nonproducer. An NB tropic virus indistinguishable from R-MuLV, however, was recovered after treatment with 5-iodo-2'-deoxyuridine (optimal concentration, 200 microgram/ml). Dexamethasone treatment slightly boosted the production of the activated virus but did not by itself activate the virus. RBL-3 cells were found to have Fc receptors but no surface immunoglobulin or Thy 1.2 antigen. RBL-3 cells exhibited the Friend-Moloney-Rauscher virus-specific transplantation antigen as shown by its immunosensitivity and immunogenicity in tumor rejection experiments. Crude membrane and crude soluble antigen preparations obtained from RBL-3 cell membranes retained the capacity to induce tumor rejection.",,,,,
276611,NLM,MEDLINE,19780925,20190709,0022-2623 (Print) 0022-2623 (Linking),21,7,1978 Jul,Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity.,597-8,"['Bobek, M', 'Cheng, Y C', 'Bloch, A']","['Bobek M', 'Cheng YC', 'Bloch A']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med Chem,Journal of medicinal chemistry,9716531,IM,"['Animals', 'Antineoplastic Agents/*chemical synthesis/metabolism/therapeutic use', 'Cell Line', 'Cytarabine/*analogs & derivatives/chemical synthesis/metabolism/therapeutic use', 'Cytidine Deaminase/metabolism', 'Deamination', 'Humans', 'Leukemia L1210/drug therapy', 'Leukemia, Lymphoid/drug therapy/enzymology', 'Liver/enzymology', 'Mice']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1021/jm00205a001 [doi]'],ppublish,J Med Chem. 1978 Jul;21(7):597-8. doi: 10.1021/jm00205a001.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', 'EC 3.5.4.5 (Cytidine Deaminase)']",,,,,,
276591,NLM,MEDLINE,19780925,20190630,0022-3476 (Print) 0022-3476 (Linking),93,2,1978 Aug,Commentary: Significance of hand mirror cells.,335-6,"['Schumacher, H R', 'Stass, S A']","['Schumacher HR', 'Stass SA']",['eng'],['Journal Article'],United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Acute Disease', 'Animals', 'Bone Marrow/immunology/*pathology', 'Bone Marrow Cells', 'Female', 'Humans', 'Leukemia/*pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid, Acute/pathology', 'Prognosis', 'Rats']",1978/08/01 00:00,1978/08/01 00:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '1978/08/01 00:01 [medline]', '1978/08/01 00:00 [entrez]']","['S0022-3476(78)80583-6 [pii]', '10.1016/s0022-3476(78)80583-6 [doi]']",ppublish,J Pediatr. 1978 Aug;93(2):335-6. doi: 10.1016/s0022-3476(78)80583-6.,,,,,,,
276569,NLM,MEDLINE,19780915,20061115,0025-7044 (Print) 0025-7044 (Linking),47,12,1978 Jun,Splenic abscess in acute leukemia: report of two cases.,22-4,"['Smith, J F Jr', 'Omura, G A', 'Conrad, M E']","['Smith JF Jr', 'Omura GA', 'Conrad ME']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med Assoc State Ala,Journal of the Medical Association of the State of Alabama,7503083,IM,"['Abscess/*complications', 'Adult', 'Humans', 'Leukemia, Myeloid/*complications', 'Male', 'Middle Aged', 'Splenic Diseases/*complications']",1978/06/01 00:00,2001/03/28 10:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,J Med Assoc State Ala. 1978 Jun;47(12):22-4.,,,,,,,
276561,NLM,MEDLINE,19780915,20141120,0025-7850 (Print) 0025-7850 (Linking),9,1,1978,Kinetics of methotrexate uptake by human tumor cells from routine pathological samples.,43-52,"['Curtis, R Jr', 'Wingard, L B Jr', 'Ladoulis, C T']","['Curtis R Jr', 'Wingard LB Jr', 'Ladoulis CT']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med,Journal of medicine,7505566,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Female', 'Humans', 'In Vitro Techniques', 'Kinetics', 'Leukemia, Myeloid, Acute/*metabolism', 'Lymphocytes/metabolism', 'Lymphoma/*metabolism', 'Methotrexate/*metabolism', 'Ovarian Neoplasms/*metabolism', 'Palatine Tonsil/cytology']",1978/01/01 00:00,2001/03/28 10:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,J Med. 1978;9(1):43-52.,['YL5FZ2Y5U1 (Methotrexate)'],"The kinetics of cell uptake of methotrexate were measured in vitro using primary human tumor cells from malignant pleural effusions, leukemic cells from leukopheresis samples, and normal tonsillar lymphocytes. The results were consistent with either passive diffusion or carrier mediated uptake kinetics, with the latter applicable only under conditions where the extracellular concentration of methotrexate was smaller than the drug-transport receptor binding constant. The intial rates of uptake for the same cell type differed signicantly between patients; however no differences in uptake rates were noted between cell types. All three sources of cells proved suitable for uptake studies. The results suggest that the variation in response in normally methotrexate responsive neoplasms, such as leukemia or lymphoma, may be due to between-patient differences in the cellular rates of methotrexate uptake.",,,,,
276559,NLM,MEDLINE,19780915,20061115,0025-7850 (Print) 0025-7850 (Linking),9,1,1978,Preliminary report on radiation and heart disease.,3-15,"['Bross, I D', 'Ball, M', 'Rzepka, T', 'Laws, R E']","['Bross ID', 'Ball M', 'Rzepka T', 'Laws RE']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med,Journal of medicine,7505566,IM,"['Aged', 'Heart Diseases/*etiology', 'Humans', 'Leukemia, Radiation-Induced/etiology', 'Male', 'Models, Biological', 'Radiation Injuries/*etiology', 'Radiography/*adverse effects', 'Risk']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,J Med. 1978;9(1):3-15.,,"Using data from the Tri-State and a mathematical model, the hypothesis that low levels of diagnostic radiation can produce both leukemia and heart disease has been tested. The range of radiation considered is within a factor of 10 of 5 rads (0.5-50 rads). Even at the lowest levels, an estimated 5% of the persons exposed suffer damage to the DNA which is subsequently expressed as heart disease or leukemia. The risk of heart disease in an affected group is roughly tripled and there is a 10-fold increase in the risk of leukemia according to preliminary estimates.",,,,,
276528,NLM,MEDLINE,19780915,20210212,0021-9258 (Print) 0021-9258 (Linking),253,15,1978 Aug 10,Hemin control of heme biosynthesis in mouse Friend virus-transformed erythroleukemia cells in culture.,5402-6,"['Granick, J L', 'Sassa, S']","['Granick JL', 'Sassa S']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Biol Chem,The Journal of biological chemistry,2985121R,IM,"['Animals', '*Cell Transformation, Viral', 'Cells, Cultured', '*Friend murine leukemia virus', 'Heme/*analogs & derivatives/*biosynthesis', 'Hemin/*pharmacology', 'Hemoglobins/metabolism', 'Hydroxymethylbilane Synthase/metabolism', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Mice', 'Porphobilinogen Synthase/metabolism']",1978/08/10 00:00,1978/08/10 00:01,['1978/08/10 00:00'],"['1978/08/10 00:00 [pubmed]', '1978/08/10 00:01 [medline]', '1978/08/10 00:00 [entrez]']",['S0021-9258(17)30385-X [pii]'],ppublish,J Biol Chem. 1978 Aug 10;253(15):5402-6.,"['0 (Hemoglobins)', '42VZT0U6YR (Heme)', '743LRP9S7N (Hemin)', 'EC 2.5.1.61 (Hydroxymethylbilane Synthase)', 'EC 4.2.1.24 (Porphobilinogen Synthase)']","Hemin treatment of mouse Friend virus-transformed cells in cultured caused a dose-dependent increase in hemoglobin synthesis. By the addition of radioactively labeled hemin and by the analysis of the radioactive heme in hemoglobin, only 60 to 70% of heme in the newly synthesized hemoglobin was accounted for by the exogenously added hemin. In keeping with this finding, hemin treatment increased the activity of two enzymes in the heme biosynthetic activity, i.e. delta-aminolevulinate (ALA) dehydratase and uroporphyrinogen-I (URO) synthase in these cells. Incorporation of [2(-14C)]glycine, [14C]ALA, and 59Fe into heme was also significantly increased in the cells treated with hemin, suggesting that essentially all enzyme activities in the heme biosynethetic pathway were increased after hemin treatment. These results indicate that heme in the newly synthesized hemoglobin in hemin-treated Friend cells derives both from hemin added to the culture and from heme synthesized intracellularly. In addition, these results suggest that the stimulation of heme biosynthesis by hemin in Friend virus-transformed cells is in contrast to the hemin repression of heme biosynthesis in liver cells.",,,,,
276515,NLM,MEDLINE,19780930,20190722,0340-6717 (Print) 0340-6717 (Linking),43,1,1978 Jul 12,15/17 translocation in acute promyelocytic leukaemia.,115-7,"['Scheres, J M', 'Hustinx, T W', 'de Vaan, G A', 'Rutten, F J']","['Scheres JM', 'Hustinx TW', 'de Vaan GA', 'Rutten FJ']",['eng'],"['Case Reports', 'Journal Article']",Germany,Hum Genet,Human genetics,7613873,IM,"['Adolescent', 'Bone Marrow/ultrastructure', '*Chromosomes, Human, 13-15', '*Chromosomes, Human, 16-18', 'Humans', 'Leukemia, Myeloid, Acute/diagnosis/*genetics', 'Male', '*Translocation, Genetic']",1978/07/12 00:00,1978/07/12 00:01,['1978/07/12 00:00'],"['1978/07/12 00:00 [pubmed]', '1978/07/12 00:01 [medline]', '1978/07/12 00:00 [entrez]']",['10.1007/BF00396488 [doi]'],ppublish,Hum Genet. 1978 Jul 12;43(1):115-7. doi: 10.1007/BF00396488.,,"A translocation between a chromosome 15 and a chromosome 17 was found in the bone marrow of a 14-year-old boy who had clinical and laboratory symptoms of acute promyelocytic leukemia (APL). As far as we know, this is the sixth case of APL with 15/17 translocation to be reported in the literature. This observation gives further support to the hypothesis that there is an association between this chromosomal rearrangement and APL.",,,,,
276514,NLM,MEDLINE,19780915,20190722,0340-6717 (Print) 0340-6717 (Linking),42,2,1978 Jun 9,Reciprocal translocation and the Philadelphia chromosome.,163-70,"['Watt, J L', 'Page, B M']","['Watt JL', 'Page BM']",['eng'],['Journal Article'],Germany,Hum Genet,Human genetics,7613873,IM,"['Azure Stains', 'Chromosomes/ultrastructure', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Female', 'Heterochromatin', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics', 'Male', '*Translocation, Genetic']",1978/06/09 00:00,1978/06/09 00:01,['1978/06/09 00:00'],"['1978/06/09 00:00 [pubmed]', '1978/06/09 00:01 [medline]', '1978/06/09 00:00 [entrez]']",['10.1007/BF00283636 [doi]'],ppublish,Hum Genet. 1978 Jun 9;42(2):163-70. doi: 10.1007/BF00283636.,"['0 (Azure Stains)', '0 (Heterochromatin)']","We examined metaphases from three patients with chronic myeloid leukaemia and a typical Philadelphia chromosome with one chromosome 9 as the recipient to determine whether the 9q+22q- translocation is reciprocal. Good quality G-banded photographs of the chromosomes concerned were subjected to light absorption density analysis. This provided enlarged tracings corresponding to the relevant chromosome regions and so facilitated accurate measurement. This technique has unambiguously shown that the typical Philadelphia chromosome results from a reciprocal translocation and that probably no material is gained or lost in the exchange. Furthermorein a total of six patients for whom sequential G and C banding was performed, the chromosome 9 with the largest block of centromeric heterochromatin received the translocated material. We offer tentative explanations for this curious observation.",,,,,
276512,NLM,MEDLINE,19780929,20131121,0015-8178 (Print) 0015-8178 (Linking),96,31,1978 Aug 17,[Perthes disease after successfully treated acute juvenile lymphoblastic leukemia].,1569-71,"['Eckhardt, D', 'Kircher, E']","['Eckhardt D', 'Kircher E']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Fortschr Med,Fortschritte der Medizin,2984763R,IM,"['Child', 'Cortisone/adverse effects/therapeutic use', 'Diagnosis, Differential', 'Femur Head Necrosis/diagnosis', 'Humans', 'Legg-Calve-Perthes Disease/chemically induced/diagnosis/*etiology', 'Leukemia, Lymphoid/*complications/drug therapy', 'Male', 'Osteochondritis/*etiology']",1978/08/17 00:00,1978/08/17 00:01,['1978/08/17 00:00'],"['1978/08/17 00:00 [pubmed]', '1978/08/17 00:01 [medline]', '1978/08/17 00:00 [entrez]']",,ppublish,Fortschr Med. 1978 Aug 17;96(31):1569-71.,['V27W9254FZ (Cortisone)'],"The manifestation of Perthes disease after succesfully treated lymphoblastic leukemia is extremely rare. At the first signs of a femoral head necrosis--sonsidering the basic disease--and after cortisone treatment one has to think of a possible femoral head necrosis. It has been observed by several authors after long-term cortison therapy. The case of a 7 year old boy with Perthes disease after acute lymphatic leukemia is demonstrated. After treatment with chemotherapy, cortisone and radiation of the head he was free of pain for 2 years, then the Perthes disease became manifest with a deformed femural head. It could be cured but operation is necessary now or at the latest after termination of growth. In the case there seems to be no connexion between cortisone treatment and the manifestation of Perthes disease. It is more probable that this developed independently of the basic disease and its successful treatment because of the unilateral affection of the hip joint and the interval between treatment of leukemia and manifestion of the first symptoms of Perthes disease.",Morbus Perthes nach erfolgreich behandelter akuter Lymphoblasten-Leukamie im Kindesalter.,,,,
276510,NLM,MEDLINE,19780915,20071115,0017-6559 (Print) 0017-6559 (Linking),11,1-2,1977,Serum lysozyme activity in some myeloproliferative diseases.,111-4,"['Merkiel, K', 'Prokopowicz, J', 'Bielawiec, M', 'Kiersnowska, B']","['Merkiel K', 'Prokopowicz J', 'Bielawiec M', 'Kiersnowska B']",['eng'],['Journal Article'],Netherlands,Haematologia (Budap),Haematologia,0130266,IM,"['Humans', 'Leukemia, Lymphoid/diagnosis/enzymology', 'Leukemia, Myeloid/diagnosis/enzymology', 'Leukemia, Myeloid, Acute/diagnosis/enzymology', 'Muramidase/antagonists & inhibitors/*blood', 'Myeloproliferative Disorders/*enzymology', 'Pancytopenia/diagnosis/enzymology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Haematologia (Budap). 1977;11(1-2):111-4.,['EC 3.2.1.17 (Muramidase)'],"Serum lysozyme activity has been determined in patients suffering from myeloproliferative diseases, chronic myelogenous leukaemia (CML), acute myelogenous leukaemia (AML), chronic lymphatic leukaemia (CLL) and pancytopenia (P). Lysozyme activity was tested in undiluted and tenfold diluted sera. Increased lysozyme activity was found in patients with CML and CLI, whereas there was no change in patients with AML and P. Dilution of sera enhanced lysozyme activity. These data may indicate the presence of inhibitor in the sera tested. The diagnostic significance of the presented findings is discussed.",,,,,
276506,NLM,MEDLINE,19780915,20191007,0065-1214 (Print) 0065-1214 (Linking),23,,1977,[Acute myeloblastic leukemia in children].,635-42,"['Zisovski, N', 'Mladenovski, B', 'Sadikario, A']","['Zisovski N', 'Mladenovski B', 'Sadikario A']",['hrv'],"['English Abstract', 'Journal Article']",North Macedonia,God Zb Med Fak Skopje,Godisen zbornik na Medicinskiot fakultet vo Skopje,0414607,IM,"['Acute Disease', 'Adolescent', 'Antineoplastic Agents/*therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Retrospective Studies', 'Yugoslavia']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,God Zb Med Fak Skopje. 1977;23:635-42.,['0 (Antineoplastic Agents)'],,Akutne mijeloblasticne leukoze u dece.,,,,
276505,NLM,MEDLINE,19780915,20191007,0065-1214 (Print) 0065-1214 (Linking),23,,1977,[Acute leukoses in pregnancy].,607-12,"['Stojcevski, T', 'Nedelkovski, J', 'Siljanovski, N']","['Stojcevski T', 'Nedelkovski J', 'Siljanovski N']",['hrv'],"['English Abstract', 'Journal Article']",North Macedonia,God Zb Med Fak Skopje,Godisen zbornik na Medicinskiot fakultet vo Skopje,0414607,IM,"['Acute Disease', 'Adult', 'Female', 'Humans', '*Leukemia', 'Leukemia, Lymphoid', 'Leukemia, Myeloid, Acute', 'Pregnancy', '*Pregnancy Complications, Hematologic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,God Zb Med Fak Skopje. 1977;23:607-12.,,,Akutne leukoze u graviditetu.,,,,
276504,NLM,MEDLINE,19780929,20181113,0364-2356 (Print) 0364-2356 (Linking),3,1,1978 Apr 15,Necrotizing enterocolitis in acute leukemia: radiographic findings.,63-5,"['Archibald, R B', 'Nelson, J A']","['Archibald RB', 'Nelson JA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Gastrointest Radiol,Gastrointestinal radiology,7611134,IM,"['Acute Disease', 'Adult', 'Enterocolitis, Pseudomembranous/*diagnostic imaging/etiology/surgery', 'Humans', 'Intestine, Small/*diagnostic imaging/surgery', 'Leukemia, Lymphoid/*complications', 'Leukemia, Myeloid, Acute/*complications', 'Radiography']",1978/04/15 00:00,1978/04/15 00:01,['1978/04/15 00:00'],"['1978/04/15 00:00 [pubmed]', '1978/04/15 00:01 [medline]', '1978/04/15 00:00 [entrez]']",['10.1007/BF01887037 [doi]'],ppublish,Gastrointest Radiol. 1978 Apr 15;3(1):63-5. doi: 10.1007/BF01887037.,,"Acute gangrenous appendicitis or right lower quadrant necrotizing enterocolitis occurs with a high incidence in patients undergoing treatment for acute leukemia. In a series of 81 fully documented cases with complete charts and follow-up we identified seven surgically or pathologically proved cases of this syndrome. Plain radiographs of the abdomen were available in five of the seven cases, and a barium enema was performed on one. In three of the five cases the radiographic examination suggested or confirmed the nature of the right lower quadrant syndrome. Two of the seven patients were sucessfully treated by appropriate surgery. The radiographic findings in this series are reviewed and re-emphasized since an accurate diagnosis becomes important in appropriate management of this formerly uniformly fatal complication of acute leukemia and/or its therapy.",,,,,
276472,NLM,MEDLINE,19780930,20061115,0301-472X (Print) 0301-472X (Linking),6,6,1978 Jun,Production of mesenchymal tumors in nude mice by Ph1 negative fibroblasts obtained from a Ph 1 positive CML patient: a preliminary report.,549-57,"['Wilson, F D', 'Greenberg, B', 'Spangler, W', 'Shifrine, M', 'Gershwin, M E', 'Dyck, J']","['Wilson FD', 'Greenberg B', 'Spangler W', 'Shifrine M', 'Gershwin ME', 'Dyck J']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Exp Hematol,Experimental hematology,0402313,IM,"['Animals', 'Bone Marrow/pathology', 'Cells, Cultured', 'Chromosomes, Human, 21-22 and Y', 'Female', 'Fibroblasts/pathology/transplantation', '*Hematopoiesis', 'Humans', 'Leukemia, Myeloid/genetics/*pathology', 'Mice', 'Mice, Nude', 'Middle Aged', 'Models, Biological', 'Neoplasms, Experimental/*etiology/pathology', 'Transplantation, Heterologous']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Exp Hematol. 1978 Jun;6(6):549-57.,,"An experimental model system is presented for the investigation in humans of the role of hematopoietic stromal elements in the regulation of hematopoiesis as well as in the pathogenesis of myelofibrosis in myeloproliferative disorders. The model is based on the simultaneous application of three experimental techniques: (1) growth of bone-marrow derived fibroblastic colonies in vitro, (2) cytogenetic demonstration of marker chromosomes associated with hematopoietic malignancies, and (3) the transplantation of isolated stromal elements into athymic (nude) mice. Using this model, we describe the induction of mesenchymal tumors in nude mice by Ph1 negative fibroblasts obtained from the bone marrow of a patient with a Ph1 positive chronic myelogenous leukemia. Mesenchymal tumors also were induced in nude mice with bone marrow-derived fibroblasts from a patient with aplastic anemia, who was successfully treated with bone marrow transplantation, and from a normal human volunteer. Morphologic, cytogenetic and electron microscopic studies of bone marrow mesenchymal elements in culture and of tumors induced in nude mice from the CML patient indicate the cells composing the tumor are of human origin and are negative for the Ph1 chromosome. The results provide the first in vivo morphological and cytogenetic support using human materials, of the hypothesized relationship of progenitors of in vitro fibroblastic colonies to marrow stromal elements.",,,,,
276471,NLM,MEDLINE,19780930,20061115,0301-472X (Print) 0301-472X (Linking),6,6,1978 Jun,"Intramembranous particles in erythrocyte, reticulocyte and erythroblastic leukemic cells of the rat: a model system for erythrocyte maturation.",528-38,"['Bank, H L', 'Wise, C', 'Hargrove, K', 'Spicer, S S']","['Bank HL', 'Wise C', 'Hargrove K', 'Spicer SS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Exp Hematol,Experimental hematology,0402313,IM,"['Animals', 'Bone Marrow Cells', 'Erythroblasts/cytology/ultrastructure', 'Erythrocyte Aging', 'Erythrocyte Membrane/ultrastructure', 'Erythrocytes/cytology/physiology/*ultrastructure', 'Freeze Etching', 'Leukemia, Erythroblastic, Acute/pathology', 'Microscopy, Electron, Scanning', 'Models, Biological', 'Rats', 'Reticulocytes/cytology/ultrastructure']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Exp Hematol. 1978 Jun;6(6):528-38.,,"The density and size distribution of intramembranous particles (IMP) were determined for cells of the erythroid series. The number and size of IMP were measured on both fracture faces of erythroblastic leukemia cells, phenylhydrazine-induced reticulocytes and mature erythrocytes. We found that the number of IMP adhering to the protoplasmic fracture face of the plasma membrane increased with increasing maturation, while the number of particles adhering to the external fracture face did not correlate with maturational stage. In general, the mean size of particles adhering to both fracture faces decreased with increasing maturation after the erythroblastic stage. We interpret these results to mean that the IMP seen are derived from more than one macromolecular species and that they are distributed asymmetrically in the plasma membrane.",,,,,
276470,NLM,MEDLINE,19780925,20190813,0340-6199 (Print) 0340-6199 (Linking),127,4,1978 Apr 20,Serum lysozyme activity in children with acute leukemia.,263-8,"['Bratlid, D', 'Moe, P J']","['Bratlid D', 'Moe PJ']",['eng'],['Journal Article'],Germany,Eur J Pediatr,European journal of pediatrics,7603873,IM,"['Acute Disease', 'Child', 'Humans', 'Leukemia/*enzymology', 'Leukemia, Lymphoid/enzymology', 'Leukemia, Myeloid/enzymology', 'Leukemia, Myeloid, Acute/enzymology', 'Muramidase/*blood', 'Remission, Spontaneous']",1978/04/20 00:00,1978/04/20 00:01,['1978/04/20 00:00'],"['1978/04/20 00:00 [pubmed]', '1978/04/20 00:01 [medline]', '1978/04/20 00:00 [entrez]']",['10.1007/BF00493542 [doi]'],ppublish,Eur J Pediatr. 1978 Apr 20;127(4):263-8. doi: 10.1007/BF00493542.,['EC 3.2.1.17 (Muramidase)'],"Serum lysozyme activity was measured in samples from children with acute leukemia, malignant tumours, and in normal children. All children with acute lymphatic leukemia (ALL) had significantly reduced levels of lysozyme at diagnosis, and none of the children fell within the normal range. Children with ALL in complete remission had lysozyme levels comparable to normal chidren, while children with ALL in relapse also had pathological low levels. Children with ALL in remission and off therapy also had normal levels of lysozyme. Children with acute myelogenous leukemia had normal lysozyme levels, while children with monomyelocytic leukemia had substantially elevated lysozyme levels before treatment. Determination of serum lysozyme activity in children with acute leukemia is of value both for diagnosis and for evaluating the effect of therapy.",,,,,
276469,NLM,MEDLINE,19780925,20190813,0340-6199 (Print) 0340-6199 (Linking),127,4,1978 Apr 20,Cranial computerized tomography in children with lymphoid malignancy and seizures.,255-62,"['Schwenk, H U', 'Neuhauser, G', 'Huk, W']","['Schwenk HU', 'Neuhauser G', 'Huk W']",['eng'],"['Case Reports', 'Journal Article']",Germany,Eur J Pediatr,European journal of pediatrics,7603873,IM,"['Adolescent', 'Atrophy', 'Brain/pathology', 'Brain Neoplasms/complications', 'Cerebral Hemorrhage/complications/etiology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/complications/*diagnostic imaging', 'Lymphoma/complications/*diagnostic imaging', 'Male', 'Neoplasm Metastasis', 'Radionuclide Imaging', 'Seizures/*diagnostic imaging/etiology', 'Tomography, X-Ray Computed']",1978/04/20 00:00,1978/04/20 00:01,['1978/04/20 00:00'],"['1978/04/20 00:00 [pubmed]', '1978/04/20 00:01 [medline]', '1978/04/20 00:00 [entrez]']",['10.1007/BF00493541 [doi]'],ppublish,Eur J Pediatr. 1978 Apr 20;127(4):255-62. doi: 10.1007/BF00493541.,,"Focal and generalized seizures occurred in 4 patients with acute lymphoblastic leukemia and non-Hodgkin-lymphoma. The etiology of the neurological complications could be established by cranial computerized tomography (CT): i.e., 1. localized metastasis with calcification and 2. acute intracerebral hemorrhage during induction therapy in two patients with malignant lymphomas; 3. diffuse cerebral infiltration with blast cells and 4. cerebral atrophy in two children with acute lymphoblastic leukemia who were in relapse. Accurate diagnosis of cerebral complications in hemoblastoses is essential for appropriate therapy and CT may lead to more effective treatment in patients with lymphoid malignancy and seizures.",,,,,
276447,NLM,MEDLINE,19780929,20180216,0009-3157 (Print) 0009-3157 (Linking),24,5,1978,Chronic granulocytic leukemia cutis treated with hydroxyurea. Report of a case.,321-6,"['Friedhoff, F W', 'Atamer, M A', 'Thelmo, W L']","['Friedhoff FW', 'Atamer MA', 'Thelmo WL']",['eng'],"['Case Reports', 'Journal Article']",Switzerland,Chemotherapy,Chemotherapy,0144731,IM,"['Female', 'Humans', 'Hydroxyurea/*therapeutic use', 'Leukemia, Myeloid/complications/*drug therapy/pathology', 'Middle Aged', 'Primary Myelofibrosis/complications/*drug therapy/pathology', 'Punctures', 'Skin Diseases/*etiology/pathology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1159/000237799 [doi]'],ppublish,Chemotherapy. 1978;24(5):321-6. doi: 10.1159/000237799.,['X6Q56QN5QC (Hydroxyurea)'],"The clinical course of a patient with chronic granulocytic leukemia cutis associated with myeloid metaplasia is described. Cutaneous manifestations of leukemia appeared only at the sites of bone marrow aspiration and vena puncture. Radiotherapy to both spleen and skin and chemotherapy with busulfan failed to control spreading cutaneous lesions. Treatment with hydroxyurea was followed by a marked reduction in spleen size, a decrease in white cell count and healing of the skin lesions.",,,,,
276432,NLM,MEDLINE,19780925,20170214,0009-9228 (Print) 0009-9228 (Linking),17,8,1978 Aug,Skin ulceration due to faulty adriamycin administration.,663-4,"['Mehta, P', 'Najar, N']","['Mehta P', 'Najar N']",['eng'],"['Case Reports', 'Journal Article']",United States,Clin Pediatr (Phila),Clinical pediatrics,0372606,IM,"['Adolescent', 'Antineoplastic Agents/administration & dosage', 'Doxorubicin/administration & dosage/*adverse effects', 'Drug Therapy, Combination', 'Humans', 'Injections, Intravenous/adverse effects', 'Leukemia, Myeloid/drug therapy', 'Male', 'Skin Ulcer/*chemically induced']",1978/08/01 00:00,1978/08/01 00:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '1978/08/01 00:01 [medline]', '1978/08/01 00:00 [entrez]']",['10.1177/000992287801700813 [doi]'],ppublish,Clin Pediatr (Phila). 1978 Aug;17(8):663-4. doi: 10.1177/000992287801700813.,"['0 (Antineoplastic Agents)', '80168379AG (Doxorubicin)']",,,,,,
276431,NLM,MEDLINE,19780925,20181113,0009-9104 (Print) 0009-9104 (Linking),32,2,1978 May,Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.,253-8,"['Chapuis, B J', 'Powles, R', 'Alexander, P']","['Chapuis BJ', 'Powles R', 'Alexander P']",['eng'],['Journal Article'],England,Clin Exp Immunol,Clinical and experimental immunology,0057202,IM,"['Adult', 'Aged', 'Antibodies/*analysis', 'Cytotoxicity, Immunologic', 'Female', 'Humans', 'Immunotherapy', 'Leukemia, Myeloid, Acute/*immunology/therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Clin Exp Immunol. 1978 May;32(2):253-8.,['0 (Antibodies)'],"The sera from seven patients with acute myelogenous leukaemia (AML) who had achieved a clinical remission and who were being maintained by weekly immunotherapy using irradiated allogeneic AML cells and BCG, were examined for the presence of antibodies which were lytic to autologous AML cells using either a complement- or cell-dependent assay. The AML cells had been stored at --179 degrees C and put into a short-term tissue culture prior to testing. At no time during the period of remission or relapse could cytotoxic activity to the autologous cells be detected, although all of the sera had lytic antibodies for some allogenic leukaemia cells. We concluded that the patients were capable of raising lytic antibodies to histocompatibility antigens but did not raise comparable lytic antibodies directed against a leukaemia-specific membrane antigen.",,PMC1541284,,,
276420,NLM,MEDLINE,19780925,20141120,0008-5472 (Print) 0008-5472 (Linking),38,8,1978 Aug,Effects of glucocorticoids on the interaction of lymphoblastoid cells with human endothelial cells in vitro.,2224-8,"['Maca, R D', 'Fry, G L', 'Hakes, A D']","['Maca RD', 'Fry GL', 'Hakes AD']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Blood Vessels/cytology', 'Cell Adhesion/*drug effects', 'Cell Line', 'Colchicine/pharmacology', 'Dexamethasone/*pharmacology', 'Endothelium/cytology/*drug effects', 'Humans', 'Hydrocortisone/*pharmacology', 'In Vitro Techniques', 'Leukemia, Lymphoid/*pathology', 'Lymphoma/pathology', 'Neoplasm Metastasis', 'Neoplasms, Experimental/pathology', 'Neoplastic Cells, Circulating', 'Neuraminidase/pharmacology', 'Pronase/pharmacology', 'Vinblastine/pharmacology']",1978/08/01 00:00,1978/08/01 00:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '1978/08/01 00:01 [medline]', '1978/08/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Aug;38(8):2224-8.,"['5V9KLZ54CY (Vinblastine)', '7S5I7G3JQL (Dexamethasone)', 'EC 3.2.1.18 (Neuraminidase)', 'EC 3.4.24.- (Pronase)', 'SML2Y3J35T (Colchicine)', 'WI4X0X7BPJ (Hydrocortisone)']","The adhesive characteristics of cultured acute lymphocytic leukemia cells (CCRF-CEM), lymphoma cells (Raji), and freshly isolated acute lymphocytic leukemia cells to human cultured endothelial cells were studied. An assay system was used whereby these neoplastic cells were allowed to interact with endothelial cells while being continuously agitated on a rocking platform. All cell lines adhered significantly to the endothelium monolayers. This process appeared not to be dependent upon intact microtubular or microfilament function. Likewise, removing surface sialic acid from either cell type did not alter this process. In contrast incubating the endothelial cells for 24 or 48 hr with dexamethasone decreased adhesiveness of either CCRF-CEM or Raji cells to the endothelial cells by approximately 40%. Incubating these cells with hydrocortisone instead of dexamethasone for 48 hr was equally as effective in altering the endothelial cell adhesiveness. The decreased adhesiveness could be blocked by cycloheximide, indicating that this altered adhesiveness of the endothelial cells involves protein synthesis, presumably of a surface protein. We suggest that this assay system may provide a means to evaluate other agents that can alter the surface characteristics of endothelial cells, which may have important implications in various disease states such as inflammation, thrombogenesis, and metastatic disease.",,,,,
276418,NLM,MEDLINE,19780915,20211203,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,The changing survivorship of white and black children with leukemia.,59-66,"['Szklo, M', 'Gordis, L', 'Tonascia, J', 'Kaplan, E']","['Szklo M', 'Gordis L', 'Tonascia J', 'Kaplan E']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Acute Disease', 'Adolescent', 'Adult', '*Blacks', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia/*mortality', 'Leukemia, Lymphoid/*mortality', 'Male', 'Maryland', 'Socioeconomic Factors', 'Time Factors', '*Whites']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<59::aid-cncr2820420109>3.0.co;2-j [doi]'],ppublish,Cancer. 1978 Jul;42(1):59-66. doi: 10.1002/1097-0142(197807)42:1<59::aid-cncr2820420109>3.0.co;2-j.,,"A study was conducted in metropolitan Baltimore to examine changes in survival of white and black children with acute leukemia from 1960 through 1975. Two-hundred eighty-seven cases were identified, of which 77% were acute lymphocytic leukemia (ALL). Eighty-three percent of all cases occurred in white children. In white children with ALL, two-year survival rates increased from 32% in 1960--64 to 47% in 1965--69, and to 79% in 1970--75 (p less than .005). In the small sample of black children with ALL, two-year survival rates increased from 25% in 1960--64 to 59% in 1965--69 (p less than .01), with no further increase in 1970--75. For acute nonlymphocytic leukemia (ANLL), survivorship was analyzed in white children, among whom one-year survival rates increased from 42% in 1965--69 to 71% in 1970--75 (p less than .005). The increasingly better survival over time of white children with acute leukemia probably reflects the increasing efficacy of new therapeutic approaches.",,,,,
276417,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia.,53-8,"['Eden, O B', 'Goldie, W', 'Wood, T', 'Etcubanas, E']","['Eden OB', 'Goldie W', 'Wood T', 'Etcubanas E']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Brain Neoplasms/prevention & control', 'Child, Preschool', 'Cytarabine/administration & dosage/*adverse effects', 'Female', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/diagnostic imaging/*drug therapy', 'Methotrexate/therapeutic use', 'Radiography', 'Seizures/*chemically induced', 'Seizures, Febrile/*chemically induced', 'Time Factors']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<53::aid-cncr2820420108>3.0.co;2-3 [doi]'],ppublish,Cancer. 1978 Jul;42(1):53-8. doi: 10.1002/1097-0142(197807)42:1<53::aid-cncr2820420108>3.0.co;2-3.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']",Two young children (3 1/2 years and 19 months) developed seizures within 24 hours of receiving intrathecal cytosine arabinoside. Both had previously received intrathecal cytosine and methotrexate as well as cranial irradiation without untoward effect. Possible mechanisms of causation are discussed and caution is stressed for use of intrathecal cytosine arabinoside in young children.,,,,,
276416,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood.,305-10,"['Meyer, R J', 'Cuttner, J']","['Meyer RJ', 'Cuttner J']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Antineoplastic Agents/therapeutic use', 'Centrifugation', 'Child', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid/blood/*diagnosis/therapy', 'Leukocyte Count', 'Male', 'Meningeal Neoplasms/blood/*diagnosis/therapy', 'Retinal Diseases/diagnosis', 'Time Factors']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<305::aid-cncr2820420146>3.0.co;2-n [doi]'],ppublish,Cancer. 1978 Jul;42(1):305-10. doi: 10.1002/1097-0142(197807)42:1<305::aid-cncr2820420146>3.0.co;2-n.,['0 (Antineoplastic Agents)'],With the advent of more effective chemotherapy an increasing incidence of central nervous system involvement in acute lymphocyte (ALL) and myelocytic leukemias (AML) and chronic myelocytic leukemia (CML) in blast crisis has become evident. Meningeal involvement in the chronic phase of CML is rare. We report two children whose initial presentation of Ph1 CML was in the central nervous system as documented by cytocentrifugation. Aggressive combination chemotherapy and cranial irradiation has resulted in prolonged survival without blastic transformation or further meningeal disease. An approach to children with CML is suggested.,,,,,
276415,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study.,229-42,"['Vardiman, J W', 'Golomb, H M', 'Rowley, J D', 'Variakojis, D']","['Vardiman JW', 'Golomb HM', 'Rowley JD', 'Variakojis D']",['eng'],"['Comparative Study', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Aged', 'Bone Marrow/metabolism/pathology', 'Erythrocytes, Abnormal/pathology', 'Female', 'Hodgkin Disease/*pathology/therapy', 'Humans', 'Leukemia, Erythroblastic, Acute/*pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Lymphoma, Non-Hodgkin/*pathology/therapy', 'Male', 'Middle Aged', 'Neoplasms, Multiple Primary/*pathology', 'Preleukemia/blood/*pathology', 'Reticulin/metabolism', 'Time Factors']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<229::aid-cncr2820420137>3.0.co;2-a [doi]'],ppublish,Cancer. 1978 Jul;42(1):229-42. doi: 10.1002/1097-0142(197807)42:1<229::aid-cncr2820420137>3.0.co;2-a.,['0 (Reticulin)'],,,,,,
276414,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Effects of ultraviolet light on nude mice: cutaneous carcinogenesis and possible leukemogenesis.,182-8,"['Eaton, G J', 'Custer, R P', 'Crane, A R']","['Eaton GJ', 'Custer RP', 'Crane AR']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Animals', 'Carcinoma, Squamous Cell/*etiology/pathology', 'Female', 'Granulocytes/pathology', 'Leukemia, Myeloid/etiology', 'Leukemia, Radiation-Induced/*etiology/pathology', 'Male', 'Mice', 'Mice, Nude', 'Neoplasm Transplantation', 'Neoplasms, Experimental/etiology', 'Neoplasms, Radiation-Induced/*etiology/pathology', 'Skin Neoplasms/*etiology/pathology', 'Transplantation, Isogeneic', 'Ultraviolet Rays/*adverse effects']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<182::aid-cncr2820420130>3.0.co;2-c [doi]'],ppublish,Cancer. 1978 Jul;42(1):182-8. doi: 10.1002/1097-0142(197807)42:1<182::aid-cncr2820420130>3.0.co;2-c.,,Squamous cell carcinomas were induced by ultraviolet irradiation in the skin of all T-cell deficient nude mice rendered sufficiently long-lived by reconstitution with syngeneic splenic or thymic cells. All homozygous hairless mice similarly exposed developed squamous cell carcinomas. Striking granulocytic proliferation was provoked in one hairless and in five reconstituted nude mice; two of the latter were interpreted as having true granulocytic leukemia.,,,,,
276413,NLM,MEDLINE,19780915,20211203,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia.,167-70,"['Ritch, P S', 'McCredie, K B', 'Gutterman, J U', 'Hersh, E M']","['Ritch PS', 'McCredie KB', 'Gutterman JU', 'Hersh EM']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Aged', 'BCG Vaccine/administration & dosage/*adverse effects', 'Humans', 'Immunosuppression Therapy', 'Leukemia, Myeloid, Acute/complications/immunology/*therapy', 'Male', 'Mycobacterium Infections, Nontuberculous/complications/etiology', 'Tuberculosis/complications/*etiology']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<167::aid-cncr2820420128>3.0.co;2-d [doi]'],ppublish,Cancer. 1978 Jul;42(1):167-70. doi: 10.1002/1097-0142(197807)42:1<167::aid-cncr2820420128>3.0.co;2-d.,['0 (BCG Vaccine)'],"Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.",,,,,
276412,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,Immunologic dysfunction in the myeloproliferative disorders.,149-58,"['DiBella, N J', 'Brown, G L']","['DiBella NJ', 'Brown GL']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adult', 'Aged', 'Complement C3/analysis', 'Female', 'Hemoglobinuria, Paroxysmal/immunology', 'Humans', '*Immunity', 'Immunoglobulins/analysis', 'In Vitro Techniques', 'Lectins/pharmacology', 'Leukemia, Myeloid/immunology', 'Lymphocyte Activation', 'Lymphocytes/immunology', 'Male', 'Middle Aged', 'Mitogens/pharmacology', 'Myeloproliferative Disorders/*immunology', 'Polycythemia Vera/immunology', 'Preleukemia/immunology', 'Primary Myelofibrosis/immunology', 'Skin Tests', 'Thrombocytosis/immunology']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<149::aid-cncr2820420125>3.0.co;2-i [doi]'],ppublish,Cancer. 1978 Jul;42(1):149-58. doi: 10.1002/1097-0142(197807)42:1<149::aid-cncr2820420125>3.0.co;2-i.,"['0 (Complement C3)', '0 (Immunoglobulins)', '0 (Lectins)', '0 (Mitogens)']","Forty patients with various types of myeloproliferative disorders were evaluated immunologically. Serum immunoglobulin levels were within the normal range in most patients and no monoclonal gammopathies were detected. Serum C'3 levels were decreased in 19 of 40 (48%) patients. The response of peripheral blood lymphocytes to phytohemagglutinin was decreased in 26 of 40 (65%) and to pokeweed mitogen in 18 of 28 (64%) patients studied. Lymphocytes from patients with polycythemia vera were least affected. Unstimulated lymphocytes from some patients demonstrated markedly increased thymidine uptake activity. Despite the diminished mitogenic response, only 2 of 33 patients (6%) were anergic by intradermal skin testing. There was no association between depressed lymphocyte response and recent chemotherapy except in chronic myelogenous leukemia where 6 of 8 patients were receiving cytotoxic therapy when studied. These observations suggest that most of our patients with myeloproliferative disorders have abnormal cellular responses in vitro, but that delayed hypersensitivity and humoral responses are minimally affected.",,,,,
276411,NLM,MEDLINE,19780915,20190619,0008-543X (Print) 0008-543X (Linking),42,1,1978 Jul,I and i antigens on normal and leukemic leukocytes.,140-8,"['Moore, J O', 'Logue, G L']","['Moore JO', 'Logue GL']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Antibodies', 'Antigens/*analysis', 'Antigens, Neoplasm/*analysis', 'Cold Temperature', 'Female', 'Fetus/immunology', 'Humans', 'Immunoglobulin M', 'Leukemia/*immunology', 'Leukemia, Hairy Cell/immunology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid, Acute/immunology', 'Leukocytes/*immunology', 'Lymphocytes/immunology', 'Male']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1002/1097-0142(197807)42:1<140::aid-cncr2820420124>3.0.co;2-b [doi]'],ppublish,Cancer. 1978 Jul;42(1):140-8. doi: 10.1002/1097-0142(197807)42:1<140::aid-cncr2820420124>3.0.co;2-b.,"['0 (Antibodies)', '0 (Antigens)', '0 (Antigens, Neoplasm)', '0 (Immunoglobulin M)']",Human leukocyte I and i antigens were quantitated using 125I labelled purified antibodies. Binding of these antibodies to leukocytes was dependent on reduced temperature. No significant difference in antigen content was observed between normal and leukemic myeloid leukocytes. B lymphocytes bound much greater amounts of both I and i antibodies than did T lymphocytes. Neoplastic lymphoid cells bound widely divergent amounts of both antibodies with chronic lymphocytic leukemia and lymphosarcoma cell leukemia cells binding much decreased amounts compared to normal lymphocytes. Cells from patients with hairy cell leukemia bound very large quantities of these antibodies in a cold dependent fashion. These elevated levels of binding were not due to nonspecific binding of IgM.,,,,,
276410,NLM,MEDLINE,19780925,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6130,1978 Jul 8,Bone-marrow relapse in acute lymphoblastic leukaemia in childhood.,104-6,"['Cornbleet, M A', 'Chessells, J M']","['Cornbleet MA', 'Chessells JM']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Acute Disease', 'Bone Marrow/*pathology', 'Child', 'Humans', 'Leukemia, Lymphoid/*diagnosis/drug therapy/pathology', 'Prognosis', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1978/07/08 00:00,1978/07/08 00:01,['1978/07/08 00:00'],"['1978/07/08 00:00 [pubmed]', '1978/07/08 00:01 [medline]', '1978/07/08 00:00 [entrez]']",['10.1136/bmj.2.6130.104 [doi]'],ppublish,Br Med J. 1978 Jul 8;2(6130):104-6. doi: 10.1136/bmj.2.6130.104.,,"The outcome after bone-marrow relapse was assessed in 53 children with acute lymphoblastic leukaemia (ALL). Twenty-five out of 37 children (67%) whose first remission ended in relapse during treatment (group A) achieved a second remission, as did 15 out of 16 (94%) who relapsed after treatment had been stopped (group B). Nevertheless, the median duration of second remission was only 12 weeks in group A and 35 weeks in group B. The median survival from time of relapse was 32 weeks in group A and 75 weeks in group B. It is concluded that marrow relapse is equally serious whether it occurs during treatment or after treatment has been stopped, and that most children with ALL have a single chance of cure at the time of diagnosis.",,PMC1605904,,,
276388,NLM,MEDLINE,19780929,20210216,0006-4971 (Print) 0006-4971 (Linking),52,2,1978 Aug,Acute lymphoblastic leukemia and complement receptors.,467,"['Richie, E', 'Culbert, S', 'Sullivan, M P', 'Van Eys, J']","['Richie E', 'Culbert S', 'Sullivan MP', 'Van Eys J']",['eng'],['Letter'],United States,Blood,Blood,7603509,IM,"['*Binding Sites, Antibody', 'Child', 'Child, Preschool', '*Complement System Proteins', 'Female', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Lymphocytes/*immunology', 'Male']",1978/08/01 00:00,1978/08/01 00:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '1978/08/01 00:01 [medline]', '1978/08/01 00:00 [entrez]']",['S0006-4971(20)68290-8 [pii]'],ppublish,Blood. 1978 Aug;52(2):467.,['9007-36-7 (Complement System Proteins)'],,,,,,
276387,NLM,MEDLINE,19780929,20210216,0006-4971 (Print) 0006-4971 (Linking),52,2,1978 Aug,Cellular maturation in human preleukemia.,355-61,"['Koeffler, H P', 'Golde, D W']","['Koeffler HP', 'Golde DW']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adult', 'Aged', 'Bone Marrow/*pathology', 'Cell Division', 'Cells, Cultured', 'Chromosomes, Human, 6-12 and X', 'Clone Cells', 'Female', 'Hematopoietic Stem Cells/pathology', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid, Acute/pathology', 'Male', 'Preleukemia/*pathology', 'Trisomy']",1978/08/01 00:00,1978/08/01 00:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '1978/08/01 00:01 [medline]', '1978/08/01 00:00 [entrez]']",['S0006-4971(20)68281-7 [pii]'],ppublish,Blood. 1978 Aug;52(2):355-61.,,"Bone marrow cells from three preleukemic patients with prominent marrow karyotypic abnormalities were studied in liquid culture to determine if the neoplastic clones were capable of maturation. Parallel cytogenetic and cytologic studies were performed in sequentially harvested bone marrow cultures. Maturation, albeit delayed, occurred in cultures from all three patients. By 14 days of culture in vitro, morphologic, cytochemical, and functional evidence of maturation was observed in about 70% of the cells. By day 21, 85% of the cells were mature by these criteria. All but 2 of 249 metaphases from the cultured cells contained the cytogenetic abnormality of the neoplastic clone. We conclude that some preleukemic cells identified by a chromosomal abnormality can mature in vitro. Preleukemia may be viewed as a syndrome of ""early leukemia"" in which the neoplastic clone is established and manifested functionally as ineffective hematopoiesis. Hematopoietic cell differentiation becomes progressively abnormal with termination in the nearly complete maturational block characteristic of acute myelogenous leukemia.",,,,,
276386,NLM,MEDLINE,19780929,20210216,0006-4971 (Print) 0006-4971 (Linking),52,2,1978 Aug,Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity.,272-80,"['Testa, J R', 'Golomb, H M', 'Rowley, J D', 'Vardiman, J W', 'Sweet, D L Jr']","['Testa JR', 'Golomb HM', 'Rowley JD', 'Vardiman JW', 'Sweet DL Jr']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adult', 'Bone Marrow/ultrastructure', '*Chromosomes, Human, 13-15', '*Chromosomes, Human, 16-18', 'Cytoplasmic Granules/ultrastructure', 'Disseminated Intravascular Coagulation/complications', 'Humans', 'Karyotyping', '*Leukemia, Myeloid, Acute/complications/genetics/ultrastructure', 'Male', '*Translocation, Genetic']",1978/08/01 00:00,2001/03/28 10:01,['1978/08/01 00:00'],"['1978/08/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/08/01 00:00 [entrez]']",['S0006-4971(20)68271-4 [pii]'],ppublish,Blood. 1978 Aug;52(2):272-80.,,"Cytogenetic and ultrastructural findings were important diagnostic indicators of hypergranular promyelocytic leukemia (APL) in a patient whose bone marrow morphology appeared, by light microscopy, to be similar to that in acute myeloblastic leukemia (AML) with maturation. Peripheral blood smears and bone marrow specimens examined by light microscopy showed few cells with the numerous coarse, azurophilic granules typical of APL. Cytogenetic analyses, with several banding techniques, of cells from bone marrow and unstimulated peripheral blood revealed the 15;17 translocation, which has been observed only in APL. A reinterpretation of the reciprocal translocation, based on R banding, suggests that the breakpoints are distal to q24 in No. 15 and at or near the junction of q21 and q22 in No. 17. In addition, the patient had disseminated intravascular coagulation. The characteristic morphology of granules seen in APL was observed in this case only when transmission electron microscopy was used, since the granules were quite small. Since treatment for AML differs from that for APL, identification of the 15;17 translocation and ultrastructural evidence of granules represent valuable diagnostic aids for APL.",,,,,
276385,NLM,MEDLINE,19780915,20131121,0365-9615 (Print) 0365-9615 (Linking),85,3,1978 Mar,[Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].,340-3,"['Bukhman, V M', 'Lichinitser, M R', 'Svet-Moldavskii, G Ia', 'Mkheidze, D M']","['Bukhman VM', 'Lichinitser MR', 'Svet-Moldavskii GIa', 'Mkheidze DM']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Biull Eksp Biol Med,Biulleten' eksperimental'noi biologii i meditsiny,0370627,IM,"['Administration, Oral', 'Animals', 'Cytarabine/*administration & dosage/therapeutic use', 'Deoxycytidine/*administration & dosage/therapeutic use', 'Drug Evaluation', 'Drug Therapy, Combination', 'Injections, Intraperitoneal', 'Leukemia L1210/*drug therapy', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Mice']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Biull Eksp Biol Med. 1978 Mar;85(3):340-3.,"['04079A1RDZ (Cytarabine)', '0W860991D6 (Deoxycytidine)']",Oral administration of deoxycytidine simultaneously with intraperitoneal injections of toxic doses of cytosine arabinosidetomice with advanced L1210 leukemia diminished the toxic effects preventing drug death of these mice. They developed a marked antitumor effect. The mean survival time of these mice was considerably extended as compared to that of untreated animals or those given one of these drugs alone. At the optimum schedule of treatment about 23% of the mice survived over 60 days. Deoxycytidine protection reduced the antileukemic effect of cytosine arabinoside administered in nontoxic doses. The deoxycytidine plus cytosine arabinose combination was ineffective in the treatment of transplantable myeloid leukemia in mice.,Selektivnaia terapiia leikemii L1210 kombinatsiei dezoksitsitidina i letal'nykh doz tsitozin-arabinozida.,,,,
276384,NLM,MEDLINE,19780929,20071115,0300-0893 (Print) 0300-0893 (Linking),29,2,1978 Apr,Modifications of lectin binding on human leukemic cells after neuraminidase treatment.,75-9,"['Sharif, A', 'Pico, J L', 'Choquet, C', 'Rosenfeld, C', 'Bourrillon, R']","['Sharif A', 'Pico JL', 'Choquet C', 'Rosenfeld C', 'Bourrillon R']",['eng'],"['Comparative Study', 'Journal Article']",France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Binding Sites/drug effects', 'Cell Membrane/metabolism', 'Concanavalin A/metabolism', 'Humans', 'Lectins/*metabolism', 'Leukemia, Lymphoid/metabolism', 'Leukocytes/*drug effects/metabolism', 'Neuraminidase/*pharmacology', 'Plant Lectins', 'Plants, Toxic', 'Receptors, Drug/*drug effects', 'Ricinus', 'Sialic Acids/metabolism']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Biomedicine. 1978 Apr;29(2):75-9.,"['0 (Lectins)', '0 (Plant Lectins)', '0 (Receptors, Drug)', '0 (Sialic Acids)', '11028-71-0 (Concanavalin A)', 'EC 3.2.1.18 (Neuraminidase)']","Cell surface modifications after vibrio cholerae neuraminidase treatment were investigated using three different tritiated lectins: Concanavalin A, Ricinus sanguineus agglutinin (R.S.A.) and Robinia pseudoacacia lectin. Lectin binding measurements were performed on untreated and enzyme treated cells. The cells used were from chronic and acute leukemic donors. After neuraminidase treatment, a significant increase in the number of receptor sites, from 1 to 3 times, was found in all cases tested and for all three lectins utilized with only one exception. The affinity constant was generally decreased after neuraminidase treatment. The increase in number lectin binding sites, indicating extensive modification of the cell surface, is completely consistant with the known importance of sialic acid in determining immunogenicity.",,,,,
276383,NLM,MEDLINE,19780925,20071115,0300-0893 (Print) 0300-0893 (Linking),29,1,1978 Feb,Immunological rebound following cessation of chemotherapy in 15 acute lymphoid leukemia patients in complete remission.,11-3,"['De Rossi, G', 'Tribalto, M', 'Monarca, B', 'Bolle, C', 'Pasqualetti, D', 'Mandelli, F']","['De Rossi G', 'Tribalto M', 'Monarca B', 'Bolle C', 'Pasqualetti D', 'Mandelli F']",['eng'],['Journal Article'],France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Antineoplastic Agents/therapeutic use', 'Bone Marrow Cells', 'Child', 'Follow-Up Studies', 'Humans', 'Immunoglobulins/analysis', 'Leukemia, Lymphoid/drug therapy/*immunology', 'Leukocyte Count', '*Lymphocytes/immunology', 'Remission, Spontaneous', 'Rosette Formation']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Biomedicine. 1978 Feb;29(1):11-3.,"['0 (Antineoplastic Agents)', '0 (Immunoglobulins)']","The number of blood and bone marrow lymphocytes, the E-rosette forming cells, the Ig-bearing lymphocytes, the serum immunoglobulin levels were evaluated after discontinuation of 36 months of chemotherapy in 15 acute lymphocytic leukemia patients in complete remission. The study provides further information on the immunological rebound during the ""off-therapy"" period.",,,,,
276382,NLM,MEDLINE,19780925,20071115,0300-0893 (Print) 0300-0893 (Linking),28,2,1978 May,BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.,96-104,"['Miale, T D', 'Yocum, D', 'Yocum, C']","['Miale TD', 'Yocum D', 'Yocum C']",['eng'],['Journal Article'],France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Adolescent', 'BCG Vaccine/*therapeutic use', 'Child', 'Child, Preschool', 'Follow-Up Studies', 'Humans', 'Immunotherapy', 'Intradermal Tests', 'Lectins', 'Leukemia, Lymphoid/*therapy', 'Leukocyte Count', 'Lymphocytes/immunology', 'Phagocytosis', 'Remission, Spontaneous', 'Rosette Formation']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Biomedicine. 1978 May;28(2):96-104.,"['0 (BCG Vaccine)', '0 (Lectins)']","Currently at the University of Florida, 22/45 children and adolescents are long-term survivors in complete sustained remission of standard chemotherapy regimens and central nervous system prophylaxis. All such therapy was discontinued in these survivors at 36 months after diagnosis and they were given monthly inoculations of BCG of the Tice strain by tine technique. 19/22 of BCG-treated patients remain in remission for 12 to 44 + months after cessation of chemotherapy. 1/22 has suffered relapse. Immunological function tests have shown statistically significant increased lymphocyte responses to PPD in contrast to age-matched controls and normal siblings. A trend to earlier than expected return to normal in other immunological parameters, including absolute lymphocyte counts, intradermal skin tests, phagocytosis indices, PHA transformation, and E-rosette forming cells was also observed, coincident with the BCG treatment. Further study of the role of BCG in acute lymphoblastic leukemia patients after cessation of chemotherapy is encouraged.",,,,,
276381,NLM,MEDLINE,19780929,20190609,0006-3002 (Print) 0006-3002 (Linking),542,1,1978 Aug 3,"Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells.",154-62,"['Glass, J', 'Nunez, M T', 'Fischer, S', 'Robinson, S H']","['Glass J', 'Nunez MT', 'Fischer S', 'Robinson SH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Biochim Biophys Acta,Biochimica et biophysica acta,0217513,IM,"['Animals', 'Cell Line', 'Dimethyl Sulfoxide/pharmacology', 'Erythropoiesis/drug effects', 'Ferritins/*metabolism', 'Friend murine leukemia virus', 'Heme/biosynthesis', 'Iron/*metabolism', 'Iron Radioisotopes', 'Leukemia, Erythroblastic, Acute/metabolism', 'Leukemia, Experimental/*metabolism/pathology', 'Receptors, Drug', 'Transferrin/*metabolism', 'Tumor Virus Infections/metabolism']",1978/08/03 00:00,1978/08/03 00:01,['1978/08/03 00:00'],"['1978/08/03 00:00 [pubmed]', '1978/08/03 00:01 [medline]', '1978/08/03 00:00 [entrez]']","['0304-4165(78)90241-6 [pii]', '10.1016/0304-4165(78)90241-6 [doi]']",ppublish,Biochim Biophys Acta. 1978 Aug 3;542(1):154-62. doi: 10.1016/0304-4165(78)90241-6.,"['0 (Iron Radioisotopes)', '0 (Receptors, Drug)', '0 (Transferrin)', '42VZT0U6YR (Heme)', '9007-73-2 (Ferritins)', 'E1UOL152H7 (Iron)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
276380,NLM,MEDLINE,19780929,20190609,0006-3002 (Print) 0006-3002 (Linking),524,2,1978 Jun 9,Arginine methyltransferase activity in chronic erythremic myelosis (Diguglielmo syndrome).,497-500,"['Kass, L', 'Munster, D']","['Kass L', 'Munster D']",['eng'],['Journal Article'],Netherlands,Biochim Biophys Acta,Biochimica et biophysica acta,0217513,IM,"['Arginine', 'Bone Marrow/enzymology', 'Chronic Disease', 'Erythroblasts/enzymology', 'Humans', 'Leukemia, Erythroblastic, Acute/*enzymology', 'Methyltransferases/*metabolism']",1978/06/09 00:00,1978/06/09 00:01,['1978/06/09 00:00'],"['1978/06/09 00:00 [pubmed]', '1978/06/09 00:01 [medline]', '1978/06/09 00:00 [entrez]']","['0005-2744(78)90189-4 [pii]', '10.1016/0005-2744(78)90189-4 [doi]']",ppublish,Biochim Biophys Acta. 1978 Jun 9;524(2):497-500. doi: 10.1016/0005-2744(78)90189-4.,"['94ZLA3W45F (Arginine)', 'EC 2.1.1.- (Methyltransferases)']","Activity of S-adenosylmethionine-dependent arginine methyltransferase was substantially higher in sonicated bone marrow samples from 6 patients with chronic erythremic myelosis than in bone marrow from 3 patients with untreated pernicious anemia, 2 patients with autoimmune hemolytic anemia, and 4 normal persons. Increased activity of this enzyme may be one of the factors contributing to the pathogenesis fo methylated arginines in histones of erythroblasts from patients with chronic erythremic myelosis.",,,,,
276312,NLM,MEDLINE,19780814,20190501,1468-2044 (Electronic) 0003-9888 (Linking),53,5,1978 May,Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation.,391-5,"['Eiser, C']",['Eiser C'],['eng'],['Journal Article'],England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['Acute Disease', 'Brain/*radiation effects', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Intelligence/*radiation effects', 'Intelligence Tests', 'Leukemia, Lymphoid/*diagnostic imaging/drug therapy', 'Male', 'Radiography', 'Remission, Spontaneous', 'Time Factors']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1136/adc.53.5.391 [doi]'],ppublish,Arch Dis Child. 1978 May;53(5):391-5. doi: 10.1136/adc.53.5.391.,,"Twenty-eight children in remission at least 2 years after completing chemotherapy for acute lymphoblastic leukaemia were assessed on standardised psychological tests. It was found that 7 who never had central nervous system (CNS) irradiation and 9 having prophylactic CNS irradiation at least 6 months after diagnosis tended to perform at average or above levels, while those 10 each having prophylactic CNS irradiation (within 2 months of diagnosis) were generally of lower ability. Within the latter group, 3 children showed serious intellectual impairments, while the group as a whole functioned especially poorly on quantitative tasks and those involving speeded performance with abstract material. General language ability was not affected. Practical and theoretical implantation are discussed.",,PMC1544910,,,
276311,NLM,MEDLINE,19780814,20080317,0003-987X (Print) 0003-987X (Linking),114,6,1978 Jun,Mycosis fungoides evolving to myelomonocytic leukemia.,916-20,"['Lofgren, R K', 'Wiltsie, J C', 'Winkelmann, R K']","['Lofgren RK', 'Wiltsie JC', 'Winkelmann RK']",['eng'],['Journal Article'],United States,Arch Dermatol,Archives of dermatology,0372433,IM,"['Female', 'Humans', 'Leukemia, Myeloid/*etiology/pathology', 'Middle Aged', 'Mycosis Fungoides/*complications/pathology/therapy', 'Skin Neoplasms/*complications/pathology/therapy']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Arch Dermatol. 1978 Jun;114(6):916-20.,,"Acute myelomonocytic leukemia, a type of leukemic conversion that may be a manifestation of mycosis fungoides, developed in two patients with fairly typical courses of mycosis fungoides. The cases of five other patients with myelogenous leukemia as the terminal event of mycosis fungoides have been reported in the literature. A relationship to therapy could not be established, although all patients had had irradiation or chemotherapy or both.",,,,,
276285,NLM,MEDLINE,19780828,20190619,0003-4819 (Print) 0003-4819 (Linking),89,1,1978 Jul,Lymphoblastic-like leukemic transformation of polycythemia vera.,71,"['Hoffman, R', 'Estren, S', 'Kopel, S', 'Marks, S M', 'McCaffrey, R P']","['Hoffman R', 'Estren S', 'Kopel S', 'Marks SM', 'McCaffrey RP']",['eng'],"['Case Reports', 'Journal Article']",United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Aged', 'Cell Transformation, Neoplastic', 'DNA Nucleotidyltransferases/metabolism', 'Humans', 'Leukemia, Lymphoid/enzymology/*etiology', 'Leukocytes/enzymology', 'Male', 'Oligonucleotides', 'Polycythemia Vera/*complications']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.7326/0003-4819-89-1-71 [doi]'],ppublish,Ann Intern Med. 1978 Jul;89(1):71. doi: 10.7326/0003-4819-89-1-71.,"['0 (Oligonucleotides)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)']",,,,,,
276264,NLM,MEDLINE,19780901,20071115,0148-7299 (Print) 0148-7299 (Linking),1,4,1978,Familial non-Hodgkin lymphoma: histologic diversity and relation to other cancers.,437-43,"['Greene, M H', 'Miller, R W']","['Greene MH', 'Miller RW']",['eng'],['Journal Article'],United States,Am J Med Genet,American journal of medical genetics,7708900,IM,"['Carcinoma/genetics', 'Female', 'Hodgkin Disease/genetics', 'Humans', 'Immunologic Deficiency Syndromes/*complications/genetics', 'Leukemia, Lymphoid/genetics', 'Liver Neoplasms/genetics', 'Lung Neoplasms/genetics', 'Lymphoma/etiology/*genetics/pathology', 'Male', 'Pedigree', 'Sex Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/ajmg.1320010406 [doi]'],ppublish,Am J Med Genet. 1978;1(4):437-43. doi: 10.1002/ajmg.1320010406.,,"Familial non-Hodgkin lymphoma (NHL) cases were classified according to the histologic criteria (modified) of Rappaport, to determine the extent of morphologic similarities of the tumors. In four families affected members had different tumor histologies that may be observed in an individual patient as the lymphoma progresses. In two families, the affected relatives had tumors of seemingly discordant histology. These tumors may nonetheless be etiologically related as indicated by the pattern of laboratory abnormalities, especially immunologic, in affected as well as unaffected members. The 20 cases had a reversal of the sex ratio (M/F) usually seen in NHL: 0.5 instead of 1.3. Other tumors observed in these families included primary hepatocellular carcinoma, pulmonary adenocarcinoma, Hodgkin disease, and acute lymphocytic leukemia - all of which have been associated with inborn or acquired immunodeficiency states.",,,,,
276263,NLM,MEDLINE,19780814,20190716,0002-9629 (Print) 0002-9629 (Linking),275,2,1978 Mar-Apr,Localized mucormycosis following intramuscular corticosteroid. Case report and review of the literature.,209-16,"['Jain, J K', 'Markowitz, A', 'Khilanani, P V', 'Lauter, C B']","['Jain JK', 'Markowitz A', 'Khilanani PV', 'Lauter CB']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med Sci,The American journal of the medical sciences,0370506,IM,"['Adult', 'Female', 'Humans', 'Immunoglobulins/analysis', 'Injections, Intramuscular/*adverse effects', 'Leukemia, Myeloid/*complications/immunology', 'Leukocyte Count', 'Lymphocytes/drug effects', 'Methylprednisolone/*administration & dosage', 'Mucormycosis/*etiology', 'Skin Tests']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1097/00000441-197803000-00013 [doi]'],ppublish,Am J Med Sci. 1978 Mar-Apr;275(2):209-16. doi: 10.1097/00000441-197803000-00013.,"['0 (Immunoglobulins)', 'X4W7ZR7023 (Methylprednisolone)']","A case of subcutaneous localized mucormycosis infection which developed following intramuscular (IM) injection of corticosteroid in a patient with leukemia is presented. Aggressive treatment, which included wide local excision, systemic amphotericin-B, and chemotherapy for the leukemia, resulted in eradication of the infection and complete healing of the wound. A review of the literature revealed nine other patients with the localized subcutaneous form of mucormycosis (excluding patients with burns and rhinocerebral types) and six of those nine patients also survived the infection. It is possibly the mildness of the underlying predisposing factors that allows some of these patients to contain the infection at a single site. It is apparent from review of the literature that in subcutaneous localized forms of mucormycosis, the outcome has been generally good. This contrasts sharply with other clinical forms of mucormycosis infections where the underlying predisposing factors are usually severe and any kind of therapeutic approach has been almost always futile. Subcutaneous mucormycosis infection differs clinically and histopathologically from subcutaneous localized entomophthoromycosis which is seen predominantly in tropical countries. An attempt is made to clarify the terminology of these interesting fungi in language that is taxonomically up-to-date and still useful to clinicians.",,,,,
276262,NLM,MEDLINE,19780828,20190509,0002-9173 (Print) 0002-9173 (Linking),69,6,1978 Jun,Chronic monocytic leukemia.,648-9,"['Burdick, C O', 'De Carvalho, L', 'Carson, J']","['Burdick CO', 'De Carvalho L', 'Carson J']",['eng'],"['Case Reports', 'Letter']",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Aged', 'Humans', 'Leukemia, Myeloid/*diagnosis/drug therapy/pathology', 'Male']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1093/ajcp/69.6.648a [doi]'],ppublish,Am J Clin Pathol. 1978 Jun;69(6):648-9. doi: 10.1093/ajcp/69.6.648a.,,,,,,,
276243,NLM,MEDLINE,19780901,20071115,0001-5814 (Print) 0001-5814 (Linking),9,2,1978 Apr-Jun,[Usefulness of beta-glucuronidase activity determination in the differential diagnosis of acute leukemia].,121-4,"['Litwin, J', 'Kolakowska-Polubiec, K', 'Polubiec, A', 'Rokicka, R', 'Bieleckiej, B']","['Litwin J', 'Kolakowska-Polubiec K', 'Polubiec A', 'Rokicka R', 'Bieleckiej B']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Acute Disease', 'Adult', 'Child', 'Diagnosis, Differential', 'Glucuronidase/*metabolism', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/diagnosis', 'Leukemia, Monocytic, Acute/diagnosis', 'Leukemia, Myeloid/diagnosis']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1978 Apr-Jun;9(2):121-4.,['EC 3.2.1.31 (Glucuronidase)'],In 95 cases of acute leukemias the cytochemical type was determined according to Loffler's classification and the activity of beta-glucuronidase was determined in blast cells. In the light of these investigations it was demonstrated that determination of the activity of this enzyme may be useful only in the differential diagnosis and classification of certain cases of acute lymphoblastic or undifferentiated-cell leukaemias.,Ocena przydatnosci badania aktywnosci beta-glukuronidazy w roznicowaniu ostrych biallaczek.,,,,
276242,NLM,MEDLINE,19780814,20071115,0001-5814 (Print) 0001-5814 (Linking),9,1,1978 Jan-Mar,[Preliminary analysis of intensive treatment of acute lymphoblastic leukemia in children].,1-7,"['Radwanska, U', 'Michalewska, D']","['Radwanska U', 'Michalewska D']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Age Factors', 'Antineoplastic Agents/administration & dosage/therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination/methods', 'Humans', 'Infant', 'Leukemia, Lymphoid/*drug therapy', 'Recurrence', 'Remission, Spontaneous']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1978 Jan-Mar;9(1):1-7.,['0 (Antineoplastic Agents)'],"The analysis was carried out on 31 children with acute lymphoblastic leukaemias. In 29 of them remissions were obtained conducting later during 3 years intensive maintenance therapy associated with radiotherapy to the central nervous system (according to the method of the Memphis group). Superiority of intensive treatment in relation to more sparing treatment has been demonstrated. Therapeutic failures were observed in children with primarily poor prognosis of leukaemia, especially with blastic hyperleucocytosis. The behavior of serum immunoglobulins and especially infections occurring in children during treatment are discussed.",Wstepna analiza wynikow intensywnego leczenia ostrych bialaczek limfoblastycznych u dzieci.,,,,
276201,NLM,MEDLINE,19780814,20151119,0042-8809 (Print) 0042-8809 (Linking),24,1,1978 Jan-Feb,[Adenyl cyclase activity of human blood platelets in various blood diseases].,28-31,"['Egorova, V A', 'Beliaeva, Z N', 'Blinov, M N']","['Egorova VA', 'Beliaeva ZN', 'Blinov MN']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Vopr Med Khim,Voprosy meditsinskoi khimii,0416601,IM,"['Adenylyl Cyclases/*metabolism', 'Blood Platelets/*enzymology', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid/*blood', 'Primary Myelofibrosis/*blood', 'Purpura, Thrombocytopenic/blood/*genetics', 'Syndrome']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Vopr Med Khim. 1978 Jan-Feb;24(1):28-31.,['EC 4.6.1.1 (Adenylyl Cyclases)'],"Adenyl cyclase activity was estimated in blood platelets of healthy persons and of patients with myeloleukosis, osteomyelofibrosis and with Glanzmann's thrombasthenia. Six-fold decrease in the adenyl cyclase activity from the platelets was observed in chronic myeloleukosis. The enzymatic activity in platelets was similar to normal level in osteomyelofibrosis and Glanzmann's thrombasthenia.",Aktivnost' adeniltsiklazy krovianykh plastinok cheloveka pri nekotorykh zabolevaniiakh sistemy krovi.,,,,
276093,NLM,MEDLINE,19780814,20191028,0098-0366 (Print) 0098-0366 (Linking),4,2,1978 Mar,Maintenance of hemoglobin inducibility in somatic cell hybrids of tetraploid (2S) mouse erythroleukemia cells with mouse or human fibroblasts.,157-68,"['Axelrod, D E', 'Gopalakrishnan, T V', 'Willing, M', 'Anderson, W F']","['Axelrod DE', 'Gopalakrishnan TV', 'Willing M', 'Anderson WF']",['eng'],['Journal Article'],United States,Somatic Cell Genet,Somatic cell genetics,7506054,IM,"['Animals', 'Cell Line', 'Dimethyl Sulfoxide/pharmacology', 'Fibroblasts', 'Hemoglobins/*biosynthesis', 'Humans', 'Hybrid Cells/*metabolism', 'Isoenzymes', 'L-Lactate Dehydrogenase/metabolism', 'Leukemia, Erythroblastic, Acute', 'Mice', 'Phenotype', 'Polyploidy']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1007/BF01538981 [doi]'],ppublish,Somatic Cell Genet. 1978 Mar;4(2):157-68. doi: 10.1007/BF01538981.,"['0 (Hemoglobins)', '0 (Isoenzymes)', 'EC 1.1.1.27 (L-Lactate Dehydrogenase)', 'YOW8V9698H (Dimethyl Sulfoxide)']","It has previously been reported that Friend mouse erythroleukemia (MEL) cells synthesize hemoglobin when exposed to 2% dimethylsulfoxide, and that hybrids between MEL cells and fibroblasts (or other nonerythroid cells) do not synthesize hemoglobin. We have been successful in obtaining hybrids (3/15) between MEL cells and mouse L-cell fibroblasts that maintain hemoglobin inducibility by preserving nonadherent cells after fusion. The proportion of hemoglobin inducible hybrids can be increased (8/11) by using a stable 2S (pseudotetraploid) MEL parent in addition to preserving nonadherent cells after fusion. All hybrids which were nonadherent were hemoglobin inducible, and all hybrids which were adherent were not. Five nonadherent hybrid clones were analyzed from fusions between a stable 2S MEL parent and a human fibroblast (WI-38, VA-2). All these clones were inducible for hemoglobin. It is concluded that gene dosage is effective in increasing the proportion of hemoglobin inducible hybrids, but hybrid morphology is the phenotype characteristic that correlates most closely with expression of hemoglobin inducibility.",,,,,
276046,NLM,MEDLINE,19780828,20190907,0036-553X (Print) 0036-553X (Linking),20,5,1978 May,Myelomatosis terminating in acute myelogenic leukaemia.,410-2,"['Jaeger, S']",['Jaeger S'],['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Alkylating Agents/*adverse effects/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/*chemically induced', 'Male', 'Middle Aged', 'Multiple Myeloma/*drug therapy/radiotherapy']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02475.x [doi]'],ppublish,Scand J Haematol. 1978 May;20(5):410-2. doi: 10.1111/j.1600-0609.1978.tb02475.x.,['0 (Alkylating Agents)'],"A case of acute myelogenic leukaemia developing after 7 months treatment with alkylating agents for multiple myeloma is reported. The patients was also given irradiation for an expansive process in the thoracic column. By immunofluorescence staining of the bone marrow cells there was no evidence for production of pathological globulins in the blast cells, while the plasma cells contained IgA, kappa.",,,,,
276021,NLM,MEDLINE,19780814,20071115,0035-6905 (Print) 0035-6905 (Linking),46,10,1977 Oct,[Periodontal changes in leukemia].,60-6,"['Cattabriga, M', 'Granozio, E']","['Cattabriga M', 'Granozio E']",['ita'],"['Case Reports', 'English Abstract', 'Journal Article']",Italy,Riv Ital Stomatol,Rivista italiana di stomatologia,0404364,,"['Adult', 'Female', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Myeloid/*diagnosis', '*Oral Manifestations']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Riv Ital Stomatol. 1977 Oct;46(10):60-6.,,,Sulle alterazioni parodontali della leucemia.,,,,
276015,NLM,MEDLINE,19780828,20041117,0041-8781 (Print) 0041-8781 (Linking),33,1,1978 Feb,[Pathogenesis of chronic myeloid leukemia].,52-6,"['Bottura, C']",['Bottura C'],['por'],['Journal Article'],Brazil,Rev Hosp Clin Fac Med Sao Paulo,Revista do Hospital das Clinicas,0415246,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Chronic Disease', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/etiology/*genetics']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Rev Hosp Clin Fac Med Sao Paulo. 1978 Feb;33(1):52-6.,,,Patogenia da leucemia mieloide cronica.,,,,
275896,NLM,MEDLINE,19780901,20140603,,8,12,1977 Dec,Cancer chemotherapy and dentistry.,9-14,"['Carl, W']",['Carl W'],['eng'],['Journal Article'],Germany,Quintessence Int Dent Dig,"Quintessence international, dental digest",101281344,,"['Alkylating Agents/adverse effects', 'Antibiotics, Antineoplastic/adverse effects', 'Antimetabolites, Antineoplastic/*adverse effects', 'Asparaginase/adverse effects', 'Carcinoma/drug therapy', 'Humans', 'Leukemia/drug therapy', 'Lymphoma/drug therapy', 'Melanoma/drug therapy', 'Mouth Neoplasms/*drug therapy', 'Procarbazine/adverse effects', 'Sarcoma/drug therapy', 'Vinca Alkaloids/adverse effects']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Quintessence Int Dent Dig. 1977 Dec;8(12):9-14.,"['0 (Alkylating Agents)', '0 (Antibiotics, Antineoplastic)', '0 (Antimetabolites, Antineoplastic)', '0 (Vinca Alkaloids)', '35S93Y190K (Procarbazine)', 'EC 3.5.1.1 (Asparaginase)']",,,,,,
275868,NLM,MEDLINE,19780901,20161123,0031-9325 (Print) 0031-9325 (Linking),9,6,1977,Antineoplaston A in cancer therapy. (I).,485-500,"['Burzynski, S R', 'Stolzmann, Z', 'Szopa, B', 'Stolzmann, E', 'Kaltenberg, O P']","['Burzynski SR', 'Stolzmann Z', 'Szopa B', 'Stolzmann E', 'Kaltenberg OP']",['eng'],"['Case Reports', 'Journal Article']",United States,Physiol Chem Phys,Physiological chemistry and physics,0202364,IM,"['Administration, Topical', 'Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use', 'Breast Neoplasms/drug therapy', 'Cell Line', 'Female', 'Humans', 'Injections', 'Injections, Intramuscular', 'Injections, Intravenous', 'Leukemia, Lymphoid/drug therapy', 'Liver Neoplasms/diagnostic imaging/drug therapy', 'Lung Neoplasms/drug therapy', 'Male', 'Middle Aged', 'Neoplasm Metastasis', 'Neoplasms/*drug therapy', 'Peptides/administration & dosage/adverse effects/*therapeutic use', 'Pleura', 'Radionuclide Imaging', 'Rectum', 'Remission, Spontaneous', 'Urinary Bladder', 'Urinary Bladder Neoplasms/drug therapy']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Physiol Chem Phys. 1977;9(6):485-500.,"['0 (Antineoplastic Agents)', '0 (Peptides)']","Twenty-one patients with advanced cancer or leukemia were treated with antineoplaston A and followed for up to nine months. Dosage by intravenous, intramuscular, subcutaneous, rectal, intrapleural, intravesical and/or topical administration ranged from 0.6 to 33 U/m2/24 h. Treatment was well tolerated, although side effects included fever of short duration and elevation of platelet and white blood count. In 18 cases some degree of clinical improvement was observed. Complete remission occurred in 4 cases. More than 50% remission occurred in 4 other cases which, along with another 6 cases, are continuing the treatment with high doses of antineoplaston A and show a continuing regression of the tumors although not yet achieving the criteria for complete remission; 2 of these 6 cases seem unlikely to achieve remission. Two patients temporarily discontinued treatment. During treatment, 5 patients expired; in 2 of them, however, was seen significant regression of the neoplastic process. The deaths were not due to cancer or to any toxicity incurred by the treatment.",,,,,
275867,NLM,MEDLINE,19780828,20041117,0361-7742 (Print) 0361-7742 (Linking),21,,1978,"Erythrocyte cytochrome b5; structure, role in methemoglobin reduction, and solubilization from endoplasmic reticulum.",199-216,"['Hultquist, D E', 'Slaughter, S R', 'Douglas, R H', 'Sannes, L J', 'Sahagian, G G']","['Hultquist DE', 'Slaughter SR', 'Douglas RH', 'Sannes LJ', 'Sahagian GG']",['eng'],['Journal Article'],United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Amino Acid Sequence', 'Animals', 'Cattle', 'Cytochromes/*blood', 'Endoplasmic Reticulum/analysis', 'Erythrocytes/*metabolism', 'Humans', 'Leukemia, Erythroblastic, Acute/blood', 'Methemoglobin/*metabolism', 'Mice', 'Microsomes, Liver', 'Oxidation-Reduction', 'Protein Conformation', 'Solubility']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1978;21:199-216.,"['0 (Cytochromes)', '9008-37-1 (Methemoglobin)']",,,,,,
275849,NLM,MEDLINE,19780901,20190501,0027-8424 (Print) 0027-8424 (Linking),75,6,1978 Jun,Induction of murine erythroleukemia differentiation by actinomycin D.,2795-9,"['Terada, M', 'Epner, E', 'Nudel, U', 'Salmon, J', 'Fibach, E', 'Rifkind, R A', 'Marks, P A']","['Terada M', 'Epner E', 'Nudel U', 'Salmon J', 'Fibach E', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Differentiation/*drug effects', 'Cell Line', 'DNA, Neoplasm/biosynthesis', 'Dactinomycin/*pharmacology', 'Erythropoiesis/drug effects', 'Hemoglobins/biosynthesis', 'Leukemia, Erythroblastic, Acute/*pathology', 'Leukemia, Experimental/pathology', 'Neoplasm Proteins/biosynthesis', 'RNA, Messenger/metabolism', 'RNA, Neoplasm/biosynthesis', 'Rubidium/metabolism']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1073/pnas.75.6.2795 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1978 Jun;75(6):2795-9. doi: 10.1073/pnas.75.6.2795.,"['0 (DNA, Neoplasm)', '0 (Hemoglobins)', '0 (Neoplasm Proteins)', '0 (RNA, Messenger)', '0 (RNA, Neoplasm)', '1CC1JFE158 (Dactinomycin)', 'MLT4718TJW (Rubidium)']","Murine erythroleukemia cells are induced to differentiate by 0.5-5 ng of actinomycin D per ml. Murine erythroleukemia cells cultured with actinomycin D prolong cell doubling time but achieve the same density after 5 days as cells without inducer. Actinomycin D causes over 95% of the cells to become benzidine-reactive. [(3)H]Actinomycin D uptake into DNA can be detected within 2 hr and reaches a maximum (approximately 0.1 pmol/10(6) cells) by 10-12 hr. It is estimated that about one out of 10(5) dG.dC pairs is bound to actinomycin D. Commitment to differentiation, assayed by transfer of cells to culture without inducer, was detected as early as 5 hr. Unlike Me(2)SO, which causes a transient prolongation in G(1) at about 15-20 hr, cells cultured with actinomycin D show a more sustained increase in the proportion of the cells in G(1). Globin mRNA accumulation was detectable by 19 hr in culture. Alteration in DNA stability in alkaline sucrose gradients was detected by 19 hr. Actinomycin D induces synthesis of Hb(maj) and Hb(min) in approximately equal amounts. A decrease in rates of synthesis of RNA, DNA, and total protein occurs in cells cultured with actinomycin D, as well as in cells cultured with Me(2)SO. No evidence for an early action of actinomycin D at the plasma membrane was obtained by measurement of changes in cell volume or (86)RbCl uptake. Taken together, the present results indicate that actinomycin D is a potent inducer of differentiation of murine erythroleukemia cells and suggest that the target of its effect may be at the level of DNA.",,PMC392651,,,
275794,NLM,MEDLINE,19780828,20151119,0301-1518 (Print) 0301-1518 (Linking),7,19,1978 May 13,"[Anaemia induced by vitamin B12 or folate deficiency: diagnostic value of the ""dU suppression"" test (author's transl)].",1617-20,"['Zittoun, J', 'Zittoun, R', 'Marquet, J', 'Bilski-Pasquier, G', 'Sultan, C']","['Zittoun J', 'Zittoun R', 'Marquet J', 'Bilski-Pasquier G', 'Sultan C']",['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Anemia/*diagnosis', 'Anemia, Macrocytic/diagnosis', 'Anemia, Megaloblastic/diagnosis', 'Anemia, Sideroblastic/diagnosis', 'Bone Marrow/metabolism', 'DNA/biosynthesis', '*Deoxyuridine', 'Diagnosis, Differential', 'Folic Acid Deficiency/*diagnosis', 'Leukemia, Myeloid, Acute/diagnosis', 'Male', 'Thymidine/metabolism', 'Vitamin B 12 Deficiency/*diagnosis']",1978/05/13 00:00,1978/05/13 00:01,['1978/05/13 00:00'],"['1978/05/13 00:00 [pubmed]', '1978/05/13 00:01 [medline]', '1978/05/13 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 May 13;7(19):1617-20.,"['9007-49-2 (DNA)', 'VC2W18DGKR (Thymidine)', 'W78I7AY22C (Deoxyuridine)']","The ""dU suppression"" test, studying thymine-DNA synthesis from deoxyuridine is abnormal in folate and vitamin B12 deficiency, these two vitamins being involved in this reaction. We have done it in 7 cases of anaemia by folate deficiency, 12 cases of anaemia by vitamin B12 deficiency, in 3 cases of combined deficiency, in 3 cases of acute myeloid leukaemia, 2 cases of sideroblastic anaemia and 2 cases of intoxication by antifolate. This test is very sensitive: it is abnormal even when there is an anaemia related to a vitamin deficiency with only very light morphologic abnormalities and can discriminate the cases, mainly in myelodysplastic syndromes, where folate deficiency is only an epiphenomen in the genesis of anaemia. The abnormalities of the ""dU suppression"" are quite corrected by added folate derivatives in folate deficiency. However, cobalamin derivatives did not correct completely the test in vitamin B12 deficiency except when a folate compound is also added. The ""dU suppression"" test becomes normal about one week after starting vitaminotherapy in vitamin B12 deficiency.",Anemies par carence en vitamine B12 ou en folates: valeur diagnostique du test de suppression par deoxyuridine.,,,,
275793,NLM,MEDLINE,19780828,20041117,0301-1518 (Print) 0301-1518 (Linking),7,13,1978 Apr 1,[Chronic myeloid leukemia with Philadelphia chromosome complicating the evolution of Vaquez' disease].,1114-5,"['Pris, J', 'Launais, B', 'Capdeville, J', 'Monnier, J', 'Borrouilloux, G', 'Duchayne, E', 'Colombies, P']","['Pris J', 'Launais B', 'Capdeville J', 'Monnier J', 'Borrouilloux G', 'Duchayne E', 'Colombies P']",['fre'],"['Case Reports', 'Letter']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Aged', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/complications/*genetics', 'Polycythemia Vera/*complications/genetics']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 Apr 1;7(13):1114-5.,,,Leucemie myeloide chronique avec chromosome Philadelphie compliquant l'evolution d'une maladie de Vaquez.,,,,
275605,NLM,MEDLINE,19780814,20091111,0028-3894 (Print) 0028-3894 (Linking),16,1,1978 Jan-Mar,[Chronic myeloblastic leukemia with a clinical and morphological appearance polyganglioradiculoneuritis].,135-41,"['Borowska-Lehman, J', 'Nyka, W']","['Borowska-Lehman J', 'Nyka W']",['pol'],"['Case Reports', 'English Abstract', 'Journal Article']",Poland,Neuropatol Pol,Neuropatologia polska,0020712,IM,"['Adult', 'Chronic Disease', 'Ganglia, Spinal/pathology', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Male', 'Polyradiculopathy/*pathology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Neuropatol Pol. 1978 Jan-Mar;16(1):135-41.,,,Przewlekla bialaczka szpikowa o obrazie kliniczno-morfologicznym polyganglioradiculoneuritis.,,,,
275564,NLM,MEDLINE,19780814,20071115,0028-2162 (Print) 0028-2162 (Linking),122,23,1978 Jun 10,"[Bone marrow culture, a new method of study in hematology].",820-4,"['Lowenberg, B']",['Lowenberg B'],['dut'],"['English Abstract', 'Journal Article']",Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['*Bone Marrow', 'Culture Techniques/methods', '*Hematopoietic Stem Cells', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/diagnosis', 'Leukemia, Myeloid/diagnosis', 'Leukemia, Myeloid, Acute/diagnosis']",1978/06/10 00:00,1978/06/10 00:01,['1978/06/10 00:00'],"['1978/06/10 00:00 [pubmed]', '1978/06/10 00:01 [medline]', '1978/06/10 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1978 Jun 10;122(23):820-4.,,,"Beenmergkweek, een nieuwe methode van onderzoek in de hematologie.",,,,
275534,NLM,MEDLINE,19780901,20190902,0098-1532 (Print) 0098-1532 (Linking),4,2,1978,Repeated use of L-asparaginase in multi-drug therapy of childhood leukemia.,91-7,"['Trueworthy, R C', 'Sutow, W W', 'Pullen, J', 'Komp, D', 'Berry, D H']","['Trueworthy RC', 'Sutow WW', 'Pullen J', 'Komp D', 'Berry DH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Acute Disease', 'Adolescent', 'Asparaginase/adverse effects/*therapeutic use', 'Child', 'Daunorubicin/therapeutic use', 'Drug Administration Schedule', 'Drug Hypersensitivity/etiology', 'Drug Therapy, Combination', 'Hematopoietic Stem Cells', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Prednisone/therapeutic use', 'Vincristine/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040202 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(2):91-7. doi: 10.1002/mpo.2950040202.,"['5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)', 'ZS7284E0ZP (Daunorubicin)']","The capacity of 1-asparaginase in two separate schedules (consecutive and intermittent), along with vincristine and prednisone to produce multiple responses, was evaluated in previously treated children with acute leukemia in relapse. The response rates varied inversely with previous 1-asparaginase exposure. A history of prior resistance to prednisone and vincristine appeared to reduce the response rate. Hypersensitivity reactions occurred in 14%.",,,,,
275533,NLM,MEDLINE,19780901,20190902,0098-1532 (Print) 0098-1532 (Linking),4,2,1978,Blastic transformation in chronic myelogenous leukemia: experience with 50 patients.,159-67,"['Marks, S M', 'McCaffrey, R', 'Rosenthal, D S', 'Moloney, W C']","['Marks SM', 'McCaffrey R', 'Rosenthal DS', 'Moloney WC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adult', 'Antineoplastic Agents/therapeutic use', 'Chromosome Mapping', 'DNA Nucleotidyltransferases/blood', 'Female', 'Humans', 'Leukemia, Lymphoid/diagnosis/enzymology', 'Leukemia, Myeloid/*diagnosis/enzymology/genetics', 'Leukemia, Myeloid, Acute/*diagnosis/enzymology/genetics', 'Male', 'Middle Aged', 'Prognosis']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040212 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(2):159-67. doi: 10.1002/mpo.2950040212.,"['0 (Antineoplastic Agents)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)']","Fifty consecutive patients with blastic chronic myelogenous leukemia were evaluated clinically, morphologically, biochemically, and therapeutically. Forty-five patients had a preceding stable phase (38 Ph'+, 7 Ph'-); five patients presented with de novo Ph+ blast crisis. The most frequent clinical signs of impending blast crisis were weakness, fatigue, increasing splenomegaly, anemia, thrombocytopenia, marrow fibrosis, and a rising neutrophil alkaline phosphatase. Fever (unrelated to infection), skin infiltration, lymphadenopathy, hepatomegaly, thrombocytosis, and basophilia were much less common. The development of aneuploidy occurred in less than one-half of the total group. Myeloblastic morphology at blastic transformation was most frequent with occasional lymphoblastic, promyelocytic, and undifferentiated cases seen. Terminal deoxynucleotidyl transferase was present in one-third of the patients, but had no clear-cut relationship to the morphology. Response to treatment was generally disappointing (two complete and 15 partial remissions in 45 treated patients).",,,,,
275532,NLM,MEDLINE,19780901,20190902,0098-1532 (Print) 0098-1532 (Linking),4,2,1978,Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group study.,127-32,"['Nitschke, R', 'Starling, K A', 'Vats, T', 'Bryan, H']","['Nitschke R', 'Starling KA', 'Vats T', 'Bryan H']",['eng'],['Journal Article'],United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Blood Urea Nitrogen', 'Child', 'Child, Preschool', 'Cisplatin/adverse effects/*therapeutic use', 'Creatinine/blood', 'Female', 'Humans', 'Infusions, Parenteral', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Neoplasm Metastasis', 'Neoplasm Recurrence, Local/drug therapy', 'Neoplasms/*drug therapy', 'Vomiting/chemically induced']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040208 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(2):127-32. doi: 10.1002/mpo.2950040208.,"['AYI8EX34EU (Creatinine)', 'Q20Q21Q62J (Cisplatin)']","Children with malignancies resistant to conventional therapy were treated with cis-diamminedichloroplatinum (PDD), 15 to 20 mg/m2, given daily by rapid intravenous infusion for 5 days at 3-wk intervals. Eleven of 24 children with acute lymphocytic leukemia (ALL) received two or more courses; among these no remissions occurred. Fifty-four children with solid tumors were treated: 25 neuroblastoma, 9 rhabdomyosarcoma, 4 Ewing sarcoma, 2 testicular embryonal carcinoma, 2 retinoblastoma, and 12 miscellaneous tumors. One complete remission, 3 partial remissions, and 2 improvements were observed in children with neuroblastoma. One girl with metastatic osteogenic sarcoma achieved a partial remission. One child with metastatic testicular embryonal carcinoma showed improvement. The side effects were vomiting controlled by antiemetics in 26 children and transient elevations of serum creatinine and BUN in 14 children. Nineteen of 39 children with solid tumors, who received more than one course of PDD, had moderately severe myelosuppression caused by PDD. In summary, PDD is a promising agent in neuroblastoma, osteogenic sarcoma, and testicular embryonal carcinoma, and an ineffective agent in ALL. The effect of PDD on other types of solid tumors should be evaluated in the future.",,,,,
275531,NLM,MEDLINE,19780901,20190902,0098-1532 (Print) 0098-1532 (Linking),4,2,1978,Positive monospot tests preceding the diagnosis of acute monocytic leukemia in two adolescents.,111-4,"['Miale, T D', 'Barbosa, J L', 'Dellinger, C T', 'Wolfson, S L']","['Miale TD', 'Barbosa JL', 'Dellinger CT', 'Wolfson SL']",['eng'],"['Case Reports', 'Journal Article']",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Antibodies, Heterophile/analysis', 'Antibodies, Viral/analysis', 'Bone Marrow Examination', 'Child', 'False Positive Reactions', 'Humans', 'Infectious Mononucleosis/*diagnosis/immunology', 'Leukemia, Monocytic, Acute/*diagnosis/immunology', 'Male']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040205 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(2):111-4. doi: 10.1002/mpo.2950040205.,"['0 (Antibodies, Heterophile)', '0 (Antibodies, Viral)']","The early detection and treatment of two cases of acute monocytic leukemia (AMoL) was hampered by the presence of positive slide tests for infectious mononucleosis (IM). This assumes great importance with the recent development of specific therapy, effective for certain subtypes of nonlymphocytic leukemia.",,,,,
275529,NLM,MEDLINE,19780901,20210313,0025-729X (Print) 0025-729X (Linking),1,8,1978 Apr 22,Towards a cure of acute granulocytic leukaemia?,421-2,"['Gunz, F W']",['Gunz FW'],['eng'],['Editorial'],Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Acute Disease', 'Cell Division', 'Humans', 'Leukemia, Myeloid, Acute/physiopathology/*therapy', 'Remission, Spontaneous']",1978/04/22 00:00,1978/04/22 00:01,['1978/04/22 00:00'],"['1978/04/22 00:00 [pubmed]', '1978/04/22 00:01 [medline]', '1978/04/22 00:00 [entrez]']",['10.5694/j.1326-5377.1978.tb141914.x [doi]'],ppublish,Med J Aust. 1978 Apr 22;1(8):421-2. doi: 10.5694/j.1326-5377.1978.tb141914.x.,,,,,,,
275528,NLM,MEDLINE,19780901,20210313,0025-729X (Print) 0025-729X (Linking),1,8,1978 Apr 22,Adult acute lymphoblastic leukaemia: a five-year experience.,414-6,"['Abbott, R L', 'Kimber, R J']","['Abbott RL', 'Kimber RJ']",['eng'],['Journal Article'],Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Age Factors', 'Aged', 'Australia', 'Child', 'Female', 'Follow-Up Studies', 'Humans', 'Leukemia, Lymphoid/drug therapy/epidemiology/*mortality', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1978/04/22 00:00,1978/04/22 00:01,['1978/04/22 00:00'],"['1978/04/22 00:00 [pubmed]', '1978/04/22 00:01 [medline]', '1978/04/22 00:00 [entrez]']",['10.5694/j.1326-5377.1978.tb141910.x [doi]'],ppublish,Med J Aust. 1978 Apr 22;1(8):414-6. doi: 10.5694/j.1326-5377.1978.tb141910.x.,,"The case histories of all patients for whom the diagnosis of acute lymphoblastic leukaemia (ALL) was made over a five-year period at the Royal Adelaide Hospital and Institute of Medical and Veterinary Science were studied. There were 34 patients with a median age of 47.5 years. Adequate follow-up was obtained on 33 patients, and their median survival was 5.4 months. The remission rate was 77% in the under-30 years age group, but only 15% in the over-30 years age group. The median duration of remission was 24 months while the median survival of remitters has not yet been reached. The median survival of non-remitters was two months with 100% being dead at 12-3 months. Of 20 patients without remission, seven died of haemorrhage and/or infection before an adequate trial of therapy had been completed, while nine patients had ""adequate"" intensive therapy but failed to achieve remission.",,,,,
275527,NLM,MEDLINE,19780901,20210313,0025-729X (Print) 0025-729X (Linking),1,5,1978 Mar 11,Developing role of anticancer drugs in cancer treatment.,265-70,"['Colebatch, J H']",['Colebatch JH'],['eng'],['Journal Article'],Australia,Med J Aust,The Medical journal of Australia,0400714,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Antineoplastic Agents/*therapeutic use', 'Child', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia/drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Lymphoma/drug therapy', 'Male', 'Neoplasms/mortality', 'Sarcoma/drug therapy']",1978/03/11 00:00,1978/03/11 00:01,['1978/03/11 00:00'],"['1978/03/11 00:00 [pubmed]', '1978/03/11 00:01 [medline]', '1978/03/11 00:00 [entrez]']",['10.5694/j.1326-5377.1978.tb112529.x [doi]'],ppublish,Med J Aust. 1978 Mar 11;1(5):265-70. doi: 10.5694/j.1326-5377.1978.tb112529.x.,['0 (Antineoplastic Agents)'],,,,,,
275525,NLM,MEDLINE,19780828,20071115,0190-2350 (Print) 0190-2350 (Linking),6,6,1978 Jun,Doctor sues to treat child's leukemia. Resumption of chemotherapy produces remission.,41,"['Regier, H']",['Regier H'],['eng'],"['Case Reports', 'Journal Article']",United States,Leg Aspects Med Pract,Legal aspects of medical practice,7801257,IM,"['Antineoplastic Agents/*therapeutic use', 'Child, Preschool', 'Humans', 'Judicial Role', '*Jurisprudence', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Massachusetts', '*Parental Consent', 'Parents', 'Remission, Spontaneous']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Leg Aspects Med Pract. 1978 Jun;6(6):41.,['0 (Antineoplastic Agents)'],,,,['KIE: 07566'],"['KIE: KIE BoB Subject Heading: GREEN, CHAD', 'KIE: KIE BoB Subject Heading: TREATMENT REFUSAL/INFANTS/LEUKEMIA', 'KIE: KIE BoB Subject Heading: TREATMENT REFUSAL/PARENTAL CONSENT', 'KIE: Full author name: Regier, Hilda']",
275524,NLM,MEDLINE,19780814,20041117,0038-3139 (Print) 0038-3139 (Linking),74,6,1978 Jun,A group experience for parents of children with malignancy.,290-2,"['Taylor, C I', 'DeAntonio, M', 'Draffin, N C', 'Morgan, S K']","['Taylor CI', 'DeAntonio M', 'Draffin NC', 'Morgan SK']",['eng'],['Journal Article'],United States,J S C Med Assoc,Journal of the South Carolina Medical Association (1975),7503045,IM,"['Brain Neoplasms', 'Child', 'Humans', 'Leukemia', '*Neoplasms', '*Parents', '*Psychotherapy, Group']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,J S C Med Assoc. 1978 Jun;74(6):290-2.,,,,,,,
275520,NLM,MEDLINE,19780828,20041117,0023-2149 (Print) 0023-2149 (Linking),56,5,1978 May,[Clinico-morphological and immunological characteristics of unfolded (terminal) stage of myelocytic leukemia].,79-86,"['Loginskii, V E', 'Vygovskaia, Ia I', 'Mazurok, A A', 'Liubashchenko, Iu I']","['Loginskii VE', 'Vygovskaia IaI', 'Mazurok AA', 'Liubashchenko IuI']",['rus'],['Journal Article'],Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Adolescent', 'Adult', 'Aged', 'Female', 'Humans', 'Immunity, Cellular', 'Immunoglobulins/analysis', '*Leukemia, Myeloid/immunology/pathology', 'Male', 'Middle Aged', 'Time Factors']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1978 May;56(5):79-86.,['0 (Immunoglobulins)'],,Kliniko-morfologicheskaia i immunologichaskaia kharakteristika razvernutoi (terminal'noi) stadii khronicheskogo mieloleikoza.,,,,
275519,NLM,MEDLINE,19780828,20071115,0023-2149 (Print) 0023-2149 (Linking),56,5,1978 May,[Case of disseminated intravascular coagulation in lymphoblastic leukemia].,113-4,"['Khvatova, N V', 'Probatova, N A', 'Zhukovskaia, R S', 'Ermilova, V D']","['Khvatova NV', 'Probatova NA', 'Zhukovskaia RS', 'Ermilova VD']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Disseminated Intravascular Coagulation/*etiology', 'Humans', 'Leukemia, Lymphoid/*blood', 'Male', 'Middle Aged']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1978 May;56(5):113-4.,,,Sluchai disseminirovannogo vnutrisosudistogo svertyvaniia pri ostrom limfoblastnom leikoze.,,,,
275517,NLM,MEDLINE,19780814,20131121,0021-7263 (Print) 0021-7263 (Linking),142,6,1978 Jun,Acute leukemia following cyclophosphamide therapy for Sjogren's syndrome.,211-4,"['Hochberg, M C', 'Shulman, L E']","['Hochberg MC', 'Shulman LE']",['eng'],"['Case Reports', 'Journal Article']",United States,Johns Hopkins Med J,The Johns Hopkins medical journal,0072456,IM,"['Acute Disease', 'Cyclophosphamide/*adverse effects/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid/*chemically induced/complications', 'Middle Aged', ""Sjogren's Syndrome/complications/*drug therapy""]",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Johns Hopkins Med J. 1978 Jun;142(6):211-4.,['8N3DW7272P (Cyclophosphamide)'],"A fatal myeloproliferative syndrome diagnosed as subacute myelomonocytic leukemia developed in a patient with Sjogren's syndrome following treatment with cyclophosphamide. Although patients with Sjogren's syndrome have a recognized increased risk of developing lymphoproliferative disorders, particularly reticulum cell sarcoma, there is no evidence to support a similar predisposition to leukemia. As immunosuppressive therapy is becoming more common in the treatment of patients with rheumatoid arthritis, there have been recent reports of patients developing fatal myeloproliferative disorders after receiving immunosuppressive therapy. Review of these cases shows similar duration of therapy, and cyclophosphamide, among others, has been implicated as the leukemogenic agent in other patients. We feel that great caution should be exercised in the use of immunosuppressive drugs in patients with chronic, nonfatal disorders sich as rheumatoid arthritis and Sjogren's syndrome.",,,,,
275516,NLM,MEDLINE,19780828,20161017,0098-7484 (Print) 0098-7484 (Linking),240,4,1978 Jul 28,Pure RBC aplasia associated with chronic granulocytic leukemia.,376,"['Kitahara, M']",['Kitahara M'],['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Anemia/chemically induced/*etiology', 'Bone Marrow/pathology', 'Busulfan/adverse effects/therapeutic use', '*Erythrocytes/drug effects', 'Female', 'Humans', 'Hyperplasia', 'Leukemia, Myeloid/drug therapy/*pathology', 'Middle Aged']",1978/07/28 00:00,1978/07/28 00:01,['1978/07/28 00:00'],"['1978/07/28 00:00 [pubmed]', '1978/07/28 00:01 [medline]', '1978/07/28 00:00 [entrez]']",,ppublish,JAMA. 1978 Jul 28;240(4):376.,['G1LN9045DK (Busulfan)'],,,,,,
275472,NLM,MEDLINE,19780814,20190630,0022-3476 (Print) 0022-3476 (Linking),92,6,1978 Jun,Infantile genetic agranulocytosis and acute lymphocytic leukemia in two sibs.,1028,"['Lui, V', 'Ragab, A H', 'Findley, H', 'Frauen, B']","['Lui V', 'Ragab AH', 'Findley H', 'Frauen B']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Agranulocytosis/*genetics', 'Bone Marrow/immunology', 'Cell Division', 'Child', 'Clone Cells', 'Female', 'Humans', 'Infant, Newborn', 'Leukemia, Lymphoid/*genetics']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']","['S0022-3476(78)80399-0 [pii]', '10.1016/s0022-3476(78)80399-0 [doi]']",ppublish,J Pediatr. 1978 Jun;92(6):1028. doi: 10.1016/s0022-3476(78)80399-0.,,,,,,,
275409,NLM,MEDLINE,19780828,20190723,0021-5384 (Print) 0021-5384 (Linking),67,4,1978 Apr 10,[A case of hypokalemia in acute monocytic leukemia (author's transl)].,398-402,"['Tagawa, H', 'Isshiki, T', 'Yamakado, M']","['Tagawa H', 'Isshiki T', 'Yamakado M']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Nihon Naika Gakkai Zasshi,Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,19130210R,IM,"['Female', 'Humans', 'Hypokalemia/*complications', 'Leukemia, Monocytic, Acute/*complications', 'Middle Aged']",1978/04/10 00:00,1978/04/10 00:01,['1978/04/10 00:00'],"['1978/04/10 00:00 [pubmed]', '1978/04/10 00:01 [medline]', '1978/04/10 00:00 [entrez]']",['10.2169/naika.67.398 [doi]'],ppublish,Nihon Naika Gakkai Zasshi. 1978 Apr 10;67(4):398-402. doi: 10.2169/naika.67.398.,,,,,,,
275358,NLM,MEDLINE,19780828,20071115,0019-5847 (Print) 0019-5847 (Linking),70,2,1978 Jan 16,Acute leukaemia presenting with neurological manifestations without any evidence of systemic disease.,41-2,"['Majumdar, G', 'Mangalik, A']","['Majumdar G', 'Mangalik A']",['eng'],"['Case Reports', 'Journal Article']",India,J Indian Med Assoc,Journal of the Indian Medical Association,7505608,IM,"['Adult', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', '*Neurologic Manifestations']",1978/01/16 00:00,1978/01/16 00:01,['1978/01/16 00:00'],"['1978/01/16 00:00 [pubmed]', '1978/01/16 00:01 [medline]', '1978/01/16 00:00 [entrez]']",,ppublish,J Indian Med Assoc. 1978 Jan 16;70(2):41-2.,,,,,,,
275252,NLM,MEDLINE,19780828,20210210,0021-9258 (Print) 0021-9258 (Linking),253,12,1978 Jun 25,Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.,4214-8,"['Reuben, R C', 'Khanna, P L', 'Gazitt, Y', 'Breslow, R', 'Rifkind, R A', 'Marks, P A']","['Reuben RC', 'Khanna PL', 'Gazitt Y', 'Breslow R', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Biol Chem,The Journal of biological chemistry,2985121R,IM,"['Acetamides/pharmacology', 'Amides/pharmacology', 'Carboxylic Acids/pharmacology', 'Cell Differentiation/*drug effects', 'Cell Line', 'Dicarboxylic Acids/pharmacology', 'Dimethyl Sulfoxide/pharmacology', 'Leukemia, Erythroblastic, Acute/*physiopathology', 'Structure-Activity Relationship']",1978/06/25 00:00,1978/06/25 00:01,['1978/06/25 00:00'],"['1978/06/25 00:00 [pubmed]', '1978/06/25 00:01 [medline]', '1978/06/25 00:00 [entrez]']",['S0021-9258(17)34705-1 [pii]'],ppublish,J Biol Chem. 1978 Jun 25;253(12):4214-8.,"['0 (Acetamides)', '0 (Amides)', '0 (Carboxylic Acids)', '0 (Dicarboxylic Acids)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Hexamethylenebisacetamide is a potent inducer of erythroid differentiation in murine erythroleukemia cells. A series of chemical compounds structurally related to hexamethylenebisacetamide were tested for inducing activity including polymethylene chains terminally substituted with various combinations of carboxylate, amino, amide, or sulfoxide groups. Effective ""dimerization"" of dimethyl sulfoxide through a linear polymethylene chain increases its inducing activity by a magnitude similar to that observed when N-methylacetamide is effectively dimerized in such a manner. It was found that all potent inducing agents possess both a hydrophilic and hydrophobic portion of the molecule, as well as a planar portion. All are Lewis bases, possessing a free electron pair available for hydrogen bonding. The polymethylene chain joining functional groups must be flexible and must be 5 to 6 carbon atoms in length to achieve maximal activity. Introduction of triple or double (cis or trans) bonds into the polymethylene chain does not alter activity.",,,,,
275251,NLM,MEDLINE,19780814,20131121,0004-5772 (Print) 0004-5772 (Linking),25,8,1977 Aug,Observations on the therapy of chronic granulocytic leukaemia (C.G.L.) in adults.,547-53,"['Das, K V', 'Thomas, M', 'Pilla, M V', 'Vijayakumar']","['Das KV', 'Thomas M', 'Pilla MV', 'Vijayakumar']",['eng'],['Journal Article'],India,J Assoc Physicians India,The Journal of the Association of Physicians of India,7505585,IM,"['Adolescent', 'Adult', 'Aged', 'Busulfan/administration & dosage/*therapeutic use', 'Child', 'Chronic Disease', 'Female', 'Humans', 'India', 'Leukemia, Myeloid/drug therapy/mortality/radiotherapy/*therapy', 'Male', 'Middle Aged']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,J Assoc Physicians India. 1977 Aug;25(8):547-53.,['G1LN9045DK (Busulfan)'],,,,,,
275199,NLM,MEDLINE,19780828,20071115,0017-7768 (Print) 0017-7768 (Linking),94,3-4,1978 Feb,[Unusual acute lymphoblastic leukemia in an elderly patient].,127-30,"['Berrebi, A', 'Segal, E', 'Yaari, A', 'Nir, E']","['Berrebi A', 'Segal E', 'Yaari A', 'Nir E']",['heb'],"['Case Reports', 'English Abstract', 'Journal Article']",Israel,Harefuah,Harefuah,0034351,IM,"['Aged', 'Humans', 'Leukemia, Lymphoid/*diagnosis/pathology', 'Male']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Harefuah. 1978 Feb;94(3-4):127-30.,,,,,,,
275198,NLM,MEDLINE,19780828,20131121,0017-7768 (Print) 0017-7768 (Linking),94,3-4,1978 Feb,[Multiple myeloma terminating in leukemia].,115-9,"['Manor, Y', 'Steiner, Z', 'Klajman, A', 'Rozenszajn, A']","['Manor Y', 'Steiner Z', 'Klajman A', 'Rozenszajn A']",['heb'],"['English Abstract', 'Journal Article']",Israel,Harefuah,Harefuah,0034351,IM,"['Humans', 'Leukemia, Myeloid/*complications/etiology', 'Melphalan/adverse effects/therapeutic use', 'Multiple Myeloma/*complications/drug therapy']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Harefuah. 1978 Feb;94(3-4):115-9.,['Q41OR9510P (Melphalan)'],,,,,,
275197,NLM,MEDLINE,19780828,20071115,0017-7768 (Print) 0017-7768 (Linking),94,3-4,1978 Feb,[Acute lymphoblastic leukemia with eosinophilia].,115-7,"['Weiss, S', 'Mandel, E M', 'Gafter, U', 'Lewinski, U H', 'Djaldetti, M']","['Weiss S', 'Mandel EM', 'Gafter U', 'Lewinski UH', 'Djaldetti M']",['heb'],"['Case Reports', 'English Abstract', 'Journal Article']",Israel,Harefuah,Harefuah,0034351,IM,"['Adolescent', 'Eosinophilia/*etiology/pathology', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Harefuah. 1978 Feb;94(3-4):115-7.,,,,,,,
275196,NLM,MEDLINE,19780828,20131121,0017-7768 (Print) 0017-7768 (Linking),94,3-4,1978 Feb,[Chronic myeloid leukemia with transition to basophilic leukemia].,111-4,"['Shoham, D', 'Steiner, Z', 'Bar-Sela, S', 'David, E B', 'Pomerantz, A', 'Rozenszajn, L A']","['Shoham D', 'Steiner Z', 'Bar-Sela S', 'David EB', 'Pomerantz A', 'Rozenszajn LA']",['heb'],"['Case Reports', 'English Abstract', 'Journal Article']",Israel,Harefuah,Harefuah,0034351,IM,"['Basophils/*pathology', 'Bone Marrow/pathology', 'Busulfan/therapeutic use', 'Humans', 'Leukemia, Myeloid/drug therapy/*pathology']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Harefuah. 1978 Feb;94(3-4):111-4.,['G1LN9045DK (Busulfan)'],,,,,,
275059,NLM,MEDLINE,19780901,20190907,0014-2964 (Print) 0014-2964 (Linking),14,7,1978 Jul,Hemodialysis and enzymatic cleavage of methotrexate in man.,787-92,"['Howell, S B', 'Blair, H E', 'Uren, J', 'Frei, E 3rd']","['Howell SB', 'Blair HE', 'Uren J', 'Frei E 3rd']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",England,Eur J Cancer,European journal of cancer,0074126,IM,"['Acute Kidney Injury/metabolism', 'Carboxypeptidases/*metabolism', 'Humans', 'Leukemia, Myeloid/drug therapy', 'Male', 'Methotrexate/adverse effects/*blood', 'Middle Aged', '*Renal Dialysis', 'Time Factors']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['10.1016/0014-2964(78)90010-5 [doi]'],ppublish,Eur J Cancer. 1978 Jul;14(7):787-92. doi: 10.1016/0014-2964(78)90010-5.,"['EC 3.4.- (Carboxypeptidases)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
275058,NLM,MEDLINE,19780828,20190907,0014-2964 (Print) 0014-2964 (Linking),14,6,1978 Jun,Effect of medium conditioned by acute myeloid leukaemia cells on normal marrow colony-forming ability and sensitivity to cytosine arabinoside.,661-5,"['Gordon, M Y', 'Douglas, I D', 'Blackett, N M']","['Gordon MY', 'Douglas ID', 'Blackett NM']",['eng'],['Journal Article'],England,Eur J Cancer,European journal of cancer,0074126,IM,"['Bone Marrow/drug effects', '*Bone Marrow Cells', 'Cell Survival/drug effects', 'Clone Cells', 'Culture Media', 'Cytarabine/*pharmacology', 'Humans', 'Leukemia, Myeloid, Acute/*immunology']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1016/0014-2964(78)90301-8 [doi]'],ppublish,Eur J Cancer. 1978 Jun;14(6):661-5. doi: 10.1016/0014-2964(78)90301-8.,"['0 (Culture Media)', '04079A1RDZ (Cytarabine)']",,,,,,
275027,NLM,MEDLINE,19780828,20180214,0301-0171 (Print) 0301-0171 (Linking),21,3,1978,One case of a Ph1 chromosome resulting from translocation of the distal end 22q onto the short arm of chromosome 15.,168-9,"['Jotterand-Bellomo, M']",['Jotterand-Bellomo M'],['eng'],"['Case Reports', 'Journal Article']",Switzerland,Cytogenet Cell Genet,Cytogenetics and cell genetics,0367735,IM,"['Adult', '*Chromosomes, Human, 13-15', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/genetics', '*Translocation, Genetic']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1159/000130889 [doi]'],ppublish,Cytogenet Cell Genet. 1978;21(3):168-9. doi: 10.1159/000130889.,,,,,,,
275026,NLM,MEDLINE,19780828,20130912,0011-4162 (Print) 0011-4162 (Linking),21,6,1978 Jun,Skin manifestations of leukemias and lymphomas.,814-8,"['Stawiski, M A']",['Stawiski MA'],['eng'],['Journal Article'],United States,Cutis,Cutis,0006440,IM,"['Hodgkin Disease/complications', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/complications', 'Leukemia, Myeloid/complications', 'Leukemia, Myeloid, Acute/complications', 'Lymphoma/*diagnosis', 'Lymphoma, Non-Hodgkin/complications', 'Skin Diseases/complications', '*Skin Manifestations']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Cutis. 1978 Jun;21(6):814-8.,,"The diseases discussed in this paper include chronic lymphocytic leukemia, monocytic leukemia, chronic granulocytic leukemia, acute leukemias, Hodgkin's disease, and lymphosarcoma. Cutaneous manifestations of these disorders are often sufficiently different to indicate a certain leukemia or lymphoma. The cutaneous manifestations of leukemias and lymphomas may help the clinician suspect the diagnosis.",,,,,
274997,NLM,MEDLINE,19780901,20131121,0361-5960 (Print) 0361-5960 (Linking),62,5,1978 May,Actinomycin D in childhood acute lymphocytic leukemia.,829-31,"['Green, D M', 'Sallan, S E', 'Krishan, A']","['Green DM', 'Sallan SE', 'Krishan A']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Child', 'Dactinomycin/adverse effects/*therapeutic use', 'Drug Evaluation', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Remission, Spontaneous']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1978 May;62(5):829-31.,['1CC1JFE158 (Dactinomycin)'],"Eighteen evaluable children who relapsed with acute lymphocytic leukemia (ALL) were treated with intermittent, high-dose actinomycin D. Objective responses occurred in four of 11 children who had relapsed with chemotherapy which did not contain an anthracycline. The major toxic effects included thrombocytopenia and granulocytopenia. Minor toxic effects included nausea, vomiting, skin rash, and stomatitis. The onset of the maculopapular skin rash coincided with the platelet count nadir. These data suggested that actinomycin D is active in ALL.",,,,,
274996,NLM,MEDLINE,19780901,20151119,0361-5960 (Print) 0361-5960 (Linking),62,5,1978 May,"Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.",805-9,"['Mathe, G', 'Misset, J L', 'De Vassal, F', 'Gouveia, J', 'Hayat, M', 'Machover, D', 'Belpomme, D', 'Pico, J L', 'Schwarzenberg, L', 'Ribaud, P', 'Musset, M', 'Jasmin, C', 'De Luca, L']","['Mathe G', 'Misset JL', 'De Vassal F', 'Gouveia J', 'Hayat M', 'Machover D', 'Belpomme D', 'Pico JL', 'Schwarzenberg L', 'Ribaud P', 'Musset M', 'Jasmin C', 'De Luca L']",['eng'],['Journal Article'],United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', 'Drug Evaluation', 'Drug Resistance', 'Female', 'Hodgkin Disease/*drug therapy', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Lymphoma, Non-Hodgkin/*drug therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Vinca Alkaloids/*therapeutic use', 'Vincristine/therapeutic use']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1978 May;62(5):805-9.,"['0 (Vinca Alkaloids)', '5J49Q6B70F (Vincristine)']","Vindesine, an analog of vinblastine and vincristine, has been submitted to a phase II trial, the results of which are judged in terms of remission induction. A high proportion of remissions were obtained in acute lymphoid leukemia and blastic crisis of chronic myeloid leukemia, and a few responses have been registered in lymphosarcoma and Hodgkin's disease. A continuous 48-hour iv infusion may induce a remission where an iv push of the same dose has failed. The most remarkable characteristic of vindesine is the absence of cross-resistance with vincristine as documented in acute lymphoid leukemia.",,,,,
274995,NLM,MEDLINE,19780901,20190619,0008-543X (Print) 0008-543X (Linking),41,6,1978 Jun,Prophylactic heparin therapy in acute promyelocytic leukemia.,2484-90,"['Drapkin, R L', 'Gee, T S', 'Dowling, M D', 'Arlin, Z', 'McKenzie, S', 'Kempin, S', 'Clarkson, B']","['Drapkin RL', 'Gee TS', 'Dowling MD', 'Arlin Z', 'McKenzie S', 'Kempin S', 'Clarkson B']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*therapeutic use', 'Cerebral Hemorrhage/complications/prevention & control', 'Disseminated Intravascular Coagulation/complications/*prevention & control', 'Drug Therapy, Combination', 'Female', 'Heparin/*therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/complications/*drug therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Time Factors']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1002/1097-0142(197806)41:6<2484::aid-cncr2820410659>3.0.co;2-# [doi]'],ppublish,Cancer. 1978 Jun;41(6):2484-90. doi: 10.1002/1097-0142(197806)41:6<2484::aid-cncr2820410659>3.0.co;2-#.,"['0 (Antineoplastic Agents)', '9005-49-6 (Heparin)']","Twenty-four patients with acute promyelocytic leukemia were reviewed. Group I, treated between July 1970 and September 1973, received arabinosylcytosine and 6-thioguanine, and there was one complete remission, with 4/7 dying during induction with intracerebral hemorrhages, and 2/7 dying within one month. Group II, treated between May 1974 and March 1975, received daunomycin and arabinosylcytosine without heparin and 2/8 went into remission, with 6/8 dying during induction, 5 with intracerebral hemorrhages. Group III, treated between March 1975 and November 1976, received the identical chemotherapy as group II but with the addition of prophylactic heparin and there were 7/9 complete remissions, with 2/9 dying with intracerebral hemorrhages. In Group III there was an increased incidence of remission induction when compared to Group II (p less than .05) or when compared to Groups I and II combined (p less than .05). There was also a decreased incidence of fatal hemorrhage in Group III. This suggests that prophylactic heparin is useful during remission induction in acute promyelocytic leukemia.",,,,,
274993,NLM,MEDLINE,19780901,20190619,0008-543X (Print) 0008-543X (Linking),41,6,1978 Jun,The Ommaya reservoir: newly recognized complications and recommendations for insertion and use.,2431-7,"['Bleyer, W A', 'Pizzo, P A', 'Spence, A M', 'Platt, W D', 'Benjamin, D R', 'Kolins, C J', 'Poplack, D G']","['Bleyer WA', 'Pizzo PA', 'Spence AM', 'Platt WD', 'Benjamin DR', 'Kolins CJ', 'Poplack DG']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Antineoplastic Agents/*administration & dosage', 'Brain Neoplasms/*drug therapy', 'Burkitt Lymphoma/drug therapy', 'Catheters, Indwelling/*adverse effects', 'Humans', 'Infant', 'Injections, Intraventricular/*adverse effects/instrumentation', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Meningeal Neoplasms/*drug therapy', 'Methotrexate/administration & dosage', 'Neoplasm Seeding']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1002/1097-0142(197806)41:6<2431::aid-cncr2820410650>3.0.co;2-3 [doi]'],ppublish,Cancer. 1978 Jun;41(6):2431-7. doi: 10.1002/1097-0142(197806)41:6<2431::aid-cncr2820410650>3.0.co;2-3.,"['0 (Antineoplastic Agents)', 'YL5FZ2Y5U1 (Methotrexate)']","Two of 27 patients treated with intraventricular chemotherapy via an Ommaya reservoir developed unusual life-threatening complications attributable to the reservoir. In one patient treated for meningeal Burkitt's lymphoma, the cause of death was a large mass of tumor cells growing around the cannula. Also the tip of the cannula was found in the contralateral cerebral peduncle. In the other patient, the tip of the cannula apparently perforated the ventricular wall postoperatively and migrated into the contralateral thalamus. In both cases evidence for methotrexate-associated leukoencephalopathy was present at autopsy. Based on the experience with these two patients, we offer specific recommendations for reservoir insertion and use.",,,,,
274987,NLM,MEDLINE,19780814,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6126,1978 Jun 10,Long remission after lymphoblastic transformation of chronic granulocytic leukaemia.,1525,"['Joyner, M V', 'Dujardin, P', 'Cassuto, J P', 'Audoly, P', 'Schneider, M']","['Joyner MV', 'Dujardin P', 'Cassuto JP', 'Audoly P', 'Schneider M']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy/*pathology', 'Remission, Spontaneous', 'Time Factors']",1978/06/10 00:00,1978/06/10 00:01,['1978/06/10 00:00'],"['1978/06/10 00:00 [pubmed]', '1978/06/10 00:01 [medline]', '1978/06/10 00:00 [entrez]']",['10.1136/bmj.1.6126.1525 [doi]'],ppublish,Br Med J. 1978 Jun 10;1(6126):1525. doi: 10.1136/bmj.1.6126.1525.,,,,PMC1605014,,,
274970,NLM,MEDLINE,19780828,20181113,0028-7091 (Print) 0028-7091 (Linking),54,4,1978 Apr,Epidemiological outlook on cancer.,349-65,"['Curnen, M G']",['Curnen MG'],['eng'],['Journal Article'],United States,Bull N Y Acad Med,Bulletin of the New York Academy of Medicine,7505398,IM,"['Adolescent', 'Adult', 'Aged', 'Breast Neoplasms/epidemiology', 'Female', 'Humans', 'Leukemia/epidemiology', 'Lung Neoplasms/epidemiology', 'Male', 'Middle Aged', 'Neoplasms/*epidemiology', 'Sex Factors', 'United States']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Bull N Y Acad Med. 1978 Apr;54(4):349-65.,,,,PMC1807507,,,
274968,NLM,MEDLINE,19780828,20200108,0006-5242 (Print) 0006-5242 (Linking),36,6,1978 Jun 20,"[Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)].",372-6,"['Buchner, T h', 'Kamanabroo, D', 'Urbanitz, D', 'Hiddemann, W', 'van de Loo, J']","['Buchner Th', 'Kamanabroo D', 'Urbanitz D', 'Hiddemann W', 'van de Loo J']",['ger'],"['English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Adolescent', 'Adult', 'Aged', 'Cell Movement/drug effects', 'Cyclophosphamide/*analogs & derivatives', 'Cytarabine/*therapeutic use', 'Daunorubicin/*therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Ifosfamide/*therapeutic use', 'Leukemia, Lymphoid/*drug therapy', 'Middle Aged', 'Remission, Spontaneous', 'Thioguanine/therapeutic use', 'Vincristine/*therapeutic use']",1978/06/20 00:00,1978/06/20 00:01,['1978/06/20 00:00'],"['1978/06/20 00:00 [pubmed]', '1978/06/20 00:01 [medline]', '1978/06/20 00:00 [entrez]']",['10.1007/BF01000596 [doi]'],ppublish,Blut. 1978 Jun 20;36(6):372-6. doi: 10.1007/BF01000596.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'FTK8U1GZNX (Thioguanine)', 'UM20QQM95Y (Ifosfamide)', 'ZS7284E0ZP (Daunorubicin)']","31 adult patients (study A) with acute myelocytic leukaemia were treated for remission induction with cytosine arabinoside (ARA-C, 100 mg/m2/day) by a 7 (5) day continuous infusion. 3 (2) doses of daunorubicin (DNR, 45 mg/m2 i.v.) were added at daily intervals. For maintenance 5 day ARA-C was given monthly in sequential combination with DNR, thioguanine (TG), or ifosfamide (IFOS). 16 (52%) patients achieved complete remission (C.R.) after 1.8 (1-3) courses and 6.7 (3-10) weeks from treatment start. The median survival for responders and non-responders was 11.5 months, early death rate within 6 weeks was 3 (10%). Median remission duration was 13.5 months. Among 11 patients surving for 7-22 months 7 patients are in first remission for 5.5-20.5 months. DNR, IFOS and TG were given before the 3rd day of ARA-C infusion. In a previous group of 34 leukaemic patients and in 44 therapy courses DNA histograms of bone marrow cells using pulse cytophotometry showed marked accumulation in S-phase for 75% of courses. Also (G2 + M)-cells in the DNA distribution and thymidine pulse labelling indices were markedly increased in most cases, whereas thymidine uptake by scintillation counter was diminished and mitotic indices had not changed significantly. In now 15 patients (study B) the induction regimen was intensified by adding vincristine (VCR, 2 mg i.v.) and 3 doses of IFOS (600 mg/m2 i.v.). Preliminary results are 50% C.R. after 1,7 (1-2) courses and 6.8 (5-10) weeks from initiation of therapy. 2 patients died in the first 6 weeks.","Induktionsbehandlung der akuten myeloischen Leukamie mit Cytosin-Arabinosid -- Daunorubicin, zusatzlicher Effekt von Ifosfamid und Vincristin.",,,,
274967,NLM,MEDLINE,19780828,20190902,0006-5242 (Print) 0006-5242 (Linking),36,6,1978 Jun 20,[PHA- and PWM-stimulation in acute leukaemia (author's transl)].,347-351,"['Koeppen, K M', 'Boll, I']","['Koeppen KM', 'Boll I']",['ger'],"['English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Humans', 'In Vitro Techniques', 'Lectins', 'Leukemia, Myeloid, Acute/*immunology', 'Leukocytes/drug effects/*immunology', 'Lymphocyte Activation/drug effects', 'Mitogens', 'Stimulation, Chemical']",1978/06/20 00:00,1978/06/20 00:01,['1978/06/20 00:00'],"['1978/06/20 00:00 [pubmed]', '1978/06/20 00:01 [medline]', '1978/06/20 00:00 [entrez]']",['10.1007/BF01000592 [doi]'],ppublish,Blut. 1978 Jun 20;36(6):347-351. doi: 10.1007/BF01000592.,"['0 (Lectins)', '0 (Mitogens)']","Peripheral blood cells from patients with acute leukaemia were stimulated in RPMI-medium with Phytohaemagglutinin (PHA) and/or Pokeweed-Mitogen (PWM). Samples of the cultures were taken at 3, 5 and 7 day intervals for cytological characterization. From 119 cultures from 65 patients 76 cultures from 47 patients could be analysed. Cultures stimulated with PHA and/or PWM showed in 43,4% a higher stimulation rate in comparison with cultures from normal persons. These findings are discussed in relation to the increased agar-colony growth growth of leukaemic cells after in vitro PHA-stimulation and transformation of blast cells.",Antigenstimulation peripherer Leukozyten von Patienten mit akuten Leukamien.,,,,
274966,NLM,MEDLINE,19780828,20190902,0006-5242 (Print) 0006-5242 (Linking),36,6,1978 Jun 20,"[ALL-Associated antigen: occurrence on normal blood cells, cell-lines and leukaemic cells (author's transl)].",339-45,"['Rodt, H', 'Netzel, B', 'Thiel, E', 'Haas, R J', 'Huhn, D', 'Thierfelder, S']","['Rodt H', 'Netzel B', 'Thiel E', 'Haas RJ', 'Huhn D', 'Thierfelder S']",['ger'],"['English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Antigens, Neoplasm/*analysis', 'Cell Line', 'Cells, Cultured', 'Humans', 'Immune Sera', 'In Vitro Techniques', 'Leukemia/pathology', 'Leukemia, Lymphoid/*immunology', 'Lymphocytes/immunology']",1978/06/20 00:00,1978/06/20 00:01,['1978/06/20 00:00'],"['1978/06/20 00:00 [pubmed]', '1978/06/20 00:01 [medline]', '1978/06/20 00:00 [entrez]']",['10.1007/BF01000591 [doi]'],ppublish,Blut. 1978 Jun 20;36(6):339-45. doi: 10.1007/BF01000591.,"['0 (Antigens, Neoplasm)', '0 (Immune Sera)']","The specificity of an antiserum against ALL-cells lacking B- and T-cell markers was characterized. The antiserum was used in several indicator systems to investigate the expression of leukaemia-associated antigens on normal lymphocytes, lymphoid cell lines and various leukaemia cells. The relevance of such antisera for the detection and classification of leukaemic cell populations is discussed.","ALL-assoziiertes Antigen: Vorkommen auf normalen Blutzellen, Zell-Linien und Leukamiezellen.",,,,
274965,NLM,MEDLINE,19780814,20210216,0006-4971 (Print) 0006-4971 (Linking),52,1,1978 Jul,Inhibitor of hematopoietic cell proliferation derived from a human leukemic cell line.,143-52,"['Olofsson, T', 'Cline, M J']","['Olofsson T', 'Cline MJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Bone Marrow Cells', 'Cell Line', 'Cell Transformation, Neoplastic', 'Cells, Cultured', '*Hematopoiesis', 'Humans', 'Lectins/pharmacology', 'Leukemia, Myeloid/*blood', 'Lymphocyte Activation']",1978/07/01 00:00,1978/07/01 00:01,['1978/07/01 00:00'],"['1978/07/01 00:00 [pubmed]', '1978/07/01 00:01 [medline]', '1978/07/01 00:00 [entrez]']",['S0006-4971(20)68306-9 [pii]'],ppublish,Blood. 1978 Jul;52(1):143-52.,['0 (Lectins)'],"A continuously growing human myeloid leukemia cell line (K562) produced a potent high-molecular-weight inhibitor of hematopoietic cell proliferation. It was most active against myeloid stem cells (CFU-C) and proliferating T lymphocytes; it was less active against erythroid precursors (CFU-E) and did not inhibit fibroblasts or established lines of epithelioid cells or B lymphocytes. Inhibition of CFU-C was by direct interaction rather than by modulation of production of colony-stimulating activity and probably occurred at restricted points in the cell cycle. Inhibition could, within limits, be reversed by washing the target cells. Production of inhibitors of hematopoiesis is not a general property of established cell lines, and only two have thus far been identified in screening of 30 such lines.",,,,,
274942,NLM,MEDLINE,19780715,20190823,0004-8291 (Print) 0004-8291 (Linking),7,6,1977 Dec,Acute myeloblastic leukaemia with marrow fibrosis (malignant myelosclerosis): acute leukaemia or malignant myelosclerosis?,638-41,"['Manoharan, A', 'Pitney, W R']","['Manoharan A', 'Pitney WR']",['eng'],"['Case Reports', 'Journal Article']",Australia,Aust N Z J Med,Australian and New Zealand journal of medicine,1264322,IM,"['Acute Disease', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Male', 'Middle Aged', 'Primary Myelofibrosis/*complications']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1111/j.1445-5994.1977.tb02322.x [doi]'],ppublish,Aust N Z J Med. 1977 Dec;7(6):638-41. doi: 10.1111/j.1445-5994.1977.tb02322.x.,,"Malignant myelosclerosis has been described as a rare form of acute myeloproliferative disorder characterised by minimal or absent splenomegaly, cytopenias, circulating myeloblasts and diffuse marrow fibrosis, but distinction between this entity and acute myeloblastic leukaemia with marrow fibrosis is difficult. This report describes a 50-year-old man who presented with features similar to those of malignant myelosclerosis but ther terminal stage was characterised by generalised lymphadenopathy, bone tenderness, marked leucocytosis and myeloblastaemia. Post mortem examination showed multiple chloromata consisting of myeloblasts. These findings suggest that malignant myelosclerosis may be but a variant of acute myeloblastic leukaemia and probably should be treated similarly. A possible association between diagnostic medical irradiation and this acute myeloproliferative disorder is discussed.",,,,,
274919,NLM,MEDLINE,19780724,20190717,0003-9942 (Print) 0003-9942 (Linking),35,6,1978 Jun,Allescheria (Petriellidium) boydii brain abscess in a child with leukemia.,386-8,"['Bell, W E', 'Myers, M G']","['Bell WE', 'Myers MG']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Neurol,Archives of neurology,0372436,IM,"['Amphotericin B/therapeutic use', 'Ascomycota', 'Brain Abscess/*etiology/therapy', 'Child, Preschool', 'Drainage', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Mycoses/*etiology/therapy']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1001/archneur.1978.00500300060011 [doi]'],ppublish,Arch Neurol. 1978 Jun;35(6):386-8. doi: 10.1001/archneur.1978.00500300060011.,['7XU7A7DROE (Amphotericin B)'],A 3-year-old boy with acute lymphoblastic leukemia developed a right frontal lobe abscess from which Allescheria (Petriellidium) boydii was cultured. The mycotic infection complicating his underlying disease appeared to be confined to the brain. Surgical drainage and therapy with amphotericin B were followed by eventual recovery with no neurologic deficits.,,,,,
274915,NLM,MEDLINE,19780715,20071115,0003-4509 (Print) 0003-4509 (Linking),35,11-12,1977 Nov-Dec,[Disparity in the regression of various biosyntheses affecting blasts from acute leukemia of low myeloblastic differentiation].,427-33,"['Piette, C', 'Piette, M']","['Piette C', 'Piette M']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Pharm Fr,Annales pharmaceutiques francaises,2985176R,IM,"['Animals', 'Leukemia, Myeloid, Acute/*metabolism/pathology', 'Mice']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Ann Pharm Fr. 1977 Nov-Dec;35(11-12):427-33.,,,Disparite dans la regression de certaines biosyntheses affectant les blastes des leucemies aigues a faible differenciation myeloblastique.,,,,
274914,NLM,MEDLINE,19780724,20131121,0003-410X (Print) 0003-410X (Linking),129,3,1978 Mar,"[Myelomonocytoid leukemia, abnormal cellular clone with a marker chromosome, evolution with a possible cure].",215-8,"['Rouesse, J', 'Berger, R', 'Amiel, J L']","['Rouesse J', 'Berger R', 'Amiel JL']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,IM,"['Adult', 'Chromosomes, Human, 21-22 and Y/analysis', 'Clone Cells/*analysis', 'Cytodiagnosis', 'Cytogenetics', 'Etoposide/therapeutic use', 'Female', 'Humans', 'Leukemia/drug therapy', 'Leukemia, Myeloid/*diagnosis/genetics']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1978 Mar;129(3):215-8.,['6PLQ3CP4P3 (Etoposide)'],,"Leucemie myelomonocytoide, clone cellulaire anormal avec chromosome ""marqueur"", evolution vers une possible guerison.",,,,
274907,NLM,MEDLINE,19780724,20190626,0002-9343 (Print) 0002-9343 (Linking),64,6,1978 Jun,Cellular immunologic studies of a patient with monocytic leukemia.,1061-8,"['Ackerman, S K', 'Bumol, T F', 'Kay, N E', 'Douglas, S D']","['Ackerman SK', 'Bumol TF', 'Kay NE', 'Douglas SD']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med,The American journal of medicine,0267200,IM,"['Chemotaxis, Leukocyte', 'Cytotoxicity, Immunologic', 'Humans', '*Immunity, Cellular', 'Leukemia, Myeloid/*immunology/pathology', 'Leukocyte Adherence Inhibition Test', 'Leukocytes/immunology', 'Male', 'Middle Aged', 'Monocytes/ultrastructure', 'Receptors, Antigen, B-Cell/analysis']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']","['0002-9343(78)90462-X [pii]', '10.1016/0002-9343(78)90462-x [doi]']",ppublish,Am J Med. 1978 Jun;64(6):1061-8. doi: 10.1016/0002-9343(78)90462-x.,"['0 (Receptors, Antigen, B-Cell)']",,,,,,
274906,NLM,MEDLINE,19780724,20190819,0361-8609 (Print) 0361-8609 (Linking),4,1,1978,The distinctive features of acute monocytic leukemia.,97-103,"['Shaw, M T']",['Shaw MT'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Hematol,American journal of hematology,7610369,IM,"['Blood Coagulation Disorders/etiology', 'Cell Nucleus/ultrastructure', 'Disseminated Intravascular Coagulation/etiology', 'Esterases', 'Etoposide/therapeutic use', 'Gingival Hypertrophy/etiology', 'Histocytochemistry', 'Humans', 'Leukemia, Monocytic, Acute/*diagnosis/drug therapy', 'Lymph Nodes/pathology', 'Monocytes/ultrastructure', 'Muramidase/blood', 'Prednisolone/therapeutic use', 'Vinblastine/therapeutic use', 'Vincristine/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/ajh.2830040113 [doi]'],ppublish,Am J Hematol. 1978;4(1):97-103. doi: 10.1002/ajh.2830040113.,"['5J49Q6B70F (Vincristine)', '5V9KLZ54CY (Vinblastine)', '6PLQ3CP4P3 (Etoposide)', '9PHQ9Y1OLM (Prednisolone)', 'EC 3.1.- (Esterases)', 'EC 3.2.1.17 (Muramidase)']","Acute monocytic leukemia is an uncommon form of acute leukemia. Distinctive clinical features include gingival hypertrophy, lymphoadenopathy, coagulation disorders, and lysozymuria. Blast cell morphology and cytochemistry are diagnostic. Receptors for the Fc fragment of IgG have been demonstrated on the basis of a few cases. The drug VP 16-213 has been shown to be very effective in treatment of untreated and previously treated patients.",,,,,
274905,NLM,MEDLINE,19780724,20190819,0361-8609 (Print) 0361-8609 (Linking),4,1,1978,Acute lymphoblastic leukemia--hand mirror cell variant: a detailed cytological and ultrastructural study with an analysis of the immunologic surface markers.,67-77,"['Stass, S A', 'Perlin, E', 'Jaffe, E S', 'Simon, D R', 'Creegan, W J', 'Robinson, J J', 'Holloway, M L', 'Schumacher, H R']","['Stass SA', 'Perlin E', 'Jaffe ES', 'Simon DR', 'Creegan WJ', 'Robinson JJ', 'Holloway ML', 'Schumacher HR']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Am J Hematol,American journal of hematology,7610369,IM,"['Binding Sites', 'Bone Marrow/immunology/*ultrastructure', 'Cell Membrane/immunology/ultrastructure', 'Chromosomes, Human', 'Female', 'Humans', 'Immunoglobulin G', 'Immunoglobulin M', 'Karyotyping', 'Leukemia, Lymphoid/immunology/*ultrastructure', 'Microscopy, Electron', 'Rosette Formation']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/ajh.2830040109 [doi]'],ppublish,Am J Hematol. 1978;4(1):67-77. doi: 10.1002/ajh.2830040109.,"['0 (Immunoglobulin G)', '0 (Immunoglobulin M)']","Acute lymphoblastic leukemia was observed in a 22-year-old white female patient and was manifested by normal palelet counts, 50--60% hand mirror cells (HMC) in the bone marrow, and prolonged survival without treatment. The characteristic neoplastic cell had a nucleus within the ""mirror"" portion and a cytoplasmic uropod forming the ""handle"" portion. The presence of acid phosphatase and beta-glucuronidase activity suggested that the cell was a T cell lymphoblast. However, extensive immunologic surface marker studies indicated the cells were non-T, non-B. Terminal transferase activity further supported the lymphoid nature of the cell. The hand mirrow cells were considered a real phenomenon since they were demonstrated on phase contrast microscopy, scanning electron microscopy, and transmission electron microscopy. The cells did not grow in tissue culture and cytogenetics revealed a normal female karyotype. From the above observations, the HMC is a lymphoblast with morphological, cytochemical, and immunological features which may differentiate it from the usual cell in acute lymphoblastic leukemia. Therefore, cases involving increased numbers of hand mirror cells in the bone marrow and acute lymphoblastic leukemia require further investigation to elucidate the full importance of this cell. This study represents the first attempt to investigate this cell in detail.",,,,,
274904,NLM,MEDLINE,19780726,20190716,0002-922X (Print) 0002-922X (Linking),132,6,1978 Jun,Spinal fluid LDH activity in children with acute leukemia.,634-5,"['Reeves, J D', 'Hutter, J J Jr', 'Favara, B E']","['Reeves JD', 'Hutter JJ Jr', 'Favara BE']",['eng'],['Journal Article'],United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Adolescent', 'Central Nervous System Diseases/*cerebrospinal fluid/etiology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'L-Lactate Dehydrogenase/*cerebrospinal fluid', 'Leukemia, Lymphoid/*cerebrospinal fluid/diagnosis', 'Male', 'Recurrence']",1978/06/01 00:00,2001/03/28 10:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1001/archpedi.1978.02120310098022 [doi]'],ppublish,Am J Dis Child. 1978 Jun;132(6):634-5. doi: 10.1001/archpedi.1978.02120310098022.,['EC 1.1.1.27 (L-Lactate Dehydrogenase)'],,,,,,
274898,NLM,MEDLINE,19780715,20190819,0001-656X (Print) 0001-656X (Linking),67,3,1978 May,Blood volume of children with leukemia.,281-4,"['Linderkamp, O', 'Lau, B', 'Riegel, K P', 'Betke, K']","['Linderkamp O', 'Lau B', 'Riegel KP', 'Betke K']",['eng'],['Journal Article'],Sweden,Acta Paediatr Scand,Acta paediatrica Scandinavica,0000211,IM,"['Adolescent', '*Blood Volume', 'Child', 'Child, Preschool', 'Erythrocyte Volume', 'Hematocrit', 'Hepatomegaly/blood', 'Humans', 'Infant', 'Leukemia/*physiopathology', 'Leukemia, Lymphoid/physiopathology', 'Leukemia, Monocytic, Acute/physiopathology', 'Leukemia, Myeloid/physiopathology', 'Leukemia, Myeloid, Acute/physiopathology', 'Plasma Volume', 'Splenomegaly/blood']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1111/j.1651-2227.1978.tb16321.x [doi]'],ppublish,Acta Paediatr Scand. 1978 May;67(3):281-4. doi: 10.1111/j.1651-2227.1978.tb16321.x.,,"Blood volume was measured using 125iodinated human serum albumin in 27 children with acute lymphoblastic leukemia, and in 7 children with various types of leukemia. Total blood volume was normal in patients without marked enlargement of spleen and liver, and increased progressively as spleen and liver size increased. The hypervolemia was entirely due to expansion of plasma volume. In the children with marked hepatosplenomegaly, only hematocrit (but not red cell mass) was below the normal range in most cases. Both hematocrit and red cell mass were subnormal in the majority of patients without considerably enlarged spleen and liver. Therefore, anemia in children with marked hepatosplenomegaly may be partly caused by hemodilution of red blood cells in expanded plasma volume.",,,,,
274887,NLM,MEDLINE,19780726,20071115,0001-5547 (Print) 0001-5547 (Linking),22,1,1978 Jan-Feb,Intracellular starch granules in cytologic material.,36-7,"['Reinhartz, T', 'Lijovetzky, G', 'Levij, I S']","['Reinhartz T', 'Lijovetzky G', 'Levij IS']",['eng'],"['Case Reports', 'Journal Article']",Switzerland,Acta Cytol,Acta cytologica,0370307,IM,"['Cerebrospinal Fluid/*cytology', 'Child', 'Cytodiagnosis', '*Diagnostic Errors', 'Humans', 'Leukemia, Lymphoid/*diagnosis', 'Male', 'Phagocytes/*physiology', '*Phagocytosis', '*Starch']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Acta Cytol. 1978 Jan-Feb;22(1):36-7.,['9005-25-8 (Starch)'],"Starch glove powder may contaminate the environment and material removed from patients. When such material is not fixed immediately, starch granules may be ingested by viable phagocytes, possibly giving rise to the mistaken impression that phagocytosis took place in the body of the patient. The presence of phagocytosed material in cytologic preparations should not automatically lead to the conclusion that intravital phagocytosis has taken place.",,,,,
274807,NLM,MEDLINE,19780715,20190907,0036-553X (Print) 0036-553X (Linking),20,4,1978 Apr,Familial erythroleukaemia: a cytogenetic and haematological study.,351-9,"['Davidson, R J', 'Walker, W', 'Watt, J L', 'Page, B M']","['Davidson RJ', 'Walker W', 'Watt JL', 'Page BM']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Bone Marrow/ultrastructure', '*Chromosome Aberrations', 'Female', 'Humans', 'Leukemia, Erythroblastic, Acute/blood/*genetics', 'Male', 'Pedigree']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02467.x [doi]'],ppublish,Scand J Haematol. 1978 Apr;20(4):351-9. doi: 10.1111/j.1600-0609.1978.tb02467.x.,,Clinical and haematological details of 2 siblings with a familial myeloproliferative disorder (erythroleukaemia) are presented. Their father is presumed to have died from a similar disease. The 2 siblings showed similar but not identical chromosomal abnormalities detected initially in marrow and later in peripheral blood. Serial studies revealed the emergence of an increasingly diverse pattern of chromosomal changes coincident with the haematological and clinical progression of the disease. Other members of the family were screened for cytogenetic and haematological changes. The paternal sibship displayed an increased incidence of cancer.,,,,,
274806,NLM,MEDLINE,19780715,20190907,0036-553X (Print) 0036-553X (Linking),20,4,1978 Apr,Subcutaneous cerebrospinal fluid reservoirs in patients with acute leukaemia.,289-96,"['Spiers, A S', 'Booth, A E', 'Firth, J L']","['Spiers AS', 'Booth AE', 'Firth JL']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Antineoplastic Agents/*administration & dosage/therapeutic use', 'Catheterization/instrumentation', 'Child', 'Child, Preschool', 'Evaluation Studies as Topic', 'Female', 'Follow-Up Studies', 'Humans', 'Injections, Intraventricular/*instrumentation', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Lymphoma/*drug therapy', 'Male', 'Meningeal Neoplasms/cerebrospinal fluid/*drug therapy/prevention & control', 'Methods', 'Neoplasm Recurrence, Local']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02460.x [doi]'],ppublish,Scand J Haematol. 1978 Apr;20(4):289-96. doi: 10.1111/j.1600-0609.1978.tb02460.x.,['0 (Antineoplastic Agents)'],"Subcutaneous cerebrospinal fluid (Ommaya) reservoirs were inserted in 23 patients wich acute leukaemia and 2 patients with malignant lymphoma. In 9 leukaemia patients reservoirs were used for the prophylaxis of central nervous system leukaemia: only 1 patient developed meningeal leukaemia but less invasive therapy has now been shown to achieve effective prophylaxis and prophylactic use of Ommaya reservoirs has been discontinued. In 16 patients, reservoirs were inserted as aids to the treatment of meningeal leukaemia or lymphoma. Intracranial disease was successfully controlled and recurrences were prevented but patients eventually died from relapse of their systemic disease. The principal complications of the subcutaneous reservoirs were obstruction, misplacement, and one case of infection. Leucoencephalopathy in several patients was attributable to irradiation and cytotoxic drugs and not to the reservoirs. Problems due to misplacement of the reservoir occurred in 3 out of 13 reservoirs inserted by the occipital route and in only 1 of 12 reservoirs inserted by a frontal approach. With adequate supervision, the reservoirs are valuable aids to intrathecal therapy in patients with established meningeal leukaemia or lymphoma.",,,,,
274770,NLM,MEDLINE,19780724,20071115,0035-1628 (Print) 0035-1628 (Linking),26,2-3,1978 Feb-Mar,"[Psychoanalysis, psychotherapy, and the sick child].",79-86,"['Bouras, M']",['Bouras M'],['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",France,Rev Neuropsychiatr Infant,Revue de neuropsychiatrie infantile et d'hygiene mentale de l'enfance,7905374,IM,"['*Attitude to Death', '*Attitude to Health', 'Child', 'Humans', 'Leukemia, Lymphoid/*psychology', 'Male', 'Psychoanalysis', 'Psychotherapy']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Rev Neuropsychiatr Infant. 1978 Feb-Mar;26(2-3):79-86.,,,"Psychanalyse, psychotherapie, enfant malade.",,,,
274746,NLM,MEDLINE,19780726,20200930,0037-9727 (Print) 0037-9727 (Linking),157,4,1978 Apr,Characterization of transplantable myelomonocytic leukemia WEHI-3B in syngeneic BALB/c mice.,556-64,"['Murphy, W H', 'Urnovitz, H B', 'Maryanski, J L', 'Abrams, G D']","['Murphy WH', 'Urnovitz HB', 'Maryanski JL', 'Abrams GD']",['eng'],['Journal Article'],United States,Proc Soc Exp Biol Med,"Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)",7505892,IM,"['Animals', 'Cell Count', 'Cell Line', 'Disease Models, Animal', 'Female', 'Leukemia, Experimental/blood/*pathology', 'Leukemia, Myeloid, Acute/pathology', 'Liver/pathology', 'Mice', 'Mice, Inbred BALB C', 'Neoplasm Transplantation', 'Spleen/pathology', 'Transplantation, Isogeneic']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.3181/00379727-157-40096 [doi]'],ppublish,Proc Soc Exp Biol Med. 1978 Apr;157(4):556-64. doi: 10.3181/00379727-157-40096.,,,,,,,
274726,NLM,MEDLINE,19780715,20190501,0027-8424 (Print) 0027-8424 (Linking),75,3,1978 Mar,Indirect induction of differentiation in myeloid leukemic cells by lipid A.,1374-8,"['Weiss, B', 'Sachs, L']","['Weiss B', 'Sachs L']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Binding Sites', 'Cell Differentiation/*drug effects', 'Complement C3/metabolism', 'Growth Substances/metabolism', 'Immunoglobulin Fc Fragments/metabolism', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid, Acute/pathology', 'Lipid A/*pharmacology', 'Lipopolysaccharides/*pharmacology', 'Macrophages/*cytology', 'Muramidase/biosynthesis', 'Species Specificity']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1073/pnas.75.3.1374 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1978 Mar;75(3):1374-8. doi: 10.1073/pnas.75.3.1374.,"['0 (Complement C3)', '0 (Growth Substances)', '0 (Immunoglobulin Fc Fragments)', '0 (Lipid A)', '0 (Lipopolysaccharides)', 'EC 3.2.1.17 (Muramidase)']","Normal myeloid and MGI(+)D(+) clones of myeloid leukemic cells can be induced for Fc and complement component 3 rosettes, lysozme, and mature macrophages and granulocytes by a protein with macrophage- and granulocyte-inducing (MGI) activity, whereas MGI(+)D(-) clones can be induced by this protein for rosettes and lysozme but not mature cells. Lipopolysaccharides (LPS) from different bacteria induced the appearance of rosettes, lysozyme, and macrophages in some MGI(+)D(+) clones but did not induce any of these changes in MGI(+)D(-) clones. Lipid A gave the same results as LPS. Incubation of MGI(+)D(+) cells with LPS also induced an MGI activity detectable in the culture medium. This activity behaved like MGI in inducing (i) rosettes, lysozyme, and mature cells in MGI(+)D(+) leukemic cells including a clone resistant to LPS, (ii) rosettes and lysozyme in MGI(+)D(-) leukemic cells, and (iii) differentiation of normal myeloid cells to mature macrophages and granulocytes. This activity was induced in MGI(+)D(+) cells by LPS before the induction of rosettes or lysozyme. The results indicate that the lipid A portion of LPS indirectly induces differentiation of MGI(+)D(+) myeloid leukemic cells by inducing MGI protein. It is suggested that induction of specific regulatory proteins may be a more general mechanism for the induction of differentiation by surface-acting compounds.",,PMC411474,,,
274695,NLM,MEDLINE,19780715,20071115,0552-2080 (Print) 0552-2080 (Linking),23,4,1978 Apr,"[Case of ""low-grade"" acute leukemia].",47-8,"['Vasygova, N F', 'Osipova, L A']","['Vasygova NF', 'Osipova LA']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Anemia, Aplastic/*pathology', 'Anemia, Hypochromic/pathology', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Middle Aged']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1978 Apr;23(4):47-8.,,,"O sluchae ""maloprotsentnogo"" ostrogo leikoza.",,,,
274693,NLM,MEDLINE,19780724,20080620,0032-3756 (Print) 0032-3756 (Linking),33,16,1978 Apr 17,[Cytomorphological and cytochemical observations of leukocytes in blastic crisis in chronic myeloid leukemia].,633-6,"['Kotlarek-Haus, S', 'Brodzka, W', 'Fleischer, J', 'Kuliszkiewicz-Janus, M']","['Kotlarek-Haus S', 'Brodzka W', 'Fleischer J', 'Kuliszkiewicz-Janus M']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Acid Phosphatase/blood', 'Acute Disease', 'Humans', 'Leukemia, Myeloid/*blood/pathology', 'Leukocytes/enzymology/*pathology']",1978/04/17 00:00,1978/04/17 00:01,['1978/04/17 00:00'],"['1978/04/17 00:00 [pubmed]', '1978/04/17 00:01 [medline]', '1978/04/17 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1978 Apr 17;33(16):633-6.,['EC 3.1.3.2 (Acid Phosphatase)'],,Cytomorfologiczne i cytochemiczne obserwacje leukocytow przelomu blastycznego przewleklej bialaczki szpikowej.,,,,
274692,NLM,MEDLINE,19780724,20080620,0032-3756 (Print) 0032-3756 (Linking),33,15,1978 Apr 10,[Results of intensive cytostatic treatment of blastic exacerbation of chronic myeloid leukemia].,583-6,"['Sylwestrowicz, T', 'Zdziechowska, H', 'Maj, S', 'Pawelski, S', 'Lewicka, T']","['Sylwestrowicz T', 'Zdziechowska H', 'Maj S', 'Pawelski S', 'Lewicka T']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Acute Disease', 'Adult', 'Aged', 'Antineoplastic Agents/*administration & dosage/therapeutic use', 'Drug Therapy, Combination/methods', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Middle Aged']",1978/04/10 00:00,1978/04/10 00:01,['1978/04/10 00:00'],"['1978/04/10 00:00 [pubmed]', '1978/04/10 00:01 [medline]', '1978/04/10 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1978 Apr 10;33(15):583-6.,['0 (Antineoplastic Agents)'],,Wyniki intensywnego leczenia zaostrzenia blastycznego przewleklej bialaczki szpikowej.,,,,
274680,NLM,MEDLINE,19780715,20091021,0030-6002 (Print) 0030-6002 (Linking),119,17,1978 Apr 23,[Cytogenetic examination of the spleen in the blastic phase of chronic granulocytic leukemia].,1039-43,"['Olah, E', 'Kiss, A', 'Jako, J']","['Olah E', 'Kiss A', 'Jako J']",['hun'],"['Case Reports', 'Journal Article']",Hungary,Orv Hetil,Orvosi hetilap,0376412,IM,"['Adult', 'Chromosome Aberrations', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics/immunology', 'Lymphocyte Activation', 'Male', 'Spleen/*cytology/immunology', 'Splenectomy']",1978/04/23 00:00,1978/04/23 00:01,['1978/04/23 00:00'],"['1978/04/23 00:00 [pubmed]', '1978/04/23 00:01 [medline]', '1978/04/23 00:00 [entrez]']",,ppublish,Orv Hetil. 1978 Apr 23;119(17):1039-43.,,,A lep cytogenetikai vizsgalata a chronikus granulocytas leukaemia blastos fazisaban.,,,,
274679,NLM,MEDLINE,19780715,20201226,0030-2414 (Print) 0030-2414 (Linking),35,2,1978,An autopsy study of the metastatic patterns of human leukemias.,87-96,"['Viadana, E', 'Bross, I D', 'Pickren, J W']","['Viadana E', 'Bross ID', 'Pickren JW']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Switzerland,Oncology,Oncology,0135054,IM,"['Autopsy', 'Humans', 'Leukemia/*pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid/pathology', 'Leukemia, Myeloid, Acute/pathology', 'Lymphatic Metastasis/pathology', 'Neoplasm Metastasis/*pathology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1159/000225262 [doi]'],ppublish,Oncology. 1978;35(2):87-96. doi: 10.1159/000225262.,,"This paper analyses the distribution of metastases at every site of the human body in acute lymphoblastic, chronic lymphocytic, acute myeblastic and chronic myelocytic leukemias in patients that come to autopsy. It appeared that the 4 types of leukemia had a similar seeding frequency of the skin, breast, trachea, diaphragm and all other muscles. The highest incidence of metastases was found in the lymphatic system (i.e. all lymph-nodes and spleen). Acute lymphoblastic leukemia showed an excess of metastases in the major blood vessels, pleura, large intestines, extrahepatic biliary tract, ureters, prostate, cervix uteri, central nervous system, thymus, ovaries and pituitary. The excess of metastases at specific sites did not cluster either in topographical areas or in anatomical systems, with the exception of metastases in the central nervous and endocrine systems (acute lymphoblastic leukemia). Chronic lymphocytic leukemia showed an excess of metastases in all lymph nodes, kidney, adrenals and heart. A lymphatic route of dissemination, as opposed to a blood-borne spread of malignant cells, was hypothesised to account for the excess of metastases in the above mentioned organs in patients affected with chronic lymphocytic leukemia. Soil specificity with the degree of anaplasia of leukemic cells may account for the higher than expected occurrence of metastases in a given organ, for a specific leukemia. This remark holds true particularly for acute lymphoblastic leukemia.",,,,,
274608,NLM,MEDLINE,19780724,20071115,0028-4793 (Print) 0028-4793 (Linking),298,22,1978 Jun 1,Spurious thrombocytosis in acute myelocytic leukemia.,1260,"['Malcolm, I D', 'Monks, P', 'Katz, M']","['Malcolm ID', 'Monks P', 'Katz M']",['eng'],"['Case Reports', 'Letter']",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Aged', 'Blood Cell Count/methods', 'Diagnosis, Differential', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Male', 'Thrombocytosis/*diagnosis']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1056/NEJM197806012982215 [doi]'],ppublish,N Engl J Med. 1978 Jun 1;298(22):1260. doi: 10.1056/NEJM197806012982215.,,,,,,,
274606,NLM,MEDLINE,19780715,20071115,0024-3507 (Print) 0024-3507 (Linking),23,3,1978 May,[Specific ovarian localizations in acute leukemias (apropos of 3 cases)].,151-7,"['Bauters, F', 'Roussy, M', 'Leduc, M', 'Jouet, J P', 'Goudemand, J', 'Goudemand, M']","['Bauters F', 'Roussy M', 'Leduc M', 'Jouet JP', 'Goudemand J', 'Goudemand M']",['fre'],"['Case Reports', 'Journal Article']",France,Lille Med,Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,8203780,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Female', 'Humans', '*Leukemia, Lymphoid/pathology', '*Leukemia, Myeloid, Acute/pathology', '*Ovarian Neoplasms/pathology', 'Ovary/pathology']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Lille Med. 1978 May;23(3):151-7.,,,Les localisations ovariennes specifiques au cours des leucemies aiguues (a propos de 3 observations).,,,,
274595,NLM,MEDLINE,19780724,20110727,0047-1852 (Print) 0047-1852 (Linking),35 Suppl 1,,1977 Spring,[di Guglielmo's syndrome].,930-1,"['Yamada, H']",['Yamada H'],['jpn'],['Journal Article'],Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Humans', '*Leukemia, Erythroblastic, Acute']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nihon Rinsho. 1977 Spring;35 Suppl 1:930-1.,,,,,,,
274592,NLM,MEDLINE,19780715,20071115,0485-1439 (Print) 0485-1439 (Linking),19,2,1978 Feb,[Aplastic anemia and acute leukemia in two siblings (author's transl)].,180-6,"['Sawa, F', 'Shinomiya, N', 'Maruyama, S', 'Nakagawa, T', 'Tsukimoto, I', 'Nakayama, K']","['Sawa F', 'Shinomiya N', 'Maruyama S', 'Nakagawa T', 'Tsukimoto I', 'Nakayama K']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Anemia, Aplastic/*genetics', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Japan', 'Leukemia, Lymphoid/*genetics', 'Male', 'Nuclear Warfare']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1978 Feb;19(2):180-6.,,,,,,,
274591,NLM,MEDLINE,19780715,20061115,0485-1439 (Print) 0485-1439 (Linking),19,2,1978 Feb,"[A case of 45, X, -Y, Ph1 chronic granulocytic leukemia in an atomic bomb survivor and a review of the literature (author's transl)].",139-46,"['Mikami, M', 'Sofuni, T']","['Mikami M', 'Sofuni T']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Japan', 'Leukemia, Myeloid/*genetics', 'Leukemia, Radiation-Induced/*genetics', 'Male', 'Middle Aged', '*Nuclear Warfare']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1978 Feb;19(2):139-46.,,,,,,,
274588,NLM,MEDLINE,19780726,20190630,0098-7484 (Print) 0098-7484 (Linking),239,23,1978 Jun 9,"Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.",2472-4,"['Ettinger, D S', 'Harker, W G', 'Gerry, H W', 'Sanders, R C', 'Saral, R']","['Ettinger DS', 'Harker WG', 'Gerry HW', 'Sanders RC', 'Saral R']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,JAMA,JAMA,7501160,IM,"['Acute Kidney Injury/*chemically induced', 'Adult', 'Antineoplastic Agents/*adverse effects/therapeutic use', 'Humans', 'Hypocalcemia/*chemically induced', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Phosphates/*blood']",1978/06/09 00:00,1978/06/09 00:01,['1978/06/09 00:00'],"['1978/06/09 00:00 [pubmed]', '1978/06/09 00:01 [medline]', '1978/06/09 00:00 [entrez]']",['10.1001/jama.239.23.2472 [doi]'],ppublish,JAMA. 1978 Jun 9;239(23):2472-4. doi: 10.1001/jama.239.23.2472.,"['0 (Antineoplastic Agents)', '0 (Phosphates)']",,,,,,
274587,NLM,MEDLINE,19780715,20190509,0027-8874 (Print) 0027-8874 (Linking),60,6,1978 Jun,Thirteen cases of leukemia in a family.,1243-50,"['Gunz, F W', 'Gunz, J P', 'Vincent, P C', 'Bergin, M', 'Johnson, F L', 'Bashir, H', 'Kirk, R L']","['Gunz FW', 'Gunz JP', 'Vincent PC', 'Bergin M', 'Johnson FL', 'Bashir H', 'Kirk RL']",['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Adolescent', 'Aged', 'Blood Proteins', 'Child', 'Child, Preschool', 'Chromosomes', 'Erythrocytes/enzymology', 'Female', 'HLA Antigens', 'Humans', 'Immunity, Cellular', 'Leukemia/*genetics/immunology/microbiology', 'Leukemia, Myeloid/genetics', 'Leukemia, Myeloid, Acute/genetics', 'Male', 'Middle Aged', 'Oncogenic Viruses/isolation & purification', 'Pedigree']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['10.1093/jnci/60.6.1243 [doi]'],ppublish,J Natl Cancer Inst. 1978 Jun;60(6):1243-50. doi: 10.1093/jnci/60.6.1243.,"['0 (Blood Proteins)', '0 (HLA Antigens)']","Thirteen cases of leukemia, 12 of them acute, occurred in 3 generations of a family comprising 293 members. Individual cases could not be linked to the possession of any of a range of genetic markers. Cytogenetic studies showed no constitutional chromosome abnormalities. Preliminary results of virologic studies suggested the presence of oncornaviruses in at least 1 leukemic individual in this family. This aggregation of leukemia cases likely resulted from a genetic, probably polygenic, predisposition, in association with the activity of leukemogenic factors whose nature remains to be clearly defined.",,,,,
274500,NLM,MEDLINE,19780715,20071115,0025-0694 (Print) 0025-0694 (Linking),69,4,1978 Apr,Treatment of acute leukemia in adults.,"109-10, 112","['Case, D C Jr']",['Case DC Jr'],['eng'],['Journal Article'],United States,J Maine Med Assoc,The Journal of the Maine Medical Association,7505619,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Leukemia/*therapy', 'Leukemia, Lymphoid/therapy', 'Leukemia, Myeloid/therapy', 'Leukemia, Myeloid, Acute/therapy', 'Male', 'Middle Aged']",1978/04/01 00:00,2001/03/28 10:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,"J Maine Med Assoc. 1978 Apr;69(4):109-10, 112.",,,,,,,
274499,NLM,MEDLINE,19780726,20131121,0022-2143 (Print) 0022-2143 (Linking),91,6,1978 Jun,The identification and measurement of a folate-binding protein in human serum by radioimmunoassay.,901-7,"['da Costa, M', 'Rothenberg, S P', 'Fischer, C', 'Rosenberg, Z']","['da Costa M', 'Rothenberg SP', 'Fischer C', 'Rosenberg Z']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Lab Clin Med,The Journal of laboratory and clinical medicine,0375375,IM,"['Antigen-Antibody Complex', 'Carrier Proteins/*blood/immunology', 'Female', 'Folic Acid/*blood', 'Humans', 'Leukemia, Myeloid/blood', 'Pregnancy', 'Radioimmunoassay/*methods']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['0022-2143(78)90230-5 [pii]'],ppublish,J Lab Clin Med. 1978 Jun;91(6):901-7.,"['0 (Antigen-Antibody Complex)', '0 (Carrier Proteins)', '935E97BOY8 (Folic Acid)']","Antiserum raised in rabbits against the FBP obtained from CML cells, and the purified binder labeled with 125I, have been used for an RIA which can measure an immunologically similar protein in human serum. The concentration of the binding protein in normal serums ranged from 1.2 to 9.3 ng/ml, with a mean +/- S.E.M. of 3.8 +/- 0.4 ng/ml. Elevated values of the binder protein were measured in the serums from patients with folate deficiency, vitamin B12 deficiency, liver disease, uremia, myeloproliferative disease, chronic lymphocytic leukemia, and various types of cancer and in the serum from pregnant women. The concentration of the binder protein and the capacity of the serum to specifically bind isotopically labeled PGA correlated poorly, indicating that the binding protein concentration and degree of saturation by endogenous serum folate vary independently in many instances.",,,,,
274447,NLM,MEDLINE,19780715,20190629,,145,2,1978 Mar 1,Specific and sensitive combined high-performance liquid chromatographic-flow fluorometric assay for intracellular 6-thioguanine nucleotides metabolites of 6-mercaptopurine and 6-thioguanine.,237-46,"['Tidd, D M', 'Dedhar, S']","['Tidd DM', 'Dedhar S']",['eng'],['Journal Article'],Netherlands,J Chromatogr,Journal of chromatography,0427043,IM,"['Body Fluids/*analysis', 'Chromatography, High Pressure Liquid/methods', 'Fluorometry/methods', 'Humans', 'Intracellular Fluid/*analysis', 'Leukemia, Myeloid, Acute/drug therapy/*metabolism', 'Mercaptopurine/*analysis', 'Thioguanine/*analysis', 'Thionucleotides/*metabolism']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1016/s0378-4347(00)81344-4 [doi]'],ppublish,J Chromatogr. 1978 Mar 1;145(2):237-46. doi: 10.1016/s0378-4347(00)81344-4.,"['0 (Thionucleotides)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)']","A new non-radioisotopic technique is described for measuring rates of intracellular formation by human leukemic blasts of 6-thioguanine nucleotide metabolites, obligatory intermediates in the antineoplastic action of both 6-mercaptopurine and 6-thioguanine itself. The method is both specific and sensitive, and involves combined high-performance liquid chromatography and flow fluormetric detection of oxidized 6-thioquanine nucleotides in alkaline permanganate-treated cell extracts. Non-metabolized 6-thioguanine and 6-thioxanthine are also separated and quantitated in this system, permitting complementary in vivo pharmacokinetic analysis. The assay may be applied to detect resistant disease at an early stage in therapy, and thereby provides the opportunity for alternative treatments to be instituted.",,,,,
274446,NLM,MEDLINE,19780715,20131121,0021-9541 (Print) 0021-9541 (Linking),95,2,1978 May,Significance of the cell cycle in commitment of murine erythroleukemia cells to erythroid differentiation.,213-22,"['Geller, R', 'Levenson, R', 'Housman, D']","['Geller R', 'Levenson R', 'Housman D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Cell Physiol,Journal of cellular physiology,0050222,IM,"['Animals', 'Cell Cycle', 'Cell Differentiation', 'Cell Separation', 'Clone Cells', 'Dimethyl Sulfoxide/pharmacology', 'Leukemia, Erythroblastic, Acute/*pathology', 'Mice', 'Neoplasms, Experimental', 'Time Factors']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1002/jcp.1040950211 [doi]'],ppublish,J Cell Physiol. 1978 May;95(2):213-22. doi: 10.1002/jcp.1040950211.,['YOW8V9698H (Dimethyl Sulfoxide)'],"The relationship between differentiation of murine erythroleukemia cells (MEL) induced by DMSO and the cell division cycle has been analyzed. We demonstrate that incubation in the presence of DMSO increases the length of the G1 phase of the cell cycle. A method of synchronization of MEL cells by unit gravity sedimentation has been developed and characterized. Using this method, a series of synchronized cell populations covering the entire cell division cycle can be generated simultaneously. Cells synchronized by this technique were challenged with DMSO and analyzed for kinetics of commitment to the differentiation program. Our results indicate that populations of cells in G1 or G2 at the time of addition of inducer give rise to a greater proportion of committed cells than an unfractionated population, while cells in S phase result in a lower percentage of committed cells than the unfractionated population when cultured in DMSO.",,,,,
274444,NLM,MEDLINE,19780715,20190606,0018-0661 (Print) 0018-0661 (Linking),88,1,1978,Duplication of part of the long arm of chromosome 1 in myelofibrosis terminating in acute myeloblastic leukemia.,1-5,"['Gahrton, G', 'Friberg, K', 'Lindsten, J', 'Zech, L']","['Gahrton G', 'Friberg K', 'Lindsten J', 'Zech L']",['eng'],"['Case Reports', 'Journal Article']",England,Hereditas,Hereditas,0374654,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 1-3', '*Chromosomes, Human, 6-12 and X', 'Humans', 'Leukemia, Myeloid, Acute/*genetics', 'Male', 'Metaphase', 'Middle Aged', 'Primary Myelofibrosis/complications/genetics']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1111/j.1601-5223.1978.tb01594.x [doi]'],ppublish,Hereditas. 1978;88(1):1-5. doi: 10.1111/j.1601-5223.1978.tb01594.x.,,,,,,,
274443,NLM,MEDLINE,19780715,20041117,0021-2180 (Print) 0021-2180 (Linking),14,2,1978 Feb,Serum lysozyme in inflammatory bowel disease--an uncertain indicator.,278-80,"['Feldman, C', 'Clejan, L', 'Stern, R', 'Menahem, H', 'Gilat, T']","['Feldman C', 'Clejan L', 'Stern R', 'Menahem H', 'Gilat T']",['eng'],['Journal Article'],Israel,Isr J Med Sci,Israel journal of medical sciences,0013105,IM,"['Acute Disease', 'Adult', 'Colitis, Ulcerative/*diagnosis', 'Crohn Disease/*diagnosis', 'Female', 'Humans', 'Leukemia, Monocytic, Acute/enzymology', 'Male', 'Middle Aged', 'Muramidase/*blood', 'Uremia/enzymology']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Isr J Med Sci. 1978 Feb;14(2):278-80.,['EC 3.2.1.17 (Muramidase)'],,,,,,
274438,NLM,MEDLINE,19780724,20111117,0018-5817 (Print) 0018-5817 (Linking),59,5,1978 May,Chemotherapy withheld from retarded patient.,"94, 96","['Regan, W A']",['Regan WA'],['eng'],['Journal Article'],United States,Hosp Prog,Hospital progress,0374656,IM,"['Aged', '*Euthanasia', '*Euthanasia, Passive', 'Humans', 'Informed Consent/*legislation & jurisprudence', 'Intellectual Disability', 'Leukemia, Myeloid, Acute/drug therapy', 'Life Support Care/*legislation & jurisprudence', 'Male', 'Massachusetts']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,"Hosp Prog. 1978 May;59(5):94, 96.",,,,,,,
274437,NLM,MEDLINE,19780724,20131121,1110-6638 (Print) 1110-6638 (Linking),26,1,1977 Jan,Value of serum copper measurement in acute leukaemia of childhood.,67-72,"['El-Haddad, S', 'Mahfouz, M', 'Magahed, Y', 'Mahmoud, F', 'Kamel, M', 'Ali, M A']","['El-Haddad S', 'Mahfouz M', 'Magahed Y', 'Mahmoud F', 'Kamel M', 'Ali MA']",['eng'],['Journal Article'],Egypt,Gaz Egypt Paediatr Assoc,The Gazette of the Egyptian Paediatric Association,7509401,IM,"['Acute Disease', 'Child', 'Child, Preschool', 'Copper/*blood', 'Female', 'Humans', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid, Acute/blood', 'Male', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Gaz Egypt Paediatr Assoc. 1977 Jan;26(1):67-72.,['789U1901C5 (Copper)'],"Serum copper level (SCL) determination was carried out on sixteen normal children and on 16 with acute leukaemia. A significant increase in SCL was observed in cases of leukaemia than in normal controls. Drop of SCL occurs in cases who respond to quadruple chemotherapy, while those who failed to respond showed persistantly high serum copper level.",,,,,
274297,NLM,MEDLINE,19780724,20190907,0014-2964 (Print) 0014-2964 (Linking),14,4,1978 Apr,Bacterial infection and acute myeloblastic leukaemia: an analysis of two hundred patients undergoing intensive remission induction therapy.,383-91,"['Tobias, J S', 'Wrigley, P F', ""O'Grady, F""]","['Tobias JS', 'Wrigley PF', ""O'Grady F""]",['eng'],['Journal Article'],England,Eur J Cancer,European journal of cancer,0074126,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Anti-Bacterial Agents/therapeutic use', 'Bacterial Infections/*complications/drug therapy', 'Blood Cell Count', 'Blood Platelets', 'Female', 'Granulocytes', 'Humans', 'Leukemia, Myeloid, Acute/*complications/drug therapy', 'Male', 'Middle Aged', 'Prognosis']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1016/0014-2964(78)90209-8 [doi]'],ppublish,Eur J Cancer. 1978 Apr;14(4):383-91. doi: 10.1016/0014-2964(78)90209-8.,['0 (Anti-Bacterial Agents)'],,,,,,
274258,NLM,MEDLINE,19780724,20190721,0012-3706 (Print) 0012-3706 (Linking),21,3,1978 Apr,Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers.,165-8,"['Lynch, H T', 'Bardawil, W A', 'Harris, R E', 'Lynch, P M', 'Guirgis, H A', 'Lynch, J F']","['Lynch HT', 'Bardawil WA', 'Harris RE', 'Lynch PM', 'Guirgis HA', 'Lynch JF']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Dis Colon Rectum,Diseases of the colon and rectum,0372764,IM,"['Adenocarcinoma/genetics/mortality', 'Adult', 'Aged', 'Colonic Neoplasms/*genetics/mortality', 'Female', 'Humans', 'Leukemia, Myeloid/genetics/mortality', 'Middle Aged', 'Neoplasms, Multiple Primary/*genetics/mortality', 'Ovarian Neoplasms/genetics/mortality', 'Pedigree', 'Uterine Neoplasms/*genetics/mortality']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1007/BF02586560 [doi]'],ppublish,Dis Colon Rectum. 1978 Apr;21(3):165-8. doi: 10.1007/BF02586560.,,"We describe features of multiple cancers in a small kindred wherein a cluster of tumors affecting various anatomic sites has been observed among eight directline relatives. Three of these individuals have had two or more primary malignancies, and one woman showed a remarkable tolerance to invasive cancer, having had four histologically verified neoplasms (cancers of the ovary, endometrium, and colon, and myelogenous leukemia). The constellation of tumors occurring at an early age among relatives of the kindred supports a genetic etiology.",,,,,
274177,NLM,MEDLINE,19780715,20191210,0361-5960 (Print) 0361-5960 (Linking),62,3,1978 Mar,"Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3.",341-4,"['Laszlo, J', 'Fyfe, M J', 'Swedwick, D', 'Lee, L', 'Brown, O']","['Laszlo J', 'Fyfe MJ', 'Swedwick D', 'Lee L', 'Brown O']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Antineoplastic Agents/*pharmacology', 'Cells, Cultured', 'DNA, Neoplasm/*biosynthesis', 'Deoxyuridine/*metabolism', 'Depression, Chemical', 'Humans', 'Leukemia/*metabolism', 'Leukemia, Myeloid/metabolism', 'Leukemia, Myeloid, Acute/metabolism', 'Leukocytes/metabolism', 'Pyrimethamine/*analogs & derivatives/pharmacology', 'Time Factors']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1978 Mar;62(3):341-4.,"['0 (Antineoplastic Agents)', '0 (DNA, Neoplasm)', '2L9RKX796Q (metoprine)', '406PGU9KGI (etoprine)', 'W78I7AY22C (Deoxyuridine)', 'Z3614QOX8W (Pyrimethamine)']","In vitro studies were used to measure the incorporation of labeled deoxyuridine into the DNA of human leukemic cells in autologous plasma in order to compare the inhibitory effects of two diaminopyrimidines, metoprine and etoprine. The results indicate that these two lipid-soluble folate antagonists give similar qualitative and quantitative effects over a concentration range of from 1 to 100 micrometer. However, drug-induced inhibition of deoxyuridine incorporation into DNA was quite variable for cells obtained from different adult patients, even within a given morphologic type of leukemia. Despite these biologic varitions in leukemic sensitivity in vitro, both drugs gave virtually identical results on an equimolar basis.",,,,,
274176,NLM,MEDLINE,19780726,20071115,0008-5472 (Print) 0008-5472 (Linking),38,6,1978 Jun,Comparative cytogenetic studies of normal and leukemic lymphoblastoid cell lines during the course of their establishment.,1815-25,"['Venuat, A M', 'Rosenfeld, C', 'Testu, M J']","['Venuat AM', 'Rosenfeld C', 'Testu MJ']",['eng'],"['Comparative Study', 'Journal Article']",United States,Cancer Res,Cancer research,2984705R,IM,"['Aneuploidy', 'Animals', 'Cell Line', '*Chromosome Aberrations', 'Clone Cells/ultrastructure', 'Diploidy', 'Humans', 'Karyotyping/methods', 'Leukemia, Experimental/*genetics', 'Leukemia, Myeloid, Acute/genetics', 'Lymphocytes/*ultrastructure', 'Polyploidy', 'Time Factors']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jun;38(6):1815-25.,,"A comparative chromosomal analysis was made of 10 human lymphoblastoid cell lines, four of which originated from normal donor lymphocytes and six of which were from leukemic peripheral blood. For comparison of lymphoblastoid cells with respect to their normal or leukemic origin, cytogenetic studies have been carried out regularly since the beginning of the culture during more than 3 years. Samples were drawn during the three phases previously described for the establishment of these lines. The chromosome distribution remained diploid for at least 2 years in normal cell lines, and the cells were euploid. In contrast, an important variability of the chromosome set was demonstrated during the same period in leukemic cell lines. Moreover, in these lines, it was always possible to observe a nonsystemic pseudodiploidy. After 2 years, a clonal evolution was described in both types of cell lines that carried at least one marker. With a controlled-heating denaturation technique, it was possible to identify the markers as specific to each cell line. The cells with marker chromosomes appeared to have a selective advantage of growth.",,,,,
274175,NLM,MEDLINE,19780726,20131121,0008-5472 (Print) 0008-5472 (Linking),38,6,1978 Jun,Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells.,1730-3,"['Lauzon, G J', 'Paterson, A R', 'Belch, A W']","['Lauzon GJ', 'Paterson AR', 'Belch AW']",['eng'],['Journal Article'],United States,Cancer Res,Cancer research,2984705R,IM,"['3-Deazauridine/pharmacology', 'Animals', 'Choline/*analogs & derivatives', 'Cytarabine/*analogs & derivatives/biosynthesis/metabolism/pharmacology', 'Cytidine Diphosphate Choline/*analogs & derivatives/biosynthesis', 'Drug Synergism', 'Female', 'HeLa Cells/metabolism', 'Leukemia L1210/metabolism', 'Leukemia, Experimental/drug therapy/*metabolism', 'Leukemia, Myeloid, Acute/metabolism', 'Liver/metabolism', 'Lymphocytes/metabolism', 'Mice', 'Mice, Inbred Strains']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jun;38(6):1730-3.,"['04079A1RDZ (Cytarabine)', '263CU738ZY (3-Deazauridine)', '536BQ2JVC7 (Cytidine Diphosphate Choline)', 'N91BDP6H0X (Choline)']","1-beta-D-Arabinofuranosylcytosine diphosphate choline was formed from 1-beta-D-arabinofuranosylcytosine (ara-C) during incubation in vitro of peripheral myeloblasts from patients with acute myelogenous leukemia and cultured cells (nonleukemic human lymphocytes, mouse lymphoma L5178Y, and HeLa); as well, 1-beta-D-arabinofuranosylcytosine diphosphate choline was formed in vivo in mouse leukemia L1210 cells and mouse liver. 3-Deazauridine enhanced the anabolism of ara-C in nonleukemic lymphocytes in vitro and leukemia L1210 cells in vivo but did not influence ara-C anabolism in the other cell types. In acute myelogenous leukemia myeloblasts incubated in vitro with ara-C, concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate were maximal after 8 hr of incubation and formation of the latter preceded that of 1-beta-D-arabinofuranosylcytosine diphosphate choline.",,,,,
274174,NLM,MEDLINE,19780726,20131121,0008-5472 (Print) 0008-5472 (Linking),38,6,1978 Jun,Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.,1723-9,"['Lauzon, G J', 'Paran, J H', 'Paterson, A R']","['Lauzon GJ', 'Paran JH', 'Paterson AR']",['eng'],['Journal Article'],United States,Cancer Res,Cancer research,2984705R,IM,"['3-Deazauridine/pharmacology', 'Animals', 'Cell Division/drug effects', 'Cells, Cultured', 'Choline/*analogs & derivatives', 'Cytarabine/*analogs & derivatives/biosynthesis/metabolism/pharmacology', 'Cytidine Diphosphate Choline/*analogs & derivatives/biosynthesis', 'Drug Synergism', 'Humans', 'Hydrolysis', 'Leukemia, Experimental/drug therapy/*metabolism', 'Leukemia, Myeloid, Acute/drug therapy/metabolism']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jun;38(6):1723-9.,"['04079A1RDZ (Cytarabine)', '263CU738ZY (3-Deazauridine)', '536BQ2JVC7 (Cytidine Diphosphate Choline)', 'N91BDP6H0X (Choline)']","When incubated with 1-beta-D-arabinofuranosylcytosine (ara-C), RPMI 6410 cells formed a hitherto unrecognized ara-C metabolite, 1-beta-D-arabinofuranosylcytosine diphosphate choline. This compound was characterized by (a) chromatographic behavior, (b) chemical and enzymatic hydrolysis, (c) phosphorus content, and (d) incorporation of [5-3H]ara-C and [methyl-14C]choline. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline by RPMI 6410 cells was enhanced in the presence of 3-deazauridine (DU) and was preceded by that of 1-beta-D-arabinofuranosylcytosine triphosphate. The antiproliferative effects of ara-C and DU toward RPMI 6410 cells were potentiated when the agents were present together. The anabolism of ara-C during a 24-hr interval of culture was markedly enhanced by the presence of DU; cellular concentrations of 1-beta-D-arabinofuranosylcytosine triphosphate and 1-beta-D-arabinofuranosylcytosine diphosphate choline were 5- and 15-fold higher than those in the absence of DU. This enhancement appears to be the basis of the potentiation of cytotoxicity resulting from combination of the agents. Pretreatment of RPMI 6410 cells with DU resulted in enhanced rates of cellular uptake of ara-C. ara-C uptake under these circumstances was blocked by the inhibitor of nucleoside transport, nitrobenzylthioinosine.",,,,,
274173,NLM,MEDLINE,19780726,20131121,0008-5472 (Print) 0008-5472 (Linking),38,6,1978 Jun,Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.,1561-7,"['Olson, H M', 'Capen, C C']","['Olson HM', 'Capen CC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Bone Neoplasms/*drug therapy/pathology', 'Doxorubicin/administration & dosage/adverse effects/*therapeutic use', 'Heart Failure/chemically induced', 'Moloney murine leukemia virus', 'Osteosarcoma/drug therapy', 'Rats', 'Remission, Spontaneous', 'Sarcoma, Experimental/*drug therapy/pathology', 'Tumor Virus Infections/drug therapy']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jun;38(6):1561-7.,['80168379AG (Doxorubicin)'],,,,,,
274172,NLM,MEDLINE,19780724,20190619,0008-543X (Print) 0008-543X (Linking),41,5,1978 May,Malignant histiocytosis occurring in patients with acute lymphocytic leukemia.,1967-73,"['Karcher, D S', 'Head, D R', 'Mullins, J D']","['Karcher DS', 'Head DR', 'Mullins JD']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Child', 'Child, Preschool', 'Female', 'Hematopoietic Stem Cells/pathology', 'Histiocytes/pathology', 'Humans', 'Leukemia, Lymphoid/drug therapy/*etiology/pathology', 'Liver/pathology', 'Lymphatic Diseases/*etiology/pathology', 'Male', 'Neoplasms, Multiple Primary/*etiology/pathology', 'Spleen/pathology']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1002/1097-0142(197805)41:5<1967::aid-cncr2820410542>3.0.co;2-7 [doi]'],ppublish,Cancer. 1978 May;41(5):1967-73. doi: 10.1002/1097-0142(197805)41:5<1967::aid-cncr2820410542>3.0.co;2-7.,['0 (Antineoplastic Agents)'],"Five cases of malignant histiocytosis (MH) in patients being treated for acute lymphocytic leukemia (ALL) have been previously reported. Two additional cases are described here, all known cases are reviewed, and the phenomenon is discussed. The most tenable explanation for this phenomenon appears to be that ALL and MH may have been interrelated in these patients with both diseases originating from a common stem cell.",,,,,
274171,NLM,MEDLINE,19780724,20190619,0008-543X (Print) 0008-543X (Linking),41,5,1978 May,A fatal myeloproliferative syndrome in a family with thrombocytopenia and platelet dysfunction.,1959-63,"['Luddy, R E', 'Champion, L A', 'Schwartz, A D']","['Luddy RE', 'Champion LA', 'Schwartz AD']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Alkaline Phosphatase/analysis', 'Blood Platelet Disorders/complications/*genetics', 'Child', 'Child, Preschool', 'Family Characteristics', 'Female', 'Fetal Hemoglobin/analysis', 'Humans', 'Infant', 'Leukemia, Monocytic, Acute/genetics', 'Leukemia, Myeloid/genetics', 'Leukocytes/enzymology', 'Male', 'Myeloproliferative Disorders/complications/*genetics', 'Pedigree', 'Thrombocytopenia/complications/*genetics', 'Vitamin B 12/blood']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1002/1097-0142(197805)41:5<1959::aid-cncr2820410540>3.0.co;2-8 [doi]'],ppublish,Cancer. 1978 May;41(5):1959-63. doi: 10.1002/1097-0142(197805)41:5<1959::aid-cncr2820410540>3.0.co;2-8.,"['9034-63-3 (Fetal Hemoglobin)', 'EC 3.1.3.1 (Alkaline Phosphatase)', 'P6YC3EG204 (Vitamin B 12)']","Three siblings with a lifelong history of a bleeding disorder and thrombocytopenia died from a myeloproliferative disease. In 2, the terminal event resembled juvenile chronic myelogenous leukemia, and in the third, the diagnosis was acute monocytic leukemia. A family study revealed that the mother and 5 other siblings had a variety of hematologic abnormalities. These included chronic thrombocytopenia, abnormal platelet function, elevated concentrations of HgbF or serum vitamin B12, and low leukocyte alkaline phosphatase (LAP) scores either singly or in combination. At the time of study, none had evidence of malignancy. Members of this family have a myeloproliferative disorder that has the potential for terminating in nonlymphocytic leukemia, a combination of events which appears not to have been reported previously.",,,,,
274166,NLM,MEDLINE,19780724,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6123,1978 May 20,Price of survival in childhood leukaemia.,1346-7,"['Shalet, S M', 'Beardwell, C G', 'Jones, P H', 'Pearson, D']","['Shalet SM', 'Beardwell CG', 'Jones PH', 'Pearson D']",['eng'],['Letter'],England,Br Med J,British medical journal,0372673,IM,"['Child', 'Growth Hormone/*deficiency', 'Humans', 'Hypothalamo-Hypophyseal System/radiation effects', 'Leukemia, Lymphoid/*radiotherapy', 'Relative Biological Effectiveness']",1978/05/20 00:00,1978/05/20 00:01,['1978/05/20 00:00'],"['1978/05/20 00:00 [pubmed]', '1978/05/20 00:01 [medline]', '1978/05/20 00:00 [entrez]']",['10.1136/bmj.1.6123.1346-d [doi]'],ppublish,Br Med J. 1978 May 20;1(6123):1346-7. doi: 10.1136/bmj.1.6123.1346-d.,['9002-72-6 (Growth Hormone)'],,,PMC1604684,,,
274165,NLM,MEDLINE,19780715,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6122,1978 May 13,HLA phenotypes in long-term survivors treated with BCG immunotherapy for childhood ALL.,1250-1,"['Tursz, T', 'Hors, J', 'Lipinski, M', 'Aamiel, J L']","['Tursz T', 'Hors J', 'Lipinski M', 'Aamiel JL']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Adult', 'BCG Vaccine/*therapeutic use', 'Child', 'Child, Preschool', 'Female', 'HLA Antigens/*genetics', 'Humans', 'Leukemia, Lymphoid/*immunology/mortality/therapy', 'Male', 'Phenotype', 'Time Factors']",1978/05/13 00:00,1978/05/13 00:01,['1978/05/13 00:00'],"['1978/05/13 00:00 [pubmed]', '1978/05/13 00:01 [medline]', '1978/05/13 00:00 [entrez]']",['10.1136/bmj.1.6122.1250-a [doi]'],ppublish,Br Med J. 1978 May 13;1(6122):1250-1. doi: 10.1136/bmj.1.6122.1250-a.,"['0 (BCG Vaccine)', '0 (HLA Antigens)']",,,PMC1604574,,,
274161,NLM,MEDLINE,19780715,20190902,0006-5242 (Print) 0006-5242 (Linking),36,4,1978 Apr 20,Cap formation on lymphocytes from patients with leukemic diseases induced by four different lectins.,239-45,"['Gurtler, L G', 'Emmerich, B']","['Gurtler LG', 'Emmerich B']",['eng'],['Journal Article'],Germany,Blut,Blut,0173401,IM,"['Adolescent', 'Adult', 'Aged', 'Castor Bean', 'Fabaceae', 'Hodgkin Disease/blood', 'Humans', 'Lectins/*pharmacology', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood', 'Lymphocytes/*drug effects', 'Lymphoma/*blood', 'Lymphoma, Non-Hodgkin/blood', 'Middle Aged', 'Plant Lectins', 'Plants, Medicinal', 'Plants, Toxic']",1978/04/20 00:00,1978/04/20 00:01,['1978/04/20 00:00'],"['1978/04/20 00:00 [pubmed]', '1978/04/20 00:01 [medline]', '1978/04/20 00:00 [entrez]']",['10.1007/BF01079956 [doi]'],ppublish,Blut. 1978 Apr 20;36(4):239-45. doi: 10.1007/BF01079956.,"['0 (Lectins)', '0 (Plant Lectins)']","When ficoll purified peripheral blood lymphocytes were treated with fluorescein conjugated lectins from lentils (LCH), castor beans (RCA) and phaseolus coccineus beans (L-and E-PHA) for 15 min and the percentages of the cap forming cells were examined, the values of leukemic lymphocytes were reduced compared to the values obtained with normal lymphocytes. The reduction was more than half in patients with acute and chronic myelogenous leukemia and immunoblastoma, it was only one quarter in patients with chronic lymphocytic leukemia, Hodgkin's disease and lymphosarcoma. The lowest number of cap forming cells was found in lymphoblasts of established lymphoblastoid cell lines. The four different lectins showed nearly the same capacity in the induction of caps. After successive binding, the different lectins showed cocapping on the lymphocyte surface.",,,,,
274160,NLM,MEDLINE,19780724,20210216,0006-4971 (Print) 0006-4971 (Linking),51,6,1978 Jun,Clonal evolution in atypical chronic granulocytic leukemia: a non-Philadelphia translocation.,997-1004,"['Bagby, G C Jr', 'Kaiser-McCaw, B', 'Hecht, F', 'Koler, R D', 'Linman, J W']","['Bagby GC Jr', 'Kaiser-McCaw B', 'Hecht F', 'Koler RD', 'Linman JW']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adult', 'Bone Marrow Cells', 'Cell Transformation, Neoplastic', '*Chromosomes, Human, 21-22 and Y', 'Clone Cells', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics', 'Male', '*Translocation, Genetic']",1978/06/01 00:00,2001/03/28 10:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/06/01 00:00 [entrez]']",['S0006-4971(20)74749-X [pii]'],ppublish,Blood. 1978 Jun;51(6):997-1004.,,"Hemopoietic cells in chronic granulocytic leukemia (CGL) frequently contain a chromosome translocation involving chromosome 22 and another autosome, usually number 9. The translocated chromosome 22 is known as the Philadelphia (Ph) chromosome. The appearance of a second Ph chromosome is the most common cytogenetic abnormality in CGL signaling the blastic phase. For 6 yr we serially studied a man with atypical CGL whose marrow cells were marked by a translocation from chromosome 18 to chromosome 11 [46XY,t(11;18)(q23;q12)]. Three months prior to blast transformation there appeared an extra copy of the marker chromosome 18: 47XY,t(11;18)(q23;q12),+(18p11 leads to 18q12). This man presents a new cytogenetic pattern of clonal evolution in CGL. The pattern is analogous to that of the Ph chromosome and is characterized by a balanced chromosomal rearrangement and the subsequent acquisition of an extra copy of the small translocation chromosome immediately prior to blast transformation.",,,,,
274159,NLM,MEDLINE,19780724,20210216,0006-4971 (Print) 0006-4971 (Linking),51,6,1978 Jun,Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.,1051-6,"['Mertelsmann, R', 'Koziner, B', 'Ralph, R', 'Filippa, D', 'McKenzie, S', 'Arlin, Z A', 'Gee, T S', 'Moore, M A', 'Clarkson, B D']","['Mertelsmann R', 'Koziner B', 'Ralph R', 'Filippa D', 'McKenzie S', 'Arlin ZA', 'Gee TS', 'Moore MA', 'Clarkson BD']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adult', 'Cell Separation', 'Female', 'Flucytosine/therapeutic use', 'Humans', 'Leukemia, Lymphoid/blood', 'Leukemia, Monocytic, Acute/*blood/drug therapy/enzymology', '*Lymphocytes', '*Monocytes', 'Nucleotidyltransferases/*blood', 'Prednisone/therapeutic use', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['S0006-4971(20)74756-7 [pii]'],ppublish,Blood. 1978 Jun;51(6):1051-6.,"['5J49Q6B70F (Vincristine)', 'D83282DT06 (Flucytosine)', 'EC 2.7.7.- (Nucleotidyltransferases)', 'FTK8U1GZNX (Thioguanine)', 'VB0R961HZT (Prednisone)']","Two distinct cell populations with lymphoblastic and monocytic characteristics were separated and characterized by multiple cell markers in a patient with terminal transferase-positive acute acute leukemia. The clinical course and sequential cell marker studies were consistent with the interpretation of a defect at the level of a common stem cell giving rise to a terminal transferase--positive lymphoblastic cell population at diagnosis and, following initial therapy, a terminal transferase--negative monocytic population.",,,,,
274158,NLM,MEDLINE,19780724,20210216,0006-4971 (Print) 0006-4971 (Linking),51,6,1978 Jun,Cytogentics of fibroblastic colonies in Ph1-positive chronic myelogenous leukemia.,1039-44,"['Greenberg, B R', 'Wilson, F D', 'Woo, L', 'Jenks, H M']","['Greenberg BR', 'Wilson FD', 'Woo L', 'Jenks HM']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Bone Marrow Cells', 'Cells, Cultured', '*Chromosomes, Human, 21-22 and Y', '*Cytogenetics', 'Fibroblasts', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*blood']",1978/06/01 00:00,1978/06/01 00:01,['1978/06/01 00:00'],"['1978/06/01 00:00 [pubmed]', '1978/06/01 00:01 [medline]', '1978/06/01 00:00 [entrez]']",['S0006-4971(20)74754-3 [pii]'],ppublish,Blood. 1978 Jun;51(6):1039-44.,,"The cytogenetic status of bone marrow stromal elements obtained from six patients with Ph1-positive chronic myelogenous leukemia (CML), two in blast crisis, was studied in vitro utilizing the potential of marrow to form surface-adherent colonies morphologically compatible with mesenchymal elements. We demonstrated the absence of both the marker chromosome and other chromosomal abnormalities in all the fibroblastic colonies studied, indicating that the progenitors of such colonies (plaque-forming units in culture, PFU-C) are not closely related to hematopoietic elements including macrophages. This supports previous reports suggesting that the stromal elements in myelofibrosis associated with CML are not derived from the primary Ph1-positive malignant clone but represent a stromal reactive component of benign or independent malignant potential.",,,,,
274145,NLM,MEDLINE,19780724,20190704,0007-1048 (Print) 0007-1048 (Linking),38,4,1978 Apr,Erythropoietin dependent erythropoiesis during the erythroblastic phase of juvenile chronic granulocytic leukaemia.,511-6,"['Hoffman, R', 'Zanjani, E D']","['Hoffman R', 'Zanjani ED']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Br J Haematol,British journal of haematology,0372544,IM,"['Child, Preschool', 'Erythroblasts', '*Erythropoiesis', 'Erythropoietin/blood/*physiology', 'Female', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid/*blood']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1111/j.1365-2141.1978.tb01076.x [doi]'],ppublish,Br J Haematol. 1978 Apr;38(4):511-6. doi: 10.1111/j.1365-2141.1978.tb01076.x.,['11096-26-7 (Erythropoietin)'],A child aged 3 1/2 years with typical juvenile chronic granulocytic leukaemia whose course terminated in an erythroblastic phase is described. Both in-vivo transfusion studies and in-vitro bone marrow culture studies indicate that red cell production remains erythropoietin dependent in this situation. The relationship of erythropoietin to the reversion to fetal haematopoiesis which characterizes juvenile chronic granulocytic leukaemia is discussed.,,,,,
274102,NLM,MEDLINE,19780617,20190501,1468-2044 (Electronic) 0003-9888 (Linking),53,3,1978 Mar,Chronic myeloid leukaemia in a child. A closely observed case.,252-4,"['Hann, I M', 'Gorst, D W', 'Jones, P M', 'Evans, D I']","['Hann IM', 'Gorst DW', 'Jones PM', 'Evans DI']",['eng'],"['Case Reports', 'Journal Article']",England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['Bone Marrow/pathology', 'Child', 'Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Lymphoid/*diagnosis', 'Leukemia, Myeloid/*diagnosis', 'Male', 'Nucleotidyltransferases/blood']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1136/adc.53.3.252 [doi]'],ppublish,Arch Dis Child. 1978 Mar;53(3):252-4. doi: 10.1136/adc.53.3.252.,['EC 2.7.7.- (Nucleotidyltransferases)'],,,PMC1545151,,,
274101,NLM,MEDLINE,19780612,20080317,0003-987X (Print) 0003-987X (Linking),114,4,1978 Apr,Mycosis fungoides with blast cell transformation.,611-2,"['Harrington, C I', 'Slater, D N']","['Harrington CI', 'Slater DN']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Dermatol,Archives of dermatology,0372433,IM,"['Humans', 'Leukemia, Lymphoid/blood/*pathology', 'Lymphocytes/*pathology', 'Male', 'Middle Aged', 'Mycosis Fungoides/blood/*pathology', 'Skin Neoplasms/blood/*pathology']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Arch Dermatol. 1978 Apr;114(4):611-2.,,,,,,,
274100,NLM,MEDLINE,19780617,20130926,0066-4758 (Print) 0066-4758 (Linking),23,,1978,Induction of murine erythroleukemia cells to differentiate: a model for the detection of new anti-tumor drugs.,33-41,"['Marks, P A', 'Reuben, R', 'Epner, E', 'Breslow, R', 'Cobb, W', 'Bogden, A E', 'Rifkind, R A']","['Marks PA', 'Reuben R', 'Epner E', 'Breslow R', 'Cobb W', 'Bogden AE', 'Rifkind RA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",Switzerland,Antibiot Chemother (1971),Antibiotics and chemotherapy,1305576,IM,"['Animals', 'Antineoplastic Agents/therapeutic use', 'Cell Differentiation/*drug effects', 'Cells, Cultured', 'Drug Evaluation, Preclinical/methods', 'Friend murine leukemia virus', 'Leukemia, Erythroblastic, Acute/drug therapy/pathology', 'Leukemia, Experimental/drug therapy/*pathology', 'Mice', 'Neoplasm Transplantation', 'Stimulation, Chemical', 'Structure-Activity Relationship']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Antibiot Chemother (1971). 1978;23:33-41.,['0 (Antineoplastic Agents)'],,,,,,
274070,NLM,MEDLINE,19780628,20190626,0002-9343 (Print) 0002-9343 (Linking),64,5,1978 May,Development of a histiocytic medullary reticulosis-like syndrome during the course of acute lymphocytic leukemia.,851-8,"['Griffin, J D', 'Ellman, L', 'Long, J C', 'Dvorak, A M']","['Griffin JD', 'Ellman L', 'Long JC', 'Dvorak AM']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med,The American journal of medicine,0267200,IM,"['Bone Marrow/pathology/ultrastructure', 'Female', '*Histiocytes', 'Humans', 'Leukemia, Lymphoid/*complications/pathology', 'Microscopy, Electron', 'Middle Aged', '*Reticulocytes']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']","['0002-9343(78)90527-2 [pii]', '10.1016/0002-9343(78)90527-2 [doi]']",ppublish,Am J Med. 1978 May;64(5):851-8. doi: 10.1016/0002-9343(78)90527-2.,,"A 54 year old woman presented with acute lymphocytic leukemia. Following an initial response to chemotherapy with vincristine and prednisone, progressive pancytopenia developed coincident with intense bone marrow infiltration by abnormal histiocytes. At autopsy two months later, no evidence of leukemia was found, but the bone marrow was replaced by abnormal histiocytes showing active erythrophagocytosis, consistent with histiocytic medullary reticulosis. Detailed morphologic, ultrastructural and histochemical studies performed throughout the course of the patient's illness served to confirm the transition from leukemia to histiocytosis. Four similar cases of acute lymphocytic leukemia terminating in histiocytic medullary reticulosis have been reported. This association may represent a distinct clinicopathologic syndrome.",,,,,
274069,NLM,MEDLINE,19780628,20190626,0002-9343 (Print) 0002-9343 (Linking),64,4,1978 Apr,"Adenocarcinoma of the lung, choledocholithiasis, hepatosplenomegaly and leukocytosis.",651-8,,,['eng'],"['Case Reports', 'Journal Article']",United States,Am J Med,The American journal of medicine,0267200,IM,"['Cholecystitis/pathology', 'Cholelithiasis/pathology', 'Gallbladder Diseases/pathology', '*Hematopoiesis', 'Humans', 'Leukemia, Myeloid/*pathology', 'Liver Diseases/*pathology/physiopathology', 'Male', 'Middle Aged']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']","['0002-9343(78)90586-7 [pii]', '10.1016/0002-9343(78)90586-7 [doi]']",ppublish,Am J Med. 1978 Apr;64(4):651-8. doi: 10.1016/0002-9343(78)90586-7.,,,,,,,
274068,NLM,MEDLINE,19780628,20190812,0001-6101 (Print) 0001-6101 (Linking),203,4,1978,Smouldering acute myelogenous leukemia.,305-7,"['Evensen, S A', 'Stavem, P']","['Evensen SA', 'Stavem P']",['eng'],"['Case Reports', 'Journal Article']",Sweden,Acta Med Scand,Acta medica Scandinavica,0370330,IM,"['Adolescent', 'Adult', 'Aged', 'Blood Cell Count', 'Bone Marrow/pathology', 'Female', 'Humans', '*Leukemia, Myeloid, Acute/blood/diagnosis/mortality', 'Male', 'Middle Aged', 'Prognosis']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1111/j.0954-6820.1978.tb14878.x [doi]'],ppublish,Acta Med Scand. 1978;203(4):305-7. doi: 10.1111/j.0954-6820.1978.tb14878.x.,,"Among 195 patients with variants of acute myelogenous leukemia (AML), a minimum of 11 met our criteria of smouldering AML: patients with less than 30% of blast cells plus promyelocytes in the bone marrow at the time of diagnosis who were observed without specific antileukemic therapy for a period of at least 6 months without entering a fulminant stage of the disease. These patients were older than other patients with AML, they had initially relatively few infections, bled rarely, and did not enter the fullblown clinical picture typical of acute leukemia until the last months of life. For these 11 patients the median survival time was 29 months from the time of diagnosis. Patients with smouldering leukemia shall be observed carefully and not be given specific antileukemic therapy, at least not before they flare into a blast crisis. Transfusions, antibiotics and a small dose of prednisone should be given when necessary.",,,,,
274024,NLM,MEDLINE,19780612,20071115,0070-4067 (Print) 0070-4067 (Linking),83,,1977 Apr 17-21,[Isoenzyme pattern of acid phosphotases from normal and leukemic white blood cells].,1113-5,"['von Heyden, H W', 'Weber, R', 'Nerke, O']","['von Heyden HW', 'Weber R', 'Nerke O']",['ger'],"['Comparative Study', 'Journal Article']",Germany,Verh Dtsch Ges Inn Med,Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,7503702,IM,"['Acid Phosphatase/*blood', 'Granulocytes/enzymology', 'Humans', 'Isoenzymes/*blood', 'Leukemia/*blood', 'Leukemia, Hairy Cell/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukocytes/*enzymology', 'Lymphocytes/enzymology', 'Macrophages/enzymology', 'Monocytes/enzymology']",1977/04/17 00:00,1977/04/17 00:01,['1977/04/17 00:00'],"['1977/04/17 00:00 [pubmed]', '1977/04/17 00:01 [medline]', '1977/04/17 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1113-5.,"['0 (Isoenzymes)', 'EC 3.1.3.2 (Acid Phosphatase)']",,Isoenzymmuster der sauren Phosphatasen aus normalen und leukamischen weissen Blutzellen.,,,,
274023,NLM,MEDLINE,19780612,20071115,0070-4067 (Print) 0070-4067 (Linking),83,,1977 Apr 17-21,[Lysozymuria - a regular characteristic of PAS-positive myeloid leukemia].,1103-5,"['Ledderose, G', 'Tischendorf, F W', 'Wilms, K']","['Ledderose G', 'Tischendorf FW', 'Wilms K']",['ger'],['Journal Article'],Germany,Verh Dtsch Ges Inn Med,Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,7503702,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*urine', '*Lysosomes', 'Male', 'Middle Aged', 'Periodic Acid-Schiff Reaction', '*Proteinuria']",1977/04/17 00:00,1977/04/17 00:01,['1977/04/17 00:00'],"['1977/04/17 00:00 [pubmed]', '1977/04/17 00:01 [medline]', '1977/04/17 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1103-5.,,,Lysozymurie - ein regelmassiges Charakteristikum der PAS-positiven myeloischen Leukamie.,,,,
274022,NLM,MEDLINE,19780612,20071115,0070-4067 (Print) 0070-4067 (Linking),83,,1977 Apr 17-21,[Hematology. Preleukemia (contribution to the natural history of acute leukemia)].,1093-6,"['Brucher, H']",['Brucher H'],['ger'],['Journal Article'],Germany,Verh Dtsch Ges Inn Med,Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,7503702,IM,"['Anemia, Aplastic/pathology', 'Anemia, Sideroblastic/pathology', 'Bone Marrow Cells', 'Hematopoietic Stem Cells/*pathology', 'Humans', 'Leukemia, Monocytic, Acute/*pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Preleukemia/*pathology']",1977/04/17 00:00,1977/04/17 00:01,['1977/04/17 00:00'],"['1977/04/17 00:00 [pubmed]', '1977/04/17 00:01 [medline]', '1977/04/17 00:00 [entrez]']",,ppublish,Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:1093-6.,,,Hamatologie. Praleukamie (Beitrag zur Naturgeschichte der akuten Leukamie).,,,,
273988,NLM,MEDLINE,19780617,20190702,0038-4348 (Print) 0038-4348 (Linking),71,5,1978 May,Blast crisis of chronic myelogenous leukemia.,612,"['Krause, J R', 'Kapadia, S B']","['Krause JR', 'Kapadia SB']",['eng'],['Letter'],United States,South Med J,Southern medical journal,0404522,IM,"['Child, Preschool', 'Chronic Disease', 'Humans', 'Leukemia, Myeloid/*blood/therapy', '*Leukocytes']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1097/00007611-197805000-00040 [doi]'],ppublish,South Med J. 1978 May;71(5):612. doi: 10.1097/00007611-197805000-00040.,,,,,,,
273979,NLM,MEDLINE,19780612,20131121,0036-7672 (Print) 0036-7672 (Linking),108,15,1978 Apr 15,[Megaloblastic vitamin B 12 deficiency anemia with erythroleukemic blood picture].,560-3,"['Kappeler, R', 'Gubser, M']","['Kappeler R', 'Gubser M']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,IM,"['Aged', 'Anemia, Macrocytic/*etiology', 'Anemia, Megaloblastic/*etiology', 'Bone Marrow Examination', 'Digitalis Glycosides/therapeutic use', 'Diuretics/therapeutic use', 'Female', 'Folic Acid/therapeutic use', 'Heart Failure/complications', 'Humans', 'Leukemia, Erythroblastic, Acute/*etiology', 'Obesity/complications', 'Vitamin B 12/therapeutic use', 'Vitamin B 12 Deficiency/*complications']",1978/04/15 00:00,1978/04/15 00:01,['1978/04/15 00:00'],"['1978/04/15 00:00 [pubmed]', '1978/04/15 00:01 [medline]', '1978/04/15 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1978 Apr 15;108(15):560-3.,"['0 (Digitalis Glycosides)', '0 (Diuretics)', '935E97BOY8 (Folic Acid)', 'P6YC3EG204 (Vitamin B 12)']","Report on a case of severe megaloblastic anemia in a vegetarian, associated with marked erythroleukemic blood findings probably caused by infections (bronchopneumonia, asthmatic bronchitis, urinary tract infection) and severe heart failure. Successful treatment of the above mentioned complications resulted in almost complete disappearance of pathologic cells from the blood even before vitamin B12 treatment was started. With this therapy complete recovery was achieved and the signs suspect for erythroleukemia in blood and bone marrow disappeared definitively. The case also fulfilled all the criteria of pernicious anemia (Schilling's test and determination of intrinsic factor were not done).",Megaloblastare Vitamin-B12-Mangel-Anamie mit erythroleukamischem Blutbild.,,,,
273978,NLM,MEDLINE,19780628,20190907,0036-553X (Print) 0036-553X (Linking),20,3,1978 Mar,Stem cell (CFU-C) proliferation and emergence in a case of chronic granulocytic leukaemia: the role of the spleen.,193-9,"['Bagby, G C Jr']",['Bagby GC Jr'],['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Bone Marrow Cells', '*Cell Division/drug effects', 'Cell Survival/drug effects', 'Cells, Cultured', 'Clone Cells', 'Cytarabine/pharmacology', 'Hematopoietic Stem Cells/*physiology', 'Humans', 'Leukemia, Myeloid/*blood', 'Male', 'Spleen/*cytology', 'Splenectomy']",1978/03/01 00:00,2001/03/28 10:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02447.x [doi]'],ppublish,Scand J Haematol. 1978 Mar;20(3):193-9. doi: 10.1111/j.1600-0609.1978.tb02447.x.,['04079A1RDZ (Cytarabine)'],,,,,,
273912,NLM,MEDLINE,19780617,20190501,0027-8424 (Print) 0027-8424 (Linking),75,4,1978 Apr,Production of autoinhibitory factors by mouse lymphoma cells in vitro and its relationship to thiol dependence.,1849-53,"['Tanapat, P', 'Gaetjens, E', 'Broome, J D']","['Tanapat P', 'Gaetjens E', 'Broome JD']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Division/drug effects', 'Cell Line', 'Cells, Cultured', 'Culture Media', 'Disulfides/pharmacology', 'Dose-Response Relationship, Drug', 'Leukemia L1210/*physiopathology', 'Macrophages/*physiology', 'Molecular Weight', 'Sulfhydryl Compounds/*pharmacology']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1073/pnas.75.4.1849 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1978 Apr;75(4):1849-53. doi: 10.1073/pnas.75.4.1849.,"['0 (Culture Media)', '0 (Disulfides)', '0 (Sulfhydryl Compounds)']","Five different kinds of mouse lymphoma cells conditioned culture medium so that it became inhibitory to thiol-dependent cells but not to thiol-independent cells. Conditioning was rapid and appeared to be complete in 1-3 hr. The inhibitory effects could be reversed by concentrations of 2-mercaptoethanol higher than those usually required for growth promotion. Inhibitory factors were concentrated by ultrafiltration and chromatography on Sephadex G-10 which showed their apparent molecular weights to be 300-600. The factors were stable at 100 degrees and to proteases but were inactivated (after reduction) by iodoacetamide, indicating that they may be thiols or disulfides.",,PMC392438,,,
273893,NLM,MEDLINE,19780612,20071115,0091-746X (Print) 0091-746X (Linking),31,8,1977 Oct-Dec,Current challenges in childhood leukemia.,205,"['Mauer, A M']",['Mauer AM'],['eng'],['Journal Article'],United States,Proc Inst Med Chic,The Proceedings of the Institute of Medicine of Chicago,7505869,IM,"['Acute Disease', 'Antineoplastic Agents/therapeutic use', 'Child', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Remission, Spontaneous']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Proc Inst Med Chic. 1977 Oct-Dec;31(8):205.,['0 (Antineoplastic Agents)'],,,,,,
273892,NLM,MEDLINE,19780612,20061115,0552-2080 (Print) 0552-2080 (Linking),23,3,1978 Mar,[Human bone marrow organ cultures from trephination material].,23-6,"['Kolesnikova, A I', 'Luriia, E A', ""Vorob'ev, A I"", 'Domracheva, E V', 'Smirnov, A N']","['Kolesnikova AI', 'Luriia EA', ""Vorob'ev AI"", 'Domracheva EV', 'Smirnov AN']",['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Biopsy/methods', 'Bone Marrow/*pathology', 'Cell Count', 'Chromosomes, Human, 21-22 and Y', 'Clone Cells/cytology', 'Hematopoietic Stem Cells/cytology', 'Humans', 'Leukemia, Myeloid/pathology', 'Organ Culture Techniques/methods', 'Remission, Spontaneous']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1978 Mar;23(3):23-6.,,,Organnye kul'tury kostnogo mozga cheloveka iz materiala trepanatov.,,,,
273891,NLM,MEDLINE,19780612,20071115,0552-2080 (Print) 0552-2080 (Linking),23,3,1978 Mar,[State of the megakaryocyte-thrombocyte system in acute leukemias].,19-23,"['Mirrakhimov, M M', 'Prizhivoit, G N', 'Bortashuk, E I', 'Rachkov, A G', 'Nadtochii, L A']","['Mirrakhimov MM', 'Prizhivoit GN', 'Bortashuk EI', 'Rachkov AG', 'Nadtochii LA']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adolescent', 'Adult', 'Aged', 'Blood Cell Count', 'Blood Platelets/metabolism/*ultrastructure', 'Female', 'Humans', 'Leukemia, Lymphoid/*physiopathology', 'Leukemia, Myeloid/*physiopathology', 'Leukemia, Myeloid, Acute/*physiopathology', 'Male', 'Megakaryocytes/metabolism/*ultrastructure', 'Middle Aged']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1978 Mar;23(3):19-23.,,,K voprosu o sostoianii sistemy megakariotsity-trombotsity u bol'nykh ostrymy leikozami.,,,,
273890,NLM,MEDLINE,19780617,20201209,0032-3756 (Print) 0032-3756 (Linking),33,14,1978 Apr 3,[Skin reactions to dinitrochlorobenzene in different clinical conditions in acute lymphoblastic leukemia in children].,539-41,"['Zajaczkowski, J', 'Halikowski, B']","['Zajaczkowski J', 'Halikowski B']",['pol'],['Journal Article'],Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', '*Dinitrochlorobenzene/pharmacology', 'Humans', 'Immunity, Cellular', 'Leukemia, Lymphoid/*immunology', '*Nitrobenzenes/pharmacology', 'Skin/drug effects/*immunology']",1978/04/03 00:00,1978/04/03 00:01,['1978/04/03 00:00'],"['1978/04/03 00:00 [pubmed]', '1978/04/03 00:01 [medline]', '1978/04/03 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1978 Apr 3;33(14):539-41.,"['0 (Dinitrochlorobenzene)', '0 (Nitrobenzenes)']",,Reaktywnosc skorna na dwunitrochlorobenzen (DNCB) w roznych stanach klinicznych ostrej bialaczki limfoblastycznej u dzieci.,,,,
273889,NLM,MEDLINE,19780617,20071115,0301-1518 (Print) 0301-1518 (Linking),7,8,1978 Feb 25,[Therapeutic schedule applied to 100 acute myeloid leukemias].,668,"['Fiere, D', 'Bryon, P A', 'Felman, P', 'Coiffier, B', 'Vu Van, H', 'Revol, L']","['Fiere D', 'Bryon PA', 'Felman P', 'Coiffier B', 'Vu Van H', 'Revol L']",['fre'],['Letter'],France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Aged', 'Antineoplastic Agents/*therapeutic use', 'Drug Administration Schedule', 'Drug Therapy, Combination', 'Follow-Up Studies', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Remission, Spontaneous']",1978/02/25 00:00,1978/02/25 00:01,['1978/02/25 00:00'],"['1978/02/25 00:00 [pubmed]', '1978/02/25 00:01 [medline]', '1978/02/25 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 Feb 25;7(8):668.,['0 (Antineoplastic Agents)'],,Protocole therapeutique applique a 100 leucemies aigues myeloides.,,,,
273888,NLM,MEDLINE,19780617,20151119,0301-1518 (Print) 0301-1518 (Linking),7,7,1978 Feb 18,[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].,525-8,"['Marthe, G', 'Misset, J L', 'de Vassal, F', 'Hayat, M', 'Gouveia, J', 'Machover, D', 'Belpomme, D', 'Schwarzenberg, L', 'Ribaud, P', 'Pico, J L', 'Musset, M', 'Jasmin, C', 'de Luca, L']","['Marthe G', 'Misset JL', 'de Vassal F', 'Hayat M', 'Gouveia J', 'Machover D', 'Belpomme D', 'Schwarzenberg L', 'Ribaud P', 'Pico JL', 'Musset M', 'Jasmin C', 'de Luca L']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Drug Resistance', 'Female', 'Hodgkin Disease/drug therapy', 'Humans', 'Injections, Intravenous', 'Leukemia/*drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Lymphoma/*drug therapy', 'Lymphoma, Non-Hodgkin/drug therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Vinblastine/administration & dosage/*analogs & derivatives/therapeutic use', 'Vincristine/therapeutic use']",1978/02/18 00:00,1978/02/18 00:01,['1978/02/18 00:00'],"['1978/02/18 00:00 [pubmed]', '1978/02/18 00:01 [medline]', '1978/02/18 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 Feb 18;7(7):525-8.,"['5J49Q6B70F (Vincristine)', '5V9KLZ54CY (Vinblastine)']","Vindesine is a derivative of vinblastine and of vincristine. A high proportion of remissions were obtained in acute lymphoid leukaemia (6 complete and 1 incomplete remissions in 15 patients), in blastic crisis of chronic myeloid leukaemia, and a few responses have been registered in lymphosarcoma and Hodgkin's disease. Permanent 48 h i.v. infusion may include a remission where i.v. pusch of the same dose has failed. The most remarkable characteristic of vindesine is the absence of cross-resistance with vincristine as documented in acute lymphoid leukaemia.",Traitement de leucemies et hematosarcomes par la vindesine. Resultats d'un essai phase II en termes d'induction de remission.,,,,
273887,NLM,MEDLINE,19780617,20131121,0301-1518 (Print) 0301-1518 (Linking),7,3,1978 Mar 4,[Acute myeloid leukemia following chlorambucil administration. 2 observations].,756,"['Fiere, D', 'Felman, P', 'Vu Van, H', 'Coiffier, B']","['Fiere D', 'Felman P', 'Vu Van H', 'Coiffier B']",['fre'],"['Case Reports', 'Letter']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Arthritis, Rheumatoid/drug therapy', 'Chlorambucil/*adverse effects', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*chemically induced', 'Middle Aged', 'Nephrotic Syndrome/drug therapy', 'Time Factors']",1978/03/04 00:00,1978/03/04 00:01,['1978/03/04 00:00'],"['1978/03/04 00:00 [pubmed]', '1978/03/04 00:01 [medline]', '1978/03/04 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 Mar 4;7(3):756.,['18D0SL7309 (Chlorambucil)'],,Leucemies aigues myeloides apres administration de chlorambucil. Deux observations.,,,,
273885,NLM,MEDLINE,19780628,20071115,0301-1518 (Print) 0301-1518 (Linking),7,11,1978 Mar 18,[Prolonged survival in 16 cases of acute myeloid leukemia [author's transl)].,899-902,"['Fiere, D', 'Martin, C', 'Vu Van, H', 'Coiffier, B', 'Felman, P', 'Bryon, P A', 'Gentilhomme, O', 'Revol, L']","['Fiere D', 'Martin C', 'Vu Van H', 'Coiffier B', 'Felman P', 'Bryon PA', 'Gentilhomme O', 'Revol L']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Adult', 'Aged', 'Antineoplastic Agents/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy/*mortality', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Time Factors']",1978/03/18 00:00,1978/03/18 00:01,['1978/03/18 00:00'],"['1978/03/18 00:00 [pubmed]', '1978/03/18 00:01 [medline]', '1978/03/18 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1978 Mar 18;7(11):899-902.,['0 (Antineoplastic Agents)'],"16 our of 370 acute myeloid leukemias treated between 1964 and 1973 have been in long survival for more than three years. In the first period 1964-1971 the overall remission rate was 20% and 6 patients has a long survival. In the last two years of study, 10 out of 96 patients have more than three years of survival, the remission rate was over 50%. All the cases were slightly proliferative the first group did not recieve intensive chemotherapy and appear as spontaneous long remission, but in thelast patients intensive chemotherapy seems responsible for the good results.",Leucemies myeloides aigues. Survie superieure a 3 ans chez 16 malades.,,,,
273845,NLM,MEDLINE,19780628,20190712,0030-4220 (Print) 0030-4220 (Linking),45,4,1978 Apr,The management of the oral complications of leukemia.,543-8,"['Shepherd, J P']",['Shepherd JP'],['eng'],['Journal Article'],United States,Oral Surg Oral Med Oral Pathol,"Oral surgery, oral medicine, and oral pathology",0376406,IM,"['Adrenal Cortex Hormones/therapeutic use', 'Analgesics/therapeutic use', 'Anti-Infective Agents/therapeutic use', 'Anti-Infective Agents, Local/therapeutic use', 'Dental Care', 'Hexetidine/therapeutic use', 'Humans', 'Leukemia/*complications', 'Mouth Diseases/etiology/*therapy']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1016/0030-4220(78)90035-x [doi]'],ppublish,Oral Surg Oral Med Oral Pathol. 1978 Apr;45(4):543-8. doi: 10.1016/0030-4220(78)90035-x.,"['0 (Adrenal Cortex Hormones)', '0 (Analgesics)', '0 (Anti-Infective Agents)', '0 (Anti-Infective Agents, Local)', '852A84Y8LS (Hexetidine)']","Current management of the oral complications of leukemia has been reviewed by means of a questionnaire circulated to leukemia units in Great Britain. Oral manifestations of the disease appear to be common and symptoms severe despite advances in the general management of this group of diseases. It is confirmed that infection involving a wide variety of commensal organisms is an important problem, and it is suggested that improvements can be made in management, especially with the use of broad-spectrum antiseptic agents (for example, 0.2 per cent chlorhexidine gluconate which reduces the total number of organisms in the mouth by about 98 per cent.).",,,,,
273716,NLM,MEDLINE,19780612,20131121,0026-4946 (Print) 0026-4946 (Linking),30,4,1978 Feb 28,[Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].,333-8,"['Marni, E', 'Marchi, A', 'Laini, C', 'Zanol, M G', 'Martini, A', 'Livieri, C', 'Genova, R']","['Marni E', 'Marchi A', 'Laini C', 'Zanol MG', 'Martini A', 'Livieri C', 'Genova R']",['ita'],"['English Abstract', 'Journal Article']",Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Arrhythmias, Cardiac/*chemically induced', 'Child', 'Child, Preschool', 'Daunorubicin/administration & dosage/*adverse effects/therapeutic use', 'Electrocardiography', 'Female', 'Heart/*drug effects', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male']",1978/02/28 00:00,1978/02/28 00:01,['1978/02/28 00:00'],"['1978/02/28 00:00 [pubmed]', '1978/02/28 00:01 [medline]', '1978/02/28 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1978 Feb 28;30(4):333-8.,['ZS7284E0ZP (Daunorubicin)'],,Studi sulla cardiotossicita della daunomicina in soggetti affetti da leucemia acuta.,,,,
273714,NLM,MEDLINE,19780628,20071115,0025-5246 (Print) 0025-5246 (Linking),10,1,1978 Jan-Mar,Intensive chemotherapy of acute leukaemias in adults. Preliminary communication.,75-8,"['Maj, S', 'Pawelski, S']","['Maj S', 'Pawelski S']",['eng'],['Journal Article'],Poland,Mater Med Pol,Materia medica Polona. Polish journal of medicine and pharmacy,0236526,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use', 'Drug Evaluation', 'Drug Therapy, Combination', 'Female', 'Follow-Up Studies', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/mortality', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Mater Med Pol. 1978 Jan-Mar;10(1):75-8.,['0 (Antineoplastic Agents)'],,,,,,
273712,NLM,MEDLINE,19780617,20191210,0021-7263 (Print) 0021-7263 (Linking),142,4,1978 Apr,Childhood leukemia--a perspective.,115-27,"['Zuelzer, W W']",['Zuelzer WW'],['eng'],['Journal Article'],United States,Johns Hopkins Med J,The Johns Hopkins medical journal,0072456,IM,"['Antimetabolites, Antineoplastic/therapeutic use', 'Bone Marrow/radiation effects', 'Central Nervous System/radiation effects', 'Central Nervous System Diseases/prevention & control/radiotherapy', 'Child', 'Child, Preschool', 'Humans', 'Iatrogenic Disease', 'Infections/complications', '*Leukemia, Lymphoid/complications/drug therapy/genetics/mortality/prevention & control/radiotherapy', 'Leukemia, Myeloid', 'Leukemia, Myeloid, Acute', 'Leukocyte Count', 'Prognosis', 'Radiotherapy Dosage']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Johns Hopkins Med J. 1978 Apr;142(4):115-27.,"['0 (Antimetabolites, Antineoplastic)']",,,,,,
273711,NLM,MEDLINE,19780617,20131121,0021-7263 (Print) 0021-7263 (Linking),142,4,1978 Apr,Maxillary sinus infection with Allescheria boydii (Petriellidium boydii).,107-9,"['Hecht, R', 'Montgomerie, J Z']","['Hecht R', 'Montgomerie JZ']",['eng'],"['Case Reports', 'Journal Article']",United States,Johns Hopkins Med J,The Johns Hopkins medical journal,0072456,IM,"['Adult', 'Amphotericin B/therapeutic use', 'Anti-Bacterial Agents/therapeutic use', 'Face/microbiology', 'Flucytosine/therapeutic use', 'Humans', 'Leukemia, Lymphoid/complications', 'Male', '*Maxillary Sinus/microbiology/pathology', 'Mycoses/*drug therapy/pathology', 'Paranasal Sinus Diseases/drug therapy/pathology', 'Pseudallescheria/drug effects']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Johns Hopkins Med J. 1978 Apr;142(4):107-9.,"['0 (Anti-Bacterial Agents)', '7XU7A7DROE (Amphotericin B)', 'D83282DT06 (Flucytosine)']","Allescheria boydii (Petriellidium boydii) has previously been described as a cause of Madura foot and pulmonary and other visceral infections. This report describes infection of the maxillary sinus and facial soft tissue with A. boydii in a compromised host. The infection did not respond to antibiotics, including amphotericin B and 5-fluorocytosine. Miconazole was not used in our patient, although in vitro data obtained after death indicated sensitivity of the fungus to miconazole.",,,,,
273710,NLM,MEDLINE,19780617,20110727,0047-1852 (Print) 0047-1852 (Linking),35 Suppl 2,,1977 Fall,"[Pyrexia, an increase in blood sedimentation rate, a loss of weight and anemia (blood pictures and bone marrow biopsy): (chronic myelogenous leukemia)].","3134-5, 3500-1","['Hasegawa, Y', 'Sadatoshi, M', 'Oyama, K', 'Sekine, I', 'Ito, Y']","['Hasegawa Y', 'Sadatoshi M', 'Oyama K', 'Sekine I', 'Ito Y']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Humans', 'Leukemia, Myeloid/*pathology', 'Male', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,"Nihon Rinsho. 1977 Fall;35 Suppl 2:3134-5, 3500-1.",,,,,,,
273709,NLM,MEDLINE,19780617,20110727,0047-1852 (Print) 0047-1852 (Linking),35 Suppl 2,,1977 Fall,"[Backache and coxalgia (bone radiography, bone marrow cytology and blood pictures): (myelogenous leukemia-abnormal proliferation of 3 series of bone marrow cells)].","3132-3, 3496-8","['Abe, M', 'Morimoto, Y', 'Minami, N', 'Kuraishi, Y', 'Meguro, S']","['Abe M', 'Morimoto Y', 'Minami N', 'Kuraishi Y', 'Meguro S']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Bone Marrow/pathology', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,"Nihon Rinsho. 1977 Fall;35 Suppl 2:3132-3, 3496-8.",,,,,,,
273708,NLM,MEDLINE,19780617,20110727,0047-1852 (Print) 0047-1852 (Linking),35 Suppl 2,,1977 Fall,"[Low grade fever, gingival and nose bleeding (blood pictures)--early induction of labor: (chronic myelogenous leukemia and Corynebacterium septicemia)].","3128-9, 3492-3","['Ishikawa, H', 'Honjo, A', 'Nonaka, H', 'Hiasa, Y']","['Ishikawa H', 'Honjo A', 'Nonaka H', 'Hiasa Y']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Adult', 'Corynebacterium Infections/etiology/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/complications/*pathology', 'Pregnancy', 'Pregnancy Complications, Hematologic/*pathology', 'Pregnancy Complications, Infectious/*pathology', 'Sepsis/etiology/*pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,"Nihon Rinsho. 1977 Fall;35 Suppl 2:3128-9, 3492-3.",,,,,,,
273707,NLM,MEDLINE,19780617,20110727,0047-1852 (Print) 0047-1852 (Linking),35 Suppl 2,,1977 Fall,"[Sensation of pressure at the anterior thorax, hemoptysis and melena (ECG and blood pictures): (acute myocardial infarct and monocytic leukemia)].","2944-5, 3302-3","['Toba, K', 'Nishi, K', 'Uchijima, H', 'Niitani, H', 'Kazama, K']","['Toba K', 'Nishi K', 'Uchijima H', 'Niitani H', 'Kazama K']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,IM,"['Acute Disease', '*Electrocardiography', 'Humans', 'Leukemia, Myeloid/complications/*pathology', 'Male', 'Middle Aged', 'Myocardial Infarction/complications/*pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,"Nihon Rinsho. 1977 Fall;35 Suppl 2:2944-5, 3302-3.",,,,,,,
273678,NLM,MEDLINE,19780617,20190630,0022-3476 (Print) 0022-3476 (Linking),92,5,1978 May,Rubinstein-Taybi syndrome and acute leukemia.,851-2,"['Jonas, D M', 'Heilbron, D C', 'Ablin, A R']","['Jonas DM', 'Heilbron DC', 'Ablin AR']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Abnormalities, Multiple/*complications', 'Acute Disease', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/*etiology', 'Male', 'Rubinstein-Taybi Syndrome/*complications']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']","['S0022-3476(78)80178-4 [pii]', '10.1016/s0022-3476(78)80178-4 [doi]']",ppublish,J Pediatr. 1978 May;92(5):851-2. doi: 10.1016/s0022-3476(78)80178-4.,,,,,,,
273677,NLM,MEDLINE,19780617,20190630,0022-3476 (Print) 0022-3476 (Linking),92,5,1978 May,Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma.,849-50,"['Reaman, G H', 'Poplack, D G', 'Pizzo, P A']","['Reaman GH', 'Poplack DG', 'Pizzo PA']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Acute Disease', 'Adult', 'Antineoplastic Agents/therapeutic use', '*Facial Injuries', 'Female', 'Humans', '*Leukemia, Lymphoid/drug therapy/pathology', 'Recurrence', 'Remission, Spontaneous', '*Soft Tissue Neoplasms/drug therapy/pathology']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']","['S0022-3476(78)80176-0 [pii]', '10.1016/s0022-3476(78)80176-0 [doi]']",ppublish,J Pediatr. 1978 May;92(5):849-50. doi: 10.1016/s0022-3476(78)80176-0.,['0 (Antineoplastic Agents)'],,,,,,
273620,NLM,MEDLINE,19780628,20190501,0021-9746 (Print) 0021-9746 (Linking),31,4,1978 Apr,Bone marrow fibrosis in acute lymphoblastic leukaemia of childhood.,313-5,"['Hann, I M', 'Evans, D I', 'Marsden, H B', 'Jones, P M', 'Palmer, M K']","['Hann IM', 'Evans DI', 'Marsden HB', 'Jones PM', 'Palmer MK']",['eng'],['Journal Article'],England,J Clin Pathol,Journal of clinical pathology,0376601,IM,"['Bone Marrow/pathology', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications/mortality/pathology', 'Male', 'Primary Myelofibrosis/*complications', 'Prospective Studies', 'Remission, Spontaneous']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1136/jcp.31.4.313 [doi]'],ppublish,J Clin Pathol. 1978 Apr;31(4):313-5. doi: 10.1136/jcp.31.4.313.,,"A prospective study of bone marrow fibrosis was made in a group of 40 children with acute lymphoblastic leukaemia to see whether it affected the prognosis or course of the disease. Secondary myelofibrosis (SMF) was present at diagnosis in 57% of the cases. It was not statistically significantly related to the prognosis or course of the disease. Thus, although trephine biopsy occasionally provided useful information in different diagnosis and when aspiration was difficult, it provided little information of use for management.",,PMC1145268,,,
273570,NLM,MEDLINE,19780612,20190722,0340-6717 (Print) 0340-6717 (Linking),41,2,1978 Mar 17,Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.,143-56,"['Prigogina, E L', 'Fleischman, E W', 'Volkova, M A', 'Frenkel, M A']","['Prigogina EL', 'Fleischman EW', 'Volkova MA', 'Frenkel MA']",['eng'],['Journal Article'],Germany,Hum Genet,Human genetics,7613873,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', '*Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/complications/*genetics', 'Male', 'Middle Aged', 'Time Factors', 'Translocation, Genetic']",1978/03/17 00:00,1978/03/17 00:01,['1978/03/17 00:00'],"['1978/03/17 00:00 [pubmed]', '1978/03/17 00:01 [medline]', '1978/03/17 00:00 [entrez]']",['10.1007/BF00273096 [doi]'],ppublish,Hum Genet. 1978 Mar 17;41(2):143-56. doi: 10.1007/BF00273096.,,"Forty cases of chronic myeloid leukemia (CML) were studied and subgroups of cases with similar chromosomal abnormalities in terminal stage were defined. Certain correlations were observed between the type of chromosomal changes, and clinical and morphologic manifestations of the disease: (1) It seems that, in cases without any karyotype changes other than translocation (9;22), the terminal stage is longer and milder than in cases with additional chromosomal abnormalities; (2) cases with marker i(17q) are clinically and morphologically rather uniform and are characterized by distinct signs of myeloid differentiation of blast cells, absent in other cases; (3) in cases with various atypical chromosomal abnormalities, the course of the terminal stage is the most rapid and grave. The blast cells differ from myeloblasts and resemble lymphoid elements.",,,,,
273566,NLM,MEDLINE,19780628,20190706,0300-5127 (Print) 0300-5127 (Linking),6,1,1978,Plasma glycosyltransferase activities as an index of marrow status in acute myelogenous leukaemias [proceedings].,187-90,"['Kessel, D', 'Chou, T H', 'Khilanani, P']","['Kessel D', 'Chou TH', 'Khilanani P']",['eng'],['Journal Article'],England,Biochem Soc Trans,Biochemical Society transactions,7506897,IM,"['Bone Marrow/*physiopathology', 'Fucose', 'Hexosyltransferases/*blood/metabolism', 'Humans', 'Leukemia, Myeloid/enzymology/*physiopathology', 'Sialyltransferases/blood']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1042/bst0060187 [doi]'],ppublish,Biochem Soc Trans. 1978;6(1):187-90. doi: 10.1042/bst0060187.,"['28RYY2IV3F (Fucose)', 'EC 2.4.1.- (Hexosyltransferases)', 'EC 2.4.99.- (Sialyltransferases)']",,,,,,
273500,NLM,MEDLINE,19780628,20180214,0301-0171 (Print) 0301-0171 (Linking),19,6,1977,Chromosomes in leukemia. General report on the First International Workshop on Chromosomes in Leukemia.,321-5,,,['eng'],['Journal Article'],Switzerland,Cytogenet Cell Genet,Cytogenetics and cell genetics,0367735,IM,"['*Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Humans', 'Leukemia/*genetics', 'Leukemia, Myeloid/genetics', 'Middle Aged', 'Translocation, Genetic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000130825 [doi]'],ppublish,Cytogenet Cell Genet. 1977;19(6):321-5. doi: 10.1159/000130825.,,,,,,,
273471,NLM,MEDLINE,19780617,20131121,0008-5472 (Print) 0008-5472 (Linking),38,5,1978 May,Synthesis of murine leukemia virus proteins differentiating Friend erythroleukemia cells.,1426-33,"['Sherton, C C', 'Dresler, S L', 'Polonoff, E', 'Webb, M C', 'Kabat, D']","['Sherton CC', 'Dresler SL', 'Polonoff E', 'Webb MC', 'Kabat D']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Cell Line', 'Dimethyl Sulfoxide/pharmacology', 'Friend murine leukemia virus', '*Hematopoiesis', 'Leukemia, Erythroblastic, Acute/physiopathology', 'Leukemia, Experimental/microbiology/*physiopathology/ultrastructure', 'Microscopy, Electron', 'Neoplasm Proteins/*biosynthesis', 'Tumor Virus Infections/physiopathology', 'Viral Proteins/*biosynthesis', 'Virus Replication/drug effects']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 May;38(5):1426-33.,"['0 (Neoplasm Proteins)', '0 (Viral Proteins)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
273470,NLM,MEDLINE,19780628,20190619,0008-543X (Print) 0008-543X (Linking),41,4,1978 Apr,Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features.,1642-6,"['Champion, L A', 'Luddy, R E', 'Schwartz, A D']","['Champion LA', 'Luddy RE', 'Schwartz AD']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Asparaginase/adverse effects/therapeutic use', 'Child', 'Disseminated Intravascular Coagulation/*complications/etiology', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications/drug therapy', 'Male', 'Prednisone/therapeutic use', 'Prognosis', 'Vincristine/therapeutic use']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1002/1097-0142(197804)41:4<1642::aid-cncr2820410456>3.0.co;2-r [doi]'],ppublish,Cancer. 1978 Apr;41(4):1642-6. doi: 10.1002/1097-0142(197804)41:4<1642::aid-cncr2820410456>3.0.co;2-r.,"['5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)']","Three children with ALL having poor prognostic features developed clinical and laboratory evidence of disseminated intravascular coagulation (DIC). Two developed a bleeding diathesis associated temporally with a rapid drop in blast cell counts during induction therapy with L-asparaginase, prednisone, and vincristine. One of these children died of massive cerebral hemorrhage. The third patient developed episodes of superficial thrombophlebitis associated with relapses and rising blast cell counts which responded to chemotherapy and treatment with heparin. The unusual association of ALL with DIC and the fact that all 3 patients had multiple poor prognostic signs have led us to monitor carefully the coagulation system and withhold L-asparaginase in patients with massive disease until the white cell count and organomegaly have responded to prednisone and vincristine. The more common association of DIC with non-lymphocytic leukemia and recent reports of the presence of the Ph' chromosome in children with leukemia morphologically resembling ALL suggest that chromosomal evaluation be done in selected leukemic patients.",,,,,
273468,NLM,MEDLINE,19780628,20190619,0008-543X (Print) 0008-543X (Linking),41,4,1978 Apr,Simultaneous presentation of acute myelomonocytic leukemia and multiple myeloma.,1381-6,"['Cleary, B', 'Binder, R A', 'Kales, A N', 'Veltri, B J']","['Cleary B', 'Binder RA', 'Kales AN', 'Veltri BJ']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Humans', 'Immunity', 'Immunoglobulin A/analysis', 'Leukemia, Myeloid, Acute/etiology/*pathology', 'Male', 'Middle Aged', 'Multiple Myeloma/etiology/*pathology', 'Neoplasms, Multiple Primary/etiology/*pathology']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['10.1002/1097-0142(197804)41:4<1381::aid-cncr2820410423>3.0.co;2-a [doi]'],ppublish,Cancer. 1978 Apr;41(4):1381-6. doi: 10.1002/1097-0142(197804)41:4<1381::aid-cncr2820410423>3.0.co;2-a.,['0 (Immunoglobulin A)'],A patient with acute myelomonocytic leukemia and multiple myeloma occurring simultaneously prior to initiation of chemotherapy is described. Possible mechanisms for this occurrence are discussed.,,,,,
273466,NLM,MEDLINE,19780612,20190619,0008-543X (Print) 0008-543X (Linking),41,3,1978 Mar,Atypical chronic myelogenous leukemia with Philadelphia (Ph') chromosome and an additional translocation.,1123-7,"['Norman, C S', 'Boucher, B J']","['Norman CS', 'Boucher BJ']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics', 'Middle Aged', '*Translocation, Genetic']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1002/1097-0142(197803)41:3<1123::aid-cncr2820410347>3.0.co;2-9 [doi]'],ppublish,Cancer. 1978 Mar;41(3):1123-7. doi: 10.1002/1097-0142(197803)41:3<1123::aid-cncr2820410347>3.0.co;2-9.,,"A case of chronic myelogenous leukemia in which the disease pursued an atypical course is described. The presence of a previously unreported translocation t(1;20), in addition to a Ph' chromosome t(9;22), is demonstrated, and its possible significance and relationship to the disease are discussed.",,,,,
273461,NLM,MEDLINE,19780628,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6121,1978 May 6,Leukostasis associated with blood transfusion in acute myeloid leukaemia.,1169-71,"['Harris, A L']",['Harris AL'],['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Age Factors', 'Blood Cell Count', 'Blood Platelets', 'Blood Viscosity', 'Cerebrovascular Circulation', 'Female', 'Hemoglobins/analysis', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Lymphocytes', 'Male', 'Middle Aged', 'Time Factors', '*Transfusion Reaction']",1978/05/06 00:00,1978/05/06 00:01,['1978/05/06 00:00'],"['1978/05/06 00:00 [pubmed]', '1978/05/06 00:01 [medline]', '1978/05/06 00:00 [entrez]']",['10.1136/bmj.1.6121.1169 [doi]'],ppublish,Br Med J. 1978 May 6;1(6121):1169-71. doi: 10.1136/bmj.1.6121.1169.,['0 (Hemoglobins)'],"Three patients with acute myeloblastic leukaemia and blast cell counts greater than 100 X 10(9)/1 (100 000/mm3) died unexpectedly soon after blood transfusion. In two cases postmortem examination disclosed cerebral leukostasis. Analysis of the records from the MRC's fourth and fifth acute myeloid leukaemia trials showed that in the first week after diagnosis mortality was five times greater in patients with blast counts above 100 X 10(9)/1 than in patients with lower counts. Age and platelet count did not explain this excess. The mean haemoglobin concentration in the patients with high blast counts who died within the first week was 10.5 +/- 2.8 g/dl, which was significantly higher than that in the surviving group (7.6 +/- 2.4 g/dl). Only half the patients received chemotherapy within two days of diagnosis. Leukostasis is an important cause of early death in patients with high blast counts, and the increase in viscosity produced by transfusing to a haemoglobin concentration above 10 g/dl may lead to sudden deterioration. Transfusion to such concentrations should be avoided until the blast count has been reduced by early chemotherapy.",,PMC1604257,,,
273460,NLM,MEDLINE,19780617,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6118,1978 Apr 15,Price of survival in childhood leukaemia.,986-7,"['Swift, P', 'Savage, D C', 'Mott, M G', 'Bullimore, J A']","['Swift P', 'Savage DC', 'Mott MG', 'Bullimore JA']",['eng'],['Letter'],England,Br Med J,British medical journal,0372673,IM,"['Child', '*Growth', 'Humans', '*Leukemia, Lymphoid/physiopathology/therapy', 'Time Factors']",1978/04/15 00:00,1978/04/15 00:01,['1978/04/15 00:00'],"['1978/04/15 00:00 [pubmed]', '1978/04/15 00:01 [medline]', '1978/04/15 00:00 [entrez]']",['10.1136/bmj.1.6118.986-b [doi]'],ppublish,Br Med J. 1978 Apr 15;1(6118):986-7. doi: 10.1136/bmj.1.6118.986-b.,,,,PMC1603818,,,
273452,NLM,MEDLINE,19780612,20190902,0006-5242 (Print) 0006-5242 (Linking),36,3,1978 Mar 15,[Delivery of a normal child after chemotherapy of acute promyelocytic leukaemia during pregnancy (author's transl)].,171-4,"['Gstottner, M', 'Frisch, H', 'Dienstl, F']","['Gstottner M', 'Frisch H', 'Dienstl F']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Cesarean Section', 'Cytarabine/*adverse effects/therapeutic use', 'Daunorubicin/*adverse effects/therapeutic use', 'Female', 'Humans', 'Infant, Newborn', 'Infant, Premature', 'Leukemia, Myeloid, Acute/*drug therapy', 'Pregnancy', 'Pregnancy Complications, Hematologic/*drug therapy', 'Remission, Spontaneous']",1978/03/15 00:00,1978/03/15 00:01,['1978/03/15 00:00'],"['1978/03/15 00:00 [pubmed]', '1978/03/15 00:01 [medline]', '1978/03/15 00:00 [entrez]']",['10.1007/BF00996656 [doi]'],ppublish,Blut. 1978 Mar 15;36(3):171-4. doi: 10.1007/BF00996656.,"['04079A1RDZ (Cytarabine)', 'ZS7284E0ZP (Daunorubicin)']","Upon chemotherapy with daunorubidomycin and cytosinarabinoside, a patient suffering from acute promyelocytic leukaemia during the 28. week of pregnancy achieved complete haematological remission. In spite of complicating disseminated intravascular coagulopathy and aggressive chemotherapy a normal child was delivered by cesarian section during the 34. week of pregnancy. Specific problems in the treatment of acute leukaemia during pregnancy are discussed.",Normales Neugeborenes nach zytostatischer Therapie bei akuter Promyelozytenleukamie in der Schwangerschaft.,,,,
273451,NLM,MEDLINE,19780628,20210216,0006-4971 (Print) 0006-4971 (Linking),51,5,1978 May,Congenital hypoplastic anemia (Diamond-Blackfan syndrome) terminating in acute myelogenous leukemia.,991-5,"['Wasser, J S', 'Yolken, R', 'Miller, D R', 'Diamond, L']","['Wasser JS', 'Yolken R', 'Miller DR', 'Diamond L']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adult', 'Anemia, Aplastic/complications/*congenital/diagnosis', '*Erythrocytes, Abnormal', 'Female', 'Humans', 'Leukemia, Myeloid/complications', 'Syndrome']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['S0006-4971(20)70090-X [pii]'],ppublish,Blood. 1978 May;51(5):991-5.,,"A 31-yr-old female with congenital hypoplastic anemia (Diamond-Blackfan syndrome) whose long course terminated in acute myelogenous leukemia is described. In contrast to Fanconi anemia, malignant transformation rarely occurs in congenital hypoplastic anemia. This patient's diagnosis of congenital hypoplastic anemia is supported by her clinical course, absence of renal abnormalities, a negative family history for hematologic disorders, normal chromosome studies, failure of her skin fibroblasts to transform in culture with SV-40 virus, macrocytic erythrocyte indices, erythrocyte enzyme studies, and bone marrow findings. Only two other cases of malignancy have been reported in patients with congenital hypoplastic anemia. The development of malignancy in these patients suggests that malignant transformation may be a concern in the long-term progression of congenital hypoplastic anemia.",,,,,
273450,NLM,MEDLINE,19780628,20210216,0006-4971 (Print) 0006-4971 (Linking),51,5,1978 May,Membrane marker and cell separation studies in Ph1-positive leukemia.,861-77,"['Janossy, G', 'Woodruff, R K', 'Paxton, A', 'Greaves, M F', 'Capellaro, D', 'Kirk, B', 'Innes, E M', 'Eden, O B', 'Lewis, C', 'Catovsky, D', 'Hoffbrand, A V']","['Janossy G', 'Woodruff RK', 'Paxton A', 'Greaves MF', 'Capellaro D', 'Kirk B', 'Innes EM', 'Eden OB', 'Lewis C', 'Catovsky D', 'Hoffbrand AV']",['eng'],"['Case Reports', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['Adolescent', 'Adult', 'Cell Membrane/enzymology/immunology', 'Cell Separation', '*Cell Transformation, Neoplastic', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Lymphoid/*immunology', 'Leukemia, Myeloid/*immunology', 'Male', 'Middle Aged']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['S0006-4971(20)70079-0 [pii]'],ppublish,Blood. 1978 May;51(5):861-77.,,,,,,,
273449,NLM,MEDLINE,19780628,20210216,0006-4971 (Print) 0006-4971 (Linking),51,5,1978 May,Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia.,843-50,"['Kamada, N', 'Uchino, H']","['Kamada N', 'Uchino H']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Basophils', 'Chromosomes, Human, 21-22 and Y', 'Granulocytes', 'Humans', 'Leukemia, Myeloid/*blood', 'Leukemia, Radiation-Induced', 'Leukocyte Count', 'Time Factors']",1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['S0006-4971(20)70077-7 [pii]'],ppublish,Blood. 1978 May;51(5):843-50.,,,,,,,
273431,NLM,MEDLINE,19780617,20190704,0007-1048 (Print) 0007-1048 (Linking),38,3,1978 Mar,Acute myeloid leukaemia with monosomy-7 follows acute lymphoblastic leukaemia.,359-66,"['Walker, L M', 'Sandler, R M']","['Walker LM', 'Sandler RM']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['*Aneuploidy', 'Child', 'Child, Preschool', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Lymphoid/*complications/therapy', 'Leukemia, Myeloid, Acute/*complications/etiology/genetics', 'Pancytopenia/complications', 'Pedigree']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1111/j.1365-2141.1978.tb01055.x [doi]'],ppublish,Br J Haematol. 1978 Mar;38(3):359-66. doi: 10.1111/j.1365-2141.1978.tb01055.x.,,,,,,,
273430,NLM,MEDLINE,19780617,20190704,0007-1048 (Print) 0007-1048 (Linking),38,3,1978 Mar,Acquired haemoglobin H disease in leukemia: pathophysiology and molecular basis.,305-22,"['Weatherall, D J', 'Old, J', 'Longley, J', 'Wood, W G', 'Clegg, J B', 'Pollock, A', 'Lewis, M J']","['Weatherall DJ', 'Old J', 'Longley J', 'Wood WG', 'Clegg JB', 'Pollock A', 'Lewis MJ']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Aged', 'DNA', 'Globins/biosynthesis', 'Hemoglobin H/*analysis', 'Hemoglobinopathies/*complications', 'Hemoglobins/biosynthesis', 'Hemoglobins, Abnormal/*analysis', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Male', 'Nucleic Acid Hybridization', 'RNA, Messenger/analysis']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1111/j.1365-2141.1978.tb01049.x [doi]'],ppublish,Br J Haematol. 1978 Mar;38(3):305-22. doi: 10.1111/j.1365-2141.1978.tb01049.x.,"['0 (Hemoglobins)', '0 (Hemoglobins, Abnormal)', '0 (RNA, Messenger)', '9004-22-2 (Globins)', '9007-49-2 (DNA)', '9034-79-1 (Hemoglobin H)']",,,,,,
273429,NLM,MEDLINE,19780612,20190704,0007-1048 (Print) 0007-1048 (Linking),38,1,1978 Jan,"8/21 translocation, loss of the Y chromosome and Philadelphia chromosome.",149-50,"['Francesconi, D', 'Pasquali, F']","['Francesconi D', 'Pasquali F']",['eng'],"['Case Reports', 'Letter']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adolescent', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/genetics', 'Male', '*Sex Chromosomes', '*Translocation, Genetic', '*Y Chromosome']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1111/j.1365-2141.1978.tb07117.x [doi]'],ppublish,Br J Haematol. 1978 Jan;38(1):149-50. doi: 10.1111/j.1365-2141.1978.tb07117.x.,,,,,,,
273418,NLM,MEDLINE,19780517,20191021,0004-993X (Print) 0004-993X (Linking),13,3,1977 Sep,Family reactions in childhood acute lymphoblastic leukaemia in remission.,176-81,"['Tiller, J W', 'Ekert, H', 'Rickards, W S']","['Tiller JW', 'Ekert H', 'Rickards WS']",['eng'],['Journal Article'],Australia,Aust Paediatr J,Australian paediatric journal,15420340R,IM,"['Acute Disease', 'Adolescent', 'Adult', '*Attitude to Health', 'Child', 'Child, Preschool', '*Family', 'Female', 'Humans', '*Leukemia, Lymphoid/psychology', 'Male', 'Remission, Spontaneous']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1440-1754.1977.tb01147.x [doi]'],ppublish,Aust Paediatr J. 1977 Sep;13(3):176-81. doi: 10.1111/j.1440-1754.1977.tb01147.x.,,,,,,,
273405,NLM,MEDLINE,19780524,20190718,0004-8682 (Print) 0004-8682 (Linking),47,5,1977 Oct,The creation of artificial subcutaneous arteriovenous fistulas in patients with malignant haematological disease.,614-7,"['Bell, S N', 'Sullivan, J R', 'Hurley, T H', 'Marshall, V C']","['Bell SN', 'Sullivan JR', 'Hurley TH', 'Marshall VC']",['eng'],"['Case Reports', 'Journal Article']",Australia,Aust N Z J Surg,The Australian and New Zealand journal of surgery,0373115,IM,"['Adult', 'Arm/blood supply', '*Arteriovenous Shunt, Surgical', 'Blood Vessel Prosthesis', 'Female', 'Hodgkin Disease/*surgery', 'Humans', 'Leukemia, Lymphoid/*surgery', 'Leukemia, Myeloid, Acute/pathology/*surgery', 'Male', 'Middle Aged', 'Veins/pathology']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1111/j.1445-2197.1977.tb06592.x [doi]'],ppublish,Aust N Z J Surg. 1977 Oct;47(5):614-7. doi: 10.1111/j.1445-2197.1977.tb06592.x.,,"Creation of an artificial subcutaneous arteriovenous fistula was attempted in five patients with malignant haematological disorders (two with Hodgkin's disease, two with acute lymphatic leukaemia, and one with acute myeloid leukaemia). The average time from the start of treatment to attempted creation of the fistulae was four years. Neither direct arteriovenous anastomosis nor an interposition mandril graft was successful in any patient. Failure was attributed to impaired venous run-off secondary to previous episodes of thrombophlebitis induced by the intravenous administration of cytotoxic drugs. The use of an arteriovenous fistula early in the course of the disease might minimize these later problems.",,,,,
273389,NLM,MEDLINE,19780524,20061115,0003-9926 (Print) 0003-9926 (Linking),138,4,1978 Apr,Acquired hemoglobin H in refractor sideroblastic anemia. A preleukemic marker.,603-6,"['Boehme, W M', 'Piira, T A', 'Kurnick, J E', 'Bethlenfalvay, N C']","['Boehme WM', 'Piira TA', 'Kurnick JE', 'Bethlenfalvay NC']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Aged', 'Anemia, Sideroblastic/*blood', '*Hemoglobin H', '*Hemoglobins, Abnormal', 'Humans', 'Leukemia/*blood', 'Leukemia, Myeloid/blood', 'Male', 'Middle Aged', 'Preleukemia/*blood']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1978 Apr;138(4):603-6.,"['0 (Hemoglobins, Abnormal)', '9034-79-1 (Hemoglobin H)']","Two patients with idiopathic refractory sideroblastic anemia (IRSA) were found to have acquired hemoglobin H. Both developed leukemic syndromes. Six other patients with IRSA had normal hemoglobin electrpohoretic patterns, and none has developed acute leukemia in up to five years. We suggest that hemoglobin electrphoresis be performed routinely in IRSA. The finding of hemoglobin H in this population may be a relatively frequent occurrence and may serve to distinguish the preleukemic patients from those not destined to develop leukemia.",,,,,
273382,NLM,MEDLINE,19780517,20190509,0002-9173 (Print) 0002-9173 (Linking),69,3,1978 Mar,Electrophoretic properties of esterases in chronic granulocytic leukemia.,329-32,"['Kass, L', 'Peters, C L', 'Vugrin, D']","['Kass L', 'Peters CL', 'Vugrin D']",['eng'],['Journal Article'],England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Chronic Disease', 'Electrophoresis, Polyacrylamide Gel', 'Esterases/*blood/isolation & purification', 'Granulocytes/*enzymology', 'Humans', 'Leukemia, Myeloid/blood/*enzymology', 'Leukocytes/*enzymology', 'Neutrophils/enzymology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1093/ajcp/69.1.329 [doi]'],ppublish,Am J Clin Pathol. 1978 Mar;69(3):329-32. doi: 10.1093/ajcp/69.1.329.,['EC 3.1.- (Esterases)'],"Granulocytes were obtained from samples of peripheral blood of five patients who had untreated chronic granulocytic leukemia, and polymorphonuclear leukocytes were isolated from peripheral blood of three normal persons. Specific and nonspecific esterases were extracted from leukocyte preparations with cetyltrimethylammonium bromide and with lysolecithin, and subjected to polyacrylamide disk electrophoresis. In samples from both patients and normal persons, electrophoretic patterns of nonspecific esterase activity using alpha-naphthyl acetate and alpha-naphthyl butyrate were similar, and the esterase bands were weakly inhibited by fluoride. Lysolecithin extracts of specific esterase showed similar electrophoretic patterns for patients and normal subjects. However in cetyltrimethylammonium bromide extracts of specific esterase, 11 bands were seen in preparations from all of the patients with chronic granulocytic leukemia. In preparations of normal polymorphonuclear leukocytes, only eight bands were visualized. The results are consistent with an interpretation that these fast-moving components of specific esterase in chronic granulocytic leukemia granulocytes are present in normal polymorphonuclear leukocytes, but in quantities too small to be visualized with the technics used. Alternatively, the apparent ""additional"" bands of specific esterase may reflect abnormal metabolism of malignant granulocytes in chronic granulocytic leukemia.",,,,,
273361,NLM,MEDLINE,19780524,20110728,0001-5806 (Print) 0001-5806 (Linking),40,6,1977 Dec,The function and clinical significance of DNA polymerases in human hematopoietic cells.,1104-16,"['Sasaki, R', 'Sakamoto, S']","['Sasaki R', 'Sakamoto S']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Animals', 'DNA-Directed DNA Polymerase/*metabolism', 'Hematopoietic Stem Cells/*enzymology', 'Humans', 'Leukemia, Myeloid/enzymology', 'Leukemia, Myeloid, Acute/enzymology', 'Rats']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Dec;40(6):1104-16.,['EC 2.7.7.7 (DNA-Directed DNA Polymerase)'],,,,,,
273360,NLM,MEDLINE,19780524,20141120,0001-5806 (Print) 0001-5806 (Linking),40,6,1977 Dec,Deoxyribonucleoside triphosphate metabolism of leukemic cells.,1092-103,"['Omine, M', 'Iwata, N', 'Arai, T', 'Suda, T']","['Omine M', 'Iwata N', 'Arai T', 'Suda T']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Bone Marrow/metabolism', 'DNA, Neoplasm/biosynthesis', 'Deoxyribonucleotides/*metabolism', 'Humans', 'In Vitro Techniques', 'Leukemia/*metabolism', 'Leukemia, Myeloid/metabolism', 'Leukemia, Myeloid, Acute/metabolism', 'Nucleic Acid Precursors/*metabolism']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Dec;40(6):1092-103.,"['0 (DNA, Neoplasm)', '0 (Deoxyribonucleotides)', '0 (Nucleic Acid Precursors)']",,,,,,
273353,NLM,MEDLINE,19780520,20071115,0066-1562 (Print) 0066-1562 (Linking),,71 Pt 2,1977,[Ultrastructure of leukemic blood cells].,811-5,"['Stang-Voss, C', 'Scheerer, B', 'Behrendt, H']","['Stang-Voss C', 'Scheerer B', 'Behrendt H']",['ger'],"['English Abstract', 'Journal Article']",Germany,Verh Anat Ges,Verhandlungen der Anatomischen Gesellschaft,7501276,IM,"['Hematopoietic Stem Cells/*ultrastructure', 'Humans', 'Leukemia/*ultrastructure', 'Leukemia, Hairy Cell/ultrastructure', 'Leukemia, Myeloid/ultrastructure', 'Leukemia, Myeloid, Acute/ultrastructure']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Verh Anat Ges. 1977;(71 Pt 2):811-5.,,,Zur Ultrastruktur leukamischer Blutzellen.,,,,
273347,NLM,MEDLINE,19780517,20071115,0507-3758 (Print) 0507-3758 (Linking),24,1,1978,[Morphological and histoenzymatic characteristics of the bone marrow in the blastic crisis of chronic myeloleukosis].,24-9,"['Khittsov, G A']",['Khittsov GA'],['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Vopr Onkol,Voprosy onkologii,0413775,IM,"['Autopsy', 'Bone Marrow/enzymology/*pathology', 'Enzyme Activation', 'Humans', 'Leukemia, Myeloid/enzymology/*pathology', 'Leukemia, Myeloid, Acute/enzymology/*pathology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Vopr Onkol. 1978;24(1):24-9.,,"Morphological and histoenzymatic characteristics of bone marrow in blastic crisis of chronic myeloleukemia are presented. Its involvement is proved to be irregular even within the limits of small topographic zones. The later is of importance in establishing the diagnosis of the disease by trepine biopsies in hematological practice. The histoenzymatic analysis of the cells in blastic crisis, indicates low degree of their differentiation reaching presumably the level of committed elements of hemopoiesis.",Morfologicheskaia i gistifermentativania kharakteristika kostnogo mozga pri blastnom krize khronicheskogo mieloleikoza.,,,,
273318,NLM,MEDLINE,19780517,20190727,0040-8727 (Print) 0040-8727 (Linking),124,1,1978 Jan,Histone synthesis and differentiation in murine virus-infected erythroleukemia cells.,13-20,"['Tanaka, M']",['Tanaka M'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Japan,Tohoku J Exp Med,The Tohoku journal of experimental medicine,0417355,IM,"['Animals', '*Cell Differentiation', 'Cells, Cultured', 'Cytoplasm/metabolism', 'Electrophoresis, Polyacrylamide Gel', 'Friend murine leukemia virus', 'Histones/*biosynthesis', 'Leukemia, Erythroblastic, Acute/*metabolism/pathology', 'Leukemia, Experimental/metabolism/pathology', 'Mice', 'Neoplasm Proteins/biosynthesis', 'Sulfoxides/pharmacology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1620/tjem.124.13 [doi]'],ppublish,Tohoku J Exp Med. 1978 Jan;124(1):13-20. doi: 10.1620/tjem.124.13.,"['0 (Histones)', '0 (Neoplasm Proteins)', '0 (Sulfoxides)']",The murine virus-infected erythroleukemia cells (MELC) has been used as a useful tool to examine the regulatory mechanism of the cytodifferentiation by the genetic approach. Addition of dimethylsulfoxide (DMSO) to the MELC culture induces erythroid differentiation. A study was made to assess whether stimulation of histone synthesis is associated with DMSO-induced differentiation of MELC during 4 days of culture in vitro. The synthesis of histone increased 2-fold in the 48 hr-incubated cells while the synthesis of non-histone protein was not stimulated. The histone synthesis was maximal at 48 hr and declined by 72 hr. 3H-leucine-labeled cells treated with DMSO was mixed with an equal weight of 14C-labeled control cells. Histones were isolated and fractionated on polyacrylamide gel. A 3.6-fold increase in 3H/14C ratio occurred in histone fraction 3 and 3.4-fold in histone fraction 2b. The data indicate that the stimulation of histone synthesis is an early event following DMSO treatment of MELC cells.,,,,,
273311,NLM,MEDLINE,19780517,20161123,0036-4355 (Print) 0036-4355 (Linking),23,1,1978,[Pericardial tamponade as the initial manifestation of acute leukaemia. Report of a case and review of the literature (author's transl)].,89-93,"['Oliveira Filho, J A', 'Amaral, R F', 'Lorand, G H', 'Silveira, E']","['Oliveira Filho JA', 'Amaral RF', 'Lorand GH', 'Silveira E']",['spa'],"['Case Reports', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Cardiac Tamponade/diagnostic imaging/*etiology', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications/diagnostic imaging', 'Pericarditis, Constrictive/diagnostic imaging/*etiology', 'Pleural Effusion/cytology', 'Radiography']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1978;23(1):89-93.,,,Pericarditis compresiva como manifestacion inicial de leucemia aguda. Presentacion de un caso y revision de la literatura.,,,,
273310,NLM,MEDLINE,19780517,20131121,0036-4355 (Print) 0036-4355 (Linking),23,1,1978,[Trysomy of chromosome 1 long arms plus chromosome 9 inversion in leukaemic cells (author's transl)].,64-8,"['Prieto, F', 'Badia, L', 'Mayans, J', 'Besalduch, J', 'Marty, M L']","['Prieto F', 'Badia L', 'Mayans J', 'Besalduch J', 'Marty ML']",['spa'],"['Case Reports', 'English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Chromosome Aberrations/*diagnosis', 'Chromosome Disorders', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', '*Drug Resistance', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid, Acute/drug therapy/*genetics', 'Middle Aged', '*Trisomy']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1978;23(1):64-8.,"['04079A1RDZ (Cytarabine)', 'ZS7284E0ZP (Daunorubicin)']",,Trisomia de los brazos largos del cromosoma 1 e inversion del cromosoma 9 en celulas leucemicas.,,,,
273309,NLM,MEDLINE,19780517,20151119,0036-4355 (Print) 0036-4355 (Linking),23,1,1978,[Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author's transl)].,1-12,"['Aur, J A', 'Simone, J V', 'Verzosa, M S', 'Hustu, H O', 'Pinkel, D P', 'Barker, L F']","['Aur JA', 'Simone JV', 'Verzosa MS', 'Hustu HO', 'Pinkel DP', 'Barker LF']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/*adverse effects', 'Asparaginase/adverse effects', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Injections, Spinal/adverse effects', 'Leukemia, Lymphoid/*drug therapy/radiotherapy', 'Leukoencephalopathy, Progressive Multifocal/*chemically induced', 'Male', 'Methotrexate/adverse effects', 'Prednisone/*adverse effects', 'Radiotherapy/adverse effects', 'Vincristine/adverse effects']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1978;23(1):1-12.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']",,Leucoencefalopatia en ninos con leucemia linfocitica aguda sometidos a terapeutica preventiva del sistema nervioso central.,,,,
273308,NLM,MEDLINE,19780517,20191210,0256-9574 (Print),52,26,1977 Dec 17,The infective complications of aggressive induction of clinical remission in adult acute non-lymphoblastic leukaemia.,1061-2,"['Dubovsky, D', 'Jacobs, P']","['Dubovsky D', 'Jacobs P']",['eng'],['Journal Article'],South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Bacterial Infections/complications', 'Humans', 'Infections/*complications', 'Leukemia, Myeloid, Acute/*complications/drug therapy', 'Male', 'Mycoses/complications', 'Remission, Spontaneous']",1977/12/17 00:00,1977/12/17 00:01,['1977/12/17 00:00'],"['1977/12/17 00:00 [pubmed]', '1977/12/17 00:01 [medline]', '1977/12/17 00:00 [entrez]']",,ppublish,S Afr Med J. 1977 Dec 17;52(26):1061-2.,,"The infectious complications after induction of remission in 31 previously untreated adult patients with acute myeloid leukaemia are described. Clinically, most of the febrile episodes were associated with infection, and in 11 of the patients who died infection was the direct cause. In 6 out of these 11 the causal organism was diagnosed ante mortem. In 6 of the 15 patients who regenerated to clinical remission and who had fever the causal organism was isolated. The policy of management of fever in this group of patients is outlined.",,,,,
273306,NLM,MEDLINE,19780517,20190907,0036-553X (Print) 0036-553X (Linking),20,2,1978 Feb,Mitotic activity in myeloid leukaemias. A study of 277 cases.,159-67,"['Sjogren, U']",['Sjogren U'],['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Aged', 'Bone Marrow/*pathology', 'Eosinophils', 'Female', 'Humans', 'Leukemia/classification', 'Leukemia, Myeloid/blood/classification/*pathology', 'Leukemia, Myeloid, Acute/classification', 'Male', 'Middle Aged', 'Mitosis', 'Neutrophils']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02441.x [doi]'],ppublish,Scand J Haematol. 1978 Feb;20(2):159-67. doi: 10.1111/j.1600-0609.1978.tb02441.x.,,"The proportions of myeloblasts, promyelocytes, myelocytes and promonocytes within the granulopoietic precursor pool of the bone marrow and mitotic indices (MI) of the precursor cells were determined in 277 patients with various forms of myeloid leukaemias. The MI of the leukaemic patients were significantly lower than those of 20 normals. Thus the median MI in 186 cases of acute myeloid leukaemias was 0.68%, compared with 1.0% in 85 cases of chronic leukaemias and 1.2% in the normals. Separate MI of the different leukaemic precursor cells were counted in 21 cases of acute myeloid leukaemias and these indices were lower than those of the corresponding normal cells. There were significant differences between the different groups and subtypes of leukaemias and it is suggested that mitotic countings might be of diagnostic and prognostic significance.",,,,,
273305,NLM,MEDLINE,19780517,20190907,0036-553X (Print) 0036-553X (Linking),20,2,1978 Feb,Isozymes of amino acid naphthylamidase in chronic meyloid leukaemia and erythroleukaemia.,153-8,"['Sinna, G A', 'Lenner, P', 'Lundgren, E', 'Roos, G']","['Sinna GA', 'Lenner P', 'Lundgren E', 'Roos G']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Aminopeptidases/*blood', 'Electrophoresis', 'Granulocytes/enzymology', 'Humans', 'Isoenzymes/*blood', 'Leukemia, Erythroblastic, Acute/*enzymology', 'Leukemia, Myeloid/*enzymology']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02440.x [doi]'],ppublish,Scand J Haematol. 1978 Feb;20(2):153-8. doi: 10.1111/j.1600-0609.1978.tb02440.x.,"['0 (Isoenzymes)', 'EC 3.4.11.- (Aminopeptidases)']","Isozymes of amino acid naphthylamidase were investigated in 11 patients with chronic myeloid leukaemia (CML) and 1 patient with erythroleukaemia. Two isozymes were found in all cases (isozymes A and C) which also occur in normal granulocytes. An isozyme with intermediate mobility appeared in all the patients in two main forms (isozymes BF and BS), which both differed from the isozyme B found in normal granulocytes. This may therefore support the diagnosis. In 3 patients a shift occurred between isozymes BF and BS, the possible significance of which is discussed.",,,,,
273304,NLM,MEDLINE,19780517,20190907,0036-553X (Print) 0036-553X (Linking),20,2,1978 Feb,"Erythroblast kinetics in pernicious anaemia, erythroleukaemia and sideroblastic anaemia.",117-28,"['Suda, T', 'Omine, M', 'Tsuchiya, J']","['Suda T', 'Omine M', 'Tsuchiya J']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Anemia, Pernicious/*blood/drug therapy', 'Anemia, Sideroblastic/*blood', 'Autoradiography', 'Cell Cycle', 'DNA/biosynthesis', 'Erythroblasts/*cytology/metabolism', 'Erythrocytes/*cytology', 'Erythropoiesis/drug effects', 'Humans', 'Leukemia, Erythroblastic, Acute/*blood', 'Time Factors', 'Vitamin B 12/therapeutic use']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb02436.x [doi]'],ppublish,Scand J Haematol. 1978 Feb;20(2):117-28. doi: 10.1111/j.1600-0609.1978.tb02436.x.,"['9007-49-2 (DNA)', 'P6YC3EG204 (Vitamin B 12)']","DNA synthesis time (Ts) and 3H-thymidine labelling index (TLI) of erythroblasts have been determined in 25 patients with various types of haematologic disorders using in vitro double labelling method. No remarkable differences in both Ts and TLI were noted between haematologically normal subjects and patients with increased effective erythropoiesis (haemolytic anaemias), suggesting that the cell cycle time is not principally altered under the augmented erythropoiesis. In pernicious anaemia, Ts of basophilic erythroblasts was significantly shortened and TLI was elevated above normal. Normalization of erythropoiesis by vitamin B12 was associated with a transient increase of TLI in polychromatic erythroblasts, which was interpreted to reflect prevention of intramedullary premature death of basophilic megaloblasts. Erythroleukaemia showed a markedly prolonged Ts and lowered TLI indicating the presence of cells with prolonged cell cycle time. These findings contrasted to that of pernicious anaemia despite certain morphological as well as functional similarities. In idiopathic sideroblastic anaemia, prolongation of Ts was observed to a similar extent as erythroleukaemia, while TLI remained almost normal. In 2 cases with suspected erythroleukaemia presenting an intermediate clinical picture between erythroleukaemia and sideroblastic anaemia, Ts of basophilic erythroblasts was found to be prolonged along with modestly lowered TLI.",,,,,
273297,NLM,MEDLINE,19780520,20071115,0035-760X (Print) 0035-760X (Linking),74,6,1977 Nov-Dec,Acute leukemia presenting as a ruptured spleen: report of a case.,319-20,"['Saiers, J H']",['Saiers JH'],['eng'],"['Case Reports', 'Journal Article']",United States,Rocky Mt Med J,Rocky Mountain medical journal,0404505,IM,"['Humans', 'Leukemia, Myeloid, Acute/complications/*diagnosis', 'Male', 'Middle Aged', 'Rupture, Spontaneous', 'Splenic Rupture/*etiology']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Rocky Mt Med J. 1977 Nov-Dec;74(6):319-20.,,,,,,,
273272,NLM,MEDLINE,19780517,20071115,0014-2565 (Print) 0014-2565 (Linking),148,1,1978 Jan 15,[Hemoblastosis and 2d hematic disease].,73-7,"['Narvaiza, M J', 'Angulo, P', 'Ceballos, L', 'Goni, M', 'Lopez Borrasca, A']","['Narvaiza MJ', 'Angulo P', 'Ceballos L', 'Goni M', 'Lopez Borrasca A']",['spa'],"['Case Reports', 'English Abstract', 'Journal Article']",Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Adult', 'Aged', 'Antineoplastic Agents/therapeutic use', 'Female', 'Hodgkin Disease/complications', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Lymphoma, Non-Hodgkin/*etiology', 'Male', 'Middle Aged', 'Mycosis Fungoides/etiology', 'Recurrence']",1978/01/15 00:00,1978/01/15 00:01,['1978/01/15 00:00'],"['1978/01/15 00:00 [pubmed]', '1978/01/15 00:01 [medline]', '1978/01/15 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1978 Jan 15;148(1):73-7.,['0 (Antineoplastic Agents)'],,Hemoblastosis y segunda enfermedad hematica.,,,,
273260,NLM,MEDLINE,19780517,20200930,0037-9727 (Print) 0037-9727 (Linking),157,3,1978 Mar,"Granulocyte colony formation in chronic granulocytic leukemia during stable, accelerated and blastic disease.",337-41,"['Rhodes, C A', 'Robinson, W A', 'Entringer, M A']","['Rhodes CA', 'Robinson WA', 'Entringer MA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Soc Exp Biol Med,"Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)",7505892,IM,"['Bone Marrow/pathology', 'Cell Division', 'Clone Cells/pathology', 'Granulocytes/*pathology', 'Humans', 'Leukemia, Myeloid/blood/*pathology', 'Leukemia, Myeloid, Acute/blood/*pathology', 'Leukocytes/*pathology', 'Prognosis']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.3181/00379727-157-40049 [doi]'],ppublish,Proc Soc Exp Biol Med. 1978 Mar;157(3):337-41. doi: 10.3181/00379727-157-40049.,,,,,,,
273211,NLM,MEDLINE,19780508,20161123,0342-7498 (Print) 0342-7498 (Linking),32,2,1978 Feb,[Pulmonary alveolar proteinosis (author's transl)].,116-9,"['Thoma, R', 'Hirschmann, W D', 'du Mesnil de Rochemont, W']","['Thoma R', 'Hirschmann WD', 'du Mesnil de Rochemont W']",['ger'],"['Case Reports', 'Journal Article']",Germany,Prax Klin Pneumol,Praxis und Klinik der Pneumologie,7705449,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Myeloid/*complications', 'Pulmonary Alveolar Proteinosis/*complications/diagnostic imaging', 'Radiography']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Prax Klin Pneumol. 1978 Feb;32(2):116-9.,,,Die pulmonale alveolare Proteinose.,,,,
273209,NLM,MEDLINE,19780517,20190501,0032-5473 (Print) 0032-5473 (Linking),54,628,1978 Feb,Aplasia and leukaemia following chloroquine therapy.,108-12,"['Nagaratnam, N', 'Chetiyawardana, A D', 'Rajiyah, S']","['Nagaratnam N', 'Chetiyawardana AD', 'Rajiyah S']",['eng'],"['Case Reports', 'Journal Article']",England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Adult', 'Anemia, Aplastic/*chemically induced', 'Bone Marrow/pathology', 'Chloroquine/*adverse effects/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*chemically induced', 'Malaria/drug therapy', 'Male', 'Middle Aged']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1136/pgmj.54.628.108 [doi]'],ppublish,Postgrad Med J. 1978 Feb;54(628):108-12. doi: 10.1136/pgmj.54.628.108.,['886U3H6UFF (Chloroquine)'],"Three patients with aplastic anaemia following chloroquine therapy are described. In two, chloroquine had been administered in large doses over a long period. One of them subsequently developed acute myeloblastic leukaemia. The third received only a small dose and pancytopenia with aplasia followed three weeks after ingestion of the drug. The mechanism(s) of chloroquine-induced marrow injury is not known. A parallel to chloramphenicol-induced blood dyscrasias is drawn, but remains unproved.",,PMC2425073,,,
273201,NLM,MEDLINE,19780508,20131121,0031-4021 (Print) 0031-4021 (Linking),33,1,1978 Jan-Feb,[Trial of androgen therapy in the treatment of acute non-lymphoblastic leukemia in children. Initial results].,89-97,"['Poirot, P', 'Pouzol, P', 'Sotto, J J', 'Bachelot, C', 'Berthier, R', 'Hollard, D', 'Bost, M']","['Poirot P', 'Pouzol P', 'Sotto JJ', 'Bachelot C', 'Berthier R', 'Hollard D', 'Bost M']",['fre'],"['English Abstract', 'Journal Article']",France,Pediatrie,Pediatrie,0401127,IM,"['Adolescent', 'Androgens/adverse effects/*therapeutic use', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Monocytic, Acute/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Stanozolol/therapeutic use']",1978/01/01 00:00,2000/05/05 09:00,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '2000/05/05 09:00 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Pediatrie. 1978 Jan-Feb;33(1):89-97.,"['0 (Androgens)', '0 (Antineoplastic Agents)', '4R1VB9P8V3 (Stanozolol)']",,Essai d'androgenotherapie dans le traitement des leucemies aigues non lymphoblastiques de l'enfant. Premiers resultats.,,,,
273152,NLM,MEDLINE,19780508,20071115,0028-2685 (Print) 0028-2685 (Linking),25,1,1978,L-asparaginase in treatment of acute leukemia in children.,133-9,"['Misikova, Z', 'Cap, J']","['Misikova Z', 'Cap J']",['eng'],['Journal Article'],Slovakia,Neoplasma,Neoplasma,0377266,IM,"['Asparaginase/*therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Erythroblastic, Acute/drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Male']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Neoplasma. 1978;25(1):133-9.,['EC 3.5.1.1 (Asparaginase)'],"L-asparaginase from Escherichia coli--Crasnitin was used in 14 children with acute leukemia unresponsive to conventional treatment: 11 acute lymphoblastic leukemias, 1 acute myeloblastic leukemia, 2 other forms of leukemia. The remission induction was obtained in 70% of applications. Median of remission duration was 90 days. Serious side effects were observed. The validity of L-asparaginase in therapy of advanced childhood ALL is stressed.",,,,,
273147,NLM,MEDLINE,19780517,20190617,0028-0836 (Print) 0028-0836 (Linking),272,5652,1978 Mar 30,Myeloid leukaemia in x-ray irradiated CBA mice.,455-6,"['Major, I R', 'Mole, R H']","['Major IR', 'Mole RH']",['eng'],['Journal Article'],England,Nature,Nature,0410462,IM,"['Animals', 'Cell Transformation, Neoplastic/radiation effects', 'Dose-Response Relationship, Radiation', 'Leukemia, Myeloid/*etiology', 'Leukemia, Myeloid, Acute/*etiology', 'Leukemia, Radiation-Induced/*etiology', 'Mice', '*Mice, Inbred CBA', 'X-Rays']",1978/03/30 00:00,1978/03/30 00:01,['1978/03/30 00:00'],"['1978/03/30 00:00 [pubmed]', '1978/03/30 00:01 [medline]', '1978/03/30 00:00 [entrez]']",['10.1038/272455a0 [doi]'],ppublish,Nature. 1978 Mar 30;272(5652):455-6. doi: 10.1038/272455a0.,,,,,,,
273145,NLM,MEDLINE,19780517,20071115,0028-4793 (Print) 0028-4793 (Linking),298,15,1978 Apr 13,Leukemia in patients treated for Hodgkin's disease.,853-4,"['Hall, T C']",['Hall TC'],['eng'],['Letter'],United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Hodgkin Disease/*complications', 'Humans', 'Leukemia, Myeloid, Acute/complications/*etiology']",1978/04/13 00:00,1978/04/13 00:01,['1978/04/13 00:00'],"['1978/04/13 00:00 [pubmed]', '1978/04/13 00:01 [medline]', '1978/04/13 00:00 [entrez]']",['10.1056/NEJM197804132981516 [doi]'],ppublish,N Engl J Med. 1978 Apr 13;298(15):853-4. doi: 10.1056/NEJM197804132981516.,,,,,,,
273144,NLM,MEDLINE,19780517,20151119,0028-4793 (Print) 0028-4793 (Linking),298,15,1978 Apr 13,Terminal transferase: its evolving role.,845-6,"['Meyskens, F L Jr', 'Jones, S E']","['Meyskens FL Jr', 'Jones SE']",['eng'],['Editorial'],United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['DNA Nucleotidyltransferases/blood/*metabolism', 'Humans', 'Leukemia, Myeloid/*drug therapy/*enzymology/mortality/pathology', 'Leukocytes/enzymology', 'Lymphoma/classification', 'Oligonucleotides', 'Prednisone/therapeutic use', 'Prognosis', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1978/04/13 00:00,2001/03/28 10:01,['1978/04/13 00:00'],"['1978/04/13 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/04/13 00:00 [entrez]']",['10.1056/NEJM197804132981510 [doi]'],ppublish,N Engl J Med. 1978 Apr 13;298(15):845-6. doi: 10.1056/NEJM197804132981510.,"['0 (Oligonucleotides)', '5J49Q6B70F (Vincristine)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)', 'VB0R961HZT (Prednisone)']",,,,,,
273143,NLM,MEDLINE,19780517,20161123,0028-4793 (Print) 0028-4793 (Linking),298,15,1978 Apr 13,Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy.,815-8,"['Peylan-Ramu, N', 'Poplack, D G', 'Pizzo, P A', 'Adornato, B T', 'Di Chiro, G']","['Peylan-Ramu N', 'Poplack DG', 'Pizzo PA', 'Adornato BT', 'Di Chiro G']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial']",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adolescent', 'Brain/*diagnostic imaging/*radiation effects', 'Child', 'Child, Preschool', 'Cytarabine/*administration & dosage/therapeutic use', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/drug therapy/radiotherapy/*therapy', 'Meningeal Neoplasms/*prevention & control', 'Methotrexate/*administration & dosage/therapeutic use', '*Tomography, X-Ray Computed']",1978/04/13 00:00,1978/04/13 00:01,['1978/04/13 00:00'],"['1978/04/13 00:00 [pubmed]', '1978/04/13 00:01 [medline]', '1978/04/13 00:00 [entrez]']",['10.1056/NEJM197804132981504 [doi]'],ppublish,N Engl J Med. 1978 Apr 13;298(15):815-8. doi: 10.1056/NEJM197804132981504.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']","Thirty-two asymptomatic patients with acute lymphocytic leukemia, who had received prophylactic cranial radiation (2400 rads) and either intrathecal methotrexate or cytosine arabinoside were studied by computed tomography of the brain 19 to 67 months after initiation of prophylaxis. Seventeen of 32 (53 per cent) had one or more abnormal findings. Dilatation of the ventricles (eight patients) and widening of the subarachnoid spaces (nine patients) were equally distributed among patients in both intrathecal-chemotherapy groups. Areas of decreased attenuation coefficient (hypodense, abnormally radiolucent regions) (four patients) and intracerebral calcification (one patient)--lesions previously described in methotrexate leukoencephalopathy--were found only in those who had received intrathecal methotrexate. Mild central-nervous-system dysfunction was detected in seven patients but did not correlate with the presence of tomographic abnormalities. Nevertheless, these tomographic findings may represent preclinical lesions. The unexpectedly high prevalence of such abnormalities contrasts with the essentially normal tomographic findings in a control group with acute lymphocytic leukemia who received no central-nervous-system prophylaxis. These results suggest that alternative approaches to such prophylaxis be considered.",,,,,
273142,NLM,MEDLINE,19780517,20151119,0028-4793 (Print) 0028-4793 (Linking),298,15,1978 Apr 13,Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.,812-4,"['Marks, S M', 'Baltimore, D', 'McCaffrey, R']","['Marks SM', 'Baltimore D', 'McCaffrey R']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'DNA Nucleotidyltransferases/blood/*metabolism', 'Humans', 'Leukemia, Myeloid/*drug therapy/*enzymology/pathology', 'Leukocytes/enzymology', 'Middle Aged', 'Oligonucleotides', 'Prednisone/administration & dosage/*therapeutic use', 'Prognosis', 'Prospective Studies', 'Remission, Spontaneous', 'Vincristine/administration & dosage/*therapeutic use']",1978/04/13 00:00,1978/04/13 00:01,['1978/04/13 00:00'],"['1978/04/13 00:00 [pubmed]', '1978/04/13 00:01 [medline]', '1978/04/13 00:00 [entrez]']",['10.1056/NEJM197804132981503 [doi]'],ppublish,N Engl J Med. 1978 Apr 13;298(15):812-4. doi: 10.1056/NEJM197804132981503.,"['0 (Oligonucleotides)', '5J49Q6B70F (Vincristine)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)', 'VB0R961HZT (Prednisone)']","We undertook a prospective trial to evaluate terminal deoxynucleotidyl transferase activity as a predictor of responsiveness to vincristine and prednisone in 22 Philadelphia-chromosome-positive patients with blastic chronic myelogenous leukemia. Thirteen patients were transferase positive, and nine negative. None of the nine negative patients responded, whereas eight of the 13 positive (P = 0.004) responded with complete clearing of peripheral blood blast cells and a return of normal marrow cellularity with less than 5 per cent blast cells. Among transferase-positive patients under 50 years of age the response rate was 78 per cent. Blast-cell morphology (i.e., lymphoblastic versus myeloblastic) had no significant correlation with either responsiveness or terminal transferase activity. The results of this study suggest that responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia is confined to patients whose leukemic cells are transferase positive.",,,,,
273136,NLM,MEDLINE,19780508,20131121,0377-1504 (Print) 0377-1504 (Linking),14,1,1978 Jan,Was it 'pseudoleukaemia' or the real thing?,47-8,"['Cardamone, J M']",['Cardamone JM'],['eng'],"['Case Reports', 'Journal Article']",China,Mod Med Asia,Modern medicine of Asia,7513643,,"['Aged', 'Breast Neoplasms/drug therapy', 'Diagnostic Errors', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/chemically induced/*diagnosis', 'Mastectomy', 'Melphalan/adverse effects/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Mod Med Asia. 1978 Jan;14(1):47-8.,['Q41OR9510P (Melphalan)'],,,,,,
273135,NLM,MEDLINE,19780517,20071115,0025-7583 (Print) 0025-7583 (Linking),106,3,1978 Mar,Treatment of the leukemias.,"42-5, 49","['Canellos, G P']",['Canellos GP'],['eng'],['Journal Article'],United States,Med Times,Medical times,0406055,IM,"['Antineoplastic Agents/*therapeutic use', 'Humans', 'Leukemia/*drug therapy/pathology', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Remission, Spontaneous']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,"Med Times. 1978 Mar;106(3):42-5, 49.",['0 (Antineoplastic Agents)'],,,,,,
273134,NLM,MEDLINE,19780524,20131213,0025-6196 (Print) 0025-6196 (Linking),53,4,1978 Apr,Hypothalamic syndrome in children with acute lymphocytic leukemia.,217-20,"['Greydanus, D E', 'Burgert, E O Jr', 'Gilchrist, G S']","['Greydanus DE', 'Burgert EO Jr', 'Gilchrist GS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Mayo Clin Proc,Mayo Clinic proceedings,0405543,IM,"['Body Weight', 'Child, Preschool', '*Eating', 'Humans', '*Hypothalamus', 'Infant', 'Leukemia, Lymphoid/*complications', 'Syndrome']",1978/04/01 00:00,2001/03/28 10:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Mayo Clin Proc. 1978 Apr;53(4):217-20.,,"Five children had six episodes of central nervous system leukemia which were characterized by features suggestive of hypothalamic infiltration. All five patients had been in prolonged bone marrow remission and had no other evidence of active leukemia when the hypothalamic syndrome was diagnosed. Five of the six episodes responded promptly to intrathecally administered methotrexate and cranial irradiation, but bone marrow relapse, which was resistant to further therapy, developed within 4 months in three patients and after 18 months in the fourth. Only one patient remains in bone marrow remission without recurrence of hypothalamic symptoms 10 months later.",,,,,
273133,NLM,MEDLINE,19780524,20131213,0025-6196 (Print) 0025-6196 (Linking),53,4,1978 Apr,Testicular relapse in childhood leukemia.,212-6,"['Saiontz, H I', 'Gilchrist, G S', 'Smithson, W A', 'Burgert, E O Jr', 'Cupps, R E']","['Saiontz HI', 'Gilchrist GS', 'Smithson WA', 'Burgert EO Jr', 'Cupps RE']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Mayo Clin Proc,Mayo Clinic proceedings,0405543,IM,"['Child', 'Child, Preschool', 'Humans', '*Leukemia, Lymphoid/therapy', '*Leukemia, Myeloid/therapy', 'Male', '*Testicular Neoplasms']",1978/04/01 00:00,2001/03/28 10:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Mayo Clin Proc. 1978 Apr;53(4):212-6.,,"Five patients in bone marrow remission from childhood leukemia who subsequently had relapse in the testicle are reviewed. Clinically, recurrence of disease is often limited to this site. In spite of satisfactory local control with radiotherapy, further systemic progression generally occurs within 1 year. Previous studies suggest that patients who are in clinical remission harbor tumor in multiple occult ""sanctuaries."" Testicular leukemia reflects this uncontrolled extramedullary disease, and studies in optimal management of the generalized process are needed.",,,,,
273132,NLM,MEDLINE,19780524,20131213,0025-6196 (Print) 0025-6196 (Linking),53,4,1978 Apr,Extreme leukemic leukocytosis (blast crisis) in childhood.,207-11,"['Dearth, J C', 'Fountain, K S', 'Smithson, W A', 'Burgert, E O Jr', 'Gilchrist, G S']","['Dearth JC', 'Fountain KS', 'Smithson WA', 'Burgert EO Jr', 'Gilchrist GS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Mayo Clin Proc,Mayo Clinic proceedings,0405543,IM,"['Acute Disease', 'Adolescent', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia/*complications/therapy', 'Leukemia, Lymphoid/complications', 'Leukemia, Myeloid/complications', 'Leukocytosis/*complications/therapy', 'Male']",1978/04/01 00:00,2001/03/28 10:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/04/01 00:00 [entrez]']",,ppublish,Mayo Clin Proc. 1978 Apr;53(4):207-11.,,"Children with leukemia who have extremely high leukocyte counts (more than 100,000/mm3) when seen initially are at high risk of early sudden death, usually from massive intracerebral hemorrhage. Nine such patients were seen during a 39-month period. Eight had pronounced adenopathy and hepatosplenomegaly without severe anemia or thrombocytopenia. The first six patients died suddenly. Cerebral perivascular infiltration and increased blood viscosity are the probable pathophysiologic mechanisms. A treatment program was developed, the goal being the early elimination of blast cells. Three consecutive patients patients presenting with leukocyte counts greater than 100,000/mm3 were treated with emergency cranial irradiation, and all three survived to receive systemic chemotherapy.",,,,,
273119,NLM,MEDLINE,19780524,20071115,0023-6764 (Print) 0023-6764 (Linking),28,1,1978 Feb,Lymphosarcoma with lymphoblastic leukemia in a New Zealand white rabbit.,66-9,"['Cloyd, G G', 'Johnson, G R']","['Cloyd GG', 'Johnson GR']",['eng'],"['Case Reports', 'Journal Article']",United States,Lab Anim Sci,Laboratory animal science,1266503,IM,"['Animals', 'Female', 'Leukemia, Lymphoid/blood/pathology/*veterinary', 'Lymphoma, Non-Hodgkin/blood/pathology/*veterinary', '*Rabbits']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Lab Anim Sci. 1978 Feb;28(1):66-9.,,"An 8 to 10-week-old female New Zealand white rabbit, Oryctolagus cuniculus, which exhibited clinical signs of anorexia, depression, and torticollis was found to have lymphosarcoma with lymphoblastic leukemia. The multiple visceral involvement with neoplastic lymphoid cells observed in this animal was similar to previously reprted cases of lymphosarcoma in the rabbit. An unusual finding was the occurrence of lymphoblastic leukemia since lymphosarcoma in the rabbit has previously been reported as aleukemic.",,,,,
273118,NLM,MEDLINE,19780524,20131121,0300-8630 (Print) 0300-8630 (Linking),190,1,1978 Jan,"[Interstitial pneumonia in children with malignancies during cytotoxic therapie. Clinical picture, analysis of promoting factors, and detailed discussion of etiology (author's transl)].",94-103,"['Kropp, H', 'Debus-Kauschat, I', 'Ball, F']","['Kropp H', 'Debus-Kauschat I', 'Ball F']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Adolescent', 'Antineoplastic Agents/*therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/complications/*drug therapy', 'Male', 'Pentamidine/therapeutic use', 'Prognosis', 'Pulmonary Fibrosis/*complications/diagnosis/drug therapy', 'Remission, Spontaneous', 'Time Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1978 Jan;190(1):94-103.,"['0 (Antineoplastic Agents)', '673LC5J4LQ (Pentamidine)']","This communication documents a study of 35 patients with systemic malignant diseases between 1964 and 1973. All these patients developed interstitial pneumonia (int.pn.), and in two cases recurrence of int.pn. was observed after several months. Of these 35 patients 29 were diagnosed of acute lymphoblastic leukemia (ALL). In particular the occurrence of int.pn. was very frequently noticed under the more aggressive therapeutic regimes mentioned in the Memphis protocol VII. The statistical analysis revealed that the most critical period of occurrence is between 8 and 11 weeks after the induction therapy or 6-9 weeks after the reinduction or relapse therapy. These observations indicate the dependency of this disease during the intensive phase of therapy. The prognosis of int.pn. was improved significantly after the pentamidine treatment. The etiology of the int.pn. is discussed in detail. The post mortem examination of 6 patients revealed that 5 of them had pneumocystes carinii.","Interstitielle Pneumonien bei Kindern mit einer malignen Systemerkrankung unter zytostatischer Therapie. Klinisches Erscheinungsbild, Analyse der begunstigenden Faktoren und Versuch einer atiologischen Klarung.",,,,
273117,NLM,MEDLINE,19780524,20171117,0300-8630 (Print) 0300-8630 (Linking),190,1,1978 Jan,[Treatment of ALL in children. Results and side effects with a modification of protocol memphis VII (author's transl)].,73-82,"['Wehinger, H', 'Furste, H O', 'Imm, W', 'Luthardt, T', 'Sauer, M', 'Slania, J', 'Dilger, M']","['Wehinger H', 'Furste HO', 'Imm W', 'Luthardt T', 'Sauer M', 'Slania J', 'Dilger M']",['ger'],['Journal Article'],Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Adolescent', 'Asparaginase/therapeutic use', 'Chickenpox/complications', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Female', 'Herpes Zoster/complications', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/complications/*drug therapy/radiotherapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/administration & dosage', 'Prednisone/therapeutic use', 'Remission, Spontaneous', 'Skull', 'Vincristine/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1978 Jan;190(1):73-82.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']","42 patients with ALL were treated according to the following protocol: induction with vincristine + prednisone (+/- L-asparaginase), CNS-prophylaxis with cranial irradiation (2400 rads) and intrathecal methotrexate, maintenance for 3 years with 6-MP 50 mg/m2/d p.o. + MTX 75-150 mg/m2/2 wk i.v. X 4, alternating in a cyclic fashion with 6-MP 50 mg/m2/d p.o. + cyclophophshamide 600 mg/m2/2 wk i.v. X 4. The observation time is 24-67 (median 49) months. The actuarial complete remission curve shows 40% continuous complete remissions at 36 months and 30% at 60 months.--The frequency and temporal distribution of typical infectious complications are presented. The incidence of varicella was comparable to that in a southgerman normal control group (5,7% per year). During treatment there were two zoster manifestations per one varicella case, the incidence of zoster being 1 case per 106 patient-months, viz 11,4% per year.",Zur Therapie der ALL. Modifikation des Behandlungsplanes Memphis VII.,,,,
273116,NLM,MEDLINE,19780524,20171117,0300-8630 (Print) 0300-8630 (Linking),190,1,1978 Jan,[Intensification of the initial therapy according to the West-Berlin protocol in acute lymphoblastic leukemia: results after 2 1/2 years in Munster (author's transl)].,65-72,"['Schellong, G', 'Breu, H', 'Grobe, H', 'Voss, W']","['Schellong G', 'Breu H', 'Grobe H', 'Voss W']",['ger'],['Journal Article'],Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Adolescent', 'Adrenal Cortex Hormones/therapeutic use', 'Asparaginase/therapeutic use', 'Bacterial Infections/prevention & control', 'Child', 'Child, Preschool', 'Colistin/therapeutic use', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/*drug therapy/radiotherapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/administration & dosage/therapeutic use', 'Remission, Spontaneous', 'Skull', 'Vincristine/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1978 Jan;190(1):65-72.,"['0 (Adrenal Cortex Hormones)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'EC 3.5.1.1 (Asparaginase)', 'YL5FZ2Y5U1 (Methotrexate)', 'Z67X93HJG1 (Colistin)', 'ZS7284E0ZP (Daunorubicin)']",,Intensivierung der Anfangstherapie nach dem West-Berliner Protokoll bei akuter lymphoblastischer Leukamie: Ergebnisse nach 2 1/2 Jahren in Munster.,,,,
273115,NLM,MEDLINE,19780524,20071115,0300-8630 (Print) 0300-8630 (Linking),190,1,1978 Jan,"[Results of Memphis-study VII (""Pinkel-Therapy"") in 659 children with acute lymphoblastic leukemia. Cooperative therapeutic study of the German working group on childhood leukemia with participation of 42 hospitals].",57-64,"['Lampert, F']",['Lampert F'],['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Age Factors', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/diagnosis/*drug therapy', 'Leukocyte Count', 'Lymphocytes', 'Male', 'Remission, Spontaneous', 'Retrospective Studies', 'Sex Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1978 Jan;190(1):57-64.,,"659 children with acute lymphoblastic leukemia from 42 German hospitals were diagnosed from January 1, 1971 until December 31, 1974, treated according to Memphis study VII or VIII2, and observed until December 31, 1976. At diagnosis 16,1% of the patients had a leukocyte count over 50 000/mm3, 8,5% a mediastinal enlargement, 2,0% a CNS-leukemia and 1,8% a Down-syndrome. After a treatment time of 2 1/2 years and an observation time of maximal 6, minimal 2 years 329 children (= 50,0%) were living, 257 (= 39,1%) in continuous complete remission, most of these 1-3 years after cessation of therapy. A primary relapse in the bone marrow occured in 36,3%, in the CNS in 10,0% of the patients. A cranial irradiation dose of 1800 rad in 120 patients yielded a CNS-relapse rate of 7,5%. 49 of the 659 children (= 7,4%) died in continuous complete remission, the main causes being interstitial pneumonia and varicella. No difference in initial features and treatment results was found between 7 centres with many patients and 35 hospitals with fewer patients.","Ergebnis der Memphis-Studie VII (""Pinkel-Therapie"") bei 659 Kindern mit akuter lymphoblastischer Leukamie Kooperative Therapiestudie der Deutschen Arbeitsgemeinschaft fur Leukamieforschung und -Behandlung im Kindesalter e.V. (Vorsitzender: Prof. Dr. G. Landbeck, Hamburg).",,,,
273114,NLM,MEDLINE,19780508,20131121,0485-1439 (Print) 0485-1439 (Linking),19,1,1978 Jan,[Studies of carboquone therapy on chronic myelogenous leukemia (author's transl)].,9-14,"['Wakabayashi, Y', 'Takaku, F']","['Wakabayashi Y', 'Takaku F']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adult', 'Azirines/*therapeutic use', 'Carbazilquinone/*therapeutic use', 'Drug Evaluation', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Middle Aged']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1978 Jan;19(1):9-14.,"['0 (Azirines)', '1CB0HBT12C (Carbazilquinone)']",,,,,,
273113,NLM,MEDLINE,19780517,20190630,0098-7484 (Print) 0098-7484 (Linking),239,14,1978 Apr 3,Prolonged meningeal leukemia. Occurrence during hematologic remission of acute myeloblastic leukemia.,1423-4,"['Zachariah, C', 'Grunwald, H W', 'Rosner, F']","['Zachariah C', 'Grunwald HW', 'Rosner F']",['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Adult', 'Antineoplastic Agents/administration & dosage', 'Drug Therapy, Combination', 'Humans', '*Leukemia, Myeloid, Acute/drug therapy', 'Male', '*Meningeal Neoplasms/drug therapy', 'Neoplasm Metastasis', 'Remission, Spontaneous', 'Time Factors']",1978/04/03 00:00,1978/04/03 00:01,['1978/04/03 00:00'],"['1978/04/03 00:00 [pubmed]', '1978/04/03 00:01 [medline]', '1978/04/03 00:00 [entrez]']",['10.1001/jama.239.14.1423 [doi]'],ppublish,JAMA. 1978 Apr 3;239(14):1423-4. doi: 10.1001/jama.239.14.1423.,['0 (Antineoplastic Agents)'],,,,,,
273098,NLM,MEDLINE,19780508,20190503,0306-6800 (Print) 0306-6800 (Linking),4,1,1978 Mar,Leukaemia in children of Jehovah's Witnesses: issues and priorities in a conflict of care.,32-5,"['Kearney, P J']",['Kearney PJ'],['eng'],"['Case Reports', 'Journal Article']",England,J Med Ethics,Journal of medical ethics,7513619,IM,"['Acute Disease', 'Blood Transfusion', 'Child', 'Child Advocacy', '*Christianity', 'Humans', ""*Jehovah's Witnesses"", 'Leukemia, Lymphoid/drug therapy/*therapy', 'Male', 'Parental Consent', '*Religion and Medicine', 'Remission, Spontaneous', '*Risk Assessment']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1136/jme.4.1.32 [doi]'],ppublish,J Med Ethics. 1978 Mar;4(1):32-5. doi: 10.1136/jme.4.1.32.,,"Throughout this paper PJ Kearney attempts to balance the risks and benefits of different approaches in paediatric oncology. Decisions have to be considered both in the short and the long term. Where religious beliefs, such as those held by Jehovah's Witnesses in relation to blood transfusions, conflict with normal medical practice the decision is often removed from the doctor, parents or patient to the courts. This sort of solution can be counter-productive, especially as good health care and subsequent recovery rely, to a large extent, on good relationships between and among the parties concerned. Destruction of these relationships, for whatever reason, often has a detrimental effect on the patient, in whose best interest everyone believes they are acting.",,PMC1154616,['KIE: 06921'],"['KIE: KIE BoB Subject Heading: PATIENT CARE/CHILDREN/LEUKEMIA', 'KIE: KIE BoB Subject Heading: PATIENT CARE/LEUKEMIA/RISKS AND BENEFITS', ""KIE: KIE BoB Subject Heading: TREATMENT REFUSAL/JEHOVAH'S WITNESSES/LEUKEMIA"", 'KIE: Full author name: Kearney, PJ']",
273087,NLM,MEDLINE,19780517,20190630,0022-3476 (Print) 0022-3476 (Linking),92,4,1978 Apr,Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia.,593-5,"['Carpentieri, U', 'Haggard, M E', 'Lockhart, L H', 'Gustavson, L P', 'Box, Q T', 'West, E F']","['Carpentieri U', 'Haggard ME', 'Lockhart LH', 'Gustavson LP', 'Box QT', 'West EF']",['eng'],['Journal Article'],United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Candidiasis/etiology/*prevention & control', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/*complications', 'Male', 'Nystatin/*therapeutic use']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']","['S0022-3476(78)80298-4 [pii]', '10.1016/s0022-3476(78)80298-4 [doi]']",ppublish,J Pediatr. 1978 Apr;92(4):593-5. doi: 10.1016/s0022-3476(78)80298-4.,['1400-61-9 (Nystatin)'],,,,,,
273086,NLM,MEDLINE,19780517,20190630,0022-3476 (Print) 0022-3476 (Linking),92,3,1978 Mar,Etiology of pneumonitis in children with leukemia.,520,"['Wall, M A']",['Wall MA'],['eng'],['Letter'],United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Leukemia, Lymphoid/*complications/drug therapy', 'Methotrexate/adverse effects/therapeutic use', 'Pulmonary Fibrosis/chemically induced/*etiology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']","['S0022-3476(78)80481-8 [pii]', '10.1016/s0022-3476(78)80482-x [doi]']",ppublish,J Pediatr. 1978 Mar;92(3):520. doi: 10.1016/s0022-3476(78)80482-x.,['YL5FZ2Y5U1 (Methotrexate)'],,,,,,
273085,NLM,MEDLINE,19780517,20190630,0022-3476 (Print) 0022-3476 (Linking),92,3,1978 Mar,Late-onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamide.,443-6,"['Alvarado, C S', 'Boat, T F', 'Newman, A J']","['Alvarado CS', 'Boat TF', 'Newman AJ']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Child, Preschool', 'Cyclophosphamide/*adverse effects/therapeutic use', 'Female', 'Hodgkin Disease/drug therapy', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Pulmonary Fibrosis/*chemically induced', 'Thoracic Diseases/*chemically induced']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']","['S0022-3476(78)80443-0 [pii]', '10.1016/s0022-3476(78)80443-0 [doi]']",ppublish,J Pediatr. 1978 Mar;92(3):443-6. doi: 10.1016/s0022-3476(78)80443-0.,['8N3DW7272P (Cyclophosphamide)'],,,,,,
273062,NLM,MEDLINE,19780517,20190508,0022-1007 (Print) 0022-1007 (Linking),147,3,1978 Mar 1,The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils.,730-44,"['Ross, G D', 'Jarowski, C I', 'Rabellino, E M', 'Winchester, R J']","['Ross GD', 'Jarowski CI', 'Rabellino EM', 'Winchester RJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Exp Med,The Journal of experimental medicine,2985109R,IM,"['Binding Sites', 'Cell Differentiation', 'Cell Separation', 'Complement System Proteins/*metabolism', 'Humans', '*Isoantigens', 'Leukemia, Myeloid/blood/*immunology', 'Neutrophils/cytology/*immunology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1084/jem.147.3.730 [doi]'],ppublish,J Exp Med. 1978 Mar 1;147(3):730-44. doi: 10.1084/jem.147.3.730.,"['0 (Isoantigens)', '9007-36-7 (Complement System Proteins)']","Ia antigens and two different types of complement (C) receptors appeared on membrane surfaces in a distinct sequence during the maturation of human neutrophils. Taking advantage of the finding that neutrophil celll density increased with maturation, density gradient centrifugation was used to separate neutrophils into fractions that were greatly enriched in cells representing individual stages of differentiation. Myeloblasts, the earliest cells recognized in the myeloid series of both normal and myelogenous leukemic individuals, expressed Ia determinants, whereas Ia determinants were absent or diminished on the majority of promyelocytes and completely undetectable on more mature granulocytes. Double marker studies demonstrated that Ia determinants were lost from the membrane of developing myeloid cells before the appearance of any type of C receptor. In the next phase of maturation defined by surface markers, neutrophils acquired a CR2-type C receptor (C3d receptor) that was similar in specificity to CR2 of B lymphocytes. This stage of maturation approximately corresponded to the myelocyte-metamyelocyte stage defined by standard morphologic criteria, and preceded the third stage of surface marker maturation when developing neutrophils began to express CR1-type C receptors (immune adherence, C4b-C3b receptors) in addition to CR2. In the final stage of surface marker-defined maturation, CR2 was lost from high density polymorphonuclear neutrophils and CR1 was maximally expressed. Normal blood polymorphonuclear neutrophils contained only 17% of CR2-bearing cells and these were shown to be of lower density than the majority of neutrophils that expressed only CR1. There was some variation in the correlation of surface marker expression and maturation stage defined by morphologic criteria, but in all cases the sequence of marker appearance was the same: Ia leads to CR2 leads to CR1CR2 leads to CR1.",,PMC2184188,,,
273045,NLM,MEDLINE,19780517,20110728,0021-4671 (Print) 0021-4671 (Linking),12,4,1977 Dec 20,[Preventive therapy of central nervous system leukemia in children. I. Technical problems in cranial irradiation with telecobalt unit (author's transl)].,555-60,"['Ono, Y', 'Masuda, K', 'Minezaki, J', 'Hasegawa, K', 'Jingu, K', 'Murakami, J', 'Hayabuchi, N', 'Matsuurak', 'Fujimoto, T']","['Ono Y', 'Masuda K', 'Minezaki J', 'Hasegawa K', 'Jingu K', 'Murakami J', 'Hayabuchi N', 'Matsuurak', 'Fujimoto T']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Nihon Gan Chiryo Gakkai Shi,Nihon Gan Chiryo Gakkai shi,7505713,IM,"['Child', 'Cobalt Radioisotopes/*administration & dosage', 'Humans', 'Leukemia/*prevention & control', 'Leukemia, Lymphoid/radiotherapy', 'Meningeal Neoplasms/*prevention & control', 'Radiotherapy Dosage', 'Skull']",1977/12/20 00:00,1977/12/20 00:01,['1977/12/20 00:00'],"['1977/12/20 00:00 [pubmed]', '1977/12/20 00:01 [medline]', '1977/12/20 00:00 [entrez]']",,ppublish,Nihon Gan Chiryo Gakkai Shi. 1977 Dec 20;12(4):555-60.,['0 (Cobalt Radioisotopes)'],,,,,,
273018,NLM,MEDLINE,19780517,20190708,0360-3016 (Print) 0360-3016 (Linking),4,1-2,1978 Jan-Feb,Experimental studies on the combination of radiation and chemotherapy.,37-41,"['Lelieveld, P', 'Smink, T', 'van Putten, L']","['Lelieveld P', 'Smink T', 'van Putten L']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Int J Radiat Oncol Biol Phys,"International journal of radiation oncology, biology, physics",7603616,IM,"['Animals', 'Antineoplastic Agents/*therapeutic use', 'Cell Survival/drug effects/radiation effects', 'Dose-Response Relationship, Drug', 'Leukemia L1210/drug therapy/radiotherapy', 'Mice', 'Neoplasm Transplantation', 'Neoplasms, Experimental/drug therapy/*radiotherapy', 'Osteosarcoma/drug therapy/radiotherapy', 'X-Rays']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']","['0360-3016(78)90112-8 [pii]', '10.1016/0360-3016(78)90112-8 [doi]']",ppublish,Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):37-41. doi: 10.1016/0360-3016(78)90112-8.,['0 (Antineoplastic Agents)'],,,,,,
273009,NLM,MEDLINE,19780508,20190823,0021-1265 (Print) 0021-1265 (Linking),147,2,1978 Feb,Karyotype evolution in chronic myelogenous leukaemia.,73-5,"['Lyons, F', 'Power, M M', 'Masterson, J G', ""O'Sullivan, D J""]","['Lyons F', 'Power MM', 'Masterson JG', ""O'Sullivan DJ""]",['eng'],['Journal Article'],Ireland,Ir J Med Sci,Irish journal of medical science,7806864,IM,"['Adult', 'Humans', '*Karyotyping', 'Leukemia, Myeloid/*genetics', 'Male']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1007/BF02939374 [doi]'],ppublish,Ir J Med Sci. 1978 Feb;147(2):73-5. doi: 10.1007/BF02939374.,,,,,,,
273008,NLM,MEDLINE,19780517,20071115,0377-4929 (Print) 0377-4929 (Linking),20,2,1977 Apr,A study of leukaemia in Goa.,83-90,"['Menezes, S', 'Malik, G B']","['Menezes S', 'Malik GB']",['eng'],['Journal Article'],India,Indian J Pathol Microbiol,Indian journal of pathology & microbiology,7605904,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Child, Preschool', 'Female', 'Humans', 'India', 'Infant', 'Leukemia, Lymphoid/*epidemiology', 'Leukemia, Myeloid/*epidemiology', 'Leukemia, Myeloid, Acute/epidemiology', 'Male', 'Middle Aged']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Indian J Pathol Microbiol. 1977 Apr;20(2):83-90.,,,,,,,
273006,NLM,MEDLINE,19780508,20190722,0340-6717 (Print) 0340-6717 (Linking),40,3,1978 Feb 16,Multiple leukemic clones in acute leukemia of childhood.,269-78,"['Morse, H G', 'Ducore, J M', 'Hays, T', 'Peakman, D', 'Robinson, A']","['Morse HG', 'Ducore JM', 'Hays T', 'Peakman D', 'Robinson A']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Germany,Hum Genet,Human genetics,7613873,IM,"['Child', 'Child, Preschool', 'Clone Cells', 'Female', 'Humans', 'Karyotyping', 'Leukemia/*pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid/pathology', 'Lymphocytes/*ultrastructure', 'Remission, Spontaneous']",1978/02/16 00:00,1978/02/16 00:01,['1978/02/16 00:00'],"['1978/02/16 00:00 [pubmed]', '1978/02/16 00:01 [medline]', '1978/02/16 00:00 [entrez]']",['10.1007/BF00272187 [doi]'],ppublish,Hum Genet. 1978 Feb 16;40(3):269-78. doi: 10.1007/BF00272187.,,"Two abnormal karyotypes representing clonal populations have been demonstrated in three patients in the early stage of acute leukemia. The karyotypes were apparently unrelated in one patient, while in the other two, a relationship was conjectured. Both clones were present before therapy in two patients. Although a clone resistant to therapy was associated with relapse in one case, in two cases a clone has persisted in the lymphocyte culture during drug treatment with the patients in remission.",,,,,
273005,NLM,MEDLINE,19780524,20191021,0171-7111 (Print) 0171-7111 (Linking),20,,1977,Cationic proteins of leukocyte lysosomes: marker antigens for the immunological diagnosis of acute leukemias.,371-7,"['Tischendorf, F W', 'Tischendorf, M M', 'Clemens, G E', 'Ledderose, G']","['Tischendorf FW', 'Tischendorf MM', 'Clemens GE', 'Ledderose G']",['eng'],['Journal Article'],Germany,Haematol Blood Transfus,Haematology and blood transfusion,101169459,IM,"['Antigens, Neoplasm/analysis', 'Blood Proteins/*analysis', 'Isoelectric Point', 'Leukemia/analysis/*diagnosis/immunology', 'Leukemia, Myeloid/immunology', 'Leukocytes/*analysis', 'Lysosomes/analysis', 'Muramidase/*analysis', 'Periodic Acid-Schiff Reaction']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-66639-1_47 [doi]'],ppublish,Haematol Blood Transfus. 1977;20:371-7. doi: 10.1007/978-3-642-66639-1_47.,"['0 (Antigens, Neoplasm)', '0 (Blood Proteins)', 'EC 3.2.1.17 (Muramidase)']",,,,,,
273004,NLM,MEDLINE,19780524,20191021,0171-7111 (Print) 0171-7111 (Linking),20,,1977,Alterations of blood group receptors of erythrocytes in leukemia--immunofluorescence studies.,353-9,"['Poschmann, A', 'Fischer, K', 'Winkler, K', 'Landbeck, G']","['Poschmann A', 'Fischer K', 'Winkler K', 'Landbeck G']",['eng'],['Journal Article'],Germany,Haematol Blood Transfus,Haematology and blood transfusion,101169459,IM,"['*ABO Blood-Group System', 'Child', 'Child, Preschool', 'Fetus/immunology', 'Humans', 'Infant', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-66639-1_44 [doi]'],ppublish,Haematol Blood Transfus. 1977;20:353-9. doi: 10.1007/978-3-642-66639-1_44.,['0 (ABO Blood-Group System)'],,,,,,
273003,NLM,MEDLINE,19780524,20191021,0171-7111 (Print) 0171-7111 (Linking),20,,1977,Studies on the immune status of children with acute lymphocytic leukemia (ALL).,227-33,"['Pluss, H J', 'Hitzig, W H', 'Joller, P', 'Jakob, M']","['Pluss HJ', 'Hitzig WH', 'Joller P', 'Jakob M']",['eng'],['Journal Article'],Germany,Haematol Blood Transfus,Haematology and blood transfusion,101169459,IM,"['Acid Phosphatase/metabolism', 'Adolescent', '*Antibody Formation', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/classification/enzymology/*immunology', '*Lymphocyte Activation', 'Lymphocytes/*immunology', 'Male', 'Prognosis', 'Receptors, Antigen, B-Cell/analysis', 'Rosette Formation']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-66639-1_28 [doi]'],ppublish,Haematol Blood Transfus. 1977;20:227-33. doi: 10.1007/978-3-642-66639-1_28.,"['0 (Receptors, Antigen, B-Cell)', 'EC 3.1.3.2 (Acid Phosphatase)']",,,,,,
273002,NLM,MEDLINE,19780524,20191021,0171-7111 (Print) 0171-7111 (Linking),20,,1977,Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma.,147-56,"['Killander, D', 'Johansson, B', 'Haglund, S']","['Killander D', 'Johansson B', 'Haglund S']",['eng'],['Journal Article'],Germany,Haematol Blood Transfus,Haematology and blood transfusion,101169459,IM,"['Humans', 'Immunoglobulin M/*analysis', 'Leukemia/classification/*immunology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid, Acute/immunology', 'Lymphadenitis/immunology', 'Lymphocytes/*immunology', 'Lymphoma/classification/*immunology', 'Receptors, Antigen, B-Cell/*analysis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-66639-1_15 [doi]'],ppublish,Haematol Blood Transfus. 1977;20:147-56. doi: 10.1007/978-3-642-66639-1_15.,"['0 (Immunoglobulin M)', '0 (Receptors, Antigen, B-Cell)']",,,,,,
273001,NLM,MEDLINE,19780524,20191021,0171-7111 (Print) 0171-7111 (Linking),20,,1977,Myeloid antigens and antigen densities in mice and men.,109-16,"['Jager, G', 'Hoffmann-Fezer, G', 'Rodt, H', 'Huhn, D', 'Thiel, E', 'Thierfelder, S']","['Jager G', 'Hoffmann-Fezer G', 'Rodt H', 'Huhn D', 'Thiel E', 'Thierfelder S']",['eng'],['Journal Article'],Germany,Haematol Blood Transfus,Haematology and blood transfusion,101169459,IM,"['Animals', 'Antigens/*analysis', 'Antigens, Neoplasm/analysis', 'Bone Marrow/*immunology', 'Bone Marrow Cells', 'Granulocytes/*immunology', 'Hematopoietic Stem Cells/immunology', 'Humans', '*Immune Sera', 'Leukemia, Myeloid/classification/*immunology', 'Leukocytes/*immunology', 'Lymphocytes/immunology', 'Mice', 'Neutrophils/immunology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-66639-1_11 [doi]'],ppublish,Haematol Blood Transfus. 1977;20:109-16. doi: 10.1007/978-3-642-66639-1_11.,"['0 (Antigens)', '0 (Antigens, Neoplasm)', '0 (Immune Sera)']",,,,,,
273000,NLM,MEDLINE,19780524,20131121,0015-5500 (Print) 0015-5500 (Linking),24,1,1978,Treatment of acute leukaemia: implications of recent findings in cell biology.,1-15,"['Benestad, H B']",['Benestad HB'],['eng'],['Journal Article'],Czech Republic,Folia Biol (Praha),Folia biologica,0234640,IM,"['Animals', 'Antiviral Agents/therapeutic use', 'Asparaginase/therapeutic use', '*Cell Cycle', 'Cytarabine/therapeutic use', 'Hematopoietic Stem Cells/physiology', 'Humans', 'Leukemia, Lymphoid/*drug therapy/physiopathology', 'Leukemia, Myeloid, Acute/*drug therapy/physiopathology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Folia Biol (Praha). 1978;24(1):1-15.,"['0 (Antiviral Agents)', '04079A1RDZ (Cytarabine)', 'EC 3.5.1.1 (Asparaginase)']","Some aspects of the cell biology of normal and leukaemic haematopoietic cells are reviewed. Important points are: (a) normal and possibly also leukaemic stem cells differ from more mature cells in the kinetics as well as in cell surface antigens and other properties; (b) leukaemic cells are subject to a population size control as are normal haematopoietic cells; (c) part of the normal control seems to be chalone feedback regulation of proliferation and maturation rate of precursor cells; (d) evidence is accumulating that C-type oncornaviruses may cause leukaemia in man. Various experimental and established forms of therapy for leukaemia are discussed: No alterative exists to chemotherapy in acute lymphoid leukaemia. Granulocyte chalone may possibly become a valuable adjunct to other types of therapy in acute myeloid leukaemia. Immunotherapy may prove as efficient as maintenance chemotherapy in this disease. So far it has not been possible to synchronize leukaemic and normal cells so as to occupy different positions in the cell cycle. Nor has a forced maturation of human leukaemic cells been effected. Neither bone marrow transplantation nor prophylaxis by vaccination are considered worthwhile procedures for the time being. Anti-viral therapy has been promising in animal experiments, but animal leukaemias are often poor models for the disease in man. Assessment of treatment, using stem cell assays, is advocated.",,,,,
272986,NLM,MEDLINE,19780508,20190907,0014-2964 (Print) 0014-2964 (Linking),14,3,1978 Mar,Kinetic features of a lymphoid population in the blastic crisis of chronic granulocytic leukaemia.,271-7,"['Foadi, M D', 'Slater, A M', 'Pegrum, G D']","['Foadi MD', 'Slater AM', 'Pegrum GD']",['eng'],"['Case Reports', 'Journal Article']",England,Eur J Cancer,European journal of cancer,0074126,IM,"['Adult', 'Bone Marrow/metabolism/ultrastructure', 'Chromosomes, Human, 21-22 and Y', 'DNA/biosynthesis', 'Humans', 'Leucine/metabolism', 'Leukemia, Myeloid/metabolism/*pathology', 'Lymphocytes/*metabolism', 'Male', 'Mitosis']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1016/0014-2964(78)90190-1 [doi]'],ppublish,Eur J Cancer. 1978 Mar;14(3):271-7. doi: 10.1016/0014-2964(78)90190-1.,"['9007-49-2 (DNA)', 'GMW67QNF9C (Leucine)']",,,,,,
272980,NLM,MEDLINE,19780517,20190514,0012-3692 (Print) 0012-3692 (Linking),73,3,1978 Mar,Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.,415-6,"['Hankins, D G', 'Sanders, S', 'MacDonald, F M', 'Drage, C W']","['Hankins DG', 'Sanders S', 'MacDonald FM', 'Drage CW']",['eng'],"['Case Reports', 'Journal Article']",United States,Chest,Chest,0231335,IM,"['Busulfan/*adverse effects', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Lung/*drug effects', 'Male', 'Middle Aged', 'Pulmonary Fibrosis/chemically induced', 'Uracil Mustard/*adverse effects']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']","['S0012-3692(16)38061-8 [pii]', '10.1378/chest.73.3.415 [doi]']",ppublish,Chest. 1978 Mar;73(3):415-6. doi: 10.1378/chest.73.3.415.,"['G1LN9045DK (Busulfan)', 'W7KQ46GJ8U (Uracil Mustard)']","A growing number of drugs, including a number of alkylating agents, have been implicated as the cause of pulmonary diseases. A patient with chronic myelogenous leukemia presented with typical cytology, biopsy, and roentgenologic findings of lung toxicity after only six weeks of therapy with busulfan. There was subsequent clearing. A similar roentgenologic change also occurred after administration of uracil mustard. This has not been reported previously.",,,,,
272965,NLM,MEDLINE,19780520,20190722,0009-9147 (Print) 0009-9147 (Linking),24,3,1978 Mar,Effect of antibody binding on the mobility of serum lysozyme.,514-5,"['Virella, G', 'Hipp, W A', 'Hood, W']","['Virella G', 'Hipp WA', 'Hood W']",['eng'],"['Letter', ""Research Support, U.S. Gov't, P.H.S.""]",England,Clin Chem,Clinical chemistry,9421549,IM,"['Antigen-Antibody Reactions', 'Electrophoresis, Cellulose Acetate', 'Humans', 'Leukemia, Monocytic, Acute/immunology', 'Multiple Myeloma/immunology', 'Muramidase/*blood/immunology/isolation & purification']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Clin Chem. 1978 Mar;24(3):514-5.,['EC 3.2.1.17 (Muramidase)'],,,,,,
272947,NLM,MEDLINE,19780517,20190619,0008-543X (Print) 0008-543X (Linking),41,2,1978 Feb,Maintenance therapy of adult acute nonlymphoblastic leukemia: an argument against the need for central nervous system prophlyaxis.,697-700,"['Armitage, J O', 'Burns, C P']","['Armitage JO', 'Burns CP']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*therapeutic use', 'Brain Neoplasms/drug therapy/*prevention & control', 'Cytarabine/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Erythroblastic, Acute/drug therapy', 'Leukemia, Monocytic, Acute/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Thioguanine/therapeutic use']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1002/1097-0142(197802)41:2<697::aid-cncr2820410240>3.0.co;2-m [doi]'],ppublish,Cancer. 1978 Feb;41(2):697-700. doi: 10.1002/1097-0142(197802)41:2<697::aid-cncr2820410240>3.0.co;2-m.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', 'FTK8U1GZNX (Thioguanine)']","The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but no proven. Over a 4-year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6-thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6%) has had remission tenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.",,,,,
272946,NLM,MEDLINE,19780517,20190619,0008-543X (Print) 0008-543X (Linking),41,2,1978 Feb,Acute leukemia after chemotherapy (melphalan).,444-7,"['Einhorn, N']",['Einhorn N'],['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Acute Disease', 'Aged', 'Female', 'Humans', 'Leukemia/*chemically induced', 'Leukemia, Erythroblastic, Acute/chemically induced', 'Leukemia, Myeloid, Acute/chemically induced', 'Melphalan/*adverse effects', 'Middle Aged', 'Neoplasms, Multiple Primary/*chemically induced', 'Ovarian Neoplasms/drug therapy', 'Time Factors']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1002/1097-0142(197802)41:2<444::aid-cncr2820410210>3.0.co;2-8 [doi]'],ppublish,Cancer. 1978 Feb;41(2):444-7. doi: 10.1002/1097-0142(197802)41:2<444::aid-cncr2820410210>3.0.co;2-8.,['Q41OR9510P (Melphalan)'],"During the years 1966-1973 474 patients with ovarian carcinoma were treated with melphalan. Of these, 48 patients received at least 300 mg melphalan and survived at least 3 years; four cases of acute leukemia were found among these 48 patients. All cases belonged to a group of 12 cases receiving 800 mg melphalan or more.",,,,,
272945,NLM,MEDLINE,19780517,20190619,0008-543X (Print) 0008-543X (Linking),41,2,1978 Feb,"Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.",428-34,"['Kung, F H', 'Nythan, W L', 'Cuttner, J', 'Falkson, G', 'Lanzkowsky, P', 'Del Duca, V', 'Nawabi, I U', 'Koch, K', 'Pluess, H', 'Freeman, A', 'Burgert, E O', 'Leone, L A', 'Ruymann, F', 'Patterson, R B', 'Degnan, T', 'Hakami, N', 'Pajak, T F', 'Holland, J']","['Kung FH', 'Nythan WL', 'Cuttner J', 'Falkson G', 'Lanzkowsky P', 'Del Duca V', 'Nawabi IU', 'Koch K', 'Pluess H', 'Freeman A', 'Burgert EO', 'Leone LA', 'Ruymann F', 'Patterson RB', 'Degnan T', 'Hakami N', 'Pajak TF', 'Holland J']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/adverse effects', 'Asparaginase/*therapeutic use', 'Bone Marrow/drug effects', 'Brain Neoplasms/prevention & control', 'Carmustine/therapeutic use', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/*drug therapy', 'Lomustine/therapeutic use', 'Male', 'Prednisone/*therapeutic use', 'Recurrence', 'Remission, Spontaneous', 'Vincristine/*therapeutic use']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1002/1097-0142(197802)41:2<428::aid-cncr2820410208>3.0.co;2-c [doi]'],ppublish,Cancer. 1978 Feb;41(2):428-34. doi: 10.1002/1097-0142(197802)41:2<428::aid-cncr2820410208>3.0.co;2-c.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '7BRF0Z81KG (Lomustine)', '8N3DW7272P (Cyclophosphamide)', 'EC 3.5.1.1 (Asparaginase)', 'U68WG3173Y (Carmustine)', 'VB0R961HZT (Prednisone)']","Two hundred and twenty-seven children with recurrent acute lymphoblastic leukemia were treated with various combinations of vincristine, prednisone, cyclophosphamide and L-asparaginase in an approach to the induction of remission. The combination of L-asparaginase 1,000 mu/kg iv q.d. x 10, vincristine 2.0 mg/m2iv q.w. x 4 and prednisone 40 mg/m2 p.o.q.d. x 28 days was found to be highly effective. The incidence of remission was 73%. No significant improvement was achieved when cyclophosphamide was added to this regimen. Various combinations of cytosine arabinoside, cyclophosphamide, vincristine, prednisone, BCNU or CCNU failed to maintain remission duration for more than two or three months. Neither BCNU nor CCNU prevented the development of CNS leukemia.",,,,,
272944,NLM,MEDLINE,19780517,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6112,1978 Mar 4,"Outlook following ""somnolence syndrome"" after prophylactic cranial irradiation.",554,"['Parker, D', 'Malpas, J S', 'Sandland, R', 'Sheaff, P C', 'Freeman, J E', 'Paxton, A']","['Parker D', 'Malpas JS', 'Sandland R', 'Sheaff PC', 'Freeman JE', 'Paxton A']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Brain Neoplasms/prevention & control', 'Central Nervous System/radiation effects', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*radiotherapy', 'Lymphoma/radiotherapy', 'Male', 'Radiotherapy/*adverse effects', '*Sleep Stages', 'Syndrome/etiology']",1978/03/04 00:00,1978/03/04 00:01,['1978/03/04 00:00'],"['1978/03/04 00:00 [pubmed]', '1978/03/04 00:01 [medline]', '1978/03/04 00:00 [entrez]']",['10.1136/bmj.1.6112.554 [doi]'],ppublish,Br Med J. 1978 Mar 4;1(6112):554. doi: 10.1136/bmj.1.6112.554.,,,,PMC1603253,,,
272943,NLM,MEDLINE,19780517,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6112,1978 Mar 4,Immunological detection of residual leukaemic disease in the bone marrow of children with acute lymphoblastic leukaemia.,544-6,"['Kumar, S', 'Carr, T F', 'Hann, I M', 'Jones, P H', 'Evans, D I']","['Kumar S', 'Carr TF', 'Hann IM', 'Jones PH', 'Evans DI']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Bone Marrow/*immunology', 'Bone Marrow Cells', 'Child', 'Humans', 'Leukemia, Lymphoid/*diagnosis/immunology', 'Lymphocyte Activation', 'Remission, Spontaneous']",1978/03/04 00:00,1978/03/04 00:01,['1978/03/04 00:00'],"['1978/03/04 00:00 [pubmed]', '1978/03/04 00:01 [medline]', '1978/03/04 00:00 [entrez]']",['10.1136/bmj.1.6112.544 [doi]'],ppublish,Br Med J. 1978 Mar 4;1(6112):544-6. doi: 10.1136/bmj.1.6112.544.,,"Peripheral blood lymphocytes incubated with tumour cells or extracts may undergo blastogenesis. This is the basis of a technique studied in children with acute lymphoblastic leukaemia (ALL) in childhood in an attempt to predict relapse. Samples of peripheral blood and bone marrow from 82 children with varying degrees of ALL were analysed. Cultures were prepared by incubating a lymphocyte suspension with an autologous bone-marrow suspension. Final ratios of lymphocytes to bone-marrow cells (L: BM) were 1: 1 and 2: 1. Control wells received bone-marrow or lymphocyte suspension only. Cultures were incubated for 72, 96, and 120 hours. All were pulse-labelled with (3)H-TdR and radioactivity was measured by scintillation counting. Results were expressed as the stimulation index, calculated by dividing the mean counts per minute (cpm) of wells containing both lymphocytes and bone-marrow cells by the sum of the mean cpm for control wells. If the stimulation index exceeded 1 at 72, 96, or 120 hours at either L: BM ratio a positive response was recorded.Seventy-six children were in clinical remission at the time of testing (group A) and six were in clinical relapse (group B). In group A 24 patients showed stimulation and relapsed later at a mean time of 3.8 months (21 with marrow disease, two with testicular infiltration, and one with lung infiltration). Sixteen patients showed stimulation and had up to 4% blasts in their bone marrow but remained in remission. Nineteen other patients showed a positive response and several factors may have contributed to this: two underwent a ""rebound"" lymphocytosis after stopping treatment, nine had current or intercurrent infections, two had persistent unexplained bone-marrow lymphocytosis, but six had no causative symptoms and thus their responses were ""true false-positives."" Seventeen patients from group A showed no response and remained in remission for a mean of 22.9 months after testing. None of the six children in group B responded, and at testing had 17-85% blasts in their bone marrow.During the study no patient relapsed who had not shown a positive response. The technique merits further study as a guide to the presence of leukaemic cells.",,PMC1603244,,,
272929,NLM,MEDLINE,19780517,20210216,0006-4971 (Print) 0006-4971 (Linking),51,4,1978 Apr,Surface membrane characteristics and cytochemistry of the abnormal cells in adult acute leukemia.,681-92,"['Gordon, D S', 'Hubbard, M']","['Gordon DS', 'Hubbard M']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Acute Disease', 'Adult', 'Cell Membrane/immunology', 'Cell Separation', '*Cell Transformation, Neoplastic', 'Histocytochemistry', 'Humans', 'Leukemia/blood/*immunology/pathology', 'Leukemia, Erythroblastic, Acute/blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Monocytic, Acute/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['S0006-4971(20)72672-8 [pii]'],ppublish,Blood. 1978 Apr;51(4):681-92.,,"Membrane marker and cytochemical analyses were carried out on the abnormal cells from 70 adult acute leukemia patients. Such information may (1) supplement standard morphology and serve as a basis for a new classification scheme for acute leukemia, and (2) characterize the surface membranes of granulocyte, lymphocyte, and monocyte ""progenitors."" Classification of acute lymphoid leukemias solely on the basis of morphology was unsatisfactory. The presence or absence of T- or B-cell markers was helful in classifying lymphoid leukemias. Monocyte progenitors were characteristically nonspecific esterase positive and Fc-receptor and membrane-IgG positive, but poorly phagocytic. Promyelocytes and myelocytes were frequently Fc-receptor positive and consequently positive for surface immunoglobulin. Myeloblasts were characteristically Fc-receptor negative. We conclude that surface membrane markers are essential in diagnosing lymphoid leukemias and helpful in nonlymphoid acute leukemias, and that cytochemistry is essential in delineating lymphoid from nonlymphoid leukemias and in subclassifying the latter.",,,,,
272928,NLM,MEDLINE,19780517,20210216,0006-4971 (Print) 0006-4971 (Linking),51,4,1978 Apr,Treatment of chronic granulocytic leukemia with melphalan.,571-7,"['Hauch, T', 'Logue, G', 'Laszlo, J', 'Cox, E', 'Rundles, W']","['Hauch T', 'Logue G', 'Laszlo J', 'Cox E', 'Rundles W']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Adolescent', 'Adult', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid/blood/*drug therapy/mortality', 'Male', 'Melphalan/*therapeutic use', 'Middle Aged', 'Splenic Diseases/complications']",1978/04/01 00:00,1978/04/01 00:01,['1978/04/01 00:00'],"['1978/04/01 00:00 [pubmed]', '1978/04/01 00:01 [medline]', '1978/04/01 00:00 [entrez]']",['S0006-4971(20)72661-3 [pii]'],ppublish,Blood. 1978 Apr;51(4):571-7.,['Q41OR9510P (Melphalan)'],"Thirty-three patients with newly diagnosed chronic granulocytic leukemia (CGL) were treated with melphalan between 1968 and 1976. Within 3 mo of beginning therapy subjective and objective disease parameters improved. Disease control was easily maintained with this agent until hematologic exacerbation occurred. The median duration of disease control was 25.3 mo, and the median duration of survival was 28.6 mo. Serious side effects were not produced. Thus melphalan appears to be another agent that may be used to control the manifestations of CGL prior to hematologic exacerbation.",,,,,
272914,NLM,MEDLINE,19780517,20190515,0007-0920 (Print) 0007-0920 (Linking),37,2,1978 Feb,"Continuous culture of malignant haemic cells from human acute myelomonocytic leukaemia: cytological, cytochemical, cytogenetic and immunological studies.",308-15,"['Karpas, A', 'Khalid, G', 'Burns, G F', 'Hayhoe, F G']","['Karpas A', 'Khalid G', 'Burns GF', 'Hayhoe FG']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Acid Phosphatase/analysis', 'Adult', '*Cell Line', 'Chromosome Aberrations', 'Chromosome Disorders', 'Humans', 'Karyotyping', '*Leukemia, Myeloid, Acute/genetics/immunology/ultrastructure', 'Male', 'Time Factors']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1038/bjc.1978.40 [doi]'],ppublish,Br J Cancer. 1978 Feb;37(2):308-15. doi: 10.1038/bjc.1978.40.,['EC 3.1.3.2 (Acid Phosphatase)'],,,PMC2009595,,,
272913,NLM,MEDLINE,19780517,20190515,0007-0920 (Print) 0007-0920 (Linking),37,2,1978 Feb,Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.,282-8,"['Harris, R', 'Zuhrie, S R', 'Freeman, C B', 'Taylor, G M', 'MacIver, J E', 'Geary, C G', 'Delamore, I W', 'Hull, P J', 'Tooth, J A']","['Harris R', 'Zuhrie SR', 'Freeman CB', 'Taylor GM', 'MacIver JE', 'Geary CG', 'Delamore IW', 'Hull PJ', 'Tooth JA']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['BCG Vaccine/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Humans', 'Immunotherapy', 'Leukemia, Myeloid, Acute/mortality/*therapy', 'Remission, Spontaneous', 'Time Factors']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1038/bjc.1978.37 [doi]'],ppublish,Br J Cancer. 1978 Feb;37(2):282-8. doi: 10.1038/bjc.1978.37.,"['0 (BCG Vaccine)', '04079A1RDZ (Cytarabine)', 'ZS7284E0ZP (Daunorubicin)']","One hundred and ninety-one adults with acute myelogenous leukaemia were treated with combination chemotherapy consisting of daunorubicin and cytosine arabinoside (Barts III). Sixty-three patients achieved remission and were admitted to one of 3 trials of active immunotherapy: immunotherapy alone, immunotherapy and maintenance chemotherapy or neither of these. All patients had weekly clinical and blood examination and monthly marrow examination. Reinduction chemotherapy was given as soon as relapse was diagnosed in the marrow. The most striking observation was that immunotherapy was associated with easy and repeated reinduction of remission and marked prolongation of survival after first relapse when compared with immunotherapy plus chemotherapy. The possible reasons for this and the value of immunotherapy are discussed in relation to the third trial still in progress which includes 2 maintenance arms, immunotherapy alone and surveillance only.",,PMC2009578,,,
272890,NLM,MEDLINE,19780417,20091109,0350-2023 (Print) 0350-2023 (Linking),5,2,1977,[IgM and isohemagglutinins in the course of various diseases associated with immune response deficiency].,43-50,"['Jelic, S', 'Pajevic, M', 'Miletic, V', 'Plecas, V']","['Jelic S', 'Pajevic M', 'Miletic V', 'Plecas V']",['hrv'],"['English Abstract', 'Journal Article']",Serbia,Bilt Hematol Transfuz,Bilten za hematologiju i transfuziju,7601504,IM,"['Adult', 'Agammaglobulinemia/immunology', 'Aged', 'Female', 'Hemagglutinins/analysis', 'Humans', 'Hypergammaglobulinemia/immunology', 'Immune System Diseases/*immunology', 'Immunoglobulin M/*analysis', 'Isoantibodies/*analysis', 'Leukemia/*immunology', 'Leukemia, Lymphoid/immunology', 'Male', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Bilt Hematol Transfuz. 1977;5(2):43-50.,"['0 (Hemagglutinins)', '0 (Immunoglobulin M)', '0 (Isoantibodies)']",,IgM i izohemaglutinini u toku nekih oboljenja udruzenih sa poremecajima imunog odgovora.,,,,
272887,NLM,MEDLINE,19780426,20170214,0004-8674 (Print) 0004-8674 (Linking),11,4,1977 Dec,Emotional sequelae of parents and sibs following the drowning or near-drowning of a child.,265-8,"['Nixon, J', 'Pearn, J']","['Nixon J', 'Pearn J']",['eng'],['Journal Article'],England,Aust N Z J Psychiatry,The Australian and New Zealand journal of psychiatry,0111052,IM,"['Adult', 'Child', 'Drowning/*psychology', 'Female', 'Grief', 'Guilt', 'Humans', 'Male', 'Marriage', 'Mental Disorders/*etiology/prevention & control', 'Parents', 'Sibling Relations', 'Stress, Psychological']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.3109/00048677709159576 [doi]'],ppublish,Aust N Z J Psychiatry. 1977 Dec;11(4):265-8. doi: 10.3109/00048677709159576.,,"This study reports the findings from an investigation to evaluate the intra-family dynamics that occurred with 111 cases of childhood drowning and near-drowning in the City of Brisbane in 1971-1975. Personal interviews were obtained with 77 of the families. 24 per cent of parent-dyads separated following the drowning of their child, whereas none of the 54 families of surviving children separated. Accident generated stresses within the studied families tended to persist for years after the incident. Parents volunteered the information that they drank more, experienced sleep disorders and nightmares, and reported significant anxiety states. 19 per cent of parents of drowned children received specialist psychiatric treatment following the drowning. Two cases of surviving children received specialist psychiatric therapy (these were both parents who had inflicted non-accidental injury on their child, and had attempted to drown their child in the bath). In one sense, a child's death is more honourable from society's point of view if the child dies from a chronic medical illness such as leukaemia. In the case of a child's death in the family bath tub or the backyard swimming pool, the extra society sanctions of culpability and accusation further intensified the likelihood of the normal grief process being transformed into a pathological variant.",,,,,
272864,NLM,MEDLINE,19780426,20041117,0003-9926 (Print) 0003-9926 (Linking),138,3,1978 Mar,Early clinical recognition of disseminated candidiasis by muscle and skin biopsy.,429-33,"['Kressel, B', 'Szewczyk, C', 'Tuazon, C U']","['Kressel B', 'Szewczyk C', 'Tuazon CU']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Adolescent', 'Biopsy', 'Candidiasis/*diagnosis', 'Candidiasis, Cutaneous/diagnosis', 'Female', 'Humans', 'Leukemia, Hairy Cell/complications', 'Leukemia, Myeloid/complications', 'Male', 'Middle Aged', 'Muscles/*microbiology/pathology', 'Skin/*microbiology/pathology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1978 Mar;138(3):429-33.,,"Disseminated candidiasis was clinically diagnosed by muscle and skin biopsies in two patients with hematologic malignancies. One patient with acute promyelocytic leukemia presented with skin lesions as the sole manifestation of disseminated candidiasis. The other patient had leukemic reticuloendotheliosis and developed fever, severe myalgias, and maculopapular rash while receiving corticosteroid therapy; this patient is the first to have antemortem documentation of candida myositis as the initial manifestation of disseminated candidiasis. These two case reports serve to emphasize the importance of careful observation and early biopsy of skin and muscle to establish the diagnosis and permit early institution of therapy.",,,,,
272863,NLM,MEDLINE,19780417,20190812,0003-9926 (Print) 0003-9926 (Linking),138,2,1978 Feb,Acute lymphoblastic leukemia. Its occurrence with hypereosinophilic syndrome' and bilateral spontaneous pneumothorax.,292-3,"['Geltner, D', 'Friedman, G', 'Naparstek, E', 'Granot, H', 'Polliack, A']","['Geltner D', 'Friedman G', 'Naparstek E', 'Granot H', 'Polliack A']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Adolescent', 'Eosinophilia/*complications/diagnosis', 'Humans', 'Leukemia, Lymphoid/*complications/diagnosis', 'Male', 'Pneumothorax/*complications/diagnosis', 'Syndrome']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1001/archinte.138.2.292 [doi]'],ppublish,Arch Intern Med. 1978 Feb;138(2):292-3. doi: 10.1001/archinte.138.2.292.,,"A patient with acute lymphoblastic leukemia had an unusual prodrome, including clinical features of ""hypereosinophilic syndrome,"" pulmonary infiltrates, and bilateral spontaneous pneumothorax, which preceded the onset of leukemia by four months. The mechanism for the production of eosinophilia may have been related to the production of eosinopoietic factors by the leukemic cells.",,,,,
272862,NLM,MEDLINE,19780426,20190717,0003-987X (Print) 0003-987X (Linking),114,3,1978 Mar,Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'.,418-20,"['Burg, G', 'Schmoeckel, C', 'Braun-Falco, O', 'Wolff, H H']","['Burg G', 'Schmoeckel C', 'Braun-Falco O', 'Wolff HH']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Dermatol,Archives of dermatology,0372433,IM,"['Aged', 'Diagnosis, Differential', 'Esterases/analysis', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/enzymology/pathology', 'Lymphoma/*diagnosis', 'Microscopy, Electron', 'Skin/enzymology/pathology', 'Skin Neoplasms/*diagnosis/enzymology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1001/archderm.114.3.418 [doi]'],ppublish,Arch Dermatol. 1978 Mar;114(3):418-20. doi: 10.1001/archderm.114.3.418.,['EC 3.1.- (Esterases)'],"Enzyme cytochemical (hydrolytic enzymes for cell differentiation), immunocytologic (B and T lymphocyte differentiation), and electron microscopic studies of skin infiltrates facilitate the proper diagnosis of myelomonocytic and lymphoreticular proliferations. With use of these methods, the original clinical diagnosis of malignant reticulosis of the skin was corrected to monocytic leukemia in a 65-year-old woman. Because primary involvement of the skin preceded monocytosis of the blood, it was concluded that the cutaneous infiltrates in our patient resulted from proliferation of tumor cells in the skin rather than from homing of the cells to, or settling of the cells in, the skin.",,,,,
272861,NLM,MEDLINE,19780426,20080317,0003-987X (Print) 0003-987X (Linking),114,3,1978 Mar,Febrile neutrophilic dermatosis in acute myelogenous leukemia.,413-4,"['Raimer, S S', 'Duncan, W C']","['Raimer SS', 'Duncan WC']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Dermatol,Archives of dermatology,0372433,IM,"['Female', 'Fever/*etiology', 'Humans', 'Leukemia, Myeloid/*complications/pathology', 'Leukocytosis/etiology', 'Middle Aged', '*Neutrophils', 'Skin/pathology', 'Skin Diseases/*etiology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Arch Dermatol. 1978 Mar;114(3):413-4.,,"A 50-year-old woman with acute myelogenous leukemia on two occasions had fever and exquisitely tender, warm, erythematous, indurated to frankly bullous plaques on the face and upper extremities. Histologically, the lesions showed rather dense dermal infiltrates of mature polymorphonuclear leukocytes; special stains for bacteria and fungi were negative, as were all cultures for infectious agents. The lesions did not respond to antibiotics but cleared rapidly with systemic steroid treatment. Febrile neutrophilic dermatosis of acute myelogenous leukemia is believed to be a nonspecific reaction to the underlying malignant disease process. By prompt recognition of this entity, prolonged expensive courses of antibiotics may be avoided.",,,,,
272856,NLM,MEDLINE,19780426,20190627,0003-2697 (Print) 0003-2697 (Linking),85,1,1978 Mar,Preparation of a stable folate-sepharose complex for affinity chromatography.,15-9,"['Fischer, C', 'Rothenberg, S P', 'da Costa, M']","['Fischer C', 'Rothenberg SP', 'da Costa M']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Anal Biochem,Analytical biochemistry,0370535,IM,"['Chromatography, Affinity/*methods', 'Folic Acid/*analogs & derivatives', 'Leukemia, Myeloid', 'Protein Binding', 'Proteins/isolation & purification', 'Sepharose', 'Serum Albumin, Bovine']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']","['0003-2697(78)90267-1 [pii]', '10.1016/0003-2697(78)90267-1 [doi]']",ppublish,Anal Biochem. 1978 Mar;85(1):15-9. doi: 10.1016/0003-2697(78)90267-1.,"['0 (Proteins)', '27432CM55Q (Serum Albumin, Bovine)', '9012-36-6 (Sepharose)', '935E97BOY8 (Folic Acid)']",,,,,,
272849,NLM,MEDLINE,19780426,20190716,0002-922X (Print) 0002-922X (Linking),132,3,1978 Mar,Disseminated intravascular DNA thromboemboli. A complication of chemotherapy for acute lymphocytic leukemia.,294-5,"['Smith, S B', 'Blum, E B']","['Smith SB', 'Blum EB']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Child', 'Cyclophosphamide/*adverse effects/therapeutic use', 'DNA, Neoplasm/*blood', 'Disseminated Intravascular Coagulation/*chemically induced', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/blood/*drug therapy', 'Male', 'Vincristine/*adverse effects/therapeutic use']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1001/archpedi.1978.02120280078017 [doi]'],ppublish,Am J Dis Child. 1978 Mar;132(3):294-5. doi: 10.1001/archpedi.1978.02120280078017.,"['0 (DNA, Neoplasm)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)']","Seven and one-half hours after receiving antileukemic therapy, an 11 year-old boy developed massive intravascular lysis of leukemic cells with subsequent pooling of DNA to form disseminated intravascular thromboemboli. The DNA thromboemboli produced neurologic symptoms and an alveolar capillary block with resultant dyspnea and death.",,,,,
272822,NLM,MEDLINE,19780417,20190812,0001-6101 (Print) 0001-6101 (Linking),203,1-2,1978,Increase in serum alkaline phosphatase (S-ALP) in chronic myelocytic leukemia--sign of drug-induced cholestasis?,93-4,"['Hast, R']",['Hast R'],['eng'],"['Case Reports', 'Journal Article']",Sweden,Acta Med Scand,Acta medica Scandinavica,0370330,IM,"['Adult', 'Alkaline Phosphatase/*blood', 'Busulfan/*adverse effects/therapeutic use', 'Cholestasis/*chemically induced/enzymology', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy/*enzymology', 'Male', 'Time Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1111/j.0954-6820.1978.tb14837.x [doi]'],ppublish,Acta Med Scand. 1978;203(1-2):93-4. doi: 10.1111/j.0954-6820.1978.tb14837.x.,"['EC 3.1.3.1 (Alkaline Phosphatase)', 'G1LN9045DK (Busulfan)']","In four patients with chronic myelocytic leukemia, a solitary rise in serum alkaline phosphatase (S-ALP) was noted 2--12 months prior to death. All patients had received busulphan (Myleran) therapy for longer than 12 months (total dosage 1.0--2.4 g). It is suggested that the increase in S-alp was due to a cholestatic liver damage, possible secondary to the busulphan treatment.",,,,,
272817,NLM,MEDLINE,19780417,20190819,0001-656X (Print) 0001-656X (Linking),67,2,1978 Mar,Cessation of therapy in childhood leukemia. A survey of 160 cases from the Nordic Countries.,145-9,"['Moe, P J']",['Moe PJ'],['eng'],['Journal Article'],Sweden,Acta Paediatr Scand,Acta paediatrica Scandinavica,0000211,IM,"['Adolescent', 'Brain Neoplasms', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Iceland', 'Infant', 'Infant, Newborn', 'Leukemia, Lymphoid/*therapy', 'Male', 'Neoplasm Recurrence, Local', 'Remission, Spontaneous', 'Scandinavian and Nordic Countries', 'Spinal Cord Neoplasms', 'Testicular Neoplasms', 'Time Factors']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['10.1111/j.1651-2227.1978.tb16294.x [doi]'],ppublish,Acta Paediatr Scand. 1978 Mar;67(2):145-9. doi: 10.1111/j.1651-2227.1978.tb16294.x.,,"A survey is presented of 160 children from the Nordic countries who had their antileukemic therapy discontinued prior to November 1976. Twenty-seven of the 160 cases (17%) had suffered a relapse before May, 1977. Sixty-nine cases had their therapy stopped in the first ten months of 1976. All cases have been reported as acute lymphocytic leukemia. Different types of therapy schedules have been used. Thirty-five cases in sustained remission for more than 3 years without cessation of therapy are also included in the report, seventeen of whom had relapsed while still on therapy. Central nervous system or testicular relapse occurred in 21 of the total 44 cases who relapsed after three or more years of continuous remission, and whether they were on therapy or not.",,,,,
272812,NLM,MEDLINE,19780417,20061115,0001-5814 (Print) 0001-5814 (Linking),8,4,1977 Oct-Dec,[Double skin cancer coexisting with chronic myeloid leukemia].,313-8,"['Gaertner, H', 'Gurda, M', 'Troczynski, K', 'Winiarski, J', 'Markiewicz, J']","['Gaertner H', 'Gurda M', 'Troczynski K', 'Winiarski J', 'Markiewicz J']",['pol'],"['Case Reports', 'English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Aged', 'Carcinoma, Squamous Cell/*pathology', 'Ear Neoplasms/*pathology', 'Ear, External', 'Humans', 'Leukemia, Myeloid/*pathology', 'Male', 'Nose Neoplasms/*pathology', 'Skin Neoplasms/*pathology']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1977 Oct-Dec;8(4):313-8.,,In a 71-year-old man chronic myeloid leukaemia was diagnosed 4--5 years after cure of pulmonary tuberculosis and removed auricular cancer and 2 years after nasal cancer cured by means of local radiotherapy.,Dwukrotny rak skory i przewlekla bialaczka szpikowa.,,,,
272807,NLM,MEDLINE,19780417,20181113,0093-0415 (Print) 0093-0415 (Linking),128,1,1978 Jan,Hemopoietic dysplasia (preleukemia).,50-1,"['Brecher, G']",['Brecher G'],['eng'],['Journal Article'],United States,West J Med,The Western journal of medicine,0410504,IM,"['Aged', 'Diagnosis, Differential', 'Humans', 'Leukemia, Myeloid, Acute/diagnosis/drug therapy', 'Preleukemia/*diagnosis', 'Prognosis']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,West J Med. 1978 Jan;128(1):50-1.,,,,PMC1237970,,,
272803,NLM,MEDLINE,19780417,20071115,0049-6804 (Print) 0049-6804 (Linking),,1,1978 Jan,[Bone marrow carcinomatosis].,3-7,"['Rekhtman, V O', 'Germaniuk, A P']","['Rekhtman VO', 'Germaniuk AP']",['rus'],"['Case Reports', 'Journal Article']",Ukraine,Vrach Delo,Vrachebnoe delo,0413607,IM,"['Adult', 'Aged', 'Bone Marrow/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Male', 'Middle Aged']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Vrach Delo. 1978 Jan;(1):3-7.,,,O kostnomozgovom kartsinomatoze.,,,,
272800,NLM,MEDLINE,19780417,20190727,0041-1132 (Print) 0041-1132 (Linking),18,1,1978 Jan-Feb,Management of chronic myelocytic leukemia in pregnancy by cell pheresis.,120-4,"['Caplan, S N', 'Coco, F V', 'Berkman, E M']","['Caplan SN', 'Coco FV', 'Berkman EM']",['eng'],['Journal Article'],United States,Transfusion,Transfusion,0417360,IM,"['Adult', 'Blood Cell Count', 'Blood Platelets', 'Cell Separation', 'Female', 'Granulocytes', 'Humans', 'Leukemia, Myeloid/*therapy', 'Leukocyte Count', '*Plasmapheresis', 'Pregnancy', 'Pregnancy Complications, Hematologic/*therapy']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1046/j.1537-2995.1978.18178118555.x [doi]'],ppublish,Transfusion. 1978 Jan-Feb;18(1):120-4. doi: 10.1046/j.1537-2995.1978.18178118555.x.,,Cell pheresis was employed in the initial management of a pregnant patient with chronic myelocytic leukemia (CML). Reduction in circulating leukocyte and platelet counts was evident after two weeks of therapy. This technique is an effective mode of management of the pregnant patient with CML and may play an important therapeutic role in the treatment of other myeloproliferative diseases characterized by dangerously high levels of circulating platelets or myeloblasts.,,,,,
272799,NLM,MEDLINE,19780417,20190727,0041-1132 (Print) 0041-1132 (Linking),18,1,1978 Jan-Feb,Rapid cytoreduction in acute leukemia. Management of cerebral leukostasis by cell pheresis.,113-5,"['Eisenstaedt, R S', 'Berkman, E M']","['Eisenstaedt RS', 'Berkman EM']",['eng'],"['Case Reports', 'Journal Article']",United States,Transfusion,Transfusion,0417360,IM,"['Aged', '*Cerebrovascular Circulation', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*blood/*therapy', '*Plasmapheresis']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1046/j.1537-2995.1978.18178118553.x [doi]'],ppublish,Transfusion. 1978 Jan-Feb;18(1):113-5. doi: 10.1046/j.1537-2995.1978.18178118553.x.,,"A patient with acute myelogenous leukemia and symptoms of cerebral leukostasis failed to respond to initial chemotherapy. Reduction in blast count from 220,000/microliter to 40,000/microliter was accomplished over a five hour period by leukapheresis using an intermittent flow cell separator, and symptomatic improvement was dramatic. The technique is simple and rapidly effective and may prove a useful adjunct in the treatment of patients with acute leukemia and high blast counts.",,,,,
272750,NLM,MEDLINE,19780417,20171117,0029-2001 (Print) 0029-2001 (Linking),98,1,1978 Jan 10,[Long term remission in acute myelogenous leukemia in adults].,17-8,"['Ly, B', 'Gjemdal, T', 'Stavem, P']","['Ly B', 'Gjemdal T', 'Stavem P']",['nor'],['Journal Article'],Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Adult', 'Antineoplastic Agents/*therapeutic use', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/mortality', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use', 'Prognosis', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1978/01/10 00:00,1978/01/10 00:01,['1978/01/10 00:00'],"['1978/01/10 00:00 [pubmed]', '1978/01/10 00:01 [medline]', '1978/01/10 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1978 Jan 10;98(1):17-8.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']",,Langvarig remisjon ved akutt myelogen leukemi hos voksne.,,,,
272729,NLM,MEDLINE,19780417,20190907,0036-553X (Print) 0036-553X (Linking),20,1,1978 Jan,Erythrophagocytosis by acute lymphoblastic leukaemic cells.,85-8,"['Foadi, M D', 'Slater, A M', 'Pegrum, G D']","['Foadi MD', 'Slater AM', 'Pegrum GD']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Blood Platelets', 'Bone Marrow Cells', 'Child', '*Erythrocytes', 'Female', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Male', '*Phagocytosis']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1111/j.1600-0609.1978.tb01558.x [doi]'],ppublish,Scand J Haematol. 1978 Jan;20(1):85-8. doi: 10.1111/j.1600-0609.1978.tb01558.x.,,Phagocytosis of erthyrocytes and platelets by bone marrow blast cells has been noted in 4 patients in the late relapse of acute lymphoblastic leukaemia (ALL). The underlying mechanism is unclear but prolonged course of the disease seems to be a major factor in the emergence of cells with phagocytic properties.,,,,,
272707,NLM,MEDLINE,19780426,20041117,0035-6204 (Print) 0035-6204 (Linking),24,3-4,1977,[Association of breast cancer and chronic myelogenous leukemia].,128-34,"['Malacarne, P', 'Bertusi, M', 'Bariani, L']","['Malacarne P', 'Bertusi M', 'Bariani L']",['ita'],['Journal Article'],Italy,Riv Emoter Immunoematol,Rivista di emoterapia ed immunoematologia,0404352,IM,"['Aged', 'Breast Neoplasms/*complications', 'Female', 'Humans', 'Leukemia, Myeloid/*complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Riv Emoter Immunoematol. 1977;24(3-4):128-34.,,,Associazione di cancro della mammella e leucemia mieloide cronica.,,,,
272624,NLM,MEDLINE,19780426,20071115,0552-2080 (Print) 0552-2080 (Linking),23,1,1978 Jan,[Characteristics of intestinal microflora in patients with acute leukemia].,35-9,"['Tolkacheva, T V', 'Kuznetsova, G G', 'Martynova, V A', 'Abakumov, E M', 'Ermakova, G L']","['Tolkacheva TV', 'Kuznetsova GG', 'Martynova VA', 'Abakumov EM', 'Ermakova GL']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adolescent', 'Adult', 'Child', 'Ecology', 'Female', 'Humans', 'Intestines/*microbiology', 'Leukemia, Lymphoid/*microbiology', 'Leukemia, Myeloid, Acute/*microbiology', 'Male']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1978 Jan;23(1):35-9.,,,Kharakteristika kishechnoi mikroflory u bol'nykh ostrymi leikozami.,,,,
272619,NLM,MEDLINE,19780417,20131121,0030-6002 (Print) 0030-6002 (Linking),119,5,1978 Jan 29,[Successful treatment of uremia by hemodialysis in the early stages of acute lymphoid leukemia in childhood].,277-9,"['Kemeny, P', 'Szokolai, V', 'Mako, J', 'Juhasz, J']","['Kemeny P', 'Szokolai V', 'Mako J', 'Juhasz J']",['hun'],"['Case Reports', 'Journal Article']",Hungary,Orv Hetil,Orvosi hetilap,0376412,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Remission, Spontaneous', '*Renal Dialysis', 'Uremia/etiology/*therapy', 'Uric Acid/blood']",1978/01/29 00:00,1978/01/29 00:01,['1978/01/29 00:00'],"['1978/01/29 00:00 [pubmed]', '1978/01/29 00:01 [medline]', '1978/01/29 00:00 [entrez]']",,ppublish,Orv Hetil. 1978 Jan 29;119(5):277-9.,['268B43MJ25 (Uric Acid)'],,Acut lymphoid leukaemiat bevezeto uraemia eredmenyes muvese kezelese gyermeken.,,,,
272597,NLM,MEDLINE,19780417,20071115,0030-1124 (Print) 0030-1124 (Linking),74,2,1978 Feb,Acute leukemia of childhood and adolescence.,118-9,"['Gross, S', 'Staples, W I']","['Gross S', 'Staples WI']",['eng'],['Journal Article'],United States,Ohio State Med J,The Ohio State medical journal,0401013,IM,"['Acute Disease', 'Adolescent', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', 'Humans', '*Leukemia/complications/diagnosis/drug therapy', 'Leukemia, Lymphoid/diagnosis', 'Leukemia, Myeloid, Acute/diagnosis', 'Prognosis']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Ohio State Med J. 1978 Feb;74(2):118-9.,['0 (Antineoplastic Agents)'],,,,,,
272488,NLM,MEDLINE,19780426,20190617,0028-0836 (Print) 0028-0836 (Linking),272,5649,1978 Mar 9,Allylisopropylacetamide restricts expression of beta minor globin gene in Friend cells.,172-5,"['Rovera, G', 'Aden, D', 'Surrey, S']","['Rovera G', 'Aden D', 'Surrey S']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Nature,Nature,0410462,IM,"['Acetamides/*pharmacology', 'Allylisopropylacetamide/*pharmacology', 'Animals', 'Cell Line', 'Dimethyl Sulfoxide/pharmacology', 'Erythropoiesis/drug effects', 'Friend murine leukemia virus', 'Genes', 'Globins/biosynthesis/*genetics', 'Heme/metabolism', 'Leukemia, Erythroblastic, Acute/*genetics', 'Leukemia, Experimental/*genetics', 'Macromolecular Substances']",1978/03/09 00:00,1978/03/09 00:01,['1978/03/09 00:00'],"['1978/03/09 00:00 [pubmed]', '1978/03/09 00:01 [medline]', '1978/03/09 00:00 [entrez]']",['10.1038/272172a0 [doi]'],ppublish,Nature. 1978 Mar 9;272(5649):172-5. doi: 10.1038/272172a0.,"['0 (Acetamides)', '0 (Macromolecular Substances)', '299-78-5 (Allylisopropylacetamide)', '42VZT0U6YR (Heme)', '9004-22-2 (Globins)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
272486,NLM,MEDLINE,19780417,20171117,,126,1,1978 Jan,[Results and problems in the treatment of childhood leukaemia (author's transl)].,19-22,"['Schuler, D', 'Revesz, T', 'Horvath, A', 'Domjan, O', 'Istvan, L', 'Kassai, P', 'Kemeny, P', 'Koos, R', 'Laub, M W', 'Szekely, K', 'Velkey, L', 'Vinceller, M', 'Virag, I']","['Schuler D', 'Revesz T', 'Horvath A', 'Domjan O', 'Istvan L', 'Kassai P', 'Kemeny P', 'Koos R', 'Laub MW', 'Szekely K', 'Velkey L', 'Vinceller M', 'Virag I']",['ger'],['Journal Article'],Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Age Factors', 'Child', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Humans', 'Hungary', 'Leukemia/*drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Mercaptopurine/therapeutic use', 'Prednisolone/therapeutic use', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1978 Jan;126(1):19-22.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)', 'ZS7284E0ZP (Daunorubicin)']","391 children received complex chemotherapy according to uniform treatment schedules, proposed by the Hungarian Study Group for Childhood Leukaemia, which was established in 1971. Survival among the patients showed an increasing tendency: more than 50% of patients with ALL are stille alive 3 years after the beginning of treatment. One patient is in complete remission 9 3/4 years after the establishment of the diagnosis. Two types of maintenance therapy were investigated among the patients entered for this study in 1974. ""Pulses"" with Vincristine-Prednisolone every second month were found to be more optimal than monthly ""pulses"".",Ergebnisse und Probleme bei der Behandlung der kindlichen Leukamien in Ungarn.,,,,
272484,NLM,MEDLINE,19780417,20190902,0098-1532 (Print) 0098-1532 (Linking),4,1,1978,Letter to the editor.,87-8,"['Ekert, H']",['Ekert H'],['eng'],['Letter'],United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Antineoplastic Agents/*therapeutic use', 'BCG Vaccine/*therapeutic use', 'Child', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/*therapy', 'Remission, Spontaneous', 'Time Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040114 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(1):87-8. doi: 10.1002/mpo.2950040114.,"['0 (Antineoplastic Agents)', '0 (BCG Vaccine)']",,,,,,
272483,NLM,MEDLINE,19780417,20190902,0098-1532 (Print) 0098-1532 (Linking),4,1,1978,Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy.,77-83,"['Meyer, R J', 'Cuttner, J', 'Truog, P', 'Ambinder, E P', 'Holland, J F']","['Meyer RJ', 'Cuttner J', 'Truog P', 'Ambinder EP', 'Holland JF']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Blood Cell Count', 'Blood Platelets', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/blood/*complications/therapy', 'Leukocyte Count', '*Plasmapheresis', 'Pregnancy', 'Pregnancy Complications, Hematologic/blood/*therapy', 'Pregnancy Trimester, Second']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040112 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(1):77-83. doi: 10.1002/mpo.2950040112.,,"Cytopheresis techniques have proven useful in the provision of platelets and granulocytes for transfusion to the pancytopenic patient. Mechanical cell removal has been applied to the treatment of chronic myelocytic and lymphocytic leukemias and the Sezary syndrome. We have treated a 16-year-old pregnant acute myelomonocytic leukemia (AMML) patient for 12 weeks solely with the use of intensive leukopheresis utilizing batch processing centrifugation and packed red cell transfusions. The patient presented with a white blood cell count of 54,000/mm3 with 64% myelomonoblasts, a platelet count of 45,000/mm3, marked gingival hyperplasia, and splenomegaly. Patient had a normal spontaneous delivery of a 2.5-kg male infant without complications. At the time of delivery, 12 weeks later, the white blood count had fallen to 4,9000/mm3 with 8% blasts and the platelet count had risen to over 100,000/mm3. Gingival hyperplasia decreased and the patient felt well. We have treated an additional small group of patients with acute myelogenous leukemia (AML) with high white counts with short term intensive leukopheresis followed by chemotherapy with promising results.",,,,,
272482,NLM,MEDLINE,19780417,20190902,0098-1532 (Print) 0098-1532 (Linking),4,1,1978,Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.,17-27,"['Mathe, G', 'De Vassal, F', 'Schwarzenberg, L', 'Delgado, M', 'Weiner, R', 'Gil, M A', 'Pena-Angulo, J', 'Belpomme, D', 'Pouillart, P', 'Machover, D', 'Misset, J L', 'Pico, J L', 'Jasmin, C', 'Hayat, M', 'Schneider, M', 'Cattan, A', 'Amiel, J L', 'Musset, M', 'Rosenfeld, C', 'Ribaud, P']","['Mathe G', 'De Vassal F', 'Schwarzenberg L', 'Delgado M', 'Weiner R', 'Gil MA', 'Pena-Angulo J', 'Belpomme D', 'Pouillart P', 'Machover D', 'Misset JL', 'Pico JL', 'Jasmin C', 'Hayat M', 'Schneider M', 'Cattan A', 'Amiel JL', 'Musset M', 'Rosenfeld C', 'Ribaud P']",['eng'],"['Comparative Study', 'Journal Article']",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Antigens, Neoplasm/administration & dosage', 'Antineoplastic Agents/therapeutic use', 'BCG Vaccine/therapeutic use', 'Cell Count', 'Child', 'Female', 'Humans', 'Immunotherapy', 'Leukemia, Lymphoid/immunology/pathology/*therapy', 'Male', 'Prognosis', 'Remission, Spontaneous', 'Time Factors']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/mpo.2950040105 [doi]'],ppublish,Med Pediatr Oncol. 1978;4(1):17-27. doi: 10.1002/mpo.2950040105.,"['0 (Antigens, Neoplasm)', '0 (Antineoplastic Agents)', '0 (BCG Vaccine)']",,,,,,
272478,NLM,MEDLINE,19780417,20041117,0023-2149 (Print) 0023-2149 (Linking),55,12,1977 Dec,[Giant-cell pneumonia in an adult].,116-8,"['Konovalov, O V', 'Siubaeva, N I', 'Tsvetkova, I S']","['Konovalov OV', 'Siubaeva NI', 'Tsvetkova IS']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['Humans', 'Leukemia, Myeloid/complications', 'Male', 'Middle Aged', 'Pneumonia/etiology/*pathology', 'Pulmonary Alveoli/pathology']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1977 Dec;55(12):116-8.,,,Gigantokletochnaia pnevmoniia u vzroslogo.,,,,
272477,NLM,MEDLINE,19780426,20190711,0023-2173 (Print) 0023-2173 (Linking),56,1,1978 Jan 1,[Enzyme activities in platelets of different specific gravity in thrombocytosis of various etiology (author's transl)].,43-7,"['Nerke, O', 'Benohr, H C', 'Thorau, U', 'Waller, H D']","['Nerke O', 'Benohr HC', 'Thorau U', 'Waller HD']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Wochenschr,Klinische Wochenschrift,2985205R,IM,"['Blood Platelet Disorders/*enzymology', 'Blood Platelets/*enzymology', 'Enzymes/*blood', 'Humans', 'Leukemia, Myeloid/enzymology', 'Polycythemia Vera/enzymology', 'Splenectomy']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1007/BF01476742 [doi]'],ppublish,Klin Wochenschr. 1978 Jan 1;56(1):43-7. doi: 10.1007/BF01476742.,['0 (Enzymes)'],"Platelets of patients with thrombocytosis following splenectomy, in chronic granulocytic leukaemia and in polycythaemia vera were separated into five fractions by centrifugation in discontinuous Ficoll density gradient. Platelet volume, content of protein and enzyme activities of lactic dehydrogenase, phosphoglycerate kinase and glyceraldehyde phosphate dehydrogenase were distinctly higher for the three groups in the heavy fraction IV compared with the light fraction I. With regard to the platelet volume, however, these differences were compensated almost completely like in the normal persons.",Enzymaktivitaten und Proteingehalt von Thrombozyten verschiedener Dichte bei Thrombozytosen unterschiedlicher Atiologie.,,,,
272475,NLM,MEDLINE,19780426,20041117,0047-1860 (Print) 0047-1860 (Linking),25,12,1977 Dec,[Bacteriological findings in leukemic patients (author's transl)].,992-5,"['Yabuuchi, E']",['Yabuuchi E'],['jpn'],"['Case Reports', 'Journal Article']",Japan,Rinsho Byori,Rinsho byori. The Japanese journal of clinical pathology,2984781R,IM,"['Antineoplastic Agents/*pharmacology', 'Bacteria/*isolation & purification', 'Bacterial Infections/etiology', 'Female', 'Humans', 'Leukemia, Myeloid/complications/*microbiology', 'Middle Aged']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Rinsho Byori. 1977 Dec;25(12):992-5.,['0 (Antineoplastic Agents)'],,,,,,
272474,NLM,MEDLINE,19780417,20061115,0485-1439 (Print) 0485-1439 (Linking),18,12,1977 Dec,[Four autopsy cases of atypical leukemia in the higher age bracket resembling chronic myelogenous leukemia (author's transl)].,1414-21,"['Nemoto, K', 'Ohnishi, Y']","['Nemoto K', 'Ohnishi Y']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Age Factors', 'Aged', 'Bone Marrow/pathology', 'Female', 'Humans', 'Leukemia/*pathology', 'Leukemia, Myeloid/*pathology', 'Male']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Dec;18(12):1414-21.,,,,,,,
272473,NLM,MEDLINE,19780426,20161017,0098-7484 (Print) 0098-7484 (Linking),239,10,1978 Mar 6,Atypical pyoderma gangrenosum with leukemia.,935-8,"['Lewis, S J', 'Poh-Fitzpatrick, M B', 'Walther, R R']","['Lewis SJ', 'Poh-Fitzpatrick MB', 'Walther RR']",['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Acute Disease', 'Adult', 'Debridement', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Pyoderma/*complications/surgery', 'Skin Ulcer/complications/surgery']",1978/03/06 00:00,1978/03/06 00:01,['1978/03/06 00:00'],"['1978/03/06 00:00 [pubmed]', '1978/03/06 00:01 [medline]', '1978/03/06 00:00 [entrez]']",,ppublish,JAMA. 1978 Mar 6;239(10):935-8.,,"Pyoderma gangrenosum (PG) has been increasingly reported in association with myeloproliferative disorders. Monoclonal gammaopathy, myeloma, myeloid metaplasia, and polycythemia have all been found in association with PG. Recently, seven cases of PG in association with leukemia have been described: three cases with acute myeloblastic leukemia, two cases with chronic myelogenous leukemia, one case with acute lymphoblastic leukemia, and one case with acute leukemia of either plasma cell or myeloblast origin. To these we add two cases of PG with acute myeloblastic leukemia. These patients often have an atypical clinical presentation for PG, with bullae and relatively superficial involvement obscuring the correct diagnosis.",,,,,
272472,NLM,MEDLINE,19780426,20131121,0161-5548 (Print) 0161-5548 (Linking),2,,1977,Experimental benzene intoxication.,45-61,"['Leong, B K']",['Leong BK'],['eng'],['Journal Article'],United States,J Toxicol Environ Health Suppl,Journal of toxicology and environmental health. Supplement,7801250,IM,"['Administration, Oral', 'Animals', 'Benzene/administration & dosage/*poisoning/toxicity', 'Embryo, Mammalian/drug effects', 'Embryo, Nonmammalian', 'Female', 'Hematopoiesis/drug effects', 'Histocytochemistry', 'Immunity/drug effects', 'Injections', 'Lethal Dose 50', 'Leukemia/chemically induced', 'Male', 'Pregnancy', 'Species Specificity', 'Teratogens', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,J Toxicol Environ Health Suppl. 1977;2:45-61.,"['0 (Teratogens)', 'J64922108F (Benzene)']",,,,,,
272469,NLM,MEDLINE,19780426,20190509,0027-8874 (Print) 0027-8874 (Linking),60,1,1978 Jan,"Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication.",89-92,"['Paffenbarger, R S Jr', 'Wing, A L', 'Hyde, R T']","['Paffenbarger RS Jr', 'Wing AL', 'Hyde RT']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Activities of Daily Living', 'Adult', 'Coffee/adverse effects', 'Communicable Diseases/complications', 'Hodgkin Disease/etiology', 'Humans', 'Leukemia/*etiology', 'Leukemia, Lymphoid/etiology', 'Leukemia, Myeloid/etiology', 'Lymphoma/*etiology', 'Male', 'Melanoma/*etiology', 'Middle Aged', 'Obesity/complications', 'Retrospective Studies', 'Risk', 'Skin Neoplasms/*etiology', 'Smoking/complications', 'Tonsillectomy/adverse effects']",1978/01/01 00:00,2001/03/28 10:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1093/jnci/60.1.89 [doi]'],ppublish,J Natl Cancer Inst. 1978 Jan;60(1):89-92. doi: 10.1093/jnci/60.1.89.,['0 (Coffee)'],,,,,,
272468,NLM,MEDLINE,19780426,20190509,0027-8874 (Print) 0027-8874 (Linking),60,1,1978 Jan,Destruction of circulating leukemia cells by phagocytosis in rats with myelogenous leukemia.,185-95,"['Cho, Y', 'De Bruyn, P P']","['Cho Y', 'De Bruyn PP']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', 'Bone Marrow/immunology', 'Kupffer Cells/immunology', 'Leukemia, Experimental/blood/*immunology/pathology', 'Leukemia, Myeloid, Acute/immunology', 'Leukocyte Count', 'Lymph Nodes/immunology', 'Macrophages/immunology', 'Male', '*Neoplastic Cells, Circulating', '*Phagocytosis', 'Rats', 'Spleen/immunology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1093/jnci/60.1.185 [doi]'],ppublish,J Natl Cancer Inst. 1978 Jan;60(1):185-95. doi: 10.1093/jnci/60.1.185.,,"Acute myelogenous leukemia was induced in outbred Long-Evans rats by iv injections of leukemia cells from a subcutaneous tumor of Shay myelogenous leukemia. In rats with this leukemia the peripheral white blood cell (WBC) counts varied from 2.4 to 700 X 10(9)/liter. No differences were found in the bone marrow of the rats with the high WBC counts and that of rats with low WBC counts. This observation could explain the large variations in the number of circulating leukemia cells caused by differences in cell proliferation or delivery of cells into the circulation. Massive phagocytosis of leukemia cells occurred in animals with low WBC counts (less than 12 X 10(9)/liter) but not in animals with high WBC counts (greater than 150 X 10(9)/liter). This phagocytosis was directed against circulating leukemia cells. The main phagocytes were Kupffer's cells of the liver and macrophages of the spleen parenchyma. In addition, phagocytosis occurred in the spleens and bone marrow by intravascular macrophages, which were derived from extravascular sites. The endothelium of the postcapillary venules of the lymph nodes participated in the phagocytosis of circulating leukemia cells while continuing to be the locus of lymphocytic return from circulation to lymphatic parenchyma. The factors underlying the differences in macrophage activity between the rats with high and low WBC counts were unknown.",,,,,
272434,NLM,MEDLINE,19780417,20131121,0025-7850 (Print) 0025-7850 (Linking),8,6,1977,Plasma cell leukemia: response to conventional myeloma therapy.,403-14,"['Gailani, S', 'Seon, B K', 'Henderson, E S']","['Gailani S', 'Seon BK', 'Henderson ES']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med,Journal of medicine,7505566,IM,"['Aged', 'Humans', 'Leukemia, Plasma Cell/complications/*drug therapy', 'Male', 'Melphalan/*therapeutic use', 'Multiple Myeloma/complications/drug therapy', 'Prednisone/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,J Med. 1977;8(6):403-14.,"['Q41OR9510P (Melphalan)', 'VB0R961HZT (Prednisone)']","A 76-year-old man with plasma cell leukemia was treated with L-phenylalanine mustard and prednisone (CLGB 7461). There was good partial remission of the plasma cell disease characterized by disappearance of the plasma cells in the peripheral blood, reduction of plasma cells in the marrow aspirates to less than 5% of the nucleated hematopoietic cells, a reduction in the serum monoclonal IgG from 7.6 to 2 gms/100 ml, and the disappearance of urinary monoclonal IgG, Bence-Jones protein and a complex of gamma-chain fragment and beta2-microglobulins. There was also a marked improvement in the renal function and a decrease in the proteinuria from 4+ to 1+. The patient relapsed after more than 8 months of response and failed to respond to subsequent treatment with cytoxan and cytosine arabinoside. However, the efficacy of standard myeloma therapy was clearly apparent in this case of plasma cell leukemia.",,,,,
272398,NLM,MEDLINE,19780426,20141120,0002-3329 (Print) 0002-3329 (Linking),,1,1978 Jan-Feb,[Kinetics of the enzymatic degradation of lymphocyte nuclei in cattle blood normally and in leukemia].,139-43,"['Mikhalko, A P', 'Azizov, Iu M', 'Malakhov, A G']","['Mikhalko AP', 'Azizov IuM', 'Malakhov AG']",['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Izv Akad Nauk SSSR Biol,Izvestiia Akademii nauk SSSR. Seriia biologicheskaia,7505543,IM,"['Animals', 'Cattle/*blood', 'Cattle Diseases/*blood', 'Cell Nucleus/drug effects', 'Deoxyribonucleases/*pharmacology', 'Hydrolysis', 'In Vitro Techniques', 'Kinetics', 'Leukemia, Myeloid/*veterinary', 'Lymphocytes/*drug effects', 'Peptide Hydrolases/*pharmacology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Izv Akad Nauk SSSR Biol. 1978 Jan-Feb;(1):139-43.,"['EC 3.1.- (Deoxyribonucleases)', 'EC 3.4.- (Peptide Hydrolases)']",,Kinetika fermentativnoi degradatsii iader limfotsitov krovi krupnogo rogatogo skota v norme i pri leikoze.,,,,
272368,NLM,MEDLINE,19780417,20190823,0091-2700 (Print) 0091-2700 (Linking),18,2-3,1978 Feb-Mar,Toxicity study of cytosine arabinoside and methotrexate in the maintenance therapy of childhood leukemia. A Southwest Oncology Group study.,131-5,"['Nitschke, R', 'Komp, D M', 'Morgan, S K', 'Starling, K A', 'Vietti, T J']","['Nitschke R', 'Komp DM', 'Morgan SK', 'Starling KA', 'Vietti TJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,J Clin Pharmacol,Journal of clinical pharmacology,0366372,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Cytarabine/*adverse effects/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Methotrexate/*adverse effects/therapeutic use']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1002/j.1552-4604.1978.tb02433.x [doi]'],ppublish,J Clin Pharmacol. 1978 Feb-Mar;18(2-3):131-5. doi: 10.1002/j.1552-4604.1978.tb02433.x.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']","In a toxicity study to determine the feasibility of treating patients with acute lymphocytic leukemia (ALL) using an intravenous combination of cytosine arabinoside (Ara-C) and methotrexate (MTX), the drugs were given either simultaneously or sequentially every two weeks. Twenty-nine patients were studied, 17 treated simultaneously, 12 treated sequentially. The tolerated doses of Ara-C and MTX were 60 mg/m2 and 90 mg/m2, respectively, for the simultaneous treatment schedule and 90 mg/m2 and 150 mg/m2, respectively, for the sequential treatment schedule. The dose-limiting factor of the drug combination was gastrointestinal toxicity. The observed recurrent vomiting on both schedules rendered the treatment unsuitable for maintenance therapy.",,,,,
272290,NLM,MEDLINE,19780426,20061115,0301-472X (Print) 0301-472X (Linking),6,2,1978 Feb,Murine myeloid leukemia: colony formation in vitro.,213-9,"['Mori, M', 'Preisler, H', 'Oshimura, M', 'Bjornsson, S', 'Sandberg, A']","['Mori M', 'Preisler H', 'Oshimura M', 'Bjornsson S', 'Sandberg A']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Exp Hematol,Experimental hematology,0402313,IM,"['Animals', 'Cell Division', 'Cell Line', 'Chromosomes', 'Clone Cells', 'Histocytochemistry', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid/*pathology', 'Mice', 'Spleen/transplantation', 'Transplantation, Homologous']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Exp Hematol. 1978 Feb;6(2):213-9.,,"Normal and myeloid leukemic spleen cells from RF mice were cultured in vitro in plasma clots. In situ histochemical staining and karyotypic analysis of the colonies formed in the clot revealed that the colonies produced by leukemic and normal progenitors were indistinguishable morphologically and cytochemically. Colonies of leukemic origin were identified by in situ karyotypic analysis, a method not previously utilized in studies of hematopoietic proliferation in semi-solid matrices.",,,,,
272289,NLM,MEDLINE,19780417,20031114,0301-472X (Print) 0301-472X (Linking),6,1,1978 Jan,Measurement of erythropoietin in chloroleukemic rats.,91-5,"['Derelanko, M J', 'LoBue, J', 'Gordon, A S', 'Camiscoli, J F', 'Gizzi, C', 'Fredrickson, T N']","['Derelanko MJ', 'LoBue J', 'Gordon AS', 'Camiscoli JF', 'Gizzi C', 'Fredrickson TN']",['eng'],['Journal Article'],Netherlands,Exp Hematol,Experimental hematology,0402313,IM,"['Anemia/blood', 'Animals', 'Ascitic Fluid/analysis', 'Erythropoietin/analysis/*blood', 'Leukemia, Experimental/blood', 'Leukemia, Myeloid/*blood', 'Male', 'Rats']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Exp Hematol. 1978 Jan;6(1):91-5.,['11096-26-7 (Erythropoietin)'],Erythropoietin (Ep) levels were measured in Shay chloroleukemic rats at various stages of anemia. Serum Ep was shown to increase logarithmically as the anemia became more severe. This increase in Ep levels was similar to that observed in normal rats subjected to acute blood loss. Significant levels of Ep were also demonstrated in ascitic fluid extracted from the peritoneal cavity of leukemic rats. These results indicate that the anemia of this disease is not due to a diminished production of Ep.,,,,,
272285,NLM,MEDLINE,19780417,20071115,0012-0472 (Print) 0012-0472 (Linking),103,4,1978 Jan 27,[Therapy of acute leukemia in the adult].,144-7,"['Hirschmann, W D']",['Hirschmann WD'],['ger'],['Journal Article'],Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Acute Disease', 'Age Factors', 'Antineoplastic Agents/therapeutic use', 'Humans', 'Leukemia/drug therapy/*therapy', 'Leukemia, Lymphoid/complications', 'Meningeal Neoplasms/complications', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1978/01/27 00:00,1978/01/27 00:01,['1978/01/27 00:00'],"['1978/01/27 00:00 [pubmed]', '1978/01/27 00:01 [medline]', '1978/01/27 00:00 [entrez]']",['10.1055/s-0028-1104396 [doi]'],ppublish,Dtsch Med Wochenschr. 1978 Jan 27;103(4):144-7. doi: 10.1055/s-0028-1104396.,['0 (Antineoplastic Agents)'],,Therapie der akuten Leukamie des Erwachsenen.,,,,
272284,NLM,MEDLINE,19780426,20071115,0012-0472 (Print) 0012-0472 (Linking),103,2,1978 Jan 13,[Indication for splenectomy in hematologic diseases. Current views].,50-2,"['Blume, K G', 'Lohr, G W', 'Arnold, H', 'Slanina, J', 'Schettler, J']","['Blume KG', 'Lohr GW', 'Arnold H', 'Slanina J', 'Schettler J']",['ger'],['Journal Article'],Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Anemia, Hemolytic, Autoimmune/surgery', 'Anemia, Hemolytic, Congenital Nonspherocytic/surgery', 'Gaucher Disease/surgery', 'Hematologic Diseases/*surgery', 'Hodgkin Disease/surgery', 'Humans', 'Leukemia, Hairy Cell/surgery', 'Leukemia, Lymphoid/surgery', 'Leukemia, Myeloid/surgery', 'Lymphoma/surgery', 'Purpura, Thrombocytopenic/surgery', 'Spherocytosis, Hereditary/surgery', '*Splenectomy']",1978/01/13 00:00,1978/01/13 00:01,['1978/01/13 00:00'],"['1978/01/13 00:00 [pubmed]', '1978/01/13 00:01 [medline]', '1978/01/13 00:00 [entrez]']",['10.1055/s-0028-1104380 [doi]'],ppublish,Dtsch Med Wochenschr. 1978 Jan 13;103(2):50-2. doi: 10.1055/s-0028-1104380.,,,Indikation der Splenektomie bei hamatologischen Erkrankungen. Neue Gesichtspunkte.,,,,
272266,NLM,MEDLINE,19780417,20190911,0011-2240 (Print) 0011-2240 (Linking),15,1,1978 Feb,E-rosette dormation of fresh versus frozen-thawed lymphocytes from leukemic patients and normal individuals.,67-72,"['Polizzi, G J', 'Cohen, E', 'Gregory, S G']","['Polizzi GJ', 'Cohen E', 'Gregory SG']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Cryobiology,Cryobiology,0006252,IM,"['*Freezing', 'Hodgkin Disease/immunology', 'Humans', 'Leukemia/*immunology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid, Acute/immunology', 'Lymphocytes/*immunology', '*Rosette Formation', 'Tissue Preservation']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']","['0011-2240(78)90008-1 [pii]', '10.1016/0011-2240(78)90008-1 [doi]']",ppublish,Cryobiology. 1978 Feb;15(1):67-72. doi: 10.1016/0011-2240(78)90008-1.,,,,,,,
272231,NLM,MEDLINE,19780426,20131121,0361-5960 (Print) 0361-5960 (Linking),62,1,1978 Jan,Levels of two plasma fucosyltransferases as an index of disease status in acute myelogenous leukemias.,147-9,"['Kessel, D', 'Khilanani, P', 'Chou, T H']","['Kessel D', 'Khilanani P', 'Chou TH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Acetylglucosamine', 'Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Galactose', 'Guanosine Diphosphate Fucose', 'Hexosyltransferases/*blood', 'Humans', 'Leukemia, Myeloid, Acute/*blood/drug therapy/pathology', 'Remission, Spontaneous']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1978 Jan;62(1):147-9.,"['0 (Antineoplastic Agents)', '15839-70-0 (Guanosine Diphosphate Fucose)', 'EC 2.4.1.- (Hexosyltransferases)', 'V956696549 (Acetylglucosamine)', 'X2RN3Q8DNE (Galactose)']",,,,,,
272230,NLM,MEDLINE,19780426,20131121,0361-5960 (Print) 0361-5960 (Linking),62,1,1978 Jan,N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies.,119-27,"['Parker, L M', 'Hirst, M', 'Israel, M']","['Parker LM', 'Hirst M', 'Israel M']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Animals', 'DNA, Neoplasm/biosynthesis', 'Doxorubicin/*analogs & derivatives/pharmacology/toxicity', 'Drug Resistance', 'Leukemia L1210/*drug therapy/metabolism', 'Mice', 'Mice, Inbred Strains', 'Osteosarcoma/drug therapy', 'Polysorbates', 'Sarcoma, Experimental/*drug therapy']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1978 Jan;62(1):119-27.,"['0 (DNA, Neoplasm)', '0 (Polysorbates)', '80168379AG (Doxorubicin)']",,,,,,
272229,NLM,MEDLINE,19780426,20141120,0008-5472 (Print) 0008-5472 (Linking),38,3,1978 Mar,Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells.,835-40,"['Terada, M', 'Nudel, U', 'Fibach, E', 'Rifkind, R A', 'Marks, P A']","['Terada M', 'Nudel U', 'Fibach E', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Alkalies/pharmacology', 'Animals', 'Cells, Cultured', 'Centrifugation, Density Gradient', 'DNA, Neoplasm/*metabolism/radiation effects', 'DNA, Single-Stranded/metabolism', 'Dimethyl Sulfoxide/*pharmacology', 'Erythropoiesis/*drug effects/radiation effects', 'In Vitro Techniques', 'Leukemia, Erythroblastic, Acute/physiopathology', 'Leukemia, Experimental/*physiopathology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Mar;38(3):835-40.,"['0 (Alkalies)', '0 (DNA, Neoplasm)', '0 (DNA, Single-Stranded)', 'YOW8V9698H (Dimethyl Sulfoxide)']","The Friend virus-infected murine erythroleukemia cell can be induced to differentiate along erythroid cells in culture with various compounds, including dimethyl sulfoxide. DNA from murine erythroleukemia cells cultured with dimethyl sulfoxide shows a decrease in sedimentation rate in alkaline sucrose gradients after alkali lysis of the cells. These changes can be detected as early as 27 hr after the beginning of culture. Similar results are observed with DNA of the cells cultured with other inducers, butyric acid and dimethylacetamide, but not with DNA from a variant cell line resistant to induction with dimethyl sulfoxide. Ultraviolet irradiation, which is known to cause similar changes in the sedimentation rate of DNA in alkaline sucrose gradients, induces differentiation of the murine erythroleukemia cells. These studies suggest that alterations in DNA may be related to events involved in the induction of differentiation of murine erythroleukemia cells by dimethyl sulfoxide.",,,,,
272228,NLM,MEDLINE,19780426,20201209,0008-5472 (Print) 0008-5472 (Linking),38,3,1978 Mar,"Clinical, biological, and biochemical effect of pyrazofurin.",682-8,"['Cadman, E C', 'Dix, D E', 'Handschumacher, R E']","['Cadman EC', 'Dix DE', 'Handschumacher RE']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adolescent', 'Adult', 'Aged', 'Amides', 'Animals', 'Carcinoma 256, Walker/drug therapy/metabolism', 'Cell Division/drug effects', 'Cell Line', 'Female', 'Humans', 'In Vitro Techniques', 'Leukemia, Experimental/drug therapy/metabolism', 'Leukemia, Myeloid, Acute/drug therapy', 'Male', 'Mice', 'Middle Aged', 'Mouth Mucosa/drug effects', 'Neoplasms/*drug therapy', 'Orotic Acid/metabolism', 'Pyrazoles', 'Pyrimidine Nucleotides/metabolism', 'Ribonucleosides/metabolism/*pharmacology', 'Ribose', 'Uridine/pharmacology']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Mar;38(3):682-8.,"['0 (Amides)', '0 (Pyrazoles)', '0 (Pyrimidine Nucleotides)', '0 (Ribonucleosides)', '4B15044GQZ (pyrazofurin)', '61H4T033E5 (Orotic Acid)', '681HV46001 (Ribose)', 'WHI7HQ7H85 (Uridine)']",,,,,,
272227,NLM,MEDLINE,19780426,20061115,0008-5472 (Print) 0008-5472 (Linking),38,3,1978 Mar,Isolation of novel glycoprotein HNC1beta from the urine of a patient with acute monocytic leukemia.,602-7,"['Rudman, D', 'Chawla, R K', 'Nixon, D W', 'Roler, J H', 'Shah, V R']","['Rudman D', 'Chawla RK', 'Nixon DW', 'Roler JH', 'Shah VR']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Amino Acids/analysis', 'Carbohydrates/analysis', 'Female', 'Glycoproteins/blood/*urine', 'Humans', 'Leukemia, Monocytic, Acute/*urine', 'Male', 'Middle Aged', 'Molecular Weight', 'Neoplasm Proteins/blood/*urine', 'Neoplasms/blood/urine', 'Radioimmunoassay']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Mar;38(3):602-7.,"['0 (Amino Acids)', '0 (Carbohydrates)', '0 (Glycoproteins)', '0 (Neoplasm Proteins)']",,,,,,
272225,NLM,MEDLINE,19780426,20190619,0008-543X (Print) 0008-543X (Linking),41,1,1978 Jan,Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML.,153-63,"['Sonta, S', 'Sandberg, A A']","['Sonta S', 'Sandberg AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Aged', '*Chromosome Aberrations', 'Chromosomes, Human, 16-18', 'Chromosomes, Human, 19-20', '*Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/*genetics', 'Leukemia, Myeloid, Acute/genetics', 'Male', 'Middle Aged', 'Polyploidy', 'Prognosis', 'Translocation, Genetic']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/1097-0142(197801)41:1<153::aid-cncr2820410124>3.0.co;2-d [doi]'],ppublish,Cancer. 1978 Jan;41(1):153-63. doi: 10.1002/1097-0142(197801)41:1<153::aid-cncr2820410124>3.0.co;2-d.,,"Fifty-seven Ph1-positive cases of chronic myelocytic leukemia (CML) were analyzed with chromosomal banding techniques and their karyotypic progression followed. These cases included 1 without evidence of a Ph1-translocation and 1 new patient with a complex Ph1-translocation involving chromosomes No. 9, No. 17 and No. 22. Of the 57 patients, 28 had the Ph1 as the only karyotypic anomaly, whereas the remaining 29 cases developed and/or were associated with chromosomal changes usually of a hyperdiploid nature, particularly in the blastic phase, in addition to the Ph1. Even though the additional karyotypic changes frequently included chromosomes No. 8, No. 17, No. 19 and No. 21, a large number of others was also involved, although less often. The series included 3 cases with different types of translocations unrelated to the Ph1. The cytogenetic observations have been correlated with some of the clinical parameters. The survival of the patients was evaluated in relation to the karyotypic findings, indicating that the chromosomal changes may not play as important a role in the prognostic and progressive aspects of Ph1-positive CML as that of other as yet undetermined factors.",,,,,
272224,NLM,MEDLINE,19780426,20190619,0008-543X (Print) 0008-543X (Linking),41,1,1978 Jan,Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation.,108-11,"['MacLennan, I C', 'Kay, H E']","['MacLennan IC', 'Kay HE']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Brain/*radiation effects', 'Child', 'Dose-Response Relationship, Radiation', 'Female', 'Humans', 'Immunity/*radiation effects', 'Leukemia, Lymphoid/blood/immunology/*radiotherapy', 'Lymphopenia/*etiology', 'Male', 'Radiation Injuries/*etiology', 'Radiotherapy Dosage']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/1097-0142(197801)41:1<108::aid-cncr2820410116>3.0.co;2-z [doi]'],ppublish,Cancer. 1978 Jan;41(1):108-11. doi: 10.1002/1097-0142(197801)41:1<108::aid-cncr2820410116>3.0.co;2-z.,,The degree of long term lymphopenia induced by cranial irradiation is shown to be dependent upon the number of fractions into which the standard cranial dose of 2400 rads is divided. The mean lymphocyte count of patients three months after receiving this dose in five fractions was 1.84 X 10(9)/1; in twelve fractions it was 1.12 X 10(9)/1 and in twenty fractions it was 0.64 X 10(9)/1. An explanation for this finding is offered which is based upon marked radiosensitivity of certain lymphocytes and the pattern of recirculation and redistribution of these cells.,,,,,
272221,NLM,MEDLINE,19780417,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6109,1978 Feb 11,Testicular disease in acute lymphoblastic leukaemia in childhood. Report on behalf of the Medical Research Council's Working Party on leukaemia in childhood.,334-8,,,['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Cyclophosphamide/adverse effects', 'Humans', 'Infant', '*Leukemia, Lymphoid/drug therapy/radiotherapy', 'Leukocyte Count', 'Male', 'Neoplasm Metastasis', 'Prognosis', 'Remission, Spontaneous', '*Testicular Neoplasms', 'Thrombocytopenia/etiology']",1978/02/11 00:00,1978/02/11 00:01,['1978/02/11 00:00'],"['1978/02/11 00:00 [pubmed]', '1978/02/11 00:01 [medline]', '1978/02/11 00:00 [entrez]']",['10.1136/bmj.1.6109.334 [doi]'],ppublish,Br Med J. 1978 Feb 11;1(6109):334-8. doi: 10.1136/bmj.1.6109.334.,['8N3DW7272P (Cyclophosphamide)'],"In three trials conducted by the Medical Research Council on acute lymphoblastic leukaemia in childhood the incidence of testicular infiltration in relation to presenting features and treatment was analysed. Initial severe thrombocytopenia was associated with an increased incidence. Testicular infiltration was occasionally found during treatment in patients with high blood leucocyte counts at diagnosis but the main incidence in patients with all types of disease occurred within one year of stopping treatment. The incidence may be increased when ""second-line"" drugs, especially cyclophosphamide, have been used. A reappraisal of the value of additional drugs in maintenance treatment of patients with good prognosis is needed.",,PMC1602900,,,
272220,NLM,MEDLINE,19780417,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6109,1978 Feb 11,Giant-cell pneumonia caused by measles and methotrexate in childhood leukaemia in remission.,330-1,"['Lewis, M J', 'Cameron, A H', 'Shah, K J', 'Purdham, D R', 'Mann, J R']","['Lewis MJ', 'Cameron AH', 'Shah KJ', 'Purdham DR', 'Mann JR']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Measles/*complications/diagnosis', 'Methotrexate/*adverse effects', 'Pulmonary Fibrosis/*etiology', 'Remission, Spontaneous']",1978/02/11 00:00,1978/02/11 00:01,['1978/02/11 00:00'],"['1978/02/11 00:00 [pubmed]', '1978/02/11 00:01 [medline]', '1978/02/11 00:00 [entrez]']",['10.1136/bmj.1.6109.330 [doi]'],ppublish,Br Med J. 1978 Feb 11;1(6109):330-1. doi: 10.1136/bmj.1.6109.330.,['YL5FZ2Y5U1 (Methotrexate)'],"Four children who had acurate lymphoblastic leukaemia in remission and developed pneumonia were studied. Investigations including electron microscopy and immunofluorescence of lung biopsy material disclosed measles, although there was no clinical evidence of the disease. Despite an identical presentation, two types of illness developed: two children died of giant-cell pneumonia, while the other two developed pneumonia indistinguishable from that associated with methotrexate treatment, recovering when treated with steroids and gammaglobulin. Measles infection is easily overlooked in the absence of rash. The diagnosis may be suggested by clinical and radiological features and confirmed by specific immunofluorescence staining of lung biopsy tissue.",,PMC1602853,,,
272219,NLM,MEDLINE,19780417,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6109,1978 Feb 11,The price of survival in childhood leukaemia.,321-2,,,['eng'],['Editorial'],England,Br Med J,British medical journal,0372673,IM,"['Antineoplastic Agents/adverse effects', 'Child', 'Humans', 'Leukemia, Lymphoid/*therapy', 'Quality of Life', 'Radiotherapy/adverse effects']",1978/02/11 00:00,1978/02/11 00:01,['1978/02/11 00:00'],"['1978/02/11 00:00 [pubmed]', '1978/02/11 00:01 [medline]', '1978/02/11 00:00 [entrez]']",['10.1136/bmj.1.6109.321-a [doi]'],ppublish,Br Med J. 1978 Feb 11;1(6109):321-2. doi: 10.1136/bmj.1.6109.321-a.,['0 (Antineoplastic Agents)'],,,PMC1602920,,,
272208,NLM,MEDLINE,19780417,20190902,0006-5242 (Print) 0006-5242 (Linking),36,1,1978 Jan 20,Conversion of polycythemia vera to refractory anemia with hyperplastic bone marrow.,41-5,"['Mitrou, P S', 'Fischer, M', 'Krehan, L', 'Martin, H']","['Mitrou PS', 'Fischer M', 'Krehan L', 'Martin H']",['eng'],"['Case Reports', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Anemia, Aplastic/*etiology', 'Chronic Disease', 'Humans', 'Leukemia, Erythroblastic, Acute/*complications/mortality', 'Leukemia, Myeloid, Acute/etiology', 'Male', 'Middle Aged', 'Myeloproliferative Disorders/complications', 'Polycythemia Vera/*complications', 'Preleukemia/etiology', 'Prognosis', 'Syndrome', 'Terminology as Topic']",1978/01/20 00:00,1978/01/20 00:01,['1978/01/20 00:00'],"['1978/01/20 00:00 [pubmed]', '1978/01/20 00:01 [medline]', '1978/01/20 00:00 [entrez]']",['10.1007/BF01002119 [doi]'],ppublish,Blut. 1978 Jan 20;36(1):41-5. doi: 10.1007/BF01002119.,,"Clinical and morphologic findings in the conversion of treated polycythemia vera to pancytopenia with hyperplastic bone marrow (refractory anemia or pancytopenia with hyperplastic bone marrow) are described in light of our own observation. The nomenclature associated with this condition (pancytopenia, chronic erythroleukemia, preleukemia) is not uniform, whereas the morphologic findings are virtually identical. Some patients subsequently develop acute leukemia. The prognosis in cases of refractory anemia with hyperplastic bone marrow following polycythemia vera is, independent of the subsequent acute leukemia, invariably terminal.",,,,,
272207,NLM,MEDLINE,19780417,20210216,0006-4971 (Print) 0006-4971 (Linking),51,3,1978 Mar,Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results.,425-33,"['Sallan, S E', 'Cammita, B M', 'Cassady, J R', 'Nathan, D G', 'Frei, E 3rd']","['Sallan SE', 'Cammita BM', 'Cassady JR', 'Nathan DG', 'Frei E 3rd']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adolescent', 'Adult', 'Asparaginase/adverse effects', 'Bacterial Infections/etiology', 'Central Nervous System Diseases/etiology', 'Child', 'Child, Preschool', 'Doxorubicin/adverse effects/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Leukocyte Count', 'Male', 'Prednisone/adverse effects', 'Remission, Spontaneous', 'Time Factors', 'Vincristine/adverse effects']",1978/03/01 00:00,1978/03/01 00:01,['1978/03/01 00:00'],"['1978/03/01 00:00 [pubmed]', '1978/03/01 00:01 [medline]', '1978/03/01 00:00 [entrez]']",['S0006-4971(20)72696-0 [pii]'],ppublish,Blood. 1978 Mar;51(3):425-33.,"['5J49Q6B70F (Vincristine)', '80168379AG (Doxorubicin)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)']","One hundred thirty-seven children with previously untreated acute lymphoblastic leukemia were entered into a new program that included intermittent combination chemotherapy featuring Adriamycin. Remission induction was initially randomized to vincristine and prednisone with or without an anthracycline. All children received asparaginase consolidation and central nervous system prophylaxis with cranial irradiation and intrathecal methotrexate. There were no primary failures of CNS prophylaxis. Complications were primarily infectious. Clinical evidence of cardiotoxicity and leukoencephalopathy were not observed. The time to enter complete remission and the presence of an anterior mediastinal mass at diagnosis were found to be statistically significant adverse prognostic factors, whereas presenting age and white blood count were not. With a median follow-up of 26 mo, and using life plot analysis, 65% of the children have remianed in continuous complete remission.",,,,,
272206,NLM,MEDLINE,19780417,20071115,0306-042X (Print) 0306-042X (Linking),5,1,1978 Jan,Monitoring normal and malignant human white blood cells by the use of linear programmed thermal degradation mass spectrometry.,47-51,"['Yergey, A L', 'Risby, T H', 'Golomb, H M']","['Yergey AL', 'Risby TH', 'Golomb HM']",['eng'],['Journal Article'],England,Biomed Mass Spectrom,Biomedical mass spectrometry,0430246,IM,"['Computers', 'Granulocytes/*analysis', 'Humans', 'Ions/analysis', 'Leukemia/analysis/*blood', 'Leukemia, Hairy Cell/blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid, Acute/blood', 'Leukocytes/*analysis', 'Lymphocytes/*analysis', 'Mass Spectrometry']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1002/bms.1200050110 [doi]'],ppublish,Biomed Mass Spectrom. 1978 Jan;5(1):47-51. doi: 10.1002/bms.1200050110.,['0 (Ions)'],A new methodology has been applied to the analysis of human white blood cells obtained both from donors with normal white cells and from donors having one of several cytologically identified leukemias. The analytical process makes use of evolution patterns of molecular fragments generated during the well controlled degradation of the cells. The process has been shown to be effective both in grouping together malignant cells that originate from the same diseases and in distinguishing between malignant cells originating from different diseases. The reproducibility of the method has been demonstrated.,,,,,
272205,NLM,MEDLINE,19780426,20071115,0300-0893 (Print) 0300-0893 (Linking),27,9-10,1977 Dec,Serum enzymes profile in human acute myeloblastic leukaemia: preliminary results.,324-6,"['Baudon, D', 'Roda, L', 'Fiere, D']","['Baudon D', 'Roda L', 'Fiere D']",['eng'],['Journal Article'],France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Humans', 'Leukemia, Myeloid, Acute/*enzymology']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Dec;27(9-10):324-6.,,Serum enzymatic activities in 18 human acute myeloblastic leukaemias were tested using a semiquantitative micromethod: the activities of 5 enzymes were observed to be changed.,,,,,
272204,NLM,MEDLINE,19780417,20190609,0006-3002 (Print) 0006-3002 (Linking),517,1,1978 Jan 26,Terminal deoxyribonucleotidyl transferase from acute lymphoblastic leukemia cells and production of antisera.,150-7,"['Siddiqui, F A', 'Srivastava, B I']","['Siddiqui FA', 'Srivastava BI']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Biochim Biophys Acta,Biochimica et biophysica acta,0217513,IM,"['Cross Reactions', 'DNA Nucleotidyltransferases/*blood/immunology/isolation & purification', 'Humans', 'Leukemia, Lymphoid/*enzymology', 'Lymphocytes/*enzymology', 'Molecular Weight', 'Species Specificity']",1978/01/26 00:00,1978/01/26 00:01,['1978/01/26 00:00'],"['1978/01/26 00:00 [pubmed]', '1978/01/26 00:01 [medline]', '1978/01/26 00:00 [entrez]']","['0005-2787(78)90042-4 [pii]', '10.1016/0005-2787(78)90042-4 [doi]']",ppublish,Biochim Biophys Acta. 1978 Jan 26;517(1):150-7. doi: 10.1016/0005-2787(78)90042-4.,['EC 2.7.7.- (DNA Nucleotidyltransferases)'],,,,,,
272203,NLM,MEDLINE,19780417,20190704,0007-1048 (Print) 0007-1048 (Linking),37,4,1977 Dec,The significance of the Philadelphia chromosome in acute lymphoblastic leukaemia: a report of two cases.,447-53,"['Gibbs, T J', 'Wheeler, M V', 'Bellingham, A J', 'Walker, S']","['Gibbs TJ', 'Wheeler MV', 'Bellingham AJ', 'Walker S']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adult', 'Bone Marrow/ultrastructure', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Lymphoid/complications/genetics/*ultrastructure', 'Leukemia, Myeloid/complications', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb01017.x [doi]'],ppublish,Br J Haematol. 1977 Dec;37(4):447-53. doi: 10.1111/j.1365-2141.1977.tb01017.x.,,"Two cases of Philadelphia chromosome (Ph1) positive acute lymphoblastic leukaemia are reported, both of which lost the Philadelphia chromosome during remission. In one patient remission of the acute lymphoblastic leukaemia continued but classical Ph1 positive chronic granulocytic leukaemia developed. In the other patient relapse of the acute lymphoblastic leukaemia occurred associated with the return of the Ph1 chromosome. The evidence suggests that the chromosome aberration occurred in a pluripotential stem cell, which in one case proliferated along both a lymphoid cell line and a myeloid cell line. Both cases responded well to conventional therapy for acute lymphoblastic leukaemia.",,,,,
272122,NLM,MEDLINE,19780321,20171116,0002-9440 (Print) 0002-9440 (Linking),90,2,1978 Feb,Therapeutic considerations in acute lymphocytic leukemia.,521-8,"['Holland, J F']",['Holland JF'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Pathol,The American journal of pathology,0370502,IM,"['Antineoplastic Agents/*therapeutic use', 'Child', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Follow-Up Studies', 'Humans', 'Leukemia, Lymphoid/*drug therapy/mortality', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use', 'Recurrence', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,Am J Pathol. 1978 Feb;90(2):521-8.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","Evidence that the first human neoplasm systematically explored with chemotherapeutic treatments has apparently been cured in a palpable segment of affected patients evokes optimism for other types of cancer. The application of similar effort, similar logic, and quantitative experimental therapeutic approaches to the common cancers augurs well for cancer research and clinical medicine.",,PMC2018157,,,
272121,NLM,MEDLINE,19780321,20190819,0361-8609 (Print) 0361-8609 (Linking),3,,1977,"The value of reverse banding in detecting bone marrow chromosomal abnormalities: translocation between chromosomes 1, 9, and 22 in a case of chronic myelogenous leukemia (CML).",171-5,"['Verma, R S', 'Dosik, H']","['Verma RS', 'Dosik H']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Hematol,American journal of hematology,7610369,IM,"['Acridines', 'Aged', 'Bone Marrow/*pathology', 'Chromosome Aberrations/*complications', 'Chromosome Disorders', '*Chromosomes, Human, 1-3', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Humans', 'Karyotyping/methods', 'Leukemia, Myeloid/*complications', 'Male']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/ajh.2830030208 [doi]'],ppublish,Am J Hematol. 1977;3:171-5. doi: 10.1002/ajh.2830030208.,['0 (Acridines)'],"A case of chronic myelogenous leukemia (CML) with complex chromosomal abnormalities is reported. Conventional staining techniques indicated incorrectly that the Ph1 chromosome was not present. These studies showed a 46,XY,-1,+C karyotype in all bone marrow cells. Employing RFA (R bands by fluorescence using acridine orange) technique it was clear that the part of the long arm of chromosome 1 (1q23 leads to qter) was missing the tip of the long arm chromosome 22 (band q22) was translocated to it. The missing long arm of chromosome 1 was translocated to the long arm of chromosome 9. Furthermore, there was a break at band 9q22 and the whole terminal part was lost. The value of RFA technique is discussed.",,,,,
272120,NLM,MEDLINE,19780321,20190819,0361-8609 (Print) 0361-8609 (Linking),3,,1977,Chromosomes and causation of human cancer and leukemia: XXVIII. Value of detailed chromosome studies on large numbers of cells in CML.,121-6,"['Sonta, S I', 'Sandberg, A A']","['Sonta SI', 'Sandberg AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Hematol,American journal of hematology,7610369,IM,"['Blood Cell Count', 'Bone Marrow Cells', 'Cell Count', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid/*genetics', 'Leukemia, Myeloid, Acute/genetics', 'Metaphase', 'Spleen/cytology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/ajh.2830030202 [doi]'],ppublish,Am J Hematol. 1977;3:121-6. doi: 10.1002/ajh.2830030202.,,"Comparison of the chromosome findings obtained on routine examination (10-50 cells) of the marrows from patients with Ph1-positive CML with those based on a large number (110-500 cells) of metaphases in six of these patients, in whom appropriate material was available, revealed the presence of small percentages of aneuploid cells in the marrow during the chronic phase of the disease and not seen with the routine procedure. These aneuploid cells may ultimately constitute the dominant clone during the blastic phase of the chronic myelocytic leukemia (CML). Furthermore, karyotypically abnormal cells, in addition those observed on routine study, were detected in the blastic phase when a large number of cells was examined. The value and implications of these observations are discussed.",,,,,
272119,NLM,MEDLINE,19780310,20211203,0002-9173 (Print) 0002-9173 (Linking),68,6,1977 Dec,Trichinosis in an immunosuppressed human host.,791-4,"['Jacobson, E S', 'Jacobson, H G']","['Jacobson ES', 'Jacobson HG']",['eng'],"['Case Reports', 'Journal Article']",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Female', 'Humans', 'Immunosuppression Therapy/*adverse effects', 'Leukemia, Myeloid, Acute/complications/*parasitology/therapy', 'Middle Aged', 'Muscles/parasitology', 'Trichinellosis/*etiology/immunology/pathology']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1093/ajcp/68.6.791 [doi]'],ppublish,Am J Clin Pathol. 1977 Dec;68(6):791-4. doi: 10.1093/ajcp/68.6.791.,,"The clinical presentation and autopsy findings in the case of a patient with acute myelomonocytic leukemia and trichinosis are described. Cellular immunity is an important host defense against nematode infections such as strongyloidiasis. It is therefore probable that the severe trichinosis seen in this immunosuppressed patient was more than coincidental. Due to concomitant failure of humoral immunity, serodiagnosis of trichinosis would have been impossible. The only means of making the diagnosis antemortem would have been muscle biopsy.",,,,,
272084,NLM,MEDLINE,19780321,20190823,0364-2313 (Print) 0364-2313 (Linking),1,5,1977 Sep,Levamisole as an immunotherapeutic agent in the treatment of cancer.,597-604,"['Amery, W K']",['Amery WK'],['eng'],['Journal Article'],United States,World J Surg,World journal of surgery,7704052,IM,"['Animals', 'Breast Neoplasms/drug therapy', 'Cricetinae', 'Female', 'Humans', 'Immunotherapy/methods', 'Leukemia, Myeloid/drug therapy', 'Levamisole/immunology/*therapeutic use', 'Lung Neoplasms/drug therapy', 'Mice', 'Neoplasms/*drug therapy', 'Neoplasms, Experimental/drug therapy', 'Rats']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1007/BF01556185 [doi]'],ppublish,World J Surg. 1977 Sep;1(5):597-604. doi: 10.1007/BF01556185.,['2880D3468G (Levamisole)'],,,,,,
272083,NLM,MEDLINE,19780321,20200304,0364-2313 (Print) 0364-2313 (Linking),1,5,1977 Sep,Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.,555-83,"['Schwarz, M A', 'Gutterman, J U', 'Hersh, E M', 'Richman, S P', 'Mavligit, G M']","['Schwarz MA', 'Gutterman JU', 'Hersh EM', 'Richman SP', 'Mavligit GM']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,World J Surg,World journal of surgery,7704052,IM,"['Animals', 'BCG Vaccine/adverse effects/*therapeutic use', 'Breast Neoplasms/therapy', 'Child', 'Colonic Neoplasms/therapy', 'Female', 'Guinea Pigs', 'Humans', 'Immunotherapy/methods', 'Leukemia, Lymphoid/therapy', 'Leukemia, Myeloid, Acute/therapy', 'Lymphoma/therapy', 'Melanoma/therapy', 'Mycobacterium/immunology', 'Neoplasms/prevention & control/*therapy', 'Rats', 'Skin Neoplasms/therapy']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1007/BF01556181 [doi]'],ppublish,World J Surg. 1977 Sep;1(5):555-83. doi: 10.1007/BF01556181.,['0 (BCG Vaccine)'],,,,,,
272082,NLM,MEDLINE,19780321,20131121,0043-3284 (Print) 0043-3284 (Linking),74,2,1978 Feb,Acute monocytic leukemia on stage IV neuroblastoma following radiation and cyclophosphamide therapy.,35-8,"['West, W O']",['West WO'],['eng'],"['Case Reports', 'Journal Article']",United States,W V Med J,The West Virginia medical journal,0413777,IM,"['Cyclophosphamide/*therapeutic use', 'Humans', 'Leukemia, Monocytic, Acute/*complications', 'Male', 'Middle Aged', 'Neuroblastoma/*complications/drug therapy/radiotherapy', 'Nose Neoplasms/*complications/drug therapy', 'Spinal Neoplasms/complications']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",,ppublish,W V Med J. 1978 Feb;74(2):35-8.,['8N3DW7272P (Cyclophosphamide)'],,,,,,
272066,NLM,MEDLINE,19780310,20041117,0036-4355 (Print) 0036-4355 (Linking),22,6,1977,[Cellular lymphoid involvement in the blastic metamorphosis of various chronic myeloid leukemias].,994-1000,"['Sanchez Fayos, J', 'Outeirino, J']","['Sanchez Fayos J', 'Outeirino J']",['spa'],['Journal Article'],Spain,Sangre (Barc),Sangre,0404373,IM,"['Cell Transformation, Neoplastic', 'Cytogenetics', 'Humans', 'Leukemia, Myeloid/*pathology', 'Lymphocytes/*pathology', 'Mitosis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(6):994-1000.,,,El compromiso celular linfoide en la metamorfosis blastica de algunas leucemias mieloides cronicas.,,,,
272065,NLM,MEDLINE,19780310,20071115,0036-4355 (Print) 0036-4355 (Linking),22,6,1977,[Two cell populations in acute myelogenous leukaemia. Their analysis by culture in liquid medium (author's transl)].,976-85,"['Odriozola, J', 'Acebedo, G']","['Odriozola J', 'Acebedo G']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Bone Marrow Examination', 'Cell Count', '*Cell Differentiation', 'Cell Line', 'Cell Transformation, Neoplastic', 'Cells, Cultured', 'Cytodiagnosis', 'Humans', 'Leukemia, Myeloid, Acute/*diagnosis', 'Macrophages/cytology', 'Mitosis', 'Monocytes/cytology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(6):976-85.,,,Dos poblaciones celulares en las leucemias mieloides agudas Su analisis por medio de cultivos en medio liquido.,,,,
272064,NLM,MEDLINE,19780310,20131121,0036-4355 (Print) 0036-4355 (Linking),22,6,1977,[Bone-marrow and leukaemic cells preservation at temperatures below 0 degrees Celsius (author's transl)].,1030-4,"['Sanchis-Bayarri Vaillant, V', 'Gomez Llopis, J']","['Sanchis-Bayarri Vaillant V', 'Gomez Llopis J']",['spa'],"['English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Adult', '*Bone Marrow Cells', 'Cells, Cultured', 'Dimethyl Sulfoxide', 'Female', 'Humans', 'Leukemia, Myeloid', 'Male', 'Refrigeration/*methods', 'Temperature', 'Tissue Preservation']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(6):1030-4.,['YOW8V9698H (Dimethyl Sulfoxide)'],,Preservacion de celulas de medula osea y celulas leucemicas a temperaturas inferiores a 0 degrees.,,,,
272006,NLM,MEDLINE,19780310,20190902,0080-0015 (Print) 0080-0015 (Linking),,62,1977,Androgens and long-term complete remission in acute granulopoietic leukemias.,95-103,"['Hollard, D', 'Berthier, R', 'Sotto, J J']","['Hollard D', 'Berthier R', 'Sotto JJ']",['eng'],['Journal Article'],Germany,Recent Results Cancer Res,Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,0044671,IM,"['Adolescent', 'Adult', 'Aged', 'Androgens/administration & dosage/pharmacology/*therapeutic use', 'Bone Marrow/pathology', 'Cell Cycle', 'Cell Transformation, Neoplastic', 'Female', 'Hematopoiesis/drug effects', 'Humans', 'Leukemia, Myeloid, Acute/blood/*drug therapy/pathology', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-3-642-81174-6_14 [doi]'],ppublish,Recent Results Cancer Res. 1977;(62):95-103. doi: 10.1007/978-3-642-81174-6_14.,['0 (Androgens)'],,,,,,
272005,NLM,MEDLINE,19780321,20161201,0080-6234 (Print) 0080-6234 (Linking),11,3,1977 Dec,[Relations between nursing students and hospitalized children: analysis of 2 experiences].,221-60,"['Moraes, E', 'Martins, D M', 'Zanon, N', 'Angelo, M']","['Moraes E', 'Martins DM', 'Zanon N', 'Angelo M']",['por'],"['English Abstract', 'Journal Article']",Brazil,Rev Esc Enferm USP,Revista da Escola de Enfermagem da U S P,0242726,,"['Child', '*Child, Hospitalized', 'Humans', 'Leg Injuries/nursing', 'Leukemia, Lymphoid/nursing', 'Male', '*Nurse-Patient Relations', 'Patient Care Planning', 'Pediatric Nursing/*education', '*Students, Nursing']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Rev Esc Enferm USP. 1977 Dec;11(3):221-60.,,,Relacionamento entre estudantes de enfermagem e criancas hospitalizadas: analise de duas experiencias.,,,,
271998,NLM,MEDLINE,19780321,20190501,0027-8424 (Print) 0027-8424 (Linking),74,12,1977 Dec,Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17.,5729-33,"['Rowley, J D']",['Rowley JD'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Chromosome Aberrations/*genetics', 'Chromosome Deletion', 'Chromosome Disorders', 'Chromosome Mapping', '*Chromosomes, Human, 1-3', '*Chromosomes, Human, 16-18', 'Humans', 'Leukemia/*genetics', 'Polycythemia Vera/*genetics', 'Primary Myelofibrosis/genetics', '*Trisomy']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1073/pnas.74.12.5729 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Dec;74(12):5729-33. doi: 10.1073/pnas.74.12.5729.,,"In clonal aberrations leading to an excess or partial excess of chromosome 1, trisomy for bands 1q25-1q32 was noted in the myeloid cells from all of 34 patients who had various disorders such as acute leukemia, polycythemia vera, and myelofibrosis. This was not the result of a particularly fragile site in that region of the chromosome because the break points in reciprocal translocations that involve it occurred almost exclusively in the short arm. Two consistent rearrangements that have been observed in chromosome 17 produced either duplication of the entire long arm or a translocation of the distal portion of the long arm to chromosome 15. The nonrandom chromosomal changes found in hematologic disorders can now be correlated with the gene loci on these chromosomes or chromosomal segments. Seventy-five genes related to various metabolic enzymes have been mapped; it may be significant that chromosomes carrying gene loci related to nucleic acid metabolism are more frequently involved in hematologic disorders (and other malignancies as well) than are gene loci related to intermediary or carbohydrate metabolism. Furthermore, the known virus-human chromosome associations are closely correlated with the chromosomes affected in hematologic disorders. If one of the effects of carcinogens (including viruses) is to activate genes that regulate host cell DNA synthesis, and if translocations or duplications of specific chromosomal segments produce the same effect, then either of these mechanisms might provide the affected cell with a proliferative advantage.",,PMC431867,,,
271980,NLM,MEDLINE,19780321,20190501,0027-8424 (Print) 0027-8424 (Linking),74,12,1977 Dec,Genetic dissection of the control of normal differentiation in myeloid leukemic cells.,5554-8,"['Lotem, J', 'Sachs, L']","['Lotem J', 'Sachs L']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', '*Cell Differentiation', 'Cell Line', 'Complement C3/metabolism', 'Granulocytes/cytology', 'Immunoglobulin Fc Fragments/metabolism', 'Immunologic Capping', 'Leukemia, Experimental/genetics/pathology', 'Leukemia, Myeloid/genetics/*pathology', 'Macrophages/cytology', 'Muramidase/metabolism', 'Phagocytosis', 'Rosette Formation']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1073/pnas.74.12.5554 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Dec;74(12):5554-8. doi: 10.1073/pnas.74.12.5554.,"['0 (Complement C3)', '0 (Immunoglobulin Fc Fragments)', 'EC 3.2.1.17 (Muramidase)']","Normal myeloid precursors and MGI(+)D(+) myeloid leukemic cells can be induced to differentiate to mature cells by the normal protein inducer MGI. The sequence of differentiation is the induction of C3 and Fc rosettes, C3 and Fc immune phagocytosis (IP), synthesis and secretion of lysozyme, and formation of mature macrophages and granulocytes. Mutant clones of myeloid leukemic cells have been isolated with differences in the time of induction of C3 and Fc rosettes and C3 and Fc IP, in which lysozyme was induced without going through the stage of Fc or C3 IP, and with differences in inducibility by MGI to mature macrophages or granulocytes. Only one out of five MGI(-)D(-) clones gave rise to MGI(+)D(+) mutants. The ability to obtain mutants from this clone was associated with its special chromosome constitution, and these mutants showed a change in their ability for cap formation by concanavalin A. The steroid inducer dexamethasone can induce in MGI(+)D(+) clones differentiation to macrophages but not to granulocytes. Differentiation by steroid inducer in different clones occurred either with or without induction of Fc rosettes and Fc IP, and induction of C3 rosettes was not always associated with induction of C3 IP. The use of mutants that differ in their competence to be induced by MGI or steroid inducer has shown that there are separate controls for the induction of C3 and Fc rosettes, C3 and Fc IP, lysozyme, macrophages, and granulocytes.",,PMC431806,,,
271943,NLM,MEDLINE,19780310,20170306,,58,6,1977 Dec,[Leukemic cell cultures. 3. Observation of growth of populations with karyotypes with Ph' and without Ph'].,599-607,"['Rozynkowa, D', 'Stepien, J', 'Benesz, M']","['Rozynkowa D', 'Stepien J', 'Benesz M']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Arch Med Wewn,Polskie Archiwum Medycyny Wewnetrznej,0401225,IM,"['Cell Division', 'Cell Survival', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Clone Cells', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics/pathology', 'Time Factors']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Pol Arch Med Wewn. 1977 Dec;58(6):599-607.,,,Hodowle komorek bialaczkowych. III. Obserwacje wzrostu populacji o kariotypie z Ph' i bez Ph'.,,,,
271942,NLM,MEDLINE,19780310,20061115,,18,3,1977 May-Jun,Cytochemical study of the cell colonies from agar culture of normal bone marrow and of peripheral blood from patients with chronic myeloid leukemia.,563-71,"['Grande, M', 'Liso, V']","['Grande M', 'Liso V']",['eng'],['Journal Article'],France,Nouv Rev Fr Hematol Blood Cells,Nouvelle revue francaise d'hematologie; blood cells,7701899,IM,"['Agar', '*Bone Marrow Cells', 'Cells, Cultured/*analysis', 'Histocytochemistry', 'Humans', 'Leukemia, Myeloid/*blood', 'Naphthol AS D Esterase/metabolism', 'Periodic Acid-Schiff Reaction', 'Peroxidases/metabolism', 'Time Factors']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Nouv Rev Fr Hematol Blood Cells. 1977 May-Jun;18(3):563-71.,"['9002-18-0 (Agar)', 'EC 1.11.1.- (Peroxidases)', 'EC 3.1.- (Naphthol AS D Esterase)']",,,,,,
271938,NLM,MEDLINE,19780321,20080228,0377-2004 (Print) 0377-2004 (Linking),4,5-6,1977 Nov 15,Recent results in cancer research related to non-solid tumors in children.,121-4,"['Schuler, D']",['Schuler D'],['eng'],['Journal Article'],Austria,Osterr Z Onkol,Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,7507343,IM,"['Adolescent', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Humans', 'Infant', 'Leukemia/mortality/*therapy', 'Leukemia, Lymphoid/therapy', 'Leukemia, Myeloid, Acute/therapy', 'Prognosis', 'Radiotherapy Dosage', 'Research']",1977/11/15 00:00,1977/11/15 00:01,['1977/11/15 00:00'],"['1977/11/15 00:00 [pubmed]', '1977/11/15 00:01 [medline]', '1977/11/15 00:00 [entrez]']",,ppublish,Osterr Z Onkol. 1977 Nov 15;4(5-6):121-4.,['0 (Antineoplastic Agents)'],"The frequency of acute leukaemia, and the recent results of therapy are described. The requirements to achieve these relatively good results (early and exact diagnosis, intensive therapy, prophylaxis and treatment of side effects, mental and physical rehabilitation) are also discussed.",,,,,
271937,NLM,MEDLINE,19780321,20151119,0377-2004 (Print) 0377-2004 (Linking),4,4,1977 Dec 19,Treatment of acute non-lymphoid leukemias: comparison of two protocols.,80-2,"['Hauptmann, E', 'Stacher, A', 'Heinz, R', 'Jaksic, B']","['Hauptmann E', 'Stacher A', 'Heinz R', 'Jaksic B']",['eng'],"['Comparative Study', 'Journal Article']",Austria,Osterr Z Onkol,Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,7507343,IM,"['Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Erythroblastic, Acute/*drug therapy', 'Leukemia, Myeloid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Middle Aged', 'Prednisone/therapeutic use', 'Prognosis', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1977/12/19 00:00,1977/12/19 00:01,['1977/12/19 00:00'],"['1977/12/19 00:00 [pubmed]', '1977/12/19 00:01 [medline]', '1977/12/19 00:00 [entrez]']",,ppublish,Osterr Z Onkol. 1977 Dec 19;4(4):80-2.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'FTK8U1GZNX (Thioguanine)', 'VB0R961HZT (Prednisone)']","The results of treatment of 57 patients suffering from acute non-lymphoid leukemia by two protocols are compared. The more aggressive Coap protocol rendered a higher remission rate (57.1%), than the mild Guyer protocol where the remission rate has been 25%. The best results have been achieved in the former group in the younger population; in the latter group there has been no age-effect relationship. Although the remission rate differed in both protocols there has been no statistically significant difference in survival.",,,,,
271784,NLM,MEDLINE,19780321,20071115,0028-7628 (Print) 0028-7628 (Linking),77,14,1977 Dec,Myasthenia gravis: association with chronic lymphocytic leukemia.,2252-6,"['Vogel, J M', 'Kornfeld, P', 'Forte, F A', 'Jones, R A', 'Genkins, G', 'Papatestas, A E', 'Horowitz, S H']","['Vogel JM', 'Kornfeld P', 'Forte FA', 'Jones RA', 'Genkins G', 'Papatestas AE', 'Horowitz SH']",['eng'],"['Case Reports', 'Journal Article']",United States,N Y State J Med,New York state journal of medicine,0401064,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Middle Aged', 'Myasthenia Gravis/*complications']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,N Y State J Med. 1977 Dec;77(14):2252-6.,,,,,,,
271779,NLM,MEDLINE,19780321,20041117,0028-7628 (Print) 0028-7628 (Linking),77,14,1977 Dec,Thymic irradiation and chronic myelogenous leukemia.,2226-30,"['Shimaoka, K', 'Sokal, J E']","['Shimaoka K', 'Sokal JE']",['eng'],"['Case Reports', 'Journal Article']",United States,N Y State J Med,New York state journal of medicine,0401064,IM,"['Adult', 'Age Factors', 'Humans', 'Leukemia, Myeloid/*etiology', '*Leukemia, Radiation-Induced', 'Male', 'Radiotherapy/*adverse effects', 'Thymus Hyperplasia/*radiotherapy']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,N Y State J Med. 1977 Dec;77(14):2226-30.,,,,,,,
271776,NLM,MEDLINE,19780321,20071115,0026-4806 (Print) 0026-4806 (Linking),68,63,1977 Dec 29,"[Etiopathogenetical, clinical and therapeutic considerations on meningo-encephalic localizations in acute lymphatic leukemias: personal contribution].",4211-21,"['Quaglino, D', 'Piccinini, L', 'De Pasquale, A', 'Zanni, G', 'Zagni, G', 'Guerzoni, O']","['Quaglino D', 'Piccinini L', 'De Pasquale A', 'Zanni G', 'Zagni G', 'Guerzoni O']",['ita'],"['Case Reports', 'English Abstract', 'Journal Article']",Italy,Minerva Med,Minerva medica,0400732,IM,"['Adolescent', 'Adrenal Cortex Hormones/therapeutic use', 'Adult', 'Antineoplastic Agents/therapeutic use', 'Autopsy', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/diagnosis/drug therapy/*etiology', 'Male', 'Meningoencephalitis/*etiology']",1977/12/29 00:00,1977/12/29 00:01,['1977/12/29 00:00'],"['1977/12/29 00:00 [pubmed]', '1977/12/29 00:01 [medline]', '1977/12/29 00:00 [entrez]']",,ppublish,Minerva Med. 1977 Dec 29;68(63):4211-21.,"['0 (Adrenal Cortex Hormones)', '0 (Antineoplastic Agents)']","The aetiology, pathogenesis, clinical forms and therapeutic attempts carried out in connection with the central nervous system localizations in acute lymphoblastic leukaemia, on the basis of an extensive review of the literature and of personal experience are examined. The particular role which central nervous system leukaemia plays on the subsequent clinical course of the disease is stressed and the efforts made, both prophylactically and therapeutically, in order to decrease the incidence of this complication, which invariably has a deteriorating influence of the progress of the disease are described.","Considerazioni eziopatogenetiche, cliniche e terapeutiche sulle localizzazioni meningo-encefaliche nelle leucemie linfatiche acute: contributo personale.",,,,
271773,NLM,MEDLINE,19780321,20190514,0028-3878 (Print) 0028-3878 (Linking),28,2,1978 Feb,Neurologic complications of acute myelomonoblastic leukemia of four years' duration.,174-8,"['Ballard, J O', 'Towfighi, J', 'Brennan, R W', 'Saleem, S', 'Eyster, M E']","['Ballard JO', 'Towfighi J', 'Brennan RW', 'Saleem S', 'Eyster ME']",['eng'],"['Case Reports', 'Journal Article']",United States,Neurology,Neurology,0401060,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications/pathology/therapy', 'Meningeal Neoplasms/*etiology/pathology', 'Optic Nerve/pathology', 'Optic Neuritis/*etiology/pathology']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1212/wnl.28.2.174 [doi]'],ppublish,Neurology. 1978 Feb;28(2):174-8. doi: 10.1212/wnl.28.2.174.,,"An adult with acute nonlymphoblastic leukemia involving the central nervous system is presented. Unusual features included: (1) Focal signs and radiographic evidence of sagittal sinus occlusion early in the course of disease; (2) progressive meningeal, cranial nerve, and spinal nerve involvement despite a 4-year bone marrow remission; (3) intracerebral tumor formation, and (4) retrobulbar optic neuritis associated with microscopic findings of herpeslike viral particles. The incidence of clinically overt neurologic disease in adults with acute nonlymphoblastic leukemia seems to have increased in tandem with improved chemotherapy. The prophylactic treatment of the central nervous system during prolonged remission of adult acute nonlymphoblastic leukemia may prove of benefit to these patients.",,,,,
271772,NLM,MEDLINE,19780321,20131121,0028-2162 (Print) 0028-2162 (Linking),122,4,1978 Jan 28,[A patient with diffuse lung symptoms].,124-8,"['van Berkel, W', 'Haasbeek, F', 'Kuipers, F C']","['van Berkel W', 'Haasbeek F', 'Kuipers FC']",['dut'],"['Case Reports', 'Journal Article']",Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Adult', 'Antineoplastic Agents/*adverse effects/therapeutic use', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Lung/pathology', 'Methotrexate/adverse effects', 'Pulmonary Fibrosis/*chemically induced/pathology']",1978/01/28 00:00,1978/01/28 00:01,['1978/01/28 00:00'],"['1978/01/28 00:00 [pubmed]', '1978/01/28 00:01 [medline]', '1978/01/28 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1978 Jan 28;122(4):124-8.,"['0 (Antineoplastic Agents)', 'YL5FZ2Y5U1 (Methotrexate)']",,Een patiente met diffuse longafwijkingen.,,,,
271764,NLM,MEDLINE,19780329,20140729,,125,12,1977 Dec,[Correlation of the cytochemical classification of acute leukemia in children with the course of their disease (author's transl)].,959-65,"['Steilner, B', 'Pfister, S', 'Bomer, H', 'Drees, N', 'Sieron, G']","['Steilner B', 'Pfister S', 'Bomer H', 'Drees N', 'Sieron G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Acid Phosphatase/blood', 'Acute Disease', 'Child', 'Humans', 'Leukemia/*diagnosis/drug therapy/enzymology', 'Leukemia, Myeloid, Acute/diagnosis/drug therapy', 'Prognosis']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1977 Dec;125(12):959-65.,['EC 3.1.3.2 (Acid Phosphatase)'],"Acute leukemia in 93 children was cytochemically classified into three groups: 1. the PAS-Typ (acute undifferenciated leukemia) paramyeloblastic leukemia, 2. the AML, and 3. the Acid Phosphatase Typ (SP-Typ). Therapy for the first group differed from that for AML. The acid-Phosphatase-Typ was found in only a few cases, where the acid Phosphatase is good to see in the paranuclear region of the cell. These cases have a bad prognosis. It is proposed to publish even single cases of the acid Phosphatasetype leukemia in order to find the optimal therapy.",Zur Korrelation der zytochemischen Klassifizierung akuter kindlicher Leukamien mit deren klinischem Verlauf.,,,,
271763,NLM,MEDLINE,19780321,20071115,0026-4946 (Print) 0026-4946 (Linking),29,39,1977 Dec 15,[Prognostic indices of acute lymphoblastic leukemia in the child. Proposal for a prognostic classification and case contribution].,2347-56,,,['ita'],"['English Abstract', 'Journal Article']",Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Child', 'Child, Preschool', 'Hepatomegaly/etiology', 'Humans', 'Leukemia, Lymphoid/*classification/complications', 'Prognosis', 'Remission, Spontaneous', 'Splenomegaly/etiology', 'Time Factors']",1977/12/15 00:00,1977/12/15 00:01,['1977/12/15 00:00'],"['1977/12/15 00:00 [pubmed]', '1977/12/15 00:01 [medline]', '1977/12/15 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Dec 15;29(39):2347-56.,,,Gli indici prognostici della leucemia acuta linfoblastica del bambino. Proposta di una classificazione prognostica e contributo casistico.,,,,
271762,NLM,MEDLINE,19780321,20171116,0026-4946 (Print) 0026-4946 (Linking),29,37,1977 Nov 24,[Our experience with the treatment of juvenile acute leukemia].,2285-92,"['Amici, A', 'Romizi, S', 'De Benedictis, F M', 'Castellucci, G', 'Fracassini, F']","['Amici A', 'Romizi S', 'De Benedictis FM', 'Castellucci G', 'Fracassini F']",['ita'],['Journal Article'],Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Female', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1977/11/24 00:00,1977/11/24 00:01,['1977/11/24 00:00'],"['1977/11/24 00:00 [pubmed]', '1977/11/24 00:01 [medline]', '1977/11/24 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Nov 24;29(37):2285-92.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']",,La nostra esperienza nel trattamento della leucemia acuta dell'infanzia.,,,,
271761,NLM,MEDLINE,19780321,20131121,0026-4946 (Print) 0026-4946 (Linking),29,37,1977 Nov 24,[Prevention of leukemic meningitis within the framework of the therapy of juvenile acute lymphoblastic leukemia].,2279-83,"['Esposito, L', 'Di Tullio, M T']","['Esposito L', 'Di Tullio MT']",['ita'],['Journal Article'],Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Child', 'Child, Preschool', 'Humans', 'Injections, Spinal', 'Leukemia, Lymphoid/*complications', 'Meningitis/etiology/*prevention & control/radiotherapy', 'Methotrexate/*therapeutic use']",1977/11/24 00:00,1977/11/24 00:01,['1977/11/24 00:00'],"['1977/11/24 00:00 [pubmed]', '1977/11/24 00:01 [medline]', '1977/11/24 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Nov 24;29(37):2279-83.,['YL5FZ2Y5U1 (Methotrexate)'],,Sulla profilassi della meningosi leucemica nell'ambito della terapia della leucemia linfoblastica acuta nel bambino.,,,,
271760,NLM,MEDLINE,19780329,20171116,0026-4946 (Print) 0026-4946 (Linking),29,36,1977 Nov 17,[Evaluation of hepatic function during maintenance therapy of acute lymphoblastic leukemia remission in children].,2133-42,"['Mancini, A F', 'Rosito, P', 'Vecchi, V', 'Vivarelli, F', 'Faldella, G', 'De Luca, M']","['Mancini AF', 'Rosito P', 'Vecchi V', 'Vivarelli F', 'Faldella G', 'De Luca M']",['ita'],['Journal Article'],Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Chemical and Drug Induced Liver Injury/*diagnosis', 'Child', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Liver/*drug effects', 'Liver Function Tests', 'Mercaptopurine/*adverse effects/therapeutic use', 'Methotrexate/*adverse effects/therapeutic use', 'Remission, Spontaneous']",1977/11/17 00:00,1977/11/17 00:01,['1977/11/17 00:00'],"['1977/11/17 00:00 [pubmed]', '1977/11/17 00:01 [medline]', '1977/11/17 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Nov 17;29(36):2133-42.,"['E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']",,Valutazione della funzionalita epatica durante la terapia di mantenimento della remissione nella leucemia acuta linfoblastica del bambino.,,,,
271759,NLM,MEDLINE,19780321,20171116,0025-8458 (Print) 0025-8458 (Linking),73,1,1978 Jan 6,[Influence of remission induction therapy on the further outcome of acute lymphoblastic leukemia in children (author's transl)].,23-7,"['Ritter, J', 'Oehme, J', 'Miehe, G']","['Ritter J', 'Oehme J', 'Miehe G']",['ger'],['Journal Article'],Germany,Med Klin,Medizinische Klinik,0376637,IM,"['Brain Diseases/*prevention & control', 'Child', 'Cyclophosphamide/therapeutic use', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Life Expectancy', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Methylprednisolone/therapeutic use', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1978/01/06 00:00,2000/03/22 09:00,['1978/01/06 00:00'],"['1978/01/06 00:00 [pubmed]', '2000/03/22 09:00 [medline]', '1978/01/06 00:00 [entrez]']",,ppublish,Med Klin. 1978 Jan 6;73(1):23-7.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'X4W7ZR7023 (Methylprednisolone)', 'YL5FZ2Y5U1 (Methotrexate)']","An analysis of 66 children with ALL treated during the last 10 years shows an increase in medium survival time from 27.1 +/- 17.8 months to so far 39.3 +/- 15.1 months after the introduction of preventive CNS therapy. In the group with preventive CNS therapy both CNS relapses and hematological relapses are markedly reduced. Furthermore, in the group with preventive CNS therapy, patients initially treated with 3 drugs obviously survive longer than patients initially treated with only 2 drugs. Thus our study shows the importance of the quality of first remission for the further outcome of a patient with leukemia.",Einfluss der Erstbehandlung auf den Verlauf der akuten lymphatischen Leukamie (ALL) im Kindesalter.,,,,
271757,NLM,MEDLINE,19780321,20080214,0025-8342 (Print) 0025-8342 (Linking),36,8,1977 Aug,[Erythremia and secondary erythrocytosis].,47-9,"['Derbeneva, L I']",['Derbeneva LI'],['rus'],['Journal Article'],Russia (Federation),Med Sestra,Meditsinskaia sestra,18620490R,,"['Female', 'Humans', 'Leukemia, Erythroblastic, Acute/diagnosis', 'Male', 'Polycythemia/*diagnosis/etiology/therapy', 'Polycythemia Vera/*diagnosis/therapy', 'Thrombosis/diagnosis']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Med Sestra. 1977 Aug;36(8):47-9.,,,Eritremiia i vtorichnye eritrotsitozy.,,,,
271756,NLM,MEDLINE,19780321,20080214,0025-8342 (Print) 0025-8342 (Linking),36,8,1977 Aug,[Chronic myeloleukosis].,44-6,"['Markarian, V G']",['Markarian VG'],['rus'],['Journal Article'],Russia (Federation),Med Sestra,Meditsinskaia sestra,18620490R,,"['Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid/*diagnosis/drug therapy', 'Leukemia, Myeloid, Acute/diagnosis', 'Skin Manifestations']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Med Sestra. 1977 Aug;36(8):44-6.,,,Khronicheskii mieloleikoz.,,,,
271754,NLM,MEDLINE,19780321,20041117,0025-5246 (Print) 0025-5246 (Linking),9,4,1977 Oct-Dec,Pathogenetic and therapeutic problems in blastic exacerbation of chronic myeloid leukaemia.,348-54,"['Pawelski, S']",['Pawelski S'],['eng'],['Editorial'],Poland,Mater Med Pol,Materia medica Polona. Polish journal of medicine and pharmacy,0236526,IM,"['Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid/drug therapy/genetics/pathology/*therapy', 'Splenectomy']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Mater Med Pol. 1977 Oct-Dec;9(4):348-54.,,,,,,,
271753,NLM,MEDLINE,19780310,20071115,0300-8630 (Print) 0300-8630 (Linking),189,6,1977 Nov,[Acute hemorrhagic meningoencephalitis due to rubella-infection in acute lymphatic leukemia (author's transl)].,472-6,"['Korinthenberg, R', 'Breu, H', 'Palm, D', 'Jansen, P']","['Korinthenberg R', 'Breu H', 'Palm D', 'Jansen P']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Acute Disease', 'Antibodies, Viral/analysis', 'Child', 'Humans', 'Immunoglobulin G/analysis', 'Immunoglobulin M/analysis', 'Leukemia, Lymphoid/*complications/immunology', 'Male', 'Meningoencephalitis/*complications/immunology', 'Rubella/*complications']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Nov;189(6):472-6.,"['0 (Antibodies, Viral)', '0 (Immunoglobulin G)', '0 (Immunoglobulin M)']","We observed a fatal meningoencephalitis in a patient who suffered from acute lymphatic leukemia. The infection occurred after complete bone marrow remission. As the cause of this complication we discovered a rubella-infection, whose beginning had been several weeks ago. Relations to several forms of rubella-encephalitis in otherwise healthy patients are discussed and pathogenetical conclusions are made.",Akute hamorrhagische Meningoencephalitis im Rahmen einer Roteln-infektion bei akuter lymphatischer Leukamie.,,,,
271752,NLM,MEDLINE,19780321,20101118,0485-1439 (Print) 0485-1439 (Linking),18,11,1977 Nov,[A case of tumor-forming acute myelogenous leukemia with an initial manifestation of acute renal failure (author's transl)].,1363-9,"['Wakabayashi, Y', 'Kanaguchi, T', 'Shiokawa, Y', 'Takaku, F']","['Wakabayashi Y', 'Kanaguchi T', 'Shiokawa Y', 'Takaku F']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Acute Kidney Injury/*etiology/pathology', 'Humans', 'Leukemia, Myeloid, Acute/*complications/pathology', 'Male', 'Middle Aged', 'Rectal Neoplasms/complications', 'Urinary Bladder Neoplasms/complications']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Nov;18(11):1363-9.,,,,,,,
271751,NLM,MEDLINE,19780321,20071115,0485-1439 (Print) 0485-1439 (Linking),18,11,1977 Nov,[A case of acute myelogenous leukemia and brain tumor formation in complete remission (author's transl)].,1349-54,"['Sadamori, N', 'Tagawa, M', 'Yamaguchi, H', 'Ichimaru, M', 'Taira, Y', 'Fujii, I', 'Miyagawa, N', 'Miyazaki, H', 'Mori, K']","['Sadamori N', 'Tagawa M', 'Yamaguchi H', 'Ichimaru M', 'Taira Y', 'Fujii I', 'Miyagawa N', 'Miyazaki H', 'Mori K']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Brain Neoplasms/*pathology', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Male', 'Middle Aged', 'Neoplasm Metastasis', 'Remission, Spontaneous']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Nov;18(11):1349-54.,,,,,,,
271750,NLM,MEDLINE,19780321,20131121,0485-1439 (Print) 0485-1439 (Linking),18,11,1977 Nov,[A case of blastic crisis of chronic myelogenous leukemia with good response to the streptococcal agent OK-432 (author's transl)].,1336-42,"['Fujii, H']",['Fujii H'],['jpn'],"['Case Reports', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Aged', 'Betamethasone/administration & dosage/therapeutic use', 'Biological Products/*therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Picibanil/administration & dosage/*therapeutic use', 'Remission, Spontaneous']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Nov;18(11):1336-42.,"['0 (Biological Products)', '39325-01-4 (Picibanil)', '9842X06Q6M (Betamethasone)']",,,,,,
271749,NLM,MEDLINE,19780321,20191210,0368-2781 (Print) 0368-2781 (Linking),30,12,1977 Dec,[Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].,1021-5,"['Ueda, T', 'Takubo, T', 'Hasegawa, Y', 'Shibata, H', 'Nakamura, H', 'Masaoka, T', 'Yoshitake, J']","['Ueda T', 'Takubo T', 'Hasegawa Y', 'Shibata H', 'Nakamura H', 'Masaoka T', 'Yoshitake J']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Jpn J Antibiot,The Japanese journal of antibiotics,0154402,IM,"['Adolescent', 'Adult', 'Amikacin/*administration & dosage/adverse effects/therapeutic use', 'Anemia, Aplastic/complications', 'Female', 'Hematologic Diseases/*complications', 'Humans', 'Infections/*drug therapy', 'Injections, Intravenous', 'Kanamycin/*analogs & derivatives', 'Leukemia, Myeloid/complications', 'Lymphoma, Non-Hodgkin/complications', 'Male', 'Middle Aged', 'Pneumonia/drug therapy', 'Sepsis/complications/drug therapy']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Jpn J Antibiot. 1977 Dec;30(12):1021-5.,"['59-01-8 (Kanamycin)', '84319SGC3C (Amikacin)']",,,,,,
271747,NLM,MEDLINE,19780321,20190509,0027-8874 (Print) 0027-8874 (Linking),60,2,1978 Feb,Cytodifferentiation in the acute myeloblastic leukemias of man.,265-9,"['Lan, S', 'McCulloch, E A', 'Till, J E']","['Lan S', 'McCulloch EA', 'Till JE']",['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Adult', 'Aged', 'Bone Marrow/pathology', 'Clone Cells/pathology', 'Erythropoiesis', 'Female', 'Granulocytes/pathology', '*Hematopoiesis', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Male', 'Middle Aged']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1093/jnci/60.2.265 [doi]'],ppublish,J Natl Cancer Inst. 1978 Feb;60(2):265-9. doi: 10.1093/jnci/60.2.265.,,"Correlation analysis of numbers of colony-forming progenitor cells was used as an approach to the quantitation of human pluripotent stem cells. Marrow specimens were obtained from 24 patients with untreated acute myeloblastic leukemia, 22 patients under treatment, and 29 patients with no hematologic malignant disease. Three classes of progenitor cells were assayed: burst-forming units dependent on erythropoietin (BFU-E), colony-forming units dependent on erythropoietin (CFU-E), and granulopoietic progenitors (CFU-C). Significant positive correlations between numbers of BFU-E, CFU-E, and CFU-C were found in all 3 groups of patients. In contrast, no such positive correlations were seen between marrow blasts and any of the classes of colony-forming progenitors. These results were compatible with a shared relationship of the colony-forming progenitors to a pluripotent cell of origin and raised the possibility that the immediate progenitors of the blasts may not be any of the myelopoietic progenitor cells monitored in these studies.",,,,,
271739,NLM,MEDLINE,19780321,20190709,0022-2623 (Print) 0022-2623 (Linking),21,2,1978 Feb,Methotrexate analogues. 10. Direct coupling of methotrexate and diethyl L-glutamate in the presence of peptide bond-forming reagents.,170-5,"['Rosowsky, A', 'Yu, C S']","['Rosowsky A', 'Yu CS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med Chem,Journal of medicinal chemistry,9716531,IM,"['Animals', 'Cells, Cultured', '*Glutamates', 'Humans', 'Indicators and Reagents', 'Leukemia L1210/drug therapy', 'Leukemia, Lymphoid/metabolism', 'Methotrexate/*analogs & derivatives/chemical synthesis/therapeutic use', 'Mice', 'Stereoisomerism']",1978/02/01 00:00,1978/02/01 00:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '1978/02/01 00:01 [medline]', '1978/02/01 00:00 [entrez]']",['10.1021/jm00200a005 [doi]'],ppublish,J Med Chem. 1978 Feb;21(2):170-5. doi: 10.1021/jm00200a005.,"['0 (Glutamates)', '0 (Indicators and Reagents)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
271709,NLM,MEDLINE,19780321,20190630,0022-3476 (Print) 0022-3476 (Linking),92,2,1978 Feb,Hypereosinophilia with acute lymphocytic and acute myelocytic leukemia in childhood.,244-6,"['Wimmer, R S', 'Raney, R B Jr', 'Naiman, J L']","['Wimmer RS', 'Raney RB Jr', 'Naiman JL']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Child', '*Eosinophils', 'Humans', 'Infant', 'Leukemia, Lymphoid/*complications/diagnosis', 'Leukemia, Myeloid/*complications/diagnosis', 'Male', 'Remission, Spontaneous']",1978/02/01 00:00,2001/03/28 10:01,['1978/02/01 00:00'],"['1978/02/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/02/01 00:00 [entrez]']","['S0022-3476(78)80018-3 [pii]', '10.1016/s0022-3476(78)80018-3 [doi]']",ppublish,J Pediatr. 1978 Feb;92(2):244-6. doi: 10.1016/s0022-3476(78)80018-3.,,,,,,,
271678,NLM,MEDLINE,19780310,20190708,0002-8177 (Print) 0002-8177 (Linking),95,6,1977 Dec,Oral manifestations of acute leukemia in children.,1145-50,"['Michaud, M', 'Baehner, R L', 'Bixler, D', 'Kafrawy, A H']","['Michaud M', 'Baehner RL', 'Bixler D', 'Kafrawy AH']",['eng'],"['Comparative Study', 'Journal Article']",England,J Am Dent Assoc,Journal of the American Dental Association (1939),7503060,IM,"['Adolescent', 'Candidiasis, Oral/etiology', 'Child', 'Child, Preschool', 'Female', 'Hemorrhagic Disorders/etiology', 'Humans', 'Infant', 'Leukemia/*complications/drug therapy', 'Male', 'Mouth Diseases/*etiology/therapy', 'Mouth Mucosa', 'Tooth Mobility/etiology']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']","['S0002-8177(77)56030-8 [pii]', '10.14219/jada.archive.1977.0211 [doi]']",ppublish,J Am Dent Assoc. 1977 Dec;95(6):1145-50. doi: 10.14219/jada.archive.1977.0211.,,"Seventy-seven children with acute leukemia were examined. A wide spectrum of oral findings was observed as the consequence of direct leukemic infiltration of tissue, infection resulting from bone marrow and immunosuppression, impaired healing responses, and poor oral hygiene. Guidelines for dental treatment are provided.",,,,,
271632,NLM,MEDLINE,19780310,20190722,0340-6717 (Print) 0340-6717 (Linking),39,3,1977 Dec 23,Nonrandom chromosome rearrangements in 27 cases of human myeloid leukemia.,293-301,"['Rozynkowa, D', 'Stepien, J', 'Kowalewski, J', 'Nowakowski, A']","['Rozynkowa D', 'Stepien J', 'Kowalewski J', 'Nowakowski A']",['eng'],['Journal Article'],Germany,Hum Genet,Human genetics,7613873,IM,"['*Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Phenotype', 'Translocation, Genetic']",1977/12/23 00:00,1977/12/23 00:01,['1977/12/23 00:00'],"['1977/12/23 00:00 [pubmed]', '1977/12/23 00:01 [medline]', '1977/12/23 00:00 [entrez]']",['10.1007/BF00295422 [doi]'],ppublish,Hum Genet. 1977 Dec 23;39(3):293-301. doi: 10.1007/BF00295422.,,"The R-banding pattern of the chromosomes of 31 patients hospitalized in the Hematologic Clinic for myeloid leukemia were studied before chemotherapy. This analysis permitted identification of one unusual 3-chromosome rearrangement t(3;9;22) in addition to 25 classic forms of (22q-;9q+) translocation accompanied by the specific Ph' chromosome in chronic granulocytic leukemia patients, independent of the blastic course of the disease. During blastic crisis observed in 6 patients, extra 8 and 10 chromosomes, monosomy for chromosome 17, isochromosomes 17q, translocation (12q;13q), and additional Ph' were noted. The nonrandomness of these findings is determined from results published by other authors. Their significance for the cellular phenotype is presently unknown.",,,,,
271631,NLM,MEDLINE,19780310,20190722,0340-6717 (Print) 0340-6717 (Linking),39,2,1977 Nov 10,Scientific method and the Philadelphia chromosome.,257-9,"['Fitzgerald, P H']",['Fitzgerald PH'],['eng'],['Letter'],Germany,Hum Genet,Human genetics,7613873,IM,"['*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid/*genetics', '*Research Design']",1977/11/10 00:00,1977/11/10 00:01,['1977/11/10 00:00'],"['1977/11/10 00:00 [pubmed]', '1977/11/10 00:01 [medline]', '1977/11/10 00:00 [entrez]']",['10.1007/BF00287022 [doi]'],ppublish,Hum Genet. 1977 Nov 10;39(2):257-9. doi: 10.1007/BF00287022.,,,,,,,
271630,NLM,MEDLINE,19780310,20190722,0340-6717 (Print) 0340-6717 (Linking),39,2,1977 Nov 10,A case of chronic myeloid leukemia with a translocation (12;22)(p13;q11).,229-31,"['van der Blij-Philipsen, M', 'Breed, W P', 'Hustinx, T W']","['van der Blij-Philipsen M', 'Breed WP', 'Hustinx TW']",['eng'],"['Case Reports', 'Journal Article']",Germany,Hum Genet,Human genetics,7613873,IM,"['Adult', 'Bone Marrow/ultrastructure', 'Cells, Cultured', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/*genetics', 'Leukocytes/ultrastructure', '*Translocation, Genetic']",1977/11/10 00:00,1977/11/10 00:01,['1977/11/10 00:00'],"['1977/11/10 00:00 [pubmed]', '1977/11/10 00:01 [medline]', '1977/11/10 00:00 [entrez]']",['10.1007/BF00287017 [doi]'],ppublish,Hum Genet. 1977 Nov 10;39(2):229-31. doi: 10.1007/BF00287017.,,Chromosomal studies of the bone marrow and cultured peripheral blood cells in a 42-year-old female with the clinical and laboratory features typical for CML revealed a previously undescribed variant translocation involving chromosomes 12 and 22.,,,,,
271629,NLM,MEDLINE,19780321,20071115,0015-5616 (Print) 0015-5616 (Linking),19,2,1977,[Trends in incidence of leukemia in the Cracow region in the years 1951-1968].,251-61,"['Janicki, K', 'Sliwczynska, B']","['Janicki K', 'Sliwczynska B']",['pol'],"['English Abstract', 'Journal Article']",Poland,Folia Med Cracov,Folia medica Cracoviensia,0374617,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Female', 'Humans', 'Leukemia/*epidemiology', 'Leukemia, Lymphoid/epidemiology', 'Leukemia, Myeloid/epidemiology', 'Male', 'Middle Aged', 'Poland', 'Sex Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Folia Med Cracov. 1977;19(2):251-61.,,,Trendy zachorowalnosci na bialaczki w regionie krakowskim m latach 1951-1968.,,,,
271628,NLM,MEDLINE,19780321,20141003,0016-450X (Print) 0016-450X (Linking),68,6,1977 Dec,Induction of lysosomal enzyme activities with glucocorticoids during differentiation of cultured mouse myeloid leukemia cells.,765-73,"['Kasukabe, T', 'Honma, Y', 'Hozumi, M']","['Kasukabe T', 'Honma Y', 'Hozumi M']",['eng'],['Journal Article'],Japan,Gan,Gan,0151745,IM,"['Acid Phosphatase/biosynthesis', 'Animals', 'Antimetabolites/pharmacology', '*Cell Differentiation', 'Cell Line', 'Cells, Cultured', 'Deoxyribonucleases/biosynthesis', 'Dexamethasone/pharmacology', 'Enzyme Induction', 'Glucocorticoids/*pharmacology', 'Glucuronidase/biosynthesis', 'Leukemia, Experimental/enzymology/pathology', 'Leukemia, Myeloid/enzymology/*pathology', 'Lysosomes/*enzymology', 'Mice', 'Peptide Hydrolases/biosynthesis', 'Phagocytosis/drug effects', 'Ribonucleases/biosynthesis']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Gan. 1977 Dec;68(6):765-73.,"['0 (Antimetabolites)', '0 (Glucocorticoids)', '7S5I7G3JQL (Dexamethasone)', 'EC 3.1.- (Deoxyribonucleases)', 'EC 3.1.- (Ribonucleases)', 'EC 3.1.3.2 (Acid Phosphatase)', 'EC 3.2.1.31 (Glucuronidase)', 'EC 3.4.- (Peptide Hydrolases)']",,,,,,
271627,NLM,MEDLINE,19780321,20141003,0016-450X (Print) 0016-450X (Linking),68,6,1977 Dec,A factor inducing differentiation of mouse myeloid leukemia cells in human amniotic fluid.,757-64,"['Nagata, K', 'Ooguro, K', 'Saito, M', 'Kuboyama, M', 'Ogasa, K']","['Nagata K', 'Ooguro K', 'Saito M', 'Kuboyama M', 'Ogasa K']",['eng'],['Journal Article'],Japan,Gan,Gan,0151745,IM,"['Amniotic Fluid/*analysis', 'Animals', '*Cell Differentiation', 'Cells, Cultured', 'Humans', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid/*pathology', 'Macrophages/cytology/immunology', 'Mice', 'Phagocytosis', 'Rosette Formation']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Gan. 1977 Dec;68(6):757-64.,,"The M1 line cells of mouse myeloid leukemia can be induced to differentiate in vitro into macrophages by a factor in human amniotic fluid. The macrophages showed phagocytosis and locomotic activity, and also gained Fc receptors on the cell surface. This factor in amniotic fluid capable of inducing differentiation of M1 cells was heat-labile, trypsin-sensitive, and non-dialysable. A growth-stimulating factor for the M1 cells was also found in the human amniotic fluid, and it was heat-stable and trypsin-resistant. The conditioned medium obtained from the amnion had the activity of differentiating the M1 cells.",,,,,
271610,NLM,MEDLINE,19780321,20190907,0014-2964 (Print) 0014-2964 (Linking),13,7,1977 Jul,Cross-reaction between antigens of human myelogenous leukemia and Mason-Pfizer monkey virus.,721-8,"['Kim, B S']",['Kim BS'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Eur J Cancer,European journal of cancer,0074126,IM,"['*Antigens, Neoplasm/analysis', '*Antigens, Viral', 'Breast Neoplasms/immunology', 'Cross Reactions', 'Female', 'Humans', 'Leukemia, Myeloid/etiology/*immunology', 'Leukocytes/immunology', 'Retroviridae/*immunology', 'Spleen/immunology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1016/0014-2964(77)90059-7 [doi]'],ppublish,Eur J Cancer. 1977 Jul;13(7):721-8. doi: 10.1016/0014-2964(77)90059-7.,"['0 (Antigens, Neoplasm)', '0 (Antigens, Viral)']",,,,,,
271609,NLM,MEDLINE,19780321,20190907,0014-2964 (Print) 0014-2964 (Linking),13,7,1977 Jul,Nuclear labelling of leukaemic blast cells with tritiated thymidine triphosphate after daunomycin.,647-55,"['Wantzin, G L', 'Killmann, S A']","['Wantzin GL', 'Killmann SA']",['eng'],['Journal Article'],England,Eur J Cancer,European journal of cancer,0074126,IM,"['Aged', 'Bone Marrow/metabolism', 'Bone Marrow Cells', 'Cell Nucleus/metabolism', 'Daunorubicin/pharmacology/*therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Lymphocytes/cytology/*metabolism', 'Male', 'Middle Aged', 'Mitotic Index/drug effects', 'Thymine Nucleotides/*metabolism', 'Time Factors']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1016/0014-2964(77)90050-0 [doi]'],ppublish,Eur J Cancer. 1977 Jul;13(7):647-55. doi: 10.1016/0014-2964(77)90050-0.,"['0 (Thymine Nucleotides)', 'ZS7284E0ZP (Daunorubicin)']",,,,,,
271608,NLM,MEDLINE,19780329,20190620,0014-2956 (Print) 0014-2956 (Linking),82,1,1978 Jan 2,Reagents specific for cell surface components.,285-92,"['Pitha, J']",['Pitha J'],['eng'],['Journal Article'],England,Eur J Biochem,European journal of biochemistry,0107600,IM,"['Aniline Compounds', 'Cell Membrane/*analysis/metabolism', 'Cell Transformation, Viral', 'Cells, Cultured', 'DNA', 'Dextrans', '*Indicators and Reagents', 'Leukemia, Erythroblastic, Acute/metabolism', 'Organomercury Compounds', 'Proflavine', 'Serum Albumin, Bovine']",1978/01/02 00:00,1978/01/02 00:01,['1978/01/02 00:00'],"['1978/01/02 00:00 [pubmed]', '1978/01/02 00:01 [medline]', '1978/01/02 00:00 [entrez]']",['10.1111/j.1432-1033.1978.tb12022.x [doi]'],ppublish,Eur J Biochem. 1978 Jan 2;82(1):285-92. doi: 10.1111/j.1432-1033.1978.tb12022.x.,"['0 (Aniline Compounds)', '0 (Dextrans)', '0 (Indicators and Reagents)', '0 (Organomercury Compounds)', '27432CM55Q (Serum Albumin, Bovine)', '9007-49-2 (DNA)', 'CY3RNB3K4T (Proflavine)']","Mercury, diazonium ions and dyes which bind nucleic acids were covalently linked to dextrans using methods that resulted in non-hydrolyzable reagent-dextran bonds without impairing the binding abilities of the reagents, i.e. these dextran derivatives reacted with thiols, phenols/imidazoles and nucleic acids respectively. Since these dextran derivatives cannot penetrate into cells and since dextran itself does not bind to cells, these compounds represent reagents specific for the cell surface. They may be used both to evaluate cell surface constituents of intact cells and to affect viable cells via an interaction with those constituents. Mercury-dextran was found to bind to cells; the amount of mercury thus attached to the cells was about ten times smaller than when an equivalent concentration of free mercury ions was used. Mercury-dextran, bound to cells after a 30-min exposure at room temperature, was localized on the surface of these cells, as sodium borohydride reduced this complex giving rise to the intact cells, elementary mercury and free dextran which was released into medium. When cells were constantly exposed to the mercury-dextran, its toxic effects were comparable to that of free mercury ions. Diazonium-dextran, which also binds tightly to the cell surface, was also considerably toxic. Dextrans substituted with dyes which bind to nucleic acids were less toxic than the parent dyes themselves; it was shown that the attachment of such a dye to dextran decreased the binding of dye to cells under detection limits.",,,,,
271531,NLM,MEDLINE,19780329,20190918,0010-4825 (Print) 0010-4825 (Linking),8,1,1978 Jan,Cross-correlation digital registration techniques for multispectral cell images.,71-80,"['Williams, H', 'Brenner, J F', 'Neurath, R W']","['Williams H', 'Brenner JF', 'Neurath RW']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Comput Biol Med,Computers in biology and medicine,1250250,IM,"['Bone Marrow/*ultrastructure', 'Computers', 'Humans', 'Image Enhancement', 'Leukemia, Lymphoid/*pathology', 'Lymphocytes/*ultrastructure', 'Mathematics']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']","['0010-4825(78)90015-X [pii]', '10.1016/0010-4825(78)90015-x [doi]']",ppublish,Comput Biol Med. 1978 Jan;8(1):71-80. doi: 10.1016/0010-4825(78)90015-x.,,,,,,,
271527,NLM,MEDLINE,19780310,20071115,0069-2328 (Print) 0069-2328 (Linking),32,9,1977 Sep,[Therapy of recurrent acute lymphoblastic leukemia in childhood using alpha-asparginase].,565-7,"['Reddemann, H', 'Zastrow, J']","['Reddemann H', 'Zastrow J']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,IM,"['Adolescent', 'Age Factors', 'Asparaginase/*therapeutic use', 'Child', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Neoplasm Recurrence, Local/*drug therapy']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1977 Sep;32(9):565-7.,['EC 3.5.1.1 (Asparaginase)'],,Leceni recidiv akutni lymfoblasticke leukemie alfa-asparaginazou v detskem veku.,,,,
271518,NLM,MEDLINE,19780310,20061115,0361-5960 (Print) 0361-5960 (Linking),61,9,1977 Dec,Suppression of human myelosarcoma growth in athymic mice by a primate antiserum.,1679-84,"['Lozzio, B B', 'Machado, E A', 'Lair, S A', 'Lozzio, C B']","['Lozzio BB', 'Machado EA', 'Lair SA', 'Lozzio CB']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Animals', 'Cell Division', 'Cell Line', 'Complement System Proteins', '*Immunization, Passive', 'Leukemia, Myeloid/pathology/*therapy', 'Mice', 'Mice, Nude', 'Neoplasm Transplantation', 'Sarcoma, Experimental/therapy', 'Transplantation, Heterologous']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Dec;61(9):1679-84.,['9007-36-7 (Complement System Proteins)'],"A primate (Macaca speciosa) antiserum prepared against the human chronic myelogenous leukemia cell line K-562 suppressed the growth of the human myelosarcomas in nude mice. The ip administration of 0.5 ml of immune serum plus 0.5 ml of guinea pig complement, starting 7 days after sc tumor transplantation, resulted in a fourfold to fivefold decrease in tumor weight at 15 days when compared to nude mice given pre-immune serum plus complement or complement alone. Whereas the other two groups experienced an exponential increase in tumor volume at 7-9 days after tumor transplantation, the immune serum-treated mice remained in a ""lag"" phase of tumor growth during which the tumor volume neither increased nor decreased substantially. Histopathologic studies revealed various degrees of tumor alterations ranging form focal hydropic cellular degeneration to massive coagulation necrosis. The incorporation of tritiated thymidine into the tumors was also markedly diminished in the mice given immune serum.",,,,,
271516,NLM,MEDLINE,19780329,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6107,1978 Jan 28,Combination chemotherapy for acute lymphoblastic leukaemia in adults.,199-203,"['Lister, T A', 'Whitehouse, J M', 'Beard, M E', 'Brearley, R L', 'Wrigley, P F', 'Oliver, R T', 'Freeman, J E', 'Woodruff, R K', 'Malpas, J S', 'Paxton, A M', 'Crowther, D']","['Lister TA', 'Whitehouse JM', 'Beard ME', 'Brearley RL', 'Wrigley PF', 'Oliver RT', 'Freeman JE', 'Woodruff RK', 'Malpas JS', 'Paxton AM', 'Crowther D']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*therapeutic use', 'Asparaginase/adverse effects/therapeutic use', 'Central Nervous System Diseases/radiotherapy', 'Doxorubicin/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Methotrexate/therapeutic use', 'Middle Aged', 'Prednisolone/therapeutic use', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1978/01/28 00:00,1978/01/28 00:01,['1978/01/28 00:00'],"['1978/01/28 00:00 [pubmed]', '1978/01/28 00:01 [medline]', '1978/01/28 00:00 [entrez]']",['10.1136/bmj.1.6107.199 [doi]'],ppublish,Br Med J. 1978 Jan 28;1(6107):199-203. doi: 10.1136/bmj.1.6107.199.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', '80168379AG (Doxorubicin)', '9PHQ9Y1OLM (Prednisolone)', 'EC 3.5.1.1 (Asparaginase)', 'YL5FZ2Y5U1 (Methotrexate)']","Fifty-one adults with acute lymphoblastic leukaemia were entered into a trial of intense initial chemotherapy and early ""prophylaxis"" of the central nervous system (CNS). Initial treatment with OPAL (Oncovin (vincristine), prednisolone, adriamycin (doxorubicin), and L-asparaginase (colaspase)) followed by craniospinal or cranial irradiation and intrathecal methotrexate produced remission in 36 patients (71%). Seventeen of these patients relapsed three to 18 months after the start of remission; the remainder had been in remission for 12 to 52 months by the end of the study. The predicted median duration of complete remission was 18.5 months. None of the four patients who initially had clinical evidence of CNS disease, three of whom also had leukaemic cells identical to those found in Burkitt's lymphoma, achieved remission. Those patients who initially had hepatomegaly or splenomegaly had a shorter remission than those without. The predicted median survival was 27 months in those who achieved complete remission, one month in those who did not, and 21 months overall. The addition of colaspase and doxorubicin to vincristine and prednisolone and the use of early CNS treatment clearly improved the remission rate among adults with acute lymphoblastic leukaemia, though the presence and length of remission was affected by the extent of disease at presentation. Burkitt-like leukaemia, which had a poor prognosis, is probably a separate disease and may benefit from a different therapeutic approach.",,PMC1602526,,,
271515,NLM,MEDLINE,19780321,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6104,1978 Jan 7,Philadelphia-chromosome-positive childhood chronic myeloid leukaemia.,49,"['Saffhill, R', 'Dexter, T M', 'Testa, N', 'Morris-Jones, P H', 'Hann, I M']","['Saffhill R', 'Dexter TM', 'Testa N', 'Morris-Jones PH', 'Hann IM']",['eng'],['Letter'],England,Br Med J,British medical journal,0372673,IM,"['Alkaline Phosphatase/*analysis', 'Child, Preschool', '*Chromosomes, Human, 21-22 and Y', 'DNA-Directed DNA Polymerase/*analysis', 'Humans', 'Infant', 'Leukemia, Myeloid/*enzymology']",1978/01/07 00:00,1978/01/07 00:01,['1978/01/07 00:00'],"['1978/01/07 00:00 [pubmed]', '1978/01/07 00:01 [medline]', '1978/01/07 00:00 [entrez]']",['10.1136/bmj.1.6104.49-b [doi]'],ppublish,Br Med J. 1978 Jan 7;1(6104):49. doi: 10.1136/bmj.1.6104.49-b.,"['EC 2.7.7.7 (DNA-Directed DNA Polymerase)', 'EC 3.1.3.1 (Alkaline Phosphatase)']",,,PMC1602503,,,
271514,NLM,MEDLINE,19780321,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6104,1978 Jan 7,Meningeal leukaemia in lymphoid blast crisis of chronic myeloid leukaemia.,48,"['Eden, O B', 'Innes, E M']","['Eden OB', 'Innes EM']",['eng'],"['Case Reports', 'Letter']",England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Female', 'Humans', 'Leukemia, Myeloid/*complications', '*Meningeal Neoplasms', 'Thrombocytopenia/complications']",1978/01/07 00:00,1978/01/07 00:01,['1978/01/07 00:00'],"['1978/01/07 00:00 [pubmed]', '1978/01/07 00:01 [medline]', '1978/01/07 00:00 [entrez]']",['10.1136/bmj.1.6104.48-b [doi]'],ppublish,Br Med J. 1978 Jan 7;1(6104):48. doi: 10.1136/bmj.1.6104.48-b.,,,,PMC1602442,,,
271512,NLM,MEDLINE,19780329,20190515,0007-0920 (Print) 0007-0920 (Linking),36,6,1977 Dec,Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.,770-6,"['Rees, J K', 'Sandler, R M', 'Challener, J', 'Hayhoe, F G']","['Rees JK', 'Sandler RM', 'Challener J', 'Hayhoe FG']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Adolescent', 'Adult', 'Aged', 'Cytarabine/*therapeutic use', 'Daunorubicin/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Middle Aged', 'Prognosis', 'Remission, Spontaneous', 'Thioguanine/*therapeutic use']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1038/bjc.1977.260 [doi]'],ppublish,Br J Cancer. 1977 Dec;36(6):770-6. doi: 10.1038/bjc.1977.260.,"['04079A1RDZ (Cytarabine)', 'FTK8U1GZNX (Thioguanine)', 'ZS7284E0ZP (Daunorubicin)']","Twenty patients with acute myeloid leukaemia (AML) were treated with a combination of chemotherapy which included daunorubicin, cytosine arabino-side and 6-thioguanine (DAT). The complete remission rate was 85% and was achieved, in responsive cases, after an average of 2 courses of therapy. Patients remained in hospital for an average of 37.5 days during remission-induction therapy and 3.7 days per month thereafter. The median remission period was 48 weeks and median survival was 70 weeks. A disappointing feature was the high relapse rate. This feature of the results re-affirms the need for a more effective form of remission therapy.",,PMC2025567,,,
271462,NLM,MEDLINE,19780218,20190819,0361-8609 (Print) 0361-8609 (Linking),2,3,1977,Development of chronic myelocytic leukemia during the course of acute lymphocytic leukemia in an adult.,291-7,"['Fisher, B L', 'Lyons, R M', 'Sears, D A']","['Fisher BL', 'Lyons RM', 'Sears DA']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Hematol,American journal of hematology,7610369,IM,"['Bone Marrow/ultrastructure', 'Chromosomes, Human', 'Chromosomes, Human, 21-22 and Y', 'Humans', 'Karyotyping', 'Leukemia, Lymphoid/*complications/diagnosis', 'Leukemia, Myeloid/*complications/diagnosis', 'Male', 'Middle Aged', '*Neoplasms, Multiple Primary', 'Periodic Acid-Schiff Reaction']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/ajh.2830020311 [doi]'],ppublish,Am J Hematol. 1977;2(3):291-7. doi: 10.1002/ajh.2830020311.,,"A 59-year-old patient is described who presented with acute lymphocytic leukemia. Complete remission was induced rapidly with vincristine and prednisone. Nine months later he acquired the clinical and hematological picture of a myeloproliferative disease, and bone marrow cytogenetic studies demonstrated the presence of the Philadelphia chromosome. Within 4 months he again developed overt acute lymphocytic leukemia and died. Several lines of evidence have recently indicated a relationship between myeloproliferative and lymphoproliferative disorders, particularly chronic myelocytic and acute lymphocytic leukemia. This patient's course is another example of that association.",,,,,
271427,NLM,MEDLINE,19780218,20131121,0043-5325 (Print) 0043-5325 (Linking),89,24,1977 Dec 23,[Anaemia with medullary myeloblastosis (author's transl)].,821-5,"['Hinterberger, W', 'Kinast, H', 'Tragl, K H']","['Hinterberger W', 'Kinast H', 'Tragl KH']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,IM,"['Aged', 'Aminopyrine/adverse effects/therapeutic use', 'Anemia, Aplastic/*complications', 'Arthritis, Rheumatoid/drug therapy', 'Bone Marrow Examination', 'Drug Combinations', 'Erythropoiesis', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Phenylbutazone/adverse effects/therapeutic use']",1977/12/23 00:00,1977/12/23 00:01,['1977/12/23 00:00'],"['1977/12/23 00:00 [pubmed]', '1977/12/23 00:01 [medline]', '1977/12/23 00:00 [entrez]']",,ppublish,Wien Klin Wochenschr. 1977 Dec 23;89(24):821-5.,"['0 (Drug Combinations)', '01704YP3MO (Aminopyrine)', 'GN5P7K3T8S (Phenylbutazone)']","A case of refractory anaemia with medullary myeloblastosis (RAMM) is described. RAMM is a very rare disease and its relationship to aplastic anaemia and smouldering leukaemia is not clearly established. The diagnosis is confirmed by evaluation of the bone-marrow aspirate and ferrokinetic studies which demonstrate ineffective erythropoiesis. The disease is combined with leucopenia, thrombocytopenia and a hyperplastic bone-marrow. Our patient was monitored for 18 months, during which time her haematological findings remained stable. Since transformation into acute leukaemia occurs in about 25% of the cases, a bone-marrow culture study was performed in order to determine such a leukaemic transformation which is not detectable on examination by the light microscope. Culture studies are discussed along with some prognostic, therapeutic and pathophysiological problems of RAMM.",Refraktare Anamie mit medullarer Myeloblastose.,,,,
271418,NLM,MEDLINE,19780223,20141120,0042-8809 (Print) 0042-8809 (Linking),,6,1977 Nov-Dec,[Comparative study of nuclear RNA in leukocytes of normal individuals and patients with leukemia by the method of molecular DNA-RNA hybridization].,812-8,"['Morozova, E O', 'Blinov, M N']","['Morozova EO', 'Blinov MN']",['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Vopr Med Khim,Voprosy meditsinskoi khimii,0416601,IM,"['Humans', 'In Vitro Techniques', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood', 'Leukocytes/*analysis', '*Nucleic Acid Hybridization', 'RNA/*blood', 'RNA, Neoplasm/*blood']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Vopr Med Khim. 1977 Nov-Dec;(6):812-8.,"['0 (RNA, Neoplasm)', '63231-63-0 (RNA)']","Spectra of nuclear RNA were studied in leukocytes in healthy donors and in patients with leukoses by DNA-RNA hybridization. Cross competitive hybridization showed that in chronic lymphoid leukosis and acute myeloblastosis new forms of nuclear RNA were observed, which were not found in normal state; in myeloleukosis the nuclear RNA spectra were similar to those of normal granulocytes. The results obtained suggest that universal type of impairments appears to be absent in regulation of transcription in leukoses; it may be related not only to leukosis transformation but depends on variations in cell content of leukocyte populations studied.",Sravnitel'noe izuchenie iadernykh RNK leikotsitov cheloveka v norme i pri leikozakh metodom molekuliarnoi DNK-RNK-gibridizatsii.,,,,
271416,NLM,MEDLINE,19780218,20061115,0042-773X (Print) 0042-773X (Linking),23,12,1977 Dec,[Primary simultaneous multiplicity of chronic myelosis and Grawitz's tumor].,1192-5,"['Jarcuska, J', 'Nemcikova, S', 'Jakubciak, J', 'Mizla, K']","['Jarcuska J', 'Nemcikova S', 'Jakubciak J', 'Mizla K']",['slo'],"['Case Reports', 'English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Adenocarcinoma/*complications', 'Adult', 'Humans', 'Kidney Neoplasms/*complications', 'Leukemia, Myeloid/*complications', 'Male', 'Neoplasms, Multiple Primary/*complications']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Dec;23(12):1192-5.,,,Primarna simultanna multiplicita chronickej myelozy a Grawitzovho nadora.,,,,
271414,NLM,MEDLINE,19780223,20190727,0041-1132 (Print) 0041-1132 (Linking),17,6,1977 Nov-Dec,Undetectable ABO isoagglutinin in a patient with chronic myelocytic leukemia.,651-4,"['Ogata, H', 'Hasegawa, S']","['Ogata H', 'Hasegawa S']",['eng'],"['Case Reports', 'Journal Article']",United States,Transfusion,Transfusion,0417360,IM,"['*ABO Blood-Group System', 'Adolescent', '*Agglutinins', 'Chronic Disease', 'Female', 'Humans', '*Isoantibodies', 'Leukemia, Myeloid/*blood']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1046/j.1537-2995.1977.17678075669.x [doi]'],ppublish,Transfusion. 1977 Nov-Dec;17(6):651-4. doi: 10.1046/j.1537-2995.1977.17678075669.x.,"['0 (ABO Blood-Group System)', '0 (Agglutinins)', '0 (Isoantibodies)']","An instance of undetectable anti(A+B) was described in a patient, group O, in acute crisis of chronic myelocytic leukemia. The finding was not parallel to the level of gamma globulin in the patient and a possibility of functional abnormality of the related antibody was discussed.",,,,,
271366,NLM,MEDLINE,19780218,20161123,0256-9574 (Print),52,23,1977 Nov 26,Leukaemic involvement of the pleura. A case report.,938-40,"['Jacobson, R J', 'Jacobson, H J', 'Derman, D P']","['Jacobson RJ', 'Jacobson HJ', 'Derman DP']",['eng'],"['Case Reports', 'Journal Article']",South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,IM,"['Adult', 'Antineoplastic Agents/therapeutic use', 'Chronic Disease', 'Humans', 'Leukemia, Myeloid/blood/*complications/drug therapy', 'Male', 'Pleural Effusion/cytology/diagnostic imaging/*etiology', 'Radiography']",1977/11/26 00:00,1977/11/26 00:01,['1977/11/26 00:00'],"['1977/11/26 00:00 [pubmed]', '1977/11/26 00:01 [medline]', '1977/11/26 00:00 [entrez]']",,ppublish,S Afr Med J. 1977 Nov 26;52(23):938-40.,['0 (Antineoplastic Agents)'],"In chronic myelocytic leukaemia (CML), the pleura is a most uncommon site of extramedullary involvement. A 34-year-old man with CML presented with a massive pleural effusion. His peripheral blood contained few blast cells and the leucocyte alkaline phosphatase level was low. Cytological examination of the pleural fluid revealed cells with the morphological features of myeloblasts and monoblasts. The patient was treated with systemic chemotherapy, with no effect on the leukaemic pleural effusion.",,,,,
271365,NLM,MEDLINE,19780218,20190702,0038-4348 (Print) 0038-4348 (Linking),70,12,1977 Dec,Multiple myeloma terminating in acute myelogenous leukemia with the presence of a Philadelphia (Ph1) chromosome.,1477-9,"['Daneshvar-Alavi, B', 'Lutcher, C L', 'Welter, D']","['Daneshvar-Alavi B', 'Lutcher CL', 'Welter D']",['eng'],"['Case Reports', 'Journal Article']",United States,South Med J,Southern medical journal,0404522,IM,"['*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid, Acute/*complications/genetics', 'Male', 'Middle Aged', 'Multiple Myeloma/*complications/genetics']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1097/00007611-197712000-00032 [doi]'],ppublish,South Med J. 1977 Dec;70(12):1477-9. doi: 10.1097/00007611-197712000-00032.,,,,,,,
271352,NLM,MEDLINE,19780218,20190907,0036-553X (Print) 0036-553X (Linking),19,5,1977 Nov,Experience on the treatment of chronic myelocytic leukaemia (CML) in blastic crisis.,496-502,"['Mandelli, F', 'Amadori, S', 'Alimena, G', 'Annino, L', 'Nardelli, S', 'Papa, G']","['Mandelli F', 'Amadori S', 'Alimena G', 'Annino L', 'Nardelli S', 'Papa G']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/adverse effects/*therapeutic use', 'Child', 'Child, Preschool', 'Drug Evaluation', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy/mortality', 'Male', 'Middle Aged', 'Prognosis', 'Remission, Spontaneous']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01506.x [doi]'],ppublish,Scand J Haematol. 1977 Nov;19(5):496-502. doi: 10.1111/j.1600-0609.1977.tb01506.x.,['0 (Antineoplastic Agents)'],"A group of 50 patients with chronic myelocytic leukaemia in blastic crisis were treated with different chemotherapeutic regimens. A total of 19 remissions (6 CR + 13 PR) were achieved with an overall and complete response rate of 38% and 12% respectively. Of the 4 patients presenting with a lymphoblast-like appearance of the blasts, the 3 treated with the combination of vincristine and prednisone all achieved remission (2 CR + 1 PR). Duration of survival was significantly longer in responding patients (median 11.5 versus 4.5 months). Either more effective therapeutic regimens or prevention by aggressively approaching the chronic phase are to be sought in order to improve the prognosis of blastic crisis of CML.",,,,,
271351,NLM,MEDLINE,19780218,20190907,0036-553X (Print) 0036-553X (Linking),19,5,1977 Nov,The transcobalamins in polycythaemia vera.,453-62,"['Rachmilewitz, B', 'Manny, N', 'Rachmilewitz, M']","['Rachmilewitz B', 'Manny N', 'Rachmilewitz M']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Blood Proteins/*analysis', 'Busulfan/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/blood/etiology', 'Melphalan/therapeutic use', 'Polycythemia Vera/*blood/drug therapy', 'Protein Binding', 'Transcobalamins/*analysis', 'Vitamin B 12/blood']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01501.x [doi]'],ppublish,Scand J Haematol. 1977 Nov;19(5):453-62. doi: 10.1111/j.1600-0609.1977.tb01501.x.,"['0 (Blood Proteins)', '0 (Transcobalamins)', 'G1LN9045DK (Busulfan)', 'P6YC3EG204 (Vitamin B 12)', 'Q41OR9510P (Melphalan)']","The unsaturated B12 binding capacity (UBBC) of the serum and the binding capacity of each of the 3 vitamin B12 binders--the transcobalamins (TC) I, II and III were determined in 21 patients with polycythaemia vera (PV) during the course of the disease and following treatment, using the recently described charged cellulose filter technique. High serum UBBC due to elevated serum TCIII was found in all patients. TCI was moderately elevated in patients who had leucocytosis with a shift to the left. The changes in serum TCIII and UBBC correlated with the activity of the disease. Chemotherapy resulted in a decrease in TCIII and UBBC. The decrease in TCIII and UBBC folowing chemotherapy may be observed before a decrease in the haematocrit and the leucocyte count occurs. Activation of the disease may be assessed by the elevation of TCIII and UBBC. The onset of acute myeloblastic crisis in 1 patient was associated with a decrease in TCIII and TCI levels and a rise in serum TCII. The determination of TCIII and UBBC may be helpful in differentiating true from secondary polycythaemia.",,,,,
271350,NLM,MEDLINE,19780218,20190907,0036-553X (Print) 0036-553X (Linking),19,5,1977 Nov,Acute myeloid leukaemia with the Philadelphia chromosome.,449-52,"['Gustavsson, A', 'Mitelman, F', 'Olsson, I']","['Gustavsson A', 'Mitelman F', 'Olsson I']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Bone Marrow/ultrastructure', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid, Acute/*genetics', 'Male', '*Translocation, Genetic']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01500.x [doi]'],ppublish,Scand J Haematol. 1977 Nov;19(5):449-52. doi: 10.1111/j.1600-0609.1977.tb01500.x.,,"A case report of serial chromosome studies on a 26-year-old male with acute myeloid leukaemia (AML) is presented. The classic Philadelphia chromosome (Ph1) translocation, t (9;22) was found in 77% of the metaphases at diagnosis and in 100% in relapse; during a 3-month remission period the cytogenetic picture was normal or the Ph1 was present in a minor cell population only. The clinical and morphologic features of this case indicated that it was really a case of AML and less likely chronic myeloid leukaemia (CML) presenting in blast crisis. It is suggested that the oncogen producing the 9;22-translocation and CML may also induce AML in rare instances.",,,,,
271330,NLM,MEDLINE,19780218,20071115,0034-9704 (Print) 0034-9704 (Linking),2,4,1977 Oct,The management of extramedullary disease in acute leukemia with therapeutic radiations.,191-7,"['Shapiro, R', 'Gilbert, H', 'Skeel, R T', 'Kagan, A R', 'Jacobs, M', 'Senyszyn, J', 'Chan, P', 'Nussbaum, H']","['Shapiro R', 'Gilbert H', 'Skeel RT', 'Kagan AR', 'Jacobs M', 'Senyszyn J', 'Chan P', 'Nussbaum H']",['eng'],['Journal Article'],United States,Rev Interam Radiol,Revista interamericana de radiologia,7708012,IM,"['California', 'Evaluation Studies as Topic', 'Humans', 'Leukemia, Lymphoid/mortality/*radiotherapy', 'Leukemia, Myeloid/mortality/*radiotherapy', 'Meningeal Neoplasms/radiotherapy', 'Radiation Dosage', 'Time Factors']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Rev Interam Radiol. 1977 Oct;2(4):191-7.,,"The authors reviewed 181 patients who received local radiation therapy for the prevention or control of extramedullary disease resulting from acute leukemia. 126 had acute lymphocytic leukemia and 55 had acute granulocytic leukemia. They were treated over a 18-year period of time with different forms of chemotherapy. Most had not received prophylactic CNS radiation therapy. Patients were evaluated for local control until death or hematologic relapse intervened. More than 80% of patients with clinical ALL meningeal leukemia had a successful response to doses over 1000 rads. This same response was not apparent in AML. More than 80% of clinical non-CNS extra medullary leukemia was controlled with doses of 600 rads or greater. Only one patient with extra-medullary relapse is still alive. The authors feel that lower preventative doses of radiation to the CNS are compatible with similar control rates, based on their own data and other suggestive data.",,,,,
271308,NLM,MEDLINE,19780218,20151119,0031-9325 (Print) 0031-9325 (Linking),9,3,1977,Pulsed nuclear magnetic resonance studies of human bone marrow.,297-9,"['Ranade, S S', 'Shah, S', 'Advani, S H', 'Kasturi, S R']","['Ranade SS', 'Shah S', 'Advani SH', 'Kasturi SR']",['eng'],['Journal Article'],United States,Physiol Chem Phys,Physiological chemistry and physics,0202364,IM,"['*Bone Marrow', 'Humans', '*Leukemia, Myeloid', '*Leukemia, Myeloid, Acute', '*Magnetic Resonance Spectroscopy']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Physiol Chem Phys. 1977;9(3):297-9.,,Pulsed nuclear magnetic resonance (NMR) studies of human bone marrow reveal that the proton spin-lattice relaxation times (T1) of acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) are much greater than the T1 of normal bone marrow.,,,,,
271307,NLM,MEDLINE,19780218,20071115,0552-2080 (Print) 0552-2080 (Linking),,11,1977 Nov,[Study of the colony-forming activity of the bone marrow stroma in children with acute leukemia].,28-31,"['Vladimirskaia, E B']",['Vladimirskaia EB'],['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Bone Marrow/*physiopathology', 'Bone Marrow Examination', 'Cell Division', 'Child', 'Clone Cells/physiology', 'Fibroblasts/physiology', 'Humans', 'Leukemia, Lymphoid/*physiopathology', 'Leukemia, Monocytic, Acute/*physiopathology', 'Leukemia, Myeloid, Acute/*physiopathology', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Nov;(11):28-31.,,,"Izuchenie kolonieobrazuiushchei aktivnosti stromy kostnogo mozga u detei, bol'nykh ostrym leikozom.",,,,
271306,NLM,MEDLINE,19780218,20131121,0552-2080 (Print) 0552-2080 (Linking),,11,1977 Nov,[Prevention and treatment of neuroleukemia].,26-8,"['Dzherieva, A V']",['Dzherieva AV'],['rus'],['Journal Article'],Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adolescent', 'Adult', 'Brain Neoplasms/*therapy', 'Child', 'Child, Preschool', 'Cytarabine/administration & dosage', 'Humans', 'Leukemia, Lymphoid/*complications/drug therapy/prevention & control', 'Methotrexate/administration & dosage', 'Neoplasm Metastasis', 'Recurrence', 'Spinal Cord Neoplasms/*therapy']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Nov;(11):26-8.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']",,K voprosu o profilaktike i lechenii neiroleikemii.,,,,
271305,NLM,MEDLINE,19780218,20071115,0552-2080 (Print) 0552-2080 (Linking),,11,1977 Nov,[Functional state of the kidneys in acute leukemia].,20-5,"['Mendeleev, I M', 'Pchelko, S P', 'Livshits, E A', 'Kobelev, V A']","['Mendeleev IM', 'Pchelko SP', 'Livshits EA', 'Kobelev VA']",['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adolescent', 'Adult', 'Child', 'Female', 'Humans', 'Kidney/*physiopathology', 'Kidney Function Tests', 'Leukemia, Lymphoid/*physiopathology/urine', 'Leukemia, Monocytic, Acute/*physiopathology/urine', 'Leukemia, Myeloid, Acute/*physiopathology/urine', 'Male', 'Middle Aged']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Nov;(11):20-5.,,,Funktsional'noe sostoianie pochek u bol'nykh ostrym leikozom.,,,,
271297,NLM,MEDLINE,19780218,20071115,0031-3890 (Print) 0031-3890 (Linking),85,3,1977 Sep 30,[The postirradiation syndrome in children with acute lymphoblastic leukemia treated with central nervous system prophylaxis].,375-92,"['Esposito, L', 'Bravaccio, F', 'Di Tullio, M T', 'Casale, F']","['Esposito L', 'Bravaccio F', 'Di Tullio MT', 'Casale F']",['ita'],"['English Abstract', 'Journal Article']",Italy,Pediatria (Napoli),La Pediatria,0401207,IM,"['Brain/*radiation effects', 'Brain Neoplasms/*prevention & control', 'Child', 'Child, Preschool', 'Electroencephalography', 'Humans', 'Leukemia, Lymphoid/*radiotherapy', 'Male', '*Radiation Injuries', 'Radiotherapy/*adverse effects']",1977/09/30 00:00,1977/09/30 00:01,['1977/09/30 00:00'],"['1977/09/30 00:00 [pubmed]', '1977/09/30 00:01 [medline]', '1977/09/30 00:00 [entrez]']",,ppublish,Pediatria (Napoli). 1977 Sep 30;85(3):375-92.,,,Sindrome da postirradiazione in bambini con leucemia linfoblastica acuta sottoposti a profilassi del sistema nervoso centrale.,,,,
271272,NLM,MEDLINE,19780218,20190617,0028-0836 (Print) 0028-0836 (Linking),270,5635,1977 Nov 24,Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.,347-9,"['Collins, S J', 'Gallo, R C', 'Gallagher, R E']","['Collins SJ', 'Gallo RC', 'Gallagher RE']",['eng'],['Journal Article'],England,Nature,Nature,0410462,IM,"['Adult', 'Aneuploidy', 'Cell Differentiation', 'Cell Division', 'Cells, Cultured', 'Culture Media', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/genetics/*pathology']",1977/11/24 00:00,1977/11/24 00:01,['1977/11/24 00:00'],"['1977/11/24 00:00 [pubmed]', '1977/11/24 00:01 [medline]', '1977/11/24 00:00 [entrez]']",['10.1038/270347a0 [doi]'],ppublish,Nature. 1977 Nov 24;270(5635):347-9. doi: 10.1038/270347a0.,['0 (Culture Media)'],,,,,,
271271,NLM,MEDLINE,19780218,20101118,0028-4793 (Print) 0028-4793 (Linking),298,2,1978 Jan 12,Cellular distribution of hemoglobin F in a clonal hemopoietic stem-cell disorder.,72-5,"['Papayannopoulou, T', 'Bunn, H F', 'Stamatoyannopoulos, G']","['Papayannopoulou T', 'Bunn HF', 'Stamatoyannopoulos G']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adult', 'Anemia, Sickle Cell/blood/genetics', 'Cell Differentiation', 'Fetal Hemoglobin/*metabolism', 'Follow-Up Studies', 'Genetic Linkage', 'Glucosephosphate Dehydrogenase/metabolism', '*Hematopoietic Stem Cells', 'Heterozygote', 'Humans', 'Leukemia, Myeloid/*blood/genetics', 'Male', 'Thalassemia/blood/genetics']",1978/01/12 00:00,1978/01/12 00:01,['1978/01/12 00:00'],"['1978/01/12 00:00 [pubmed]', '1978/01/12 00:01 [medline]', '1978/01/12 00:00 [entrez]']",['10.1056/NEJM197801122980203 [doi]'],ppublish,N Engl J Med. 1978 Jan 12;298(2):72-5. doi: 10.1056/NEJM197801122980203.,"['9034-63-3 (Fetal Hemoglobin)', 'EC 1.1.1.49 (Glucosephosphate Dehydrogenase)']","Because all erythroid cells in chronic myelogenous leukemia are believed to arise from a common pluripotent stem cell, we studied the cellular distribution of fetal hemoglobin in patients with the disease to test whether cells with and without hemoglobin F have a common or separate pluripotent stem-cell origin. In a patient with chronic myelogenous leukemia and sickle/beta thalassemia, 17 per cent of the red cells during remission and 18 to 22 per cent during the blastic phase contained fetal hemoglobin. In 24 non-hemoglobinopathic leukemic patients 0.3 to 28 per cent of red cells contained hemoglobin F. Since the erythrocytes in chronic myelogenous leukemia are almost exclusively derived from the malignant clone, these data suggest that cells containing fetal hemoglobin originate from the same pluripotent stem-cell progenitor as those without hemoglobin F. The findings argue against a separate line of ""partially switched"" pluripotent stem cells as being responsible for maintenance of hemoglobin F production in the adult.",,,,,
271269,NLM,MEDLINE,19780218,20101118,0028-4793 (Print) 0028-4793 (Linking),298,2,1978 Jan 12,Cells on stems.,104,"['Desforges, J F']",['Desforges JF'],['eng'],['Editorial'],United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adult', 'Age Factors', 'Erythrocytes/analysis', 'Fetal Hemoglobin/*analysis', 'Genetic Linkage', 'Glucosephosphate Dehydrogenase/metabolism', '*Hematopoietic Stem Cells/metabolism', 'Humans', 'Leukemia, Myeloid/*blood/genetics']",1978/01/12 00:00,1978/01/12 00:01,['1978/01/12 00:00'],"['1978/01/12 00:00 [pubmed]', '1978/01/12 00:01 [medline]', '1978/01/12 00:00 [entrez]']",['10.1056/NEJM197801122980212 [doi]'],ppublish,N Engl J Med. 1978 Jan 12;298(2):104. doi: 10.1056/NEJM197801122980212.,"['9034-63-3 (Fetal Hemoglobin)', 'EC 1.1.1.49 (Glucosephosphate Dehydrogenase)']",,,,,,
271252,NLM,MEDLINE,19780218,20061115,0485-1439 (Print) 0485-1439 (Linking),18,9,1977 Sep 30,"[A case of granulocytic sarcoma of the ovary with minimal involvement of the bone marrow, liver and spleen (author's transl)].",1154-9,"['Kobayashi, M', 'Ohno, R', 'Yamada, K', 'Hirabayashi, N']","['Kobayashi M', 'Ohno R', 'Yamada K', 'Hirabayashi N']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adolescent', 'Bone Marrow Diseases/pathology', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Liver Neoplasms/pathology', 'Neoplasm Metastasis', 'Ovarian Neoplasms/*pathology', 'Splenic Neoplasms/pathology']",1977/09/30 00:00,1977/09/30 00:01,['1977/09/30 00:00'],"['1977/09/30 00:00 [pubmed]', '1977/09/30 00:01 [medline]', '1977/09/30 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Sep 30;18(9):1154-9.,,,,,,,
271251,NLM,MEDLINE,19780218,20061115,0485-1439 (Print) 0485-1439 (Linking),18,9,1977 Sep 30,[A case of chronic myelogenous leukemia with atypical clinical course seen in a radiological worker (author's transl)].,1143-9,"['Sato, I', 'Endo, K', 'Mikami, M', 'Niikawa, K', 'Sasaki, T']","['Sato I', 'Endo K', 'Mikami M', 'Niikawa K', 'Sasaki T']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Female', 'Humans', 'Leukemia, Myeloid/*etiology', '*Leukemia, Radiation-Induced/diagnosis', 'Middle Aged', '*Occupational Diseases/diagnosis', '*Public Health Nursing', '*Radiology']",1977/09/30 00:00,1977/09/30 00:01,['1977/09/30 00:00'],"['1977/09/30 00:00 [pubmed]', '1977/09/30 00:01 [medline]', '1977/09/30 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Sep 30;18(9):1143-9.,,,,,,,
271250,NLM,MEDLINE,19780218,20171116,0485-1439 (Print) 0485-1439 (Linking),18,9,1977 Sep 30,[Incidence of the Philadelphia chromosome before and after DCMP-therapy during the chronic phase of chronic myelocytic leukemia (author's transl)].,1121-7,"['Misawa, S', 'Sawai, K', 'Ide, T', 'Sonoda, Y', 'Takemura, S']","['Misawa S', 'Sawai K', 'Ide T', 'Sonoda Y', 'Takemura S']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adult', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Cytarabine/administration & dosage', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Mercaptopurine/administration & dosage', 'Mitobronitol/administration & dosage', 'Prednisone/administration & dosage']",1977/09/30 00:00,1977/09/30 00:01,['1977/09/30 00:00'],"['1977/09/30 00:00 [pubmed]', '1977/09/30 00:01 [medline]', '1977/09/30 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Sep 30;18(9):1121-7.,"['04079A1RDZ (Cytarabine)', '5UP30YED7N (Mitobronitol)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)']",,,,,,
271249,NLM,MEDLINE,19780218,20071115,0485-1439 (Print) 0485-1439 (Linking),18,9,1977 Sep 30,[Clinical study of central nervous system leukemia in childhood: analysis of factors influencing incidence of CNS-leukemia (author's transl)].,1082-9,"['Fujimoto, T', 'Miyazaki, S', 'Take, H', 'Kishida, K', 'Goya, N']","['Fujimoto T', 'Miyazaki S', 'Take H', 'Kishida K', 'Goya N']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adolescent', 'Central Nervous System Diseases/*etiology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/*complications', 'Male']",1977/09/30 00:00,1977/09/30 00:01,['1977/09/30 00:00'],"['1977/09/30 00:00 [pubmed]', '1977/09/30 00:01 [medline]', '1977/09/30 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Sep 30;18(9):1082-9.,,,,,,,
271248,NLM,MEDLINE,19780218,20131121,0485-1439 (Print) 0485-1439 (Linking),18,10,1977 Oct,[Uric acid nephropathy in a case of AML (author's transl)].,1241-5,"['Sonoda, Y', 'Sawai, K', 'Misawa, S', 'Takino, T', 'Abe, T']","['Sonoda Y', 'Sawai K', 'Misawa S', 'Takino T', 'Abe T']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Acute Kidney Injury/*etiology/therapy', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications/drug therapy', 'Middle Aged', 'Prednisolone/adverse effects', 'Renal Dialysis', 'Uric Acid/*metabolism']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Oct;18(10):1241-5.,"['268B43MJ25 (Uric Acid)', '9PHQ9Y1OLM (Prednisolone)']",,,,,,
271247,NLM,MEDLINE,19780218,20041117,0485-1439 (Print) 0485-1439 (Linking),18,10,1977 Oct,[The significance of splenectomy and its indication in chronic myelocytic leukemia (author's transl)].,1191-201,"['Kamada, N']",['Kamada N'],['jpn'],['Journal Article'],Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Humans', 'Leukemia, Myeloid/*therapy', '*Splenectomy']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Oct;18(10):1191-201.,,,,,,,
271171,NLM,MEDLINE,19780223,20190819,0022-1422 (Print) 0022-1422 (Linking),33,1,1978 Jan,Age and treatment response in acute nonlymphoblastic leukemia.,52-6,"['Crowell, E B Jr', 'MacKinney, A A', 'Pisciotta, A V', 'Schloesser, L L', 'Keimowitz, R M']","['Crowell EB Jr', 'MacKinney AA', 'Pisciotta AV', 'Schloesser LL', 'Keimowitz RM']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial']",United States,J Gerontol,Journal of gerontology,0374762,IM,"['Age Factors', 'Aged', 'Antineoplastic Agents/pharmacology/*therapeutic use', 'Bone Marrow/drug effects', 'Cytarabine/therapeutic use', 'Depression, Chemical', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Middle Aged', 'Prednisone/therapeutic use', 'Prognosis', 'Thioguanine/therapeutic use', 'Time Factors', 'Vincristine/therapeutic use']",1978/01/01 00:00,2001/03/28 10:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1093/geronj/33.1.52 [doi]'],ppublish,J Gerontol. 1978 Jan;33(1):52-6. doi: 10.1093/geronj/33.1.52.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']",Treatment of older acute leukemia patients has been the subject of recent debate. We treated 101 acute leukemia patients in a prospective randomized trial. Fifty-seven per cent of the population was over 50. Half were treated with a mild induction program (VAMP) and half with a vigorous program (CAT). The older patients who received vigorous treatment did better than those who received mild treatment. We suggest that patients over 50 should be regarded as a separate category in design of treatment protocols in order to further maximize the benefits of therapy.,,,,,
271151,NLM,MEDLINE,19780218,20131121,0021-9541 (Print) 0021-9541 (Linking),93,2,1977 Nov,Glucocorticoid binding and mechanism of resistance in some clones of mouse myeloid leukemic cells resistant to induction of differentiation by dexamethasone.,227-35,"['Honma, Y', 'Kasukabe, T', 'Okabe, J', 'Hozumi, M']","['Honma Y', 'Kasukabe T', 'Okabe J', 'Hozumi M']",['eng'],['Journal Article'],United States,J Cell Physiol,Journal of cellular physiology,0050222,IM,"['Animals', 'Cell Nucleus/metabolism', 'Clone Cells', 'Cytoplasm/metabolism', 'Dexamethasone/*metabolism', 'Leukemia, Myeloid/*metabolism', 'Mice', 'Rauscher Virus', '*Receptors, Steroid']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1002/jcp.1040930208 [doi]'],ppublish,J Cell Physiol. 1977 Nov;93(2):227-35. doi: 10.1002/jcp.1040930208.,"['0 (Receptors, Steroid)', '7S5I7G3JQL (Dexamethasone)']","Several clones of dexamethasone-resistant cells, which could not differentiate even in a high concentration of dexamethasone, were isolated from glucocorticoid-sensitive myeloid leukemic cells. Some of them were shown to be deficient in steroid binding to specific cytoplasmic receptors, while the others contained glucocorticoid-specific cytoplasmic receptors that might be the same as those in sensitive cells. One of the resistant clones was found to be almost completely deficient in nuclear acceptor sites for cytoplasmic steroid-receptor complexes. The remaining clones were also characterized by significantly reduced amounts of nuclear-bound glucocorticoid. These results suggest that resistibility to glucocorticoids in the resistant clones of myeloid leukemic cells is due mainly to a defect in some steps of intracellular transfer of the steroid. Dexamethasone-sensitive cells, which could differentiate in the presence of dexamethasone, could be also induced to differentiate by protein factor(s) in ascitic fluid. Although all the resistant cells showed a low response to ascitic fluid, some of them showed 10-fold enhancement of phagocytic activity which is a typical character of differentiated cells. These results suggest that response to steroids is not directly correlated with that to protein inducer(s).",,,,,
271145,NLM,MEDLINE,19780218,20190708,0360-3016 (Print) 0360-3016 (Linking),2,9-10,1977 Sep-Oct,Special set-up and treatment techniques for the radiotherapy of pediatric malignancies.,1007-16,"['Martinez, A', 'Donaldson, S S', 'Bagshaw, M A']","['Martinez A', 'Donaldson SS', 'Bagshaw MA']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Int J Radiat Oncol Biol Phys,"International journal of radiation oncology, biology, physics",7603616,IM,"['Adolescent', 'Bone Neoplasms/*radiotherapy', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/*radiotherapy', 'Male', 'Maxilla', 'Radiotherapy/*methods', 'Rhabdomyosarcoma/*radiotherapy', 'Ribs', 'Sarcoma, Ewing/*radiotherapy']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']","['0360-3016(77)90203-6 [pii]', '10.1016/0360-3016(77)90203-6 [doi]']",ppublish,Int J Radiat Oncol Biol Phys. 1977 Sep-Oct;2(9-10):1007-16. doi: 10.1016/0360-3016(77)90203-6.,,,,,,,
271144,NLM,MEDLINE,19780218,20190708,0020-7136 (Print) 0020-7136 (Linking),20,6,1977 Dec 15,Inhibition of RNA and protein syntheses makes non-differentiating mouse myeloid leukemia cells sensitive to a factor(s) stimulating differentiation.,933-40,"['Okabe, J', 'Honma, Y', 'Hozumi, M']","['Okabe J', 'Honma Y', 'Hozumi M']",['eng'],['Journal Article'],United States,Int J Cancer,International journal of cancer,0042124,IM,"['Animals', 'Antibiotics, Antineoplastic/pharmacology', '*Ascitic Fluid', '*Cell Differentiation', '*Cell Line', 'Cell Movement/drug effects', 'Clone Cells', 'Dactinomycin/pharmacology', 'Granulocytes/drug effects', 'Leukemia, Experimental/immunology', 'Leukemia, Myeloid/*immunology', 'Macrophages/drug effects', 'Neoplasm Proteins/*biosynthesis', 'Phagocytosis/drug effects', 'RNA, Neoplasm/*biosynthesis', 'Rats']",1977/12/15 00:00,1977/12/15 00:01,['1977/12/15 00:00'],"['1977/12/15 00:00 [pubmed]', '1977/12/15 00:01 [medline]', '1977/12/15 00:00 [entrez]']",['10.1002/ijc.2910200617 [doi]'],ppublish,Int J Cancer. 1977 Dec 15;20(6):933-40. doi: 10.1002/ijc.2910200617.,"['0 (Antibiotics, Antineoplastic)', '0 (Neoplasm Proteins)', '0 (RNA, Neoplasm)', '1CC1JFE158 (Dactinomycin)']","Treatment with ascitic fluid from animals bearing various tumors, can induce mouse myeloid leukemia line cells, M1, to differentiate in vitro into macrophages and granulocytes. Cells were isolated that were resistant to the ascitic fluid factor(s) stimulating differentiation (D-factor). The resistant cells became sensitive to the D-factor and differentiated after treatment with various inhibitors of RNA synthesis (actinomycin D, nogalamycin, chromomycin A3 or cordycepin) or protein synthesis (puromycin or cycloheximide). The cells could not be induced to differentiate by treatment with the inhibitors alone. The effective doses of the inhibitors of protein synthesis were toxic to the cells. Among these inhibitors actinomycin D (5 ng/ml) was the most effective for sensitizing the resistant cells. Inhibitors of DNA synthesis did not sensitize the resistant cells. Added actinomcyin D was mainly recovered in the nuclear fraction of the cells. The sensitizing effect of actinomycin D on the cells was roughly parallel to the extent of its inhibition of RNA synthesis in the cells. The effective concentration of actinomycin D (5 ng/ml) mainly inhibited it also inhibited alpha-amanitin-resistant RNA synthesis to some extent. These results suggest that alpha-amanitin-sensitive RNA synthesis may be involved in sensitization of the resistant cells to the D-factor.",,,,,
271143,NLM,MEDLINE,19780218,20190708,0020-7136 (Print) 0020-7136 (Linking),20,6,1977 Dec 15,Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia.,869-72,"['Rowley, J D', 'Golomb, H M', 'Vardiman, J', 'Fukuhara, S', 'Dougherty, C', 'Potter, D']","['Rowley JD', 'Golomb HM', 'Vardiman J', 'Fukuhara S', 'Dougherty C', 'Potter D']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Int J Cancer,International journal of cancer,0042124,IM,"['Adult', '*Chromosome Deletion', '*Chromosomes, Human, 16-18', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid, Acute/*genetics', 'Male', '*Translocation, Genetic']",1977/12/15 00:00,1977/12/15 00:01,['1977/12/15 00:00'],"['1977/12/15 00:00 [pubmed]', '1977/12/15 00:01 [medline]', '1977/12/15 00:00 [entrez]']",['10.1002/ijc.2910200608 [doi]'],ppublish,Int J Cancer. 1977 Dec 15;20(6):869-72. doi: 10.1002/ijc.2910200608.,,"We have previously reported on two patients with acute promyelocytic leukemia (APL) who had what appeared to be a deletion of chromosome No. 17. We now describe a third patient with APL. All three patients had a structural rearrangement involving No. 15 and No. 17. Our current interpretation of the chromosomal abnormality is that it is a reciprocal translocation, t (15;17) (q22; q21). Evidence that this is a consistent rearrangement associated with APL comes not only from our three patients, but also from two other published cases of APL, studied with banding, who also had an identical abnormality.",,,,,
271142,NLM,MEDLINE,19780218,20190708,0020-7136 (Print) 0020-7136 (Linking),20,6,1977 Dec 15,Tumor-associated humoral cytotoxicity in patients with acute myelogenous leukemia before and after chemotherapy.,824-33,"['Faldt, R', 'Ankerst, J']","['Faldt R', 'Ankerst J']",['eng'],['Journal Article'],United States,Int J Cancer,International journal of cancer,0042124,IM,"['Adult', 'Antineoplastic Agents/*therapeutic use', 'Complement System Proteins', 'Cytotoxicity Tests, Immunologic', '*Cytotoxicity, Immunologic', 'Female', 'Humans', 'Immunoglobulins/analysis', 'Leukemia, Myeloid, Acute/drug therapy/*immunology', 'Leukocytes/*immunology', 'Male', 'Middle Aged']",1977/12/15 00:00,1977/12/15 00:01,['1977/12/15 00:00'],"['1977/12/15 00:00 [pubmed]', '1977/12/15 00:01 [medline]', '1977/12/15 00:00 [entrez]']",['10.1002/ijc.2910200603 [doi]'],ppublish,Int J Cancer. 1977 Dec 15;20(6):824-33. doi: 10.1002/ijc.2910200603.,"['0 (Antineoplastic Agents)', '0 (Immunoglobulins)', '9007-36-7 (Complement System Proteins)']","Sera of eight unselected adult patients with acute myelogenous leukemia obtained before and after chemotherapy were repeatedly tested for specific complement-dependent cytotoxicity against autochthonous peripheral white blood cells from the acute leukemia stage and from the remission stage, respectively. Complement-dependent cytotas demonstrated in all of the eight patients, while none of three patients' sera were reactive against white blood cells from the remission stage tested in parallel. The cytotoxicity was increased after chemotherapy, also in those patients in whom remission was not achieved.",,,,,
271076,NLM,MEDLINE,19780223,20190707,0014-4827 (Print) 0014-4827 (Linking),110,2,1977 Dec,Decreased deoxy-D-glucose transport in Friend cells during exposure to inducers of erythroid differentiation.,375-85,"['Germinario, R J', 'Kleiman, L', 'Peters, S', 'Oliveira, M']","['Germinario RJ', 'Kleiman L', 'Peters S', 'Oliveira M']",['eng'],['Journal Article'],United States,Exp Cell Res,Experimental cell research,0373226,IM,"['Biological Transport/drug effects', 'Cell Line', 'Cytochalasin B/pharmacology', 'Deoxy Sugars/*metabolism', 'Deoxyglucose/*metabolism', 'Dimethyl Sulfoxide/pharmacology', '*Erythropoiesis/drug effects', 'Friend murine leukemia virus', 'Glucose/metabolism', 'Hemoglobins/biosynthesis', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Neoplasms, Experimental/metabolism', 'RNA, Messenger/biosynthesis']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']","['0014-4827(77)90304-4 [pii]', '10.1016/0014-4827(77)90304-4 [doi]']",ppublish,Exp Cell Res. 1977 Dec;110(2):375-85. doi: 10.1016/0014-4827(77)90304-4.,"['0 (Deoxy Sugars)', '0 (Hemoglobins)', '0 (RNA, Messenger)', '3CHI920QS7 (Cytochalasin B)', '9G2MP84A8W (Deoxyglucose)', 'IY9XDZ35W2 (Glucose)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
271074,NLM,MEDLINE,19780218,20190907,0014-2964 (Print) 0014-2964 (Linking),13,11,1977 Nov,A method for the quantitative detection of human acute lymphatic leukemia.,1231-6,"['Inbar, M', 'Larnicol, N', 'Jasmin, C', 'Mishal, Z', 'Augery, Y', 'Rosenfeld, C', 'Mathe, G']","['Inbar M', 'Larnicol N', 'Jasmin C', 'Mishal Z', 'Augery Y', 'Rosenfeld C', 'Mathe G']",['eng'],['Journal Article'],England,Eur J Cancer,European journal of cancer,0074126,IM,"['Humans', 'Leukemia, Lymphoid/*diagnosis/pathology', 'Lymphocytes/pathology', 'Membrane Lipids/*analysis', 'Prognosis', 'Spectrometry, Fluorescence', 'Viscosity']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1016/0014-2964(77)90029-9 [doi]'],ppublish,Eur J Cancer. 1977 Nov;13(11):1231-6. doi: 10.1016/0014-2964(77)90029-9.,['0 (Membrane Lipids)'],,,,,,
271073,NLM,MEDLINE,19780218,20190620,0014-2956 (Print) 0014-2956 (Linking),81,1,1977 Nov 15,Correlation between hypomethylation of DNA and expression of globin genes in Friend erythroleukemia cells.,53-61,"['Christman, J K', 'Price, P', 'Pedrinan, L', 'Acs, G']","['Christman JK', 'Price P', 'Pedrinan L', 'Acs G']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Eur J Biochem,European journal of biochemistry,0107600,IM,"['Cell Differentiation/drug effects', 'Cell Division/drug effects', 'Cell Line', 'DNA (Cytosine-5-)-Methyltransferases/*metabolism', 'DNA, Viral/*metabolism', 'Ethionine/pharmacology', 'Globins/*biosynthesis', 'Kinetics', 'Leukemia, Erythroblastic, Acute/metabolism', 'Methyltransferases/*metabolism', 'Neoplasms, Experimental/metabolism', 'Nucleic Acid Hybridization', '*Protein Biosynthesis', 'RNA, Messenger/metabolism', 'RNA, Transfer/metabolism', '*Transcription, Genetic', 'tRNA Methyltransferases/metabolism']",1977/11/15 00:00,1977/11/15 00:01,['1977/11/15 00:00'],"['1977/11/15 00:00 [pubmed]', '1977/11/15 00:01 [medline]', '1977/11/15 00:00 [entrez]']",['10.1111/j.1432-1033.1977.tb11926.x [doi]'],ppublish,Eur J Biochem. 1977 Nov 15;81(1):53-61. doi: 10.1111/j.1432-1033.1977.tb11926.x.,"['0 (DNA, Viral)', '0 (RNA, Messenger)', '9004-22-2 (Globins)', '9014-25-9 (RNA, Transfer)', 'EC 2.1.1.- (Methyltransferases)', 'EC 2.1.1.- (tRNA Methyltransferases)', 'EC 2.1.1.37 (DNA (Cytosine-5-)-Methyltransferases)', 'WX1BN24WZT (Ethionine)']","This report identifies L-ethionine as an inducer of differentiation in murine erythroleukemia cells. When Friend erythroleukemia cells are grown in the presence of 4mM L-ethionine, globin mRNA accumulates and in 4-5 days, 25-30% of the cells in the culture contain hemoglobin. Incubation of the cells with bromodeoxyuridine prevents both ethionine-induced accumulation of globin mRNA and erythroide differentiation. At the concentration where L-ethionine acts as an inducer of FL cell differentiation it inhibits methylation of DNA and tRNA in vivo but does not prevent macromolecular synthesis or cell division. To establish whether a link existed between inhibition of a specific methyltransferase and activation of globin synthesis in FL cells, we examined the degree of hypomethylation of DNA and tRNA from FL cells induced to differentiate with dimethylsulfoxide and butyrate. In contrast to the tRNA from ethionine-treated cells, tRNA from cells induced by butyrate or Me2SO cannot be methylated in vitro using homologous enzymes. DNA isolated from cells exposed to any of the three inducers, however, was significantly hypomethylated when compared with DNA from uninduced cells. These data suggest that methylation of DNA may play a role in the regulation of gene expression.",,,,,
271072,NLM,MEDLINE,19780218,20071115,0012-0472 (Print) 0012-0472 (Linking),102,49,1977 Dec 9,[Acute myeloid leukemia in the course of Hodgkin's disease].,1824,"['Kuse, R', 'Hausmann, K']","['Kuse R', 'Hausmann K']",['ger'],['Letter'],Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Hodgkin Disease/*complications', 'Humans', 'Leukemia, Myeloid, Acute/*etiology']",1977/12/09 00:00,1977/12/09 00:01,['1977/12/09 00:00'],"['1977/12/09 00:00 [pubmed]', '1977/12/09 00:01 [medline]', '1977/12/09 00:00 [entrez]']",,ppublish,Dtsch Med Wochenschr. 1977 Dec 9;102(49):1824.,,,Akute myeloische Leukamie im Krankheitsverlauf des Morbus Hodgkin.,,,,
271046,NLM,MEDLINE,19780218,20131121,0361-5960 (Print) 0361-5960 (Linking),61,7,1977 Oct,Time relationship between last dose of daunorubicin and congestive heart failure.,1411-3,"['Von Hoff, D D', 'Layard, M', 'Rozencweig, M', 'Muggia, F M']","['Von Hoff DD', 'Layard M', 'Rozencweig M', 'Muggia FM']",['eng'],['Letter'],United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Daunorubicin/administration & dosage/therapeutic use', 'Heart Failure/*chemically induced', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Time Factors']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Oct;61(7):1411-3.,['ZS7284E0ZP (Daunorubicin)'],,,,,,
271045,NLM,MEDLINE,19780218,20131121,0361-5960 (Print) 0361-5960 (Linking),61,7,1977 Oct,Treatment of refractory acute leukemia with high-dose chemotherapy.,1397-8,"['Kramer, B S', 'Appelbaum, F R', 'Herzig, G P', 'Graw, R G Jr', 'Levine, A S']","['Kramer BS', 'Appelbaum FR', 'Herzig GP', 'Graw RG Jr', 'Levine AS']",['eng'],['Journal Article'],United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/*administration & dosage', 'Child', 'Cyclophosphamide/administration & dosage/therapeutic use', 'Cytarabine/administration & dosage/therapeutic use', 'Drug Administration Schedule', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Semustine/administration & dosage/therapeutic use', 'Thioguanine/administration & dosage/therapeutic use']",1977/10/01 00:00,2001/03/28 10:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Oct;61(7):1397-8.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', '13909-09-6 (Semustine)', '8N3DW7272P (Cyclophosphamide)', 'FTK8U1GZNX (Thioguanine)']",,,,,,
271044,NLM,MEDLINE,19780218,20071115,0361-5960 (Print) 0361-5960 (Linking),61,7,1977 Oct,Murine myeloid leukemia: I. Pathophysiology and drug sensitivity.,1259-68,"['Preisler, H D', 'Bjornsson, S', 'Mori, M']","['Preisler HD', 'Bjornsson S', 'Mori M']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Alkylating Agents/therapeutic use', 'Animals', 'Antimetabolites, Antineoplastic/therapeutic use', 'Bone Marrow/pathology', 'Leukemia, Experimental/drug therapy/*physiopathology', 'Leukemia, Myeloid, Acute/drug therapy/*physiopathology', 'Mice', 'Spleen/pathology']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Oct;61(7):1259-68.,"['0 (Alkylating Agents)', '0 (Antimetabolites, Antineoplastic)']",The pathophysiology of serially passaged myeloid leukemia of the RFM mouse was studied. The disease was characterized by progressive splenomegaly and infiltration of both marrow and spleen by myeloblasts. The animals became anemic and there was an associated erythroid hyperplasia in the spleen. Leukemic spleen cells obtained from animals early in the course of the leukemia were less malignant than those obtained from preterminal mice. The leukemia is most sensitive to alkylating agents but is also responsive to antimetabolites.,,,,,
271043,NLM,MEDLINE,19780218,20071115,0008-5472 (Print) 0008-5472 (Linking),38,1,1978 Jan,Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy.,181-4,"['Khilanani, P', 'Chou, T H', 'Kessel, D']","['Khilanani P', 'Chou TH', 'Kessel D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Antineoplastic Agents/*pharmacology', 'Bone Marrow/drug effects/*enzymology/pathology', 'Guanosine Diphosphate Fucose', 'Hexosyltransferases/*blood', 'Humans', 'Hyperplasia', 'Leukemia, Myeloid, Acute/drug therapy/*enzymology/pathology', 'Lymphoma/drug therapy/*enzymology/pathology', 'Remission, Spontaneous']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jan;38(1):181-4.,"['0 (Antineoplastic Agents)', '15839-70-0 (Guanosine Diphosphate Fucose)', 'EC 2.4.1.- (Hexosyltransferases)']","We have measured the plasma level of a fucosyltransferase in patients with acute myelogenous leukemia and non-Hodgkin's lymphoma at various stages of the disease and in normal controls. This enzyme transfers the sugar fucose from a guanosine diphosphate-L-fucose donor to high-molecular-weight acceptors with a terminal N-acetyl-glucosamine residue. The enzyme levels of fucosyltransferase in individuals free from disease and in patients with untreated leukemia or lymphoma were comparable. A substantial increase in plasma enzyme level was measured during drug-induced remissions, three weeks after drug therapy. The enzyme level fell to the normal range during unmaintained remissions inpatients with lymphomas; comparable information for the leukemia is not available since all remissions were drug maintained. These data, together with microscopic examination of marrow samples, indicate that the level of this fucosyltransferase is correlated with regeneration of a normal marrow population after chemotherapy. The enzyme assay may prove useful in defining normal bone marrow recovery and in timing cyclic combination chemotherapy in patients with neoplastic disease.",,,,,
271042,NLM,MEDLINE,19780218,20061115,0008-5472 (Print) 0008-5472 (Linking),38,1,1978 Jan,Transplantable granulocytic leukemia in strain 13 guinea pigs.,130-6,"['Evans, W H', 'Mage, M G', 'Hsu, C K', 'Himmelhoch, S R', 'Smith, G H']","['Evans WH', 'Mage MG', 'Hsu CK', 'Himmelhoch SR', 'Smith GH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Alkaline Phosphatase/metabolism', 'Animals', 'Female', 'Granulocytes/pathology', 'Guinea Pigs', 'Inclusion Bodies, Viral', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid/chemically induced/enzymology/*pathology', 'Neoplasm Transplantation', 'Nitrosourea Compounds', 'Transplantation, Homologous']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jan;38(1):130-6.,"['0 (Nitrosourea Compounds)', 'EC 3.1.3.1 (Alkaline Phosphatase)']","The occurrence of a granulocytic leukemia in 1 of 40 female strain 13/N guinea pigs given N-nitroso-N-butylurea continuously in their drinking water for 21 weeks is reported here. This leukemia has been successfully transplanted in this guinea pig strain for 13 transplant generations by i.p. inoculation of leukemic blood or marrow cells. Macroscopically and microscopically, this leukemia resembles the chronic myelogenous form in humans. Histochemical studies showed, however, that unlike the human leukemic cells those in the leukemic guinea pigs are alkaline phosphatase positive. Electron microscopic studies of the guinea pig leukemic cells revealed the presence of numerous intracisternal A-type particles that are not found in corresponding normal leukocytes.",,,,,
271041,NLM,MEDLINE,19780218,20141120,0008-5472 (Print) 0008-5472 (Linking),38,1,1978 Jan,A factor in human saliva that induces differentiation of mouse myeloid leukemia cells.,103-9,"['Nakayasu, M', 'Shimamura, S', 'Takeuchi, T', 'Sato, S', 'Sugimura, T']","['Nakayasu M', 'Shimamura S', 'Takeuchi T', 'Sato S', 'Sugimura T']",['eng'],['Journal Article'],United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Cell Differentiation', 'Cell Movement', 'Cells, Cultured', 'Granulocytes/pathology/physiology', 'Humans', 'In Vitro Techniques', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid/*pathology/physiopathology', 'Macrophages/pathology/physiology', 'Mice', 'Phagocytosis', 'Saliva/*physiology']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cancer Res. 1978 Jan;38(1):103-9.,,"The differentiated functions of phagocytosis, locomotion, and morphological changes into cells resembling granulocytes and macrophages were induced in cultured mouse myeloid leukemic cells, M1 clone 34, by treatment with human saliva. The rates of induction of these differentiated phenotypes were proportional to the concentration of saliva added and the period of treatment. The factor inducing differentiation was nondialyzable and heat labile. This factor was purified 70-fold by fractionation with Diaflo membranes and DE52 column chromatography. The activities inducing the three differentiated characters examined were purified together, suggesting that they were all due to the same factor.",,,,,
271040,NLM,MEDLINE,19780223,20190619,0008-543X (Print) 0008-543X (Linking),40,6,1977 Dec,Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: report of a case.,3107-11,"['Myerowitz, R L', 'Edwards, P A', 'Sartiano, G P']","['Myerowitz RL', 'Edwards PA', 'Sartiano GP']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adenocarcinoma/*blood/pathology', 'Breast Neoplasms/*blood', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/diagnosis', 'Middle Aged', 'Neoplasm Metastasis/blood', '*Neoplastic Cells, Circulating']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1002/1097-0142(197712)40:6<3107::aid-cncr2820400653>3.0.co;2-5 [doi]'],ppublish,Cancer. 1977 Dec;40(6):3107-11. doi: 10.1002/1097-0142(197712)40:6<3107::aid-cncr2820400653>3.0.co;2-5.,,"A patient with a 17-year course of metastatic lobular carcinoma of the breast is described who developed large numbers of circulating carcinoma cells which were easily detectable in several routine peripheral blood smears shortly before death. This rare complication of carcinoma has been called ""carcinocythemia."" Carcinocythemia is probably due to widespread infiltration of many bone marrow sites and may also be related to splenectomy, which may impair reticuloendothelial clearance of circulating tumor cells. The differential diagnosis of carcinocythemia from superimposed acute myelogenous leukemia, which can complicate radiotherapy and chemotherapy for the primary tumor, is discussed. Cytomorphology, histochemistry, and electron microscopy of abnormal circulating cells should aid in the distinction of these two processes.",,,,,
271037,NLM,MEDLINE,19780223,20190619,0008-543X (Print) 0008-543X (Linking),40,6,1977 Dec,Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.,2817-22,"['Breuer, A C', 'Pitman, S W', 'Dawson, D M', 'Schoene, W C']","['Breuer AC', 'Pitman SW', 'Dawson DM', 'Schoene WC']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Aged', 'Cytarabine/administration & dosage/*adverse effects', 'Humans', 'Injections, Spinal', 'Leukemia, Myeloid, Acute/therapy', 'Male', 'Muscle Spasticity/*chemically induced/etiology/pathology', 'Spinal Cord/*drug effects/pathology']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1002/1097-0142(197712)40:6<2817::aid-cncr2820400611>3.0.co;2-v [doi]'],ppublish,Cancer. 1977 Dec;40(6):2817-22. doi: 10.1002/1097-0142(197712)40:6<2817::aid-cncr2820400611>3.0.co;2-v.,['04079A1RDZ (Cytarabine)'],"A 65-year-old white male with acute myelogenous leukemia received whole brain irradiation (2550 rads) and intrathecal cytosine arabinoside for CNS prophylaxis. Bone marrow remission had been previously achieved with systemic chemotherapy (vincristine, Adriamycin, prednisone, and cytosine arabinoside). Two weeks following the last intrathecal cytosine arabinoside treatment, the patient developed a spastic paraparesis requiring the use of a walker. A gas myelogram was normal and CSF examination revealed a protein of 50 mg/100 ml but was otherwise unremarkable. Five months later, the patient had improved in that he could stand on his own. A relapse of his leukemia subsequently occurred and the patient died the following month. Striking degenerative changes were found in the spinal cord at postmortem examination. These included microvacuolization, axonal swellings, and loss of myelin with scattered macrophages laden with fat.",,,,,
271033,NLM,MEDLINE,19780218,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6101,1977 Dec 10,Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.,1511-2,"['Craft, A W', 'Kay, H', 'Lawson, D N', 'McElwain, T J']","['Craft AW', 'Kay H', 'Lawson DN', 'McElwain TJ']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Malabsorption Syndromes/*chemically induced', 'Male', 'Methotrexate/*adverse effects/therapeutic use', 'Time Factors', 'Xylose/metabolism']",1977/12/10 00:00,1977/12/10 00:01,['1977/12/10 00:00'],"['1977/12/10 00:00 [pubmed]', '1977/12/10 00:01 [medline]', '1977/12/10 00:00 [entrez]']",['10.1136/bmj.2.6101.1511 [doi]'],ppublish,Br Med J. 1977 Dec 10;2(6101):1511-2. doi: 10.1136/bmj.2.6101.1511.,"['A1TA934AKO (Xylose)', 'YL5FZ2Y5U1 (Methotrexate)']","A one-hour D-xylose absorption test was performed on 18 children with acute lymphoblastic leukaemia. Xylose absorption was normal in children who had not received methotrexate, but there was a significant degree of malabsorption in those who had taken methotrexate within the previous seven days. There was a progressive and significant increase in malabsorption related to the cumulative dose of methotrexate. These findings provide further evidence that regular methotrexate treatment every seven days is more toxic than if it is more widely spaced. The spacing of treatment is currently under investigation.",,PMC1632775,,,
271032,NLM,MEDLINE,19780218,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6099,1977 Nov 26,Chronic myeloid leukaemia of adult type in 5-month-old infant.,1397,"['Boque, A', 'Wilson, R G']","['Boque A', 'Wilson RG']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Age Factors', 'Humans', 'Infant', 'Leukemia, Myeloid/*blood/drug therapy', 'Male']",1977/11/26 00:00,1977/11/26 00:01,['1977/11/26 00:00'],"['1977/11/26 00:00 [pubmed]', '1977/11/26 00:01 [medline]', '1977/11/26 00:00 [entrez]']",['10.1136/bmj.2.6099.1397 [doi]'],ppublish,Br Med J. 1977 Nov 26;2(6099):1397. doi: 10.1136/bmj.2.6099.1397.,,,,PMC1632343,,,
271031,NLM,MEDLINE,19780218,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6098,1977 Nov 19,Meningeal leukaemia in lymphoid blast crisis of chronic myeloid leukaemia.,1325-6,"['Woodruff, R K', 'Malpas, J S', 'Wrigley, P F', 'Lister, T A', 'Paxton, A M', 'Janossy, G']","['Woodruff RK', 'Malpas JS', 'Wrigley PF', 'Lister TA', 'Paxton AM', 'Janossy G']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Cell Cycle', 'Chromosome Aberrations', 'Chromosome Disorders', 'Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia/complications', 'Leukemia, Myeloid/*complications', '*Lymphocyte Activation', 'Meningeal Neoplasms/*complications', 'Middle Aged']",1977/11/19 00:00,1977/11/19 00:01,['1977/11/19 00:00'],"['1977/11/19 00:00 [pubmed]', '1977/11/19 00:01 [medline]', '1977/11/19 00:00 [entrez]']",['10.1136/bmj.2.6098.1325 [doi]'],ppublish,Br Med J. 1977 Nov 19;2(6098):1325-6. doi: 10.1136/bmj.2.6098.1325.,,,,PMC1632520,,,
271030,NLM,MEDLINE,19780218,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6098,1977 Nov 19,Lymphoid blast crisis in chronic myeloid leukaemia.,1303-4,,,['eng'],['Editorial'],England,Br Med J,British medical journal,0372673,IM,"['Cell Cycle', 'Chromosome Aberrations', 'Chromosome Disorders', 'Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Myeloid/*pathology', '*Lymphocyte Activation']",1977/11/19 00:00,1977/11/19 00:01,['1977/11/19 00:00'],"['1977/11/19 00:00 [pubmed]', '1977/11/19 00:01 [medline]', '1977/11/19 00:00 [entrez]']",['10.1136/bmj.2.6098.1303 [doi]'],ppublish,Br Med J. 1977 Nov 19;2(6098):1303-4. doi: 10.1136/bmj.2.6098.1303.,,,,PMC1632557,,,
271023,NLM,MEDLINE,19780223,20210216,0006-4971 (Print) 0006-4971 (Linking),51,1,1978 Jan,Method for enrichment of proliferating myeloid cells from normal and leukemic human bone marrow.,9-20,"['Burghouts, J', 'Plas, A M', 'Wessels, J', 'Hillen, H', 'Steenbergen, J', 'Haanen, C']","['Burghouts J', 'Plas AM', 'Wessels J', 'Hillen H', 'Steenbergen J', 'Haanen C']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['*Bone Marrow Cells', 'Cell Count', 'Cell Separation', '*Cell Transformation, Neoplastic', 'Centrifugation', 'Centrifugation, Density Gradient', 'DNA/biosynthesis', '*Hematopoiesis', 'Humans', 'Hypotonic Solutions', 'Leukemia, Myeloid, Acute/*blood']",1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['S0006-4971(20)66581-8 [pii]'],ppublish,Blood. 1978 Jan;51(1):9-20.,"['0 (Hypotonic Solutions)', '9007-49-2 (DNA)']",,,,,,
271013,NLM,MEDLINE,19780218,20071115,0007-1048 (Print) 0007-1048 (Linking),37,1,1977 Sep,Refractory anaemia with excess of myeloblasts in the bone marrow: a clinical trial of androgens in 90 patients.,25-33,"['Najean, Y', 'Pecking, A']","['Najean Y', 'Pecking A']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adult', 'Aged', 'Androgens/adverse effects/*therapeutic use', 'Anemia, Aplastic/*drug therapy', 'Bone Marrow/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/chemically induced', 'Male', 'Middle Aged', 'Prognosis']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Br J Haematol. 1977 Sep;37(1):25-33.,['0 (Androgens)'],"In a cooperative trial, 90 patients with refractory anaemia with an excess of blast cells in the marrow were evaluated and treated with androgens. The clinical presentation was very similar to previously published observations: features of medullary insufficiency were less marked than in primary aplastic anaemia; bone marrow blastic infiltration varied from case to case, and remained stable until death or until an acute leukaemic change. All the patients were treated with high doses of androgens as for aplastic anaemia. The efficacy of this therapy was poor. The average life expectancy was 13 months, 64% of deaths being associated with a change to acute myeloid leukaemia. A severe bone marrow deficiency foreshadowed early death, but myeloblastic transformation was observed whatever the initial degree of blastic infiltration of the bone marrow. A comparison with the literature suggests that androgen therapy may accelerate the change to acute leukaemia.",,,,,
271012,NLM,MEDLINE,19780218,20190704,0007-1048 (Print) 0007-1048 (Linking),37,1,1977 Sep,The immunotherapy of acute myelogenous leukaemia using intravenous BCG.,153-4,"['Whittaker, J A', 'Slater, A J']","['Whittaker JA', 'Slater AJ']",['eng'],['Letter'],England,Br J Haematol,British journal of haematology,0372544,IM,"['BCG Vaccine/*therapeutic use', 'Leukemia, Myeloid, Acute/mortality/*therapy', 'Time Factors']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb08822.x [doi]'],ppublish,Br J Haematol. 1977 Sep;37(1):153-4. doi: 10.1111/j.1365-2141.1977.tb08822.x.,['0 (BCG Vaccine)'],,,,,,
271011,NLM,MEDLINE,19780218,20190515,0007-0920 (Print) 0007-0920 (Linking),36,4,1977 Oct,Direct and serial transplantation of a Ph + ve human myeloblastoid tumour into nude mice.,523-7,"['Ueyama, Y', 'Morita, K', 'Kondo, Y', 'Sato, N', 'Asano, S', 'Ohsawa, N', 'Sakurai, M', 'Nagumo, F', 'Iijima, K', 'Tamaoki, N']","['Ueyama Y', 'Morita K', 'Kondo Y', 'Sato N', 'Asano S', 'Ohsawa N', 'Sakurai M', 'Nagumo F', 'Iijima K', 'Tamaoki N']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Animals', '*Bone Neoplasms/pathology', 'Chromosomes, Human, 21-22 and Y', 'Humans', 'Karyotyping', '*Leukemia, Myeloid/pathology/ultrastructure', 'Male', 'Mice', 'Mice, Nude', '*Neoplasm Transplantation', '*Transplantation, Heterologous']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1038/bjc.1977.222 [doi]'],ppublish,Br J Cancer. 1977 Oct;36(4):523-7. doi: 10.1038/bjc.1977.222.,,,,PMC2025368,,,
270999,NLM,MEDLINE,19780218,20071115,0539-6115 (Print) 0539-6115 (Linking),34,6,1977 Nov-Dec,[Results of the treatment of nonlymphoblastic acute leukemia in a pediatric population].,1343-55,"['Rivera Luna, R', 'Ajuria Gottwald, E', 'Silva Sosa, M', 'Gonzalez Chirinos, P']","['Rivera Luna R', 'Ajuria Gottwald E', 'Silva Sosa M', 'Gonzalez Chirinos P']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article']",Mexico,Bol Med Hosp Infant Mex,Boletin medico del Hospital Infantil de Mexico,0414106,IM,"['Adolescent', 'Antibiotics, Antineoplastic/*therapeutic use', 'Child', 'Child, Preschool', 'Drug Evaluation', 'Drug Therapy, Combination', 'Female', 'Humans', 'Injections, Intravenous', 'Leukemia, Monocytic, Acute/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Bol Med Hosp Infant Mex. 1977 Nov-Dec;34(6):1343-55.,"['0 (Antibiotics, Antineoplastic)']","On a prospective fashion during approximately two years, 22 pediatric patients with acute non lymphocytic leukemia were evaluated. Of this population the majority had acute mielocytic leukemia, followed by acute myelomonocytic leukemia. Absolutely all patients at the time of diagnosis and subsequently every 4 to 6 weeks had a bone marrow aspiration test. When the patients were first seen, 54% of them presented fever; lymph node enlargement was not a common finding. Only few of this patients presented splenomegaly and/or hepatomegaly. In regards to complete blood counts the most outstanding of its was the presence of leukocyte count above 20000/mm.3 in 8 of this patients. From the 22 patients studied only 21 are evaluable. All 21 patients were treated with a 4 drug combination (modified COAP). Sixteen patients (76%) achieved bone marrow remission, of which only 15 patients (71%) achieved complete remission. The median duration remission was of 9.2 months with a range of 2 to 26 months. At the present time only 7 patients (33%) are alive and on remission. Two more patients are alive but in full relapse. The mortality rate of this study is of 59%. The review of recent chemotherapy reports is presented and the need for further trials is emphasized especially in view of recent papers published in which it appears that better results are being obtained at last in children's acute non lymphocitic leukemia.",Resultado del tratamiento de leucemia aguda no linfoblastica en poblacion pediatrica.,,,,
270966,NLM,MEDLINE,19780127,20071115,0003-9764 (Print) 0003-9764 (Linking),34,7,1977 Aug-Sep,[Results of 3 protocols of treatment of acute lymphoid leukemia in children].,611-21,"['Mathe, G', 'de Vassal, F', 'Schwarzenberg, L', 'Delgado, M', 'Weiner, R', 'Gil, M A', 'Pena-Angulo, J', 'Belpomme, D', 'Pouillart, P', 'Machover, D', 'Misset, J L', 'Pico, J L', 'Jasmin, C', 'Hayat, M', 'Schneider, M', 'Cattan, A', 'Amiel, J L', 'Musset, M', 'Rosenfeld, C', 'Ribaud, P']","['Mathe G', 'de Vassal F', 'Schwarzenberg L', 'Delgado M', 'Weiner R', 'Gil MA', 'Pena-Angulo J', 'Belpomme D', 'Pouillart P', 'Machover D', 'Misset JL', 'Pico JL', 'Jasmin C', 'Hayat M', 'Schneider M', 'Cattan A', 'Amiel JL', 'Musset M', 'Rosenfeld C', 'Ribaud P']",['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,Arch Fr Pediatr,Archives francaises de pediatrie,0372421,IM,"['Adolescent', 'Antineoplastic Agents/therapeutic use', 'BCG Vaccine/therapeutic use', 'Child', 'Child, Preschool', 'Evaluation Studies as Topic', 'Female', 'Follow-Up Studies', 'Humans', 'Immunotherapy', 'Leukemia, Lymphoid/*therapy', 'Male', 'Time Factors']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Arch Fr Pediatr. 1977 Aug-Sep;34(7):611-21.,"['0 (Antineoplastic Agents)', '0 (BCG Vaccine)']",,Resultats de trois protocoles de traitement de la leucemie aigue lymphoide des enfants.,,,,
270965,NLM,MEDLINE,19780127,20131121,0003-9926 (Print) 0003-9926 (Linking),137,12,1977 Dec,Therapy of chronic granulocytic leukemia.,1717-8,"['Crosby, W H']",['Crosby WH'],['eng'],['Journal Article'],United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Busulfan/administration & dosage/adverse effects/*therapeutic use', 'Dose-Response Relationship, Drug', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Leukocyte Count']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1977 Dec;137(12):1717-8.,['G1LN9045DK (Busulfan)'],,,,,,
270964,NLM,MEDLINE,19780127,20190501,1468-2044 (Electronic) 0003-9888 (Linking),52,10,1977 Oct,Role of infection in the death of children with acute lymphoblastic leukaemia.,752-7,"['Craft, A W', 'Reid, M M', 'Bruce, E', 'Kernahan, J', 'Gardner, P S']","['Craft AW', 'Reid MM', 'Bruce E', 'Kernahan J', 'Gardner PS']",['eng'],['Journal Article'],England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['Acute Disease', 'Bacterial Infections/*complications', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Hemorrhage/complications', 'Humans', 'Infant', 'Leukemia, Lymphoid/complications/*mortality', 'Leukocyte Count', 'Virus Diseases/complications']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1136/adc.52.10.752 [doi]'],ppublish,Arch Dis Child. 1977 Oct;52(10):752-7. doi: 10.1136/adc.52.10.752.,,"Twenty-four consecutive deaths from a total of 70 children receiving treatment for acute lymphoblastic leukaemia (ALL) have been reviewed. An attempt has been made to ascribe the cause of death to either infection, haemorrhage, the leukaemia itself, or a combination of these factors. No child was free of infection at death. Infection, with or without haemorrhage, was responsible for the deaths of all 15 children whose leukaemia had not relapsed. Although infection was present at death in all 9 children whose leukaemia had relapsed, the leukaemia process itself was also a major contributing factor. Viruses were associated with death in many of the children and may be emerging as important pathogens in children with ALL. Familiarity with a protocol may be an important factor in the prevention of fatal infections in such children. Centralization of treatment is necessary if this expertise is to be acquired.",,PMC1544806,,,
270906,NLM,MEDLINE,19780127,20211203,0002-9343 (Print) 0002-9343 (Linking),63,5,1977 Nov,Allescheria boydii infections in the immunosuppressed host.,830-5,"['Winston, D J', 'Jordan, M C', 'Rhodes, J']","['Winston DJ', 'Jordan MC', 'Rhodes J']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Med,The American journal of medicine,0267200,IM,"['Adult', 'Brain Abscess/*complications/etiology', 'Female', 'Humans', 'Immunosuppression Therapy', 'Leukemia, Myeloid/*complications', 'Male', 'Middle Aged', 'Mycoses/*complications', 'Pancoast Syndrome/*complications/etiology', 'Pseudallescheria']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']","['0002-9343(77)90170-X [pii]', '10.1016/0002-9343(77)90170-x [doi]']",ppublish,Am J Med. 1977 Nov;63(5):830-5. doi: 10.1016/0002-9343(77)90170-x.,,"Allescheria boydii, a true fungus frequently isolated from soil, is best known as a causative agent of maduromycosis of the foot. In our report we describe two patients under treatment for acute leukemia who died from rapidly progressive A. boydii infections. One patient had signs of central nervous system infection and was found at autopsy to have had a large brain abscess. The second patient had a cavitary necrotizing pneumonia with thoracic inlet obstruction (Pancoast's syndrome) and failed to show improvement despite treatment with amphotericin B. The clinical spectrum of allescheriasis is reviewed with particular emphasis on its role as a pathogen in the compromised host. Since A. boydii may resemble other fungi morphologically in tissue sections and may produce infections clinically similar to other mycoses, culture of the organism is required for definitive diagnosis. Based on recently reported in vitro susceptibility studies, miconazole may have a future role in the therapy of A. boydii infections which are resistant to presently available antifungal agents.",,,,,
270905,NLM,MEDLINE,19780127,20190626,0002-9343 (Print) 0002-9343 (Linking),63,5,1977 Nov,Some new aspects of modern cancer chemotherapy.,772-87,"['Silver, R T', 'Young, R C', 'Holland, J F']","['Silver RT', 'Young RC', 'Holland JF']",['eng'],['Journal Article'],United States,Am J Med,The American journal of medicine,0267200,IM,"['Animals', 'Antineoplastic Agents/pharmacology', 'Cell Cycle', 'Cell Survival/drug effects', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Kinetics', 'Leukemia, Experimental/immunology', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid/drug therapy', 'Methotrexate/therapeutic use', 'Mitosis', 'Neoplasms/*drug therapy/pathology/physiopathology', 'Neuraminidase/therapeutic use', 'Prednisone/therapeutic use', 'Vincristine/therapeutic use']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']","['0002-9343(77)90164-4 [pii]', '10.1016/0002-9343(77)90164-4 [doi]']",ppublish,Am J Med. 1977 Nov;63(5):772-87. doi: 10.1016/0002-9343(77)90164-4.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', 'EC 3.2.1.18 (Neuraminidase)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']",,,,,,
270904,NLM,MEDLINE,19780127,20190716,0002-922X (Print) 0002-922X (Linking),131,12,1977 Dec,Acute granulocytic leukemia following successful treatment of rhabdomyosarcoma.,1417,"['Hensley, M F', 'Cangir, A', 'Culbert, S J', 'van Eys, J']","['Hensley MF', 'Cangir A', 'Culbert SJ', 'van Eys J']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Antineoplastic Agents/therapeutic use', 'Axilla', 'Child, Preschool', 'Drug Therapy, Combination', 'Female', 'Forearm', 'Humans', 'Leukemia, Myeloid, Acute/*etiology', 'Lymphatic Metastasis', 'Neoplasms, Multiple Primary/*etiology', 'Neoplasms, Radiation-Induced/etiology', 'Rhabdomyosarcoma/drug therapy/radiotherapy/*therapy', 'Soft Tissue Neoplasms/*therapy']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['10.1001/archpedi.1977.02120250099032 [doi]'],ppublish,Am J Dis Child. 1977 Dec;131(12):1417. doi: 10.1001/archpedi.1977.02120250099032.,['0 (Antineoplastic Agents)'],,,,,,
270893,NLM,MEDLINE,19780127,20071115,0001-7310 (Print) 0001-7310 (Linking),68,7-8,1977 Jul-Aug,[Histopathological aspects of the cutaneous lesions of myeloblastic leukemia].,445-58,"['Bunuel, C', 'Gil, J L', 'Valero, M I', 'Raichs, A']","['Bunuel C', 'Gil JL', 'Valero MI', 'Raichs A']",['spa'],"['English Abstract', 'Journal Article']",Spain,Actas Dermosifiliogr,Actas dermo-sifiliograficas,0373062,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/complications/*pathology', 'Male', 'Middle Aged', 'Skin Diseases/etiology/pathology', '*Skin Manifestations']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Actas Dermosifiliogr. 1977 Jul-Aug;68(7-8):445-58.,,,Aspectos histopatologicos de las lesiones cutaneas de la leucemia mieloblastica.,,,,
270892,NLM,MEDLINE,19780127,20071115,0001-6276 (Print) 0001-6276 (Linking),32,2,1977 Mar-Apr,[Value of electroencephalographic and cerebrospinal fluid signs in the early diagnosis of leukemic meningitis].,189-203,"['Montuori, R', 'Stella, L']","['Montuori R', 'Stella L']",['ita'],"['English Abstract', 'Journal Article']",Italy,Acta Neurol (Napoli),Acta neurologica,0421100,IM,"['Adolescent', 'Adult', 'Aged', 'Brain/*physiopathology', 'Child', 'Child, Preschool', 'Electroencephalography', 'Evaluation Studies as Topic', 'Female', 'Humans', '*Intracranial Pressure', 'Leukemia, Lymphoid/*complications/physiopathology', 'Leukemia, Myeloid, Acute/*complications/physiopathology', 'Male', 'Meningeal Neoplasms/*diagnosis/physiopathology', 'Middle Aged']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Acta Neurol (Napoli). 1977 Mar-Apr;32(2):189-203.,,,Valore dei segni elettro-encefalografici e liquorali nella diagnosi precoce della meningosi leucemica.,,,,
270865,NLM,MEDLINE,19780127,20071115,0042-773X (Print) 0042-773X (Linking),23,11,1977 Nov,[Progressive rheumatoid polyarthritis complicated by acute myeloid leukemia].,1097-101,"['Blaha, M', 'Hrncir, Z']","['Blaha M', 'Hrncir Z']",['cze'],"['Case Reports', 'English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Arthritis, Rheumatoid/*complications', 'Humans', 'Leukemia, Myeloid, Acute/*etiology', 'Male', 'Middle Aged', 'Time Factors']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Nov;23(11):1097-101.,,,Progresivni polyartritida komplikovana akutni myeloidni leukemii.,,,,
270864,NLM,MEDLINE,19780127,20131121,0041-6959 (Print) 0041-6959 (Linking),106,11,1977 Nov,[Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].,1522-8,"['Gyger, M', 'LeGresley, L P', 'Boulianne, P', 'Lacombe, M', 'Lavallee, R', 'Bonny, Y', 'Boileau, J', ""D'Angelo, G""]","['Gyger M', 'LeGresley LP', 'Boulianne P', 'Lacombe M', 'Lavallee R', 'Bonny Y', 'Boileau J', ""D'Angelo G""]",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",Canada,Union Med Can,L'union medicale du Canada,0030444,IM,"['Busulfan/*adverse effects/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Lung/pathology', 'Middle Aged', 'Pulmonary Fibrosis/*chemically induced/pathology']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Union Med Can. 1977 Nov;106(11):1522-8.,['G1LN9045DK (Busulfan)'],,Heterogeneite clinique de la pneumopathie au myleran: A propos de deux nouvelles observations et d'une revue de la litterature.,,,,
270863,NLM,MEDLINE,19780127,20171213,0300-8916 (Print) 0300-8916 (Linking),63,4,1977 Jul-Aug,Prevention of meningeal CNS involvement as a factor influencing the duration of complete remission and survival in childhood acute lymphoblastic leukemia.,367-72,"['Madon, E', 'Cordero di Montezemolo, L', 'Pastore, G']","['Madon E', 'Cordero di Montezemolo L', 'Pastore G']",['eng'],"['Clinical Trial', 'Controlled Clinical Trial', 'Journal Article']",United States,Tumori,Tumori,0111356,IM,"['Age Factors', 'Antineoplastic Agents/*administration & dosage/therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination/methods', 'Female', 'Humans', 'Hydrocortisone/administration & dosage', 'Infant', 'Leukemia/*prevention & control', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Meningeal Neoplasms/*prevention & control', 'Methotrexate/administration & dosage', 'Prognosis', 'Remission, Spontaneous', 'Time Factors']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Tumori. 1977 Jul-Aug;63(4):367-72.,"['0 (Antineoplastic Agents)', 'WI4X0X7BPJ (Hydrocortisone)', 'YL5FZ2Y5U1 (Methotrexate)']","The influence on the duration of CR and survival of 2 modalities (MTX + hydrocortisone IT, with and without TCT) for the prevention of meningeal CNS involvement was assessed in 24 children with acute lymphoblastic leukemia. Of the 9 subjects who received MTX and hydrocortisone only, 42% were still in CR 33 months after its attainment, as opposed to 75% of the 15 who also received TCT. Survival at 33 months after diagnosis was 89% and 82% in the 2 groups. The results are compared with those obtained in an earlier series of 14 children who received no prophylactic treatment. Here CR at 45 months was 25% and survival 46%. Eight subjects died, as opposed to 3 (1 in CR) in the present series.",,,,,
270824,NLM,MEDLINE,19780127,20041117,0040-3660 (Print) 0040-3660 (Linking),49,9,1977,[Case of extensive specific lesion of the brain in the terminal stage of myelocytic leukemia].,140-1,"['Osipova, M V', 'Popov, Iu P', 'Volkov, V P']","['Osipova MV', 'Popov IuP', 'Volkov VP']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Brain/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/complications/*pathology', 'Meningeal Neoplasms/complications/*pathology', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(9):140-1.,,,Sluchai obshirnogo spetsificheskogo porazheniia golovnogo mozga v terminal'noi stadii khronicheskogo mieloidnogo leikoza.,,,,
270823,NLM,MEDLINE,19780127,20151119,0040-3660 (Print) 0040-3660 (Linking),49,8,1977,[Study of the phagocytic capacity of the neutrophil granulocytes with the aid of the nitroblue tetrazolium restoration test in different forms of acute leukemia].,66-8,"['Korotkii, V V']",['Korotkii VV'],['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Female', 'Granulocytes/*immunology', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Leukemia, Myeloid, Acute/*immunology', 'Leukocytes/*immunology', 'Male', 'Middle Aged', 'Neutrophils/*immunology', '*Nitroblue Tetrazolium', '*Phagocytosis', '*Tetrazolium Salts']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(8):66-8.,"['0 (Tetrazolium Salts)', '298-83-9 (Nitroblue Tetrazolium)']",,Izuchenie fagotsitarnoi sposobnosti neitrofil'nykh granulotsitov pri pomoshchi testa vosstanovleniia nitrosinego tetrazoliia u bol'nykh s razlichnymi formami ostrogo leikoza.,,,,
270822,NLM,MEDLINE,19780127,20071115,0040-3660 (Print) 0040-3660 (Linking),49,8,1977,[Various problems of continuous treatment of acute leukemia].,60-2,"['Mendeleev, I M', 'Kheifets, L M', 'Polezhaev, Iu N', 'Arkavina, E A', 'Berliner, G B']","['Mendeleev IM', 'Kheifets LM', 'Polezhaev IuN', 'Arkavina EA', 'Berliner GB']",['rus'],"['Case Reports', 'Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/*administration & dosage/therapeutic use', 'Child', 'Child, Preschool', 'Drug Administration Schedule', 'Evaluation Studies as Topic', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(8):60-2.,['0 (Antineoplastic Agents)'],,O nekotorykh problemakh nepreryvnogo lecheniia bol'nykh ostrym leikozom.,,,,
270821,NLM,MEDLINE,19780127,20071115,0040-3660 (Print) 0040-3660 (Linking),49,8,1977,[Leukemia associated with lymphogranulomatosis].,47-52,"['Volkova, M A', 'Chervonobab, Iu V', 'Pokrovskaia, N N', ""Frenkel', M A""]","['Volkova MA', 'Chervonobab IuV', 'Pokrovskaia NN', ""Frenkel' MA""]",['rus'],"['Case Reports', 'English Abstract', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adult', 'Female', 'Hodgkin Disease/*complications', 'Humans', 'Leukemia, Myeloid/*complications/diagnosis', 'Leukemia, Myeloid, Acute/*complications/diagnosis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(8):47-52.,,,O sochetanii leikozov s limfogranulematozom.,,,,
270820,NLM,MEDLINE,19780127,20071115,0040-3660 (Print) 0040-3660 (Linking),49,8,1977,[Preventive use of the thrombocytic mass in acute leukemia].,124-5,"['Gorodetskii, V M', 'Kalinin, N N', 'Pashkov, V V', 'Rogova, E M']","['Gorodetskii VM', 'Kalinin NN', 'Pashkov VV', 'Rogova EM']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adolescent', '*Blood Platelets', '*Blood Transfusion', 'Humans', 'Leukemia, Erythroblastic, Acute/*therapy', 'Leukemia, Monocytic, Acute/*therapy', 'Leukemia, Myeloid, Acute/*therapy', 'Male', 'Thrombocytopenia/prevention & control']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(8):124-5.,,,Profilakticheskoe primenenie trombotsitnoi massy u bol'nykh ostrym leikozom.,,,,
270819,NLM,MEDLINE,19780127,20081121,0037-5675 (Print) 0037-5675 (Linking),18,2,1977 Jun,"A Chinese girl with features of Letterer-Siwe disease, histiocytic medullary reticulosis and monocytic leukaemia.",147-50,"['Thong, Y H', 'Sinniah, D', 'Kaur, K', 'Yadav, M', 'Chong, K C']","['Thong YH', 'Sinniah D', 'Kaur K', 'Yadav M', 'Chong KC']",['eng'],"['Case Reports', 'Journal Article']",Singapore,Singapore Med J,Singapore medical journal,0404516,IM,"['Female', 'Histiocytosis, Langerhans-Cell/*complications/pathology', 'Humans', 'Infant', 'Leukemia, Myeloid/*complications/pathology', 'Lymphatic Diseases/*complications/pathology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Singapore Med J. 1977 Jun;18(2):147-50.,,,,,,,
270812,NLM,MEDLINE,19780127,20190618,0036-8075 (Print) 0036-8075 (Linking),198,4322,1977 Dec 16,Localization of the globin gene in the template active fraction of chromatin of Friend leukemia cells.,1166-8,"['Wallace, R B', 'Dube, S K', 'Bonner, J']","['Wallace RB', 'Dube SK', 'Bonner J']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Animals', 'Cell Line', 'Chromatin/*genetics/isolation & purification', 'Deoxyribonucleases/metabolism', 'Dimethyl Sulfoxide/pharmacology', 'Erythropoiesis', 'Friend murine leukemia virus', '*Genes', 'Globins/*genetics', 'Leukemia, Erythroblastic, Acute/*genetics', 'Leukemia, Experimental/genetics', 'Templates, Genetic']",1977/12/16 00:00,1977/12/16 00:01,['1977/12/16 00:00'],"['1977/12/16 00:00 [pubmed]', '1977/12/16 00:01 [medline]', '1977/12/16 00:00 [entrez]']",['10.1126/science.270812 [doi]'],ppublish,Science. 1977 Dec 16;198(4322):1166-8. doi: 10.1126/science.270812.,"['0 (Chromatin)', '9004-22-2 (Globins)', 'EC 3.1.- (Deoxyribonucleases)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Friend leukemia cell chromatin has been fractionated into template active and inactive components. The globin gene sequence is associated with the template active component both prior to and after the cells are induced with dimethyl sulfoxide to synthesize hemoglobin and therefore appears to be in an active configuration in uninduced as well as in induced Friend leukemia cells. In cells which have lost the ability to produce hemoglobin, the globin gene sequence is not associated with the template active fraction of chromatin. These results demonstrate the success of the fractionation procedure.",,,,,
270702,NLM,MEDLINE,19780127,20190501,0027-8424 (Print) 0027-8424 (Linking),74,10,1977 Oct,Detection of antibody to autologous human leukemia cells by immune adherence assays.,4587-90,"['Garrett, T J', 'Takahashi, T', 'Clarkson, B D', 'Old, L J']","['Garrett TJ', 'Takahashi T', 'Clarkson BD', 'Old LJ']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Acute Disease', 'Adult', 'Antibodies, Neoplasm/*analysis', 'Cell Line', 'Humans', 'Immune Adherence Reaction', 'Leukemia/*immunology', 'Leukemia, Lymphoid/immunology', 'Male', 'Time Factors']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1073/pnas.74.10.4587 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Oct;74(10):4587-90. doi: 10.1073/pnas.74.10.4587.,"['0 (Antibodies, Neoplasm)']","The sera of 21 adult patients with acute leukemia were studied for the presence of antibody reacting with surface antigens of autologous leukemia cells. Sequential serum samples were obtained from patients and were tested on cryopreserved leukemia cells in immune adherence assays. Three patients showed autologous serum reactivity and the serum of one of them was analyzed in detail. This antibody reacted with autologous acute lymphocytic leukemia cells but not with autologous cells obtained from peripheral blood, bone marrow, or spleen during clinical remission. In absorption tests, the antigen could not be detected on normal autologous or allogeneic blood lymphocytes, lymphoblastoid lines of T- or B-cell origin, or cells infected with simian sarcoma virus, baboon C-type virus, or Mason-Pfizer virus. Leukemia cells from two other patients with acute lymphocytic leukemia and one patient with acute nonlymphocytic leukemia absorbed specific reactivity. These studies indicate that certain acute leukemia cells express a common antigen that elicits a humoral immune response in the autologous host.",,PMC431991,,,
270656,NLM,MEDLINE,19780127,20061115,0552-2080 (Print) 0552-2080 (Linking),22,9,1977 Sep,"[Obtaining of the ""self-maintaning"" cell line of erythroblastosis of mice of the AKR strain].",46-9,"['Rozinova, E N', 'Irlin, I S']","['Rozinova EN', 'Irlin IS']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Animals', 'Cell Line', 'Cell Transformation, Neoplastic', 'Culture Techniques', 'Leukemia, Erythroblastic, Acute/*pathology', 'Leukemia, Experimental/*pathology', 'Mice', 'Mice, Inbred AKR', 'Rauscher Virus']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Sep;22(9):46-9.,,,"Poluchenie ""samopodderzhivaiushchegosia"" shtamma eritroblastoza myshei linii AKR.",,,,
270655,NLM,MEDLINE,19780127,20141120,0552-2080 (Print) 0552-2080 (Linking),22,9,1977 Sep,[Preparation and properties of continuous suspension cell culture of murine erythroblastosis].,42-6,"['Irlin, I S', 'Tikhonova, Z N', 'Rozinova, E N', 'Makarova, G F', 'Kolobkov, S L']","['Irlin IS', 'Tikhonova ZN', 'Rozinova EN', 'Makarova GF', 'Kolobkov SL']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Animals', 'Cell Differentiation', 'Culture Media', 'Culture Techniques/methods', 'Leukemia, Erythroblastic, Acute/*pathology', 'Leukemia, Experimental/*pathology', 'Mice', 'Rauscher Virus']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Sep;22(9):42-6.,['0 (Culture Media)'],,Poluchenie i svoistva perevivaemoi suspenzionnoi kul'tury kletok eritroblastoza myshei.,,,,
270654,NLM,MEDLINE,19780127,20061115,0552-2080 (Print) 0552-2080 (Linking),22,9,1977 Sep,[Characteristics of mitosis of the bone marrow cells in myelocytic leukemia].,19-21,"['Pareishvili, E A', 'Akopova, M A', 'Kalantar, N R', 'Muradian, L B', 'Porosian, A S']","['Pareishvili EA', 'Akopova MA', 'Kalantar NR', 'Muradian LB', 'Porosian AS']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Bone Marrow/*pathology', 'Humans', 'Leukemia, Myeloid/*pathology', '*Mitosis', 'Mitotic Index']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Sep;22(9):19-21.,,,Osobennosti mitoticheskogo rezhima kletok kostnogo mozga u bol'nykh mieloleikozom.,,,,
270653,NLM,MEDLINE,19780127,20061115,0552-2080 (Print) 0552-2080 (Linking),22,9,1977 Sep,[Characteristics of metabolism of steroid hormones in myelocytic leukemia].,11-6,"['Goncharov, N P', 'Vorontsov, V I', 'Goncharova, N D', 'Bazilevskaia, L G', 'Zimarina, A I']","['Goncharov NP', 'Vorontsov VI', 'Goncharova ND', 'Bazilevskaia LG', 'Zimarina AI']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adrenal Cortex/metabolism', 'Adrenal Cortex Hormones/*metabolism', 'Adult', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid/*metabolism', 'Male', 'Middle Aged']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Sep;22(9):11-6.,['0 (Adrenal Cortex Hormones)'],,Osobennosti metabolizma steroidnykh gormonov u bol'nykh khronicheskim mieloleikozom.,,,,
270652,NLM,MEDLINE,19780127,20061115,0301-1518 (Print) 0301-1518 (Linking),6,35,1977 Oct 22,[Critical study of the concept of the myeloproliferative syndrome (author's transl)].,3179-83,"['Najean, Y']",['Najean Y'],['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Diagnosis, Differential', 'Humans', 'Leukemia, Myeloid/diagnosis', '*Myeloproliferative Disorders/diagnosis/physiopathology', 'Polycythemia Vera/diagnosis', 'Preleukemia/diagnosis', 'Thrombocytosis/diagnosis']",1977/10/22 00:00,1977/10/22 00:01,['1977/10/22 00:00'],"['1977/10/22 00:00 [pubmed]', '1977/10/22 00:01 [medline]', '1977/10/22 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Oct 22;6(35):3179-83.,,,Etude critique du concept de syndrome myeloproliferatif.,,,,
270618,NLM,MEDLINE,19780127,20071115,0026-4806 (Print) 0026-4806 (Linking),68,51,1977 Oct 27,[Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].,3528-32,"['Russell, J A', 'Powles, R L']","['Russell JA', 'Powles RL']",['ita'],['Journal Article'],Italy,Minerva Med,Minerva medica,0400732,IM,"['Antineoplastic Agents/therapeutic use', 'BCG Vaccine/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy/*therapy', 'Prognosis', 'Remission, Spontaneous']",1977/10/27 00:00,1977/10/27 00:01,['1977/10/27 00:00'],"['1977/10/27 00:00 [pubmed]', '1977/10/27 00:01 [medline]', '1977/10/27 00:00 [entrez]']",,ppublish,Minerva Med. 1977 Oct 27;68(51):3528-32.,"['0 (Antineoplastic Agents)', '0 (BCG Vaccine)']",,Studi sull'impiego della chemioterapia e dell'immunoterapia nel trattamento dei pazienti affetti da leucemia mielogena acuta.,,,,
270617,NLM,MEDLINE,19780127,20071115,0026-4806 (Print) 0026-4806 (Linking),68,50,1977 Oct 20,[Human lymphocyte membrane markers in lymphoproliferative diseases (proceedings)].,3441-6,"['Giunchi, G', 'Franchi, F']","['Giunchi G', 'Franchi F']",['ita'],['Journal Article'],Italy,Minerva Med,Minerva medica,0400732,IM,"['Antigens/isolation & purification', 'Cell Membrane/*immunology', 'Cytotoxicity, Immunologic', 'Hodgkin Disease/*immunology', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Lymphocytes/*immunology', 'Rosette Formation']",1977/10/20 00:00,1977/10/20 00:01,['1977/10/20 00:00'],"['1977/10/20 00:00 [pubmed]', '1977/10/20 00:01 [medline]', '1977/10/20 00:00 [entrez]']",,ppublish,Minerva Med. 1977 Oct 20;68(50):3441-6.,['0 (Antigens)'],,Marcatori di membrana dei linfociti umani nelle malattie linfoproliferative.,,,,
270616,NLM,MEDLINE,19780127,20171116,0028-2685 (Print) 0028-2685 (Linking),24,5,1977,Experimental chemotherapy of rat leukemia RBA-Le with cis-diamminedichloroplatinum.,475-86,"['Kovarik, J', 'Svec, F', 'Zemanova, D']","['Kovarik J', 'Svec F', 'Zemanova D']",['eng'],['Journal Article'],Slovakia,Neoplasma,Neoplasma,0377266,IM,"['Animals', 'Cisplatin/administration & dosage/*therapeutic use', 'Cyclophosphamide/administration & dosage/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Leukemia, Experimental/drug therapy/mortality', 'Leukemia, Myeloid/*drug therapy/mortality', 'Male', 'Methotrexate/administration & dosage/therapeutic use', 'Poly I-C/administration & dosage/therapeutic use', 'Rats']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Neoplasma. 1977;24(5):475-86.,"['8N3DW7272P (Cyclophosphamide)', 'O84C90HH2L (Poly I-C)', 'Q20Q21Q62J (Cisplatin)', 'YL5FZ2Y5U1 (Methotrexate)']","The antileukemic activity of cis-diamminedichloroplatinum (PDD) was studied in rats bearing myelogenous leukemia RBA-Le. Clinical picture, changes in life-span, hematological indices and weight changes were used to assess the effectiveness of the therapy. Maximum effectiveness was noted when PDD was given in combination with Methotrexate (MTX) and Poly I:C, respectively. The mean life-span of the rats treated with PDD and MTX was prolonged to 37 days that is an increase of 147 percent of the control level. Furthermore 20 percent of the treated animals survived symptom-free for more than 60 days. Out of 20 animals receiving PDD in combination with Poly I:C 6 rats survived 60 days symptom-free. In remaining 14 animals who finally died on leukemia an 85 percent increase in life-span was noted. Only slight increase in life-span was recorded in those groups treated with PDD alone and in combination with Cyclophosphamide regardless of dosage schedule. The general toxicity of PDD therapy is discussed.",,,,,
270615,NLM,MEDLINE,19780127,20151119,0028-2162 (Print) 0028-2162 (Linking),121,46,1977 Nov 12,[Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].,1843-7,"['Willemze, R', 'den Ottolander, G J', 'Heering, K J', 'Brand, A', 'Zwaan, F E', 'Haak, H L', 'Hartgrink-Groeneveld, C A', 'Jansen, J', 'Eernisse, J G']","['Willemze R', 'den Ottolander GJ', 'Heering KJ', 'Brand A', 'Zwaan FE', 'Haak HL', 'Hartgrink-Groeneveld CA', 'Jansen J', 'Eernisse JG']",['dut'],"['English Abstract', 'Journal Article']",Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Adolescent', 'Adult', 'Aged', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Doxorubicin/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Life Expectancy', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1977/11/12 00:00,1977/11/12 00:01,['1977/11/12 00:00'],"['1977/11/12 00:00 [pubmed]', '1977/11/12 00:01 [medline]', '1977/11/12 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1977 Nov 12;121(46):1843-7.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '80168379AG (Doxorubicin)', 'FTK8U1GZNX (Thioguanine)', 'ZS7284E0ZP (Daunorubicin)']",,Behandeling van acute myeloide leukemie bij volwassenen; een verantwoording over de jaren 1968 t.m. 1975.,,,,
270609,NLM,MEDLINE,19780127,20190902,0098-1532 (Print) 0098-1532 (Linking),3,4,1977,Lack of correlation between blast cell size and length of first remission in acute lymphocytic leukemia in childhood.,373-7,"['Wagner, V M', 'Baehner, R L']","['Wagner VM', 'Baehner RL']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Cell Count', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/drug therapy/*pathology', 'Lymphocytes/pathology', 'Male', 'Prognosis', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/mpo.2950030408 [doi]'],ppublish,Med Pediatr Oncol. 1977;3(4):373-7. doi: 10.1002/mpo.2950030408.,['0 (Antineoplastic Agents)'],"The bone marrow from 55 children with acute lymphocytic leukemia diagnosed from April 1969 to June 1973 were evaluated for blast cell morphology and size. Sixteen marrows contained a predominance of macrolymphoblasts (greater than 12 mu), while the remainder contained mainly microlymphoblasts. There was no correlation between blast cell size and the known front-end prognostic indicators of age and initial white blood count, nor could blast cell size be used to predict the length of initial bone marrow remission.",,,,,
270608,NLM,MEDLINE,19780127,20190902,0098-1532 (Print) 0098-1532 (Linking),3,4,1977,"Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).",359-64,"['Sallan, S E', 'Camitta, B M', 'Chan, D M', 'Traggis, D', 'Jaffe, N']","['Sallan SE', 'Camitta BM', 'Chan DM', 'Traggis D', 'Jaffe N']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Child', 'Child, Preschool', 'Cyclophosphamide/*therapeutic use', 'Cytarabine/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Prednisone/*therapeutic use', 'Recurrence', 'Remission, Spontaneous', 'Time Factors', 'Vincristine/*therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/mpo.2950030406 [doi]'],ppublish,Med Pediatr Oncol. 1977;3(4):359-64. doi: 10.1002/mpo.2950030406.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'VB0R961HZT (Prednisone)']","Three groups of children with acute lymphoblastic leukemia (ALL) were treated with intermittent cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP). Group A (no prior relapse) and Group B (prior single-agent relapse) received COAP after 12 months on another chemotherapy regimen. Children in Group C (prior relapse on multiagent regimens) received COAP following A-COAP (asparaginase plus COAP) reinduction. Median disease-free survival after beginning COAP was not reached for Group A, but was only 7 months for Groups B and C. As of November 1976, there were 8 of 15 Group A patients, 1 of 12 Group B patients, and 1 of 28 Group C patients who had remained disease-free from 38 to 60 (median 54.5) months and were off chemotherapy. COAP has activity in childhood ALL. However, effectiveness is markedly diminished in patients with prior bone marrow relapse.",,,,,
270597,NLM,MEDLINE,19780127,20151119,0021-7263 (Print) 0021-7263 (Linking),141,5,1977 Nov,Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.,249-51,"['Trump, D L', 'Cowall, D E']","['Trump DL', 'Cowall DE']",['eng'],"['Case Reports', 'Journal Article']",United States,Johns Hopkins Med J,The Johns Hopkins medical journal,0072456,IM,"['Adult', 'Biopsy', 'Bone Marrow/pathology', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Hodgkin Disease/complications/drug therapy/*radiotherapy', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy/*etiology', 'Leukemia, Radiation-Induced/*etiology', 'Male', 'Mechlorethamine/therapeutic use', 'Prednisone/therapeutic use', 'Procarbazine/therapeutic use', 'Radiotherapy/*adverse effects', 'Thrombocytopenia/etiology', 'Vinblastine/therapeutic use', 'Vincristine/therapeutic use']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Johns Hopkins Med J. 1977 Nov;141(5):249-51.,"['04079A1RDZ (Cytarabine)', '35S93Y190K (Procarbazine)', '50D9XSG0VR (Mechlorethamine)', '5J49Q6B70F (Vincristine)', '5V9KLZ54CY (Vinblastine)', 'VB0R961HZT (Prednisone)', 'ZS7284E0ZP (Daunorubicin)']",Progressive thrombocytopenia developed in a patient following the completion of total lymphoid irradiation and combination chemotherapy for Hodgkin's disease. Thorough evaluation eventually yielded a diagnosis of acute myelogenous leukemia (AML). Previous workers have suggested that the development of thrombocytopenia with a hypoplastic marrow following total lymphoid irradiation indicated recurrent Hodgkin's disease. When the combination cytopenias and hypoplastic marrow is recognized these workers have recommended early combination chemotherapy. Recent data suggest a 1300-fold increase in the risk of AML following multimodality therapy for Hodgkin's disease. We feel that a careful search for AML should be conducted in patients with deteriorating hematologic parameters following therapy for Hodgkin's disease and that this search should include sampling bone marrow outside irradiated areas.,,,,,
270588,NLM,MEDLINE,19780127,20061115,0033-6890 (Print) 0033-6890 (Linking),22,4,1977 Oct,Fate of 14C-glucan in normal and acute myelogenous leukemic rats.,319-27,"['Gilbert, K', 'Chu, F', 'Jones, E', 'Di Luzio, N R']","['Gilbert K', 'Chu F', 'Jones E', 'Di Luzio NR']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Reticuloendothel Soc,Journal of the Reticuloendothelial Society,0206462,IM,"['Animals', 'Bone Marrow/metabolism', 'Leukemia, Experimental/*metabolism', 'Leukemia, Myeloid/*metabolism', 'Liver/*metabolism', 'Lung/*metabolism', 'Male', 'Polysaccharides/*metabolism', 'Rats', 'Spleen/*metabolism']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,J Reticuloendothel Soc. 1977 Oct;22(4):319-27.,['0 (Polysaccharides)'],,,,,,
270476,NLM,MEDLINE,19780127,20061115,0021-9533 (Print) 0021-9533 (Linking),26,,1977 Aug,Production of mouse globin in heterokaryons of mouse erythroleukaemia cells and human fibroblasts.,347-57,"['Alter, B P', 'Goff, S C', 'Hillman, D G', 'Deisseroth, A B', 'Forget, B G']","['Alter BP', 'Goff SC', 'Hillman DG', 'Deisseroth AB', 'Forget BG']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",England,J Cell Sci,Journal of cell science,0052457,IM,"['Animals', 'Cell Fusion', 'DNA, Circular/biosynthesis', 'Erythroblasts/metabolism', 'Fibroblasts/metabolism', 'Globins/*biosynthesis', 'Humans', 'Hybrid Cells/*metabolism', 'Leukemia, Erythroblastic, Acute', 'Mice', 'RNA, Messenger/metabolism']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,J Cell Sci. 1977 Aug;26:347-57.,"['0 (DNA, Circular)', '0 (RNA, Messenger)', '9004-22-2 (Globins)']","In an effort to activate the globin genes of non-erythroid cells, tetraploid murine erythroleukaemia cells (Friend cells) were fused with diploid human amniotic fibroblasts. When the Friend cells were pretreated with dimethylsulphoxide, an average of 27% heterokaryons was observed. These cells stained with benzidine, an indication that they contained haemoglobin. The cells incorporated radioactive amino acids into proteins. Electrophoresis of [3H]leucine-labelled lysates on SDS urea polyacrylamide gels indicated that up to 7% of the newly synthesized protein co-electrophoresed with globin. CM cellulose chromatography demonstrated the presence of mouse but not human globin chains. Hybridization analyses of cytoplasmic RNA also revealed only mouse globin mRNA in the heterokaryons. Although heterokaryons form readily between mouse erythroleukaemia cells and human fibroblasts, and globin synthesis does occur, only the erythroid partner in the fusion system employed here directs globin production.",,,,,
270474,NLM,MEDLINE,19780127,20071115,0021-2180 (Print) 0021-2180 (Linking),13,7,1977 Jul,The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.,710-5,"['Rachmilewitz, B', 'Rachmilewitz, M']","['Rachmilewitz B', 'Rachmilewitz M']",['eng'],['Journal Article'],Israel,Isr J Med Sci,Israel journal of medical sciences,0013105,IM,"['Blood Proteins/*analysis', 'Humans', 'Leukemia, Myeloid/*blood/diagnosis', 'Leukemia, Myeloid, Acute/*blood', 'Leukocytosis/diagnosis', 'Myeloproliferative Disorders/*blood', 'Polycythemia Vera/diagnosis', 'Transcobalamins/*analysis']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Isr J Med Sci. 1977 Jul;13(7):710-5.,"['0 (Blood Proteins)', '0 (Transcobalamins)']",,,,,,
270473,NLM,MEDLINE,19780127,20171116,0021-2180 (Print) 0021-2180 (Linking),13,7,1977 Jul,Chemoimmunotherapy in acute myelocytic leukemia.,694-700,"['Holland, J F', 'Bekesi, J G', 'Cuttner, J', 'Glidewell, O']","['Holland JF', 'Bekesi JG', 'Cuttner J', 'Glidewell O']",['eng'],['Journal Article'],Israel,Isr J Med Sci,Israel journal of medical sciences,0013105,IM,"['Antineoplastic Agents/*administration & dosage/therapeutic use', 'Asparaginase/administration & dosage/therapeutic use', 'Child', 'Daunorubicin/administration & dosage/therapeutic use', 'Humans', '*Immunotherapy', 'Leukemia, Myeloid, Acute/drug therapy/*therapy', 'Mercaptopurine/administration & dosage/therapeutic use', 'Methotrexate/administration & dosage/therapeutic use', 'Prednisone/administration & dosage/therapeutic use', 'Remission, Spontaneous', 'Vincristine/administration & dosage/therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Isr J Med Sci. 1977 Jul;13(7):694-700.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']",,,,,,
270462,NLM,MEDLINE,19780127,20190722,0019-5456 (Print) 0019-5456 (Linking),44,351,1977 Apr,Acute infantile leukaemia.,101-5,"['Khanna, K K', 'Puri, R K']","['Khanna KK', 'Puri RK']",['eng'],['Journal Article'],India,Indian J Pediatr,Indian journal of pediatrics,0417442,IM,"['Acute Disease', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/*diagnosis', 'Leukemia, Myeloid, Acute/*diagnosis', 'Male']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1007/BF02862886 [doi]'],ppublish,Indian J Pediatr. 1977 Apr;44(351):101-5. doi: 10.1007/BF02862886.,,,,,,,
270460,NLM,MEDLINE,19780127,20131121,0019-5189 (Print) 0019-5189 (Linking),15,5,1977 May,Uptake of ascorbic acid by human leukocytes under normal & leukemic conditions.,352-4,"['Basu, B', 'Bhattacharya, D K', 'Chatterjee, G C']","['Basu B', 'Bhattacharya DK', 'Chatterjee GC']",['eng'],['Journal Article'],India,Indian J Exp Biol,Indian journal of experimental biology,0233411,IM,"['Adolescent', 'Ascorbic Acid/*metabolism', 'Dehydroascorbic Acid/metabolism', 'Female', 'Humans', 'Leukemia, Myeloid/*blood', 'Leukocytes/*metabolism', 'Male', 'Middle Aged']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Indian J Exp Biol. 1977 May;15(5):352-4.,"['PQ6CK8PD0R (Ascorbic Acid)', 'Y2Z3ZTP9UM (Dehydroascorbic Acid)']",,,,,,
270459,NLM,MEDLINE,19780127,20091111,0019-509X (Print) 0019-509X (Linking),14,3,1977 Sep,Immunoblastic leukaemia.,281-3,"['Advani, S H', 'Nadkarni, J S', 'Nadkarni, J J', 'Talwalkar, G V']","['Advani SH', 'Nadkarni JS', 'Nadkarni JJ', 'Talwalkar GV']",['eng'],"['Case Reports', 'Journal Article']",India,Indian J Cancer,Indian journal of cancer,0112040,IM,"['Acute Disease', 'Adult', 'Burkitt Lymphoma/diagnosis', 'Diagnosis, Differential', 'Humans', '*Leukemia, Lymphoid/diagnosis', 'Male']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Indian J Cancer. 1977 Sep;14(3):281-3.,,,,,,,
270458,NLM,MEDLINE,19780127,20091111,0019-509X (Print) 0019-509X (Linking),14,3,1977 Sep,Extramedullary blast crisis in chronic myeloid leukaemia simulating lymphoma.,272-7,"['Talvalkar, G V', 'Srinivasan, U', 'Advani, S H', 'Khare, A G']","['Talvalkar GV', 'Srinivasan U', 'Advani SH', 'Khare AG']",['eng'],['Journal Article'],India,Indian J Cancer,Indian journal of cancer,0112040,IM,"['Adult', 'Child', 'Chronic Disease', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/pathology', 'Lymph Nodes/pathology', 'Lymphoma/*diagnosis', 'Male', 'Middle Aged']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Indian J Cancer. 1977 Sep;14(3):272-7.,,,,,,,
270457,NLM,MEDLINE,19780127,20190722,0340-6717 (Print) 0340-6717 (Linking),39,1,1977 Nov 2,Unusual translocation (10;22) in chronic myelogenous leukemia.,127-9,"['Fleischman, E W', 'Prigogina, E L', 'Volkova, M A', 'Petkovitch, I']","['Fleischman EW', 'Prigogina EL', 'Volkova MA', 'Petkovitch I']",['eng'],"['Case Reports', 'Journal Article']",Germany,Hum Genet,Human genetics,7613873,IM,"['Adult', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics', 'Male', '*Translocation, Genetic']",1977/11/02 00:00,1977/11/02 00:01,['1977/11/02 00:00'],"['1977/11/02 00:00 [pubmed]', '1977/11/02 00:01 [medline]', '1977/11/02 00:00 [entrez]']",['10.1007/BF00273163 [doi]'],ppublish,Hum Genet. 1977 Nov 2;39(1):127-9. doi: 10.1007/BF00273163.,,,,,,,
270410,NLM,MEDLINE,19780127,20190620,0014-5793 (Print) 0014-5793 (Linking),83,1,1977 Nov 1,Degradation and localization of IgG injected into Friend erythroleukemic cells by fusion with erythrocyte ghosts.,48-52,"['Wasserman, M', 'Kulka, R G', 'Loyter, A']","['Wasserman M', 'Kulka RG', 'Loyter A']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",England,FEBS Lett,FEBS letters,0155157,IM,"['Binding Sites, Antibody', 'Cell Line', 'Cell Nucleus/physiology', 'Erythrocyte Membrane/*physiology', 'Erythrocytes/*physiology', 'Female', 'Humans', 'Kinetics', '*Leukemia, Erythroblastic, Acute/*immunology', '*Ovum']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']","['0014-5793(77)80639-X [pii]', '10.1016/0014-5793(77)80639-x [doi]']",ppublish,FEBS Lett. 1977 Nov 1;83(1):48-52. doi: 10.1016/0014-5793(77)80639-x.,,,,,,,
270409,NLM,MEDLINE,19780127,20190620,0014-5793 (Print) 0014-5793 (Linking),81,2,1977 Sep 15,The effect of hemin on the expression of beta globin genes in friend cells.,366-70,"['Rovera, G', 'Abramczuk, J', 'Surrey, S']","['Rovera G', 'Abramczuk J', 'Surrey S']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,FEBS Lett,FEBS letters,0155157,IM,"['Animals', 'Cell Differentiation/*drug effects', 'Clone Cells', 'Electrophoresis, Polyacrylamide Gel/methods', '*Friend murine leukemia virus', 'Genes/*drug effects', 'Globins/*genetics/isolation & purification', 'Heme/*analogs & derivatives', 'Hemin/*pharmacology', 'Hemoglobins/*biosynthesis', 'Leukemia, Erythroblastic, Acute/pathology', 'Mice']",1977/09/15 00:00,1977/09/15 00:01,['1977/09/15 00:00'],"['1977/09/15 00:00 [pubmed]', '1977/09/15 00:01 [medline]', '1977/09/15 00:00 [entrez]']","['0014-5793(77)80556-5 [pii]', '10.1016/0014-5793(77)80556-5 [doi]']",ppublish,FEBS Lett. 1977 Sep 15;81(2):366-70. doi: 10.1016/0014-5793(77)80556-5.,"['0 (Hemoglobins)', '42VZT0U6YR (Heme)', '743LRP9S7N (Hemin)', '9004-22-2 (Globins)']",,,,,,
270391,NLM,MEDLINE,19780127,20131121,0361-5960 (Print) 0361-5960 (Linking),61,8,1977 Nov,[Autoregulation of L-asparaginase-induced diabetes mellitus].,1607-9,"['Boston, B', 'Rosen, M', 'Capizzi, R L']","['Boston B', 'Rosen M', 'Capizzi RL']",['eng'],['Letter'],United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adult', 'Asparaginase/*adverse effects/therapeutic use', 'Diabetes Mellitus/*chemically induced', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Methotrexate/therapeutic use']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Nov;61(8):1607-9.,"['EC 3.5.1.1 (Asparaginase)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
270389,NLM,MEDLINE,19780127,20191210,0008-5472 (Print) 0008-5472 (Linking),37,12,1977 Dec,A phase 1 and 2 trial of rubidazone in patients with acute leukemia.,4623-8,"['Benjamin, R S', 'Keating, M J', 'McCredie, K B', 'Bodey, G P', 'Freireich, E J']","['Benjamin RS', 'Keating MJ', 'McCredie KB', 'Bodey GP', 'Freireich EJ']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adolescent', 'Adult', 'Aged', 'Bone Marrow/drug effects', 'Daunorubicin/adverse effects/*analogs & derivatives/therapeutic use', 'Doxorubicin/pharmacology', 'Drug Evaluation', 'Female', 'Heart Failure/chemically induced', 'Humans', 'Kidney/drug effects', 'Leukemia, Lymphoid/*drug therapy', 'Leukemia, Myeloid, Acute/*drug therapy', 'Liver/drug effects', 'Male', 'Middle Aged', 'Mucous Membrane/drug effects', 'Remission, Spontaneous', 'Time Factors']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Dec;37(12):4623-8.,"['80168379AG (Doxorubicin)', 'V25F9362OP (zorubicin)', 'ZS7284E0ZP (Daunorubicin)']",,,,,,
270388,NLM,MEDLINE,19780127,20141120,0008-5472 (Print) 0008-5472 (Linking),37,12,1977 Dec,Ultrastrual cell cycle-specific nuclear and nucleolar changes of human leukemic lymphoblasts.,4313-25,"['Parmley, R T', 'Dow, L W', 'Mauer, A M']","['Parmley RT', 'Dow LW', 'Mauer AM']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Antimony/metabolism', 'Bone Marrow/ultrastructure', 'Cell Count', 'Cell Cycle', 'Cell Nucleolus/ultrastructure', 'Cell Nucleus/ultrastructure', 'Child', 'Chromatin/ultrastructure', 'Humans', 'In Vitro Techniques', 'Leukemia, Lymphoid/metabolism/*ultrastructure', 'Thymidine/metabolism']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Dec;37(12):4313-25.,"['0 (Chromatin)', '9IT35J3UV3 (Antimony)', 'VC2W18DGKR (Thymidine)']",,,,,,
270387,NLM,MEDLINE,19780127,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6094,1977 Oct 22,Hypercalcaemia as complication of accelerated chronic granulocytic leukaemia.,1060,"['Joyner, M V', 'Dujardin, P', 'Cassuto, J P', 'Audoly, P']","['Joyner MV', 'Dujardin P', 'Cassuto JP', 'Audoly P']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Female', 'Humans', 'Hypercalcemia/*etiology', 'Leukemia, Myeloid/*complications']",1977/10/22 00:00,1977/10/22 00:01,['1977/10/22 00:00'],"['1977/10/22 00:00 [pubmed]', '1977/10/22 00:01 [medline]', '1977/10/22 00:00 [entrez]']",['10.1136/bmj.2.6094.1060 [doi]'],ppublish,Br Med J. 1977 Oct 22;2(6094):1060. doi: 10.1136/bmj.2.6094.1060.,,,,PMC1631839,,,
270386,NLM,MEDLINE,19780127,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6091,1977 Oct 1,Bronchiectasis in acute leukaemia.,857-9,"['Kearney, P J', 'Kershaw, C R', 'Stevenson, P A']","['Kearney PJ', 'Kershaw CR', 'Stevenson PA']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Bronchiectasis/diagnosis/drug therapy/*etiology', 'Child, Preschool', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications/drug therapy', 'Male', 'Remission, Spontaneous', 'Respiratory Tract Infections/*complications']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1136/bmj.2.6091.857 [doi]'],ppublish,Br Med J. 1977 Oct 1;2(6091):857-9. doi: 10.1136/bmj.2.6091.857.,,"Five children in remission from acute lymphoblastic leukaemia developed bronchiectasis when on chemotherapy. Persistent collapse or consolidation on chest radiographs was helpful in suggesting the diagnosis. Necropsy established the diagnosis in one child who died of massive haemoptysis when in complete remission, and bronchography confirmed the diagnosis in three. In a further child the diagnosis was based on clinical and chest X-ray findings alone. The surviving children were treated with prophylactic rotating antibiotics. Routine chest radiographs are recommended in children with acute lymphoblastic leukaemia, as bronchiectasis may otherwise be underdiagnosed.",,PMC1631684,,,
270374,NLM,MEDLINE,19780127,20210216,0006-4971 (Print) 0006-4971 (Linking),50,6,1977 Dec,Irradiation-induced erythroleukemia and myelogenous leukemia in the beagle dog: hematology and ultrastructure.,1061-79,"['Seed, T M', 'Tolle, D V', 'Fritz, T E', 'Devine, R L', 'Poole, C M', 'Norris, W P']","['Seed TM', 'Tolle DV', 'Fritz TE', 'Devine RL', 'Poole CM', 'Norris WP']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Animals', 'Blood Cell Count', 'Bone Marrow/ultrastructure', '*Dogs', 'Dose-Response Relationship, Radiation', 'Female', 'Gamma Rays', 'Leukemia, Erythroblastic, Acute/blood/*pathology', 'Leukemia, Experimental/etiology/pathology', 'Leukemia, Myeloid/blood/*pathology', 'Leukemia, Radiation-Induced/blood/*pathology', 'Liver/ultrastructure', 'Lymph Nodes/ultrastructure', 'Male', 'Spleen/ultrastructure']",1977/12/01 00:00,1977/12/01 00:01,['1977/12/01 00:00'],"['1977/12/01 00:00 [pubmed]', '1977/12/01 00:01 [medline]', '1977/12/01 00:00 [entrez]']",['S0006-4971(20)75638-7 [pii]'],ppublish,Blood. 1977 Dec;50(6):1061-79.,,,,,,,
270373,NLM,MEDLINE,19780127,20190515,0007-0920 (Print) 0007-0920 (Linking),36,3,1977 Sep,Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.,307-12,"['Sonis, S T', 'Falcao, R', 'MacLennan, I C']","['Sonis ST', 'Falcao R', 'MacLennan IC']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Animals', 'Blood Cells/drug effects', 'Bone Marrow Cells', 'Cell Survival/drug effects', 'Cells, Cultured', 'Cytarabine/*therapeutic use', 'Drug Evaluation, Preclinical/*methods', 'Drug Resistance', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Mice']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1038/bjc.1977.194 [doi]'],ppublish,Br J Cancer. 1977 Sep;36(3):307-12. doi: 10.1038/bjc.1977.194.,['04079A1RDZ (Cytarabine)'],"Leukaemia cells from the peripheral blood and bone marrow of patients with acute myeloblastic leukaemia were labelled in vitro with [125I]5-iodo-2'-deoxy-uridine (IUdR). The myeloblasts were then injected into groups of mice and the survival of these cells estimated by measuring isotope loss, using whole-body counting. The isotope excretion from mice treated with various doses of cytosine arabinoside (Ara-C) and those not treated with drugs were compared. This comparison showed that the sensitivity of myeloblasts to the drug varies from patient to patient, and in one case was different for myeloblasts from bone marrow and from blood from the same patient. We compare the clinical responses of myeloblasts to Ara-C in 6 patients, who had high peripheral blood myeloblast counts, with the sensitivities of their myeloblasts to Ara-C in mice. This comparison indicates that the assay might be a useful way of predicting the response of leukaemic cells in patients to cytotoxic agents.",,PMC2025424,,,
270372,NLM,MEDLINE,19780127,20190515,0007-0920 (Print) 0007-0920 (Linking),36,3,1977 Sep,Assessment of drug sensitivity of human leukaemic myeloblasts. I. Labelling human myeloblasts with 125IUdR for survival studies in mice.,297-306,"['Falcao, R P', 'Sonis, S', 'MacLennan, I C', 'Chassoux, D', 'Davies, A J', 'Munro, T R']","['Falcao RP', 'Sonis S', 'MacLennan IC', 'Chassoux D', 'Davies AJ', 'Munro TR']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Animals', 'Blood Cells/metabolism', 'Bone Marrow Cells', 'Cell Survival/drug effects', 'Cells, Cultured', 'Drug Evaluation, Preclinical/*methods', 'Freezing', 'Idoxuridine/metabolism', 'In Vitro Techniques', 'Isotope Labeling/methods', 'Leukemia, Myeloid, Acute/*drug therapy/metabolism', 'Mice']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1038/bjc.1977.193 [doi]'],ppublish,Br J Cancer. 1977 Sep;36(3):297-306. doi: 10.1038/bjc.1977.193.,['LGP81V5245 (Idoxuridine)'],"The compound (125)IUdR can be incorporated in a stable form into the DNA of cells. The isotope is released if labelled cells or their progeny die. Consequently the rate of (125)I excretion from mice can be used to follow the fate of labelled cells in vivo. Using these principles we show:(1) Sufficient label can be incorporated in vitro into both fresh and cryopreserved human leukaemic myeloblasts, in non-toxic concentrations, to allow their survival in mice to be estimated by whole-body counting;(2) The release of isotope from labelled cells is sufficiently slow to offer reasonable expectation that this technique can be used for assessing the sensitivity of myeloblasts to cytotoxic agents in vivo (an application described in the second paper in this series, Sonis, Falcao and MacLennon, 1977);(3) The rate of (125)Iexcretion from mice injected with myeloblasts from different donors varies. This probably reflects different rates of spontaneous death of injected myeloblasts;(4) Active rejection of myeloblasts starts within 48 h of their injection into mice;(5) Indirect evidence that phagocytic cells may be active agents in myeloblast destruction in mice;(6) Various methods of immunologically depriving mice were assessed to see if they would result in a useful increase in survival of injected human myeloblasts. We conclude that there is little advantage and some limitations in using mice thus deprived;(7) One of the agents used for immunological deprivation-silica powder-markedly decreased the rate of (125)I loss from mice injected with labelled killed myeloblasts. This experience emphasizes the importance of including the killed-cell control in this assay.",,PMC2025418,,,
270348,NLM,MEDLINE,19771229,20071115,0350-2023 (Print) 0350-2023 (Linking),5,1,1977,[Fetal hemoglobin in acute leukemias].,23-7,"['Stojmirovic, E']",['Stojmirovic E'],['ger'],"['English Abstract', 'Journal Article']",Serbia,Bilt Hematol Transfuz,Bilten za hematologiju i transfuziju,7601504,IM,"['Acute Disease', 'Adolescent', 'Child', 'Child, Preschool', 'Fetal Hemoglobin/*isolation & purification', 'Humans', 'Infant', 'Infant, Newborn', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Monocytic, Acute/blood', 'Leukemia, Myeloid, Acute/blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Bilt Hematol Transfuz. 1977;5(1):23-7.,['9034-63-3 (Fetal Hemoglobin)'],The question of fetal hemoglobin synthesis reactivation is a current topic both from the aspect of the genetic regulation of synthesis and from the aspect of the disorder of erythropoiesis in malignant diseases. The author presents the results of the quantitative determination of fetal hemoglobin in 84 children suffering from acute leukemias. The quantitation of HbF was performed by the method of alkalide-naturation and values of hemoglobin A2 by celulose-acetate electrophoresis. In acute lymphoblastic leukaemias fetal hemoglobin has been increased in 59% of the patients and in acute nonlymphoblastic leukaemias in 72% of the patients. The highest values of fetal hemoglobin were about 20%. The author considers that presence of fetal hemoglobin in these diseases cannot be a marker for estimation of remission and aggravation of the disease.,Fetalni hemoglobin u akutnim leukemijama.,,,,
270304,NLM,MEDLINE,19771229,20071115,0003-410X (Print) 0003-410X (Linking),128,8-9,1977 Aug-Sep,[Recurrence of acute lymphoblastic leukemia after 15 years of complete remission].,711-4,"['Carcassonne, Y', 'Bernard, R', 'Gastaut, J A', 'Sebahoun, G']","['Carcassonne Y', 'Bernard R', 'Gastaut JA', 'Sebahoun G']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,IM,"['Adult', 'Humans', '*Leukemia, Lymphoid/therapy', 'Male', 'Recurrence', 'Time Factors']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1977 Aug-Sep;128(8-9):711-4.,,,Recidive d'une leucemie aigue lymphoblastique apres quinze ans de remission complete.,,,,
270303,NLM,MEDLINE,19771229,20161123,0003-410X (Print) 0003-410X (Linking),128,6-7,1977 Jun-Jul,[Leukemic arthritis: a mode of recurrence of acute myelo-monocytic leukemia in adults].,597-601,"['Simon, F', 'Degoix-Servant, B', 'Zittoun, R', 'Bilski-Pasquier, G']","['Simon F', 'Degoix-Servant B', 'Zittoun R', 'Bilski-Pasquier G']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,IM,"['Adult', 'Arthritis/diagnostic imaging/*etiology', 'Female', 'Humans', 'Leukemia, Myeloid/*complications/pathology', 'Male', 'Radiography', 'Synovial Fluid/cytology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1977 Jun-Jul;128(6-7):597-601.,,,Les arthrites leucemiques: mode de rechute des leucemies aigues myelo-monocytaires de l'adulte.,,,,
270281,NLM,MEDLINE,19771229,20190716,0002-922X (Print) 0002-922X (Linking),131,11,1977 Nov,Radiological case of the month.,1283-4,"['Young, L W', 'Jequier, S', ""O'Gorman, A M""]","['Young LW', 'Jequier S', ""O'Gorman AM""]",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Brain Diseases/*diagnostic imaging/etiology', 'Calcinosis/*diagnostic imaging/etiology', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/complications/diagnostic imaging', 'Radiography']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1001/archpedi.1977.02120240101022 [doi]'],ppublish,Am J Dis Child. 1977 Nov;131(11):1283-4. doi: 10.1001/archpedi.1977.02120240101022.,,,,,,,
270271,NLM,MEDLINE,19771229,20071115,0001-5814 (Print) 0001-5814 (Linking),8,3,1977 Jul-Sep,[The mechanism of cell proliferation in acute (immature-cell) leukemia].,205-212,"['Urasinski, I', 'Kordecki, H']","['Urasinski I', 'Kordecki H']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Cell Transformation, Neoplastic/*pathology', 'Child', 'Female', 'Humans', 'Leukemia/*pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid, Acute/pathology', 'Male', 'Middle Aged', '*Mitosis', 'Mitotic Index', 'Remission, Spontaneous']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1977 Jul-Sep;8(3):205-212.,,"In 40 patients with acute leukaemias the 3H-thymidine and mitosis indices were determined in the population of blast cells in bone marrow and the cellularity of bone marrow was determined. The studies were carried out in the first episode of the disease before treatment and in some patients (13) they were repeated during relapse after remission or improvement. The results showed that proliferative activity of blast cells was reduced in relation to precursors of normal granulopoiesis in all forms of acute leukaemia. Myeloblastic leukaemias showed a greater scater of values of both proliferation parameters in relation to lymphoblastic leukaemias. It was found, moreover, that in highly cellular bone marrow the proliferative activity of blast cell population was significantly lower than in patients with low bone marrow cellularity. On the ground of this observation the authors put forward the view that in acute leukaemias the intrinsic mechanism controlling the proliferation of cells is disturbed.",Badania nad mechanizmem proliferacji komorkowej w bialaczkach ostrych (niedojrzalokomorkowych).,,,,
270270,NLM,MEDLINE,19771229,20110728,0001-5806 (Print) 0001-5806 (Linking),40,4,1977 Aug,High terminal deoxynucleotidyl transferase activity in the spleen of a patient with chronic myelogenous leukemia in blastic crisis.,500-4,"['Sasaki, R', 'Takaku, F', 'Kanou, Y', 'Sakamoto, S']","['Sasaki R', 'Takaku F', 'Kanou Y', 'Sakamoto S']",['eng'],"['Case Reports', 'Journal Article']",Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Adult', 'Animals', 'Female', 'Humans', 'Leukemia, Myeloid/*enzymology', 'Nucleotidyltransferases/*analysis', 'Rats', 'Spleen/*enzymology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Aug;40(4):500-4.,['EC 2.7.7.- (Nucleotidyltransferases)'],,,,,,
270269,NLM,MEDLINE,19771229,20110728,0001-5806 (Print) 0001-5806 (Linking),40,3,1977 Jun,"[Proliferation kinetics of human leukemic blasts, with a special reference to labelling index of 3H-TdR and DNA synthesis time].",284-92,"['Moteki, M']",['Moteki M'],['jpn'],"['English Abstract', 'Journal Article']",Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Cell Division', 'DNA, Neoplasm/*biosynthesis', 'Female', 'Humans', 'Kinetics', 'Leukemia, Monocytic, Acute/drug therapy/*pathology', 'Leukemia, Myeloid, Acute/drug therapy/*pathology', 'Leukocytes/metabolism', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Jun;40(3):284-92.,"['0 (Antineoplastic Agents)', '0 (DNA, Neoplasm)']",,,,,,
270253,NLM,MEDLINE,19771229,20181113,0093-0415 (Print) 0093-0415 (Linking),127,5,1977 Nov,Phagocytosis in chronic myelocytic leukemia.,424-5,"['Den Ottolander, G J']",['Den Ottolander GJ'],['eng'],['Letter'],United States,West J Med,The Western journal of medicine,0410504,IM,"['Hematopoietic Stem Cells/physiology', 'Humans', 'Leukemia, Myeloid/*physiopathology', 'Megakaryocytes/physiology', '*Phagocytosis']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,West J Med. 1977 Nov;127(5):424-5.,,,,PMC1237897,,,
270252,NLM,MEDLINE,19771229,20071115,0042-773X (Print) 0042-773X (Linking),23,9,1977 Sep,[Study of muramidase (lysozyme) using an indirect cytochemical (cytobacterial) technic. Its significance in the differential diagnosis of hemoblastoses].,893-900,"['Natonekova, K', 'Szabo, J', 'Beresova, R M', 'Ruthnerova, M O', 'Hollanova, S R']","['Natonekova K', 'Szabo J', 'Beresova RM', 'Ruthnerova MO', 'Hollanova SR']",['slo'],"['Case Reports', 'English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Adult', 'Bone Marrow/enzymology', 'Clinical Enzyme Tests', 'Diagnosis, Differential', 'Female', 'Histocytochemistry', 'Humans', 'Leukemia, Myeloid/*diagnosis', 'Male', 'Middle Aged', 'Muramidase/*blood']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Sep;23(9):893-900.,['EC 3.2.1.17 (Muramidase)'],,Vysetrenie muramidazy (lyzozymu) nepriamou cytochemickou (cytobakterialnou) technikou. Jej vyznam v diferencialnej diagnoze hemoblastoz.,,,,
270251,NLM,MEDLINE,19771229,20061115,0042-773X (Print) 0042-773X (Linking),23,10,1977 Sep,[Clinical picture of blastic crisis in chronic myelocytic leukemia].,937-45,"['Donner, L', 'Klener, P', 'Roth, Z']","['Donner L', 'Klener P', 'Roth Z']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Adult', 'Aged', 'Cell Transformation, Neoplastic/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Male', 'Middle Aged', 'Time Factors']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Sep;23(10):937-45.,,,Klinicky obraz blastickeho zvratu vlekle myeloidni leukemie.,,,,
270229,NLM,MEDLINE,19771229,20041117,0038-5077 (Print) 0038-5077 (Linking),,8,1977 Aug,[Treatment of patients with chronic myeloleucosis in outpatient clinics].,136-9,"['Osechenskaia, G V', 'Nevskaia, T P', 'Naumova, G A']","['Osechenskaia GV', 'Nevskaia TP', 'Naumova GA']",['rus'],['Journal Article'],Russia (Federation),Sov Med,Sovetskaia meditsina,0404525,IM,"['Adolescent', 'Adult', 'Aged', 'Ambulatory Care', 'Female', 'Humans', 'Leukemia, Myeloid/*therapy', 'Male', 'Middle Aged']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Sov Med. 1977 Aug;(8):136-9.,,,Lechenie bol'nykh khronicheskim mieloleikozom v ambulatornykh usloviiakh.,,,,
270228,NLM,MEDLINE,19771229,20190702,0038-4348 (Print) 0038-4348 (Linking),70,11,1977 Nov,Probable myeloblastic leukemoid reaction with disseminated sarcoidosis.,1378-80,"['Bordelon, J', 'Stone, M J', 'Frenkel, E P']","['Bordelon J', 'Stone MJ', 'Frenkel EP']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,South Med J,Southern medical journal,0404522,IM,"['Biopsy', 'Bone Marrow/pathology', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Leukemoid Reaction/*pathology', 'Middle Aged', 'Sarcoidosis/*complications/pathology']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['10.1097/00007611-197711000-00043 [doi]'],ppublish,South Med J. 1977 Nov;70(11):1378-80. doi: 10.1097/00007611-197711000-00043.,,"A 55-year-old woman had progressive weakness, weight loss, night sweats, fever, right-sided facial weakness, and hepatomegaly. Reticulonodular infiltrates were seen on chest x-ray film and a central filling defect was noted on liver scan. Study of the peripheral blood was noted on liver scan. Study of the peripheral blood revealed pancytopenia and myeloblasts. The bone marrow was not markedly hypercellular but contained noncaseating granulomas and myeloblasts. The patient's condition deteriorated and she died on the 22nd hospital day. Autopsy disclosed disseminated sarcoidosis but no evidence of leukemic infiltrates. Although concomitant ""smoldering"" acute leukemia cannot be ruled out, the findings in this patient can be best explained on the basis of a myeloblastic leukemoid reaction accompanying sarcoidosis.",,,,,
270216,NLM,MEDLINE,19771229,20131121,0036-7672 (Print) 0036-7672 (Linking),107,41,1977 Oct 15,[The determination of plasma proteolytic activity].,1467,"['Fassler, H', 'Duckert, F', 'Marbet, G A']","['Fassler H', 'Duckert F', 'Marbet GA']",['ger'],"['English Abstract', 'Journal Article']",Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,IM,"['Anilides', 'Blood Coagulation Tests/*methods', 'Blood Specimen Collection/methods', 'Fibrinolysis', 'Humans', 'Kaolin', 'Leukemia, Myeloid, Acute/physiopathology', 'Peptide Hydrolases/blood']",1977/10/15 00:00,1977/10/15 00:01,['1977/10/15 00:00'],"['1977/10/15 00:00 [pubmed]', '1977/10/15 00:01 [medline]', '1977/10/15 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1977 Oct 15;107(41):1467.,"['0 (Anilides)', '24H4NWX5CO (Kaolin)', 'EC 3.4.- (Peptide Hydrolases)']","Experience with different peptide substrates for coagulation and fibrinolysis is reported. As the specifity of these substrates is relative, appropriate characterization of the proteolytic activity of defibrination syndromes is only achieved by simultaneous assays with various substrates. The influence of contact activation on blood sampling must be strictly defined.",Bestimmung der proteolytischen Aktivitat im Plasma.,,,,
270207,NLM,MEDLINE,19771229,20190907,0036-553X (Print) 0036-553X (Linking),19,4,1977 Oct,Basophilic differentiation of chronic myelogenous leukaemia cells in vitro.,321-6,"['Miyoshi, I', 'Uchida, H', 'Tsubota, T', 'Kubonish, I', 'Hiraki, S', 'Kitajima, K']","['Miyoshi I', 'Uchida H', 'Tsubota T', 'Kubonish I', 'Hiraki S', 'Kitajima K']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', '*Basophils/pathology/ultrastructure', '*Cell Differentiation', 'Cells, Cultured', 'Chromosomes, Human', 'Culture Media', 'Female', 'Humans', 'Leukemia, Myeloid/*blood/genetics', 'Leukocyte Count', '*Leukocytes/pathology/ultrastructure', 'Male', 'Middle Aged', 'Time Factors']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01481.x [doi]'],ppublish,Scand J Haematol. 1977 Oct;19(4):321-6. doi: 10.1111/j.1600-0609.1977.tb01481.x.,['0 (Culture Media)'],Peripheral leucocytes from 10 patients with chronic myelogenous leukaemia (CML) were cultured in liquid medium and observed morphologically for 6 to 10 weeks. All cultures showed in increased proportion of mature basophilis at about 3 weeks and most cultures consisted predominantly of mature basophilis at about 5 weeks. The results indicate preferential basophilic differentiation of CML leucocytes in vitro and are consistent with basophilia frequently observed in CML patients.,,,,,
270203,NLM,MEDLINE,19771229,20071115,0033-7021 (Print) 0033-7021 (Linking),40,11,1977 Nov,Paula's legacy.,81-3,"['Jozefowski, J']",['Jozefowski J'],['eng'],"['Case Reports', 'Journal Article']",United States,RN,RN,20010080R,,"['Adult', '*Attitude to Death', '*Communication', 'Family', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications', 'Pregnancy', '*Pregnancy Complications, Hematologic', 'Videotape Recording']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,RN. 1977 Nov;40(11):81-3.,,,,,,,
270098,NLM,MEDLINE,19771229,20131121,,18,2,1977,[Treatment of acute leukemia].,293-313,"['Jacquillat, C', 'Weil, M', 'Auclerc, M F', 'Schaison, G', 'Holland, J F']","['Jacquillat C', 'Weil M', 'Auclerc MF', 'Schaison G', 'Holland JF']",['fre'],"['English Abstract', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",France,Nouv Rev Fr Hematol Blood Cells,Nouvelle revue francaise d'hematologie; blood cells,7701899,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aging', 'Asparaginase/therapeutic use', 'Child', 'Child, Preschool', 'Daunorubicin/therapeutic use', 'Humans', 'Infant', 'Leukemia/*drug therapy/mortality/radiotherapy', 'Leukemia, Monocytic, Acute/drug therapy', 'Leukemia, Myeloid/drug therapy', 'Leukemia, Myeloid, Acute/mortality', 'Methotrexate/therapeutic use', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nouv Rev Fr Hematol Blood Cells. 1977;18(2):293-313.,"['EC 3.5.1.1 (Asparaginase)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","Evaluations of 650 patients with acute lymphoblastic leukemias (A.L.L.) and of 596 patients with acute granulocytic leukemias (A.G.L.) ara analyzed. The patients were treated in the department of Professeur Jean Bernard at Saint-Louis Hospital between 1964 and 1976. In A.L.L., prognosis is influenced primarely by age, being worse in infants less than 1 year old and in adults: it is also influenced by the blastic load and by other parameters such as cytology and immunological markers which could not be studied in all patients. The correlation between high blastic load and the T lymphoblasts variety is noteworthy. Random studies are still necessary to find out the best drug combinations and the optimal duration of treatment, but the necessity for meningeal prophylaxis, reinduction treatments and of L-A sparaginase consolidation is no longer discussed. Prognostic stratification is useful for therapeutical evaluation and should load to therapeutical modulation. In acute granulocytic leukemias, age is also a significant parameter and remission rate is lower for patients over 50 years of age. Cytology and cytochemistry allow to recognize acute promyelocytic leukemias and acute monoblastic leukemias which bear specific initial risks (D.I.C. for A.P.L., renal failure for acute monoblastic leukemia) but which are highly sensitive to Daunorubicin and Rubidazone respectively. In A.M.L. remission duration is not influenced by age and seems to be improved by intermittent treatment. The role of immunotherapy is still under study.",Traitement des leucemies aigues.,,,,
270096,NLM,MEDLINE,19771229,20171116,0301-1518 (Print) 0301-1518 (Linking),6,28,1977 Aug 27-Sep 3,[Malignant blood dyscrasias occurring during immunosuppressive treatment. 4 New cases (author's transl)].,2503-9,"['Blanc, A P', 'Gastuat, J A', 'Dalivoust, P', 'Carcassonne, Y']","['Blanc AP', 'Gastuat JA', 'Dalivoust P', 'Carcassonne Y']",['fre'],"['Case Reports', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Adult', 'Aged', 'Azathioprine/adverse effects', 'Chlorambucil/adverse effects/therapeutic use', 'Female', 'Glomerulonephritis/drug therapy', 'Humans', 'Immunosuppressive Agents/*adverse effects', 'Leukemia, Myeloid/*chemically induced', 'Lymphoma/chemically induced', 'Male', 'Mercaptopurine/adverse effects', 'Middle Aged', 'Prednisone/adverse effects']",1977/08/03 00:00,1977/08/03 00:01,['1977/08/03 00:00'],"['1977/08/03 00:00 [pubmed]', '1977/08/03 00:01 [medline]', '1977/08/03 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Aug 27-Sep 3;6(28):2503-9.,"['0 (Immunosuppressive Agents)', '18D0SL7309 (Chlorambucil)', 'E7WED276I5 (Mercaptopurine)', 'MRK240IY2L (Azathioprine)', 'VB0R961HZT (Prednisone)']","In the first 3 cases, the initial disorder was a renal problem (glomerulonephritis, renal homograft). The development of secondary neoplasms appeared to be related to long term immunosuppressive therapy. By contrast, in the fourth case the primary disease was already malignant in nature (breast neoplasm) and treatment was mixed (radiotherapy and chemotherapy). In the light of these cases, the risks of treatment using immunosuppressive chemotherapy should not be neglected.",Hemopathies malignes survenant au cours d'un triatement immunosuppresseur. Quatre nouvelles observations.,,,,
270090,NLM,MEDLINE,19771229,20071115,0031-3939 (Print) 0031-3939 (Linking),52,9,1977 Sep,[Morphology of paralymphoblasts and the clinical course of acute lymphoblatic leukemia in children].,999-1004,"['Borkowski, W', 'Armata, J']","['Borkowski W', 'Armata J']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Diagnosis, Differential', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/diagnosis/*pathology', 'Lymphocytes/*pathology', 'Male', 'Myelography']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Sep;52(9):999-1004.,,,Morfologia paralimfoblastow a przebieg kliniczny ostrej bialaczki limfoblastycznej u dzieci.,,,,
270089,NLM,MEDLINE,19771229,20071115,0031-3939 (Print) 0031-3939 (Linking),52,9,1977 Sep,[Blood-cerebrospinal fluid barrier in children with acute lymphoblastic leukemia].,965-9,"['Sroczynska, M', 'Szczepanski, Z', 'Sonta-Jakimczyk, D']","['Sroczynska M', 'Szczepanski Z', 'Sonta-Jakimczyk D']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Adolescent', 'Antineoplastic Agents/*pharmacology/therapeutic use', 'Biological Transport/drug effects', '*Blood-Brain Barrier', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy/physiopathology', 'Male']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Sep;52(9):965-9.,['0 (Antineoplastic Agents)'],,Zachowanie sie bariery krew-plyn mozgowo-rdzeniowy u dzieci chorych na ostra bialaczke limfoblastyczna.,,,,
270062,NLM,MEDLINE,19771229,20180216,0030-2414 (Print) 0030-2414 (Linking),34,5,1977,Cytogenetic effects of chemotherapy and cranial irradiation on the peripheral blood lymphocytes of children with malignant disease.,224-8,"['Fischer, P', 'Vetterlein, M', 'Pohl-Ruling, J', 'Krepler, P']","['Fischer P', 'Vetterlein M', 'Pohl-Ruling J', 'Krepler P']",['eng'],['Journal Article'],Switzerland,Oncology,Oncology,0135054,IM,"['Antineoplastic Agents/*adverse effects', 'Brain Neoplasms/radiotherapy', 'Child', '*Chromosome Aberrations', 'Cortisone/adverse effects', 'Cyclophosphamide/adverse effects', 'Female', 'Humans', 'Leukemia, Lymphoid/genetics/*therapy', 'Lymphocytes/*drug effects/*radiation effects', 'Male', 'Nephrosis/drug therapy/genetics', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000225229 [doi]'],ppublish,Oncology. 1977;34(5):224-8. doi: 10.1159/000225229.,"['0 (Antineoplastic Agents)', '8N3DW7272P (Cyclophosphamide)', 'V27W9254FZ (Cortisone)']","Results of a cytogenetic analysis of peripheral blood lymphocytes of children with leukemia after massive chemotherapy and cranial irradiation, and of children with nephrosis after coritisone therapy and cyclophosphamide are presented. Prolonged intensive chemotherapy results in a significant rise in the number of chromatid aberrations after twelve months, and of chromosomal aberrations after 24 months of therapy. After cranial irradiation a sharp rise in chromosome aberrations is present for about three months. This drops after one year to levels present in cases with chemotherapy alone.",,,,,
270013,NLM,MEDLINE,19771229,20211203,0028-2162 (Print) 0028-2162 (Linking),121,43,1977 Oct 22,[Corticosteroids in oncology].,1715-20,"['Cleton, F J']",['Cleton FJ'],['dut'],['Journal Article'],Netherlands,Ned Tijdschr Geneeskd,Nederlands tijdschrift voor geneeskunde,0400770,IM,"['Adrenal Cortex Hormones/*therapeutic use', 'Antineoplastic Agents/therapeutic use', 'Brain Neoplasms/drug therapy', 'Breast Neoplasms/drug therapy', 'Drug Therapy, Combination', 'Hodgkin Disease/drug therapy', 'Humans', 'Immunosuppression Therapy', 'Leukemia, Lymphoid/drug therapy', 'Lymphoma/drug therapy', 'Male', 'Multiple Myeloma/drug therapy', 'Neoplasms/*drug therapy', 'Prostatic Neoplasms/drug therapy', 'Receptors, Estrogen', 'Receptors, Steroid']",1977/10/22 00:00,1977/10/22 00:01,['1977/10/22 00:00'],"['1977/10/22 00:00 [pubmed]', '1977/10/22 00:01 [medline]', '1977/10/22 00:00 [entrez]']",,ppublish,Ned Tijdschr Geneeskd. 1977 Oct 22;121(43):1715-20.,"['0 (Adrenal Cortex Hormones)', '0 (Antineoplastic Agents)', '0 (Receptors, Estrogen)', '0 (Receptors, Steroid)']",,Corticosteroiden in de oncologie.,,,,
270010,NLM,MEDLINE,19771229,20151119,0026-4946 (Print) 0026-4946 (Linking),29,28,1977 Sep 15,"[Paralytic ileus, convulsions and hyponatremia during vincristine treatment. Observations on a case in a young girl with acute lymphocytic leukemia].",1733-8,"['Lorini, R', 'Larizza, D', 'Garibaldi, E', 'Polito, E']","['Lorini R', 'Larizza D', 'Garibaldi E', 'Polito E']",['ita'],"['Case Reports', 'English Abstract', 'Journal Article']",Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Child, Preschool', 'Female', 'Humans', 'Hyponatremia/*chemically induced', 'Intestinal Obstruction/*chemically induced', 'Intestinal Pseudo-Obstruction/*chemically induced', 'Leukemia, Lymphoid/*drug therapy', 'Seizures/*chemically induced', 'Vincristine/*adverse effects/therapeutic use']",1977/09/15 00:00,1977/09/15 00:01,['1977/09/15 00:00'],"['1977/09/15 00:00 [pubmed]', '1977/09/15 00:01 [medline]', '1977/09/15 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Sep 15;29(28):1733-8.,['5J49Q6B70F (Vincristine)'],,"Ileo-paralitico, convulsioni e iponatremia in corso di trattamento con vincristina. Osservazione di un caso in una bambina affetta da L.L.A.",,,,
270007,NLM,MEDLINE,19771229,20171116,0037-5683 (Print) 0037-5683 (Linking),19,2,1977 Jun,Treatment and outcome of acute lymphoblastic leukaemia (ALL) in children.,71-8,"['Boon, W H', 'Chan, M', 'Vellayappan, K', 'Khor, M', 'Mui, L C', 'Boon, C K']","['Boon WH', 'Chan M', 'Vellayappan K', 'Khor M', 'Mui LC', 'Boon CK']",['eng'],['Journal Article'],Singapore,J Singapore Paediatr Soc,The Journal of the Singapore Paediatric Society,7507223,IM,"['Asparaginase/therapeutic use', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/*drug therapy/radiotherapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisolone/therapeutic use', 'Skull', 'Vincristine/therapeutic use']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,J Singapore Paediatr Soc. 1977 Jun;19(2):71-8.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)', 'EC 3.5.1.1 (Asparaginase)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
269983,NLM,MEDLINE,19771229,20190711,0023-2173 (Print) 0023-2173 (Linking),55,18,1977 Sep 15,Improvement of preparative conditions for cytogenetic studies by short-term liquid culture of haemopoietic cells.,895-8,"['Heit, W', 'Hellriegel, K P', 'Heimpel, H', 'Gross, R']","['Heit W', 'Hellriegel KP', 'Heimpel H', 'Gross R']",['eng'],['Journal Article'],Germany,Klin Wochenschr,Klinische Wochenschrift,2985205R,IM,"['Acute Disease', 'Anemia, Aplastic/blood', 'Aneuploidy', '*Cells, Cultured', 'Chromosome Mapping', 'Hematopoietic Stem Cells/*cytology', 'Humans', 'Leukemia/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood/diagnosis', 'Leukocytes/*cytology', 'Mitosis', 'Suspensions']",1977/09/15 00:00,1977/09/15 00:01,['1977/09/15 00:00'],"['1977/09/15 00:00 [pubmed]', '1977/09/15 00:01 [medline]', '1977/09/15 00:00 [entrez]']",['10.1007/BF01478824 [doi]'],ppublish,Klin Wochenschr. 1977 Sep 15;55(18):895-8. doi: 10.1007/BF01478824.,['0 (Suspensions)'],"In patients with haemopoietic failure, the low incidence of cells in mitosis often prevents successful chromosome preparations. By performing liquid cultures of myeloid cells a high incidence of mitoses could be obtained even in those cases failing to provide mitoses when the direct preparation technique was used. The cytogenetic studies demonstrated that the mitoses achieved by culture techniques were aneuploid and, thus, there is evidence that they are of leukaemic origin. The combination of short-term liquid culture and chromosome analysis appears to be a diagnostic approach in selected cases of hemopoietic insufficiency.",,,,,
269981,NLM,MEDLINE,19771229,20071115,0485-1439 (Print) 0485-1439 (Linking),18,8,1977 Aug,[A case of long-term survival of acute promyelocytic leukemia (author's transl)].,994-1000,"['Yoshikawa, H', 'Yano, Y']","['Yoshikawa H', 'Yano Y']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Humans', 'Leukemia, Myeloid, Acute/*mortality', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Time Factors']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Aug;18(8):994-1000.,,,,,,,
269980,NLM,MEDLINE,19771229,20061115,0485-1439 (Print) 0485-1439 (Linking),18,8,1977 Aug,[In vitro colony formation and histochemical studies of colony forming cells in patients with chronic myelocytic leukemia (author's transl)].,979-84,"['Yamagucchi, A', 'Yoshida, K', 'Fukuda, M', 'Sakai, T', 'Shibata, A']","['Yamagucchi A', 'Yoshida K', 'Fukuda M', 'Sakai T', 'Shibata A']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adult', 'Alkaline Phosphatase/blood', 'Bone Marrow/*enzymology/pathology', 'Cell Division', 'Cells, Cultured', 'Female', 'Humans', 'Leukemia, Myeloid/*enzymology/pathology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Aug;18(8):979-84.,['EC 3.1.3.1 (Alkaline Phosphatase)'],,,,,,
269979,NLM,MEDLINE,19771229,20061115,0485-1439 (Print) 0485-1439 (Linking),18,7,1977 Jul,[A childhood case of chronic myelogenous leukemia with meningeal involvement as first manifestation of blastic crisis (author's transl)].,883-88,"['Kurata, S', 'Komiayama, A']","['Kurata S', 'Komiayama A']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Child', 'Humans', 'Leukemia/cerebrospinal fluid/*etiology/ultrastructure', 'Leukemia, Myeloid/*complications', 'Male', 'Meningeal Neoplasms/cerebrospinal fluid/*etiology/ultrastructure']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Jul;18(7):883-88.,,,,,,,
269978,NLM,MEDLINE,19771229,20161123,0485-1439 (Print) 0485-1439 (Linking),18,7,1977 Jul,[Ferrokinetics in erythroleukemia--with special reference to whole body linear scanning-- (author's transl)].,876-82,"['Hotta, T', 'Yamada, H', 'Saito, H']","['Hotta T', 'Yamada H', 'Saito H']",['jpn'],['Journal Article'],Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adolescent', 'Adult', 'Female', 'Humans', 'Iron/*metabolism', 'Kinetics', 'Leukemia, Erythroblastic, Acute/*blood/diagnostic imaging', 'Male', 'Middle Aged', 'Radionuclide Imaging']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Jul;18(7):876-82.,['E1UOL152H7 (Iron)'],,,,,,
269977,NLM,MEDLINE,19771229,20071115,0485-1439 (Print) 0485-1439 (Linking),18,6,1977 Jun,[Use of chromosomal findings in the treatment of acute myelogenous leukemia (author's transl)].,777-84,"['Sakurai, M']",['Sakurai M'],['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adolescent', 'Aged', '*Chromosomes', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics', 'Male']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Jun;18(6):777-84.,,,,,,,
269976,NLM,MEDLINE,19771229,20071115,0485-1439 (Print) 0485-1439 (Linking),18,6,1977 Jun,[Cytogenetic studies on leukemia with special reference to the relevance of chromosome abnormalities to the development of the disease (author's transl)].,771-6,"['Abe, T', 'Misawa, S']","['Abe T', 'Misawa S']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['*Chromosome Aberrations', 'Humans', 'Leukemia, Myeloid/*genetics', 'Leukemia, Myeloid, Acute/*genetics', 'Lymphoma/*genetics', 'Prognosis']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Jun;18(6):771-6.,,,,,,,
269853,NLM,MEDLINE,19771229,20210210,0021-9258 (Print) 0021-9258 (Linking),252,21,1977 Nov 10,Human thymidylate synthetase derived from blast cells of patients with acture myelocytic leukemia. Purification and chracterization.,7697-703,"['Dolnick, B J', 'Cheng, Y c']","['Dolnick BJ', 'Cheng Yc']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Biol Chem,The Journal of biological chemistry,2985121R,IM,"['Blastocyst/*enzymology', 'Humans', 'Kinetics', 'Leukemia, Myeloid, Acute/*enzymology', 'Methotrexate/pharmacology', 'Methyltransferases/*metabolism', 'Molecular Weight', 'Thermodynamics', 'Thymidylate Synthase/isolation & purification/*metabolism']",1977/11/10 00:00,1977/11/10 00:01,['1977/11/10 00:00'],"['1977/11/10 00:00 [pubmed]', '1977/11/10 00:01 [medline]', '1977/11/10 00:00 [entrez]']",['S0021-9258(17)41024-6 [pii]'],ppublish,J Biol Chem. 1977 Nov 10;252(21):7697-703.,"['EC 2.1.1.- (Methyltransferases)', 'EC 2.1.1.45 (Thymidylate Synthase)', 'YL5FZ2Y5U1 (Methotrexate)']","Thymidylate synthetase (EC 2.1.1.B.) from blast cells of patients with acute myelocytic leukemia has been purified more than 1470-fold by affinity column chromatography. Methotrexate was the affinity ligand. dUMP was found to be a necessary additive for retention of the enzyme by the affinity column. Disc electrophoresis and sucrose density gradient centrifugation revealed a single enzyme species with a molecular weight of 76,000. The enzyme exhibits a temperature-dependent conformational change with activation energies of 5.3 +/- 0.4 and 17.3 +/- 1.9 kcal/mol, respectively, above and below a transitional temperature of 35 degrees. This conformational change is reflected in the binding affinity of dUMP but not of 5,10-methylenetetrahydrofolate. The enzyme displays a broad pH maximum in the range of pH 7.4 to 8.8. The Michaelis constants for dUMP and (+/--L-5,10-methylenetetrahydrofolate are 1.8 +/- 0.2 and 31 +/- 8.3 micrometer, respectively. Initial velocity and product inhibition studies reveal the enzymic mechanism to be ordered sequential. dUMP binds before 5,10-methylenetetrahydrofolate and dihydrofolate is released before TMP. 5-Fluoro-2'-deoxy-5'-uridylate (FdUMP) behaves as in irreversible inhibitor with a Ki of 1.68 +/- 0.45 nM. The enzyme has a turnover number of 6 min-1 per FdUMP binding site. Methotrexate inhibits noncompetitively with respect to dUMP and binds tighter to the enzyme in the presence of dUMP. Methotrexate antagonizes inactivation of the enzyme by FdUMP.",,,,,
269842,NLM,MEDLINE,19771229,20190827,0300-8126 (Print) 0300-8126 (Linking),5,3,1977,Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe.,188-94,"['Van der Waaij, D', 'Tielemans-Speltie, T M', 'De Roeck-Houben, A M']","['Van der Waaij D', 'Tielemans-Speltie TM', 'De Roeck-Houben AM']",['eng'],['Journal Article'],Germany,Infection,Infection,0365307,IM,"['Cross Infection/*complications/epidemiology', 'Enterobacteriaceae/classification/isolation & purification', 'Enterobacteriaceae Infections/*complications/epidemiology/microbiology', 'Europe', 'Feces/microbiology', 'Humans', 'Leukemia, Lymphoid/*complications', 'Mouth/microbiology', '*Patient Isolation', 'Serotyping', 'Therapeutic Irrigation']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/BF01639756 [doi]'],ppublish,Infection. 1977;5(3):188-94. doi: 10.1007/BF01639756.,,"In a cooperative study on the efficiency of isolation and decontamination in patients with acute leukaemia performed in seven hospitals in Europe, faecal samples and oral washings were collected twice weekly and shipped for culturing to a Central Bacteriological Laboratory. In this laboratory the Enterobacteriaceae species isolated from these samples were biotyped as well as those isolated from infections that occurred in these patients during treatment. Enterobacteriaceae biotypes isolated for the first time during the isolation phase of the patient indicated a leak in the isolation system. The ""colonizing"" (newly resident) biotypes of Enterobacteriaceae species were found to be more often involved in infections and to be more commonly distributed among the patients in the participating hospitals than the ""contaminating"" (transient) Enterobacteriaceae biotypes. Furthermore, a linear correlation was found between the incidence of gram-negative infections and the number of cases in which these Enterobacteriaceae biotypes colonized the gastro-intestinal tract of patients. The majority of the infections was caused by Enterobacteriaceae biotypes that had settled in the gastro-intestinal tract during treatment and consequently were of nosocomial origin.",,,,,
269841,NLM,MEDLINE,19771229,20141003,0016-450X (Print) 0016-450X (Linking),68,3,1977 Jun,Effect of leupeptin on induction of lymphoblastic leukemia in mice by N-nitrosobutylurea.,281-5,"['Kakizoe, T', 'Sano, T', 'Kawachi, T', 'Sugimura, T', 'Takeuchi, T']","['Kakizoe T', 'Sano T', 'Kawachi T', 'Sugimura T', 'Takeuchi T']",['eng'],['Journal Article'],Japan,Gan,Gan,0151745,IM,"['Animals', 'Body Weight/drug effects', 'Female', 'Leukemia, Experimental/chemically induced/pathology', 'Leukemia, Lymphoid/*chemically induced/pathology', 'Leupeptins/*pharmacology', 'Mice', 'Mice, Inbred ICR', '*Nitrosourea Compounds', 'Oligopeptides/*pharmacology', 'Thymus Gland/pathology', 'Thymus Neoplasms/pathology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Gan. 1977 Jun;68(3):281-5.,"['0 (Leupeptins)', '0 (Nitrosourea Compounds)', '0 (Oligopeptides)']","The effect of leupeptin on the induction of lymphoblastic leukemia in ICR/JCL female mice by N-nitrosobutylurea (NBU) was investigated. NBU was given as a 0.02% solution in drinking water for 10 weeks. A 0.1% concentration of leupeptin was given in the diet. Group A was fed on the leupeptin diet from the beginning, Group B received it after the end of NBU treatment, and Group C was fed on a leupeptin-free control diet throughout. The average periods in the appearance of leukemia in groups A, B, and C were 115+/-50, 112+/-43, and 100+/-17 days (mean+/-SD), respectively, and there was a significant difference between groups A and B and Group C at P less than 0.001. In regard to this point, leupeptin might have the effect of retarding the rpocess of leukemogenesis. However, leupeptin showed no effect on the incidence and histopathological finding of leukemia.",,,,,
269840,NLM,MEDLINE,19771229,20190902,0011-9075 (Print) 0011-9075 (Linking),155,1,1977,Skin manifestations in acute lymphatic leukosis.,61-4,"['Arneric, S', 'Karadaglic, D J', 'Krstic, C']","['Arneric S', 'Karadaglic DJ', 'Krstic C']",['eng'],"['Case Reports', 'Journal Article']",Switzerland,Dermatologica,Dermatologica,0211607,IM,"['Adult', 'Humans', 'Leukemia, Lymphoid/*pathology', 'Male', '*Skin Manifestations']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000250958 [doi]'],ppublish,Dermatologica. 1977;155(1):61-4. doi: 10.1159/000250958.,,,,,,,
269763,NLM,MEDLINE,19771229,20131121,0308-2261 (Print) 0308-2261 (Linking),6,1,1977 Feb,The clinical features of chronic granulocytic leukaemia.,77-95,"['Spiers, A S']",['Spiers AS'],['eng'],['Journal Article'],England,Clin Haematol,Clinics in haematology,0331547,IM,"['Adult', 'Busulfan/adverse effects', 'Cell Transformation, Neoplastic', 'Female', 'Humans', 'Leukemia, Myeloid/blood/*diagnosis/mortality/pathology', 'Male', 'Middle Aged', 'Syndrome']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Clin Haematol. 1977 Feb;6(1):77-95.,['G1LN9045DK (Busulfan)'],,,,,,
269749,NLM,MEDLINE,19771229,20190619,0008-543X (Print) 0008-543X (Linking),39,3,1977 Mar,Fanconi anemia leading to acute myelomonocytic leukemia: cytogenetic studies.,1163-7,"['Bourgeois, C A', 'Hill, F G']","['Bourgeois CA', 'Hill FG']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Anemia, Aplastic/*complications', 'Bone Marrow Cells', 'Chromosome Aberrations', 'Fanconi Anemia/*complications/genetics', 'Humans', 'Infant', 'Leukemia, Myeloid, Acute/*etiology', 'Lymphocytes/cytology', 'Male']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1002/1097-0142(197703)39:3<1163::aid-cncr2820390322>3.0.co;2-y [doi]'],ppublish,Cancer. 1977 Mar;39(3):1163-7. doi: 10.1002/1097-0142(197703)39:3<1163::aid-cncr2820390322>3.0.co;2-y.,,"A 6-year-old boy with Fanconi anemia, developed acute myelomonocytic leukemia with marker chromosomes from an interchange in the malignant clone in the bone marrow. The possible aetiological role of therapy, the morphological characteristics and chromosome aberrations of the bone marrow cell line are discussed in relation to previous reported cases of Fanconi anemia in which acute leukemia has supervened.",,,,,
269747,NLM,MEDLINE,19771229,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6090,1977 Sep 24,Prolonged remission maintenance in acute myeloid leukaemia.,831,"['Stavem, P', 'Gjemdal, T', 'Ly, B']","['Stavem P', 'Gjemdal T', 'Ly B']",['eng'],['Letter'],England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Remission, Spontaneous']",1977/09/24 00:00,1977/09/24 00:01,['1977/09/24 00:00'],"['1977/09/24 00:00 [pubmed]', '1977/09/24 00:01 [medline]', '1977/09/24 00:00 [entrez]']",['10.1136/bmj.2.6090.831-a [doi]'],ppublish,Br Med J. 1977 Sep 24;2(6090):831. doi: 10.1136/bmj.2.6090.831-a.,,,,PMC1632035,,,
269745,NLM,MEDLINE,19771229,20200304,0006-5242 (Print) 0006-5242 (Linking),35,4,1977 Sep 18,[Isoenzymes of acid phosphatase in blood cells of normal subjects and patients with leukemia (author's transl)].,295-303,"['von Heyden, H W', 'Weber, R', 'Nerke, O', 'Saal, J G', 'Stein, W']","['von Heyden HW', 'Weber R', 'Nerke O', 'Saal JG', 'Stein W']",['ger'],"['English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Acid Phosphatase/*blood', 'Acute Disease', 'Blood Platelets/enzymology', 'Granulocytes/enzymology', 'Humans', 'Isoenzymes/*blood', 'Leukemia/enzymology', 'Leukemia, Hairy Cell/*enzymology', 'Leukemia, Myeloid/*enzymology', 'Leukocytes/*enzymology', 'Lymphocytes/enzymology', 'Macrophages/enzymology']",1977/09/18 00:00,1977/09/18 00:01,['1977/09/18 00:00'],"['1977/09/18 00:00 [pubmed]', '1977/09/18 00:01 [medline]', '1977/09/18 00:00 [entrez]']",['10.1007/BF00996142 [doi]'],ppublish,Blut. 1977 Sep 18;35(4):295-303. doi: 10.1007/BF00996142.,"['0 (Isoenzymes)', 'EC 3.1.3.2 (Acid Phosphatase)']","The activities of acid phosphatases (AP) were measured in leukocytes from patients with chronic myelocytic leukemia (CML), macrophages, granulocytes, in the fractionated mononuclear cells of patients with CML and with hairy-cell-leukemia (HCL) and in the cells from patients with acute leukemia (AL). The lowest activities were found in lymphocytes of normal subjects and of patients with chronic lymphatic leukemia (CLL) and in thrombocytes. Isoenzyme (IsE) 1 was characteristic for thymocytes, IsE 2 for granulocytes, IsE 3 for pathologic blast-cells, lymphocytes and thrombocytes, IsE 4 for macrophages, IsE 5 with components a and b for the mononuclear fraction of patients with HCL. In addition IsE 5 was detected in lymphocytes, macrophages and CLL-cells. In 4 patients with HCL the relative percentage of IsE-5-fraction was slightly greater than the percentage of tartrate resistant cells. In two patients with questionable HCL well marked IsE-5-fractions were recognized but no tartrate resistant cells. In one patient with HCL a relatively high percentage of tartrate resistant hairy-cells and in comparison an inadaquate low IsE-5-fraction was found. These different relations were explained with the more sensitive method of gelelectrophoresis and different affinity of substrates to AP.",Isoenzym-Muster saurer Phosphatasen aus normalen und leukamischen weissen Blutzellen.,,,,
269744,NLM,MEDLINE,19771229,20190902,0006-5242 (Print) 0006-5242 (Linking),35,4,1977 Sep 18,A test with dexamethasone in acute leukemia.,289-94,"['Bohinjec, J']",['Bohinjec J'],['eng'],['Journal Article'],Germany,Blut,Blut,0173401,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', '*Dexamethasone', 'Diagnosis, Differential', 'Glucocorticoids/therapeutic use', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/diagnosis/drug therapy', 'Leukemia, Myeloid, Acute/diagnosis', 'Leukocyte Count', 'Middle Aged', 'Remission, Spontaneous', 'Time Factors']",1977/09/18 00:00,1977/09/18 00:01,['1977/09/18 00:00'],"['1977/09/18 00:00 [pubmed]', '1977/09/18 00:01 [medline]', '1977/09/18 00:00 [entrez]']",['10.1007/BF00996141 [doi]'],ppublish,Blut. 1977 Sep 18;35(4):289-94. doi: 10.1007/BF00996141.,"['0 (Glucocorticoids)', '7S5I7G3JQL (Dexamethasone)']","A simple test with dexamethasone (DMS) in acute leukemia (AL) is described. In peripheral blood, blast cell count is determined before 8 mg DMS are given intravenously, and 2, 4 and 6 hours afterwards. The result is expressed as the lowest blast cell count after DMS in percentage of the initial value. This test was performed on 51 adult patients with AL. The results were correlated with the morphological and cytochemical classification. Only patients with clearly classified AL were evaluated. A statistically significant difference in blast cell response between acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) was observed. In 12 out of 16 cases of ALL, but in only 1 out of 19 cases of AML, the blast cell count decreased to 50 percent or less of the initial value. The results of the test were further correlated with the results of treatment. In 11 out of 12 patients with ALL, who showed a response to DMS, glucocorticoids were included in the treatment regimen. A complete remission was obtained in 7 out of 10 patients who were treated for the first time. In the remaining 4 patients with a poor response to DMS, a complete remission after the first treatment was obtained in only one case. The number of patients examined is to small for final conclusions on the value of this test for a discrimination between glucocorticoid-responsive and non-responsive cases of AL. Nevertheless, these preliminary results indicate that further trials seem to be warranted.",,,,,
269743,NLM,MEDLINE,19771229,20190902,0006-5242 (Print) 0006-5242 (Linking),35,3,1977 Sep 29,[Extracorporeal treatment with L-asparaginase (author's transl)].,179-86,"['Pralle, H', 'Loffler, H']","['Pralle H', 'Loffler H']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Adult', 'Anaphylaxis', 'Antibodies', 'Asparaginase/adverse effects/*therapeutic use', 'Drug Hypersensitivity', '*Extracorporeal Circulation', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Molecular Weight']",1977/09/29 00:00,1977/09/29 00:01,['1977/09/29 00:00'],"['1977/09/29 00:00 [pubmed]', '1977/09/29 00:01 [medline]', '1977/09/29 00:00 [entrez]']",['10.1007/BF00999458 [doi]'],ppublish,Blut. 1977 Sep 29;35(3):179-86. doi: 10.1007/BF00999458.,"['0 (Antibodies)', 'EC 3.5.1.1 (Asparaginase)']",L-asparaginase therapy is often limited by allergy or toxicity and probably in some cases by antibody mediated inactivation of the enzyme. These problems can be avoided by extracorporeal application of l-asparaginase. As the enzyme is a stable tetramer with high molecular weight it cannot pass through the dialysis membrane in contrast to the amino acid l-asparagin which is destroyed. The resulting l-asparagin depletion of the plasma is sufficient for therapeutic success. Effective extracorporeal l-asparaginase therapy is demonstrated in two patients with ALL who were resistant to other chemotherapy and could not be treated intravenously because of allergy and toxicity.,Extrakorporale Asparaginasetherapie bei Allergie und toxischen Nebenwirkungen.,,,,
269741,NLM,MEDLINE,19771229,20190515,0007-0920 (Print) 0007-0920 (Linking),36,2,1977 Aug,Effect of methylprednisolone on the nucleoside metabolism of a human lymphoblastoid cell line.,187-91,"['Waddell, A W', 'Bird, C C', 'Currie, A R']","['Waddell AW', 'Bird CC', 'Currie AR']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Cell Line', 'Kinetics', 'Leukemia, Lymphoid/metabolism', 'Lymphocytes/drug effects/*metabolism', 'Methylprednisolone/*pharmacology', 'Thymidine/*metabolism', 'Uridine/*metabolism']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1038/bjc.1977.176 [doi]'],ppublish,Br J Cancer. 1977 Aug;36(2):187-91. doi: 10.1038/bjc.1977.176.,"['VC2W18DGKR (Thymidine)', 'WHI7HQ7H85 (Uridine)', 'X4W7ZR7023 (Methylprednisolone)']","Concentrations of methylprednisolone which have lethal effects on human lymphoblastoid cell lines in vitro cause a reduction both in the uptake of uridine and thymidine into acid-soluble material and their incorporation into acid-insoluble material. These effects are virtually instantaneous, which indicates that they do not depend on alterations in gene activity. Normal uptake of nucleosides into cells is by both simple and facilitated diffusion, and methylprednisolone appears to act directly on the cell surface to inhibit only facilitated diffusion uptake.",,PMC2025470,,,
269736,NLM,MEDLINE,19771229,20041117,0037-8771 (Print) 0037-8771 (Linking),53,1-2,1977 Jan 30,[Granulocyte acid phosphatase activity during the course of chronic myeloid leukemia and Hodgkin's disease].,50-3,"['Dallegri, F', 'Mela, G S', 'Patrone, F', 'Parodi, M']","['Dallegri F', 'Mela GS', 'Patrone F', 'Parodi M']",['ita'],['Journal Article'],Italy,Boll Soc Ital Biol Sper,Bollettino della Societa italiana di biologia sperimentale,7506962,IM,"['Acid Phosphatase/*blood', 'Antineoplastic Agents/therapeutic use', 'Granulocytes/enzymology', 'Hodgkin Disease/drug therapy/*enzymology', 'Humans', 'Leukemia, Myeloid/drug therapy/*enzymology']",1977/01/30 00:00,1977/01/30 00:01,['1977/01/30 00:00'],"['1977/01/30 00:00 [pubmed]', '1977/01/30 00:01 [medline]', '1977/01/30 00:00 [entrez]']",,ppublish,Boll Soc Ital Biol Sper. 1977 Jan 30;53(1-2):50-3.,"['0 (Antineoplastic Agents)', 'EC 3.1.3.2 (Acid Phosphatase)']",,Comportamento della fosfatasi acida granulocitaria in corso di leucemia mieloide cronica e morbo di Hodgkin.,,,,
269664,NLM,MEDLINE,19771130,20190626,0002-9343 (Print) 0002-9343 (Linking),63,4,1977 Oct,Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications.,542-7,"['Rosenthal, S', 'Canellos, G P', 'Whang-Peng, J', 'Gralnick, H R']","['Rosenthal S', 'Canellos GP', 'Whang-Peng J', 'Gralnick HR']",['eng'],['Journal Article'],United States,Am J Med,The American journal of medicine,0267200,IM,"['Adult', 'Bone Marrow/pathology', 'Carmustine/therapeutic use', 'Cytarabine/therapeutic use', 'Diploidy', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/mortality/pathology', 'Leukemia, Myeloid/genetics/mortality/*pathology/therapy', 'Leukemia, Myeloid, Acute/pathology', 'Lymphocytes/pathology', 'Male', 'Maryland', 'Middle Aged', 'Prednisone/therapeutic use', 'Retrospective Studies', 'Splenectomy', 'Vincristine/therapeutic use']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']","['0002-9343(77)90199-1 [pii]', '10.1016/0002-9343(77)90199-1 [doi]']",ppublish,Am J Med. 1977 Oct;63(4):542-7. doi: 10.1016/0002-9343(77)90199-1.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', 'U68WG3173Y (Carmustine)', 'VB0R961HZT (Prednisone)']","Chronic granulocytic leukemia (CGL) terminates in a disease similar to acute leukemia. Except for a study indicating an increased response rate to the drugs, vincristine and prednisone, therapy of this terminal phase has been universally disappointing. We have studied the bone marrows and clinical courses of 67 patients in the terminal phase of CGL to discern if any parameters were associated with an increased response rate or survival. The results of this study indicate that patients who have a lymphoblastic morphology or hypodiploid cytogenetics in the terminal phase respond better to treatment with the combination of vincristine and prednisone than those with myeloblastic morphology or hyperdiploid cytogenetics. Response rate and survival are significantly increased in those with lymphoblastic morphology. Recognition of the heterogeneity of the terminal phase of CGL may dictate specific therapeutic modalities.",,,,,
269663,NLM,MEDLINE,19771125,20190509,0002-9173 (Print) 0002-9173 (Linking),68,4,1977 Oct,"Hand-mirror cell leukemia, a new clinical and morphological variant.",531-4,"['Schumacher, H R', 'Perlin, E', 'Klos, J R', 'Holloway, M L', 'Miller, W M', 'Sanford, S A']","['Schumacher HR', 'Perlin E', 'Klos JR', 'Holloway ML', 'Miller WM', 'Sanford SA']",['eng'],"['Case Reports', 'Journal Article']",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Adult', 'Bone Marrow/*pathology', 'Bone Marrow Examination', 'Female', 'Humans', 'Leukemia, Lymphoid/*pathology', 'Lymphocytes/*pathology', 'Male']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1093/ajcp/68.4.531 [doi]'],ppublish,Am J Clin Pathol. 1977 Oct;68(4):531-4. doi: 10.1093/ajcp/68.4.531.,,,,,,,
269604,NLM,MEDLINE,19771125,20071115,0001-5547 (Print) 0001-5547 (Linking),21,4,1977 Jul-Aug,Microinterferometric measurement of dry weight of blood lymphocytes in hematologically normal patients and in patients with chronic lymphocytic leukemia.,539-42,"['Efrati, P', 'Sakal, E', 'Nir, N']","['Efrati P', 'Sakal E', 'Nir N']",['eng'],"['Comparative Study', 'Journal Article']",Switzerland,Acta Cytol,Acta cytologica,0370307,IM,"['Humans', 'Interferometry', 'Kinetics', 'Lectins/pharmacology', 'Leukemia, Lymphoid/*blood', '*Lymphocyte Activation', '*Lymphocytes/cytology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Acta Cytol. 1977 Jul-Aug;21(4):539-42.,['0 (Lectins)'],"Lymphocytes from the peripheral blood of 20 patients with nonhematologic disorders (HN patients) and 13 patients with chronic lymphocytic leukemia (CLL) were studied. A scanning and integrating microinterferometer was used for calculation of dry weight of cells. In HN patients dry weight of lymphocytes was found to be 38.09 +/- 11.11 pg. The HN patients could be divided into three groups according to their lymphocytes' mund to be 29.79 +/- 7.99 pg. This population was uniform and resembled the ""light"" group of lymphocytes in HN patients. A study of the kinetics of PHA transformation of lymphocytes from both HN and CLL patients revealed a good correlation between the morphological evaluation and dry weight calculations.",,,,,
269570,NLM,MEDLINE,19771130,20041117,0301-0481 (Print) 0301-0481 (Linking),52,19,1977 Oct 1,[Skin manifestations in chronic myelogenous leukemia].,1001-2,"['Djawari, D']",['Djawari D'],['ger'],"['Case Reports', 'Journal Article']",Germany,Z Hautkr,Zeitschrift fur Hautkrankheiten,0367576,IM,"['Eosinophils', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Middle Aged', '*Skin Manifestations']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Z Hautkr. 1977 Oct 1;52(19):1001-2.,,,Haterscheinungen bei chron. myeloischer Leukamie.,,,,
269565,NLM,MEDLINE,19771125,20061115,0042-773X (Print) 0042-773X (Linking),23,8,1977 Aug,[Occurence of cancer in chronic myeloid leukemia].,773-80,"['Chrobak, L', 'Radochova, D', 'Vacha, K']","['Chrobak L', 'Radochova D', 'Vacha K']",['cze'],"['Case Reports', 'English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Aged', 'Female', 'Humans', 'Leukemia, Myeloid/*complications', 'Male', 'Middle Aged', 'Neoplasms/*epidemiology', 'Rectal Neoplasms/epidemiology', 'Skin Neoplasms/epidemiology', 'Stomach Neoplasms/epidemiology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Aug;23(8):773-80.,,,Vyskyt rakoviny u vlekle myeloidni leukemie.,,,,
269540,NLM,MEDLINE,19771125,20071115,0041-5782 (Print) 0041-5782 (Linking),139,41,1977 Oct 10,[Intravascular leukocyte aggregation and formation of leukemic thrombi as cause of death in leukemia].,2444-6,"['Ingeberg, S', 'Jensen, M K', 'Johansen, P']","['Ingeberg S', 'Jensen MK', 'Johansen P']",['dan'],"['Case Reports', 'English Abstract', 'Journal Article']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,IM,"['Adult', 'Female', 'Humans', 'Intracranial Embolism and Thrombosis/*etiology', 'Leukemia, Myeloid/*complications', 'Leukemia, Myeloid, Acute/*complications', '*Leukocytes', 'Middle Aged', 'Pulmonary Embolism/*etiology']",1977/10/10 00:00,1977/10/10 00:01,['1977/10/10 00:00'],"['1977/10/10 00:00 [pubmed]', '1977/10/10 00:01 [medline]', '1977/10/10 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1977 Oct 10;139(41):2444-6.,,,Intravaskulaerleukocyt-aggregation og dannelse af leukaemiske tromber som dodsarsag ved leukaemi.,,,,
269510,NLM,MEDLINE,19771125,20151119,0036-4355 (Print) 0036-4355 (Linking),22,5,1977,[(Protocolo C-70). Therapy for childhood acute lymphocytic leukaemia with cyclic chemotherapy (C-70 protocol) (author's transl)].,585-605,"['Ortega, J J', 'Javier, G', 'Saenz, S', 'Tusell, J']","['Ortega JJ', 'Javier G', 'Saenz S', 'Tusell J']",['spa'],"['English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Antineoplastic Agents/*therapeutic use', 'Child', 'Child, Preschool', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Infant', 'Leukemia, Lymphoid/*drug therapy/radiotherapy', 'Prednisolone/therapeutic use', 'Vincristine/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(5):585-605.,"['0 (Antineoplastic Agents)', '5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)', 'ZS7284E0ZP (Daunorubicin)']",,Tratamiento de las leucemias agudas infantiles con un metodo de poliquimioterapia ciclica (protocolo C-70).,,,,
269509,NLM,MEDLINE,19771125,20091111,0370-8179 (Print) 0370-8179 (Linking),105,2,1977 Feb,"[Clinical, hematological and patho-histological characteristics of terminal erythremic myelosis].",135-43,"['Jelic, S', 'Dragovic, M', 'Vidakovic, B', 'Bojic, P', 'Plecas, V']","['Jelic S', 'Dragovic M', 'Vidakovic B', 'Bojic P', 'Plecas V']",['srp'],"['English Abstract', 'Journal Article']",Serbia,Srp Arh Celok Lek,Srpski arhiv za celokupno lekarstvo,0027440,IM,"['Erythroblasts/physiology', 'Humans', 'Leukemia, Erythroblastic, Acute/blood/*diagnosis/pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Srp Arh Celok Lek. 1977 Feb;105(2):135-43.,,,"Klinicke, hematoloske i patohistoloske karakteristike terminalne faze eritremijske mijeloze.",,,,
269498,NLM,MEDLINE,19771125,20171116,0036-7672 (Print) 0036-7672 (Linking),107,39,1977 Oct 1,[Therapeutic results and prognostic factors in acute lymphatic leukemia in the adult].,1361-6,"['Cavalli, F', 'Hartmann, H', 'Tschopp, L', 'Sauter, C', 'Alberto, P']","['Cavalli F', 'Hartmann H', 'Tschopp L', 'Sauter C', 'Alberto P']",['ger'],['Journal Article'],Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,IM,"['Adult', 'Asparaginase/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use', 'Prognosis', 'Remission, Spontaneous', 'Time Factors', 'Vincristine/therapeutic use']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1977 Oct 1;107(39):1361-6.,"['5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']","Induction chemotherapy consisting of vincristine, prednisone and L-asparaginase was given to 22 adult patients with acute lymphatic leukemia. Manintenance treatment consisted of methotrexate, 6-mercaptopurine, prednisone and vincristine. Of the 22 patients treated, 14 had a complete remission. The median remission duration was 14 months and the median survival 20 months. 8 further patients were included in an attempt to determine the significance of prognostic factors, but none of the parameters studied influence the course of disease with statistical significance. In general, younger patients and those with lower leukocyte counts at the time of diagnosis seemed to fare better.",Therapieresultate und prognostische Faktoren bei der akuten lymphatischen Leukamie des Erwachsenen.,,,,
269493,NLM,MEDLINE,19771125,20190907,0036-553X (Print) 0036-553X (Linking),19,3,1977 Sep,Mitotic activity of the granulopoietic precursor cells in the peripheral blood in chronic myeloid leukaemia.,309-12,"['Sjogren, U']",['Sjogren U'],['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Aged', 'Bone Marrow Cells', 'Female', '*Granulocytes', 'Hematopoiesis', 'Humans', 'Leukemia, Myeloid/*blood', 'Leukocyte Count', '*Leukocytes', 'Male', 'Middle Aged', '*Mitosis', 'Prognosis']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02111.x [doi]'],ppublish,Scand J Haematol. 1977 Sep;19(3):309-12. doi: 10.1111/j.1600-0609.1977.tb02111.x.,,"The mitotic indices (MI) of granulopoietic precursor cells in peripheral blood and bone marrow were studied in 38 patients with typical chronic myeloid leukaemia (CML) in the chronic phase. The MI in the peripheral blood were very low, in the median 0.07%, compared to those in the bone marrow with a median of 1.07%. The blood MI were significantly increasing with raising WCC and the values of the MI above the median were combined with short survival times. The bone marrow MI were negatively correlated to the blood MI and it is suggested that this is a sign of an increased exchange of cells between bone marrow and blood.",,,,,
269492,NLM,MEDLINE,19771125,20190907,0036-553X (Print) 0036-553X (Linking),19,3,1977 Sep,Hodgkin's disease and acute leukaemia. A clinical and cytogenetic study.,273-80,"['Cavallin-Stahl, E', 'Landberg, T', 'Ottow, Z', 'Mitelman, F']","['Cavallin-Stahl E', 'Landberg T', 'Ottow Z', 'Mitelman F']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Bone Marrow/ultrastructure', '*Chromosome Aberrations', 'Hodgkin Disease/*complications/genetics/therapy', 'Humans', 'Karyotyping', 'Leukemia, Myeloid, Acute/*etiology/genetics', 'Male', 'Middle Aged']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02106.x [doi]'],ppublish,Scand J Haematol. 1977 Sep;19(3):273-80. doi: 10.1111/j.1600-0609.1977.tb02106.x.,,Three patients developing acute myeloid leukaemia after treatment for Hodgkin's disease are reported. They appeared among 153 patients treated since 1971. All three patients were treated with high-voltage radiation of large target volumes as well as multiple-drug chemotherapy. In two of the patients chromosomal analyses of the leukaemic bone marrow cells were performed by modern banding technique. Chromosome abnormalities were found in both patients. The value of cytogenetic analysis with the new staining techniques for elucidating the mechanism of leukaemogenesis in Hodgkin's disease is discussed.,,,,,
269491,NLM,MEDLINE,19771125,20190907,0036-553X (Print) 0036-553X (Linking),19,3,1977 Sep,Leucocyte alkaline phosphatase elevation in human acute leukaemia derived cell lines cultured in diffusion chambers.,242-54,"['Greenberger, J S', 'Hassan, L R', 'Karpas, A', 'France, D S', 'Moloney, W C']","['Greenberger JS', 'Hassan LR', 'Karpas A', 'France DS', 'Moloney WC']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Alkaline Phosphatase/biosynthesis/*blood', 'Animals', 'Cell Line', 'Culture Techniques', 'Esterases/blood', 'Humans', 'Leukemia, Experimental/enzymology', 'Leukemia, Lymphoid/*enzymology', 'Leukemia, Myeloid, Acute/*enzymology', 'Leukocytes/*enzymology', 'Peroxidases/blood', 'Rats']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02104.x [doi]'],ppublish,Scand J Haematol. 1977 Sep;19(3):242-54. doi: 10.1111/j.1600-0609.1977.tb02104.x.,"['EC 1.11.1.- (Peroxidases)', 'EC 3.1.- (Esterases)', 'EC 3.1.3.1 (Alkaline Phosphatase)']","Leucocyte alkaline phosphatase (LAP) was histochemically detected in 7 to 18% of cells in tissue culture lines derived from the peripheral blood or bone marrow of each of 5 patients with untreated acute myelogenous or monomyelogenous leukaemia and in 30% of the cells in a clonal line of a rat promyelocytic leukaemia. Following transfer to diffusion chambers intraperitoneally implanted into total body irradiated rats, LAP levels were detected in up to 92% of human and 80% of rat leucocytes. There was no associated morphologic differentiation. In rat leukaemia cells peroxidase and myeloid specific esterase also increased from tissue culture levels. Return of cells to tissue culture decreased enzymes to pre-implant levels. Addition of plasma or peritoneal fluid from irradiated rats to cells in tissue culture again induced LAP. In contrast, LAP was not increased under these conditions with cell lines derived from patients with acute lymphatic leukaemia, or Sezary cell leukaemia. These studies indicate that a humoral factor in peritoneal fluid and plasma of irradiated rats increases LAP in human as well as rat leucocytes.",,,,,
269490,NLM,MEDLINE,19771125,20141120,0036-5327 (Print) 0036-5327 (Linking),79,7-8,1977 Aug,[In vitro cell division kinetics in cells with normal and pathological karyotypes substituted by 5'bromodeoxyuridine (author's transl)].,218-22,"['Malkova, J', 'Michalova, K', 'Cinatl, J']","['Malkova J', 'Michalova K', 'Cinatl J']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,IM,"['Adult', '*Bromodeoxyuridine', '*Cell Division', 'Cell Movement', 'Cells, Cultured', 'Humans', 'In Vitro Techniques', 'Karyotyping', 'Leukemia, Lymphoid/pathology', 'Mitosis', 'Mosaicism']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Sb Lek. 1977 Aug;79(7-8):218-22.,['G34N38R2N1 (Bromodeoxyuridine)'],,"Kinetika bunecneho deleni in vitro u bunek s normalnimi a patologickymi karyotypy, substituovanych 5'bromodeoxyuridinem.",,,,
269489,NLM,MEDLINE,19771125,20091111,0036-5327 (Print) 0036-5327 (Linking),79,7-8,1977 Aug,[Chromosomal findings in chronic myeloid leukaemia (author's transl)].,213-7,"['Chrz, R']",['Chrz R'],['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,IM,"['*Chromosome Aberrations', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/*genetics', 'Male', 'Translocation, Genetic']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Sb Lek. 1977 Aug;79(7-8):213-7.,,,Chromosomalni nalezy u chronicke myeloidni leukemie.,,,,
269459,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,HLA associations with acute myelogenous leukemia.,81-9,"['Parrish, E J', 'Heise, E R', 'Cooper, M R']","['Parrish EJ', 'Heise ER', 'Cooper MR']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Adolescent', 'Adult', 'Aged', 'Female', 'HLA Antigens/*analysis/*genetics', 'Humans', 'Leukemia, Myeloid, Acute/genetics/*immunology', 'Male', 'Middle Aged', 'Phenotype']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:81-9.,['0 (HLA Antigens)'],,,,,,
269458,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,Histocompatibility antigens in adult acute leukemia.,71-9,"['Hester, J P', 'Rossen, R D', 'Templeton, J W', 'McCredie, K B', 'Freireich, E J']","['Hester JP', 'Rossen RD', 'Templeton JW', 'McCredie KB', 'Freireich EJ']",['eng'],['Journal Article'],United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Adolescent', 'Adult', 'Aged', 'Family', 'Female', 'Genotype', 'HLA Antigens/*analysis/genetics', 'Haploidy', 'Histocompatibility Testing', 'Humans', 'Leukemia, Lymphoid/genetics/*immunology', 'Leukemia, Myeloid, Acute/genetics/*immunology', 'Male', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:71-9.,['0 (HLA Antigens)'],,,,,,
269457,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.,65-70,"['Cohen, E', 'Singal, D P', 'Khurana, U', 'Gregory, S G', 'Cox, C', 'Sinks, L', 'Henderson, E', 'Fitzpatrick, J E', 'Higby, D']","['Cohen E', 'Singal DP', 'Khurana U', 'Gregory SG', 'Cox C', 'Sinks L', 'Henderson E', 'Fitzpatrick JE', 'Higby D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Adolescent', 'Adult', 'Aged', 'Gene Frequency', 'HLA Antigens/*analysis/genetics', 'Humans', 'Leukemia, Lymphoid/genetics/immunology/*mortality', 'Leukemia, Myeloid/genetics', 'Leukemia, Myeloid, Acute/immunology/*mortality', 'Lymphocytes/immunology', 'Middle Aged', 'Phenotype']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:65-70.,['0 (HLA Antigens)'],,,,,,
269456,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.,181-6,"['Cohen, E', 'Kim, U', 'Blumenson, L', 'Gregory, S G', 'Khurana, U', 'Cox, C']","['Cohen E', 'Kim U', 'Blumenson L', 'Gregory SG', 'Khurana U', 'Cox C']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Antigens, Neoplasm/analysis', 'HLA Antigens/*analysis', 'Hodgkin Disease/immunology', 'Humans', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Lymphocytes/*immunology', 'Lymphoma/*immunology', 'Lymphoma, Non-Hodgkin/immunology', 'Spleen/*immunology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:181-6.,"['0 (Antigens, Neoplasm)', '0 (HLA Antigens)']",,,,,,
269455,NLM,MEDLINE,19771125,20101118,0361-7742 (Print) 0361-7742 (Linking),16,,1977,HLA and association with malignancy: a critical view.,131-44,"['Dausset, J']",['Dausset J'],['eng'],['Journal Article'],United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['Fanconi Anemia/genetics/immunology', 'Genetic Linkage', '*HLA Antigens/genetics', 'Haploidy', 'Humans', 'Leukemia, Lymphoid/genetics/immunology', 'Neoplasms/genetics/*immunology/mortality', 'Phenotype']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:131-44.,['0 (HLA Antigens)'],,,,,,
269454,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,HLA typing of leukemic cells and lymphoblastoid cell lines: effects of non-HLA antibodies in common typing sera.,115-28,"['DuBois, D', 'Specian, T L', 'Pollack, M S']","['DuBois D', 'Specian TL', 'Pollack MS']",['eng'],['Journal Article'],United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['*Antibodies', 'Cytotoxicity Tests, Immunologic', 'HLA Antigens/*analysis', '*Histocompatibility Testing', 'Humans', 'Leukemia/*immunology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Lymphocytes/immunology', 'Serotyping']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:115-28.,"['0 (Antibodies)', '0 (HLA Antigens)']","Several laboratories have recently observed that common HLA typing sera contain antibodies to various nonHLA antigens, including leukemia-associated antigens and normal platelet, granulocyte, or B-lymphocyte-specific alloantigens. In order to study the possible effects of these antibodies on HLA typing data in leukemia, several of these sera were adsorbed with HLA typed platelets, purified B-lymphocytes, cultured lymphoblasts, or mononuclear cells from patients with active leukemia of various types, and retested for residual activity against previously reacting cells. The results indicate that many of the reactions of leukemia cells to HLA typing sera represent reactions to nonHLA antibodies, many of which are directed against antigens common to cultured lymphoblasts, leukemia cells of several types, and normal B-cells. In the absence of family studies or prior serum adsorption, caution should be used in interpretation of all data related to HLA antigens in leukemia.",,,,,
269453,NLM,MEDLINE,19771125,20071115,0361-7742 (Print) 0361-7742 (Linking),16,,1977,"Further appraisal of antibodies to ""leukemia"" associated antigen in sera of plasmapheresis donors.",109-14,"['Cohen, E', 'Gregory, S G', 'Weinreb, N', 'Minowada, J']","['Cohen E', 'Gregory SG', 'Weinreb N', 'Minowada J']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Prog Clin Biol Res,Progress in clinical and biological research,7605701,IM,"['ABO Blood-Group System', 'Absorption', 'Antibodies, Neoplasm/*analysis', '*Antigens, Neoplasm', '*Blood Donors', 'Cytotoxicity Tests, Immunologic', 'Humans', 'Leukemia/*immunology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Lymphocytes/immunology', 'Plasmapheresis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Prog Clin Biol Res. 1977;16:109-14.,"['0 (ABO Blood-Group System)', '0 (Antibodies, Neoplasm)', '0 (Antigens, Neoplasm)']",,,,,,
269438,NLM,MEDLINE,19771130,20190501,0027-8424 (Print) 0027-8424 (Linking),74,9,1977 Sep,Low-molecular-weight peptide inhibits RNA synthesis in human leukemic and phytohemagglutinin-stimulated leukocytes and globin mRNA transcription in differentiating Friend cells.,3869-73,"['Amici, D', 'Rossi, G B', 'Cioe, L', 'Matarese, G P', 'Dolei, A', 'Guglielmi, L', 'Gianfranceschi, G L']","['Amici D', 'Rossi GB', 'Cioe L', 'Matarese GP', 'Dolei A', 'Guglielmi L', 'Gianfranceschi GL']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cattle', 'Cell Division/drug effects', 'Globins/biosynthesis', 'Humans', 'Leukemia/blood', 'Leukocytes/*metabolism', 'Lymphocyte Activation', 'Peptides/*pharmacology', 'RNA/*biosynthesis', 'RNA, Messenger/*biosynthesis', 'RNA, Neoplasm/biosynthesis', 'Transcription, Genetic/*drug effects']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1073/pnas.74.9.3869 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Sep;74(9):3869-73. doi: 10.1073/pnas.74.9.3869.,"['0 (Peptides)', '0 (RNA, Messenger)', '0 (RNA, Neoplasm)', '63231-63-0 (RNA)', '9004-22-2 (Globins)']","The RNA synthesis of human leukemic leukocytes and phytohemagglutinin-stimulated lymphocytes is markedly reduced by administration of a low-molecular-weight nonhistone peptide factor from calf thymus. Treatment with the factor strongly inhibits hemoglobin production and globin mRNA transcription in dimethyl sulfoxide-stimulated Friend cells without appreciably modifying the rate of cell growth. Evidence for specificity of these effects is provided by the lack of action of the factor on both growth rate and RNA synthesis of a number of nondifferentiating cell lines from various animal species. After removal of the compound, both human lymphocytes and Friend cells can be stimulated by phytohemagglutinin and by dimethyl sulfoxide, respectively, ruling out any toxic effect.",,PMC431764,,,
269404,NLM,MEDLINE,19771125,20191210,0027-8424 (Print) 0027-8424 (Linking),74,8,1977 Aug,Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.,3451-5,"['Yamasaki, H', 'Fibach, E', 'Nudel, U', 'Weinstein, I B', 'Rifkind, R A', 'Marks, P A']","['Yamasaki H', 'Fibach E', 'Nudel U', 'Weinstein IB', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Acetamides/pharmacology', 'Animals', 'Carcinogens/*pharmacology', 'Cell Differentiation/*drug effects', 'Cell Division/drug effects', 'Cell Line', 'Diamines/pharmacology', 'Dose-Response Relationship, Drug', 'Globins/biosynthesis', 'Leukemia, Experimental/*physiopathology', 'Mice', 'Nucleic Acid Hybridization', 'Phorbol Esters/pharmacology', 'RNA, Messenger/metabolism', 'Tetradecanoylphorbol Acetate/pharmacology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1073/pnas.74.8.3451 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Aug;74(8):3451-5. doi: 10.1073/pnas.74.8.3451.,"['0 (Acetamides)', '0 (Carcinogens)', '0 (Diamines)', '0 (Phorbol Esters)', '0 (RNA, Messenger)', '9004-22-2 (Globins)', 'LA133J59VU (hexamethylene bisacetamide)', 'NI40JAQ945 (Tetradecanoylphorbol Acetate)']","Addition of the potent tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), to murine erythroleukemia cell lines in suspension cultures inhibited both spontaneous differentiation and differentiation induced by hexamethylene bisacetamide (HMBA), dimethyl sulfoxide, or butyric acid. Inhibition was unrelated to cytotoxicity and was reversible. When several plant diterpenes were tested, there was a positive correlation between tumor-promoting activity and inhibition of differentiation. TPA inhibited HMBA-induced differentiation only if added prior to the time of commitment to differentiation, as assayed by scoring for differentiation after transfer of cells from HMBA to fresh medium without HMBA. TPA-mediated inhibition of differentiation was associated with a decrease in globin mRNA accumulation.",,PMC431603,,,
269368,NLM,MEDLINE,19771130,20071115,0301-1518 (Print) 0301-1518 (Linking),6,30,1977 Sep 17,[Visceral Kaposi sarcoma associated with a thyroid medullary carcinoma in a child in prolonged remission of lymphoblastic leukaemia (author's transl)].,2673-6,"['Caulet, T', 'Hibon, E', 'Roth, A', 'Behart, C', 'Tholon, J P', 'Dupuy, D', 'Fandre, M']","['Caulet T', 'Hibon E', 'Roth A', 'Behart C', 'Tholon JP', 'Dupuy D', 'Fandre M']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Child', 'Female', 'Humans', 'Immunosuppressive Agents/adverse effects', 'Leukemia, Lymphoid/*complications', 'Lung Neoplasms/etiology/pathology', 'Remission, Spontaneous', 'Sarcoma, Kaposi/*etiology', 'Splenic Neoplasms/etiology/pathology', 'Thyroid Neoplasms/*etiology/pathology']",1977/09/17 00:00,1977/09/17 00:01,['1977/09/17 00:00'],"['1977/09/17 00:00 [pubmed]', '1977/09/17 00:01 [medline]', '1977/09/17 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Sep 17;6(30):2673-6.,['0 (Immunosuppressive Agents)'],"This report concerns a 12-years-old child, in remission for 8 years from lymphoblastic leukaemia. The course was rapidly fatal. The authors compare this case with those published in the literature of Kaposi sarcoma occuring in transplant patients and discuss the possible mechanisms, in particular the role of immunodepression.",Sarcome de Kaposi visceral associe a un carcinome medullaire thyroidien chez une enfant en tres longue remission de leucemie lymphoblastique.,,,,
269365,NLM,MEDLINE,19771125,20071115,0031-3890 (Print) 0031-3890 (Linking),85,2,1977 Jun 30,[Data on the behavior of serum lysozyme in acute leukemia in children].,266-76,"['Esposito, L', 'Di Lena, C', 'Celentano, R']","['Esposito L', 'Di Lena C', 'Celentano R']",['ita'],"['English Abstract', 'Journal Article']",Italy,Pediatria (Napoli),La Pediatria,0401207,IM,"['Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*enzymology', 'Leukemia, Myeloid, Acute/*enzymology', 'Male', 'Muramidase/*blood']",1977/06/30 00:00,1977/06/30 00:01,['1977/06/30 00:00'],"['1977/06/30 00:00 [pubmed]', '1977/06/30 00:01 [medline]', '1977/06/30 00:00 [entrez]']",,ppublish,Pediatria (Napoli). 1977 Jun 30;85(2):266-76.,['EC 3.2.1.17 (Muramidase)'],,Rilievi sul comportamento del lisozima sierico nella leucemia acuta del bambino.,,,,
269364,NLM,MEDLINE,19771125,20071115,0031-3890 (Print) 0031-3890 (Linking),85,2,1977 Jun 30,"[Some aspects of coagulation in acute leukemia in childhood, with special reference to disseminated intravascular coagulation. Findings in 30 cases].",206-20,"['Esposito, L', 'Indolfi, P', 'Di Gennaro, C']","['Esposito L', 'Indolfi P', 'Di Gennaro C']",['ita'],"['English Abstract', 'Journal Article']",Italy,Pediatria (Napoli),La Pediatria,0401207,IM,"['Blood Coagulation Disorders/*etiology', 'Blood Coagulation Tests', 'Child', 'Child, Preschool', 'Disseminated Intravascular Coagulation/*etiology', 'Hemorrhage/etiology', 'Humans', 'Infant', 'Leukemia, Lymphoid/*complications', 'Leukemia, Myeloid, Acute/*complications']",1977/06/30 00:00,1977/06/30 00:01,['1977/06/30 00:00'],"['1977/06/30 00:00 [pubmed]', '1977/06/30 00:01 [medline]', '1977/06/30 00:00 [entrez]']",,ppublish,Pediatria (Napoli). 1977 Jun 30;85(2):206-20.,,,Su alcuni aspetti della coagulazione nella leucemia acuta dell'infanzia con particolare riguardo alla coagulazione intravascolare disseminata. Rilievi su 30 casi.,,,,
269322,NLM,MEDLINE,19771125,20071115,0028-2685 (Print) 0028-2685 (Linking),24,4,1977,Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.,357-63,"['Simkovic, D', 'Chorvath, B', 'Hlubinova, K', 'Valentova, N', 'Stevonkova, J', 'Babusikova, O', 'Simkovicova, M']","['Simkovic D', 'Chorvath B', 'Hlubinova K', 'Valentova N', 'Stevonkova J', 'Babusikova O', 'Simkovicova M']",['eng'],['Journal Article'],Slovakia,Neoplasma,Neoplasma,0377266,IM,"['AKR murine leukemia virus/*immunology', 'Animals', '*Antibodies, Neoplasm', '*Antibodies, Viral', 'Antigens, Neoplasm', 'Antigens, Viral', 'Complement Fixation Tests', 'Female', 'Hodgkin Disease/immunology', 'Humans', 'Leukemia/etiology/*immunology/microbiology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Leukemia, Myeloid, Acute/immunology', 'Lymphoma/etiology/*immunology', 'Male', 'Neoplasms, Experimental/etiology/immunology', 'Pregnancy', 'Rats', 'Thymus Gland/*immunology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Neoplasma. 1977;24(4):357-63.,"['0 (Antibodies, Neoplasm)', '0 (Antibodies, Viral)', '0 (Antigens, Neoplasm)', '0 (Antigens, Viral)']","Presence of complement-fixing antibodies against soluble antigen(s) of Gross virus-induced rat lymphoma W/Fu(C58NT)D was determined in sera of 180 healthy donors, in sera from 100 healthy pregnant women and in sera obtained from 139 patients with acute myelosis, acute lymphadenosis, acute undifferentiated leukosis, chronic myelosis, chronic lymphadenosis and Hodgkin's disease. Antibodies against soluble complement-fixing antigen from W/Fu(C58NT)D rat lymphoma were found in 33 (5).5%) out of 64 sera of patients with acute leukemia, in 15 out of 60 sera of patients with Hodgkin's disease, in 17 (9.4%) out of 180 healthy donors and in 22 (22.0%) out of 100 sera from healthy pregnant women. None of 15 sera from patients with chronic leukemia were positive. Titers of complement-fixing antibodies in positive sera remained unchanged after absorption with pooled lymphocytes from healthy human donors. Some selected positive sera reacted also with a soluble antigen prepared from normal rat thymus. Nature of complement-fixing antibodies detected and of corresponding antigens is discussed.",,,,,
269311,NLM,MEDLINE,19771130,20190617,0028-0836 (Print) 0028-0836 (Linking),269,5628,1977 Oct 6,Molecular basis for acquired haemoglobin H disease.,524-5,"['Old, J', 'Longley, J', 'Wood, W G', 'Clegg, J B', 'Weatherall, D J']","['Old J', 'Longley J', 'Wood WG', 'Clegg JB', 'Weatherall DJ']",['eng'],"['Case Reports', 'Journal Article']",England,Nature,Nature,0410462,IM,"['Aged', 'Genes', 'Hemoglobin H/*biosynthesis/genetics', 'Hemoglobins, Abnormal/*biosynthesis', 'Humans', 'Leukemia, Myeloid, Acute/*blood/genetics', 'Male', 'RNA, Messenger/*metabolism', 'Transcription, Genetic']",1977/10/06 00:00,1977/10/06 00:01,['1977/10/06 00:00'],"['1977/10/06 00:00 [pubmed]', '1977/10/06 00:01 [medline]', '1977/10/06 00:00 [entrez]']",['10.1038/269524a0 [doi]'],ppublish,Nature. 1977 Oct 6;269(5628):524-5. doi: 10.1038/269524a0.,"['0 (Hemoglobins, Abnormal)', '0 (RNA, Messenger)', '9034-79-1 (Hemoglobin H)']",,,,,,
269307,NLM,MEDLINE,19771125,20190819,0306-9877 (Print) 0306-9877 (Linking),3,5,1977 Sep-Oct,"Ethics, cancer and children.",174-9,"['Kearney, P J']",['Kearney PJ'],['eng'],['Journal Article'],United States,Med Hypotheses,Medical hypotheses,7505668,IM,"['Age Factors', 'Attitude to Death', 'Child', 'Child, Preschool', 'Emotions', '*Ethics, Medical', '*Human Experimentation', 'Humans', 'Infant', 'Leukemia, Lymphoid/*therapy', 'Neoplasms/*therapy', 'Parents', 'Pediatrics/*standards', 'Physician-Patient Relations', 'Self Concept']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']","['0306-9877(77)90003-2 [pii]', '10.1016/0306-9877(77)90003-2 [doi]']",ppublish,Med Hypotheses. 1977 Sep-Oct;3(5):174-9. doi: 10.1016/0306-9877(77)90003-2.,,,,,,,
269306,NLM,MEDLINE,19771125,20091109,0350-199X (Linking),31,2,1977 Mar-Apr,[Leukosis and pregnancy (4 cases)].,55-9,"['Obradov, S', 'Dugumovic, Z', 'Ibrahimbegovic, F', 'Aksamija, B', 'Bekic, S', 'Kusec, L', 'Nikloic, J', 'Knezevic, V', 'Jergovic, D']","['Obradov S', 'Dugumovic Z', 'Ibrahimbegovic F', 'Aksamija B', 'Bekic S', 'Kusec L', 'Nikloic J', 'Knezevic V', 'Jergovic D']",['hrv'],"['Case Reports', 'English Abstract', 'Journal Article']",Bosnia and Herzegovina,Med Arh,Medicinski arhiv,0400722,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Lymphoid/*diagnosis', 'Leukemia, Myeloid/*diagnosis', 'Pregnancy', 'Pregnancy Complications, Hematologic/*diagnosis', 'Prognosis', 'Remission, Spontaneous']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Med Arh. 1977 Mar-Apr;31(2):55-9.,,,Leukoze i trudnoca (4 slucaja).,,,,
269305,NLM,MEDLINE,19771130,20080213,0385-549X (Print) 0385-549X (Linking),2,3,1977 Mar,[Nursing of a child with acute leukemia and a poor prognosis].,49-53,"['Takeuchi, K']",['Takeuchi K'],['jpn'],['Journal Article'],Japan,Kango Tenbo,Kango tenbo. The Japanese journal of nursing science,7810064,,"['Child', 'Humans', 'Leukemia, Lymphoid/*nursing', '*Pediatric Nursing', 'Prognosis']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Kango Tenbo. 1977 Mar;2(3):49-53.,,,,,,,
269298,NLM,MEDLINE,19771125,20190711,0023-2173 (Print) 0023-2173 (Linking),55,16,1977 Aug 15,[Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)].,801-9,"['Havemann, K', 'Egbring, R', 'Gropp, C', 'Schmidt, M', 'Sodomann, C P']","['Havemann K', 'Egbring R', 'Gropp C', 'Schmidt M', 'Sodomann CP']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Wochenschr,Klinische Wochenschrift,2985205R,IM,"['Acute Disease', 'Factor XIII/*therapeutic use', 'Factor XIII Deficiency/*complications/drug therapy/etiology', 'Heparin/therapeutic use', 'Humans', 'Leukemia/*complications', 'Leukemia, Monocytic, Acute/complications', 'Leukemia, Myeloid, Acute/complications']",1977/08/15 00:00,1977/08/15 00:01,['1977/08/15 00:00'],"['1977/08/15 00:00 [pubmed]', '1977/08/15 00:01 [medline]', '1977/08/15 00:00 [entrez]']",['10.1007/BF01651269 [doi]'],ppublish,Klin Wochenschr. 1977 Aug 15;55(16):801-9. doi: 10.1007/BF01651269.,"['9005-49-6 (Heparin)', '9013-56-3 (Factor XIII)']","A decrease in fibrin stabilizing factor (Factor XIII) is the most frequent coagulation disorder seen in adults with acute leukemia. Patients with prominent reduction of factor XIII (FSF) (less than 50%) were substituted with a factor XIII concentrate from human placenta, and factor XIII plasma concentration and bleeding tendency were followed up during the course of the disease. After substitution plasma, factor XIII activity went up to normal levels in most of the patients. As compared to the course of 12 patients with distinct factor XIII reduction without factor XIII therapy, there were less bleeding complications in 13 courses of patients with prominent reduction of factor XIII substituted with factor XIII concentrate and in 11 with normal or only slightly reduced factor XIII levels.",Faktor XIII-Mangel bei akuter Leukamie des Erwachsenen: Ergebnisse einer Substitution mit Faktor XIII.,,,,
269296,NLM,MEDLINE,19771125,20041117,0485-1439 (Print) 0485-1439 (Linking),18,5,1977 May,[Alkaline phosphatase of the neutrophils in chronic myelogenous leukemia].,672-3,"['Shibata, A']",['Shibata A'],['jpn'],['Journal Article'],Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Alkaline Phosphatase/*blood', 'Humans', 'Leukemia, Myeloid/*enzymology', 'Neutrophils/*enzymology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 May;18(5):672-3.,['EC 3.1.3.1 (Alkaline Phosphatase)'],,,,,,
269295,NLM,MEDLINE,19771125,20071115,0485-1439 (Print) 0485-1439 (Linking),18,5,1977 May,[Leukapheresis of patients with acute leukemia and chronic myelogenous leukemia (author's transl)].,620-6,"['Kawashima, K', 'Ueda, R']","['Kawashima K', 'Ueda R']",['jpn'],"['Case Reports', 'Comparative Study', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Myeloid/*therapy', 'Leukemia, Myeloid, Acute/*therapy', 'Male', 'Middle Aged', 'Plasmapheresis/*methods']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 May;18(5):620-6.,,,,,,,
269294,NLM,MEDLINE,19771125,20041117,0485-1439 (Print) 0485-1439 (Linking),18,5,1977 May,[Leukapheresis. a. Treatment of chronic myelogenous leukemia].,615-20,"['Kobayashi, S']",['Kobayashi S'],['jpn'],"['Case Reports', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adult', 'Humans', 'Leukemia, Myeloid/*therapy', 'Male', 'Middle Aged', 'Plasmapheresis/*methods']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 May;18(5):615-20.,,,,,,,
269293,NLM,MEDLINE,19771130,20161017,0098-7484 (Print) 0098-7484 (Linking),238,18,1977 Oct 31,Sicca syndrome in a patient with toxic reaction to busulfan.,1951,"['Sidi, Y', 'Douer, D', 'Pinkhas, J']","['Sidi Y', 'Douer D', 'Pinkhas J']",['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Busulfan/*adverse effects/therapeutic use', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy', 'Lung', 'Middle Aged', ""Sjogren's Syndrome/*chemically induced/diagnosis""]",1977/10/31 00:00,1977/10/31 00:01,['1977/10/31 00:00'],"['1977/10/31 00:00 [pubmed]', '1977/10/31 00:01 [medline]', '1977/10/31 00:00 [entrez]']",,ppublish,JAMA. 1977 Oct 31;238(18):1951.,['G1LN9045DK (Busulfan)'],,,,,,
269243,NLM,MEDLINE,19771130,20190630,0022-3476 (Print) 0022-3476 (Linking),91,5,1977 Nov,Disseminated herpes simplex with hepatoadrenal necrosis in a child with acute leukemia.,757-9,"['Ruiz-Palacios, G', 'Pickering, L K', 'vanEys, J', 'Conklin, R']","['Ruiz-Palacios G', 'Pickering LK', 'vanEys J', 'Conklin R']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Adrenal Gland Diseases/*complications/pathology', 'Child', 'Herpes Simplex/*complications', 'Humans', 'Leukemia, Lymphoid/*complications', 'Liver Diseases/*complications/pathology', 'Male', 'Necrosis']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']","['S0022-3476(77)81032-9 [pii]', '10.1016/s0022-3476(77)81032-9 [doi]']",ppublish,J Pediatr. 1977 Nov;91(5):757-9. doi: 10.1016/s0022-3476(77)81032-9.,,,,,,,
269227,NLM,MEDLINE,19771125,20091111,0022-3247 (Print) 0022-3247 (Linking),32,3,1977 Jul-Sep,Plasmacytosis of the gingiva.,75-8,"['Ginwalla, T M', 'Bhoweer, A L', ""D'Silva, I R""]","['Ginwalla TM', 'Bhoweer AL', ""D'Silva IR""]",['eng'],"['Case Reports', 'Journal Article']",United States,J Oral Med,Journal of oral medicine,0045507,IM,"['Adult', 'Diagnosis, Differential', 'Female', 'Gingival Diseases/*pathology', 'Granuloma/*pathology', 'Humans', 'Leukemia, Plasma Cell/pathology', '*Plasma Cells']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,J Oral Med. 1977 Jul-Sep;32(3):75-8.,,,,,,,
269098,NLM,MEDLINE,19771125,20071115,0015-8178 (Print) 0015-8178 (Linking),95,34,1977 Sep 15,[Extracoporeal irradiation of blood in the treatment of leukemia. Experiences on 25 patients with chronic lymphadenosis].,2084-7,"['Heilmann, E', 'Nordiek, R', 'Wannenmacher, M']","['Heilmann E', 'Nordiek R', 'Wannenmacher M']",['ger'],"['English Abstract', 'Journal Article']",Germany,Fortschr Med,Fortschritte der Medizin,2984763R,IM,"['*Extracorporeal Circulation', 'Humans', 'Leukemia, Lymphoid/*radiotherapy', 'Leukemia, Myeloid/radiotherapy', 'Leukemia, Myeloid, Acute/radiotherapy', 'Lymphocyte Activation/radiation effects', 'Methods', 'Radiotherapy Dosage']",1977/09/15 00:00,1977/09/15 00:01,['1977/09/15 00:00'],"['1977/09/15 00:00 [pubmed]', '1977/09/15 00:01 [medline]', '1977/09/15 00:00 [entrez]']",,ppublish,Fortschr Med. 1977 Sep 15;95(34):2084-7.,,Extracorporeal irradiation of the blood (ECIB) is a valuable addition to the treatment of chronic lymphatic leukemia (CLL). Possibly the prognosis of chronic lymphatic leukemia can be significantly influenced by early treatment. In acute leukemia the increase of bone marrow proliferation can be useful in cases resistent to chemotherapy. Side effects of ECIB have not been observed.,Die extrakorporale Blutbestrahlung in der Leukamie-Behandlung. Erfahrungen an 25 Patienten mit chronischer Lymphadenose.,,,,
269090,NLM,MEDLINE,19771125,20071115,0017-0275 (Print) 0017-0275 (Linking),58,1-2,1977 Jan-Feb,[Experience with the use of aseptic isolator in the prevention of infections in patients with acute non-lymphocytic leukemia].,59-70,"['Delsignore, R', 'Rossi, G', 'Baroni, M C', 'Butturini, U']","['Delsignore R', 'Rossi G', 'Baroni MC', 'Butturini U']",['ita'],"['English Abstract', 'Journal Article']",Italy,G Clin Med,Giornale di clinica medica,0413411,IM,"['Adolescent', 'Adult', 'Aged', 'Antibody Formation', 'Asepsis', 'Bacterial Infections/*prevention & control', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications/immunology', 'Male', 'Methods', 'Middle Aged', '*Patient Isolators']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,G Clin Med. 1977 Jan-Feb;58(1-2):59-70.,,,Esperienze sull'impiego dell'isolatore asettico nella prevenzione delle infezioni in pazienti affetti da leucosi acuta non-linfocitica.,,,,
269035,NLM,MEDLINE,19771125,20191210,0147-0272 (Print) 0147-0272 (Linking),2,2,1977 Aug,Leukemias of childhood.,1-46,"['Mauer, A M']",['Mauer AM'],['eng'],['Journal Article'],United States,Curr Probl Cancer,Current problems in cancer,7702986,IM,"['Adolescent', 'Antigens, Neoplasm', 'Antineoplastic Agents/therapeutic use', 'Brain Neoplasms/therapy', 'Cell Cycle', 'Child', 'Child, Preschool', 'Chromosome Aberrations', 'Female', 'Hemorrhage/complications', 'Humans', 'Infant', 'Infant, Newborn', 'Infections/complications', 'Leukemia/etiology/physiopathology/*therapy', 'Leukemia, Lymphoid/complications/diagnosis/pathology/therapy', 'Leukemia, Myeloid/genetics/therapy', 'Male', 'Pregnancy']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']","['S0147-0272(77)80063-9 [pii]', '10.1016/s0147-0272(77)80063-9 [doi]']",ppublish,Curr Probl Cancer. 1977 Aug;2(2):1-46. doi: 10.1016/s0147-0272(77)80063-9.,"['0 (Antigens, Neoplasm)', '0 (Antineoplastic Agents)']",,,,,,
269033,NLM,MEDLINE,19771125,20190819,0090-1229 (Print) 0090-1229 (Linking),8,2,1977 Sep,Lymphocytes bearing receptors for both sheep erythrocytes and complement in patients with neoplastic and non-neoplastic diseases.,292-9,"['Gajl-Peczalska, K J', 'Chartrand, S', 'Bloomfield, C D', 'Corte, J', 'Coccia, P F', 'Nesbit, M E', 'Kersey, J H']","['Gajl-Peczalska KJ', 'Chartrand S', 'Bloomfield CD', 'Corte J', 'Coccia PF', 'Nesbit ME', 'Kersey JH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Clin Immunol Immunopathol,Clinical immunology and immunopathology,0356637,IM,"['Adult', 'Animals', 'Arthritis, Rheumatoid/immunology', 'Binding Sites', 'Complement System Proteins/*metabolism', 'Erythrocytes/*immunology', 'Female', 'Hodgkin Disease/immunology', 'Humans', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Lymphocytes/*immunology', 'Lymphoma/immunology', 'Male', 'Mediastinal Neoplasms/immunology', 'Middle Aged', 'Neoplasms/*immunology', 'Nephrotic Syndrome/immunology', 'Rosette Formation', 'Sheep']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1016/0090-1229(77)90119-2 [doi]'],ppublish,Clin Immunol Immunopathol. 1977 Sep;8(2):292-9. doi: 10.1016/0090-1229(77)90119-2.,['9007-36-7 (Complement System Proteins)'],,,,,,
269032,NLM,MEDLINE,19771130,20200304,0009-9104 (Print) 0009-9104 (Linking),29,2,1977 Aug,Immunological characteristics of lymphoblasts and lymphocytes in acute lymphoblastic leukaemia in children.,220-8,"['Olive, D', 'Sabolovic, D', 'Beugnot, M C', 'Beaugnon, M']","['Olive D', 'Sabolovic D', 'Beugnot MC', 'Beaugnon M']",['eng'],['Journal Article'],England,Clin Exp Immunol,Clinical and experimental immunology,0057202,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Electrophoresis', 'Female', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Lymphocyte Activation', 'Lymphocytes/*immunology', 'Male', 'Receptors, Antigen, B-Cell', 'Rosette Formation']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Clin Exp Immunol. 1977 Aug;29(2):220-8.,"['0 (Receptors, Antigen, B-Cell)']","By analysing the electrophoretic mobility (EM) of lymphocytes and by comparing their surface charge it is possible to distinguish rapid-moving lymphocytes (T) and slow-moving lymphocytes (B). The authors studied the EM of blood lymphocytes in children suffering from acute lymphoblastic leukaemia, before they underwent treatment. At the same time they carried out a study of classical immunological markers (E rosettes, membrane immunoglobulins, and blastic-transformation ability). The authors were able to distinguish three types of lymphocytes according to their EM i.e., rapid, slow or intermediate. This heterogeneousness could be explained by the fact that the origin of leukaemic proliferation may vary according to different stages in the maturation of the lymphoid cells. It would seem premature to establish any correlation between the initial clinical signs of the disease and its evolution.",,PMC1541098,,,
269014,NLM,MEDLINE,19771130,20131121,0008-5472 (Print) 0008-5472 (Linking),37,11,1977 Nov,Isolation and characterization of a subline of Friend erythroleukemia cells that differentiate in tissue culture in the absence of inducers.,4211-9,"['Rovera, G', 'Surrey, S']","['Rovera G', 'Surrey S']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Butyrates/pharmacology', 'Cell Differentiation/drug effects', '*Cell Line', 'Clone Cells', 'Dimethyl Sulfoxide/pharmacology', '*Friend murine leukemia virus', 'Glucose/pharmacology', 'Hemoglobins/biosynthesis', 'Histones/metabolism', '*Leukemia, Erythroblastic, Acute/metabolism/pathology', 'Leukemia, Experimental/pathology', 'Tumor Virus Infections/pathology']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Nov;37(11):4211-9.,"['0 (Butyrates)', '0 (Hemoglobins)', '0 (Histones)', 'IY9XDZ35W2 (Glucose)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
269013,NLM,MEDLINE,19771130,20061115,0008-5472 (Print) 0008-5472 (Linking),37,11,1977 Nov,Development of myelosarcomas from human myelogenous leukemia cells transplanted in athymic mice.,3995-4002,"['Machado, E A', 'Lozzio, B B', 'Lozzio, C B', 'Lair, S V', 'Aggio, M C']","['Machado EA', 'Lozzio BB', 'Lozzio CB', 'Lair SV', 'Aggio MC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Antigens, Neoplasm', 'Cell Division', 'Cell Survival', 'Chromosome Aberrations', '*Disease Models, Animal', 'Female', 'Humans', 'Leukemia, Experimental', 'Leukemia, Myeloid/pathology', 'Male', 'Mice', 'Mice, Nude', 'Neoplasm Transplantation', '*Sarcoma, Experimental/genetics/metabolism/pathology', 'Transplantation, Heterologous']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Nov;37(11):3995-4002.,"['0 (Antigens, Neoplasm)']",,,,,,
269012,NLM,MEDLINE,19771130,20141120,0008-5472 (Print) 0008-5472 (Linking),37,11,1977 Nov,Alteration of prostaglandin biosynthesis in rat chloroleukemic tumor.,3974-80,"['Ziboh, V A', 'Lord, J T', 'Blick, G', 'Kursunoglu, I', 'Poitier, J', 'Yunis, A A']","['Ziboh VA', 'Lord JT', 'Blick G', 'Kursunoglu I', 'Poitier J', 'Yunis AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Arachidonic Acids/metabolism', 'Bone Marrow/metabolism', 'Fatty Acids, Unsaturated/pharmacology', 'Hydroxyprostaglandin Dehydrogenases/metabolism', 'Hyperplasia/metabolism', 'In Vitro Techniques', 'Indomethacin/pharmacology', 'Kinetics', 'Leukemia, Experimental/*metabolism/pathology', 'Leukemia, Myeloid/metabolism/pathology', 'Prostaglandins E/*biosynthesis', 'Prostaglandins F/*biosynthesis', 'Rats']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Nov;37(11):3974-80.,"['0 (Arachidonic Acids)', '0 (Fatty Acids, Unsaturated)', '0 (Prostaglandins E)', '0 (Prostaglandins F)', 'EC 1.1.1.- (Hydroxyprostaglandin Dehydrogenases)', 'XXE1CET956 (Indomethacin)']","Data from our present studies demonstrate the capability of a 105,000 X g pellet from rat normal bone marrow, turpentine-induced hyperplastic bone marrow, and chloroma tumor to transform precursor arachidonic acid into prostaglandins. The activity of the prostaglandin synthetase systems in these tissues is inhibited by the known nonsteroid antiinflammatory drug indomethacin and by two unsaturated fatty acids previously demonstrated in other tissues. Although the overall biosynthesis of prostaglandin E2 (PGE2) was higher in the hyperplastic bone marrow than in the chloroma tumor, the PGF2alpha:PGE2 ratio was markedly higher (8-fold) in the chloroma tissue. This latter increase was probably due to the increased transformation of PGE2 into PGF2alpha by the NADPH-dependent PGE2 9-ketoreductase (an enzyme that catalyzes the transformation of PGE2 and PGF2alpha). These results indicate the greater capability of the malignant chloroma tissue to form PGF2alpha than of nonmalignant hyperplastic bone marrow. Although the role of PGF2alpha in the malignant myelogenous leukemic tumor is presently unclear, its increased formation in this tissue suggests that this substance may play a role in the hyperproliferative process.",,,,,
269011,NLM,MEDLINE,19771130,20131121,0008-5472 (Print) 0008-5472 (Linking),37,10,1977 Oct,Characterization of a glucocorticoid-sensitive human lymphoid cell line.,3785-91,"['Norman, M R', 'Thompson, E B']","['Norman MR', 'Thompson EB']",['eng'],['Journal Article'],United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Cell Division/drug effects', 'Cell Line', 'Clone Cells/drug effects', 'Dexamethasone/metabolism/pharmacology', 'Humans', 'Hydrocortisone/pharmacology', 'Leukemia, Experimental/metabolism/pathology', 'Leukemia, Lymphoid/*metabolism/pathology', 'Prednisolone/pharmacology', '*Receptors, Glucocorticoid', '*Receptors, Steroid']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Oct;37(10):3785-91.,"['0 (Receptors, Glucocorticoid)', '0 (Receptors, Steroid)', '7S5I7G3JQL (Dexamethasone)', '9PHQ9Y1OLM (Prednisolone)', 'WI4X0X7BPJ (Hydrocortisone)']","A human lymphoblastoid cell line (CEM), the growth of which is inhibited by glucocorticoids, is described. Although growth of the original uncloned cell line is only slightly retarded by dexamethasone, sensitive clones were isolated in which growth is completely blocked by 2 to 3 days of exposure to 10(-6) M dexamethasone. After 4 to 5 days, these cells become pyknotic and lyse. The inhibitory affect of dexamethasone first become apparent in suspension culture at a concentration of about 5 X 10(-8) M. Receptor analysis showed the presence of specific glucocorticoid receptors with an apparent dissociation constant for dexamethasone of about 1.3 X 10(-8) M both in the sensitive and in one resistant clone analyzed. Ability to displace dexamethasone from the receptor is correlated with the known glucocorticoid activity of all steroids tested, as is their ability to inhibit cloning of sensitive cells in agarose. These results indicate that the specificity of inhibitory effects is related to receptor specificity of inhibitory effects is related to receptor specificity. Dexamethasone is a potent inhibitor when cells are cloned in agarose, having a marked effect even at a concentration of 7 X 10(-9) M. CEM cells thus provide human cell lines suitable for in vitro analysis of steroid effects on leukemic cells.",,,,,
269010,NLM,MEDLINE,19771130,20151119,0008-5472 (Print) 0008-5472 (Linking),37,10,1977 Oct,Terminal deoxynucleotidyl transferase activity in blastic phase of chronic myelogenous leukemia.,3612-8,"['Srivastava, B I', 'Khan, S A', 'Minowada, J', 'Gomez, G A', 'Rakowski, I']","['Srivastava BI', 'Khan SA', 'Minowada J', 'Gomez GA', 'Rakowski I']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adult', 'DNA Nucleotidyltransferases/*metabolism', 'DNA-Directed DNA Polymerase/metabolism', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy/*enzymology/pathology', 'Leukocytes/drug effects/enzymology/pathology', 'Male', 'Middle Aged', 'Prednisone/pharmacology', 'Vincristine/pharmacology']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Oct;37(10):3612-8.,"['5J49Q6B70F (Vincristine)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)', 'EC 2.7.7.7 (DNA-Directed DNA Polymerase)', 'VB0R961HZT (Prednisone)']",,,,,,
269009,NLM,MEDLINE,19771130,20061115,0008-5472 (Print) 0008-5472 (Linking),37,10,1977 Oct,Quantification by DNA-based cytophotometry of the 9q+/22q-chromosomal translocation associated with chronic myelogenous leukemia.,3590-3,"['Mayall, B H', 'Carrano, A V', 'Moore, D H 2nd', 'Rowley, J D']","['Mayall BH', 'Carrano AV', 'Moore DH 2nd', 'Rowley JD']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adolescent', 'Adult', 'Chromosomes, Human', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'DNA, Neoplasm/*analysis', 'Female', 'Humans', 'Leukemia, Myeloid/analysis/*genetics', 'Male', 'Metaphase', 'Middle Aged', '*Translocation, Genetic']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Oct;37(10):3590-3.,"['0 (DNA, Neoplasm)']","DNA-based cytophotometry was used to analyze metaphase chromosomes in four patients with chronic myelogenous leukemia. In three of these patients, both Philadelphia chromosome (Ph1)-positive and Ph1-negative cells were measured. On the basis of these three patients, the characteristic 9q+/22q- translocation of chronic myelogenous leukemia involves the net transfer of 0.325% of the autosomal genome; there is no evidence of net gain or loss of DNA (apart from duplication of the Ph1 chromosome in one patient), and no significant difference is found in the amount of DNA transferred in different patients. Significant differences are found among patients in the derived Chromosomes 9 and the Ph1 chromosomes and are ascribed to preexisting variations in the Ph1-negative cells of these patients. There is no evidence in these patients of any further cytogenetic lesion associated with chronic myelogenous leukemia.",,,,,
269008,NLM,MEDLINE,19771130,20061115,0008-5472 (Print) 0008-5472 (Linking),37,10,1977 Oct,Induction of osteosarcomas and hematopoietic neoplasms by 55Fe in mice.,3545-50,"['Laissue, J A', 'Burlington, H', 'Cronkite, E P', 'Reincke, U']","['Laissue JA', 'Burlington H', 'Cronkite EP', 'Reincke U']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Bone Neoplasms/*etiology', 'Dose-Response Relationship, Radiation', 'Female', 'Iron Radioisotopes/*adverse effects', 'Leukemia, Experimental/*etiology', 'Leukemia, Radiation-Induced/etiology', 'Lymphoma/*etiology', 'Mice', 'Mice, Inbred C57BL', 'Neoplasms, Experimental/etiology', 'Neoplasms, Radiation-Induced/*etiology', 'Osteosarcoma/*etiology']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Oct;37(10):3545-50.,['0 (Iron Radioisotopes)'],,,,,,
269007,NLM,MEDLINE,19771130,20061115,0008-5472 (Print) 0008-5472 (Linking),37,10,1977 Oct,"Possible mechanisms for the genesis of common chromosome abnormalities, including isochromosomes and the philadelphia chromosome.",3501-7,"['Oshimura, M', 'Kakati, S', 'Sandberg, A A']","['Oshimura M', 'Kakati S', 'Sandberg AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Centromere', '*Chromosome Aberrations', 'Chromosomes, Human, 1-3', '*Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Crossing Over, Genetic/drug effects', 'Female', 'Humans', 'Leukemia/*genetics', 'Leukemia, Myeloid/genetics', 'Male', 'Mitomycins/pharmacology', 'Neoplasms/*genetics', 'Translocation, Genetic', 'Trisomy']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Oct;37(10):3501-7.,['0 (Mitomycins)'],,,,,,
269006,NLM,MEDLINE,19771130,20190619,0008-543X (Print) 0008-543X (Linking),40,4,1977 Oct,"Acute myelomomocytic leukemia terminating in histiocytic medullary reticulosis: cytochemical, cytogenetic and electron microscopic studies.",1735-47,"['Castoldi, G', 'Grusovin, G D', 'Gualandi, M', 'Spanedda, R', 'Anzanel, D']","['Castoldi G', 'Grusovin GD', 'Gualandi M', 'Spanedda R', 'Anzanel D']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Blood Cell Count', 'Blood Platelets', 'Bone Marrow Examination', 'Chromosome Aberrations', 'Humans', 'Leukemia, Myeloid, Acute/*complications/genetics/pathology', 'Lymphatic Diseases/*etiology/genetics/pathology', 'Male', 'Middle Aged', 'Phagocytosis']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1002/1097-0142(197710)40:4<1735::aid-cncr2820400450>3.0.co;2-f [doi]'],ppublish,Cancer. 1977 Oct;40(4):1735-47. doi: 10.1002/1097-0142(197710)40:4<1735::aid-cncr2820400450>3.0.co;2-f.,,A case of acute myelomonocytic leukemia terminating in histiocytic medullary reticulosis is reported. The evolution of a single cellular clone presenting with progressive change of the morphological features of the leukemic cells towards more anaplastic elements endowed with prominent phagocytic properties is suggested on the basis of both cytochemical and chromosomal data. The histiocytic nature of the malignant proliferating cells and platelet phagocytosis has been confirmed by electron microscopic investigation. The main pathogenetic explanations of the evolutionary patterns of the disease are discussed with relation to: a) involvement of a common stem cell giving rise to different proliferative patterns of cells in a multiphasic sequence; b) release of dysplastic platelets and defective erythrocytes with massive sequestration by histioid phagocytic cells; and c) coexistence of two different disorders.,,,,,
269005,NLM,MEDLINE,19771130,20190619,0008-543X (Print) 0008-543X (Linking),40,4,1977 Oct,Chronic myelolytic leukemia versus idiopathic myelofibrosis: a diagnostic problem in bone marrow biopsies.,1548-61,"['Buyssens, N', 'Bourgeois, N H']","['Buyssens N', 'Bourgeois NH']",['eng'],"['Comparative Study', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Aged', 'Biopsy', 'Bone Marrow/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/pathology', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Primary Myelofibrosis/*diagnosis/pathology', 'Prognosis']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1002/1097-0142(197710)40:4<1548::aid-cncr2820400427>3.0.co;2-u [doi]'],ppublish,Cancer. 1977 Oct;40(4):1548-61. doi: 10.1002/1097-0142(197710)40:4<1548::aid-cncr2820400427>3.0.co;2-u.,,,,,,,
269004,NLM,MEDLINE,19771130,20190619,0008-543X (Print) 0008-543X (Linking),40,4,1977 Oct,Long-term survival in acute leukemia in Argentina: a study of 78 cases.,1402-9,"['Pavlovsky, S', 'Muriel, F S']","['Pavlovsky S', 'Muriel FS']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Antineoplastic Agents/therapeutic use', 'Argentina', 'Blood Cell Count', 'Central Nervous System Diseases/mortality', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/drug therapy/*mortality', 'Leukemia, Myeloid, Acute/drug therapy/*mortality', 'Male', 'Middle Aged', 'Prognosis', 'Testicular Neoplasms/mortality']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1002/1097-0142(197710)40:4<1402::aid-cncr2820400407>3.0.co;2-k [doi]'],ppublish,Cancer. 1977 Oct;40(4):1402-9. doi: 10.1002/1097-0142(197710)40:4<1402::aid-cncr2820400407>3.0.co;2-k.,['0 (Antineoplastic Agents)'],"A total of 78 patients with acute leukemia [69 acute lymphoblastic leukemia (ALL) and 9 acute myeloblastic leukemia (AML)] survived more than 4 years. In the years between 1958 and 1967 the number of patients with ALL in Argentina who survived 4 years was 1%. This increased to 21% in the years between 1967 and 1972. The major cause of this increase was the initiation in 1967 of protocols of therapy on a national scale through a cooperative group known as GATLA. In AML patients the number of long-term survivals remained unchanged during both periods. A large percent of the long-term survivors had lower WBC, a higher platelet count, and no hepato- or splenomegaly, lymphadenopathy, or hemorrhagic manifestations at diagnosis. However, only for those patients with a WBC under 100,000/mm3 at diagnosis was there a significant prognostic implication (p less than 0.01). Patients with acute lymphoblastic leukemia who survive more than 4 years without relapse have about an 80% chance of long survival. For those who have lived 4 years with one or more lapses, there is only a 17% chance of long survival, and of these only those who develop extramedullar relapse (CNS or testicular) without bone marrow involvement have a chance of long survival. Patients who live 4 years in continuous complete remission have the same chance of very long survival regardless of previous therapy.",,,,,
269003,NLM,MEDLINE,19771130,20190619,0008-543X (Print) 0008-543X (Linking),40,4,1977 Oct,The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.,1398-401,"['Ramsay, N K', 'Coccia, P F', 'Krivit, W', 'Nesbit, M E', 'Edson, J R']","['Ramsay NK', 'Coccia PF', 'Krivit W', 'Nesbit ME', 'Edson JR']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Afibrinogenemia/chemically induced', 'Asparaginase/*adverse effects', 'Blood Coagulation Disorders/*chemically induced', 'Child', 'Factor XI Deficiency/chemically induced', 'Hemophilia B/chemically induced', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Prednisone/therapeutic use', 'Vincristine/therapeutic use']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1002/1097-0142(197710)40:4<1398::aid-cncr2820400406>3.0.co;2-# [doi]'],ppublish,Cancer. 1977 Oct;40(4):1398-401. doi: 10.1002/1097-0142(197710)40:4<1398::aid-cncr2820400406>3.0.co;2-#.,"['5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)']","Serial coagulation studies were performed in 26 pediatric patients with acute lymphoblastic leukemia during initial induction therapy with vincristine, prednisone, and L-asparaginase. Prolongation of screening coagulation tests was frequent: prothrombin time (in 16 of 26 patients), partial thromboplastin time (23/26) and thrombin time (21/26). In all 26 patients fibrinogen levels fell below .20 g/100 ml and 16 had levels below .10 g/100 ml. Sixteen patients had plasma coagulation factor assays performed. In these 16 patients, Factor XI was less than 40% in 14 and Factor XI was less than 70% in 9, with only a few scattered low levels of other factors. There were no clinical bleeding episodes. Coagulation abnormalities returned to normal at the completion of L-asparaginase therapy while the patients remained on vincristine and prednisone.",,,,,
269002,NLM,MEDLINE,19771130,20190619,0008-543X (Print) 0008-543X (Linking),40,4,1977 Oct,Methotrexate-induced sudden fatal pulmonary reaction.,1393-7,"['Lascari, A D', 'Strano, A J', 'Johnson, W W', 'Collins, J G']","['Lascari AD', 'Strano AJ', 'Johnson WW', 'Collins JG']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Angioedema/chemically induced', 'Drug Hypersensitivity/complications', 'Female', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Methotrexate/*adverse effects', 'Pneumonia/chemically induced', 'Pulmonary Edema/*chemically induced/pathology', 'Remission, Spontaneous', 'Respiratory Hypersensitivity/chemically induced']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1002/1097-0142(197710)40:4<1393::aid-cncr2820400405>3.0.co;2-h [doi]'],ppublish,Cancer. 1977 Oct;40(4):1393-7. doi: 10.1002/1097-0142(197710)40:4<1393::aid-cncr2820400405>3.0.co;2-h.,['YL5FZ2Y5U1 (Methotrexate)'],"A teenage girl in bone marrow remission with acute lymphocytic leukemia died suddenly from pulmonary edema. She had taken her first oral dose of methotrexate and cyclophosphamide 10 hours previously when she was feeling well and was asymptomatic. One week previously she had received the last of four intrathecal injections of methotrexate. Autopsy showed marked pulmonary edema as well as chronic lung changes, as previously described in patients with methotrexate pneumonitis. There is usually at least a 12-day interval from the onset of administration of methotrexate to the onset of the lung toxicity. The authors suggest the patient was sensitized by the intrathecal methotrexate and then reacted with angioneurotic edema of the lung when given the first oral dose of methotrexate. Careful examination for infectious agents, including electron microscopy, was negative.",,,,,
269001,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Cytosine arabinoside and 6-thioguanine in the treatment of childhood acute myeloblastic leukemia.,998-1004,"['Moreno, H', 'Castleberry, R P', 'McCann, W P']","['Moreno H', 'Castleberry RP', 'McCann WP']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Brain Neoplasms/drug therapy/prevention & control', 'Child', 'Child, Preschool', 'Cytarabine/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Pregnancy', 'Pregnancy Complications, Hematologic/drug therapy', 'Prospective Studies', 'Recurrence', 'Remission, Spontaneous', 'Thioguanine/*therapeutic use', 'Time Factors']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<998::aid-cncr2820400306>3.0.co;2-r [doi]'],ppublish,Cancer. 1977 Sep;40(3):998-1004. doi: 10.1002/1097-0142(197709)40:3<998::aid-cncr2820400306>3.0.co;2-r.,"['04079A1RDZ (Cytarabine)', 'FTK8U1GZNX (Thioguanine)']","Twenty children with acute myeloblastic leukemia were given induction and maintenance regimens combining cytosine arabinoside (ARA-C) and 6-thioguanine (TG). Two died before completing induction therapy and were considered unevaluable. Of the 18 remaining patients, 3 died shortly after induction, 2 had no response, 1 had a partial response and 12 (66%) had a complete remission (CR) lasting 4 to 68 months. Six still survive: two in their initial CR and four who relapsed but were reinduced to CR. Although no prophylactic central nervous system (CNS) therapy was given, only one patient has developed CNS involvement after diagnosis. Two girls became pregnant while on maintenance therapy. One delivered a normal, full-term infant; both she and the child are well 24 months later.",,,,,
268999,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Adult acute leukemia: frequency of central system involvement in long term survivors.,1304-6,"['Law, I P', 'Blom, J']","['Law IP', 'Blom J']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Brain Neoplasms/*pathology/prevention & control/therapy', 'Cytarabine/therapeutic use', 'Female', 'Follow-Up Studies', 'Humans', 'Leukemia/*pathology/therapy', 'Leukemia, Lymphoid/*pathology/therapy', 'Male', 'Meningeal Neoplasms/*pathology/prevention & control/therapy', 'Methotrexate/therapeutic use', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<1304::aid-cncr2820400346>3.0.co;2-v [doi]'],ppublish,Cancer. 1977 Sep;40(3):1304-6. doi: 10.1002/1097-0142(197709)40:3<1304::aid-cncr2820400346>3.0.co;2-v.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']","The incidence and frequency of CNS relapses in long term surviving adults, age eighteen and over, covering the period 1967-1972, were presented. Four of 20 patients with ANLL and 12 of 24 patients with ALL were demonstrated to have CNS leukemia during the course of their illness. The onset of neurologic manifestation in three of four ANLL patients with CNS leukemia was observed within three months of the diagnosis, whereas it was delayed to 6-12 months interval in eight of 12 ALL patients. CNS relapses, a major determinant for CNS prophylactic and maintenance therapy, were observed in 75% of the patients with ALL and none in ANLL patients who were treated with I.T. chemotherapy and cranial radiation of 2000 R. Therefore, our observation suggests that CNS prophylactic and maintenance therapy should be of value in adults with ALL as in children; whereas, in ANLL, further observation is warranted before any definite therapy can be advocated.",,,,,
268998,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Prolonged remission of leukemia associated with polycythemia vera.,1297-9,"['Hazani, A', 'Tatarsky, I', 'Barzilai, D']","['Hazani A', 'Tatarsky I', 'Barzilai D']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Aged', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Myeloid, Acute/*complications/drug therapy/etiology', 'Male', 'Polycythemia Vera/*complications/therapy', 'Prednisone/therapeutic use', 'Remission, Spontaneous', 'Time Factors', 'Vincristine/therapeutic use']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<1297::aid-cncr2820400344>3.0.co;2-m [doi]'],ppublish,Cancer. 1977 Sep;40(3):1297-9. doi: 10.1002/1097-0142(197709)40:3<1297::aid-cncr2820400344>3.0.co;2-m.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'VB0R961HZT (Prednisone)']","A patient with polycythemia vera (PV) received successive treatment by phlebotomies, radioactive phosphorus, myleran and cyclophosphamide. Sixteen years after the diagnosis, he developed acute myeloblastic leukemia. A complete remission was achieved following two courses of COAP (cyclophosphamide, vincristine, Cytosine Arabinoside, and prednisone) therapy. Four months later, while still in leukemic remission, he became mildly polycythemic again and the treatment with phlebotomies and cyclophosphamide was resume. The patient has subsequently been in complete remission of leukemia for over three years and his polycythemia is controlled by small doses of cyclophosphamide. This appears to be a unique case of such a prolonged remission of leukemia in the course of PV, with a return to a mild polycythemia state.",,,,,
268997,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Disseminated atypical tuberculosis-antedating the clinical onset of neoplasia.,1276-9,"['DiBella, N J', 'Buchanan, B D', 'Koontz, C H']","['DiBella NJ', 'Buchanan BD', 'Koontz CH']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Female', 'Hodgkin Disease/*complications/immunology', 'Humans', 'Immunity, Cellular', 'Leukemia, Myeloid, Acute/*complications/immunology', 'Male', 'Middle Aged', 'Mycobacterium Infections/*complications', 'Mycobacterium Infections, Nontuberculous/*complications/immunology', 'Precancerous Conditions/*complications', 'Time Factors', 'Tuberculin Test']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<1276::aid-cncr2820400342>3.0.co;2-x [doi]'],ppublish,Cancer. 1977 Sep;40(3):1276-9. doi: 10.1002/1097-0142(197709)40:3<1276::aid-cncr2820400342>3.0.co;2-x.,,"Two cases of disseminated atypical tuberculosis are presented in which the infection anteceded by over four years the development of acute granulocytic leukemia on one and Hodgkin's Disease in the other patient. The presence of disseminated atypical mycobacteriosis in the absence of a clearcut underlying illness suggests a ""preneoplastic state."" It should alert the clinician to the possibility of a neoplastic disorder which may not become clinically manifest for several years.",,,,,
268996,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Chromosomes and causation of human cancer and leukemia. XXVI. Binding studies in acute lymphoblastic leukemia (ALL).,1161-72,"['Oshimura, M', 'Freeman, A I', 'Sandberg, A A']","['Oshimura M', 'Freeman AI', 'Sandberg AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Adult', 'Aneuploidy', 'Antigens, Neoplasm', 'Cell Membrane/immunology', 'Child', 'Child, Preschool', '*Chromosome Aberrations', 'Chromosome Deletion', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Diploidy', 'Female', 'Humans', 'Infant', 'Karyotyping', 'Leukemia, Lymphoid/*genetics/immunology', 'Male', 'Middle Aged']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<1161::aid-cncr2820400327>3.0.co;2-2 [doi]'],ppublish,Cancer. 1977 Sep;40(3):1161-72. doi: 10.1002/1097-0142(197709)40:3<1161::aid-cncr2820400327>3.0.co;2-2.,"['0 (Antigens, Neoplasm)']","Chromosomes were studied in the bone marrow cells of 101 patients with acute lymphoblastic leukemia (ALL) hospitalized at or attending the clinics of Roswell Park Memorial Institute (RPMI) between January, 1968, and December, 1976. Aneuploidy was observed in about 50% (54/101) of the cases. Two cases were hypodiploid and the remaining were either pseudo or hyperdiploid. The frequency of abnormalities and the chromosomal numbers were similar to those of 106 cases studied in our laboratory prior to 1968. Of 50 recently unselected cases of ALL in whom Q- and G-banded karyotypes were attempted, 31 were successfully analyzed with these techniques. The banding patterns revealed 16 cases to have chromosome abnormalities and four of these to have a similar abnormality, i.e., partial deletion of the long arm of chromosome no. 6: two cases had a 6q- with additional abnormalities and two had 6q- as the sole karyotypic abnormality. The breakpoint in chromosome no. 6 seemed to involve a segment from q21 to q25. An isochromosome of the long arm of no. 7, i(7q), was observed in two cases, two additional no. 21 chromosomes were observed in five cases and, except for the Y, all other chromosomes participated in the karyotypic changes encountered in the 16 cases in which banding analyses were performed. Banding analysis has afforded the first reliable approach towards ascertaining karyotypic evolution in ALL, which was achieved in eight cases of the present study. The chromosomes contributing to this karyotypic evolution were distributed widely. Thus, all chromosomes except the Y participated in numerical and/or structural karyotypic changes. Even though nonrandom chromosome changes may occur early in ALL, the pristine prototypic picture of the karyotypes in ALL is often obfuscated by successive chromosomal changes and hyperdiploidy by the time the karyotypes are analyzed in this condition. Further cytogenetic studies are required, with special attention to karyotypic evolution, in order to uncover the significance of chromosomal changes in early and late ALL.",,,,,
268995,NLM,MEDLINE,19771125,20190619,0008-543X (Print) 0008-543X (Linking),40,3,1977 Sep,Chromosomes and causation of human cancer and leukemia. XXIII. Near-haploidy in acute leukemia.,1143-8,"['Oshimura, M', 'Freeman, A I', 'Sandberg, A A']","['Oshimura M', 'Freeman AI', 'Sandberg AA']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Bone Marrow/ultrastructure', 'Child', '*Chromosome Aberrations', 'Diploidy', 'Female', 'Haploidy', 'Humans', 'Leukemia, Lymphoid/*genetics', 'Lymphocytes/ultrastructure', 'Mitosis', 'Recurrence', 'Remission, Spontaneous', 'X Chromosome']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/1097-0142(197709)40:3<1143::aid-cncr2820400325>3.0.co;2-4 [doi]'],ppublish,Cancer. 1977 Sep;40(3):1143-8. doi: 10.1002/1097-0142(197709)40:3<1143::aid-cncr2820400325>3.0.co;2-4.,,"A case of acute lymphoblastic leukemia (ALL) with a near-haploid (27 chromosomes) leukemic cell population in the marrow has been described and the findings compared to those of the only other such case in the literature. In both cases the cells with 27 chromosomes, except for one chromosomal group, had karyotypic findings which were identical. Cells with 54 chromosomes, karyotypically exact duplicates of the cells with 27 chromosomes, were also encountered; on morphological basis it appeared that the marrow contained large and small lymphoblasts, possibly matching the metaphases with 54 and 27 chromosomes, respectively. The genesis of the cells with 27 chromosomes was uncertain and several postulates are discussed, as well as the relation of the findings to the cytogenetic observations encountered in ALL and their possible role in human leukemogenesis.",,,,,
268992,NLM,MEDLINE,19771125,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6088,1977 Sep 10,Leukapheresis for papilloedema in chronic granulocytic leukaemia.,676-7,"['Stirling, M L', 'Parker, A C', 'Keller, A J', 'Urbaniak, S J']","['Stirling ML', 'Parker AC', 'Keller AJ', 'Urbaniak SJ']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Female', 'Humans', 'Leukemia, Myeloid/*complications', 'Papilledema/etiology/*therapy', 'Plasmapheresis']",1977/09/10 00:00,1977/09/10 00:01,['1977/09/10 00:00'],"['1977/09/10 00:00 [pubmed]', '1977/09/10 00:01 [medline]', '1977/09/10 00:00 [entrez]']",['10.1136/bmj.2.6088.676 [doi]'],ppublish,Br Med J. 1977 Sep 10;2(6088):676-7. doi: 10.1136/bmj.2.6088.676.,,,,PMC1631917,,,
268983,NLM,MEDLINE,19771130,20210216,0006-4971 (Print) 0006-4971 (Linking),50,5,1977 Nov,Globin synthesis in mouse erythroleukemia cells in vitro: a switch in beta chains due to inducing agent.,867-76,"['Alter, B P', 'Goff, S C']","['Alter BP', 'Goff SC']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Butyrates/pharmacology', 'Clone Cells', 'Dimethyl Sulfoxide/pharmacology', 'Globins/*biosynthesis', 'Hemin/pharmacology', 'Leukemia, Erythroblastic, Acute/*metabolism']",1977/11/01 00:00,1977/11/01 00:01,['1977/11/01 00:00'],"['1977/11/01 00:00 [pubmed]', '1977/11/01 00:01 [medline]', '1977/11/01 00:00 [entrez]']",['S0006-4971(20)70103-5 [pii]'],ppublish,Blood. 1977 Nov;50(5):867-76.,"['0 (Butyrates)', '743LRP9S7N (Hemin)', '9004-22-2 (Globins)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Friend erythroleukemia cells, originally derived from DBA/2 mice, differentiate when cultured with inducing agents. Studies of the different effects of inducing agents on clone 745 have revealed that both dimethyl sulfoxide (DMSO) and hemin produce benzidine-positive cells. Butyric acid produced mature but benzidine-negative cells in this clone. All agents induced globin synthesis above the 0.1% of protein synthesis found in uninduced cells. DMSO induction stimulated globin synthesis 9%, hemin 2%, and butyric acid 3%. Total beta/alpha ratios were approximately unity with all agents. Although the inducing agents all stimulated total globin synthesis in Friend cells, the relative rates of synthesis of the two mouse beta chains were affected differently by the various agents. Hemin markedly increased the proportion of beta minor. For example, DBA/2 mouse reticulocytes synthesized 20% beta minor and 80% beta major. DMSO induction of clone 745 caused 20%-33% synthesis of beta minor. In contrast, hemin increased the proportion of beta minor to 64%-69%. Thus the Friend erythroleukemia cell system provides an in vitro approach to the study of the regulation of globin-chain switching.",,,,,
268982,NLM,MEDLINE,19771125,20210216,0006-4971 (Print) 0006-4971 (Linking),50,4,1977 Oct,Chromosomes and causation of human cancer and leukemia. XXIV. Unusual and complex Ph1 translocations and their clinical significance.,691-7,"['Sonta, S I', 'Sandberg, A A']","['Sonta SI', 'Sandberg AA']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['*Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Humans', 'Leukemia, Myeloid/*etiology/genetics/mortality', 'Sex Chromosomes', '*Translocation, Genetic']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['S0006-4971(20)72754-0 [pii]'],ppublish,Blood. 1977 Oct;50(4):691-7.,,,,,,,
268981,NLM,MEDLINE,19771125,20071115,0006-4971 (Print) 0006-4971 (Linking),50,4,1977 Oct,Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.,671-82,"['Dow, L W', 'Borella, L', 'Sen, L', 'Aur, R J', 'George, S L', 'Mauer, A M', 'Simone, J V']","['Dow LW', 'Borella L', 'Sen L', 'Aur RJ', 'George SL', 'Mauer AM', 'Simone JV']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Drug Therapy', 'Drug Therapy, Combination', 'Erythrocytes/immunology', 'Female', 'Hemoglobins', 'Hepatomegaly/complications', 'Humans', 'Infant', 'Leukemia, Lymphoid/diagnosis/*immunology/therapy', 'Leukocyte Count', 'Lymph Nodes/anatomy & histology', 'Male', 'Mediastinum/anatomy & histology', 'Prognosis', 'Radiotherapy', 'Regression Analysis', '*Rosette Formation']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Blood. 1977 Oct;50(4):671-82.,['0 (Hemoglobins)'],"Bone marrow lymphoblasts from 109 children admitted with untreated acute lymphoblastic leukemia (ALL) were tested for spontaneous rosette formation with sheep erythrocytes. Twenty-six children (24%) had lymphoblasts that formed rosettes (E+). Of 13 initial clinical characteristics, 8 were significantly associated with E+ lymphoblasts: mediastinal enlargement (86% of patients E+), leukocyte counts over 100 X 10(9)/liter (65% E+), nodes greater than 2 cm in any diameter (65% E+), age over 5 yr (46% E+), hemoglobin over 8 g/dl (44% E+), hepatomegaly greater than 5 cm (38% E+), boys (35% E+), and lymph node enlargement outside of the cervical area (28% E+). Spleen size, initial platelet counts, and periodic acid-Schiff scores did not distinguish E+ from E- patients. Since few patients were black and few presented with central nervous system leukemia, the association of these two characteristics with E+ blasts could not be determined. A hierarchical classification scheme and a linear logistic regression model were used to define the patterns of characteristics associated with E+ lymphoblasts. The initial clinical characteristics and the poorer course of E+ patients suggest that ALL comprises at least two biologically and clinically distinct types. The E+ ALL may result from a leukemic transformation of a non-Hodgkin lymphoma.",,,,,
268980,NLM,MEDLINE,19771130,20071115,0300-0893 (Print) 0300-0893 (Linking),27,6,1977 Jul,Cytogenetic evidence of clonal evolution in 5q- anemia.,211-2,"['Verhest, A', 'Lustman, F', 'Wittek, M', 'van Schoubroeck, F', 'Naets, J P']","['Verhest A', 'Lustman F', 'Wittek M', 'van Schoubroeck F', 'Naets JP']",['eng'],"['Case Reports', 'Letter']",France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Aged', 'Anemia, Aplastic/*genetics', 'Cell Transformation, Neoplastic', '*Chromosome Aberrations', '*Chromosomes, Human, 4-5', 'Female', 'Humans', 'Leukemia, Monocytic, Acute/genetics', 'Leukemia, Myeloid, Acute/genetics']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Jul;27(6):211-2.,,"The clinical homogeneity of myeloproliferative syndromes associated with a 5 q- marker can be contested, but nevertheless finds support in the 2 case reports we have cited. One of these observations of refractory anemia with partial myeloblastosis and 5 q- marker has shown a transformation into an acute myelomonocytic leukemia with clonal chromosomal evolution.",,,,,
268958,NLM,MEDLINE,19771014,20201209,0006-291X (Print) 0006-291X (Linking),76,4,1977 Jun 20,Selective inhibition of terminal deoxynucleotidyl transferase (TdT) by adenosine ribonucleoside triphosphate (ATP) and its application in the detection of TdT in human leukemia.,1056-61,"['Bhalla, R B', 'Schwartz, M K', 'Modak, M J']","['Bhalla RB', 'Schwartz MK', 'Modak MJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Biochem Biophys Res Commun,Biochemical and biophysical research communications,0372516,IM,"['Adenosine Triphosphate/*pharmacology', 'Animals', 'DNA Nucleotidyltransferases/antagonists & inhibitors/isolation & purification/*metabolism', 'DNA Polymerase I/metabolism', 'DNA Polymerase II/metabolism', 'DNA Polymerase III/metabolism', 'HeLa Cells/enzymology', 'Humans', 'Leukemia, Lymphoid/diagnosis/*enzymology', 'Leukemia, Myeloid/diagnosis/*enzymology', 'Rats', 'Rauscher Virus/enzymology', 'Templates, Genetic', 'Thymus Gland/enzymology']",1977/06/20 00:00,1977/06/20 00:01,['1977/06/20 00:00'],"['1977/06/20 00:00 [pubmed]', '1977/06/20 00:01 [medline]', '1977/06/20 00:00 [entrez]']","['0006-291X(77)90963-9 [pii]', '10.1016/0006-291x(77)90963-9 [doi]']",ppublish,Biochem Biophys Res Commun. 1977 Jun 20;76(4):1056-61. doi: 10.1016/0006-291x(77)90963-9.,"['8L70Q75FXE (Adenosine Triphosphate)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)', 'EC 2.7.7.7 (DNA Polymerase I)', 'EC 2.7.7.7 (DNA Polymerase II)', 'EC 2.7.7.7 (DNA Polymerase III)']",,,,,,
268956,NLM,MEDLINE,19771014,20131121,0003-9926 (Print) 0003-9926 (Linking),137,9,1977 Sep,Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia.,1246-7,"['Grund, F M', 'Armitage, J O', 'Burns, P']","['Grund FM', 'Armitage JO', 'Burns P']",['eng'],['Journal Article'],United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', '*Blood Cells', 'Female', 'Humans', 'Hydroxyurea/*therapeutic use', 'Leukemia, Lymphoid/blood/*drug therapy', 'Leukemia, Monocytic, Acute/blood/*drug therapy', 'Leukemia, Myeloid, Acute/blood/*drug therapy', 'Male', 'Middle Aged']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1977 Sep;137(9):1246-7.,['X6Q56QN5QC (Hydroxyurea)'],"Hydroxyurea was administered orally to prevent the effects of leukostasis in adults with acute leukemia who had peripheral blast cell counts greater than 100,000/cu mm. A single oral dose of 50 to 100 mg/kg was given daily until the absolute blast cell count decreased to less than 100,000/cu mm. Hydroxyurea was effective in rapidly lowering the blast cell count by an average of 50% after one dose in each of ten episodes. No patient developed symptoms or signs of the leukostasis syndrome, and no side effects directly attributable to hydroxyurea were observed. The leukostasis syndrome associated with very high blast cell counts in adults with acute leukemia can be avoided by the use of hydroxyurea in the manner described. This treatment can be particularly useful in the interval before consultation or referral and prior to the cytotoxic effect of definitive induction chemotherapy.",,,,,
268955,NLM,MEDLINE,19771020,20190628,0003-9861 (Print) 0003-9861 (Linking),182,2,1977 Aug,Terminal deoxynucleotidyl transferase: characterization of extraction and assay conditions from human and calf tissue.,525-32,"['Coleman, M S']",['Coleman MS'],['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Arch Biochem Biophys,Archives of biochemistry and biophysics,0372430,IM,"['Animals', 'Bone Marrow/*enzymology', '*Bone Marrow Cells', 'Cattle', 'Cobalt/pharmacology', '*DNA Nucleotidyltransferases/isolation & purification/metabolism', 'Guanine Nucleotides', 'Humans', 'Kinetics', 'Leukemia, Lymphoid/enzymology', 'Lymphocytes/*enzymology', 'Magnesium/pharmacology', 'Manganese/pharmacology', 'Potassium/pharmacology', 'Species Specificity', 'Thymus Gland/*enzymology', 'Zinc/pharmacology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']","['0003-9861(77)90533-1 [pii]', '10.1016/0003-9861(77)90533-1 [doi]']",ppublish,Arch Biochem Biophys. 1977 Aug;182(2):525-32. doi: 10.1016/0003-9861(77)90533-1.,"['0 (Guanine Nucleotides)', '3G0H8C9362 (Cobalt)', '42Z2K6ZL8P (Manganese)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)', 'I38ZP9992A (Magnesium)', 'J41CSQ7QDS (Zinc)', 'RWP5GA015D (Potassium)']",,,,,,
268946,NLM,MEDLINE,19771020,20161013,0300-9092 (Print) 0300-9092 (Linking),,3,1977 Mar,[Therapeutic obstetrical procedure in leukemia in pregnant women].,62-3,"['Chepeleva, M A']",['Chepeleva MA'],['rus'],['Journal Article'],Russia (Federation),Akush Ginekol (Mosk),Akusherstvo i ginekologiia,0370456,IM,"['Acute Disease', 'Delivery, Obstetric/*methods', 'Female', 'Humans', 'Leukemia/*therapy', 'Leukemia, Myeloid/*therapy', 'Obstetric Labor Complications/*therapy', 'Pregnancy', 'Pregnancy Complications, Hematologic/*therapy']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Akush Ginekol (Mosk). 1977 Mar;(3):62-3.,,,Akushersko-terapevticheskaia taktika pri leikoze u beremennykh.,,,,
268937,NLM,MEDLINE,19771020,20190615,0002-9378 (Print) 0002-9378 (Linking),129,1,1977 Sep 1,Intrauterine growth retardation following third-trimester exposure to busulfan.,111-2,"['Boros, S J', 'Reynolds, J W']","['Boros SJ', 'Reynolds JW']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Obstet Gynecol,American journal of obstetrics and gynecology,0370476,IM,"['Adult', 'Busulfan/*adverse effects', 'Female', 'Fetus/*drug effects', 'Humans', 'Kidney/abnormalities', 'Leukemia, Myeloid/*drug therapy', 'Pregnancy', 'Pregnancy Complications/*drug therapy', 'Pregnancy Trimester, Third']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']","['0002-9378(77)90830-4 [pii]', '10.1016/0002-9378(77)90830-4 [doi]']",ppublish,Am J Obstet Gynecol. 1977 Sep 1;129(1):111-2. doi: 10.1016/0002-9378(77)90830-4.,['G1LN9045DK (Busulfan)'],,,,,,
268927,NLM,MEDLINE,19771020,20071115,0001-6101 (Print) 0001-6101 (Linking),202,1-2,1977,Technics and ethics in managing acute leukemia.,1-4,"['Reizenstein, P']",['Reizenstein P'],['eng'],['Journal Article'],Sweden,Acta Med Scand,Acta medica Scandinavica,0370330,IM,"['Acute Disease', 'Anti-Bacterial Agents/therapeutic use', 'Antineoplastic Agents/therapeutic use', 'Bacterial Infections/complications/drug therapy', '*Ethics, Medical', 'Granulocytes', 'Humans', 'Leukemia, Myeloid, Acute/complications/*therapy', 'Quality of Life', 'Remission, Spontaneous', 'Terminal Care']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Acta Med Scand. 1977;202(1-2):1-4.,"['0 (Anti-Bacterial Agents)', '0 (Antineoplastic Agents)']",,,,,,
268924,NLM,MEDLINE,19771028,20190819,0001-656X (Print) 0001-656X (Linking),66,5,1977 Sep,Echocardiographic assessment of left ventricular function during the injection of adriamycin.,595-600,"['Bjorkhem, G', 'Garwicz, S']","['Bjorkhem G', 'Garwicz S']",['eng'],['Journal Article'],Sweden,Acta Paediatr Scand,Acta paediatrica Scandinavica,0000211,IM,"['Adolescent', 'Cardiac Volume/drug effects', 'Child', 'Doxorubicin/*adverse effects/therapeutic use', '*Echocardiography', 'Female', 'Heart/*drug effects', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Lymphoma/drug therapy', 'Male', 'Myocardial Contraction/*drug effects', 'Osteosarcoma/drug therapy']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1111/j.1651-2227.1977.tb07953.x [doi]'],ppublish,Acta Paediatr Scand. 1977 Sep;66(5):595-600. doi: 10.1111/j.1651-2227.1977.tb07953.x.,['80168379AG (Doxorubicin)'],"Echocardiography was used to evaluate left ventricular function in 8 children treated with adriamycin for malignant disease. Preejection period (PEP), left ventricular ejection time (LVET) and percent change in left ventricular internal dimension with systole (delta LVID) were measured before, during and immediately after 22 injections of adriamycin as well as 14 injections of other cytotoxic drugs and physiologic saline. No immediate effects on left ventricular function could be discerned. When functional parameters were evaluated longitudinally in patients with relatively higher cumulative doses of adriamycin, percent change in left ventricular internal dimension with systole showed some tendency to decrease, while the other parameters remained essentially unchanged.",,,,,
268723,NLM,MEDLINE,19771014,20161109,0507-4088 (Print) 0507-4088 (Linking),,2,1977 Mar-Apr,[Influence of Brucella abortus on the course of acute myeloid leukemia in mice].,202-6,"['Chimishkian, K L', 'Belianchikova, N I', 'Kostrykina, V N', 'Meiland, E N']","['Chimishkian KL', 'Belianchikova NI', 'Kostrykina VN', 'Meiland EN']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Vopr Virusol,Voprosy virusologii,0417337,IM,"['Animals', 'Brucella Vaccine/*therapeutic use', '*Immunotherapy', 'Leukemia, Experimental/therapy', 'Leukemia, Myeloid, Acute/*therapy', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Neoplasm Transplantation']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Vopr Virusol. 1977 Mar-Apr;(2):202-6.,['0 (Brucella Vaccine)'],,Vliianie Brucella abortus na techenie ostrogo mieloidnogo leikoza u myshei.,,,,
268722,NLM,MEDLINE,19771014,20061115,0042-773X (Print) 0042-773X (Linking),23,7,1977 Jun,[Cytochemical and cytogenetic examination in the diagnosis of Di Guglielmo's disease and erythroleukemia].,712-9,"['Steruska, M', 'Hrubisko, M', 'Izakovic, V']","['Steruska M', 'Hrubisko M', 'Izakovic V']",['slo'],"['English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Adult', 'Aged', 'Bone Marrow Examination', 'Female', 'Histocytochemistry', 'Humans', 'Karyotyping', 'Leukemia, Erythroblastic, Acute/*diagnosis', 'Male', 'Middle Aged', 'Ploidies']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Jun;23(7):712-9.,,,Prinos cytochemickeho a cytogenetickeho vysetrenia pre diagnostiku Di Guglielmovej choroby a erytroleukemie.,,,,
268721,NLM,MEDLINE,19771014,20061115,0042-773X (Print) 0042-773X (Linking),23,7,1977 Jun,[Di Guglielmo syndrome (erythroleukemia) with dyserythropoiesis in a patient with breast carcinoma treated by irradiation].,688-94,"['Chrobak, L', 'Radochova, D', 'Zizka, J', 'Smetana, K', 'Mirova, S', 'Kerekes, Z']","['Chrobak L', 'Radochova D', 'Zizka J', 'Smetana K', 'Mirova S', 'Kerekes Z']",['cze'],"['Case Reports', 'English Abstract', 'Journal Article']",Czech Republic,Vnitr Lek,Vnitrni lekarstvi,0413602,IM,"['Anemia/*etiology', 'Breast Neoplasms/*radiotherapy', 'Erythropoiesis', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Erythroblastic, Acute/*etiology', 'Middle Aged', 'Mitosis', 'Radiotherapy/*adverse effects']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Vnitr Lek. 1977 Jun;23(7):688-94.,,,Di Guglielmuv syndrom (erytroleukemie) s dyserytropoezou u nemocne s rakovinou prsu lecenou ozarenim.,,,,
268720,NLM,MEDLINE,19771020,20071115,0042-465X (Print) 0042-465X (Linking),,4,1977 Jul-Aug,[Ophthalmological lesions in extramedullary foci of leukemic infiltration].,59-61,"['Rogozina, R D', 'Kovalenko, N S']","['Rogozina RD', 'Kovalenko NS']",['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Vestn Oftalmol,Vestnik oftalmologii,0415216,IM,"['Adolescent', 'Eye Diseases/*etiology', 'Eye Manifestations', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Vestn Oftalmol. 1977 Jul-Aug;(4):59-61.,,,Oftal'mologicheskie porazheniia pri vnekostnomozgovykh ochagakh leikemicheskoi infil'tratsii.,,,,
268671,NLM,MEDLINE,19771014,20161123,0300-8592 (Print) 0300-8592 (Linking),30,6,1977 Jun,[Increased occurrence of mycoplasmal pneumonia: radiologic appearance and observation of the development of the disease in children (author's transl)].,275-83,"['Reither, M']",['Reither M'],['ger'],['Journal Article'],Germany,Rontgenblatter,Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie,0413560,IM,"['Child', 'Child, Preschool', 'Disease Outbreaks', 'Female', 'Germany, West', 'Humans', 'Leukemia, Lymphoid/complications', 'Male', 'Mycoplasma Infections/diagnostic imaging/*epidemiology', 'Pneumonia/diagnostic imaging/*epidemiology', 'Radiography', 'Seasons']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Rontgenblatter. 1977 Jun;30(6):275-83.,,"The epidemic occurrence of mycoplasmal pneumonia in children was reported. It composed 8% of all cases of pneumonia during 1975 occurring in the area served by the University Pediatric Hospital in Giessen. It should be noted that the cases were distributed throughout the year and that one fourth of the patients were small children. The diversity of the radiologic appearance with primarily interstitial-alveolar lesions in the lungs was explained in more detail. Observations of the course of the disease indicate that the illness can be recurrent; the course can be complicated as a result of immunosuppression through a primary illness which is already present, in this case an acute lymphoblastic leukemia.",Gehauftes Auftreten von Mykoplasmenpneumonien Rontgenologisches Erscheinungsbild und Verlaufsbeobachtungen im Kindesalter.,,,,
268659,NLM,MEDLINE,19771028,20200930,0037-9727 (Print) 0037-9727 (Linking),155,4,1977 Sep,N5-Methyltetrahydrofolate-homocysteine cobalamin methyltransferase activity in chronic erythremic myelosis (Di Guglielmo syndrome).,464-7,"['Kass, L', 'Peters, C L', 'Toler, L A']","['Kass L', 'Peters CL', 'Toler LA']",['eng'],['Journal Article'],United States,Proc Soc Exp Biol Med,"Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)",7505892,IM,"['5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/*metabolism', 'Anemia, Pernicious/enzymology', 'Apoenzymes/metabolism', 'Bone Marrow/*enzymology', 'Homocysteine/metabolism', 'Humans', 'Leukemia, Erythroblastic, Acute/*enzymology', 'Methyltransferases/*metabolism', 'S-Adenosylmethionine/metabolism', 'Tetrahydrofolates/metabolism', 'Vitamin B 12/metabolism']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.3181/00379727-155-39831 [doi]'],ppublish,Proc Soc Exp Biol Med. 1977 Sep;155(4):464-7. doi: 10.3181/00379727-155-39831.,"['0 (Apoenzymes)', '0 (Tetrahydrofolates)', '0LVT1QZ0BA (Homocysteine)', '7LP2MPO46S (S-Adenosylmethionine)', 'EC 2.1.1.- (Methyltransferases)', 'EC 2.1.1.13 (5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase)', 'P6YC3EG204 (Vitamin B 12)']",,,,,,
268640,NLM,MEDLINE,19771014,20190501,0027-8424 (Print) 0027-8424 (Linking),74,7,1977 Jul,Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.,2894-8,"['Rovera, G', ""O'Brien, T G"", 'Diamond, L']","['Rovera G', ""O'Brien TG"", 'Diamond L']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Differentiation/*drug effects', 'Cell Division/drug effects', 'Cell Line', 'Globins/biosynthesis', 'Hemoglobins/biosynthesis', 'Leukemia, Erythroblastic, Acute/metabolism/*pathology', 'Leukemia, Experimental/metabolism/*pathology', 'Phorbol Esters/pharmacology', 'Phorbols/*pharmacology', 'Time Factors']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1073/pnas.74.7.2894 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Jul;74(7):2894-8. doi: 10.1073/pnas.74.7.2894.,"['0 (Hemoglobins)', '0 (Phorbol Esters)', '0 (Phorbols)', '9004-22-2 (Globins)']","Clones of Friend erythroleukemia cells, characterized by the presence of 40-70% benzidine-positive cells synthesizing hemoglobin in the absence of inducing drugs, were treated with several phorbol diesters with a known range of tumor-promoting activity on mouse skin. Good correlation was found between the reported tumor-promoting activity of a particular phorbol diester and its ability to inhibit spontaneous erythroid differentiation in culture. The inhibition of differentiation by 12-O-tetradecanoyl-phorbol-13-acetate, the most active tumor promoter, was maximum after 4 days of treatment; this inhibition was reversed by removal of the phorbol diester no matter how long the period of treatment. Unlike control cells, which gradually revert to a population with a low percentage of benzidine-positive cells, cells treated with 12-O-tetradecanoyl-phorbol-13-acetate retained a high potential for spontaneous differentiation.",,PMC431336,,,
268639,NLM,MEDLINE,19771014,20191210,0027-8424 (Print) 0027-8424 (Linking),74,7,1977 Jul,Inhibition of cytokinesis in Friend leukemia cells by membrane mobility agents.,2884-8,"['Lustig, S', 'Kosower, N S', 'Pluznik, D H', 'Kosower, E M']","['Lustig S', 'Kosower NS', 'Pluznik DH', 'Kosower EM']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Division/*drug effects', 'Cell Line', 'Cell Membrane/drug effects', 'Cell Nucleus/ultrastructure', 'DNA, Neoplasm/biosynthesis', 'Fatty Acids/*pharmacology', 'Fluorescent Dyes', 'Leukemia, Erythroblastic, Acute', '*Leukemia, Experimental/metabolism/ultrastructure', 'Stearates']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1073/pnas.74.7.2884 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Jul;74(7):2884-8. doi: 10.1073/pnas.74.7.2884.,"['0 (DNA, Neoplasm)', '0 (Fatty Acids)', '0 (Fluorescent Dyes)', '0 (Stearates)', '54050-62-3 (A(2)C)']","Treatment of a line of Friend leukemia cells with a dispersion of the membrane mobility agent, A2C, yields cells that undergo successive nuclear divisions without cytokinesis, resulting eventually in cells with as many as 30 nuclei. Neither the DNA replication rate of the cells nor the generation time is different after treatment; in addition, the multiple nuclei divide synchronously, and the chromosome number corresponds to the number of nuclei in the cell. Inhibition of cytokinesis is not observed if the cells are washed with reagent-free medium within 1 hr of treatment, but is observed if washing is delayed for 24 hr. Membrane mobility agent loaded with the fluorescent probe, Flomol F20C, leads to fluorescent membrane; fluorescence disappears from the membrane after a change of medium within 1 hr, but not after a change of medium within 24 hr. Some stages in the overall development resemble those seen for cytochalasin B inhibition of cytokinesis, although the mechanisms may well be different for the inhibition promoted by membrane mobility agent. The inhibition of cytokinesis by A2C provides a potentially interesting means of studying cytokinesis and the regulation of differentiation.",,PMC431331,,,
268609,NLM,MEDLINE,19771020,20041117,,18,1,1977,[Subacute myeloid leukemia with the Philadelphia chromosome and supplementary translocation: 9-12].,245-6,"['Dor, J F', 'Matti, J F', 'Mattei, M G', 'Giraud, F', 'Mongin, M']","['Dor JF', 'Matti JF', 'Mattei MG', 'Giraud F', 'Mongin M']",['fre'],"['Case Reports', 'Journal Article']",France,Nouv Rev Fr Hematol Blood Cells,Nouvelle revue francaise d'hematologie; blood cells,7701899,IM,"['Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/*genetics', 'Middle Aged', 'Translocation, Genetic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nouv Rev Fr Hematol Blood Cells. 1977;18(1):245-6.,,,Leucemie myeloide subaigue avec chromosome Philadelphie et translocation supplementaire: 9-12.,,,,
268608,NLM,MEDLINE,19771020,20041117,,18,1,1977,"[Simultaneous discovery of myeloma, granulocytic leukemia (with polynuclear neutrophils) and Paget's disease in a patient].",240-4,"['Carcassonne, Y', 'Gastaut, J A', 'Sebahoun, G', 'Gratecos, N']","['Carcassonne Y', 'Gastaut JA', 'Sebahoun G', 'Gratecos N']",['fre'],"['Case Reports', 'Journal Article']",France,Nouv Rev Fr Hematol Blood Cells,Nouvelle revue francaise d'hematologie; blood cells,7701899,IM,"['Aged', 'Humans', 'Leukemia, Myeloid/*complications', 'Multiple Myeloma/*complications', '*Neutrophils', 'Osteitis Deformans/*complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nouv Rev Fr Hematol Blood Cells. 1977;18(1):240-4.,,,"Decouverte simultanee chez un meme malade d'un myelome, d'une leucemie granuleuse (a polynucleaires neutrophiles et d'une maladie de Paget.",,,,
268607,NLM,MEDLINE,19771020,20110816,,18,1,1977,Cerebromeningeal localizations in acute myeloblastic leukemia of the adult. Clinical and pathological study of 15 cases.,23-34,"['Renoux, M', 'Dhermy, D', 'Bernard, J F', 'Brousse, N', 'Henin, D', 'Amar, M', 'Boivin, P']","['Renoux M', 'Dhermy D', 'Bernard JF', 'Brousse N', 'Henin D', 'Amar M', 'Boivin P']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Rev Fr Hematol Blood Cells,Nouvelle revue francaise d'hematologie; blood cells,7701899,IM,"['Adolescent', 'Adult', 'Aged', 'Brain Neoplasms/*complications', 'Cerebrospinal Fluid/cytology', 'Female', 'Humans', 'Leukemia/*complications', 'Leukemia, Myeloid, Acute/*complications/drug therapy/mortality', 'Male', '*Meninges', 'Middle Aged', 'Spinal Puncture']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nouv Rev Fr Hematol Blood Cells. 1977;18(1):23-34.,,"68 consecutive adults were treated for acute myeloblastic leukaemia (A.M.L). Involvement of the central nervous system (CNS) developed in 15 cases. The clinical characteristics of nine of these patients were: symptoms of increased intra-cranial pressure in 5, cranial nerve lesions in 4, peripheral nerve lesions in 5, cord compression in 1, hemispherical symptoms in 7. Lumbar puncture vas performed systematically on seven patients, two of them with evidence of meningeal leukaemia (M.L.). Post-mortem examination was performed on seven patients who died during the first induction treatment: three had evidence of C.N.S. involvement. M.L. developed in three patients during complete hematologic remission (R.C.) In patients younger than 60 years old, the incidence of M.L. was 8/24 (approximately 33%). Medial survival time was reduced:8 months in cases with M.L., compared to 13.5 months. Cerebro-fluid protein levels were increased in six cases without blast cells: in four cases, M.L. occurred within a few months. The frequency of meningeal leukaemia in A.M.I. is under-estimated. Eradication of this frequent complication is difficult. Prophylactic meningeal treatment may be instituted for patients younger than 60, to reduce the incidence of M.L. and to improve the median remission time.",Localisations cerebro-meningees des leucemies aigues myeloblastiques de l'adulte. Etude clinique et anatomo-pathologique de 15 cas.,,,,
268606,NLM,MEDLINE,19771020,20041117,0301-1518 (Print) 0301-1518 (Linking),6,27,1977 Jul 2-9,[Extramedullary epidural severity of chronic myeloid leukemia].,2437-8,"['Aubertin, J', 'Legendre, P', 'Merlet, M', 'Issanchou, A M', 'Lacut, J Y', 'Bentegeat, J']","['Aubertin J', 'Legendre P', 'Merlet M', 'Issanchou AM', 'Lacut JY', 'Bentegeat J']",['fre'],"['Case Reports', 'Letter']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Bone Neoplasms/*etiology', '*Cell Transformation, Neoplastic', 'Female', 'Humans', 'Leukemia, Myeloid/*complications', 'Middle Aged']",1977/07/02 00:00,1977/07/02 00:01,['1977/07/02 00:00'],"['1977/07/02 00:00 [pubmed]', '1977/07/02 00:01 [medline]', '1977/07/02 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Jul 2-9;6(27):2437-8.,,,Acutisation extra-medullaire epidurale d'une leucemie myeloide chronique.,,,,
268605,NLM,MEDLINE,19771020,20061115,0301-1518 (Print) 0301-1518 (Linking),6,27,1977 Jul 2-9,[Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome?].,2409-13,"['Misset, J L', 'Venuat, A M', 'Nevarez, L', 'Mathe, G']","['Misset JL', 'Venuat AM', 'Nevarez L', 'Mathe G']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Adolescent', 'Adult', '*Cell Transformation, Neoplastic', 'Child', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/genetics', 'Male', 'Middle Aged', 'Time Factors']",1977/07/02 00:00,1977/07/02 00:01,['1977/07/02 00:00'],"['1977/07/02 00:00 [pubmed]', '1977/07/02 00:01 [medline]', '1977/07/02 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Jul 2-9;6(27):2409-13.,,"In ten cases of apparently primary acute leukaemia, the discovery of a Philadelphia chromosome at routine examination of the caryotype led a diagnosis of blastic crisis of chronic myeloid leukemia. The clinical, cytological and cytogenetic pictures varied and only routine caryotypic examination may be used in reaching the diagnosis. The prognosis appear to be less bad than in blastic crises occurring after a long course of chronic myeloid leukaemia and closer to that of primary acute myeloid leukaemia.","Crises blastiques revelatrices de leucemies myeloides chroniques et simulant des leucemies aigues primaires, ou leucemies aigues primaires a chromosome Philadelphie?",,,,
268588,NLM,MEDLINE,19771014,20190911,0031-5982 (Print) 0031-5982 (Linking),20,4,1977 Summer,On viral infectivity and carcinogenesis.,603-6,"['Theoharides, T C']",['Theoharides TC'],['eng'],['Journal Article'],United States,Perspect Biol Med,Perspectives in biology and medicine,0401132,IM,"['Adult', 'Anemia, Sickle Cell/blood/epidemiology/genetics', 'Burkitt Lymphoma/epidemiology', 'Cell Membrane/immunology', 'Child', 'Erythrocyte Membrane/ultrastructure', 'Erythrocytes, Abnormal/ultrastructure', 'Genes', 'Humans', 'Leukemia, Lymphoid/epidemiology', 'Neoplasms/*etiology/immunology', '*Oncogenic Viruses']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1353/pbm.1977.0031 [doi]'],ppublish,Perspect Biol Med. 1977 Summer;20(4):603-6. doi: 10.1353/pbm.1977.0031.,,,,,,,
268587,NLM,MEDLINE,19771028,20041117,0030-9311 (Print) 0030-9311 (Linking),17,3-4,1977 Mar-Apr,Thalassemia terminating in erythremic myelosis.,115-23,"['Kurdi, R', 'Rasjid, A', 'Wahidiyat, I']","['Kurdi R', 'Rasjid A', 'Wahidiyat I']",['eng'],"['Case Reports', 'Journal Article']",Indonesia,Paediatr Indones,Paediatrica Indonesiana,0376416,IM,"['Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Erythroblastic, Acute/*etiology', 'Male', 'Thalassemia/blood/*complications']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Paediatr Indones. 1977 Mar-Apr;17(3-4):115-23.,,,,,,,
268496,NLM,MEDLINE,19771028,20180215,1660-8151 (Print) 1660-8151 (Linking),19,3,1977,Nephrotoxicity associated with combined gentamicin-amphotericin B therapy.,176-81,"['Churchill, D N', 'Seely, J']","['Churchill DN', 'Seely J']",['eng'],"['Case Reports', 'Journal Article']",Switzerland,Nephron,Nephron,0331777,IM,"['Aged', 'Amphotericin B/*adverse effects', 'Drug Therapy, Combination', 'Female', 'Gentamicins/*adverse effects', 'Humans', 'Kidney/physiopathology', 'Leukemia, Myeloid, Acute/drug therapy', 'Male', 'Middle Aged', 'Nephritis/*etiology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000180883 [doi]'],ppublish,Nephron. 1977;19(3):176-81. doi: 10.1159/000180883.,"['0 (Gentamicins)', '7XU7A7DROE (Amphotericin B)']",The administration of a low total dose of amphotericin B to four consecutive patients already receiving gentamicin resulted in a deterioration of renal function in all. No other cause of the renal dysfunction was apparent in three cases. It appears probable that these drugs exhibit synergistic nephrotoxicity.,,,,,
268489,NLM,MEDLINE,19771031,20190617,0028-0836 (Print) 0028-0836 (Linking),268,5619,1977 Aug 4,n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells.,462-4,"['Riggs, M G', 'Whittaker, R G', 'Neumann, J R', 'Ingram, V M']","['Riggs MG', 'Whittaker RG', 'Neumann JR', 'Ingram VM']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Nature,Nature,0410462,IM,"['Acetylation', 'Butyrates/*pharmacology', 'Cell Differentiation/drug effects', 'Cell Line', 'Friend murine leukemia virus', 'HeLa Cells', 'Histones/*metabolism', 'Leukemia, Erythroblastic, Acute', 'Neoplasm Proteins/metabolism', 'Time Factors']",1977/08/04 00:00,1977/08/04 00:01,['1977/08/04 00:00'],"['1977/08/04 00:00 [pubmed]', '1977/08/04 00:01 [medline]', '1977/08/04 00:00 [entrez]']",['10.1038/268462a0 [doi]'],ppublish,Nature. 1977 Aug 4;268(5619):462-4. doi: 10.1038/268462a0.,"['0 (Butyrates)', '0 (Histones)', '0 (Neoplasm Proteins)']",,,,,,
268487,NLM,MEDLINE,19771014,20140729,,125,7,1977 Jul,[Juvenile type of chronic myelogenous leukemia in a 3 6/12 year old boy with trisomy 21 mosaicism but no symptoms of Down's syndrome (author's transl)].,740-3,"['Cap, J', 'Izakovic, V', 'Vojtassak, J']","['Cap J', 'Izakovic V', 'Vojtassak J']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Blood Cells', 'Bone Marrow Cells', 'Child, Preschool', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*complications/genetics', 'Male', '*Mosaicism', '*Trisomy']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1977 Jul;125(7):740-3.,,"In a 3 6/12 year old boy, with the juvenile type of chronic myelogeneous leukemia cytogenetic examination of bone marrow and blood, performed two months before onset of the acute blastic crisis, showed two cell lines: the first one with a normal karyotype 46, XY and the second one with a trisomic karyotype 47, XY, +21. This finding of a mosaic trisomy 21 in a patient without symptoms of Down's syndrome allow to assume the trisomy cells to be malignant, and the type of mosaicism to be proliferative. This karyologic finding could be taken for an early prognostic, unfavourable sign of the disease. The significance of karyologic examination with exact classification of atypical leukemias is stressed.",Juvenile Form der chronischen myeloischen Leukamie bei einem 3 6/12 jahrigen Knaben mit Mosaikvorkommen der Trisomie 21 ohne Merkmale eines Down-Syndroms.,,,,
268483,NLM,MEDLINE,19771014,20091111,0024-3477 (Print) 0024-3477 (Linking),99,6,1977 Jun,[Electroencephalographic changes in the course of prophylactic irradiation of the central nervous system in children with acute lymphatic leukemia (author's transl)].,369-72,"['Zeskov, P', 'Tiefenbach, A', 'Konja, J']","['Zeskov P', 'Tiefenbach A', 'Konja J']",['hrv'],"['English Abstract', 'Journal Article']",Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,IM,"['Brain/*physiopathology', 'Child', 'Child, Preschool', 'Electroencephalography', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/physiopathology/*radiotherapy', 'Male']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Lijec Vjesn. 1977 Jun;99(6):369-72.,,,Elektroencefalografske promjene u toku profilaktickog zracenja sredisnjeg zivcanog sustava u djece s akutnom limfatickom leukemijom.,,,,
268450,NLM,MEDLINE,19771014,20190711,0023-2173 (Print) 0023-2173 (Linking),55,14,1977 Jul 15,[Clinical significance of cationic proteins of leukocyte lysosomes: cationic leukocyte antigen (CLA) as a marker of blast crisis in chronic myelocytic leukaemia (author's transl)].,685-93,"['Tischendorf, F W', 'Wust, I', 'Tischendorf, M M']","['Tischendorf FW', 'Wust I', 'Tischendorf MM']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Klin Wochenschr,Klinische Wochenschrift,2985205R,IM,"['Aged', 'Antigens/*analysis', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/immunology/urine', 'Leukemia, Myeloid, Acute/*diagnosis/immunology/urine', 'Leukocytes/*immunology', 'Lysosomes/immunology', 'Middle Aged', 'Polycythemia Vera/diagnosis', 'Primary Myelofibrosis/diagnosis']",1977/07/15 00:00,1977/07/15 00:01,['1977/07/15 00:00'],"['1977/07/15 00:00 [pubmed]', '1977/07/15 00:01 [medline]', '1977/07/15 00:00 [entrez]']",['10.1007/BF01478835 [doi]'],ppublish,Klin Wochenschr. 1977 Jul 15;55(14):685-93. doi: 10.1007/BF01478835.,['0 (Antigens)'],"Cationic leukocyte antigen (CLA) was estimated in urine of acute and chronic leukaemics using quantitative immuno-precipitation techniques. The studies demonstrated that CLA is a marker of the (myelo-) blast crisis in patients with chronic myelocytic leukaemia (CML). By these studies the value of the determination of CLA for the differential diagnosis of acute myeloblastic leukaemia versus initial (myelo-) blast crisis in CML and the lymphatic leukaemias, respectively, was evident. The terminal blastic transformation in CML was indicated early by an elevation of the urinary CLA-level. The blast-crisis was accompanied by a heavy CLA-uria. The results are documented by demonstration of special studies of characteristic cases and discussed in the light of recent results of immunological and cytochemical findings on the nature of blast crisis in CML.",Klinische Wertigkeit von kationischen lysosomalen Leukozytenproteinen: Bedeutung der immunologischen Bestimmung von Kationischem Leukozytenantigen (CLA) fur die Diagnose der Blastenkrise bei chronischer Myelose.,,,,
268449,NLM,MEDLINE,19771020,20151119,0300-8630 (Print) 0300-8630 (Linking),189,4,1977 Jul,[Hodgkin's disease during remission of acute lymphoblastic leukemia (author's transl)].,292-4,"['Lampert, F', 'Boosen, K']","['Lampert F', 'Boosen K']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Child', 'Cyclophosphamide/therapeutic use', 'Female', 'Hodgkin Disease/*complications/drug therapy/radiotherapy/surgery', 'Humans', 'Leukemia, Lymphoid/*complications', 'Methotrexate/therapeutic use', '*Neoplasms, Multiple Primary', 'Remission, Spontaneous', 'Splenectomy', 'Vincristine/therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jul;189(4):292-4.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'YL5FZ2Y5U1 (Methotrexate)']","1 1/2 years after diagnosis of acute lymphoblastic leukemia, Hodgkin's disease, stage IIA of cervical lymphnodes could be verified microscopically in a 7 year old girl in continuous complete remission (of leukemia) and was treated with regional irradiation and combination chemotherapy after exploratory laporotomy with splenectomy. The patient now is off therapy, healthy and without any signs of relapse of the two malignancies.",Morbus Hodgkin in der Remission einer akuten lymphoblastischen Leukamie.,,,,
268448,NLM,MEDLINE,19771031,20131121,0023-2165 (Print) 0023-2165 (Linking),170,6,1977 Jun,[Degenerative retinal conditions after treatment with Busulfan during pregnancy (author's transl)].,818-20,"['Saraux, H', 'Lefrancois, A']","['Saraux H', 'Lefrancois A']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Monbl Augenheilkd,Klinische Monatsblatter fur Augenheilkunde,0014133,IM,"['Adult', 'Busulfan/*adverse effects/therapeutic use', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Maternal-Fetal Exchange/drug effects', 'Pregnancy', 'Pregnancy Complications, Hematologic/*drug therapy', 'Retinal Degeneration/*chemically induced/congenital']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Klin Monbl Augenheilkd. 1977 Jun;170(6):818-20.,['G1LN9045DK (Busulfan)'],A patient with chronic granulocytic leukemia was treated with Busulfan for the three last months of pregnancy. The infant appeared normal except for an atypical tapetoretinal degeneration. We studied the other cases in the literature. All pregnancies produced an apparently normal infant although three infants were small. The case of Diamond had microphthalmia. We conclude that Busulfan is perhaps toxic to fetal retina.,Degenerative Netzhauterkrankungen nach Behandlung der Mutter mit Busulfan wahrend der Schwangerschaft.,,,,
268424,NLM,MEDLINE,19771020,20190630,0022-3476 (Print) 0022-3476 (Linking),91,3,1977 Sep,Preleukemic phase in childhood acute lymphoblastic leukemia.,507-8,"['Toledano, S R']",['Toledano SR'],['eng'],"['Case Reports', 'Letter']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Acute Disease', 'Humans', 'Infant', 'Leukemia, Lymphoid/*diagnosis', 'Male', '*Preleukemia']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']","['S0022-3476(77)81340-1 [pii]', '10.1016/s0022-3476(77)81340-1 [doi]']",ppublish,J Pediatr. 1977 Sep;91(3):507-8. doi: 10.1016/s0022-3476(77)81340-1.,,,,,,,
268381,NLM,MEDLINE,19771028,20041117,0022-1767 (Print) 0022-1767 (Linking),119,3,1977 Sep,Paul-Bunnell antigen in lymphoma and leukemia spleens.,945-9,"['Kano, K', 'Fjelde, A', 'Milgrom, F']","['Kano K', 'Fjelde A', 'Milgrom F']",['eng'],['Journal Article'],United States,J Immunol,"Journal of immunology (Baltimore, Md. : 1950)",2985117R,IM,"['Agglutination Tests', 'Antibody Specificity', '*Antigens', 'Hodgkin Disease/immunology', 'Humans', 'Immune Sera/pharmacology', 'Infectious Mononucleosis/*immunology', 'Leukemia/*immunology', 'Leukemia, Myeloid/immunology', 'Lymphoma/*immunology', 'Spleen/*immunology']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,J Immunol. 1977 Sep;119(3):945-9.,"['0 (Antigens)', '0 (Immune Sera)']","Lymphoid cells obtained from spleens of patients with lymphomas or leukemias were studied for the presence of heterophile (Paul-Bunnell (P-B)) antigen. A mixed agglutination (MA) test was established utilizing monolayers of cells attached to poly-L-lysine-coated wells of plastic U plates. After incubation of the monolayers with infectious mononeucleosis (IM) sera, indicator cells, sheep, or trypsinized bovine erythrocytes were added. The results were assessed according to sedimentation patterns of the indicator cells on the monolayers. Positive MA reactions were shown to be due to specific binding of P-B antibodies to the corresponding antigens on the spleen cells. Positive results were obtained with 15 of 37 spleens from patients with Hodgkin's disease, 5 of 8 lymphoma spleens, 4 of 15 chronic myelocytic leukemia spleens and 2 of 4 chronic lymphocytic leukemia spleens. Only 2 of 25 spleens from patients with various other diseases and 1 of 26 apparently normal thymus specimens gave positive results. This study confirmed demonstration of P-B antigen in lymphoma and leukemia by means of absorption experiments, which was reported previously.",,,,,
268330,NLM,MEDLINE,19771028,20181113,0021-9738 (Print) 0021-9738 (Linking),60,4,1977 Oct,Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.,874-84,"['Carpentier, N A', 'Lange, G T', 'Fiere, D M', 'Fournie, G J', 'Lambert, P H', 'Miescher, P A']","['Carpentier NA', 'Lange GT', 'Fiere DM', 'Fournie GJ', 'Lambert PH', 'Miescher PA']",['eng'],['Journal Article'],United States,J Clin Invest,The Journal of clinical investigation,7802877,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', '*Antigen-Antibody Complex', 'Cell Line', 'Child', 'Complement C1/metabolism', 'Female', 'HLA Antigens', 'Humans', 'Immunoglobulin G/analysis', 'Isoantibodies/analysis', 'Leukemia/*immunology/pathology', 'Leukemia, Lymphoid/immunology', 'Leukemia, Myeloid/immunology', 'Leukemia, Myeloid, Acute/immunology', 'Male', 'Middle Aged', 'Molecular Weight', 'Prognosis']",1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",['10.1172/JCI108842 [doi]'],ppublish,J Clin Invest. 1977 Oct;60(4):874-84. doi: 10.1172/JCI108842.,"['0 (Antigen-Antibody Complex)', '0 (Complement C1)', '0 (HLA Antigens)', '0 (Immunoglobulin G)', '0 (Isoantibodies)']","The occurrence of circulating immune complexes was investigated in 467 serum samples from 230 leukemia patients using the [(125)I]Clq-binding test. There was an increased serum [(125)I]Clq-binding activity in 40% of patients with acute myeloid leukemia, 23% with acute lymphatic leukemia, 46% in blastic crisis of chronic myeloid leukemia, 12% with chronic lymphatic leukemia, and 13% with chronic myeloid leukemia. In 48 patients, serum was also tested for soluble immune complexes by the Raji cell radioassay; the correlation between results of the two tests was significant. The Clq-binding material had properties identical with those of immune complexes. It sedimented as 14-28s material on sucrose density gradient. It contained IgG which could be dissociated at acid pH. Its Clq-binding properties could be removed after passage through anti-IgG immuno-absorbant or after a mild reduction-alkylation treatment, but were not sensitive to deoxyribonuclease treatment. Circulating immune complexes were found most commonly during the blastic stage of leukemia.Remission took place in 75.4% of patients with no detectable circulating immune complexes at the onset of acute leukemia, but in only 32.7% of those with detected complexes during this period. Median survival times of the former group of patients were more than 18 mo in acute myeloid leukemia and acute lymphatic leukemia and more than 8(1/2) mo in blastic crisis of chronic myeloid leukemia. The corresponding median survival times in the latter patient group were 64, 135, and 90 days. These findings were unrelated to prognostic features already known.",,PMC372436,,,
268329,NLM,MEDLINE,19771020,20161123,0008-2902 (Print) 0008-2902 (Linking),28,3,1977 Sep,Renal aspergillosis: a report of two cases.,214-6,"['Myerson, D A', 'Rosenfield, A T']","['Myerson DA', 'Rosenfield AT']",['eng'],"['Case Reports', 'Journal Article']",Canada,J Can Assoc Radiol,Journal of the Canadian Association of Radiologists,7505589,IM,"['Aspergillosis/complications/*diagnostic imaging', 'Child', 'Granulomatous Disease, Chronic/complications', 'Humans', 'Kidney Diseases/complications/*diagnostic imaging', 'Leukemia, Myeloid/complications', 'Male', 'Middle Aged', 'Radiography']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",,ppublish,J Can Assoc Radiol. 1977 Sep;28(3):214-6.,,"Two cases of opportunistic aspergillosis of the kidney are presented. One patient, a child with unsuspected chronic granulomatous disease of childhood, presented with a renal mass which proved to be an abscess secondary to aspergillosis. The other patient, a terminal leukemic, had a renal vein thrombosis secondary to invasion of the renal vein by aspergillosis. Aspergillosis and other fungal diseases of the kidney should be considered in debilitated patients with an abnormal urogram.",,,,,
268328,NLM,MEDLINE,19771020,20190509,0021-924X (Print) 0021-924X (Linking),81,6,1977 Jun,Induction of globin gene expression in cultured erythroleukemia cells by butyric acid.,1901-10,"['Kameji, R', 'Obinata, M', 'Natori, Y', 'Ikawa, Y']","['Kameji R', 'Obinata M', 'Natori Y', 'Ikawa Y']",['eng'],['Journal Article'],England,J Biochem,Journal of biochemistry,0376600,IM,"['Animals', 'Butyrates/*pharmacology', 'Cell Line', 'Genes', 'Globins/*biosynthesis', 'Hemoglobins/biosynthesis', 'Kinetics', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Mice', 'Nucleic Acid Hybridization', 'Protein Biosynthesis/drug effects', 'RNA/metabolism', 'RNA, Messenger/metabolism', 'Reticulocytes/metabolism', 'Templates, Genetic', 'Transcription, Genetic/*drug effects']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1093/oxfordjournals.jbchem.a131652 [doi]'],ppublish,J Biochem. 1977 Jun;81(6):1901-10. doi: 10.1093/oxfordjournals.jbchem.a131652.,"['0 (Butyrates)', '0 (Hemoglobins)', '0 (RNA, Messenger)', '63231-63-0 (RNA)', '9004-22-2 (Globins)']","Butyric acid induces erythroid differentiation of cultured Friend leukemia cells when added to the culture medium. A high level of globin messenger RNA (mRNA) was detected in Friend leukemia cells treated with butyric acid by a liquid hybridization method using radioactive DNA complementary to reticulocyte globin mRNA. The content of globin mRNA molecules induced in the cytoplasm of the butyric acid-treated Friend leukemia cells paralleled the hemoglobin content determined by the benzidine staining method. Therefore, this hemoglobin synthesis may be most reasonably explained in terms of transcriptional activation of globin genes, as previously proposed in the case of dimethylsulfoxide, another inducer of erythroid differentiation. Induced accumulation of globin mRNA in the nuclei also supports this interpretation.",,,,,
268327,NLM,MEDLINE,19771014,20131121,0003-1488 (Print) 0003-1488 (Linking),171,3,1977 Aug 1,Treatment of feline myelogenous leukemia: four case reports.,263-6,"['Henness, A M', 'Crow, S E']","['Henness AM', 'Crow SE']",['eng'],"['Case Reports', 'Journal Article']",United States,J Am Vet Med Assoc,Journal of the American Veterinary Medical Association,7503067,IM,"['Animals', 'Blood Transfusion/veterinary', 'Cat Diseases/drug therapy/*therapy', 'Cats', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Female', 'Infusions, Parenteral', 'Leukemia, Myeloid/drug therapy/therapy/*veterinary', 'Male', 'Prednisone/therapeutic use']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,J Am Vet Med Assoc. 1977 Aug 1;171(3):263-6.,"['04079A1RDZ (Cytarabine)', '8N3DW7272P (Cyclophosphamide)', 'VB0R961HZT (Prednisone)']","Of 4 cats with myelogenous leukemia, 3 had the neutrophilic type and 1 had the basophilic type. Partial remission was achieved with chemotherapy in 2 of the cats. Their survival times, however, were 77 and 31 days from time of diagnosis. The other 2 cats did not respond to treatment and died 16 days from time of diagnosis.",,,,,
268300,NLM,MEDLINE,19771031,20190722,0019-5456 (Print) 0019-5456 (Linking),44,348,1977 Jan,Congenital myeloblastic leukaemia: report of two cases.,17-9,"['Kushwaha, M R', 'Bagchi, M', 'Mehrotra, R M']","['Kushwaha MR', 'Bagchi M', 'Mehrotra RM']",['eng'],"['Case Reports', 'Journal Article']",India,Indian J Pediatr,Indian journal of pediatrics,0417442,IM,"['Female', 'Humans', 'Infant', 'Infant, Newborn', 'Leukemia, Myeloid, Acute/*congenital']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/BF02761863 [doi]'],ppublish,Indian J Pediatr. 1977 Jan;44(348):17-9. doi: 10.1007/BF02761863.,,,,,,,
268299,NLM,MEDLINE,19771028,20071115,0019-4832 (Print) 0019-4832 (Linking),29,3,1977 May-Jun,Pleuro-pericardial effusion: a presenting manifestation of acute myeloblastic leukaemia.,165-9,"['Saha, P K', 'Agrawal, B V', 'Mishra, S K', 'Vaish, S K', 'Agrawal, S K']","['Saha PK', 'Agrawal BV', 'Mishra SK', 'Vaish SK', 'Agrawal SK']",['eng'],"['Case Reports', 'Journal Article']",India,Indian Heart J,Indian heart journal,0374675,IM,"['Acute Disease', 'Adolescent', 'Humans', 'Leukemia, Myeloid, Acute/complications/*diagnosis', 'Male', 'Pericardial Effusion/*etiology', 'Pleural Effusion/*etiology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Indian Heart J. 1977 May-Jun;29(3):165-9.,,,,,,,
268296,NLM,MEDLINE,19771031,20141120,0016-450X (Print) 0016-450X (Linking),68,2,1977 Apr,Glucorticoid-induced differentiation of cultured mouse myeloid leukemia cells.,241-6,"['Honma, Y', 'Kasukabe, T', 'Okabe, J', 'Hozumi, M']","['Honma Y', 'Kasukabe T', 'Okabe J', 'Hozumi M']",['eng'],['Journal Article'],Japan,Gan,Gan,0151745,IM,"['Animals', 'Cell Differentiation/*drug effects', 'Dexamethasone/pharmacology', 'Glucocorticoids/*pharmacology', 'In Vitro Techniques', 'Leukemia, Myeloid', 'Mice', 'Phagocytosis/drug effects']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Gan. 1977 Apr;68(2):241-6.,"['0 (Glucocorticoids)', '7S5I7G3JQL (Dexamethasone)']","Mouse myeloid leukemia cells were induced by some corticoid hormones to migrate in agar, phagocytize, and change into forms which were morphologically similar to macrophages and granulocytes. Inducing ability of corticoids was correlated with glucocorticoid activity, not mineralocorticoid activity. Other steroids were ineffective to induce differentiation of myeloid leukemia cells. Glucocorticoid-resistant cells, which could not differentiate even in a high concentrations of dexamethasone, were selected from steroid-sensitive cells by stepwise increase in concentrations of dexamethasone in culture medium.",,,,,
268295,NLM,MEDLINE,19771031,20141003,0016-450X (Print) 0016-450X (Linking),68,2,1977 Apr,Differentiation of a resistant clone of mouse myeloid leukemia cells with dimethyl sulfoxide and ascitic fluid.,151-7,"['Okabe, J', 'Honma, Y', 'Hozumi, M']","['Okabe J', 'Honma Y', 'Hozumi M']",['eng'],['Journal Article'],Japan,Gan,Gan,0151745,IM,"['Animals', 'Cell Differentiation/*drug effects', 'Cell Nucleus/ultrastructure', 'Clone Cells', 'Dimethyl Sulfoxide/*pharmacology', 'Granulocytes/ultrastructure', 'Leukemia, Myeloid/*pathology', 'Macrophages/ultrastructure', 'Mice', 'Phagocytosis/drug effects']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Gan. 1977 Apr;68(2):151-7.,['YOW8V9698H (Dimethyl Sulfoxide)'],"Mouse myeloid leukemia line cells, M1, could be induced to differentiate in vitro into macrophages and granulocytes with ascitic fluid of animals bearing various tumors. M1 cells could not be induced to differentiate with dimethyl sulfoxide alone. During the culture of M1 cells, spontaneously appearing cells resistant to factors stimulating differentiation (D-factor) in ascitic fluid were isolated. These resistant cells were more refractile to the toxic action of dimethyl sulfoxide than sensitive cells and grew in culture medium with 1% dimethyl sulfoxide. Although the resistant cells were not induced to differentiate with dimethyl sulfoxide alone, they were sensitized with the aid of dimethyl sulfoxide to undergo differentiation with the D-factor in ascitic fluid.",,,,,
268292,NLM,MEDLINE,19771020,20190629,0014-4754 (Print) 0014-4754 (Linking),33,7,1977 Jul 15,Ropalocytosis in acute leukemia.,964-5,"['Skinnider, L']",['Skinnider L'],['eng'],['Journal Article'],Switzerland,Experientia,Experientia,0376547,IM,"['Child', 'Erythrocytes/*physiology/ultrastructure', 'Humans', 'Leukemia, Lymphoid/*blood/ultrastructure', 'Lymphocytes/*physiology/ultrastructure', 'Microscopy, Electron']",1977/07/15 00:00,1977/07/15 00:01,['1977/07/15 00:00'],"['1977/07/15 00:00 [pubmed]', '1977/07/15 00:01 [medline]', '1977/07/15 00:00 [entrez]']",['10.1007/BF01951307 [doi]'],ppublish,Experientia. 1977 Jul 15;33(7):964-5. doi: 10.1007/BF01951307.,,,,,,,
268284,NLM,MEDLINE,19771028,20190620,0014-2956 (Print) 0014-2956 (Linking),77,3,1977 Aug 1,Amino acid control of stable RNA synthesis in Friend leukemia cells in relation to intracellular purine nucleoside triphosphate levels.,495-9,"['Dehlinger, P J', 'Hamilton, T A', 'Litt, M']","['Dehlinger PJ', 'Hamilton TA', 'Litt M']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Eur J Biochem,European journal of biochemistry,0107600,IM,"['Adenosine Triphosphate/*metabolism', 'Cell Line', 'Cell Nucleolus/drug effects/metabolism', 'Cell Nucleus/drug effects/metabolism', 'Friend murine leukemia virus', 'Guanosine/pharmacology', 'Guanosine Triphosphate/*metabolism', 'Histidinol/pharmacology', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Membranes/metabolism', 'RNA, Neoplasm/*biosynthesis', 'RNA, Transfer/biosynthesis', 'RNA, Viral/*biosynthesis']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1111/j.1432-1033.1977.tb11691.x [doi]'],ppublish,Eur J Biochem. 1977 Aug 1;77(3):495-9. doi: 10.1111/j.1432-1033.1977.tb11691.x.,"['0 (RNA, Neoplasm)', '0 (RNA, Viral)', '12133JR80S (Guanosine)', '501-28-0 (Histidinol)', '86-01-1 (Guanosine Triphosphate)', '8L70Q75FXE (Adenosine Triphosphate)', '9014-25-9 (RNA, Transfer)']","Histidinol is known to cause deacylation of histidyl-tRNA in cultured mammalian cells, thereby producing a functional deprivation of histidine. Such deprivation of an essential amino acid is known to produce various effects, including inhibition of tRNA synthesis and of nucleolar RNA synthesis and processing. It has been proposed [Grummt, F. & Grummt, I. (1976) Eur. J. Biochem. 64, 307-312] that this response to amino acid deprivation is mediated by decreases in GTP and ATP pool sizes caused by a deacylated-tRNA-dependent hydrolysis of GTP. In contrast, we find that Friend leukemia cells treated with histidinol show no significant changes in GTP or ATP pool sizes, although this treatment does produce the expected inhibition of rRNA and tRNA synthesis.",,,,,
268283,NLM,MEDLINE,19771014,20191210,0014-2956 (Print) 0014-2956 (Linking),76,2,1977 Jun 15,Release of interferon-induced translation inhibition by tRNA in cell-free extracts from mouse erythroleukemia cells.,541-51,"['Mayr, U', 'Bermayer, H P', 'Weidinger, G', 'Jungwirth, C']","['Mayr U', 'Bermayer HP', 'Weidinger G', 'Jungwirth C']",['eng'],['Journal Article'],England,Eur J Biochem,European journal of biochemistry,0107600,IM,"['Animals', 'Cell Line', 'Cell Transformation, Neoplastic', 'Erythroblasts/drug effects/metabolism', 'Friend murine leukemia virus', 'Globins/biosynthesis', 'Interferons/*pharmacology', 'Kinetics', 'L Cells/drug effects/metabolism', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Liver', 'Lysine', 'Mice', 'Protein Biosynthesis/*drug effects', 'RNA, Messenger/metabolism', 'RNA, Transfer/*metabolism', 'Rabbits', 'Ribosomes/drug effects/metabolism']",1977/06/15 00:00,1977/06/15 00:01,['1977/06/15 00:00'],"['1977/06/15 00:00 [pubmed]', '1977/06/15 00:01 [medline]', '1977/06/15 00:00 [entrez]']",['10.1111/j.1432-1033.1977.tb11624.x [doi]'],ppublish,Eur J Biochem. 1977 Jun 15;76(2):541-51. doi: 10.1111/j.1432-1033.1977.tb11624.x.,"['0 (RNA, Messenger)', '9004-22-2 (Globins)', '9008-11-1 (Interferons)', '9014-25-9 (RNA, Transfer)', 'K3Z4F929H6 (Lysine)']",,,,,,
268282,NLM,MEDLINE,19771020,20071115,0071-111X (Print) 0071-111X (Linking),39,,1977,[Gastrointestinal complications of acute leukemias].,59-77,"['Hensler, R A', 'Knoblauch, M']","['Hensler RA', 'Knoblauch M']",['ger'],['Journal Article'],Germany,Ergeb Inn Med Kinderheilkd,Ergebnisse der inneren Medizin und Kinderheilkunde,0370703,IM,"['Adolescent', 'Adult', 'Aged', 'Child', 'Gastrointestinal Diseases/*etiology', 'Humans', 'Intestinal Diseases/etiology', 'Leukemia, Lymphoid/*complications', 'Leukemia, Myeloid, Acute/*complications', 'Liver Diseases/etiology', 'Middle Aged', 'Pancreatic Diseases/etiology', 'Splenic Diseases/etiology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ergeb Inn Med Kinderheilkd. 1977;39:59-77.,,,Gastrointestinale Komplikationen akuter Leukamien.,,,,
268268,NLM,MEDLINE,19771028,20171116,0012-0472 (Print) 0012-0472 (Linking),102,32,1977 Aug 12,[Combination chemotherapy in acute blast crisis of chronic myeloid leukaemia (author's transl)].,1143-6,"['Cavalli, F', 'Tschopp, L', 'Alberto, P', 'Martz, G']","['Cavalli F', 'Tschopp L', 'Alberto P', 'Martz G']",['ger'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adolescent', 'Adult', 'Aged', 'Drug Therapy, Combination', 'Female', 'Humans', 'Hydroxyurea/therapeutic use', 'Leukemia, Myeloid/complications', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Mercaptopurine/therapeutic use', 'Middle Aged', 'Prednisone/therapeutic use', 'Prospective Studies', 'Remission, Spontaneous', 'Switzerland', 'Vincristine/therapeutic use']",1977/08/12 00:00,1977/08/12 00:01,['1977/08/12 00:00'],"['1977/08/12 00:00 [pubmed]', '1977/08/12 00:01 [medline]', '1977/08/12 00:00 [entrez]']",['10.1055/s-0028-1105474 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Aug 12;102(32):1143-6. doi: 10.1055/s-0028-1105474.,"['5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)', 'X6Q56QN5QC (Hydroxyurea)']","Sixteen patients in an acute blast crisis of chronic myeloid leukaemia (CML) were treated with a combination of vincristine, 6-mercaptopurine, hydroxyurea and prednisone. Only two of these patients had complete remission on this treatment, while four had partial remission. This experience, comparable to that reported by others, suggests that aggressive treatment in the terminal phase of CML is justified only as part of a prospective and well-controlled study.",Polychemotherapie-Resultate beim akuten Blastenschub der chronisch myeloischen Leukamie.,,,,
268267,NLM,MEDLINE,19771014,20071115,0012-0472 (Print) 0012-0472 (Linking),102,28,1977 Jul 15,[Acute myeloid leukaemia in the course of Hodgkin's disease (author's transl)].,1019-24,"['Cavalli, F', 'Gerber, A', 'Mosimann, W', 'Sonntag, R W', 'Tschopp, L']","['Cavalli F', 'Gerber A', 'Mosimann W', 'Sonntag RW', 'Tschopp L']",['ger'],"['English Abstract', 'Journal Article']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adolescent', 'Adult', 'Bone Marrow Examination', 'Female', 'Hodgkin Disease/*complications/diagnosis/drug therapy/radiotherapy', 'Humans', 'Leukemia, Myeloid, Acute/*complications/diagnosis', 'Male', 'Middle Aged', 'Pancytopenia/complications', 'Time Factors']",1977/07/15 00:00,1977/07/15 00:01,['1977/07/15 00:00'],"['1977/07/15 00:00 [pubmed]', '1977/07/15 00:01 [medline]', '1977/07/15 00:00 [entrez]']",['10.1055/s-0028-1105457 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Jul 15;102(28):1019-24. doi: 10.1055/s-0028-1105457.,,"Acute myeloid leukaemia occurred in six patients who had been treated for Hodgkin's disease for a number of years. Usually the leukaemia diagnosis was preceded by a striking pancytopenic phase, bone-marrow aspiration being more useful diagnostically than biopsy. Five of these six patients have come under observation in the last eighteen months. This extraordinary frequency of secondary acute myeloid leukaemia once again raises the question of the leukaemogenic effect of intensive radiotherapy and chemotherapy, and also new aspects in the therapeutic management of Hodgkin's disease, especially combined radiotherapy and chemotherapy, as well as long-term maintenance chemotherapy.",Akute myeloische Leukamie im Krankheitsverlauf des Morbus Hodgkin.,,,,
268266,NLM,MEDLINE,19771020,20191028,0147-0272 (Print) 0147-0272 (Linking),2,1,1977 Jul,Diagnosis and management of myeloproliferative disorders.,1-42,"['Laszlo, J', 'Huang, A T']","['Laszlo J', 'Huang AT']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Curr Probl Cancer,Current problems in cancer,7702986,IM,"['Alkaline Phosphatase/blood', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Bone and Bones/diagnostic imaging', 'Chromosome Aberrations', 'Diagnosis, Differential', 'Female', 'Histamine/blood', 'Histidine Decarboxylase/blood', 'Humans', 'Leukemia, Myeloid/diagnosis/therapy', 'Leukocytes/enzymology', 'Male', '*Myeloproliferative Disorders/blood/diagnosis/therapy', 'Polycythemia Vera/diagnosis/therapy', 'Primary Myelofibrosis/blood/diagnosis', 'Prognosis', 'Radiography', 'Thrombocythemia, Essential/diagnosis/therapy']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']","['S0147-0272(77)80003-2 [pii]', '10.1016/s0147-0272(77)80003-2 [doi]']",ppublish,Curr Probl Cancer. 1977 Jul;2(1):1-42. doi: 10.1016/s0147-0272(77)80003-2.,"['820484N8I3 (Histamine)', 'EC 3.1.3.1 (Alkaline Phosphatase)', 'EC 4.1.1.22 (Histidine Decarboxylase)']",,,,,,
268246,NLM,MEDLINE,19771028,20190509,0009-9236 (Print) 0009-9236 (Linking),22,3,1977 Sep,Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion system.,371-4,"['Ho, D H', 'Brown, N S', 'Benvenuto, J', 'McCredie, K B', 'Buckels, D', 'Freireich, E J']","['Ho DH', 'Brown NS', 'Benvenuto J', 'McCredie KB', 'Buckels D', 'Freireich EJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Clin Pharmacol Ther,Clinical pharmacology and therapeutics,0372741,IM,"['Arabinofuranosyluracil/urine', 'Cytarabine/*administration & dosage/metabolism/therapeutic use', 'Humans', 'Infusions, Parenteral', 'Leukemia, Myeloid, Acute/*drug therapy', 'Methods']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1002/cpt1977223371 [doi]'],ppublish,Clin Pharmacol Ther. 1977 Sep;22(3):371-4. doi: 10.1002/cpt1977223371.,"['04079A1RDZ (Cytarabine)', '3083-77-0 (Arabinofuranosyluracil)']","Arabinosylcytosine (ara-C) was administered by prolonged intravenous infusion with a portable liquid infusion system (LIS) to patients with acute myelogenous leukemia. With the use of tritiated ara-C and this portable system, pharmacologic studies were performed in 8 patients. Most of the plasma radioactivity is in the deaminated product, arabinosyluracil (ara-U). After continuous intravenous infusion, a constant ara-C level is achieved slowly in the plasma. Unless a loading (priming) dose is administered immediately before beginning the infusion, a steady-state ara-C level cannot be achieved until 8 to 24 hr after the infusion. The infusion system has two mechanisms--one for giving a loading dose (3 ml/min) and the other for regular infusion at a rate of 0.5 to 2.0 ml/hr. If a loading dose is given before continuous infusion, a steady-state are-C level is achieved within an hour. The plasma ara-C disappearance curves are biphasic with a terminal half-life of 104 min, which is the same as that of a single injection. The cumulative urinary excretion after approximately 23 hr of infusion varied from 14% to 35% in different patients; more than 90% is ara-U and the remainder is ara-C. Our results have demonstrated that LIS can be used conveniently to sustain a constant plasma level of ara-C. The LIS increases mobility of both inpatients and outpatients and is particularly convenient for ambulatory patients.",,,,,
268245,NLM,MEDLINE,19771031,20190706,0009-8981 (Print) 0009-8981 (Linking),79,2,1977 Sep 1,Urinary lysozyme phenotypes in monocytic leukemia.,503-6,"['Virella, G', 'Goudswaard, J', 'Tischendorf, F W', 'Fudenberg, H H']","['Virella G', 'Goudswaard J', 'Tischendorf FW', 'Fudenberg HH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Clin Chim Acta,Clinica chimica acta; international journal of clinical chemistry,1302422,IM,"['Electrophoresis', 'Humans', 'Leukemia, Myeloid/*enzymology/genetics', 'Methods', 'Muramidase/*urine', '*Phenotype']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']","['0009-8981(77)90447-8 [pii]', '10.1016/0009-8981(77)90447-8 [doi]']",ppublish,Clin Chim Acta. 1977 Sep 1;79(2):503-6. doi: 10.1016/0009-8981(77)90447-8.,['EC 3.2.1.17 (Muramidase)'],A method of two-dimensional electrophoresis has been devised to allow the study of the electrophoretic mobility of urinary lysozyme. Three different phenotypes have been defined in a study of thirteen purified lysozymes obtained from different patients with monocytic leukemia.,,,,,
268232,NLM,MEDLINE,19771020,20190619,0008-543X (Print) 0008-543X (Linking),40,2,1977 Aug,Clostridium septicum infection in childhood leukemia: report of a case and review of the literature.,950-3,"['Lehman, T J', 'Quinn, M J', 'Siegel, S E', 'Ortega, J A']","['Lehman TJ', 'Quinn MJ', 'Siegel SE', 'Ortega JA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Clostridium Infections/*complications/etiology/therapy', 'Digestive System/microbiology', 'Female', 'Humans', 'Hyperbaric Oxygenation', 'Leukemia, Myeloid, Acute/*complications', 'Penicillins/therapeutic use']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1002/1097-0142(197708)40:2<950::aid-cncr2820400254>3.0.co;2-q [doi]'],ppublish,Cancer. 1977 Aug;40(2):950-3. doi: 10.1002/1097-0142(197708)40:2<950::aid-cncr2820400254>3.0.co;2-q.,['0 (Penicillins)'],Overwhelming Clostridium septicum infection is a rare occurrence in children. It is seen almost exclusively as a complication of acute leukemia. A high index of suspicion in the leukemic child with an acute abdomen is the key to early diagnosis and improved survival. A case in a 13-year-old girl with acute myelogenous leukemia is reported and six pediatric cases in the literature were reviewed.,,,,,
268231,NLM,MEDLINE,19771020,20190619,0008-543X (Print) 0008-543X (Linking),40,2,1977 Aug,Lymphoid blastic crisis at the onset of chronic granulocytic leukemia: report of two cases.,865-70,"['Mauri, C', 'Torelli, U', 'di Prisco, U', 'Silingardi, V', 'Artusi, T', 'Emila, G']","['Mauri C', 'Torelli U', 'di Prisco U', 'Silingardi V', 'Artusi T', 'Emila G']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Alkaline Phosphatase/metabolism', 'Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Lymphoid/*complications/enzymology/genetics/pathology', 'Leukemia, Myeloid/enzymology/*etiology/genetics/pathology', 'Male']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1002/1097-0142(197708)40:2<865::aid-cncr2820400240>3.0.co;2-q [doi]'],ppublish,Cancer. 1977 Aug;40(2):865-70. doi: 10.1002/1097-0142(197708)40:2<865::aid-cncr2820400240>3.0.co;2-q.,['EC 3.1.3.1 (Alkaline Phosphatase)'],"Two patients with a typical hematologic pattern of acute lymphatic leukemia were brought into complete remission by treatment. A few weeks later they developed a typical peripheral and bone marrow pattern of chronic granulocytic leukemia, with Philadelphia chromosome and very low leukocyte alkaline phosphatase. These cases, along with other findings recently reported in the literature, support the possibility of a previously unrecognized relationship between lymphoblastic cell populations and chronic granulocytic leukemia.",,,,,
268229,NLM,MEDLINE,19771020,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6086,1977 Aug 27,Prolonged remission maintenance in acute myeloid leukaemia.,544-7,"['Spiers, A S', 'Goldman, J M', 'Catovsky, D', 'Costello, C', 'Galton, D A', 'Pitcher, C S']","['Spiers AS', 'Goldman JM', 'Catovsky D', 'Costello C', 'Galton DA', 'Pitcher CS']",['eng'],"['Comparative Study', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*therapeutic use', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Middle Aged', 'Prednisolone/therapeutic use', 'Remission, Spontaneous', 'Thioguanine/therapeutic use', 'Vincristine/therapeutic use']",1977/08/27 00:00,1977/08/27 00:01,['1977/08/27 00:00'],"['1977/08/27 00:00 [pubmed]', '1977/08/27 00:01 [medline]', '1977/08/27 00:00 [entrez]']",['10.1136/bmj.2.6086.544 [doi]'],ppublish,Br Med J. 1977 Aug 27;2(6086):544-7. doi: 10.1136/bmj.2.6086.544.,"['0 (Antineoplastic Agents)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","Twenty-five patients with acute myeloid leukaemia were treated with three quadruple drug combinations in predetermined rotation: TRAP (thioguanine, daunorubicin, cytarabine, prednisolone); COAP (cyclophosphamide, vincristine, cytarabine, prednisolone); and POMP (prednisolone, vincristine, methotrexate, mercaptopurine). Fifteen patients (60%) achieved complete remission and five (20%) partial remission. For maintenance, five-day courses of drugs were administered every 14 to 21 days and doses were increased to tolerance. The median length of complete remission was 66 weeks. In eight patients remission maintenance treatment was discontinued and some remained in complete remission for over two years. In this series the remission induction rate was comparable with that reported for other regimens and complete remission lasted longer with this intensive maintenance regimen than with others. Nevertheless, the TRAP programme must still be regarded as only palliative treatment for acute myeloid leukaemia.",,PMC1631479,,,
268223,NLM,MEDLINE,19771014,20190902,0006-5242 (Print) 0006-5242 (Linking),35,1,1977 Jul 20,"[Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].",21-34,"['Mende, S', 'Fulle, H H', 'Knuth, A', 'Weissenfels, I']","['Mende S', 'Fulle HH', 'Knuth A', 'Weissenfels I']",['ger'],"['English Abstract', 'Journal Article']",Germany,Blut,Blut,0173401,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', 'Bone Marrow Examination', 'Chronic Disease', 'Female', 'Histiocytes', 'Humans', 'Leukemia, Monocytic, Acute/diagnosis', 'Leukemia, Myeloid/*diagnosis/pathology', 'Male', 'Middle Aged', 'Muramidase/blood/urine', 'Prognosis']",1977/07/20 00:00,1977/07/20 00:01,['1977/07/20 00:00'],"['1977/07/20 00:00 [pubmed]', '1977/07/20 00:01 [medline]', '1977/07/20 00:00 [entrez]']",['10.1007/BF01006961 [doi]'],ppublish,Blut. 1977 Jul 20;35(1):21-34. doi: 10.1007/BF01006961.,['EC 3.2.1.17 (Muramidase)'],"44 patients suffering from myelomonocytic leukemia (MML) have been observed over the last four years. They have been subclassified in acute myelomonocytic and acute monoblastic leukemias (AMML, n = 12; AMoL, n = 10), subacute myelomonocytic leukemias (SMML, n = 13), and chronic myelomonocytic leukemias (CMML, n = 9) on the basis of bone marrow cytology(blast and promonocyte counts, maturation of granulopoesis) and cytochemical findings (peroxydase and unspecific esterase reaction). This subclassification has been proved to be of prognostic relevance by its good correlation with the mean survival times (AMML : 4.5 months, AMoL : 2.4 months, SMML : 8 months, CMML : 18 months). The acute forms have been treated in general with combined cytostatic chemotherapy, whereas SMML and CMML have been treated this way only in case of progression to an acute phase. These progressions to an AMML have been observed more often and earlier in subacute forms than in chronic forms. The diagnosis of SMML and CMML is supported by the finding of sea-blue histiocytes in the bone marrow, increased lysozyme levels in serum and urine and by the absence of the Philadelphia-Chromosome.","Myelomonozytare Leukamie: Klinische, zytologische und zytogenetische Studien bei akuten, subakuten und chronischen Verlaufsformen.",,,,
268222,NLM,MEDLINE,19771031,20071115,0300-0893 (Print) 0300-0893 (Linking),27,3,1977 Apr,Polymorphonuclear function in acute myeloblastic leukemia.,94-6,"['Coiffier, B', 'Frobert, Y', 'Revol, L']","['Coiffier B', 'Frobert Y', 'Revol L']",['eng'],['Journal Article'],France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Blood Bactericidal Activity', '*Chemotaxis, Leukocyte', 'Humans', '*Immunity', 'Leukemia, Myeloid, Acute/*blood', 'Neutrophils/*immunology', 'Phagocytosis']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Apr;27(3):94-6.,,"A study of granulocyte functions in acute myeloblastic leukemia is reported. Functions were assessed by the ability of polymorphonuclear to migrate in Boyden's chamber, to ingest and kill staphylococcus aureus. Chemotaxis was grossly impaired. Cellular imparirment of phagocytosis and bactericidal capacity was observed in 5 and 9 patients. An inhibitor of phagocytosis and bactericidal capacity was observed in 9 and 4 patients. Results improved in complete remission.",,,,,
268221,NLM,MEDLINE,19771031,20071115,0300-0893 (Print) 0300-0893 (Linking),27,3,1977 Apr,Subacute myelocytic leukemia associated with the philadelphia chromosome and supplementary translocation : 9-12.,131-4,"['Dor, J F', 'Mattei, J F', 'Mattei, M G', 'Giraud, F', 'Mongin, M']","['Dor JF', 'Mattei JF', 'Mattei MG', 'Giraud F', 'Mongin M']",['eng'],"['Case Reports', 'Journal Article']",France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/diagnosis/genetics', 'Leukemia, Myeloid, Acute/*genetics', 'Middle Aged', '*Translocation, Genetic']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Apr;27(3):131-4.,,"The authors report a case of subacute myelocytic leukemia presenting some severe aspects. The cytogenetic findings show the Philadelphia chromosome ; t (9-22) and a second translocation between the chromosome 12, and the other chromosome 9 : t (9-12). They think that this second translocation represents a supplementary cytogenetic argument for the isolation of ""Subacute myeloid Leukemia with Philadelphia chromosome"" within chronic myeloid Leukemia.",,,,,
268220,NLM,MEDLINE,19771031,20211203,0300-0893 (Print) 0300-0893 (Linking),27,3,1977 Apr,Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella.,105-8,"['Zaizov, R', 'Vogel, R', 'Cohen, I', 'Varsano, I', 'Shohat, B', 'Rotter, V', 'Trainin, N']","['Zaizov R', 'Vogel R', 'Cohen I', 'Varsano I', 'Shohat B', 'Rotter V', 'Trainin N']",['eng'],['Journal Article'],France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['Chickenpox/*drug therapy/etiology', 'Child', 'Child, Preschool', 'Female', 'Hodgkin Disease/*complications/immunology', 'Humans', 'Immunity, Cellular/drug effects', '*Immunosuppression Therapy/adverse effects', 'Leukemia, Lymphoid/*complications/immunology', 'Leukocyte Count', 'Lymphocytes', 'Male', 'Thymus Hormones/*therapeutic use']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Apr;27(3):105-8.,['0 (Thymus Hormones)'],"Four children with lymphoproliferative malignant disease, two with acute lymphocytic leukemia in remission and two with Hodgkin's disease, were treated with a Thymic Hormone, THF, for disseminated varicella infecition. It is suggested that THF increased significantly the number of peripheral blood lymphocytes and T-rosette forming lymphocytes in 3 out of 4 children, who developed the varicella at the time of impaired cellular immunity. On the other hand, in the fourth child, with Hodgkin's disease, who had a normal number of T-rosettes, a decreased absolute number of lymphocytes as well as T-rosettes was observed over a course of 14 days THF treatment, although the percent of T-cells has not changed significantly. All of the four children recovered, including the child who was at high risk, with a marked lymphopenia, severe bilateral pneumonitis, hepatitis secondary infected skin lesions and psudomonas sepsis. It is indicated that THF therapy may restore the depressed cellular immunity in immunosuppressed children with malignant disease, and has its value as a supportive immunotherapy in life-threatening disseminated varicella infection.",,,,,
268210,NLM,MEDLINE,19771020,20190704,0007-1048 (Print) 0007-1048 (Linking),36,3,1977 Jul,Occurrence of acute leukaemia in myeloproliferative disorders.,373-82,"['Rosenthal, D S', 'Moloney, W C']","['Rosenthal DS', 'Moloney WC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adult', 'Aged', 'Alkaline Phosphatase/blood', 'Female', 'Granulocytes', 'Humans', 'Leukemia, Myeloid/*complications', 'Leukemia, Myeloid, Acute/*complications', 'Male', 'Middle Aged', 'Myeloproliferative Disorders/*complications', 'Pelger-Huet Anomaly/complications', 'Polycythemia Vera/complications', 'Preleukemia/blood', 'Primary Myelofibrosis/complications']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00661.x [doi]'],ppublish,Br J Haematol. 1977 Jul;36(3):373-82. doi: 10.1111/j.1365-2141.1977.tb00661.x.,['EC 3.1.3.1 (Alkaline Phosphatase)'],"In a series of 306 cases of myeloproliferative disorders followed over a period of 21 years, 18 cases of well-documented acute leukaemia were encountered. Leukaemias were either acute myeloblastic or myelomonocytic and occurred from 6 months to 20 years after the initial diagnosis. Onset was relatively abrupt and the course rapidly fatal with with a median survival of 4 weeks. Due to the prolonged preleukaemic phase, it was possible to carry out a variety of clinical and laboratory observations. While no consistent features were noted, dysplastic haemopoiesis, a fall in leucocyte alkaline phosphatase activity, presence of Pelger-Huet anomaly and other abnormalities suggest a disturbance in granulocytic maturation. These findings suggest that, following an initial injury to a pleuripotential haemopoietic stem cell, a prolonged 'latent' period occurs and, due to exposure to additional injurious agents or to a lack of cell regulating factors, acute leukaemia develops.",,,,,
268209,NLM,MEDLINE,19771020,20190704,0007-1048 (Print) 0007-1048 (Linking),36,3,1977 Jul,Basophilic chronic granulocytic leukaemia with hyperhistaminaemia.,367-72,"['Rosenthal, S', 'Schwartz, J H', 'Canellos, G P']","['Rosenthal S', 'Schwartz JH', 'Canellos GP']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adult', 'Basophils', 'Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Histamine/*blood', 'Humans', 'Leukemia, Myeloid/*blood/genetics', 'Leukocyte Count', 'Male', 'Middle Aged']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00660.x [doi]'],ppublish,Br J Haematol. 1977 Jul;36(3):367-72. doi: 10.1111/j.1365-2141.1977.tb00660.x.,['820484N8I3 (Histamine)'],"Two patients with typical Philadelphia chromosome positive chronic granulocytic leukaemia (CGL) developed an accelerated phase of the disease characterized by an increase white blood cell count and marked basophilia in the bone marrow and peripheral blood. Histamine levels were extremely high in both patients. Hyperhistaminaemia was manifested as wheezing, urticaria, diarrhoea, and pruritus in one patient and as peptic ulcer disease and peripheral oedema in both patients. In one case, gastric acid studies revealed a very high basal to stimulated ratio (BAO/MAO). Treatment with the investigational agent metiamide, an H2 receptor histamine antagonist, resulted in marked improvement in symptoms and reduction in gastric acid output. Extreme basophilia in CGL may be associated with hyperhistaminaemia, and manifestations of both the H1 and H2 type may occur.",,,,,
268208,NLM,MEDLINE,19771020,20190704,0007-1048 (Print) 0007-1048 (Linking),36,3,1977 Jul,The Philadelphia chromosome (Ph1) in adults presenting with acute leukaemia: a comparison of Ph1+ and Ph1-patients.,347-58,"['Bloomfield, C D', 'Peterson, L C', 'Yunis, J J', 'Brunning, R D']","['Bloomfield CD', 'Peterson LC', 'Yunis JJ', 'Brunning RD']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Br J Haematol,British journal of haematology,0372544,IM,"['Adolescent', 'Adult', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Lymphoid/drug therapy/*genetics', 'Leukemia, Myeloid/*genetics', 'Leukemia, Myeloid, Acute/*genetics', 'Male', 'Middle Aged', 'Prognosis']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00658.x [doi]'],ppublish,Br J Haematol. 1977 Jul;36(3):347-58. doi: 10.1111/j.1365-2141.1977.tb00658.x.,,"To evaluate the frequency and clinical significance of the Philadelphia chromosome (Ph1) in adult acute leukaemia, bone marrow chromosomes were studied in 15 adults with acute lymphocytic leukaemia (ALL) and 55 with acute nonlymphocytic leukaemia (ANLL). Morphology, clinical findings, therapeutic response and survival were compared in patients with and without the Ph1. The Ph1 was found in six newly diagnosed adults presenting with ALL. Adults with Ph1+ ALL differed from those with Ph1-ALL in being older, in having more frequent lymphadenopathy and splenomegaly and in demonstrating higher initial leucocyte counts and more peripheral blasts. Complete remissions were obtained in all nine adults with Ph1-All but in only three of six with Ph1+ ALL. Adults with Ph1-ALL survived significantly longer. Four adults with ANALL were Ph1+. They did not respond to treatment and survived significantly shorter periods than adults with Ph1-ANLL. No clinical or morphologic features indicated which patients with acute leukaemia would have the Ph1. Since the presence of the Ph1 in acute leukaemia has therapeutic and prognostic significance, marrow chromosome studies should be performed in adults presenting with acute leukaemia, especially ALL.",,,,,
268160,NLM,MEDLINE,19770929,20061115,0003-9764 (Print) 0003-9764 (Linking),34,5,1977 May,[Erythroleukemia revealed by diabetes insipidus].,449-54,"['Demeocq, F', 'Malpuech, G', 'Perrimond, H', 'Bezou, M J', 'Palcoux, B', 'Coulet, M']","['Demeocq F', 'Malpuech G', 'Perrimond H', 'Bezou MJ', 'Palcoux B', 'Coulet M']",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",France,Arch Fr Pediatr,Archives francaises de pediatrie,0372421,IM,"['Child, Preschool', 'Diabetes Insipidus/*complications', 'Female', 'Humans', 'Leukemia, Erythroblastic, Acute/complications/*diagnosis']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Arch Fr Pediatr. 1977 May;34(5):449-54.,,"A 4 year-old girl presented simultaneously with an erythroleukemia and a diabetes insipidus. The cytologic signs of dyserythropoiesis, the increase of some red blood cell glycolytic enzymes and of fetal hemoglobin, led to discuss the existence of a double population in the red blood cell series. The revealing character of diabetes insipidus, not yet reported, is emphasized.",Erythroleucemie revelee par un diabete insipide.,,,,
268159,NLM,MEDLINE,19770929,20190717,0003-987X (Print) 0003-987X (Linking),113,8,1977 Aug,Cutaneous infarction. Manifestation of disseminated mucormycosis.,1075-6,"['Kramer, B S', 'Hernandez, A D', 'Reddick, R L', 'Levine, A S']","['Kramer BS', 'Hernandez AD', 'Reddick RL', 'Levine AS']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Dermatol,Archives of dermatology,0372433,IM,"['Adult', 'Autopsy', 'Female', 'Humans', 'Infarction/complications/*etiology', 'Leukemia, Lymphoid/complications/therapy', '*Mucormycosis/complications/pathology', 'Skin/*blood supply/pathology', '*Skin Manifestations']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1001/archderm.113.8.1075 [doi]'],ppublish,Arch Dermatol. 1977 Aug;113(8):1075-6. doi: 10.1001/archderm.113.8.1075.,,"We describe the second reported case of cutaneous infarction as a manifestation of disseminated mucormycosis. The lesion, which closely resembled ecthyma gangrenosum, occurred in a leukemic patient who was on a regimen of broad-spectrum antibiotics. In this case as in the only other reported case, Mucor pusillus was the cause.",,,,,
268158,NLM,MEDLINE,19770917,20071115,0003-410X (Print) 0003-410X (Linking),128,4,1977 Apr,[Osteonecrosis and corticotherapy in a hematology department].,369-74,"['Laurens, A', 'Pattin, S', 'Dumouchel, P', 'Charron, D', 'Mathieu, M', 'Martoia, R']","['Laurens A', 'Pattin S', 'Dumouchel P', 'Charron D', 'Mathieu M', 'Martoia R']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,IM,"['Adult', 'Anemia, Aplastic/drug therapy', 'Anemia, Hemolytic, Autoimmune/drug therapy', 'Glucocorticoids/*adverse effects/therapeutic use', 'Hematologic Diseases/*drug therapy', 'Hodgkin Disease/complications', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Middle Aged', 'Osteonecrosis/*chemically induced']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1977 Apr;128(4):369-74.,['0 (Glucocorticoids)'],,Osteonecrose et corticotherapie en milieu hematologique.,,,,
268157,NLM,MEDLINE,19770929,20190619,0003-4819 (Print) 0003-4819 (Linking),87,2,1977 Aug,Hepatotoxicity of combination chemotherapy for acute myelocytic leukemia.,247-8,"['Penta, J S', 'Von Hoff, D D', 'Muggia, F M']","['Penta JS', 'Von Hoff DD', 'Muggia FM']",['eng'],['Letter'],United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*adverse effects', 'Chemical and Drug Induced Liver Injury/*etiology', 'Child', 'Child, Preschool', 'Drug Therapy, Combination/adverse effects', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Liver/*drug effects', 'Male', 'Middle Aged']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.7326/0003-4819-87-2-247_2 [doi]'],ppublish,Ann Intern Med. 1977 Aug;87(2):247-8. doi: 10.7326/0003-4819-87-2-247_2.,['0 (Antineoplastic Agents)'],,,,,,
268142,NLM,MEDLINE,19770929,20101118,0002-922X (Print) 0002-922X (Linking),131,8,1977 Aug,Tetany and renal failure prior to chemotherapy in acute lymphocytic leukemia.,925,"['Che, J', ""O'Connor, D M"", 'Roodman, S T', 'Ahrens, R C']","['Che J', ""O'Connor DM"", 'Roodman ST', 'Ahrens RC']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Acute Kidney Injury/*complications', 'Adolescent', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications', 'Tetany/*complications']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Am J Dis Child. 1977 Aug;131(8):925.,,,,,,,
268133,NLM,MEDLINE,19770917,20071115,0001-5814 (Print) 0001-5814 (Linking),8,2,1977 May-Jun,[Impulse-cytophotometric determination of DNA content in blood cells in patients with leukemia].,127-30,"['Schneiberg, K', 'Sroczynska, M', 'Rytwinski, K', 'Sroczynski, J', 'Kardaszewicz, E']","['Schneiberg K', 'Sroczynska M', 'Rytwinski K', 'Sroczynski J', 'Kardaszewicz E']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Adolescent', 'Adult', 'Aged', 'Blood Cells/*analysis', 'Child', 'Chronic Disease', 'DNA, Neoplasm/*analysis', 'Humans', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood', 'Middle Aged', 'Photometry/instrumentation']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1977 May-Jun;8(2):127-30.,"['0 (DNA, Neoplasm)']",The method of impulse cytophotometry was applied for determination of DNA content of blood cells in patients with various types of leukaemia. It was found that at the time of improvement in acute leukaemia the proportion of cells in the non-proliferative stage increases. In chronic leukaemias the improvement was associated with shifts in reverse direction.,Impulso-cytofotometryczne badania nad zawartoscia DNA w komorkach krwi u chorych na bialaczki.,,,,
268132,NLM,MEDLINE,19770922,20110728,0001-5806 (Print) 0001-5806 (Linking),40,2,1977 Apr,[Alkaline phosphatase activity in chronic myelogenous leukemia cells in cultures (author's transl)].,172-6,"['Chiyoda, S', 'Miura, Y']","['Chiyoda S', 'Miura Y']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Alkaline Phosphatase/*analysis', 'Bone Marrow/enzymology', 'Bone Marrow Cells', 'Cells, Cultured', 'Humans', 'Leukemia, Myeloid/*enzymology']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Apr;40(2):172-6.,['EC 3.1.3.1 (Alkaline Phosphatase)'],,,,,,
268083,NLM,MEDLINE,19770922,20061115,0301-0481 (Print) 0301-0481 (Linking),52,11,1977 Jun 1,[Eosinophilic infiltration in chronic myeloid leukemia].,593-8,"['Haneke, E', 'Djawari, D']","['Haneke E', 'Djawari D']",['ger'],"['English Abstract', 'Journal Article']",Germany,Z Hautkr,Zeitschrift fur Hautkrankheiten,0367576,IM,"['Eosinophils', 'Female', 'Humans', 'Leukemia, Myeloid/*pathology', 'Middle Aged', 'Skin/*pathology', '*Skin Manifestations']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Z Hautkr. 1977 Jun 1;52(11):593-8.,,Specific infiltrations in myelogenous leukemia are rare and occur mostly in the course of an acute blast crisis often representing the terminal phase of the disease. A 50 year-old female patient is described who developed specific cutaneous lesions during such a blast crisis. The infiltrates consisted to a major part of eosinophilic myelocytes although the peripheral blood smear showed only relatively few mature eosinophils.,Eosinophiles Infiltrat bei chronischer myeloischer Leukamie.,,,,
268082,NLM,MEDLINE,19770917,20061115,0044-2542 (Print) 0044-2542 (Linking),32,8,1977 Apr 15,[Distinct hypokalemia in leukotic infiltrates of the kidney].,189-91,"['Kraatz, G', 'Neubauer, F', 'Schwesinger, G']","['Kraatz G', 'Neubauer F', 'Schwesinger G']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Z Gesamte Inn Med,Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,21730470R,IM,"['Acid-Base Equilibrium', 'Aged', 'Female', 'Humans', 'Hypokalemia/*etiology/metabolism', 'Kidney Diseases/*etiology/metabolism', 'Leukemia, Myeloid/*complications/metabolism', 'Necrosis', 'Plasmacytoma/complications/metabolism', 'Remission, Spontaneous']",1977/04/15 00:00,1977/04/15 00:01,['1977/04/15 00:00'],"['1977/04/15 00:00 [pubmed]', '1977/04/15 00:01 [medline]', '1977/04/15 00:00 [entrez]']",,ppublish,Z Gesamte Inn Med. 1977 Apr 15;32(8):189-91.,,Report on a 74-year-old female patient falling ill from a chronic myelosis. Due to leukotic infiltrates of the kidneys renal loss of potassium and extreme hypopotassaemia appeared. On the basis of the present literature clinical symptomatology and morphological finding are discussed.,Ausgepragte Hypokaliamie bei leukotischen Infiltraten der Nieren.,,,,
268078,NLM,MEDLINE,19770917,20071115,0507-3758 (Print) 0507-3758 (Linking),23,4,1977,[Immunologic reactivity of patients with acute leukemia].,30-5,"['Gerasimova, M V', 'Rozanova, L M', 'Smirnova, A I', 'Krotova, T A', 'Shcherbakova, E G']","['Gerasimova MV', 'Rozanova LM', 'Smirnova AI', 'Krotova TA', 'Shcherbakova EG']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Vopr Onkol,Voprosy onkologii,0413775,IM,"['Adult', 'Aged', 'Amino Acid Isomerases/blood', 'Antistreptolysin/analysis', 'Antitoxins/analysis', 'C-Reactive Protein/analysis', 'Complement System Proteins/analysis', 'Female', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Leukemia, Myeloid, Acute/*immunology', 'Male', 'Middle Aged', 'Muramidase/blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Vopr Onkol. 1977;23(4):30-5.,"['0 (Antitoxins)', '9006-92-2 (Antistreptolysin)', '9007-36-7 (Complement System Proteins)', '9007-41-4 (C-Reactive Protein)', 'EC 3.2.1.17 (Muramidase)', 'EC 5.1.1.- (Amino Acid Isomerases)']","In sera of patients with acute leucosis the authors have determined antibodies to alpha-toxin, streptolysin-O, the complement, lysosyme. B-lysins and C-reactive protein. It was found that the indices of immune reactivity in patients with acute leucosis are dependent on a morphological variant of the disease, the duration of the conducted therapy and presence of complications. The most high immunity indices in patients with acute leucosis were observed in a primary active stage of the disease and during the period of remission. Considerable reduction of the immunity was noted in the terminal stage of the disease.",Ob immunologicheskoi reaktivnosti bol'nykh ostrym leikozom.,,,,
268030,NLM,MEDLINE,19770922,20190618,0036-8075 (Print) 0036-8075 (Linking),197,4306,1977 Aug 26,Phi bodies: peroxidatic particles that produce crystalloidal cellular inclusions.,895-8,"['Hanker, J S', 'Romanovicz, D K']","['Hanker JS', 'Romanovicz DK']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Adult', 'Animals', 'Catalase/metabolism', 'Clofibrate/pharmacology', 'Epithelial Cells', 'Epithelium/ultrastructure', 'Humans', 'Isocitrate Dehydrogenase/metabolism', 'Kidney Tubules, Proximal/ultrastructure', 'Leukemia, Myeloid, Acute/ultrastructure', 'Leukocytes/ultrastructure', 'Male', 'Mice', 'Microbodies/*ultrastructure', 'Microscopy, Electron', 'Organoids/enzymology/*ultrastructure', 'Submandibular Gland/*ultrastructure']",1977/08/26 00:00,1977/08/26 00:01,['1977/08/26 00:00'],"['1977/08/26 00:00 [pubmed]', '1977/08/26 00:01 [medline]', '1977/08/26 00:00 [entrez]']",['10.1126/science.268030 [doi]'],ppublish,Science. 1977 Aug 26;197(4306):895-8. doi: 10.1126/science.268030.,"['EC 1.1.1.41 (Isocitrate Dehydrogenase)', 'EC 1.11.1.6 (Catalase)', 'HPN91K7FU3 (Clofibrate)']","Unique, spindle-shaped particles (phi bodies) and rods with peroxidatic activity are found in certain epithelial cells of normal mice, clofibrate-fed rats, and in leukemic leukocytes. The ellipsoidal shape of phi bodies apparently results from the deformation of spherical granules by extrusion of axial crystalloid that subsequently fragments into rods.",,,,,
268024,NLM,MEDLINE,19770917,20061115,0036-7672 (Print) 0036-7672 (Linking),107,25,1977 Jun 25,[Bone destructive foci as precursors of the blastic crisis in chronic myelocytic leukemia].,872-5,"['Cavalli, F', 'Pedrinis, E', 'Mombelli, G', 'Goldhirsch, A', 'Reiner, M']","['Cavalli F', 'Pedrinis E', 'Mombelli G', 'Goldhirsch A', 'Reiner M']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,IM,"['Adult', 'Bone Resorption/*etiology', 'Female', 'Femur', 'Humans', 'Leukemia, Myeloid/*complications/diagnosis', 'Osteolysis/*etiology']",1977/06/25 00:00,1977/06/25 00:01,['1977/06/25 00:00'],"['1977/06/25 00:00 [pubmed]', '1977/06/25 00:01 [medline]', '1977/06/25 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1977 Jun 25;107(25):872-5.,,"Shortly after diagnosis of chronic myelogenous leukemia in a 38-year-old woman, an osteolytic lesion was found in the right femur. Cytology showed this to be a destructive process caused by polymorphic myeloblast. The diagnostic and therapeutic problems of this case are discussed in the light of the very rare literature references.",Knochendestruktionsherde als Vorlaufer des Blastenshubes bei einer chronischen myeloischen Leukamie.,,,,
268023,NLM,MEDLINE,19770917,20190907,0036-553X (Print) 0036-553X (Linking),19,1,1977 Jul,Cytochemical demonstration of dihydrofolate reductase in leukaemia and other haematological diseases.,5-13,"['Tzortzatou, F']",['Tzortzatou F'],['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Hematologic Diseases/*enzymology', 'Hodgkin Disease/enzymology', 'Humans', 'Leukemia/*enzymology', 'Leukemia, Lymphoid/enzymology', 'Leukemia, Myeloid, Acute/enzymology', 'Lymphocyte Activation', 'Lymphocytes/enzymology', 'Methotrexate/therapeutic use', 'Multiple Myeloma/enzymology', 'Polycythemia Vera/enzymology', 'Tetrahydrofolate Dehydrogenase/*blood']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02712.x [doi]'],ppublish,Scand J Haematol. 1977 Jul;19(1):5-13. doi: 10.1111/j.1600-0609.1977.tb02712.x.,"['EC 1.5.1.3 (Tetrahydrofolate Dehydrogenase)', 'YL5FZ2Y5U1 (Methotrexate)']","The dihydrofolate reductase activity has been studied cytochemically in various haematological diseases. The variation between normal controls, Hodgkin's disease, myeloma, polycythaemia vera, chronic lymphocytic leukaemia and chronic myeloid leukamia was not significant, comparing the same type of cells. In acute myeloid leukaemia and acute lymphoblastic leukaemia the blast cells were weakly positive or negative. This finding is very interesting as the blast cells are capable of division. Probably the dihydrofolate reductase appears in the blast cells in some stage of mitosis. Lymphocytes stimulated by phytohaemagglutinin showed increased enzyme activity compared with normal non-stimulated lymphocytes. The ""blast like"" cells were more strongly positive than the blast cells of leukaemic patients. The patients with acute lymphoblastic leukaemia or acute myeloid leukaemia treated with methotrexate showed increased dihydrofolate reductase activity cytochemically.",,,,,
268002,NLM,MEDLINE,19770917,20191028,0338-4535 (Print) 0338-4535 (Linking),20,1,1977 Mar,Role of the HL-A system in the transfusion of platelets and leukocytes.,49-55,"['Mannoni, P', 'Rodet, M', 'Bracq, C']","['Mannoni P', 'Rodet M', 'Bracq C']",['fre'],['Journal Article'],France,Rev Fr Transfus Immunohematol,Revue francaise de transfusion et immuno-hematologie,7509497,IM,"['Anemia, Aplastic/blood', '*Blood Transfusion', '*HLA Antigens', '*Histocompatibility Antigens', 'Histocompatibility Testing', 'Humans', 'Leukemia, Myeloid, Acute/blood', '*Leukocyte Transfusion', '*Platelet Transfusion']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1016/s0338-4535(77)80013-5 [doi]'],ppublish,Rev Fr Transfus Immunohematol. 1977 Mar;20(1):49-55. doi: 10.1016/s0338-4535(77)80013-5.,"['0 (HLA Antigens)', '0 (Histocompatibility Antigens)']",,Role dy systeme HLA dans les transfusions de plaquettes et de leucocytes.,,,,
267958,NLM,MEDLINE,19770929,20131121,0033-2240 (Print) 0033-2240 (Linking),34,4,1977,[Analysis of clinical and laboratory prognostic indices in chronic myeloid leukemia (author's transl)].,407-11,"['Kotlarek-Haus, S', 'Becker, M', 'Dorczak, K']","['Kotlarek-Haus S', 'Becker M', 'Dorczak K']",['pol'],"['English Abstract', 'Journal Article']",Poland,Przegl Lek,Przeglad lekarski,19840720R,IM,"['Adolescent', 'Adult', 'Aged', 'Busulfan/therapeutic use', 'Child', 'Female', 'Humans', '*Leukemia, Myeloid/blood/drug therapy', 'Male', 'Middle Aged', 'Prognosis', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Przegl Lek. 1977;34(4):407-11.,['G1LN9045DK (Busulfan)'],,Analiza wartosci prognostycznej danych klinicznych i laboratoryjnych w przewleklej bialaczce szpikowej.,,,,
267956,NLM,MEDLINE,19770922,20071115,0033-8389 (Print) 0033-8389 (Linking),15,2,1977 Aug,Radionuclide bone scanning in diseases of the spine.,177-201,"['Patton, D D', 'Woolfenden, J M']","['Patton DD', 'Woolfenden JM']",['eng'],['Journal Article'],United States,Radiol Clin North Am,Radiologic clinics of North America,0123703,IM,"['Arthritis/diagnosis', 'Breast Neoplasms/diagnosis', 'Coccyx/injuries', 'Fractures, Bone/diagnosis', 'Humans', 'Leukemia, Lymphoid/diagnosis', 'Lung Neoplasms/diagnosis', 'Male', 'Multiple Myeloma/diagnosis', 'Neoplasm Metastasis', 'Osteitis Deformans/diagnosis', 'Osteoarthritis/diagnosis', 'Osteomyelitis/diagnosis', 'Osteoporosis/diagnosis', 'Prostatic Neoplasms/diagnosis', '*Radionuclide Imaging', 'Sacroiliac Joint', 'Scoliosis/diagnosis', 'Spinal Diseases/*diagnosis', 'Spinal Injuries/*diagnosis', 'Spinal Neoplasms/*diagnosis', 'Spondylitis, Ankylosing/diagnosis', 'Staphylococcal Infections/diagnosis']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,Radiol Clin North Am. 1977 Aug;15(2):177-201.,,"Radionuclide bone scans provide a sensitive, no-risk diagnostic technique for the detection and evaluation of a wide variety of diseases of the spine. Scans and radiographs provide complementary diagnostic information, and should both be considered in the medical imaging portion of the diagnostic plan.",,,,,
267955,NLM,MEDLINE,19770922,20131121,0033-8184 (Print) 0033-8184 (Linking),18,2,1977,[Contribution to results of treatment of telecobalt irradiation of the CNS in acute lymphatic leukoses in childhood (author's transl)].,157-64,"['Hille, M', 'Kittner, K H', 'Kruse, H', 'Blau, H J']","['Hille M', 'Kittner KH', 'Kruse H', 'Blau HJ']",['ger'],"['English Abstract', 'Journal Article']",Germany,Radiobiol Radiother (Berl),"Radiobiologia, radiotherapia",0401247,IM,"['Central Nervous System Diseases/drug therapy/*prevention & control/radiotherapy', 'Child', 'Cobalt Radioisotopes', 'Humans', 'Injections, Spinal', 'Leukemia, Lymphoid/drug therapy/*radiotherapy', 'Methotrexate/administration & dosage/therapeutic use', 'Radioisotope Teletherapy']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Radiobiol Radiother (Berl). 1977;18(2):157-64.,"['0 (Cobalt Radioisotopes)', 'YL5FZ2Y5U1 (Methotrexate)']",,Beitrag zu Behandlungsergebnissen der Telekobaltbestrahlung des ZNS bei akuten lymphatischen Leukosen im Kindesalter.,,,,
267941,NLM,MEDLINE,19770922,20190501,0027-8424 (Print) 0027-8424 (Linking),74,6,1977 Jun,Globin RNA synthesis in vitro by isolated erythroleukemic cell nuclei: direct evidence for increased transcription during erythroid differentiation.,2475-9,"['Orkin, S H', 'Swerdlow, P S']","['Orkin SH', 'Swerdlow PS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Cell Differentiation/drug effects', 'Cell Line', 'Cell Nucleus/drug effects/metabolism', 'Dimethyl Sulfoxide/pharmacology', 'Globins/*biosynthesis', 'Kinetics', 'Leukemia, Erythroblastic, Acute/metabolism', 'Protein Biosynthesis/drug effects', 'RNA, Messenger/*biosynthesis', 'Sulfhydryl Compounds/pharmacology', '*Transcription, Genetic/drug effects']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1073/pnas.74.6.2475 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Jun;74(6):2475-9. doi: 10.1073/pnas.74.6.2475.,"['0 (RNA, Messenger)', '0 (Sulfhydryl Compounds)', '9004-22-2 (Globins)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Murine erythroleukemic cells accumulate cytoplasmic globin mRNA during differentiation induced in tissue culture by dimethyl sulfoxide. Cellular accumulation of globin RNA may reflect transcriptional activation of the globin genes and/or posttranscriptional stabilization of globin RNA during differentiation. To evaluate possible transcriptional controls directly; globin RNA synthesis by isolated erythroleukemic cell nuclei was studied. Conditions were established for optimal nuclear RNA synthesis in vitro in the presence of a mercurinucleotide (Hg-CTP). Mercurated RNA synthesized in vitro was purified free of endogenous RNA by affinity chromatography on sulfhydryl-Sepharose, and analyzed for the presence of newly synthesized globin RNA sequences by molecular hybridization to globin complementary [32P]DNA. The results demonstrate markedly increased synthesis of globin RNA by nuclei isolated from dimethyl sulfoxide-treated cells, even within 5 min of nuclear transcription in vitro. These findings are most consistent with transcriptional activation of the globin genes upon induction of differentiation.",,PMC432195,,,
267916,NLM,MEDLINE,19770917,20061115,0552-2080 (Print) 0552-2080 (Linking),22,7,1977 Jul,[Attempt to identify the line of fibroblast-like cells occurring in the nomolayer cultivation of human bone marrow].,24-8,"['Moshkin, S A']",['Moshkin SA'],['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Bone Marrow/*ultrastructure', '*Bone Marrow Cells', 'Cell Line', 'Cells, Cultured', 'Chromosome Aberrations/pathology', 'Chromosome Disorders', 'Fibroblasts/*ultrastructure', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/pathology', 'Mitosis', 'Time Factors']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Jul;22(7):24-8.,,,"Popytka identifikatsii linii fibroblastopodobnykh kletok, voznikaiushchikh pri kul'tivirovanii v monosloe chelovecheskogo kostnogo mozga.",,,,
267915,NLM,MEDLINE,19770917,20071115,0552-2080 (Print) 0552-2080 (Linking),22,7,1977 Jul,[Morphological characteristics of the erythrocytes of children with acute leukemia (scanning electron microscopy)].,21-4,"['Chistiakova, A I', 'Konnikov, S G', 'Chistiakov, B I', 'Alekseev, N A', 'Papisova, D G']","['Chistiakova AI', 'Konnikov SG', 'Chistiakov BI', 'Alekseev NA', 'Papisova DG']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Child, Preschool', 'Erythrocyte Membrane/pathology', 'Erythrocytes/*pathology', 'Humans', 'Leukemia, Lymphoid/*blood', 'Leukemia, Myeloid, Acute/*blood', 'Male', 'Microscopy, Electron, Scanning']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Jul;22(7):21-4.,,,"Morfologicheskie osobennosti eritrotsitov u detei, bol'nykh ostrym leikozom (skaniruiushchaia elektronnaia mikroskopiia).",,,,
267912,NLM,MEDLINE,19770917,20190501,0032-5473 (Print) 0032-5473 (Linking),53,621,1977 Jul,A rare presentation of splenic rupture.,403-5,"['Gibbs, T J', 'Sells, R A', 'Bellingham, A J']","['Gibbs TJ', 'Sells RA', 'Bellingham AJ']",['eng'],"['Case Reports', 'Journal Article']",England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Adult', 'Humans', 'Leukemia, Lymphoid/complications', 'Male', 'Rupture, Spontaneous/diagnosis/etiology', 'Splenic Rupture/*diagnosis/etiology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1136/pgmj.53.621.403 [doi]'],ppublish,Postgrad Med J. 1977 Jul;53(621):403-5. doi: 10.1136/pgmj.53.621.403.,,"Traumatic rupture of the spleen is a well known problem, complicating many types of abdominal injury. In contrast, a spontaneous rupture is a rare occurrence, mainly associated with a large spleen resulting from infections, the most common in this country being infectious mononucleosis. It is also a rare complication of leukaemias and lymphomas and the case presented here demonstrates a peculiar diagnostic problem.",,PMC2496695,,,
267910,NLM,MEDLINE,19770917,20170306,,57,6,1977 Jun,[Blastic exacerbation of chronic myeloid leukemia].,519-23,"['Sylwestrowicz, T']",['Sylwestrowicz T'],['pol'],['Journal Article'],Poland,Pol Arch Med Wewn,Polskie Archiwum Medycyny Wewnetrznej,0401225,IM,"['Acute Disease', 'Adult', 'Age Factors', 'Aneuploidy', 'Child', 'Humans', 'Leukemia, Myeloid/genetics/*pathology', 'Preleukemia/pathology', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Pol Arch Med Wewn. 1977 Jun;57(6):519-23.,,,Mechanizmy zaostrzenia blastycznego przewleklej bialaczki szpikowej.,,,,
267908,NLM,MEDLINE,19770929,20071115,0954-7762 (Print) 0954-7762 (Linking),73,30,1977 Jul 28,Nursing children under the laminar flow-2: a boy with leukaemia.,1154-6,"['Brewis, E L', 'Robertson, H', 'House, F']","['Brewis EL', 'Robertson H', 'House F']",['eng'],"['Case Reports', 'Journal Article']",England,Nurs Times,Nursing times,0423236,IM,"['Antisepsis', 'Child, Preschool', 'Food Service, Hospital', 'Humans', 'Leukemia, Lymphoid/*nursing', 'Male', '*Patient Isolators']",1977/07/28 00:00,1977/07/28 00:01,['1977/07/28 00:00'],"['1977/07/28 00:00 [pubmed]', '1977/07/28 00:01 [medline]', '1977/07/28 00:00 [entrez]']",,ppublish,Nurs Times. 1977 Jul 28;73(30):1154-6.,,,,,,,
267907,NLM,MEDLINE,19770922,20071115,0301-1518 (Print) 0301-1518 (Linking),6,22,1977 May 28,[Acute myeloblastic leukemia following immunodepressive treatment].,1980,"['Bisson, M', 'Galanaud, P', 'Subtil, E']","['Bisson M', 'Galanaud P', 'Subtil E']",['fre'],['Letter'],France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Humans', 'Immunosuppressive Agents/*therapeutic use', 'Leukemia, Myeloid, Acute/*drug therapy']",1977/05/28 00:00,1977/05/28 00:01,['1977/05/28 00:00'],"['1977/05/28 00:00 [pubmed]', '1977/05/28 00:01 [medline]', '1977/05/28 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 May 28;6(22):1980.,['0 (Immunosuppressive Agents)'],,Leucemie aigue myeloblastique apres traitement immunodepresseur.,,,,
267892,NLM,MEDLINE,19770922,20131121,0031-3939 (Print) 0031-3939 (Linking),52,7,1977 Jul,[Diagnostic and therapeutic difficulties in a case of liver fluke infestation in a 4-year-old child].,777-9,"['Sroczynska, M', 'Sonta-Jakimczyk, D']","['Sroczynska M', 'Sonta-Jakimczyk D']",['pol'],"['Case Reports', 'Journal Article']",Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Carbenicillin/therapeutic use', 'Child, Preschool', 'Diagnosis, Differential', 'Fasciola hepatica', 'Fascioliasis/*diagnosis/drug therapy', 'Humans', 'Leukemia, Myeloid/diagnosis', 'Male']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Jul;52(7):777-9.,['G42ZU72N5G (Carbenicillin)'],,Trudnosci diagnostyczne i lecznicze w zakazeniu motylica watrobowa u 4-letniego dziecka.,,,,
267848,NLM,MEDLINE,19770917,20131121,0028-7628 (Print) 0028-7628 (Linking),77,9,1977 Aug,Inadvertent chlorambucil overdose in adult.,1480-5,"['Enck, R E', 'Bennett, J M']","['Enck RE', 'Bennett JM']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,N Y State J Med,New York state journal of medicine,0401064,IM,"['Chlorambucil/*administration & dosage', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', '*Medication Errors', 'Middle Aged', 'Remission, Spontaneous']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,N Y State J Med. 1977 Aug;77(9):1480-5.,['18D0SL7309 (Chlorambucil)'],,,,,,
267811,NLM,MEDLINE,19770917,20150216,0028-3843 (Print) 0028-3843 (Linking),11,3,1977,[Leukemic meningeal involvement in adults and its treatment].,361-5,"['Lawinska, B', 'Krzyszton, Z', 'Pawlak, L', 'Podolak-Dawidziak, M', 'Tychowski, K']","['Lawinska B', 'Krzyszton Z', 'Pawlak L', 'Podolak-Dawidziak M', 'Tychowski K']",['pol'],"['Case Reports', 'English Abstract', 'Journal Article']",Poland,Neurol Neurochir Pol,Neurologia i neurochirurgia polska,0101265,IM,"['Acute Disease', 'Adult', 'Age Factors', 'Female', 'Humans', 'Injections, Spinal', 'Leukemia/*pathology', 'Leukemia, Lymphoid/drug therapy/*pathology', 'Male', 'Meninges/*pathology', 'Methotrexate/administration & dosage/therapeutic use', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Neurol Neurochir Pol. 1977;11(3):361-5.,['YL5FZ2Y5U1 (Methotrexate)'],"The authors report two cases of acute leukaemia in adults with development of sings central nervous system involvement at the time of full haematological remission. In the first case the diagnosis was: acute undifferentiated-cell leukaemia, in the second one: acute lymphoblastic leukaemia. In both cases in the first stage of the disease complete remission of neurological manifestations was obtained; in the second case it was also obtained after the following relapse. In the first case death occurred during successive haematological exacerbation. Ametopterin was given intrathecally or X-ray therapy was applied.",Zmiany bialaczkowe opon mozgowo-rdzeniowych u doroslych i leczenie.,,,,
267810,NLM,MEDLINE,19770922,20180215,1660-8151 (Print) 1660-8151 (Linking),19,2,1977,Renal excretion of uric acid and its relation to relapse and remission in acute myeloid leukaemia.,69-80,"['Mir, M A']",['Mir MA'],['eng'],['Journal Article'],Switzerland,Nephron,Nephron,0331777,IM,"['Adolescent', 'Adult', 'Aged', 'Allopurinol/pharmacology', 'Creatinine/urine', 'Female', 'Homeostasis', 'Humans', 'Kidney/*physiopathology', 'Kidney Tubules/physiopathology', 'Leukemia, Myeloid, Acute/blood/drug therapy/physiopathology/*urine', 'Male', 'Middle Aged', 'Pyrazinamide/pharmacology', 'Recurrence', 'Remission, Spontaneous', 'Uric Acid/blood/*urine']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000180868 [doi]'],ppublish,Nephron. 1977;19(2):69-80. doi: 10.1159/000180868.,"['268B43MJ25 (Uric Acid)', '2KNI5N06TI (Pyrazinamide)', '63CZ7GJN5I (Allopurinol)', 'AYI8EX34EU (Creatinine)']",,,,,,
267806,NLM,MEDLINE,19770922,20071115,0028-4793 (Print) 0028-4793 (Linking),297,9,1977 Sep 1,Terminal transferase and lymphoblastic neoplasms.,502-3,"['Murphy, S B', 'Mauer, A M']","['Murphy SB', 'Mauer AM']",['eng'],['Editorial'],United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['DNA Nucleotidyltransferases/*analysis', 'Humans', 'Leukemia, Lymphoid/enzymology', 'Lymphoma/classification/*enzymology', 'Oligonucleotides']",1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1056/NEJM197709012970909 [doi]'],ppublish,N Engl J Med. 1977 Sep 1;297(9):502-3. doi: 10.1056/NEJM197709012970909.,"['0 (Oligonucleotides)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)']",,,,,,
267805,NLM,MEDLINE,19770929,20150427,0028-4793 (Print) 0028-4793 (Linking),297,10,1977 Sep 8,Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36--1977.,546-51,"['Scully, R E', 'Galdabini, J J', 'McNeely, B U']","['Scully RE', 'Galdabini JJ', 'McNeely BU']",['eng'],"['Case Reports', 'Journal Article']",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Aspergillosis/complications/diagnosis/*pathology', 'Bacterial Infections/complications/diagnosis', 'Blood/microbiology', 'Diagnosis, Differential', 'Ecthyma/diagnosis', 'Humans', 'Leukemia, Myeloid, Acute/complications/*pathology', 'Male', 'Middle Aged', 'Nasal Cavity/microbiology/pathology', 'Nose Diseases/complications/*pathology', 'Periapical Abscess/diagnosis', 'Sepsis/complications']",1977/09/08 00:00,1977/09/08 00:01,['1977/09/08 00:00'],"['1977/09/08 00:00 [pubmed]', '1977/09/08 00:01 [medline]', '1977/09/08 00:00 [entrez]']",['10.1056/NEJM197709082971007 [doi]'],ppublish,N Engl J Med. 1977 Sep 8;297(10):546-51. doi: 10.1056/NEJM197709082971007.,,,,,,,
267804,NLM,MEDLINE,19770917,20140729,,125,6,1977 Jun,[Acute lymphoblastic leukemia and lymphoblastic lymphoma. Two names for one disease (author's transl)].,628-33,"['Winkler, K', 'Landbeck, G']","['Winkler K', 'Landbeck G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Bone Marrow Cells', 'Cell Transformation, Neoplastic', 'Central Nervous System Diseases/diagnosis', 'Child', 'Child, Preschool', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Lymphoid/*diagnosis/therapy', 'Lymphoma, Non-Hodgkin/*diagnosis/therapy', 'Male', 'Prognosis', 'Remission, Spontaneous', 'Terminology as Topic']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1977 Jun;125(6):628-33.,,"Of 14 non-T-cell malignant non-Hodgkin lymphomas (mNHL) 5/14 presented with leukemic transformation of the bone marrow; in three more cases bone marrow involvement developed during an observation period of 60--200weeks. In 2/14 cases mNHL terminated the first continuous and complete remission of acute lymphoblastic leukemia (ALL). CNS involvement has been observed without preceding bone marrow involvement. Only 4/14 mNHL remained local diseases. These clinical courses as well as hematological findings and further clinical observations suggests a very close relationship between mNHL and ALL if not basic identity. With the same systemic treatment additional to local treatment, prognosis of mNHL is by no means worse but rather better than the prognosis of ALL.","Akute Lymphoblastische Leukamie und Lymphoblastisches Lymphosarkom. Zwei Namen, eine Krankheit (Fallbericht).",,,,
267715,NLM,MEDLINE,19770929,20131121,0025-7850 (Print) 0025-7850 (Linking),8,3-4,1977,"Antileukemic properties of combinations of radiation and malonato(1,2-diaminocyclohexane) platinum(ii) (NSC-224964).",253-9,"['Morris, C R', 'Blackwell, L H', 'Loveless, V S']","['Morris CR', 'Blackwell LH', 'Loveless VS']",['eng'],['Journal Article'],United States,J Med,Journal of medicine,7505566,IM,"['Animals', 'Antineoplastic Agents/administration & dosage/*therapeutic use', 'Cyclohexanes/administration & dosage/therapeutic use', 'Dose-Response Relationship, Drug', 'Dose-Response Relationship, Radiation', 'Evaluation Studies as Topic', 'Leukemia L1210/mortality/radiotherapy/*therapy', 'Mice', 'Organometallic Compounds/administration & dosage/*therapeutic use', 'Platinum/administration & dosage/*therapeutic use', 'Radiotherapy Dosage']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,J Med. 1977;8(3-4):253-9.,"['0 (Antineoplastic Agents)', '0 (Cyclohexanes)', '0 (Organometallic Compounds)', '49DFR088MY (Platinum)']","Mean survival times were increased an average of 23, 53 and 61%, when 10, 15, and 20 mg/kg, respectively, of the organoplatinum congener, malonato(1,2-diaminocyclohexane) platinum(II)(NSC-224964), was given as the only treatment modality to BDF1 mice bearing 1-day-old L1210 leukemia. When a single dose of 10 mg/kg was combined with either 300 or 100 R on day 1 only, the anticipated response (ILS = 30 and 38%, respectively) based on the additive effects of the single modalities was surpassed by 26 and 21%, respectively (i.e. extent of therapeutic synergism). When divided doses of radiation (200 R/day x 3 days) were combined with 15 or 20 mg/kg of NSC-224964, survival times were enhanced an average of 15% (extent of synergism) greater than would be expected if these modalities were acting through an additive process(es).",,,,,
267694,NLM,MEDLINE,19770922,20131121,0022-2143 (Print) 0022-2143 (Linking),90,2,1977 Aug,The cellular transport of chloramphenicol and thiamphenicol.,347-53,"['McLeod, T F', 'Manyan, D R', 'Yunis, A A']","['McLeod TF', 'Manyan DR', 'Yunis AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Lab Clin Med,The Journal of laboratory and clinical medicine,0375375,IM,"['Animals', 'Anti-Bacterial Agents/*metabolism', 'Biological Transport', 'Bone Marrow/metabolism', 'Bone Marrow Cells', 'Cell Line', 'Chloramphenicol/*metabolism', 'Erythrocytes/metabolism', 'Humans', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid/pathology', 'Rats', 'Sulfhydryl Reagents/pharmacology', 'Temperature', 'Thiamphenicol/*metabolism']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,J Lab Clin Med. 1977 Aug;90(2):347-53.,"['0 (Anti-Bacterial Agents)', '0 (Sulfhydryl Reagents)', '66974FR9Q1 (Chloramphenicol)', 'FLQ7571NPM (Thiamphenicol)']","The transport of chloramphenicol (CAP) and thiamphenicol (TAP) was examined in several mammalian cell systems. Chloramphenicol was concentrated by all cells by a factor of 2 to 4 (cellular/extracellular concentration [CE] ratio). Both the uptake and efflux were rapid and temperature independent. In contrast, the influx and efflux of TAP progressed slowly at 37 degrees C over a period exceeding 30 min, the maximal C/E ratios in most instances being slightly greater than 1. Thiamphenicol was virtually excluded from cells at 0 degrees C. Cells preloaded with TAP at 37 degrees C lost little or no drug at 0 degrees C. The uptake of labeled CAP and TAP was uninfluenced by metabolic inhibitors, and was only slightly reduced by the presence of relatively large concentrations of unlabeled drug. This transport pattern is most consistent with a mechanism of simple diffusion based on partitioning of CAP in cellular compartments. It is postulated that the greater polarity of the methylsulfonyl moiety of TAP renders this drug less soluble in membrane lipids and hence more slowly diffusible. The possible significance of these findings in relation to hematologic toxicity from CAP is discussed.",,,,,
267644,NLM,MEDLINE,19770929,20080213,0002-3329 (Print) 0002-3329 (Linking),,2,1977 Mar-Apr,[Cytogenetic approaches to analysis of kinetic characteristics of the growth of transplantable strains of mouse tumors].,273-80,"['Poroshenko, G G', 'Minenkova, E A', 'Fomina, M M', 'Evseenko, L S']","['Poroshenko GG', 'Minenkova EA', 'Fomina MM', 'Evseenko LS']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Izv Akad Nauk SSSR Biol,Izvestiia Akademii nauk SSSR. Seriia biologicheskaia,7505543,IM,"['Animals', 'Carcinoma, Ehrlich Tumor/*genetics', 'Leukemia, Lymphoid/*genetics', 'Mice', 'Neoplasm Transplantation', 'Neoplasms, Experimental']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Izv Akad Nauk SSSR Biol. 1977 Mar-Apr;(2):273-80.,,,O tsitogeneticheskikh podkhodakh k analizu kineticheskikh kharakteristik rosta perevivaemykh shtammov opukholei myshei.,,,,
267626,NLM,MEDLINE,19770917,20190911,0020-708X (Print) 0020-708X (Linking),28,5,1977 May,A simple and efficient method for measuring the uptake of radiolabelled compounds by leukocytes in whole blood.,509-12,"['Pauly, J L', 'Schuller, M G', 'Germain, M J']","['Pauly JL', 'Schuller MG', 'Germain MJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Int J Appl Radiat Isot,The International journal of applied radiation and isotopes,0374715,IM,"['Blood Proteins/*biosynthesis', 'DNA/*biosynthesis/blood', 'DNA, Neoplasm/biosynthesis/blood', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid/blood', 'Leukocytes/*metabolism', 'Methods', 'Neoplasm Proteins/biosynthesis/blood', 'Nucleic Acid Precursors/*metabolism', 'Protein Precursors/*metabolism', 'RNA/*biosynthesis/blood', 'RNA, Neoplasm/biosynthesis/blood', 'Tritium']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']","['0020-708X(77)90186-7 [pii]', '10.1016/0020-708x(77)90186-7 [doi]']",ppublish,Int J Appl Radiat Isot. 1977 May;28(5):509-12. doi: 10.1016/0020-708x(77)90186-7.,"['0 (Blood Proteins)', '0 (DNA, Neoplasm)', '0 (Neoplasm Proteins)', '0 (Nucleic Acid Precursors)', '0 (Protein Precursors)', '0 (RNA, Neoplasm)', '10028-17-8 (Tritium)', '63231-63-0 (RNA)', '9007-49-2 (DNA)']",,,,,,
267619,NLM,MEDLINE,19770929,20071115,0019-9613 (Print) 0019-9613 (Linking),,186,1977 Jun,[Acute childhood leukemias].,5-13,"['Rossant, L']",['Rossant L'],['fre'],['Journal Article'],France,Infirm Fr,L'Infirmiere francaise,0400674,,"['Child', 'Humans', '*Leukemia, Lymphoid']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Infirm Fr. 1977 Jun;(186):5-13.,,,Les leucoses aigues de l'enfant.,,,,
267618,NLM,MEDLINE,19770917,20071115,0019-6061 (Print) 0019-6061 (Linking),14,2,1977 Feb,Central nervous system leukemia.,147-51,"['Mohan, V M', 'Mehta, S']","['Mohan VM', 'Mehta S']",['eng'],"['Case Reports', 'Journal Article']",India,Indian Pediatr,Indian pediatrics,2985062R,IM,"['Acute Disease', 'Child', 'Humans', '*Leukemia, Lymphoid/diagnosis/etiology/therapy', 'Male', '*Meninges']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Indian Pediatr. 1977 Feb;14(2):147-51.,,,,,,,
267617,NLM,MEDLINE,19770917,20071115,0019-6061 (Print) 0019-6061 (Linking),14,2,1977 Feb,A study of leukemia.,135-9,"['Kulkarni, R', 'Rao, V K', 'Bopardikar, K V']","['Kulkarni R', 'Rao VK', 'Bopardikar KV']",['eng'],['Journal Article'],India,Indian Pediatr,Indian pediatrics,2985062R,IM,"['Acute Disease', 'Child', 'Child, Preschool', 'Female', 'Humans', '*Leukemia/therapy', 'Leukemia, Lymphoid/therapy', 'Male']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Indian Pediatr. 1977 Feb;14(2):135-9.,,,,,,,
267615,NLM,MEDLINE,19770922,20091111,0019-509X (Print) 0019-509X (Linking),14,1,1977 Mar,Evaluation of plasma lactate dehydrogenase (LDH) isoenzymes in cancer patients. I: qualitative and quantitative assessment in patients with chronic myeloid leukaemia and acute lymphatic leukemia.,42-9,"['Talageri, V R', 'Nadkarni, J S', 'Gollerkeri, M P']","['Talageri VR', 'Nadkarni JS', 'Gollerkeri MP']",['eng'],"['Case Reports', 'Journal Article']",India,Indian J Cancer,Indian journal of cancer,0112040,IM,"['Adult', 'Child', 'Follow-Up Studies', 'Humans', 'Isoenzymes', 'L-Lactate Dehydrogenase/*blood', 'Leukemia, Lymphoid/*enzymology', 'Leukemia, Myeloid/*enzymology', 'Male']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Indian J Cancer. 1977 Mar;14(1):42-9.,"['0 (Isoenzymes)', 'EC 1.1.1.27 (L-Lactate Dehydrogenase)']",,,,,,
267614,NLM,MEDLINE,19770922,20190722,0340-6717 (Print) 0340-6717 (Linking),37,2,1977 Jun 30,Variation in the Philadelphia chromosome.,141-8,"['Watt, J L', 'Hamilton, P J', 'Page, B M']","['Watt JL', 'Hamilton PJ', 'Page BM']",['eng'],['Journal Article'],Germany,Hum Genet,Human genetics,7613873,IM,"['Adult', 'Aged', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/genetics', 'Male', 'Middle Aged']",1977/06/30 00:00,1977/06/30 00:01,['1977/06/30 00:00'],"['1977/06/30 00:00 [pubmed]', '1977/06/30 00:01 [medline]', '1977/06/30 00:00 [entrez]']",['10.1007/BF00393576 [doi]'],ppublish,Hum Genet. 1977 Jun 30;37(2):141-8. doi: 10.1007/BF00393576.,,"Cytogenetic study of 17 cases of chronic myeloid leukaemia has shown that the Philadelphia chromosome is a variable entity, differing in size and banding pattern between individuals.",,,,,
267611,NLM,MEDLINE,19770917,20061115,0011-9075 (Print) 0011-9075 (Linking),154,6,1977,[Pyoderma gangraenosum associated with Philadelphia-chromosome-negative chronic myeloid leukaemia (author's transl)].,360-6,"['Kovary, P M', 'Lonauer, G', 'Niedorf, H', 'Nautsch, C', 'Pawlowitzki, I H']","['Kovary PM', 'Lonauer G', 'Niedorf H', 'Nautsch C', 'Pawlowitzki IH']",['ger'],"['English Abstract', 'Journal Article']",Switzerland,Dermatologica,Dermatologica,0211607,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/*complications/genetics', 'Middle Aged', 'Pyoderma/*complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Dermatologica. 1977;154(6):360-6.,,"Chronic myeloid leukaemia was observed 20 months after onset of pyoderma gangraenosum in a 35-year-old female. In this case an induction by cytostatic drugs could be excluded, confirming the association of pyoderma gangraenosum with leukaemias.",Pyoderma gangraenosum mit Philadelphia-Chromosomnegativer chronischer myeloischer Leukamie.,,,,
267584,NLM,MEDLINE,19770922,20190813,0340-6199 (Print) 0340-6199 (Linking),125,3,1977 Jul 1,Studies of malformation syndromes of man XLVII: disappearance of spermatogonia in the Fanconi anemia syndrome.,163-8,"['Bargman, G J', 'Shahidi, N T', 'Gilbert, E F', 'Opitz, J M']","['Bargman GJ', 'Shahidi NT', 'Gilbert EF', 'Opitz JM']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Germany,Eur J Pediatr,European journal of pediatrics,7603873,IM,"['Adolescent', 'Anemia, Aplastic/*pathology', 'Autopsy', 'Fanconi Anemia/complications/genetics/*pathology', 'Hemorrhage/complications', 'Humans', 'Hypogonadism/complications', 'Leukemia, Erythroblastic, Acute/complications/pathology', 'Male', '*Spermatogonia', '*Spermatozoa', 'Testis/pathology', 'Thrombosis/complications']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1007/BF00480592 [doi]'],ppublish,Eur J Pediatr. 1977 Jul 1;125(3):163-8. doi: 10.1007/BF00480592.,,"A 15 year old boy with the Fanconi malformation-aplastic anemia syndrome developed erythroleukemia and died of multiple arterial thromboses and hemorrhage. He was one of 10 siblings including 3 affected sisters. He was short of stature and had hypoplastic thumbs; his testes were small and secondary sexual characteristics were inadequately developed. At autopsy he was found to have very few spermatogonia, i.e., a histological picture compatible with the ""Sertoli-cell-only"" defect. Male hypogonadism in other chromosome breakage syndromes (the Bloom syndrome and ataxia telangiectasia) may have a similar pathogenesis.",,,,,
267543,NLM,MEDLINE,19770917,20170310,0011-4553 (Print) 0011-4553 (Linking),30,6,1977 Jun,[Cytology of the oral mucosal epithelium in leukemia].,529-34,"['Knychalska-Karwan, Z', 'Prostak-Kosowska, K']","['Knychalska-Karwan Z', 'Prostak-Kosowska K']",['pol'],"['English Abstract', 'Journal Article']",Poland,Czas Stomatol,Czasopismo stomatologiczne,2984742R,IM,"['Acute Disease', 'Chronic Disease', '*Epithelial Cells', 'Epithelium/*ultrastructure', 'Humans', 'Leukemia/*pathology', 'Mouth Mucosa/*pathology', 'Oral Manifestations']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Czas Stomatol. 1977 Jun;30(6):529-34.,,,Cytologia nablonka blony sluzowej jamy ustnej v bialaczkach.,,,,
267510,NLM,MEDLINE,19770922,20131121,0361-5960 (Print) 0361-5960 (Linking),61,4,1977 Jul,High-dose methotrexate in acute lymphocytic leukemia.,727-31,"['Freeman, A I', 'Wang, J J', 'Sinks, L F']","['Freeman AI', 'Wang JJ', 'Sinks LF']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Child', 'Drug Administration Schedule', 'Humans', 'Injections, Intravenous', 'Injections, Spinal', 'Kinetics', 'Leukemia, Lymphoid/blood/cerebrospinal fluid/*drug therapy', 'Methotrexate/*administration & dosage/blood/cerebrospinal fluid/therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Jul;61(4):727-31.,['YL5FZ2Y5U1 (Methotrexate)'],"A pharmacokinetic study of methotrexate (MTX) was performed in 60 patients who received high-dose MTX at 500 mg/m2 infused over 24 hours. MTX levels reached 1.2 X 10(-7) M in the cerebrospinal fluid (CSF) within 10 minutes and remained constant at that level for 24 hours. Forty of these 60 patients were children with acute lymphocytic leukemia. In these 40 patients, simultaneous intrathecal MTX was given along with high-dose MTX. The resultant CSF levels (lumbar area) were higher than those obtained with either high-dose MTX alone or simultaneous intrathecal MTX alone. To date, there have been one systemic and one central nervous system relapse in these 40 children, and the treatment program appears safe to administer.",,,,,
267509,NLM,MEDLINE,19770922,20141120,0361-5960 (Print) 0361-5960 (Linking),61,4,1977 Jul,Potential advances in the clinical use of arabinosyl cytosine.,717-22,"['Ho, D H']",['Ho DH'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adult', 'Cytarabine/administration & dosage/metabolism/pharmacology/*therapeutic use', 'Delayed-Action Preparations', 'Drug Resistance', 'Humans', 'In Vitro Techniques', 'Infusions, Parenteral', 'Leukemia, Myeloid, Acute/drug therapy/metabolism', 'Tetrahydrouridine/pharmacology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Jul;61(4):717-22.,"['0 (Delayed-Action Preparations)', '04079A1RDZ (Cytarabine)', '18771-50-1 (Tetrahydrouridine)']",,,,,,
267508,NLM,MEDLINE,19770922,20141120,0361-5960 (Print) 0361-5960 (Linking),61,4,1977 Jul,Natural resistance to methotrexate in human acute nonlymphocytic leukemia.,667-73,"['Bertino, J R', 'Sawicki, W L', 'Cashmore, A R', 'Cadman, E C', 'Skeel, R T']","['Bertino JR', 'Sawicki WL', 'Cashmore AR', 'Cadman EC', 'Skeel RT']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adult', 'DNA, Neoplasm/biosynthesis', 'Deoxyuridine/metabolism', 'Drug Resistance', 'Female', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid, Acute/enzymology/metabolism/*physiopathology', 'Leukocytes/metabolism', 'Male', 'Methotrexate/blood/*pharmacology', 'Middle Aged', 'Tetrahydrofolate Dehydrogenase/metabolism']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Jul;61(4):667-73.,"['0 (DNA, Neoplasm)', 'EC 1.5.1.3 (Tetrahydrofolate Dehydrogenase)', 'W78I7AY22C (Deoxyuridine)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
267507,NLM,MEDLINE,19770922,20131121,0361-5960 (Print) 0361-5960 (Linking),61,4,1977 Jul,Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.,661-6,"['Haghbin, M']",['Haghbin M'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adolescent', 'Antimetabolites, Antineoplastic/*therapeutic use', 'Central Nervous System Diseases/*drug therapy/prevention & control', 'Child, Preschool', 'Cytarabine/administration & dosage/adverse effects/therapeutic use', 'Drug Administration Schedule', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant', 'Injections', 'Injections, Intraventricular', 'Leukemia, Lymphoid/*drug therapy', 'Lumbosacral Region', 'Male', 'Methotrexate/administration & dosage/adverse effects/therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Jul;61(4):661-6.,"['0 (Antimetabolites, Antineoplastic)', '04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']","The results of the administration of two antimetabolites, methotrexate (MTX) and cytosine arabinoside (Ara-C), for the prevention and treatment of established central nervous system (CNS) disease in children with acute lymphoblastic leukemia are discussed. Two protocols (L-2 and L-10) for the management of patients with acute lymphoblastic leukemia have been developed. In the L-2 protocol, prophylaxis consists of repeated intralumbar injections of MTX alone, and in the L-10 regimen, both MTX and Ara-C are administered; for the patients with an initial leukocyte count of greater than or equal to 25,000/mm3, the two drugs are given intraventricularly instead of by the usual intralumbar route. In the treatment of established CNS leukemia, intralumbar MTX and Ara-C in addition to CNS irradiation are employed; for maintenance, periodic intraventricular MTX injections are given. Of the 70 children receiving the L-2 protocol, four developed CNS leukemia and in a fifth patient, CNS and bone marrow relapse were concurrent. Among the 31 children receiving the L-10 regimen, CNS disease has been observed in only one child. Of the five children treated for the established CNS leukemia, recurrence was observed in two at 19 and 29 months after remission; the other three remain in remission for 2, 15, and 39 months, respectively.",,,,,
267505,NLM,MEDLINE,19770917,20190619,0008-543X (Print) 0008-543X (Linking),40,1,1977 Jul,Complete remodeling of the vertebrae in a child successfully treated for acute lymphocytic leukemia (ALL).,398-401,"['deCastro, L A', 'Kuhn, J P', 'Freeman, A I', 'Sinks, L F', 'Mindell, E R']","['deCastro LA', 'Kuhn JP', 'Freeman AI', 'Sinks LF', 'Mindell ER']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['*Bone Regeneration', 'Child', 'Cyclophosphamide/therapeutic use', 'Daunorubicin/therapeutic use', 'Fractures, Spontaneous/etiology', 'Humans', 'Leukemia, Lymphoid/complications/drug therapy/*physiopathology', 'Lumbar Vertebrae/*physiopathology', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use', 'Thoracic Vertebrae/*physiopathology', 'Vincristine/therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1002/1097-0142(197707)40:1<398::aid-cncr2820400156>3.0.co;2-h [doi]'],ppublish,Cancer. 1977 Jul;40(1):398-401. doi: 10.1002/1097-0142(197707)40:1<398::aid-cncr2820400156>3.0.co;2-h.,"['5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","This report describes a 10-year-old white boy who presented with acute lymphocytic leukemia (ALL) and several collapsed thoracolumbar vertebrae in 1965. His ALL was successfully treated, and he has been disease-free for over 10 years. He has now completely remodeled all of the collapsed vertebrae.",,,,,
267504,NLM,MEDLINE,19770917,20190619,0008-543X (Print) 0008-543X (Linking),40,1,1977 Jul,Five-year survivors among children with acute leukemia in Japan.,349-57,"['Izawa, T', 'Yamashiro, T', 'Aoki, K', 'Taki, M', 'Kamiya, H']","['Izawa T', 'Yamashiro T', 'Aoki K', 'Taki M', 'Kamiya H']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Central Nervous System Diseases/mortality', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Japan', 'Leukemia/*mortality', 'Leukemia, Lymphoid/mortality', 'Leukemia, Myeloid, Acute/mortality', 'Male', 'Prognosis', 'Remission, Spontaneous', 'Risk']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1002/1097-0142(197707)40:1<349::aid-cncr2820400149>3.0.co;2-b [doi]'],ppublish,Cancer. 1977 Jul;40(1):349-57. doi: 10.1002/1097-0142(197707)40:1<349::aid-cncr2820400149>3.0.co;2-b.,,"This Japanese nation-wide survey was carried out on long-term survivors among children with leukemia, i.e. those who had survived more than 5 years by October of 1974. Eighty-three children were surveyed. This was about 2.5 times as many as the 31 children surveyed in the first Japanese nation-wide survey in 1971. Clinical and laboratory data were also analyzed statistically and compared to that of the first survey. Most of the children had received inductive therapy according to the old protocol, but 10 children were treated with a combination of VCR and steroids. Nine of these 10 were still in a state of remission. CNS involvement occurred in 15.3% of the cases and a late onset of this complication implied a prognostic significance: among the 9 children whose complication had occurred 3.5 years after onset of the disease, 6 died. The relapse rate decreased between the 4th and 5th year after initiation of maintenance therapy. The percentage of the risk of death became zero after the 9th year.",,,,,
267503,NLM,MEDLINE,19770917,20190619,0008-543X (Print) 0008-543X (Linking),40,1,1977 Jul,Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients.,20-9,"['Spiers, A S', 'Goldman, J M', 'Catovsky, D', 'Costello, C', 'Buskard, N A', 'Galton, D A']","['Spiers AS', 'Goldman JM', 'Catovsky D', 'Costello C', 'Buskard NA', 'Galton DA']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Asparaginase/*therapeutic use', 'Cyclophosphamide/*therapeutic use', 'Cytarabine/*therapeutic use', 'Daunorubicin/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid/drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Male', 'Methotrexate/*therapeutic use', 'Prednisolone/*therapeutic use', 'Remission, Spontaneous', 'Thioguanine/*therapeutic use', 'Vincristine/*therapeutic use']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1002/1097-0142(197707)40:1<20::aid-cncr2820400106>3.0.co;2-w [doi]'],ppublish,Cancer. 1977 Jul;40(1):20-9. doi: 10.1002/1097-0142(197707)40:1<20::aid-cncr2820400106>3.0.co;2-w.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', '9PHQ9Y1OLM (Prednisolone)', 'EC 3.5.1.1 (Asparaginase)', 'FTK8U1GZNX (Thioguanine)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","A combination of eight cytotoxic drugs, administered simultaneously, has been used in 86 cases of acute leukemia. The regimen, designated TRAMPCOL, incorporated thioguanine, rubidomycin, (daunorubicin), cytosine arabinoside, methotrexate, prednisolone, cyclophosphamide, vincristine, and usually L-asparaginase. Treatment was administered in five-day pulses with treatment-free intervals varying from nine to 23 days. Subjective and objective toxic effects were not more severe than those seen with two- and four-drug regimens previously employed. Substantial clinical and hematologic improvement occurred in 8/19 patients with chronic granulocytic leukemia (CGL) in acute transformation. Complete clinical and hematologic remission (CR) was achieved in 3/7 patients with untreated acute myeloid leukemia (AML), 5/19 patients with AML who had failed to achieve CR with other therapy, and 4/18 patients with AML in relapse after CR obtained with regimens other than TRAMPCOL. CR occurred in 15/17 patients with acute lymphocytic leukemia (ALL), most of whom had had multiple previous relapses. CR was not achieved in four patients with AML superimposed on pre-existing myeloproliferative disorders. The TRAMPCOL regimen merits further evaluation in CGL after acute transformation, as a primary treatment for AML, and as therapy for ALL 1) in relapse, 2) in adults, 3) in children with adverse prognostic features, and 4) in T-cell ALL.",,,,,
267492,NLM,MEDLINE,19770929,20081008,0365-9615 (Print) 0365-9615 (Linking),83,6,1977 Jun,"[Detection of an antigen, associated with cells during the blast crisis of chronic myeloleukemia, in a cytotoxic test using xenogenic antibodies].",719-21,"['Baryshnikov, A Iu', 'Radzikhovskaia, R M', 'Morozova, L F', 'Slavina, E G', 'Belianchikova, N I']","['Baryshnikov AIu', 'Radzikhovskaia RM', 'Morozova LF', 'Slavina EG', 'Belianchikova NI']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Biull Eksp Biol Med,Biulleten' eksperimental'noi biologii i meditsiny,0370627,IM,"['Animals', 'Antibodies, Neoplasm', 'Antigens, Neoplasm/*analysis', 'Cytotoxicity Tests, Immunologic/methods', 'Horses/immunology', 'Humans', 'Leukemia, Myeloid/*immunology', 'Species Specificity']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Biull Eksp Biol Med. 1977 Jun;83(6):719-21.,"['0 (Antibodies, Neoplasm)', '0 (Antigens, Neoplasm)']","The immune antimyeloblast serum (AMS) was obtained from horses immunized with white blood cells from patients suffering from chronic myeloid leukemia (CML) at the blast crisis stage; the serum was completely absorbed with normal red blood cells and white blood cells (WBC). The absorbed antiserum remained cytotoxic to blast cells from 20 of 42 patients with CML at the blast crisis stage. AMS failed to react with the WBC from patients with CML in its chronic phase, and from patients with other types of leukemia Morphological studies indicated a possibility of identification of the antigen associated with myeloblasts from the blood of patients with CML blast crisis, by means to AMS.","Obnaruzhenie antigena, assotsiirovannogo s kletkami pri blastnom krize khronicheskogo mieloleikoza, v tsitotoksicheskoi reaktsii s pomoshch'iu ksenogennykh antitel.",,,,
267491,NLM,MEDLINE,19770922,20190911,0303-2647 (Print) 0303-2647 (Linking),8,4,1977 Apr,Model of cell kinetics with applications to the acute myeloblastic leukemic state in man.,265-6,"['Rubinow, S I', 'Lebowitz, J L']","['Rubinow SI', 'Lebowitz JL']",['eng'],['Journal Article'],Ireland,Biosystems,Bio Systems,0430773,IM,"['Cell Division', 'Humans', 'Kinetics', 'Leukemia, Myeloid, Acute/*physiopathology', 'Models, Biological']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']","['0303-2647(77)90053-3 [pii]', '10.1016/0303-2647(77)90053-3 [doi]']",ppublish,Biosystems. 1977 Apr;8(4):265-6. doi: 10.1016/0303-2647(77)90053-3.,,,,,,,
267484,NLM,MEDLINE,19770917,20041117,0007-0610 (Print) 0007-0610 (Linking),142,11,1977 Jun 7,The leukaemias.,369-72,"['Pollock, A']",['Pollock A'],['eng'],['Journal Article'],England,Br Dent J,British dental journal,7513219,IM,"['Bacterial Infections/etiology', 'Forecasting', 'Humans', '*Leukemia/classification/diagnosis/drug therapy/etiology/pathology']",1977/06/07 00:00,1977/06/07 00:01,['1977/06/07 00:00'],"['1977/06/07 00:00 [pubmed]', '1977/06/07 00:01 [medline]', '1977/06/07 00:00 [entrez]']","['10.1038/sj.bdj.4803921 [doi]', '4803921 [pii]']",ppublish,Br Dent J. 1977 Jun 7;142(11):369-72. doi: 10.1038/sj.bdj.4803921.,,,,,,,
267448,NLM,MEDLINE,19770902,20190501,1468-2044 (Electronic) 0003-9888 (Linking),52,7,1977 Jul,Prognostic significance of radiological bone involvement in childhood acute lymphoblastic leukaemia.,530-3,"['Masera, G', 'Carnelli, V', 'Ferrari, M', 'Recchia, M', 'Bellini, F']","['Masera G', 'Carnelli V', 'Ferrari M', 'Recchia M', 'Bellini F']",['eng'],"['Comparative Study', 'Journal Article']",England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['*Bone Neoplasms/diagnostic imaging', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', '*Leukemia, Lymphoid/diagnostic imaging/mortality', 'Male', 'Neoplasm Metastasis', 'Prognosis', 'Radiography', 'Remission, Spontaneous']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1136/adc.52.7.530 [doi]'],ppublish,Arch Dis Child. 1977 Jul;52(7):530-3. doi: 10.1136/adc.52.7.530.,,"In 98 children with acute lymphoblastic leukaemia, aged 1 to 12 years, the prognostic significance of radiological bone involvement was studied. The mean duration of remission and of survival was much shorter in cases with multiple bone involvement (3 or more bones) than in those where bone involvement was absent. In those cases presenting with 1 or 2 bone lesions no statement of prognostic significance can be made at this stage. A radiological skeletal survey should be made in all children presenting with leukaemia to identify those (about 15%) having multiple bone lesions and therefore a poor prognosis, in order that they can be given more intensive therapy.",,PMC1544760,,,
267447,NLM,MEDLINE,19770902,20190501,1468-2044 (Electronic) 0003-9888 (Linking),52,7,1977 Jul,Retrospective study of intellectual development in children treated for acute lymphoblastic leukaemia.,525-9,"['Eiser, C', 'Lansdown, R']","['Eiser C', 'Lansdown R']",['eng'],"['Comparative Study', 'Journal Article']",England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['Age Factors', 'Child', 'Child, Preschool', 'Female', 'Humans', '*Intelligence/drug effects/radiation effects', 'Language Development', 'Leukemia, Lymphoid/drug therapy/radiotherapy/*therapy', 'Male', 'Motor Skills', 'Retrospective Studies']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1136/adc.52.7.525 [doi]'],ppublish,Arch Dis Child. 1977 Jul;52(7):525-9. doi: 10.1136/adc.52.7.525.,,"Nine younger children (mean age 6-3 years) and 6 older children (mean age 9-0 years), previously treated for acute lymphoblastic leukaemia by cranial irradiation and subsequently by 2 or 3 years of chemotherapy, were assessed in terms of intellectual development in relation to 15 controls, matched individually for age, sex, and social background. All children were functioning within a normal range. The older group of children performed as well as their matched controls in all tasks. However, the younger group tended to perform somewhat below their matched controls, and this applied especially to tasks measuring quantitative, memory, and motor skills, but not to language tasks. It is concluded that there is a continual need to monitor the development of children treated for leukaemia, especially when diagnosed in the 2- to 5- year age range.",,PMC1544775,,,
267446,NLM,MEDLINE,19770825,20190619,0003-4819 (Print) 0003-4819 (Linking),87,1,1977 Jul,Neutrophilic leukemia and blastic crisis.,66-7,"['Shindo, T', 'Sakai, C', 'Shibata, A']","['Shindo T', 'Sakai C', 'Shibata A']",['eng'],"['Case Reports', 'Journal Article']",United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Aged', 'Diagnosis, Differential', 'Humans', 'Leukemia, Myeloid/blood/*diagnosis', 'Leukemia, Myeloid, Acute/blood/*diagnosis', 'Leukemoid Reaction/blood/diagnosis', 'Male', '*Neutrophils']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.7326/0003-4819-87-1-66 [doi]'],ppublish,Ann Intern Med. 1977 Jul;87(1):66-7. doi: 10.7326/0003-4819-87-1-66.,,,,,,,
267432,NLM,MEDLINE,19770825,20071115,0002-936X (Print) 0002-936X (Linking),77,7,1977 Jul,Leukapheresis: the process.,1133-4,"['Tenczynski, J']",['Tenczynski J'],['eng'],['Journal Article'],United States,Am J Nurs,The American journal of nursing,0372646,IM,"['Blood Donors', 'Blood Transfusion', 'Cell Separation/instrumentation/*methods', 'Granulocytes', 'Histocompatibility Testing', 'Humans', 'Leukemia, Lymphoid/therapy', 'Leukemia, Myeloid/therapy', '*Leukocytes', 'Leukopenia/therapy', 'Lymphocytes']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Am J Nurs. 1977 Jul;77(7):1133-4.,,,,,,,
267431,NLM,MEDLINE,19770825,20190626,0002-9343 (Print) 0002-9343 (Linking),63,1,1977 Jul,"Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.",125-30,"['Fialkow, P J', 'Jacobson, R J', 'Papayannopoulou, T']","['Fialkow PJ', 'Jacobson RJ', 'Papayannopoulou T']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med,The American journal of medicine,0267200,IM,"['Adolescent', 'Adult', 'Aged', 'Blood Platelets/*pathology', 'Chromosome Mapping', 'Chronic Disease', 'Erythrocytes/*pathology', 'Female', 'Fibroblasts/enzymology', 'Glucosephosphate Dehydrogenase', 'Granulocytes/enzymology/*pathology', 'Hematopoietic Stem Cells/*pathology', 'Heterozygote', 'Humans', 'Isoenzymes', 'Leukemia, Myeloid/enzymology/genetics/*pathology', 'Leukocytes/*pathology', 'Macrophages/*pathology', 'Middle Aged', 'Monocytes/*pathology', 'Phenotype', 'Sex Chromosomes', 'Skin/pathology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']","['0002-9343(77)90124-3 [pii]', '10.1016/0002-9343(77)90124-3 [doi]']",ppublish,Am J Med. 1977 Jul;63(1):125-30. doi: 10.1016/0002-9343(77)90124-3.,"['0 (Isoenzymes)', 'EC 1.1.1.49 (Glucosephosphate Dehydrogenase)']","Glucose-6-phosphate dehydrogenase (G-6-PD) isoenzymes types of granulocytes were determined in eight women with chronic myelocytic leukemia (CML). The patients were heterozygous at the X-linked G-6-PD locus for the common gene, GdB, and a variant, such as GdA, so that both B and A enzyme types were found in skin cells. In contrast to these normal cells, only one G-6-PD type was found in CML granulocytes. The fact that such single-enzyme phenotypes are found in CML granulocytes, but not in nonleukemic granulocytes, provides strong evidence that the disease has a clonal origin. Single-enzyme phenotypes were also found in erythrocytes, platelets and cultured blood macrophages indicating that these cells have a common stem cell which is the site of the abnormality in CML. In the one studied patient, no evidence was found for involvement of cultured marrow fibroblasts. Clonal origin of CML virtually excludes cell recruitment as a sole pathogenetic mechanism. Either the leukemia arises as a consequence of a rare initial event in a single cell, or a series of events occurs in a clone such that it evolves into CML, or both.",,,,,
267430,NLM,MEDLINE,19770825,20190626,0002-9343 (Print) 0002-9343 (Linking),63,1,1977 Jul,Erythroblastic transformation of chronic granulocytic leukemia.,116-24,"['Rosenthal, S', 'Cancellos, G P', 'Gralnick, H P']","['Rosenthal S', 'Cancellos GP', 'Gralnick HP']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Med,The American journal of medicine,0267200,IM,"['Adult', 'Cell Transformation, Neoplastic/*pathology', 'Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Erythroblasts/*pathology', 'Erythrocytes/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/genetics/*pathology', 'Male', 'Middle Aged']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']","['0002-9343(77)90123-1 [pii]', '10.1016/0002-9343(77)90123-1 [doi]']",ppublish,Am J Med. 1977 Jul;63(1):116-24. doi: 10.1016/0002-9343(77)90123-1.,,"Erythroblastic transformation of chronic granulocytic leukemia was found in seven of 67 unselected patients with blast crisis. This morphologic picture of erythroblastic transformation was indistinguishable from that in erythroleukemia or Di Guglielmo's syndrome. The median survival of the patients with erythroblastic transformation was two months, considerably less than the four-month median survival in the entire series of 67 patients. Only two brief partial remissions were obtained with combination chemotherapy. The causes of death were primarily hemorrhage and infection, related to thrombocytopenia and neutropenia. In this regard, the patients with erythroblastic transformation resembled all the patients with blast crisis and patients with acute leukemia in general. The erythroblastic transformation seems to represent a morphologic variant of chronic granulocytic leukemia blast crisis, without apparent prognostic or therapeutic implications.",,,,,
267429,NLM,MEDLINE,19770902,20190509,0002-9262 (Print) 0002-9262 (Linking),106,1,1977 Jul,"A population-based study of referral, diagnostic and treatment patterns for childhood acute lymphocytic leukemia.",53-60,"['Green, S B', 'Myers, M H', 'Fink, D J']","['Green SB', 'Myers MH', 'Fink DJ']",['eng'],['Journal Article'],United States,Am J Epidemiol,American journal of epidemiology,7910653,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Female', 'Hospitalization', 'Humans', 'Infant', '*Leukemia, Lymphoid/diagnosis/mortality/therapy', 'Male']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1093/oxfordjournals.aje.a112431 [doi]'],ppublish,Am J Epidemiol. 1977 Jul;106(1):53-60. doi: 10.1093/oxfordjournals.aje.a112431.,,"In order to make decisions about cancer control programs, information is needed on the current management of cancer as actually practiced in the United States. A study to address this issue for acute lymphocytic leukemia in children (age 15 years and under) has been performed. The 101 patients represent all reported incident cases during 1972 in five regions which have population-based registries. Data on patient characteristics, referral patterns, treatment regimens, remission/relapse status, and survival are presented. It is concluded that the treatment strategies developed in leukemia research are reaching the general patient population. The present study can be considered a model for future studies of other forms of malignancy.",,,,,
267428,NLM,MEDLINE,19770902,20190509,0002-9173 (Print) 0002-9173 (Linking),68,2,1977 Aug,Nonspecific esterase activity in pernicious anemia and chronic erythremic myelosis: a cytochemical and electrophoretic study.,273-5,"['Kass, L', 'Peters, C L']","['Kass L', 'Peters CL']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Anemia, Pernicious/*enzymology', 'Bone Marrow/enzymology', 'Electrophoresis', 'Erythrocytes/enzymology', 'Esterases/*metabolism', 'Humans', 'Leukemia, Erythroblastic, Acute/*enzymology']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['10.1093/ajcp/68.2.273 [doi]'],ppublish,Am J Clin Pathol. 1977 Aug;68(2):273-5. doi: 10.1093/ajcp/68.2.273.,['EC 3.1.- (Esterases)'],"Cytochemically, nonspecific esterase activity was detected in megaloblasts from three patients with severe untreated pernicious anemia, in megaloblastoid erythroblasts from five patients with chronic erythremic myelosis (DiGuglielmo syndrome), and in normoblasts from a patient with severe untreated iron-deficiency anemia. Nonspecific esterase activity in all of these erythroblasts was inhibited by sodium fluoride. Enzymatic activity could not be detected in normoblasts from normal marrows. Electrophoretically, three bands of nonspecific esterase activity could be visualized in marrow sonicates from the anemic patients and normal persons. All of these bands were inhibited by sodium fluoride. The results demonstrate that electrophoretically and in terms of fluoride inhibition, nonspecific esterases obtained primarily from erythroid precursors in various types of anemias are similar to nonspecific esterases found in normal marrows presumably containing a more heterogeneous population of cells.",,,,,
267427,NLM,MEDLINE,19770812,20071115,0002-9106 (Print) 0002-9106 (Linking),149,2,1977 Jun,The transmural migration and release of blood cells in acute myelogenous leukemia.,247-67,"['Bruyn, P P', 'Becker, R P', 'Michelson, S']","['Bruyn PP', 'Becker RP', 'Michelson S']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Anat,The American journal of anatomy,0376312,IM,"['Animals', 'Bone Marrow/*ultrastructure', '*Bone Marrow Cells', 'Leukemia, Experimental', 'Leukemia, Myeloid, Acute/*pathology', 'Male', 'Microscopy, Electron', 'Microscopy, Electron, Scanning', 'Rats']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1002/aja.1001490208 [doi]'],ppublish,Am J Anat. 1977 Jun;149(2):247-67. doi: 10.1002/aja.1001490208.,,"The transmural passage of malignant blood cells from the extravascular parenchyma into sinusoidal lumen has been studied in the bone marrow of rats with myelogenous leukemia. The Shay myelogenous leukemia was chosen as a model system because an increased bone marrow cellularity is, in this leukemia, usually accompanied by an increase in circulating myeloid cells. By means of light microscopy, transmission electron microscopy (TEM) and scanning electron microscopy (SEM) it was found that the sinusoidal endothelial lining of the bone marrow remains intact and continuous even in advanced stages of the disease. SEM shows that the malignant myeloblast-like cell enters the sinusoidal lumen by means of a temporary migration pore, which appears only during the transmural passage of the cell. Certain nondegenerative changes in the sinusoidal blood vessels are associated with the myelogenous leukemia. The normal radial alignment of sinusoids about the central sinusoid is changed into a tortuous pattern, and intraluminal cytoplasmic bridges which impede the blood flow are formed by the endothelial cells.",,,,,
267408,NLM,MEDLINE,19770812,20110728,0001-5806 (Print) 0001-5806 (Linking),40,1,1977 Feb,Variability in differentiation stages observed in a rat myeloid leukemia and its relation to human myeloid leukemia.,87-106,"['Okada, K', 'Teratani, M', 'Takahashi, A', 'Mikami, M', 'Okita, H']","['Okada K', 'Teratani M', 'Takahashi A', 'Mikami M', 'Okita H']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Animals', 'Bone Marrow/pathology', 'Bone Marrow Cells', '*Cell Differentiation', 'Leukemia, Experimental', 'Leukemia, Myeloid/*pathology', 'Neoplasm Transplantation', 'Rats', 'Transplantation, Homologous']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Feb;40(1):87-106.,,,,,,,
267407,NLM,MEDLINE,19770812,20110728,0001-5806 (Print) 0001-5806 (Linking),40,1,1977 Feb,A rat myeloid leukemia model of the human disease. Hematological characteristics of N-nitrosobutylurea-induced W/Fu rat leukemia L1504 and L1005.,72-86,"['Okada, K', 'Teratani, M', 'Takahashi, A', 'Uchino, H', 'Kajihara, H']","['Okada K', 'Teratani M', 'Takahashi A', 'Uchino H', 'Kajihara H']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Animals', 'Cell Nucleus/ultrastructure', 'Disease Models, Animal', 'Leukemia, Experimental', 'Leukemia, Myeloid/chemically induced/*ultrastructure', 'Leukocyte Count', 'Leukocytes/ultrastructure', 'Male', '*Nitrosourea Compounds', 'Rats']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Feb;40(1):72-86.,['0 (Nitrosourea Compounds)'],,,,,,
267406,NLM,MEDLINE,19770812,20110728,0001-5806 (Print) 0001-5806 (Linking),40,1,1977 Feb,Fetal erythropoesis in aplastic anemia and acute leukemia.,24-32,"['Tanaka, M', 'Hirota, Y']","['Tanaka M', 'Hirota Y']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Adult', 'Aged', 'Anemia, Aplastic/*blood', 'Fetal Hemoglobin/*analysis', 'Humans', 'Leukemia, Myeloid, Acute/*blood', 'Middle Aged']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Feb;40(1):24-32.,['9034-63-3 (Fetal Hemoglobin)'],,,,,,
267405,NLM,MEDLINE,19770812,20110728,0001-5806 (Print) 0001-5806 (Linking),40,1,1977 Feb,An autopsy case of aplastic anemia-PNH syndrome terminated in acute granulocytic leukemia.,16-23,"['Hiroshige, Y', 'Matsumoto, N', 'Harima, K', 'Miwa, S', 'Kamei, T', 'Ishihara, T']","['Hiroshige Y', 'Matsumoto N', 'Harima K', 'Miwa S', 'Kamei T', 'Ishihara T']",['eng'],"['Case Reports', 'Journal Article']",Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Adult', 'Anemia, Aplastic/*complications', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Female', 'Hemoglobinuria, Paroxysmal/*complications', 'Humans', 'Leukemia, Myeloid/*etiology/pathology', 'Preleukemia/*pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Feb;40(1):16-23.,,,,,,,
267404,NLM,MEDLINE,19770812,20131121,0001-5806 (Print) 0001-5806 (Linking),40,1,1977 Feb,Chemotherapy of N-nitrosobutylurea-induced W/Fu rat myeloid leukemias.,107-18,"['Okada, K', 'Teratani, M', 'Takahashi, A', 'Uchino, H', 'Ohkita, T']","['Okada K', 'Teratani M', 'Takahashi A', 'Uchino H', 'Ohkita T']",['eng'],['Journal Article'],Japan,Nihon Ketsueki Gakkai Zasshi,Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,2984803R,IM,"['Animals', 'Cyclophosphamide/therapeutic use', 'Drug Therapy, Combination', 'Leukemia, Experimental', 'Leukemia, Myeloid, Acute/chemically induced/drug therapy', '*Nitrosourea Compounds', 'Rats']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Nihon Ketsueki Gakkai Zasshi. 1977 Feb;40(1):107-18.,"['0 (Nitrosourea Compounds)', '8N3DW7272P (Cyclophosphamide)']",,,,,,
267381,NLM,MEDLINE,19770812,20131121,0301-0481 (Print) 0301-0481 (Linking),52,10,1977 May 15,"[Herpes simplex diseases with questions on their oncogenicity, epidemiology, diagnosis and therapy--discussion].",576-87,,,['ger'],['Journal Article'],Germany,Z Hautkr,Zeitschrift fur Hautkrankheiten,0367576,IM,"['Adult', 'Animals', 'Antibodies, Viral', 'Antibody Formation', 'Cricetinae', 'Female', 'Germany, West', '*Herpes Simplex/diagnosis/epidemiology/etiology', 'Humans', 'Leukemia, Myeloid/complications', 'Levamisole/therapeutic use', 'Male', 'Melanoma/complications', 'Mice', 'Middle Aged', 'Skin Neoplasms/complications']",1977/05/15 00:00,1977/05/15 00:01,['1977/05/15 00:00'],"['1977/05/15 00:00 [pubmed]', '1977/05/15 00:01 [medline]', '1977/05/15 00:00 [entrez]']",,ppublish,Z Hautkr. 1977 May 15;52(10):576-87.,"['0 (Antibodies, Viral)', '2880D3468G (Levamisole)']",,"Herpes simplex-Erkrankungen mit Fragen zur Onkogenitat, Epidemiologie, Diagnostik und Therapie--Diskussion.",,,,
267380,NLM,MEDLINE,19770812,20141120,0043-5325 (Print) 0043-5325 (Linking),89,11,1977 May 27,[Zinc uptake of normal and leukaemic lymphocytes in an in vitro model (author's transl)].,389-92,"['Fuchswans, W', 'Binder, B', 'Hocker, P', 'Binder, C']","['Fuchswans W', 'Binder B', 'Hocker P', 'Binder C']",['ger'],"['Comparative Study', 'English Abstract', 'Journal Article']",Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,IM,"['Adult', 'Biological Transport', 'Erythrocytes/metabolism', 'Female', 'Humans', 'In Vitro Techniques', 'Leukemia, Lymphoid/*blood', 'Leukemia, Myeloid/*blood', 'Lymphocytes/*metabolism', 'Male', 'Middle Aged', 'Zinc/*blood']",1977/05/27 00:00,1977/05/27 00:01,['1977/05/27 00:00'],"['1977/05/27 00:00 [pubmed]', '1977/05/27 00:01 [medline]', '1977/05/27 00:00 [entrez]']",,ppublish,Wien Klin Wochenschr. 1977 May 27;89(11):389-92.,['J41CSQ7QDS (Zinc)'],"Zinc uptake and/or possible exchange by isolated lymphocytes from normal persons and from patients with chronic lymphatic leukemia and chronic myeloid leukemia were studied in an in vitro model. The uptake of zinc per 10(9) lymphocytes of normal persons was 60 +/- 10 nanomoles and 120 +/- 15 nanomoles during incubation for 30 and 60 minutes, respectively. Two out of the 3 patients with chronic myeloid leukemia showed normal zinc uptake in this test system, whereas zinc uptake by lymphocytes from patients with chronic lymphatic leukemia was significantly decreased (22+/-8 nanomoles in 30 minutes and 35+/-10 nanomoles in 60 minutes).",Zur Frage der Zinkaufnahme von normalen und leukamischen Lymphozyten.,,,,
267331,NLM,MEDLINE,19770825,20071115,0040-3660 (Print) 0040-3660 (Linking),49,5,1977,[Acute lymphoblastic leukemia in lymphogranulomatosis].,116-7,"['Frank, G A', 'Orlova, L D', 'Lyshina, L I', 'Bolotova, N P', 'Kolpikova, L A']","['Frank GA', 'Orlova LD', 'Lyshina LI', 'Bolotova NP', 'Kolpikova LA']",['rus'],"['Case Reports', 'English Abstract', 'Journal Article']",Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adult', 'Female', 'Hodgkin Disease/*complications', 'Humans', 'Kidney Neoplasms/complications', 'Leukemia, Lymphoid/*complications', 'Peritoneal Neoplasms/complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(5):116-7.,,,Ostryi limfoblastnyi leikoz pri limfogranulomatoze.,,,,
267330,NLM,MEDLINE,19770812,20140912,0256-9574 (Print),51,23,1977 Jun 4,Chronic myelomonocytic leukaemia: a case report.,852-3,"['Getaz, E P', 'Staples, W G']","['Getaz EP', 'Staples WG']",['eng'],"['Case Reports', 'Journal Article']",South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,IM,"['Aged', 'Chronic Disease', 'Etoposide/*therapeutic use', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Podophyllotoxin/*analogs & derivatives']",1977/06/04 00:00,1977/06/04 00:01,['1977/06/04 00:00'],"['1977/06/04 00:00 [pubmed]', '1977/06/04 00:01 [medline]', '1977/06/04 00:00 [entrez]']",,ppublish,S Afr Med J. 1977 Jun 4;51(23):852-3.,"['6PLQ3CP4P3 (Etoposide)', 'L36H50F353 (Podophyllotoxin)']",,,,,,
267329,NLM,MEDLINE,19770902,20190702,0038-4348 (Print) 0038-4348 (Linking),70,7,1977 Jul,Osteogenic sarcoma in a patient with aplastic anemia.,874-5,"['Lascari, A D', 'Eveloff, A R']","['Lascari AD', 'Eveloff AR']",['eng'],"['Case Reports', 'Journal Article']",United States,South Med J,Southern medical journal,0404522,IM,"['Adolescent', 'Anemia, Aplastic/chemically induced/*complications/drug therapy', 'Bone Neoplasms/*chemically induced/drug therapy/pathology', 'Chloramphenicol/adverse effects/therapeutic use', 'Humans', 'Male', 'Methotrexate/therapeutic use', 'Osteosarcoma/*chemically induced/drug therapy/pathology', 'Prednisone/adverse effects', 'Testosterone/adverse effects']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1097/00007611-197707000-00034 [doi]'],ppublish,South Med J. 1977 Jul;70(7):874-5. doi: 10.1097/00007611-197707000-00034.,"['3XMK78S47O (Testosterone)', '66974FR9Q1 (Chloramphenicol)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']","Osteogenic sarcoma developed in a 14-year-old boy 13 years after he had partially recovered from chloramphenicol-induced aplastic anemia. A possible relationship is considered between aplastic anemia, chloramphenicol, testosterone, prednisone, and osteogenic sarcoma. Leukemia has been reported following chloramphenicol-induced aplastic anemia and liver tumors have been associated with testosterone therapy. Certain chemicals have caused osteogenic sarcoma in animals. Thus, we believe there are sufficient a priori reasons to question an etiologic relationship between the cause or treatment of aplastic anemia and osteogenic sarcoma.",,,,,
267328,NLM,MEDLINE,19770902,20190618,0036-8075 (Print) 0036-8075 (Linking),197,4303,1977 Aug 5,Host control of tumor growth.,571-3,"['Ting, C C', 'Tsai, S C', 'Rogers, M J']","['Ting CC', 'Tsai SC', 'Rogers MJ']",['eng'],['Journal Article'],United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Animals', 'Ascitic Fluid/*immunology', 'Breast Neoplasms/immunology', 'Cell Line', 'Cytotoxicity Tests, Immunologic', 'Humans', 'Immune Tolerance', 'Immunity, Cellular', 'Leukemia, Erythroblastic, Acute/blood/*immunology', 'Mice', 'Mice, Inbred C57BL', 'Neoplasms, Experimental/blood/immunology', 'Pleural Effusion/immunology', 'Spleen/immunology']",1977/08/05 00:00,1977/08/05 00:01,['1977/08/05 00:00'],"['1977/08/05 00:00 [pubmed]', '1977/08/05 00:01 [medline]', '1977/08/05 00:00 [entrez]']",['10.1126/science.267328 [doi]'],ppublish,Science. 1977 Aug 5;197(4303):571-3. doi: 10.1126/science.267328.,,"A humoral factor (molecular weight less than 60,000) that was present in the ascitic fluid of mice bearing intraperitoneal tumors and in pleural effusions from human cancer patients was found to promote the growth of a murine tumor and to suppress cell-mediated tumor immunity. However, the hosts that had recovered from the immunosuppressive state produced a serum factor that could neutralize the immunosuppressive effect.",,,,,
267327,NLM,MEDLINE,19770902,20190618,0036-8075 (Print) 0036-8075 (Linking),197,4303,1977 Aug 5,Inducibility of transferrin receptors on friend erythroleukemic cells.,559-61,"['Hu, H Y', 'Gardner, J', 'Aisen, P']","['Hu HY', 'Gardner J', 'Aisen P']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Cell Line', 'Dimethyl Sulfoxide/pharmacology', 'Erythrocytes/metabolism', 'Erythropoiesis/drug effects', 'Fibroblasts/metabolism', 'Friend murine leukemia virus', 'Iron/metabolism', 'Kinetics', 'Leukemia, Erythroblastic, Acute/*metabolism/pathology', 'Lymphoma/metabolism', 'Receptors, Drug/*metabolism', 'Transferrin/*metabolism']",1977/08/05 00:00,1977/08/05 00:01,['1977/08/05 00:00'],"['1977/08/05 00:00 [pubmed]', '1977/08/05 00:01 [medline]', '1977/08/05 00:00 [entrez]']",['10.1126/science.267327 [doi]'],ppublish,Science. 1977 Aug 5;197(4303):559-61. doi: 10.1126/science.267327.,"['0 (Receptors, Drug)', '0 (Transferrin)', 'E1UOL152H7 (Iron)', 'YOW8V9698H (Dimethyl Sulfoxide)']","The ability of Friend erythroleukemic cells to bind transferrin and take up its iron increases substantially as a result of dimethyl sulfoxide-stimulated differentiation. Although transferrin-binding activity is also demonstrable in another mouse cell line of hematopoietic origin, the lymphoma cell, it does not increase on exposure to dimethyl sulfoxide. Gel filtration studies corroborate that the binding of transferrin to the erythroleukemic cells is due to the formation of a specific complex of transferrin and a membrane receptor. Thus, the specific interaction of transferrin with its receptor is another expression of dimethyl sulfoxide-induced differentiation in the Friend cell.",,,,,
267326,NLM,MEDLINE,19770825,20190618,0036-8075 (Print) 0036-8075 (Linking),197,4300,1977 Jul 15,Oscillation and chaos in physiological control systems.,287-9,"['Mackey, M C', 'Glass, L']","['Mackey MC', 'Glass L']",['eng'],['Journal Article'],United States,Science,"Science (New York, N.Y.)",0404511,IM,"['Cheyne-Stokes Respiration/physiopathology', '*Hematopoiesis', 'Leukemia, Myeloid/physiopathology', '*Models, Biological', '*Periodicity', '*Respiration']",1977/07/15 00:00,1977/07/15 00:01,['1977/07/15 00:00'],"['1977/07/15 00:00 [pubmed]', '1977/07/15 00:01 [medline]', '1977/07/15 00:00 [entrez]']",['10.1126/science.267326 [doi]'],ppublish,Science. 1977 Jul 15;197(4300):287-9. doi: 10.1126/science.267326.,,"First-order nonlinear differential-delay equations describing physiological control systems are studied. The equations display a broad diversity of dynamical behavior including limit cycle oscillations, with a variety of wave forms, and apparently aperiodic or ""chaotic"" solutions. These results are discussed in relation to dynamical respiratory and hematopoietic diseases.",,,,,
267311,NLM,MEDLINE,19770812,20190907,0036-553X (Print) 0036-553X (Linking),18,5,1977 May,Increase of proliferative activity of leukaemic blast cells from human peripheral blood in liquid culture.,427-36,"['Kurrle, E', 'Schmucker, H', 'Hoelzer, D']","['Kurrle E', 'Schmucker H', 'Hoelzer D']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Aged', '*Cell Division', 'Cells, Cultured', 'Culture Media', 'Female', 'Humans', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Monocytic, Acute/blood', 'Leukemia, Myeloid, Acute/blood', 'Leukocyte Count', 'Leukocytes', 'Lymphocytes', 'Male', 'Middle Aged', 'Monocytes']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02097.x [doi]'],ppublish,Scand J Haematol. 1977 May;18(5):427-36. doi: 10.1111/j.1600-0609.1977.tb02097.x.,['0 (Culture Media)'],"The proliferative behaviour of leukaemic cells from the peripheral blood of 12 patients suffering from acute leukaemia was investigated in short term liquid culture. In 3 cases of AML an increase of the blast cell number was observed exceeding the initial value whereas in 9 other cases the cell number decreased more or less rapidly. In 9 of these patients the proliferation kinetics of the cultured leukaemic blast cells were studied with 3H-thymidine labelling. In all these cases the labelling index increased during the first days of culture, in 3 cases to values of 48%, 45% and 38% on day 3. Only in 5 cases, however, did an absolute increase of the blast cells incorporating 3H-thymidine occur. Here the doubling times of the proliferating leukaemic blast cells were estimated to be 12, 13, 14, 28 and 55 h. Since a doubling time of 12 to 14 h seems to be too short to be explained only by an exponential growth of the initially proliferating cells it is postulated that leukaemic blast cells in a G0- or long G1-phase were present in the peripheral blood of these patients and that these entered the cell cycle during liquid culture.",,,,,
267284,NLM,MEDLINE,19770825,20071115,0552-2080 (Print) 0552-2080 (Linking),22,5,1977 May,[Survival of patients with acute leukemia as a criterion of the effectiveness of treatment].,3-8,"['Fainshtein, R E', 'Kovaleva, L G', 'Levitin, E I', 'Isaev, V G', 'Abakumov, E M']","['Fainshtein RE', 'Kovaleva LG', 'Levitin EI', 'Isaev VG', 'Abakumov EM']",['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Antineoplastic Agents/administration & dosage/therapeutic use', 'Drug Administration Schedule', 'Drug Evaluation', 'Humans', 'Leukemia, Lymphoid/drug therapy/*mortality', 'Leukemia, Myeloid, Acute/drug therapy/*mortality']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 May;22(5):3-8.,['0 (Antineoplastic Agents)'],,Vyzhivaemost' bol'nykh ostrym leikozom kak kriterii effektivnosti terapii.,,,,
267283,NLM,MEDLINE,19770825,20141120,0552-2080 (Print) 0552-2080 (Linking),22,5,1977 May,[Characteristics of the morphology and function of the thrombocytes in myeloproliferative diseases].,18-23,"['Petrov, M N', ""Vashkinel', V K""]","['Petrov MN', ""Vashkinel' VK""]",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Aged', 'Blood Platelets/*pathology/physiology', 'Female', 'Humans', 'In Vitro Techniques', 'Leukemia, Myeloid/*blood', 'Male', 'Middle Aged', '*Platelet Adhesiveness', 'Polycythemia Vera/*blood', 'Primary Myelofibrosis/*blood']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 May;22(5):18-23.,,,Osobennosti morfologii i funktsii trombotsitov pri mieloproliferativnykh zabolevaniiakh.,,,,
267282,NLM,MEDLINE,19770825,20061115,0552-2080 (Print) 0552-2080 (Linking),22,5,1977 May,[Hyperplasia of the erythropoietic tissue in acute leukemia].,16-8,"[""Frenkel', M A"", ""Solov'eva, E A""]","[""Frenkel' MA"", ""Solov'eva EA""]",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Acute Disease', 'Bone Marrow/*pathology', '*Bone Marrow Cells', 'Erythroblasts/pathology', 'Humans', 'Hyperplasia/pathology', 'Leukemia, Erythroblastic, Acute/*pathology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 May;22(5):16-8.,,,K voprosu o giperplazii eritropoeticheskoi tkani u bol'nykh ostrym leikozom.,,,,
267281,NLM,MEDLINE,19770902,20190501,0032-5473 (Print) 0032-5473 (Linking),53,619,1977 May,Portal hypertension in a patient with chronic myeloid leukaemia.,267-9,"['Foadi, M D', 'Shaw, S', 'Paradinas, F J']","['Foadi MD', 'Shaw S', 'Paradinas FJ']",['eng'],"['Case Reports', 'Journal Article']",England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Busulfan/*adverse effects/therapeutic use', 'Humans', 'Hypertension, Portal/*chemically induced', 'Leukemia, Myeloid/*complications/drug therapy', 'Liver/pathology', 'Male', 'Middle Aged']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1136/pgmj.53.619.267 [doi]'],ppublish,Postgrad Med J. 1977 May;53(619):267-9. doi: 10.1136/pgmj.53.619.267.,['G1LN9045DK (Busulfan)'],"A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice. At post-mortem there was minimal leukaemic infiltration but there were alterations in the liver architecture sufficient to explain the portal hypertension. The pathogenesis of the liver changes and their possible relationship to splenomegaly and busulphan toxicity are considered.",,PMC2496554,,,
267280,NLM,MEDLINE,19770902,20190501,0032-5473 (Print) 0032-5473 (Linking),53,619,1977 May,Lysozyme: a brief review.,257-9,"['Mir, M A']",['Mir MA'],['eng'],['Journal Article'],England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Animals', 'Humans', 'Hypokalemia/etiology', 'Kidney Diseases/etiology', 'Leukemia, Myeloid, Acute/etiology', 'Muramidase/*blood', 'Prognosis']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1136/pgmj.53.619.257 [doi]'],ppublish,Postgrad Med J. 1977 May;53(619):257-9. doi: 10.1136/pgmj.53.619.257.,['EC 3.2.1.17 (Muramidase)'],"Serum lysozyme (muramidase) estimation is a simple, convenient and useful laboratory investigation. A review of the literature shows that lysozyme has been implicated as an aetiological factor in various disorders, and credited with being a prognostic indicator in acute myeloid leukaemia, but these promises have not been fulfilled. This low molecular weight protein is found in the urine of some patients with renal tubular disorders, but some workers have emphasized its importance as a causal agent in hypokalaemia of acute myeloid leukaemia. Research should be concentrated on muramidase as an expression of cell functions rather than as an aetiological factor. Hypokalaemia in acute myeloid leukaemia may be caused by an unidentified substance of molecular weight similar to that of lysozyme.",,PMC2496565,,,
267279,NLM,MEDLINE,19770812,20071115,0029-6511 (Print) 0029-6511 (Linking),144,24,1977 Jun 16,Leukaemia in childhood.,15-7,"['Kay, H E']",['Kay HE'],['eng'],['Journal Article'],England,Nurs Mirror,Nursing mirror,7708429,,"['Antineoplastic Agents/administration & dosage', 'Child', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/*drug therapy/radiotherapy']",1977/06/16 00:00,1977/06/16 00:01,['1977/06/16 00:00'],"['1977/06/16 00:00 [pubmed]', '1977/06/16 00:01 [medline]', '1977/06/16 00:00 [entrez]']",,ppublish,Nurs Mirror. 1977 Jun 16;144(24):15-7.,['0 (Antineoplastic Agents)'],,,,,,
267278,NLM,MEDLINE,19770825,20071115,0301-1518 (Print) 0301-1518 (Linking),6,21,1977 May 21,[Anuria with hyperuricemia revealing acute leukemia. Treatment with urate oxidase].,1880-1,"['Saint-Hillier, Y', 'Colomb, H', 'Perol, C', 'Bosset, J F', 'Rozenbaum, A', 'Dupond, F L', 'Leconte des Floris, R']","['Saint-Hillier Y', 'Colomb H', 'Perol C', 'Bosset JF', 'Rozenbaum A', 'Dupond FL', 'Leconte des Floris R']",['fre'],"['Case Reports', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Aged', 'Anuria/complications/*drug therapy', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Male', 'Urate Oxidase/*therapeutic use']",1977/05/21 00:00,1977/05/21 00:01,['1977/05/21 00:00'],"['1977/05/21 00:00 [pubmed]', '1977/05/21 00:01 [medline]', '1977/05/21 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 May 21;6(21):1880-1.,['EC 1.7.3.3 (Urate Oxidase)'],,Anurie par hyperuricemie revelatrice d'une leucemie aigue. Traitement medical par l'urate oxydase.,,,,
267268,NLM,MEDLINE,19770812,20071115,0031-3890 (Print) 0031-3890 (Linking),85,1,1977 Mar 31,[Data on the behavior of hemopexin in acute leukemia in childhood in relation to the blood coagulation picture].,12-20,"['Esposito, L', 'di Gennaro, C']","['Esposito L', 'di Gennaro C']",['ita'],"['English Abstract', 'Journal Article']",Italy,Pediatria (Napoli),La Pediatria,0401207,IM,"['Blood Cell Count', '*Blood Coagulation', '*Blood Coagulation Factors/analysis', 'Blood Platelets', 'Child', 'Child, Preschool', 'Disseminated Intravascular Coagulation/etiology', '*Hemopexin/analysis', 'Humans', 'Infant', 'Leukemia, Lymphoid/*blood/complications']",1977/03/31 00:00,1977/03/31 00:01,['1977/03/31 00:00'],"['1977/03/31 00:00 [pubmed]', '1977/03/31 00:01 [medline]', '1977/03/31 00:00 [entrez]']",,ppublish,Pediatria (Napoli). 1977 Mar 31;85(1):12-20.,"['0 (Blood Coagulation Factors)', '9013-71-2 (Hemopexin)']",,Rilievi sul comportamento della emopessina nella leucemia acuta della infanzia in rapporto al profilo emocoagulativo.,,,,
267267,NLM,MEDLINE,19770812,20071115,0031-4005 (Print) 0031-4005 (Linking),60,1,1977 Jul,Measles pneumonia in childhood leukemia.,38-40,"['Siegel, M M', 'Walter, T K', 'Ablin, A R']","['Siegel MM', 'Walter TK', 'Ablin AR']",['eng'],"['Case Reports', 'Journal Article']",United States,Pediatrics,Pediatrics,0376422,IM,"['Autopsy', 'Child', 'Humans', 'Leukemia, Lymphoid/*complications', 'Lung/pathology', 'Male', 'Measles/*complications/diagnosis', 'Pneumonia, Viral/*complications/diagnosis']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Pediatrics. 1977 Jul;60(1):38-40.,,Fatal measles pneumonia developed in a 7-year-old boy who was in complete remission from acute lymphoblastic leukemia. There was no detectable antibody titer in two specimens taken eight days apart. Measles virus was grown from a lung biopsy taken shortely after hospital admission. Classical measles had been diagnosed in the patient and his siblings nine months previously. Immunosuppressed children who do not develop an antibody rise after a measles infection are at risk of later development of measles giant cell pneumonia. Suggestions are offered for the prevention of this often fatal complication.,,,,,
267266,NLM,MEDLINE,19770825,20071115,0031-3939 (Print) 0031-3939 (Linking),52,6,1977 Jun,"[Serum levels of IgG, IgA and IgM and the survival time of children with acute lymphoblastic leukemia].",599-602,"['Zajaczkowski, J', 'Michalik, R']","['Zajaczkowski J', 'Michalik R']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Acute Disease', 'Adolescent', 'Child', 'Child, Preschool', 'Humans', 'Immunoglobulin A/analysis', 'Immunoglobulin G/analysis', 'Immunoglobulin M/analysis', 'Immunoglobulins/*analysis', 'Leukemia, Lymphoid/*immunology/mortality', 'Prognosis', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Jun;52(6):599-602.,"['0 (Immunoglobulin A)', '0 (Immunoglobulin G)', '0 (Immunoglobulin M)', '0 (Immunoglobulins)']",,"Poziom IGG, IGA, IGM w surowicy krwi a czas przezycia dzieci z ostra bialaczka limfoblastyczna.",,,,
267265,NLM,MEDLINE,19770825,20201209,0031-3939 (Print) 0031-3939 (Linking),52,6,1977 Jun,[Skin reactivity to dinitrochlorobenzene and the survival time of children with acute lymphoblastic leukemia].,595-8,"['Zajaczkowski, J', 'Halikowski, B']","['Zajaczkowski J', 'Halikowski B']",['pol'],['Journal Article'],Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Acute Disease', 'Adolescent', 'Child', 'Child, Preschool', 'Dinitrochlorobenzene/immunology', 'Humans', 'Leukemia, Lymphoid/immunology/*mortality', 'Prognosis', 'Remission, Spontaneous', 'Skin/*immunology', 'Skin Tests']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Jun;52(6):595-8.,['0 (Dinitrochlorobenzene)'],,Reaktywnosc skorna na dwunitrochlorobenzen a czas prezezycia dzieci z ostra bialaczka limfoblastyczna.,,,,
267259,NLM,MEDLINE,19770902,20041117,0028-8535 (Print) 0028-8535 (Linking),70,4,1977 Apr,Nursing management of childhood leukaemia.,12-5,"['Bremner, G']",['Bremner G'],['eng'],['Journal Article'],New Zealand,N Z Nurs J,The New Zealand nursing journal. Kai tiaki,19110850R,,"['Antineoplastic Agents/adverse effects/therapeutic use', 'Child', 'Humans', 'Leukemia/drug therapy/*nursing', '*Pediatric Nursing', 'Professional-Family Relations']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,N Z Nurs J. 1977 Apr;70(4):12-5.,['0 (Antineoplastic Agents)'],,,,,,
267250,NLM,MEDLINE,19770812,20190514,0028-3878 (Print) 0028-3878 (Linking),27,7,1977 Jul,Leukoencephalopathy in childhood leukemia.,609-13,"['Devivo, D C', 'Malas, D', 'Nelson, J S', 'Land, V J']","['Devivo DC', 'Malas D', 'Nelson JS', 'Land VJ']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Neurology,Neurology,0401060,IM,"['Adolescent', 'Cerebral Cortex/pathology', 'Gliosis/pathology', 'Humans', 'Leukemia, Lymphoid/*complications/pathology', 'Leukoencephalopathy, Progressive Multifocal/chemically induced/*etiology/pathology', 'Male', 'Pyrimethamine/adverse effects', 'Temporal Lobe/pathology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['10.1212/wnl.27.7.609 [doi]'],ppublish,Neurology. 1977 Jul;27(7):609-13. doi: 10.1212/wnl.27.7.609.,['Z3614QOX8W (Pyrimethamine)'],"A 14-year-old boy survived for 7 years after the initial diagnosis and treatment of acute lymphocytic leukemia. Neurologic deterioration occured repeatedly throughout his complicated clinical course but it was most severe and only partially reversible following orally administered pyrimethamine. The neuropathologic lesions were distinctive and included a diffuse reactive astrocytosis, axonal degeneration, status spongiosis, circumscribed foci of demyelination and coagulative necrosis, and mural thickening with luminal narrowing of microcirculatory vessels. This collection of findings represents the leukoencephalopathy of childhood leukemia that we and others believe results in large part from the combined effects of cranial irradiation and chemotherapy. The role of folic acid antagonists, namely methotrexate and pyrimethamine, are particularly noteworthy in this regard.",,,,,
267248,NLM,MEDLINE,19770812,20190617,0028-0836 (Print) 0028-0836 (Linking),266,5604,1977 Apr 21,Comparable complex rearrangements involving 8;21 and 9;22 translocations in leukaemia.,744-5,"['Lindgren, V', 'Rowley, J D']","['Lindgren V', 'Rowley JD']",['eng'],['Journal Article'],England,Nature,Nature,0410462,IM,"['*Chromosome Aberrations/*pathology', '*Chromosome Disorders', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia/*genetics', 'Leukemia, Myeloid/genetics', 'Leukemia, Myeloid, Acute/genetics', '*Translocation, Genetic']",1977/04/21 00:00,1977/04/21 00:01,['1977/04/21 00:00'],"['1977/04/21 00:00 [pubmed]', '1977/04/21 00:01 [medline]', '1977/04/21 00:00 [entrez]']",['10.1038/266744a0 [doi]'],ppublish,Nature. 1977 Apr 21;266(5604):744-5. doi: 10.1038/266744a0.,,,,,,,
267246,NLM,MEDLINE,19770825,20140729,,125,5,1977 May,[Infections in childhood neoplasms].,565-6,"['Simon, C', 'Harhausen, S', 'Harms, D', 'Lasson, U']","['Simon C', 'Harhausen S', 'Harms D', 'Lasson U']",['ger'],['Journal Article'],Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Adolescent', 'Age Factors', 'Bacterial Infections/*etiology', 'Brain Neoplasms/complications', 'Child', 'Child, Preschool', 'Hodgkin Disease/complications', 'Humans', 'Infant', 'Infant, Newborn', 'Leukemia, Lymphoid/complications', 'Lymphoma, Non-Hodgkin/complications', 'Neoplasms/*complications/surgery', 'Postoperative Complications', 'Prognosis']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1977 May;125(5):565-6.,,,Infektionen bei kindlichen Tumorleiden.,,,,
267245,NLM,MEDLINE,19770825,20140729,,125,5,1977 May,[Differential diagnosis of acute leukemia in childhood by means of electronic cell-volume determination].,563-5,"['Tausch, W', 'Thom, R', 'Odenwald, E', 'Riehm, H']","['Tausch W', 'Thom R', 'Odenwald E', 'Riehm H']",['ger'],['Journal Article'],Germany,Monatsschr Kinderheilkd,Monatsschrift fur Kinderheilkunde,0400751,IM,"['Adolescent', 'Blood Volume', 'Child', 'Child, Preschool', 'Diagnosis, Differential', 'Electronics, Medical/*methods', 'Erythrocytes/physiology', 'Humans', 'Infant', 'Leukemia, Lymphoid/blood/*diagnosis', 'Leukemia, Monocytic, Acute/blood/*diagnosis', 'Leukemia, Myeloid, Acute/blood/*diagnosis', 'Lymphocytes/physiology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Monatsschr Kinderheilkd. 1977 May;125(5):563-5.,,,Differentialdiagnose der akuten Leukamie im Kindesalter mit Hilfe der elektronischen Zellvolumenbestimmung.,,,,
267239,NLM,MEDLINE,19770812,20071115,0026-4946 (Print) 0026-4946 (Linking),29,10,1977 Mar 24,[Studies of the function of the alternate pathway of complement activation in acute leukemia in children].,693-6,"['Brai, M', 'Lo Curto, M', 'Macaluso, M']","['Brai M', 'Lo Curto M', 'Macaluso M']",['ita'],['Journal Article'],Italy,Minerva Pediatr,Minerva pediatrica,0400740,IM,"['Adolescent', 'Antigen-Antibody Complex', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', '*Complement System Proteins', 'Female', 'Hemolysis', 'Humans', 'Immunoglobulins/*analysis', 'Leukemia, Lymphoid/drug therapy/*immunology', 'Male', 'Recurrence', 'Remission, Spontaneous']",1977/03/24 00:00,1977/03/24 00:01,['1977/03/24 00:00'],"['1977/03/24 00:00 [pubmed]', '1977/03/24 00:01 [medline]', '1977/03/24 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1977 Mar 24;29(10):693-6.,"['0 (Antigen-Antibody Complex)', '0 (Antineoplastic Agents)', '0 (Immunoglobulins)', '9007-36-7 (Complement System Proteins)']",,Studi sulla funzionalita della via alternativa di attivazione complementare nella leucimia acuta del bambino,,,,
267208,NLM,MEDLINE,19770825,20071115,0022-8362 (Print) 0022-8362 (Linking),29,4,1977 Apr,[Nursing care at the time of changing the degree of rest - from a case study of assisting a patient with acute lymphatic leukemia].,37-42,"['Hasegawa, K']",['Hasegawa K'],['jpn'],"['Case Reports', 'Journal Article']",Japan,Kango,[Kango] Japanese journal of nursing,18110540R,,"['*Bed Rest', 'Humans', 'Leukemia, Lymphoid/*nursing']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Kango. 1977 Apr;29(4):37-42.,,,,,,,
267207,NLM,MEDLINE,19770902,20161017,0098-7484 (Print) 0098-7484 (Linking),238,5,1977 Aug 1,Erythroleukemia (di Guglielmo's disease). Occurrence 28 years after thorium administration.,423,"['Waddell, C C', 'Brown, J A', 'Rueb, D L']","['Waddell CC', 'Brown JA', 'Rueb DL']",['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Contrast Media/*adverse effects', 'Headache/diagnosis', 'Humans', 'Leukemia, Erythroblastic, Acute/*chemically induced', 'Male', 'Middle Aged', 'Thorium Dioxide/*adverse effects', 'Time Factors']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",,ppublish,JAMA. 1977 Aug 1;238(5):423.,"['0 (Contrast Media)', '9XA7X17UQC (Thorium Dioxide)']",,,,,,
267202,NLM,MEDLINE,19770825,20190621,0022-5347 (Print) 0022-5347 (Linking),118,1 Pt 1,1977 Jul,Acute lymphoblastic leukemia diagnosed by renal biopsy.,103-4,"['Barakat, A Y', 'Mnaymneh, L G']","['Barakat AY', 'Mnaymneh LG']",['eng'],"['Case Reports', 'Journal Article']",United States,J Urol,The Journal of urology,0376374,IM,"['Acute Disease', 'Acute Kidney Injury/etiology/pathology', 'Biopsy', 'Child', 'Humans', 'Kidney/pathology', 'Leukemia, Lymphoid/complications/*diagnosis/pathology', 'Male']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']","['S0022-5347(17)57906-9 [pii]', '10.1016/s0022-5347(17)57906-9 [doi]']",ppublish,J Urol. 1977 Jul;118(1 Pt 1):103-4. doi: 10.1016/s0022-5347(17)57906-9.,,An 8-year-old boy who presented with recurrent attacks of acute non-oliguric renal failure is described. Hemograms were normal and the kidneys were not enlarged. A renal biopsy was done and diagnosis was acute lymphoblastic leukemia. The etiology of renal failure in leukemia is discussed.,,,,,
267196,NLM,MEDLINE,19770812,20211203,0022-345X (Print) 0022-345X (Linking),14,2,1977 Mar-Apr,Mumps uveitis complicating the course of acute leukemia.,100-2,"['Al-Rashid, R A', 'Cress, C']","['Al-Rashid RA', 'Cress C']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr Ophthalmol,Journal of pediatric ophthalmology,0044350,IM,"['Child', 'Diagnosis, Differential', 'Humans', 'Immunity, Cellular/drug effects', 'Immunosuppression Therapy/adverse effects', 'Leukemia, Lymphoid/*complications/drug therapy', 'Male', 'Mumps/*complications', 'Remission, Spontaneous', 'Uveitis/*etiology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,J Pediatr Ophthalmol. 1977 Mar-Apr;14(2):100-2.,,A case of a nine-year-old child with acute lymphocytic leukemia in remission who developed infectious parotitis with uveitis was presented. Ocular complications of mumps have been briefly discussed and the differential diagnosis particularly in relationship to leukemia have been emphasized. The significance of depressed cellular immunity in the development of this complication was entertained.,,,,,
267155,NLM,MEDLINE,19770812,20071115,0022-2143 (Print) 0022-2143 (Linking),90,1,1977 Jul,Renal handling of endogenous lysozyme in man.,61-7,"['Pruzanski, W', 'Wilson, D R']","['Pruzanski W', 'Wilson DR']",['eng'],['Journal Article'],United States,J Lab Clin Med,The Journal of laboratory and clinical medicine,0375375,IM,"['Adult', 'Aged', 'Fanconi Syndrome/enzymology', 'Female', 'Humans', 'Kidney/*enzymology', 'Kidney Tubules, Proximal/enzymology', 'Leukemia, Myeloid/metabolism', 'Male', 'Metabolic Clearance Rate', 'Middle Aged', 'Muramidase/blood/*metabolism/urine', 'Renal Artery', 'Renal Veins']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,J Lab Clin Med. 1977 Jul;90(1):61-7.,['EC 3.2.1.17 (Muramidase)'],,,,,,
267154,NLM,MEDLINE,19770812,20071115,0022-8699 (Print) 0022-8699 (Linking),78,6,1977 Jun,Multiple threat: second primary malignancies in patients with ovarian carcinoma treated with radiation and chemotherapy.,283-5,"['Masterson, B J', 'Snyder, T E']","['Masterson BJ', 'Snyder TE']",['eng'],"['Case Reports', 'Journal Article']",United States,J Kans Med Soc,The Journal of the Kansas Medical Society,7505612,IM,"['Aged', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/complications', '*Neoplasms, Multiple Primary', '*Ovarian Neoplasms/therapy']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,J Kans Med Soc. 1977 Jun;78(6):283-5.,,,,,,,
267143,NLM,MEDLINE,19770812,20111117,0161-5505 (Print) 0161-5505 (Linking),18,7,1977 Jul,The association of Ga-67 and lactoferrin.,713-7,"['Hoffer, P B', 'Huberty, J', 'Khayam-Bashi, H']","['Hoffer PB', 'Huberty J', 'Khayam-Bashi H']",['eng'],['Journal Article'],United States,J Nucl Med,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",0217410,IM,"['Adult', 'Female', 'Galactorrhea/*metabolism', 'Gallium Radioisotopes/*analysis', 'Humans', 'Lactation Disorders/*metabolism', 'Lactoferrin/*metabolism', 'Lactoglobulins/*metabolism', 'Leukemia, Myeloid, Acute/diagnosis', 'Neoplasm Metastasis', 'Pregnancy', 'Protein Binding', 'Radionuclide Imaging', 'Spinal Cord Neoplasms/diagnosis']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,J Nucl Med. 1977 Jul;18(7):713-7.,"['0 (Gallium Radioisotopes)', '0 (Lactoglobulins)', 'EC 3.4.21.- (Lactoferrin)']","Activity was seen in the breasts of a patient with galactorrhea 72 h after intravenous injection of Ga-67 citrate. Differential protein separation of breast secretion, extracted from the breast, revealed that the Ga-67 was contained primarily in the lactoferrin-rich protein fraction. Additional studies on partially purified lactoferrin revealed that lactoferrin binds Ga-67 more avidly than does transferrin. Since lactoferrin is present in high concentration non only in human colostrum and milk, but also in neutrophilic leukocytes, bone marrow, spleen, colon, tears, and in genital, salivary, and nasopharyngeal secretions, binding of Ga-67 to lactoferrin may explain the localization of Ga-67 in certain normal tissues and inflammatory lesions.",,,,,
267048,NLM,MEDLINE,19770825,20131121,0017-8594 (Print) 0017-8594 (Linking),36,6,1977 Jun,Development of chronic granulocytic leukemia in a patient treated with pyrimethamine.,"173,176","['Jim, R T', 'Elizaga, F V']","['Jim RT', 'Elizaga FV']",['eng'],"['Case Reports', 'Journal Article']",United States,Hawaii Med J,Hawaii medical journal,2984209R,IM,"['Female', 'Humans', 'Leukemia, Myeloid/*chemically induced', 'Pyrimethamine/*adverse effects']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,"Hawaii Med J. 1977 Jun;36(6):173,176.",['Z3614QOX8W (Pyrimethamine)'],,,,,,
267047,NLM,MEDLINE,19770812,20190823,0021-1265 (Print) 0021-1265 (Linking),146,5,1977 May,Does influenza and contact with malignant neoplasia predispose to leukaemia?,132-5,"['Kemmoona, I']",['Kemmoona I'],['eng'],"['Case Reports', 'Journal Article']",Ireland,Ir J Med Sci,Irish journal of medical science,7806864,IM,"['Adolescent', 'Adult', 'Aged', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Influenza, Human/*complications', 'Leukemia/*etiology/immunology', 'Leukemia, Lymphoid/etiology', 'Leukemia, Myeloid/etiology', 'Leukemia, Myeloid, Acute/etiology', 'Lymphoma, Non-Hodgkin/etiology', 'Male', 'Middle Aged', 'Neoplasms/*immunology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1007/BF03030947 [doi]'],ppublish,Ir J Med Sci. 1977 May;146(5):132-5. doi: 10.1007/BF03030947.,,,,,,,
267045,NLM,MEDLINE,19770902,20041117,0367-6102 (Print) 0367-6102 (Linking),52,1,1977 Jan,[Erythroleukemia with PAS negative megaerythroblast-like cells--a case study].,68-70,"['Morioka, T', 'Sakurama, T', 'Mikami, A', 'Fujine, M', 'Okamoto, M']","['Morioka T', 'Sakurama T', 'Mikami A', 'Fujine M', 'Okamoto M']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Hokkaido Igaku Zasshi,[Hokkaido igaku zasshi] The Hokkaido journal of medical science,17410290R,IM,"['Adult', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Erythroblasts/*pathology', 'Erythrocytes/*pathology', 'Humans', 'Leukemia, Erythroblastic, Acute/*blood', 'Liver/pathology', 'Male', 'Spleen/pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Hokkaido Igaku Zasshi. 1977 Jan;52(1):68-70.,,,,,,,
267010,NLM,MEDLINE,19770812,20190813,0340-6199 (Print) 0340-6199 (Linking),125,2,1977 Jun 1,Accuracy of blood volume estimations in critically ill children using 125I-labelled albumin and 51Cr-labelled red cells.,143-51,"['Linderkamp, O', 'Holthausen, H', 'Seifert, J', 'Butenandt, I', 'Riegel, K P']","['Linderkamp O', 'Holthausen H', 'Seifert J', 'Butenandt I', 'Riegel KP']",['eng'],['Journal Article'],Germany,Eur J Pediatr,European journal of pediatrics,7603873,IM,"['Adolescent', 'Blood Volume Determination/methods/*standards', 'Burns/blood', 'Child', 'Child, Preschool', 'Chromium Radioisotopes', 'Erythrocytes', 'Female', 'Humans', 'Infant', 'Leukemia, Lymphoid/blood', 'Male', 'Sepsis/blood', 'Serum Albumin, Radio-Iodinated']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1007/BF00489987 [doi]'],ppublish,Eur J Pediatr. 1977 Jun 1;125(2):143-51. doi: 10.1007/BF00489987.,"['0 (Chromium Radioisotopes)', '0 (Serum Albumin, Radio-Iodinated)']","Blood volume was estimated using 51chromium labelled red cells and 125iodinated human serum albumin in 5 children with sepsis, in 6 burned children and 7 children with acute lymphoblastic leukaemia. Studies of the equilibration pattern demonstrated that the mixing time of labelled red cells was prolonged to 40 minutes or more in 5 children, indicating the existence of slowly circulating red cells. Mixing of labelled albumin was complete within 10 minutes in 15 patients and within 20 minutes in all the children studied. In a burned patient with severe sepsis, exchange transfusion improved the clinical state and normalized the equilibration pattern of labelled red cells. The mean body/venous haematocrit ratio was 0.893+/-0.018 (SD) in the children with sepsis, 0.859+/-0.052 in the burned patients, and 0.916+/-0.078 in the children with acute lymphoblastic leukaemia, increasing with spleen size in the latter group.",,,,,
266988,NLM,MEDLINE,19770812,20131121,0012-0472 (Print) 0012-0472 (Linking),102,24,1977 Jun 17,[Splenectomy for chronic myeloid leukaemia in the early and late phases (author's transl)].,889-93,"['Stolzenbach, G', 'Garbrecht, M', 'Delling, G']","['Stolzenbach G', 'Garbrecht M', 'Delling G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adult', 'Biopsy', 'Busulfan/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy/pathology/*surgery', 'Liver/pathology', 'Male', 'Middle Aged', 'Spleen/pathology', '*Splenectomy', 'Time Factors']",1977/06/17 00:00,1977/06/17 00:01,['1977/06/17 00:00'],"['1977/06/17 00:00 [pubmed]', '1977/06/17 00:01 [medline]', '1977/06/17 00:00 [entrez]']",['10.1055/s-0028-1104983 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Jun 17;102(24):889-93. doi: 10.1055/s-0028-1104983.,['G1LN9045DK (Busulfan)'],"Splenectomy was perfomed in three patients with typical chronic myeloid leukaemia after a compensated stage had been reached with busulphan. Marked pancytopenia as a result of hypersplenism occurred in one patient 14 months after the end of the primary induction, and was successfully treated by splenectomy after radiotherapy of the spleen had failed. Splenectomy was performed without complication, and the histological appearance of the spleen showed myeloid infiltrates while there was none in the liver biopsy. After another 18 months the patient remained compensated, without busulphan administration. In the two other patients splenectomy was performed in the recompensated stage, one month and five years, respectively, after the primary induction had been concluded. In these two patients, too, there was myeloid infiltration of the spleen. In both, mild leucocytosis with shift to the left as far as promyelocytes occurred six and two weeks, respectively, after splenectomy and busulphan was started again. Twelve and ten months, respectively, after splenectomy they are both in the compensated stage. The importance of splenectomy in the early phase lies in the possibility of delaying blast crisis and avoiding myelofibrosis, as well as in the prevention of complications in the later stages.",Bedeutung der Splenektomie bei chronischer meyloischer Leukamie in der fruhen und spaten phase.,,,,
266986,NLM,MEDLINE,19770812,20081121,0012-0472 (Print) 0012-0472 (Linking),102,23,1977 Jun 10,[Megakaryocytic myelosis: clinical and morphological features (author's transl)].,853-7,"['Prechtel, K', 'Beil, E', 'Kronseder, A']","['Prechtel K', 'Beil E', 'Kronseder A']",['ger'],"['English Abstract', 'Journal Article']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adult', 'Age Factors', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid/complications', 'Male', 'Middle Aged', 'Polycythemia Vera/complications', 'Sex Factors', 'Splenomegaly/complications', 'Thrombocythemia, Essential/*blood/complications/pathology', 'Thromboembolism/complications']",1977/06/10 00:00,1977/06/10 00:01,['1977/06/10 00:00'],"['1977/06/10 00:00 [pubmed]', '1977/06/10 00:01 [medline]', '1977/06/10 00:00 [entrez]']",['10.1055/s-0028-1104976 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Jun 10;102(23):853-7. doi: 10.1055/s-0028-1104976.,,"In general, megakaryocytic myelosis is nowadays considered to be a separate disease entity, one of the myeloproliferative syndromes. Morphologically there are localised or diffuse proliferations of usually large pleomorphic megakaryocytes and immature atypical megakaryocytes up to megakaryoblasts in the bone marrow, in the sense of a haemoblastosis. In the course of the disease megakaryocytic splenomegaly develops. A sarcomatous form (megakaryoblastoma, megakaryo-sarcoma) is rare. Megakaryocytic myelosis may arise from chronic meyloid leukaemia or polycythaemia vera, rarely as a transitional stage to an acute myeloblastic leukaemia or megakaryoblastic leukemia in the sense of a blast crisis. The mature form of the disease, which has an age peak at 59 years and is not sex-linked, often takes a course over years with increasing splenomegaly, anaemia, moderate leucocytosis and usually marked thrombocytosis (average value of 720 X 10(9)/1). Life threatening complications are haemorrhages, thromboembolism and increased frequency of infections due to antibody deficiency in the advanced stage.",Megakaryozytare Myelose Klinik und Morphologie,,,,
266971,NLM,MEDLINE,19770812,20201209,0008-543X (Print) 0008-543X (Linking),39,6,1977 Jun,Adult respiratory distress syndrome (ARDS) following aggressive management of extensive acute lymphoblastic leukemia.,2422-5,"['Hewlett, R I', 'Wilson, A F']","['Hewlett RI', 'Wilson AF']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Drug Therapy, Combination/*adverse effects', 'Humans', 'Leukemia, Lymphoid/complications/*drug therapy', 'Male', 'Respiratory Distress Syndrome/*etiology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1002/1097-0142(197706)39:6<2422::aid-cncr2820390618>3.0.co;2-u [doi]'],ppublish,Cancer. 1977 Jun;39(6):2422-5. doi: 10.1002/1097-0142(197706)39:6<2422::aid-cncr2820390618>3.0.co;2-u.,,The adult respiratory distress syndrome occurred during aggressive therapy of extensive acute leukemia. The pathogenic mechanisms involved includes development of disseminated intravascular coagulation probably initiated by tissue factors from necrotic leukemic cells following chemotherapy. Awareness of the possibility of the complication is stressed.,,,,,
266970,NLM,MEDLINE,19770812,20190619,0008-543X (Print) 0008-543X (Linking),39,6,1977 Jun,Phytohemagglutinin skin tests in cancer patients.,2355-61,"['Zuckerman, K S', 'LoBuglio, A F']","['Zuckerman KS', 'LoBuglio AF']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Breast Neoplasms/immunology', 'Colonic Neoplasms/immunology', 'Hodgkin Disease/immunology', 'Humans', '*Hypersensitivity, Delayed', 'Lectins', 'Leukemia, Myeloid/immunology', 'Lung Neoplasms/immunology', 'Lymphoma/immunology', 'Melanoma/immunology', 'Neoplasms/*immunology', 'Skin Tests']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1002/1097-0142(197706)39:6<2355::aid-cncr2820390607>3.0.co;2-p [doi]'],ppublish,Cancer. 1977 Jun;39(6):2355-61. doi: 10.1002/1097-0142(197706)39:6<2355::aid-cncr2820390607>3.0.co;2-p.,['0 (Lectins)'],"Phytohemagglutinin (PHA) stimulates blastic transformation of normal lymphocytes in vitro and when injected intradermally produces a skin response histologically similar to a delayed hypersensitivity reaction. We investigated the skin test responses to PHA, mumps, candida, and varidase (SK-SD) and the PHA-induced lymphocyte transformation in patients with malignant neoplasms. Increased incidence of anergy to recall antigens and unresponsiveness to PHA skin testing was observed in patients with lymphoreticular malignancies but not in those with solid tumors. There was a direct correlation between skin test reactivity to at least one recall antigen and/or PHA and survival in lymphoma patients. This was true of both short and long terms survival in Hodgkin's disease and of survival at least through 42 months in non-Hodgkin's lymphomas. In vitro stimulation of lymphocytes with PHA did not correlate with PHA skin test reactivity. We conclude that PHA skin testing is a useful adjunct in the evaluation of patients with lymphoreticular malignancies.",,,,,
266969,NLM,MEDLINE,19770812,20190619,0008-543X (Print) 0008-543X (Linking),39,6,1977 Jun,HLA linked resistance factors and survival in acute myelogenous leukemia.,2337-41,"['Oliver, R T', 'Pillai, A', 'Klouda, P T', 'Lawler, S D']","['Oliver RT', 'Pillai A', 'Klouda PT', 'Lawler SD']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['HLA Antigens/*analysis', 'Histocompatibility Antigens/*analysis', 'Humans', 'Leukemia, Myeloid, Acute/*immunology/mortality', 'Phenotype']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1002/1097-0142(197706)39:6<2337::aid-cncr2820390603>3.0.co;2-x [doi]'],ppublish,Cancer. 1977 Jun;39(6):2337-41. doi: 10.1002/1097-0142(197706)39:6<2337::aid-cncr2820390603>3.0.co;2-x.,"['0 (HLA Antigens)', '0 (Histocompatibility Antigens)']","The concept that HLA-linked immune response genes may influence survival of patients with malignant disease has been investigated by performing HLA typing on a series of 150 patients with acute myelogenous leukemia. Patients with A1 and B8 and/or A2 and B12 survival longer than patients without either of these pairs of antigens in association. However, after correction of the statistical probability for the number of A and B locus combinations theoretically possible, these differences are not statistically significant. Clarification of this must await independent analysis of other series and more direct approaches to the study of immune response genes in man.",,,,,
266965,NLM,MEDLINE,19770902,20190501,0007-1447 (Print) 0007-1447 (Linking),2,6079,1977 Jul 9,Colony-forming cells and myeloblasts in chronic granulocytic leukaemia.,125-6,"['Goldman, J M', 'Lewis, D', 'Buskard, N A']","['Goldman JM', 'Lewis D', 'Buskard NA']",['eng'],"['Case Reports', 'Letter']",England,Br Med J,British medical journal,0372673,IM,"['*Bone Marrow', '*Bone Marrow Cells', 'Clone Cells', 'Female', 'Humans', 'Leukemia, Myeloid/*blood', 'Leukocytes', 'Middle Aged']",1977/07/09 00:00,1977/07/09 00:01,['1977/07/09 00:00'],"['1977/07/09 00:00 [pubmed]', '1977/07/09 00:01 [medline]', '1977/07/09 00:00 [entrez]']",['10.1136/bmj.2.6079.125-d [doi]'],ppublish,Br Med J. 1977 Jul 9;2(6079):125-6. doi: 10.1136/bmj.2.6079.125-d.,,,,PMC1631015,,,
266964,NLM,MEDLINE,19770825,20171116,0007-1064 (Print) 0007-1064 (Linking),17,5,1977 May,Leukaemia in children.,"444, 446-7, 449-50","['Malpas, J S']",['Malpas JS'],['eng'],['Journal Article'],England,Br J Hosp Med,British journal of hospital medicine,0171545,IM,"['Central Nervous System Diseases/drug therapy/radiotherapy', 'Child', 'Child, Preschool', 'Diagnosis, Differential', 'Female', 'Humans', 'Immunotherapy', 'Injections, Spinal', '*Leukemia/diagnosis/therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid/therapy', 'Leukemia, Myeloid, Acute/therapy', 'Male', 'Mercaptopurine/administration & dosage', 'Methotrexate/administration & dosage', 'Prednisolone/administration & dosage', 'Remission, Spontaneous', 'Vincristine/administration & dosage']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,"Br J Hosp Med. 1977 May;17(5):444, 446-7, 449-50.","['5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
266956,NLM,MEDLINE,19770812,20190902,0006-5242 (Print) 0006-5242 (Linking),34,5,1977 May,[Effect of short-time suspension culture of hematopoietic cells on the mitosis rate in early blastic leukemia: method for the improvement of preparation conditions for cytogenetic studies].,398-402,"['Hellriegel, K P', 'Heit, W', 'Byrne, P']","['Hellriegel KP', 'Heit W', 'Byrne P']",['ger'],['Journal Article'],Germany,Blut,Blut,0173401,IM,"['Acute Disease', 'Adolescent', 'Aged', 'Anemia, Aplastic/pathology', 'Culture Techniques/*methods', 'Humans', 'Karyotyping', 'Leukemia/*pathology', 'Leukemia, Myeloid/pathology', 'Male', 'Middle Aged', 'Time Factors']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1007/BF00996083 [doi]'],ppublish,Blut. 1977 May;34(5):398-402. doi: 10.1007/BF00996083.,,,Effekt von Kurzzeit-Suspensionskulturen hamatopoetischer Zellen auf die Mitoserate bei Fruhstadien unreifzelliger Leukamien: Eine Methode zur Verbesserung der Praparations-bedingungen fur zytogenetische Untersuchungen,,,,
266955,NLM,MEDLINE,19770812,20190902,0006-5242 (Print) 0006-5242 (Linking),34,5,1977 May,[Tartrate-resistant acid phosphatase in various cell types of lympho-reticular and hematopoietic system].,393-7,"['Schaefer, H E', 'Hellriegel, K P', 'Fischer, R']","['Schaefer HE', 'Hellriegel KP', 'Fischer R']",['ger'],['Journal Article'],Germany,Blut,Blut,0173401,IM,"['Acid Phosphatase/*analysis', 'Adult', 'Aged', 'Bone Marrow/enzymology', 'Bone Marrow Cells', 'Female', 'Hematopoietic System/*enzymology', 'Humans', 'Leukemia/*enzymology', 'Leukemia, Lymphoid/enzymology', 'Leukemia, Myeloid/enzymology', 'Lymphocytes/enzymology', 'Male', 'Mononuclear Phagocyte System/*enzymology', 'Pregnancy', 'Tartrates']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1007/BF00996082 [doi]'],ppublish,Blut. 1977 May;34(5):393-7. doi: 10.1007/BF00996082.,"['0 (Tartrates)', 'EC 3.1.3.2 (Acid Phosphatase)']",,Vorkommen von Tartrat-resistenter saurer Phosphatase in verschiedenen Zelltypen des lympho-retikularen und hamopoetischen Systems,,,,
266954,NLM,MEDLINE,19770902,20210216,0006-4971 (Print) 0006-4971 (Linking),50,2,1977 Aug,Divergent patterns of marrow cell suspension culture growth in the myeloid leukemias: correlation of in vitro findings with clinical features.,263-74,"['Elias, L', 'Greenberg, P']","['Elias L', 'Greenberg P']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['*Bone Marrow', '*Bone Marrow Cells', 'Cell Division', 'Cells, Cultured', 'Humans', 'Leukemia, Myeloid/*blood/pathology', 'Leukemia, Myeloid, Acute/*blood/pathology', 'Remission, Spontaneous']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['S0006-4971(20)66606-X [pii]'],ppublish,Blood. 1977 Aug;50(2):263-74.,,"Cellular recovery, maturation, and colony-forming cell (CFC) generation patterns of bone marrow cells from 23 patients with acute, subacute, and chronic myeloid leukemia (AML, SML, and CML) were studied using liquid and agar culture techniques. Increased recovery of proliferative myeloid cells from liquid culture was noted in 6 of 8 AML patients at diagnosis or relapse and 5 of 7 untreated SML patients. Patients with either AML or SML with rapid clinical progression exhibited greater recovery of cells in vitro with less maturation than patients with more stable disease. Studies from 3 patients with CML showed normal to increased cellular recovery with normal maturation. Three of 4 studies of AML patients followed sequentially in apparent remission, but with impending relapse, exhibited increased numbers of myeloblasts and promyelocytes, whereas 28 of 32 studies performed during stable remission were normal. The normally observed increase in CFC during liquid culture was absent in most leukemic marrow samples studied (3 of 4 AML, 4 of 6 SML, and 2 of 3 CML). Persistent low recovery of CFC during AML remission was associated in 3 patients with short remission duration. These studies indicated the potential utility of these techniques for the clinical evaluation of patients with myeloid leukemia and for studying factors involved in the progression of these diseases.",,,,,
266953,NLM,MEDLINE,19770902,20210216,0006-4971 (Print) 0006-4971 (Linking),50,2,1977 Aug,A case of acute myeloblastic leukemia with Ph1 chromosome showing translocation 9q+;22q-.,259-62,"['Nagao, K', 'Yonemitsu, H', 'Yamaguchi, K', 'Okuda, K']","['Nagao K', 'Yonemitsu H', 'Yamaguchi K', 'Okuda K']",['eng'],"['Case Reports', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['*Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Cytarabine/therapeutic use', 'Humans', 'Japan', 'Leukemia, Myeloid, Acute/drug therapy/*genetics', 'Male', 'Mercaptopurine/therapeutic use', 'Middle Aged', 'Nuclear Warfare', 'Prednisolone/therapeutic use', 'Translocation, Genetic']",1977/08/01 00:00,1977/08/01 00:01,['1977/08/01 00:00'],"['1977/08/01 00:00 [pubmed]', '1977/08/01 00:01 [medline]', '1977/08/01 00:00 [entrez]']",['S0006-4971(20)66605-8 [pii]'],ppublish,Blood. 1977 Aug;50(2):259-62.,"['04079A1RDZ (Cytarabine)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)']","Cytogenetic studies of the bone marrow and peripheral blood with the quinacrine fluorescence banding technique in a patient with the clinical diagnosis of acute myeloblastic leukemia revealed the Philadelphia chromosome due to a translocation between chromosomes 22 and 9. He had been exposed to the atomic bomb in Hiroshima, and some hours after the exposure he wandered into the hypocenter.",,,,,
266952,NLM,MEDLINE,19770812,20210216,0006-4971 (Print) 0006-4971 (Linking),50,1,1977 Jul,Acute lymphoblastic leukemia in persons over the age of 30 yr in the middle east.,180,"['Al-Mondhiry, H']",['Al-Mondhiry H'],['eng'],['Letter'],United States,Blood,Blood,7603509,IM,"['Adult', '*Aging', 'Humans', 'Iraq', 'Leukemia, Lymphoid/*epidemiology']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",['S0006-4971(20)66639-3 [pii]'],ppublish,Blood. 1977 Jul;50(1):180.,,,,,,,
266951,NLM,MEDLINE,19770812,20210216,0006-4971 (Print) 0006-4971 (Linking),50,1,1977 Jul,Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapy.,107-13,"['Smalley, R V', 'Vogel, J', 'Huguley, C M Jr', 'Miller, D']","['Smalley RV', 'Vogel J', 'Huguley CM Jr', 'Miller D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Blood Cell Count', 'Blood Platelets', 'Bone Marrow/*drug effects', '*Bone Marrow Cells', 'Chromosomes, Human, 21-22 and Y', 'Cytarabine/*therapeutic use', 'Granulocytes', 'Humans', 'Leukemia, Myeloid/drug therapy/*genetics', 'Leukocyte Count', 'Thioguanine/*therapeutic use', 'Time Factors']",1977/07/01 00:00,2001/03/28 10:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/07/01 00:00 [entrez]']",['S0006-4971(20)66630-7 [pii]'],ppublish,Blood. 1977 Jul;50(1):107-13.,"['04079A1RDZ (Cytarabine)', 'FTK8U1GZNX (Thioguanine)']","Sixteen patients with Ph1-positive chronic granulocytic leukemic (CGL) were entered on a pulsing chemotherapy program consisting of cytosine arabinoside 100 mg/sq m/day X 5 and thioguanine 100 mq/sq m/day X 5 every 21 days in an attempt to convert the Ph1-positive marrow to a Ph1-negative state and thereby achieve a complete remission. Twelve patients had an adequate trail of drug treatment, and ten of these had adequate chromosome examinations. There were two ""conversions,"" one of which was maintained for 5+ mo, while the other was transient. The program was unacceptable, however, to most patients due to intolerable nausea and vomiting. Thus a prospective chemotherapeutic attempt to convert a Ph1-positive marrow without splenectomy has induced a conversion in two of ten patients. Other regimens which might induce less nausea and vomiting and a higher rate of conversions should be sought in future attempts to alter the invariably fatal outcome of CGL.",,,,,
266949,NLM,MEDLINE,19770812,20211203,0007-1048 (Print) 0007-1048 (Linking),35,4,1977 Apr,Analysis of treatment in childhood leukaemia. III. Independence of lymphopenia induced by irradiation and by chemotherapy.,597-612,"['Waller, C A', 'MacLennan, I C', 'Campbell, A C', 'Festenstein, M', 'Kay, H E']","['Waller CA', 'MacLennan IC', 'Campbell AC', 'Festenstein M', 'Kay HE']",['eng'],"['Comparative Study', 'Journal Article']",England,Br J Haematol,British journal of haematology,0372544,IM,"['Antimetabolites, Antineoplastic/*adverse effects', 'Humans', 'Immunosuppression Therapy', 'Leukemia, Lymphoid/*therapy', 'Lymphocytes/drug effects/immunology/radiation effects', 'Lymphopenia/*etiology/immunology', 'Mercaptopurine/adverse effects', 'Methotrexate/adverse effects', 'Radiation Injuries/pathology', 'Radiotherapy/*adverse effects']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00624.x [doi]'],ppublish,Br J Haematol. 1977 Apr;35(4):597-612. doi: 10.1111/j.1365-2141.1977.tb00624.x.,"['0 (Antimetabolites, Antineoplastic)', 'E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']","Lymphopenia induced by treatment for acute lymphoblastic leukaemia is analysed and discussed in relation to the type and incidence of infection occurring in those patients during complete remission. Blood lymphocytes can be placed into three largely independent groups: (1) those lymphocytes susceptible to long-term depletion following irradiation; (2) those lost from the blood during and for a short period after maintenance chemotherapy with methotrexate and 6-mercaptopurine; and (3) the remainder which are not depleted by irradiation or maintenance chemotherapy. The number of cells in each compartment varies from child to child and probably with age but on average is about 1.2 x 10(9)/1. for group 1, 0.7 x 10(9)/1. for group 2 and 0.4 x 10(9)/1. for group 3. Conventional lymphocyte typing crosses these barriers in that: Group 1 consists mainly of E-rosetting cells and cells which show a mitotic response to phytohaemagglutinin; Group 2 also contains E-rosetting cells but contains a major proportion of blood lymphocytes with surface immunoglobulin and essentially all antibody dependent cytotoxic lymphocyte (K-cell) activity; Group 3 comprises E-rosetting cells and a few immunoglobulin-staining cells.",,,,,
266948,NLM,MEDLINE,19770902,20190515,0007-0920 (Print) 0007-0920 (Linking),35,6,1977 Jun,Changes in granulopoiesis detected by in vitro colony formation in acute lymphatic leukaemia.,868-74,"['Morris, T C', 'Butler, M', 'Muldrew, J G', 'McNeill, T A', 'Bridges, J M']","['Morris TC', 'Butler M', 'Muldrew JG', 'McNeill TA', 'Bridges JM']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Adolescent', 'Adult', 'Bone Marrow/physiology', 'Bone Marrow Cells', 'Child', 'Child, Preschool', 'Clone Cells', 'Female', 'Granulocytes/*physiology', '*Hematopoiesis', 'Humans', 'Leukemia, Lymphoid/*physiopathology', 'Leukocytes/*physiology', 'Male', 'Middle Aged', 'Prognosis', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1038/bjc.1977.130 [doi]'],ppublish,Br J Cancer. 1977 Jun;35(6):868-74. doi: 10.1038/bjc.1977.130.,,"Patients with acute lymphatic leukaemia (ALL) could be divided into two groups at diagnosis--those whose peripheral blood and/or bone marrow exhibited in vitro colony formation and those in whom it did not, but this finding did not appear to correlate with any clinical or haematological parameter, or with prognosis. The colonly-forming potential of patients with ALL in their first full remission, early relapse or second remission did not deviate significantly from previously established normal values, but the colony-forming potential of patients in early remission was very significantly reduced. No loss of colony-forming potential of normal marrow cells was noted when they were cultured with cells from patients with ALL.",,PMC2025522,,,
266851,NLM,MEDLINE,19770718,20071115,0151-9638 (Print) 0151-9638 (Linking),104,2,1977 Feb,[Sweet syndrome and acute myeloid leukemia].,160-1,"['Pirard, C', 'Delannoy, A']","['Pirard C', 'Delannoy A']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Dermatol Venereol,Annales de dermatologie et de venereologie,7702013,IM,"['Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications', 'Leukocytosis/complications', 'Middle Aged', 'Neutrophils', 'Skin/pathology', 'Skin Diseases/*complications/pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Ann Dermatol Venereol. 1977 Feb;104(2):160-1.,,,Syndrome de Sweet et leucemie myeloide aigue,,,,
266850,NLM,MEDLINE,19770718,20071115,0003-410X (Print) 0003-410X (Linking),128,2,1977 Feb,[Peripheral neuropathy with leukoblastic infiltration in nerve and muscle biopsies].,137-41,"['Buge, A', 'Escourolle, R', 'Poisson, M', 'Rancurel, G', 'Hauw, J J', 'Denvil, D']","['Buge A', 'Escourolle R', 'Poisson M', 'Rancurel G', 'Hauw JJ', 'Denvil D']",['fre'],"['Case Reports', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,IM,"['Female', 'Humans', '*Leukemia, Myeloid, Acute/pathology', 'Male', 'Middle Aged', 'Muscles/pathology', 'Neoplasm Metastasis', 'Peripheral Nerves/pathology', '*Peripheral Nervous System Neoplasms/pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1977 Feb;128(2):137-41.,,,Neuropathie peripherique avec infiltration leucoblastique sur les biopsies nerveuse et musculaire,,,,
266846,NLM,MEDLINE,19770718,20181113,0002-9440 (Print) 0002-9440 (Linking),87,3,1977 Jun,Radiation-induced erythroleukemia in the beagle dog. A hematologic summary of five cases.,499-510,"['Tolle, D V', 'Fritz, T E', 'Norris, W P']","['Tolle DV', 'Fritz TE', 'Norris WP']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Am J Pathol,The American journal of pathology,0370502,IM,"['Animals', 'Bone Marrow/pathology/radiation effects', 'Cobalt Radioisotopes/*adverse effects', 'Disease Models, Animal', 'Dog Diseases/etiology', 'Dogs', 'Erythrocytes/pathology', 'Erythrocytes, Abnormal/radiation effects', 'Female', 'Leukemia, Erythroblastic, Acute/*blood/etiology', 'Liver/pathology/radiation effects', 'Male', 'Radiation Effects', 'Spleen/pathology/radiation effects']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Am J Pathol. 1977 Jun;87(3):499-510.,['0 (Cobalt Radioisotopes)'],"Eleven cases of myeloproliferative disease occurred in a group of 24 beagle dogs placed in a 60Co gamma-ray field at about 13 months of age and irradiated at an exposure rate of 5 R/22-hour day for duratior of life. Of these 11 dogs, 5 (described in this paper) were diagnosed as having erythroleukemia. The bone marrow showed marked erythroblastic hyperplasia, with maturation arrest of the erythroid elements, and increased numbers of myeloblasts and promyelocytes. The terminal peripheral blood was characterized by marked anemia and thrombocytopenia, with circulating erythrocytic precursors and abnormal erythrocyte morphology. Splenomegaly and hepatomegaly occurred in 4 of the 5 animals. In the spleens and livers of all 5, there was extensive leukemic infiltration and proliferation. The extent of leukemic involvement in other tissues and organs varied in individual dogs.",,PMC2032130,,,
266841,NLM,MEDLINE,19770729,20131121,0002-9629 (Print) 0002-9629 (Linking),273,3,1977 May-Jun,Acute leukemia after azathioprine treatment of connective tissue disease.,335-40,"['Alexson, E', 'Brandt, K D']","['Alexson E', 'Brandt KD']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med Sci,The American journal of the medical sciences,0370506,IM,"['Adult', 'Arthritis, Rheumatoid/drug therapy', 'Aspirin/therapeutic use', 'Azathioprine/*adverse effects/therapeutic use', 'Collagen Diseases/*drug therapy', 'Humans', 'Leukemia, Monocytic, Acute/*chemically induced', 'Lupus Erythematosus, Systemic/drug therapy', 'Male', 'Prednisone/therapeutic use', 'Salicylates/therapeutic use']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Am J Med Sci. 1977 May-Jun;273(3):335-40.,"['0 (Salicylates)', 'MRK240IY2L (Azathioprine)', 'R16CO5Y76E (Aspirin)', 'VB0R961HZT (Prednisone)']","A 23-year-old man is reported who had a connective tissue disorder with features of rheumatoid arthritis and systemic lupus erythematosus. Because of the development of severe myocarditis and acute cerebral dysfunction treatment with azathioprine and prednisone was instituted, with dramatic clinical improvement. Ten months later, when a total of some 52 g of azathioprine had been administered, acute myelomonocytic leukemia developed. Although acute myelogenous leukemia has been noted in several individuals receiving immunosuppressive drugs for treatment of lymphoreticular neoplasms, this complication has heretofore been rare in patients given azathioprine for non-neoplastic disease. The present case is documented because of the increasing use of immunosuppressive drugs in treatment of various rheumatic disorders and the need to establish the relationship, if any, between the use of such agents and malignancy.",,,,,
266840,NLM,MEDLINE,19770729,20071115,0002-9629 (Print) 0002-9629 (Linking),273,3,1977 May-Jun,Acute myeloblastic leukemia presenting with diabetes insipidus.,325-7,"['Betkerur, U', 'Shende, A', 'Lanzkowsky, P']","['Betkerur U', 'Shende A', 'Lanzkowsky P']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Med Sci,The American journal of the medical sciences,0370506,IM,"['Child', 'Diabetes Insipidus/*etiology', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications/urine', 'Osmolar Concentration']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Am J Med Sci. 1977 May-Jun;273(3):325-7.,,Diabetes insipidus as the presenting manifestation of acute myeloblastic leukemia in a nine-year-old female is reported. In patients with recent onset of diabetes insipidus an underlying leukemic process should be excluded as an etiologic factor.,,,,,
266839,NLM,MEDLINE,19770729,20131121,0002-922X (Print) 0002-922X (Linking),131,6,1977 Jun,Busulfan lung.,650-2,"['Pearl, M']",['Pearl M'],['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Busulfan/*adverse effects/therapeutic use', 'Humans', 'Infant', 'Leukemia, Myeloid/drug therapy', 'Male', 'Pulmonary Fibrosis/*chemically induced/pathology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Am J Dis Child. 1977 Jun;131(6):650-2.,['G1LN9045DK (Busulfan)'],"An uncommon, but lethal, toxic side effect of busulfan (Myleran) therapy for chronic myelogenous leukemia is pulmonary fibrosis. A 16-month-old male infant treated for 11 months with busulfan for chronic myelogenous leukemia is, we believe, the first case of ""busulfan lung"" in the pediatric age group to be reported. Progressive roentgenographic changes in the lung of a diffuse intra-alveolar and interstitial pattern were noted. The patient died after a four-day episode of cough, fever, and progressive dyspnea. At autopsy, no evidence of infection or leukemic infiltrates were seen in the lungs. Characteristic histologic findings as a result of busulfan therapy were observed in the lung and pancreas.",,,,,
266838,NLM,MEDLINE,19770718,20190509,0002-9173 (Print) 0002-9173 (Linking),67,6,1977 Jun,Malignant myelosclerosis. Myeloproliferative disorder or leukemia?,512-20,"['Bird, T', 'Proctor, S J']","['Bird T', 'Proctor SJ']",['eng'],"['Case Reports', 'Journal Article']",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Adult', 'Aged', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid/*classification/diagnosis/pathology', 'Liver/pathology', 'Liver Diseases/etiology', 'Male', 'Mycoses/etiology', 'Myeloproliferative Disorders/*classification/diagnosis/pathology', 'Primary Myelofibrosis/*classification/diagnosis', 'Prognosis', 'Spleen/pathology']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1093/ajcp/67.6.512 [doi]'],ppublish,Am J Clin Pathol. 1977 Jun;67(6):512-20. doi: 10.1093/ajcp/67.6.512.,,"Four patients with the picture of ""malignant myelosclerosis"" are described and the relationship of this condition to acute granulocytic leukemia is discussed. It is suggested that there is a leukemic process from the beginning, that the fibrosis of the marrow is reactive rather than neoplastic, and that the disease should not be regarded as an accelerated form of chronic (primary) myelosclerosis. The presence of excessive reticulin in the marrow in acute leukemia, especially when the patient is first seen, indicates a bad prognosis and poor response to chemotherapy. A systemic fungal infection in one patient is described.",,,,,
266807,NLM,MEDLINE,19770723,20131121,0043-5341 (Print) 0043-5341 (Linking),127,9,1977 May 15,[Terminal acute leukemia with pseudo-Pelger phenocopy in IgG plasmacytoma].,283-4,"['Seewann, H L']",['Seewann HL'],['ger'],"['Case Reports', 'Journal Article']",Austria,Wien Med Wochenschr,Wiener medizinische Wochenschrift (1946),8708475,IM,"['Aged', 'Cyclophosphamide/therapeutic use', 'Female', 'Femoral Fractures/etiology', 'Fractures, Spontaneous', 'Humans', 'Immunoglobulin G', 'Leukemia, Myeloid, Acute/*complications', 'Pelger-Huet Anomaly/*complications', 'Plasmacytoma/*complications/radiotherapy', 'Spinal Neoplasms/drug therapy']",1977/05/15 00:00,1977/05/15 00:01,['1977/05/15 00:00'],"['1977/05/15 00:00 [pubmed]', '1977/05/15 00:01 [medline]', '1977/05/15 00:00 [entrez]']",,ppublish,Wien Med Wochenschr. 1977 May 15;127(9):283-4.,"['0 (Immunoglobulin G)', '8N3DW7272P (Cyclophosphamide)']",,Terminale akute Myelose mit Pseudo-Pelger-Phanokopie bei IgG-Plasmozytom,,,,
266800,NLM,MEDLINE,19770718,20211203,0041-1345 (Print) 0041-1345 (Linking),9,1,1977 Mar,Tumor immunity.,1307-9,"['Sanford, B', 'McKhann, C F']","['Sanford B', 'McKhann CF']",['eng'],['Journal Article'],United States,Transplant Proc,Transplantation proceedings,0243532,IM,"['Animals', 'Dogs', 'Humans', '*Immunity, Cellular', 'Immunosuppression Therapy', 'Leukemia, Myeloid/therapy', 'Mammary Neoplasms, Experimental/therapy', 'Neoplasms, Experimental/*immunology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Transplant Proc. 1977 Mar;9(1):1307-9.,,,,,,,
266762,NLM,MEDLINE,19770718,20161123,0036-4355 (Print) 0036-4355 (Linking),22,3,1977,[Avascular necrosis of bone attributed to intermitent corticosteroid therapy in patients with acute lymphocytic leukemia (author's transl)].,398-404,"['Zabala, P', 'Barbolla, L', 'Fernandez, M N']","['Zabala P', 'Barbolla L', 'Fernandez MN']",['spa'],['Journal Article'],Spain,Sangre (Barc),Sangre,0404373,IM,"['Adolescent', 'Adrenal Cortex Hormones/*adverse effects/therapeutic use', 'Child', 'Drug Therapy, Combination/adverse effects', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Osteonecrosis/*chemically induced/diagnostic imaging', 'Prednisolone/adverse effects/therapeutic use', 'Radiography', 'Vincristine/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(3):398-404.,"['0 (Adrenal Cortex Hormones)', '5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)']",,Necrosis osea avascular atribuible a corticoterapia intermitente en pacientes con leucemia linfatica aguda,,,,
266761,NLM,MEDLINE,19770718,20071115,0036-4355 (Print) 0036-4355 (Linking),22,3,1977,[Acute lymphocytic leukaemia with polycythaemia vera. Report of a case (author's transl)].,393-7,"['Svarch, E', 'Garcia Triana, Y']","['Svarch E', 'Garcia Triana Y']",['spa'],"['Case Reports', 'English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/*complications', 'Polycythemia/*etiology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(3):393-7.,,,Leucosis aguda linfoblastica con policitemia relativa Descripcion de un caso,,,,
266723,NLM,MEDLINE,19770729,20190501,0027-8424 (Print) 0027-8424 (Linking),74,5,1977 May,Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon.,2036-40,"['Rossi, G B', 'Dolei, A', 'Cioe, L', 'Benedetto, A', 'Matarese, G P', 'Belardelli, F']","['Rossi GB', 'Dolei A', 'Cioe L', 'Benedetto A', 'Matarese GP', 'Belardelli F']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Line', 'Cell Nucleus/metabolism', 'Cytoplasm/metabolism', 'Dimethyl Sulfoxide/pharmacology', 'Friend murine leukemia virus', 'Globins/biosynthesis', 'Heme/biosynthesis', 'Hemoglobins/biosynthesis', 'Interferons/*pharmacology', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Leukemia, Experimental/metabolism', 'Neoplasm Proteins/biosynthesis', 'Protein Biosynthesis/*drug effects', 'RNA, Messenger/*metabolism', 'Transcription, Genetic/*drug effects']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1073/pnas.74.5.2036 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 May;74(5):2036-40. doi: 10.1073/pnas.74.5.2036.,"['0 (Hemoglobins)', '0 (Neoplasm Proteins)', '0 (RNA, Messenger)', '42VZT0U6YR (Heme)', '9004-22-2 (Globins)', '9008-11-1 (Interferons)', 'YOW8V9698H (Dimethyl Sulfoxide)']","The addition of appropriate doses of interferon (IF) to cultures of Friend erythroleukemic cells inhibits dimethyl sulfoxide (Me2SO)-stimulated erythroid differentiation. In this study, the synthesis of heme, hemoglobin, and globin mRNA in Me2SO-stimulated cultures, with or without IF added, was compared. Although the hemoglobin content in Me2SO+IF-treated cultures was reduced 6- to 9-fold compared to that of cultures treated with Me2SO alone, there was less than a 2-fold decrease in the amount of heme accumulated. Globin mRNA, although unchanged in size or base sequence, was reduced in content in the Me2SO+IF cultures. The level of reduction of globin mRNA was insufficient to account for the lack of globin synthesis. Thus, it appears that IF may operate on two levels--one involving the transcription of globin mRNA and the other involving its translation.",,PMC431068,,,
266707,NLM,MEDLINE,19770729,20190501,0027-8424 (Print) 0027-8424 (Linking),74,5,1977 May,Identification of Rauscher murine leukemia virus-specific mRNAs for the synthesis of gag- and env-gene products.,1855-9,"['Zaane, D V', 'Gielkens, A L', 'Hesselink, W G', 'Bloemers, H P']","['Zaane DV', 'Gielkens AL', 'Hesselink WG', 'Bloemers HP']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Antigen-Antibody Reactions', 'Cell-Free System', 'Genes', '*Genes, Viral', 'Molecular Weight', 'Poly A/metabolism', 'Protein Precursors/*biosynthesis', 'RNA, Messenger/isolation & purification/*metabolism', 'RNA, Viral/isolation & purification/*metabolism', 'Rauscher Virus/*metabolism', 'Viral Proteins/*biosynthesis/immunology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1073/pnas.74.5.1855 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 May;74(5):1855-9. doi: 10.1073/pnas.74.5.1855.,"['0 (Protein Precursors)', '0 (RNA, Messenger)', '0 (RNA, Viral)', '0 (Viral Proteins)', '24937-83-5 (Poly A)']","Polyadenylylated mRNA isolated from cells infected with Rauscher murine leukemia virus was fractionated by centrifugation in in a denaturing sucrose gradient into different sizes. Each RNA fraction was injected into oocytes of Xenopus laevis and the virus-specific products were analyzed by immunoprecipitation with polyvalent and monospecific antisera against polypeptides of Rauscher murine leukemia virus, and then by gel electrophoresis and scintillation autoradiography. It was shown that a 35S mRNA species directs the synthesis of a precursor of the internal or group-specific antigens of the virion (the gag-gene products). A 22S mRNA species directs the synthesis of two viral envelope polypeptides and their precursor polypeptide (env-gene products). The results indicate that the gag- and env-related polypeptides of Rauscher murine leukemia virus are synthesized uncoordinately and provide evidence for open and closed cistrons on the virus-specific mRNAs.",,PMC431029,,,
266700,NLM,MEDLINE,19770723,20071115,0143-2524 (Print),144,18,1977 May 5,Childhood leukaemia.,45-7,"['Little, A']",['Little A'],['eng'],"['Case Reports', 'Journal Article']",England,Nurs Mirror Midwives J,Nursing mirror and midwives journal,7708428,,"['Child, Preschool', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*nursing', 'Parents', '*Pediatric Nursing', 'Professional-Family Relations']",1977/05/05 00:00,1977/05/05 00:01,['1977/05/05 00:00'],"['1977/05/05 00:00 [pubmed]', '1977/05/05 00:01 [medline]', '1977/05/05 00:00 [entrez]']",,ppublish,Nurs Mirror Midwives J. 1977 May 5;144(18):45-7.,,,,,,,
266699,NLM,MEDLINE,19770729,20151119,0301-1518 (Print) 0301-1518 (Linking),6,18,1977 Apr 30,[Value of the etiocholanolone test in Hematology. Preliminary results (68 tests)].,1547-50,"['Gorin, N C', 'Feron, R', 'Homberg, J C', 'Najman, A', 'Duhamel, G']","['Gorin NC', 'Feron R', 'Homberg JC', 'Najman A', 'Duhamel G']",['fre'],['Journal Article'],France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Blood Cell Count', 'Bone Marrow Cells', 'Drug Tolerance', '*Etiocholanolone/adverse effects/metabolism', 'Fever/chemically induced', 'Hematologic Diseases/*diagnosis', 'Humans', 'Leukemia, Lymphoid/diagnosis', 'Myelography', 'Neutropenia/diagnosis', 'Prognosis', 'Purpura, Thrombocytopenic/diagnosis']",1977/04/30 00:00,1977/04/30 00:01,['1977/04/30 00:00'],"['1977/04/30 00:00 [pubmed]', '1977/04/30 00:01 [medline]', '1977/04/30 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Apr 30;6(18):1547-50.,['97CGB1M48I (Etiocholanolone)'],,Interet du test a l'etiocholanolone en hematologie. Resultats preliminaires (68 tests),,,,
266693,NLM,MEDLINE,19770718,20071115,0031-4005 (Print) 0031-4005 (Linking),59,6,1977 Jun,"Loffler's endomyocardial fibrosis, eosinophilia, and acute lymphoblastic leukemia.",950-1,"['Pereira, F', 'Moreno, H', 'Crist, W', 'Ermocilla, R']","['Pereira F', 'Moreno H', 'Crist W', 'Ermocilla R']",['eng'],"['Case Reports', 'Journal Article']",United States,Pediatrics,Pediatrics,0376422,IM,"['Acute Disease', 'Adolescent', 'Endocarditis/*complications/pathology', 'Eosinophilia/*complications/pathology', 'Humans', 'Leukemia, Lymphoid/*complications/pathology', 'Male', 'Syndrome']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Pediatrics. 1977 Jun;59(6):950-1.,,,,,,,
266692,NLM,MEDLINE,19770718,20071115,0031-4005 (Print) 0031-4005 (Linking),59,6,1977 Jun,Selective erythroid aplasia during therapy for acute lymphoblastic leukemia.,895-8,"['Sallan, S E', 'Buchanan, G R']","['Sallan SE', 'Buchanan GR']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Pediatrics,Pediatrics,0376422,IM,"['Acute Disease', 'Anemia/*complications/etiology', 'Antineoplastic Agents/administration & dosage/adverse effects/*therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Erythropoiesis', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,Pediatrics. 1977 Jun;59(6):895-8.,['0 (Antineoplastic Agents)'],"Selective erythroid aplasia occured in two children receiving chemotherapy for acute lymphoblastic leukemia. The aplasia was reversible on cessation of therapy in one patient, and the other child remains transfusion-dependent on chemotherapy. Possible causes of pure red cell aplasia are discussed.",,,,,
266691,NLM,MEDLINE,19770718,20071115,0031-3939 (Print) 0031-3939 (Linking),52,4,1977 Apr,[Transient diabetes following treatment of acute lymphoblastic leukemia with L-asparaginase].,437-9,"['Cyklis, R', 'Armata, J', 'Legutko, L']","['Cyklis R', 'Armata J', 'Legutko L']",['pol'],"['Case Reports', 'Journal Article']",Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Acute Disease', 'Adolescent', 'Asparaginase/*adverse effects/therapeutic use', 'Diabetes Mellitus/*chemically induced', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Time Factors']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Apr;52(4):437-9.,['EC 3.5.1.1 (Asparaginase)'],,Przejsciowa cukrzyca po leczeniu L-asparaginaza ostrej bialaczki limfoblastycznej,,,,
266674,NLM,MEDLINE,19770729,20180216,0030-2414 (Print) 0030-2414 (Linking),34,1,1977,"Remission induction with daunomycin, vincristine, and prednisone in adult acute lymphocytic leukemia.",25-8,"['Einhorn, L H', 'Bond, W H']","['Einhorn LH', 'Bond WH']",['eng'],['Journal Article'],Switzerland,Oncology,Oncology,0135054,IM,"['Adolescent', 'Adult', 'Brain Neoplasms/prevention & control', 'Daunorubicin/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Prednisone/*therapeutic use', 'Remission, Spontaneous', 'Spinal Cord Neoplasms/prevention & control', 'Time Factors', 'Vincristine/*therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000225176 [doi]'],ppublish,Oncology. 1977;34(1):25-8. doi: 10.1159/000225176.,"['5J49Q6B70F (Vincristine)', 'VB0R961HZT (Prednisone)', 'ZS7284E0ZP (Daunorubicin)']","Prednisone plus vincristine plus daunomycin induced complete remission in nine adults with acute lymphocytic leukemia. The median duration of complete remission will be between 14 and 18 months, with three patients remaining in hematological remission at 10+, 11+, and 18+ months. The median survival will be between 19 and 23 months, with all patients surviving at least one year. This remission induction regimen produced rapid complete remission in adult acute lymphocytic leukemia (ALL) with minimal toxicity, and could be administered predominantly on an outpatient basis.",,,,,
266637,NLM,MEDLINE,19770718,20131121,0025-8334 (Print) 0025-8334 (Linking),22,1,1977 Jan,[Chief results and tasks of the organization of medical supervision of workers with radiation sources].,5-15,"[""Gus'kova, A K"", 'Denisova, E A', 'Chernega, G V', 'Soldatova, V A', 'Gorbarenko, N I']","[""Gus'kova AK"", 'Denisova EA', 'Chernega GV', 'Soldatova VA', 'Gorbarenko NI']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Med Radiol (Mosk),Meditsinskaia radiologiia,2984767R,IM,"['Blood Cell Count', 'Bone Neoplasms/prevention & control', 'Chronic Disease', 'Gamma Rays', 'Humans', 'Leukemia/prevention & control', 'Lung Neoplasms/prevention & control', 'Neoplasms, Radiation-Induced/prevention & control', 'Occupational Diseases/diagnosis/*prevention & control', '*Occupational Health Services', 'Organization and Administration', 'Osteosarcoma/prevention & control', 'Plutonium', 'Radiation Dosage', 'Radiation Injuries/diagnosis/*prevention & control', 'Radiation Protection', 'Radiology', 'Skin Neoplasms/prevention & control', 'X-Rays']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Med Radiol (Mosk). 1977 Jan;22(1):5-15.,['53023GN24M (Plutonium)'],,Osnovnye itogi i zadachi organizatsii meditsinskogo nabliudeniia za rabotaiushchimi s istochnikami izluchenii,,,,
266633,NLM,MEDLINE,19770723,20190819,0022-4790 (Print) 0022-4790 (Linking),9,2,1977,Failure of mice infected with Rauscher leukemia virus (RLV-A) to develop splenic colonies.,117-21,"['Bergson, A', 'LoBue, J', 'Fredrickson, T N', 'Gordon, A S']","['Bergson A', 'LoBue J', 'Fredrickson TN', 'Gordon AS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Surg Oncol,Journal of surgical oncology,0222643,IM,"['Animals', '*Hematopoietic Stem Cells', 'Leukemia, Erythroblastic, Acute/*pathology', 'Leukemia, Experimental/pathology', 'Male', 'Mice', 'Mice, Inbred BALB C', '*Rauscher Virus', 'Spleen/*pathology', 'Tumor Virus Infections/*pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/jso.2930090204 [doi]'],ppublish,J Surg Oncol. 1977;9(2):117-21. doi: 10.1002/jso.2930090204.,,"A progressive increase occurs in the CFU-S/10(6) spleen cells with the development of RLV-A-induced erythroleukemia. In addition, alteration of the spleen by the RLV-A appears to prevent the seeding and development of spleen colonies in infected mice.",,,,,
266628,NLM,MEDLINE,19770729,20190509,0027-8874 (Print) 0027-8874 (Linking),58,6,1977 Jun,A new complex Ph1 translocation involving three chromosomes.,1583-6,"['Sonta, S', 'Sandberg, A A']","['Sonta S', 'Sandberg AA']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 16-18', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Myeloid/*genetics', 'Middle Aged', 'Translocation, Genetic']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1093/jnci/58.6.1583 [doi]'],ppublish,J Natl Cancer Inst. 1977 Jun;58(6):1583-6. doi: 10.1093/jnci/58.6.1583.,,"A case of Ph1-positive chronic myelocytic leukemia associated with a complex translocation involving chromosomes No. 9, No. 17, and No. 22 was described. All cells in the marrow contained this complex karyotypic picture, and no cells with the usual type of Ph1 translocation were present. With banding analysis, the karyotypic picture consisted of 46,XX,t(9;22;17)(q34;q11;q21). The published cases of usual and complex Ph1 translocations were summarized in tabular form and some aspects of the translocations discussed.",,,,,
266494,NLM,MEDLINE,19770723,20131121,0003-1488 (Print) 0003-1488 (Linking),170,11,1977 Jun 1,Monocytic leukemia in three cats.,1325-8,"['Henness, A M', 'Crow, S E', 'Anderson, B C']","['Henness AM', 'Crow SE', 'Anderson BC']",['eng'],"['Case Reports', 'Journal Article']",United States,J Am Vet Med Assoc,Journal of the American Veterinary Medical Association,7503067,IM,"['Animals', 'Brain/pathology', '*Cat Diseases/blood/pathology', 'Cats', 'Cytarabine/therapeutic use', 'Female', 'Leukemia, Myeloid/blood/pathology/*veterinary', 'Lung/pathology', 'Male']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",,ppublish,J Am Vet Med Assoc. 1977 Jun 1;170(11):1325-8.,['04079A1RDZ (Cytarabine)'],"Of 3 cats with monocytic leukemia, 1 responded favorably to treatment with cytosine arabinoside. With supportive therapy, it lived 78 days from the time of diagnosis, at which time it developed dyspnea and signs of toxicosis and died. The other 2 cats did not respond to treatment and died 4 and 16 days from time of diagnosis. Prior to death, they were bleeding from injection sites, and their blood had greater than 200,000 WBC/mm3. Necropsy of those 2 cats revealed extensive perivascular hemorrhagic infarcts within the cerebellum, medulla, and cerebrum.",,,,,
266492,NLM,MEDLINE,19770718,20190708,0360-3016 (Print) 0360-3016 (Linking),2,3-4,1977 Mar-Apr,Meningeal leukemia--control versus cure.,371-3,"['Kun, L E', 'Pinkel, D']","['Kun LE', 'Pinkel D']",['eng'],['Journal Article'],United States,Int J Radiat Oncol Biol Phys,"International journal of radiation oncology, biology, physics",7603616,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/drug therapy/radiotherapy/*therapy', '*Meninges', 'Methotrexate/*therapeutic use']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']","['0360-3016(77)90099-2 [pii]', '10.1016/0360-3016(77)90099-2 [doi]']",ppublish,Int J Radiat Oncol Biol Phys. 1977 Mar-Apr;2(3-4):371-3. doi: 10.1016/0360-3016(77)90099-2.,['YL5FZ2Y5U1 (Methotrexate)'],,,,,,
266491,NLM,MEDLINE,19770718,20190708,0360-3016 (Print) 0360-3016 (Linking),2,3-4,1977 Mar-Apr,Repetitive low-dose radiation therapy for acute stem-cell leukemia.,257-60,"['Considine, B Jr', 'Cook, J J', 'Zuelzer, W W', 'Ravindranath, Y', 'Lusher, J M']","['Considine B Jr', 'Cook JJ', 'Zuelzer WW', 'Ravindranath Y', 'Lusher JM']",['eng'],['Journal Article'],United States,Int J Radiat Oncol Biol Phys,"International journal of radiation oncology, biology, physics",7603616,IM,"['Brain Neoplasms/radiotherapy', 'Child, Preschool', 'Humans', 'Injections, Spinal', 'Leukemia, Lymphoid/drug therapy/*radiotherapy', 'Methotrexate/administration & dosage/*therapeutic use', 'Spinal Cord Neoplasms/radiotherapy']",1977/03/01 00:00,2001/03/28 10:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/03/01 00:00 [entrez]']","['0360-3016(77)90082-7 [pii]', '10.1016/0360-3016(77)90082-7 [doi]']",ppublish,Int J Radiat Oncol Biol Phys. 1977 Mar-Apr;2(3-4):257-60. doi: 10.1016/0360-3016(77)90082-7.,['YL5FZ2Y5U1 (Methotrexate)'],,,,,,
266473,NLM,MEDLINE,19770718,20190629,0014-4754 (Print) 0014-4754 (Linking),33,5,1977 May 15,Degradation of [3H]thymidine by a pentosyltransferase (EC 2.4.2.4) in the plasma of man and different animals.,668-70,"['Pauly, J L', 'Schuller, M G', 'Zelcer, A A', 'Germain, M J']","['Pauly JL', 'Schuller MG', 'Zelcer AA', 'Germain MJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Switzerland,Experientia,Experientia,0376547,IM,"['Animals', 'DNA/biosynthesis', 'Female', 'Humans', 'Kinetics', 'Leukemia, Myeloid/enzymology', 'Male', 'Pentosyltransferases/*blood', 'Species Specificity', 'Thymidine/*blood', 'Thymidine Phosphorylase/*blood']",1977/05/15 00:00,1977/05/15 00:01,['1977/05/15 00:00'],"['1977/05/15 00:00 [pubmed]', '1977/05/15 00:01 [medline]', '1977/05/15 00:00 [entrez]']",['10.1007/BF01946565 [doi]'],ppublish,Experientia. 1977 May 15;33(5):668-70. doi: 10.1007/BF01946565.,"['9007-49-2 (DNA)', 'EC 2.4.2.- (Pentosyltransferases)', 'EC 2.4.2.4 (Thymidine Phosphorylase)', 'VC2W18DGKR (Thymidine)']","[3H]Thymidine is degraded by an enzyme (thymidine phosphorylase; EC 2.4.2.4) which we have identified in the plasma of man and some animals. The presence of this enzyme in plasma or sera used to supplement culture media may, under certain experimental conditions, limit the validity of measuring the uptake of radiolabeled thymidine as a means of defining DNA synthesis.",,,,,
266439,NLM,MEDLINE,19770729,20180214,0301-0171 (Print) 0301-0171 (Linking),18,2,1977,"A new translocation involving three chromosomes in chronic myelocytic leukemia, 46,XY,t(9;11;22).",75-81,"['Gahrton, G', 'Friberg, K', 'Zech, L']","['Gahrton G', 'Friberg K', 'Zech L']",['eng'],"['Case Reports', 'Journal Article']",Switzerland,Cytogenet Cell Genet,Cytogenetics and cell genetics,0367735,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Humans', 'Leukemia, Myeloid/*genetics', 'Male', 'Middle Aged', 'Sex Chromosomes', '*Translocation, Genetic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1159/000130750 [doi]'],ppublish,Cytogenet Cell Genet. 1977;18(2):75-81. doi: 10.1159/000130750.,,"Bone-marrow metaphases in a 63-year-old male with newly discovered chronic myelocytic leukemia (CML) showed a complex translocation involving chromosomes 9, 11, and 22. About half of the short arm of chromosome 11 was translocated to the terminal part of the long arm of chromosome 9, and the missing fragment on chromosome 22 was translocated to the short arm of the abnormal chromosome 9. The clinical features were typical of CML, and the patient is in good physical condition 10 months after diagnosis on a regimen of busulfan.",,,,,
266438,NLM,MEDLINE,19770718,20190911,0011-2240 (Print) 0011-2240 (Linking),14,2,1977 Apr,Factors in the cryopreservation of bone marrow cells from children with acute lymphocytic leukemia.,125-34,"['Ragab, A H', 'Gilkerson, E', 'Myers, M']","['Ragab AH', 'Gilkerson E', 'Myers M']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Cryobiology,Cryobiology,0006252,IM,"['Adult', 'Blood', '*Bone Marrow', '*Bone Marrow Cells', 'Cell Survival', 'Child', 'Dimethyl Sulfoxide', 'Freezing', 'Humans', '*Leukemia, Lymphoid', 'Nitrogen', '*Preservation, Biological']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']","['0011-2240(77)90132-8 [pii]', '10.1016/0011-2240(77)90132-8 [doi]']",ppublish,Cryobiology. 1977 Apr;14(2):125-34. doi: 10.1016/0011-2240(77)90132-8.,"['N762921K75 (Nitrogen)', 'YOW8V9698H (Dimethyl Sulfoxide)']",,,,,,
266428,NLM,MEDLINE,19770723,20190509,0009-9236 (Print) 0009-9236 (Linking),21,6,1977 Jun,Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia.,744-50,"['van Prooijen, R', 'van der Kleijn, E', 'Haanen, C']","['van Prooijen R', 'van der Kleijn E', 'Haanen C']",['eng'],"['Comparative Study', 'Journal Article']",United States,Clin Pharmacol Ther,Clinical pharmacology and therapeutics,0372741,IM,"['Adult', 'Aged', 'Cytarabine/*metabolism/therapeutic use', 'Deamination', 'Female', 'Glomerular Filtration Rate', 'Humans', 'Infusions, Parenteral', 'Injections, Intravenous', 'Leukemia, Myeloid, Acute/*drug therapy/metabolism', 'Male', 'Middle Aged']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1002/cpt1977216744 [doi]'],ppublish,Clin Pharmacol Ther. 1977 Jun;21(6):744-50. doi: 10.1002/cpt1977216744.,['04079A1RDZ (Cytarabine)'],"In 14 patients with acute myeloid leukemia (AML) the plasma concentration of cytosine arabinoside (Ara-C) was determined at the start of the first course of treatment at various intervals after a bolus injection. In 10 patients plasma concentration/time data were fitted to a biexponential equation and pharmacokinetic parameters were estimated from the coefficient and exponents of such equations. The plasma half-life (t1/2) of Ara-C of the first phase varied from 1.2 to 1.9 min (mean 1.6). The t1/2 of the second phase varied from 8.8 to 18.9 min. All patients were treated with Ara-C alone in a dose of 100 mg/m2 for 10 or 14 days. There was poor treatment response in five patients with second-phase t1/2 of Ara-C ranging from 6.6 to 10.7 min whereas there was complete remission in nine patients with t1/2 exceeding 12.7 min. In three patients plasma Ara-C concentrations were measured during constant-rate infusion of different amounts of drug. It appeared that the plateau concentrations were directly proportional to the dose, which indicated that in the therapeutic range no enzyme capacity-limited elimination occurs.",,,,,
266427,NLM,MEDLINE,19770729,20170214,0009-9228 (Print) 0009-9228 (Linking),16,6,1977 Jun,Bone marrow necrosis in children: three instances.,565-8,"['Kinney, T R', 'Koch, P A', 'Gottlieb, R P', 'Donaldson, M H']","['Kinney TR', 'Koch PA', 'Gottlieb RP', 'Donaldson MH']",['eng'],"['Case Reports', 'Journal Article']",United States,Clin Pediatr (Phila),Clinical pediatrics,0372606,IM,"['Adolescent', 'Bone Marrow/*pathology', 'Breast Neoplasms/complications/diagnosis', 'Child', 'Female', 'Humans', 'Leukemia, Lymphoid/complications/diagnosis', 'Lymphoma, Non-Hodgkin/complications/diagnosis', 'Male', 'Necrosis', 'Pain/complications', 'Prognosis']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['10.1177/000992287701600615 [doi]'],ppublish,Clin Pediatr (Phila). 1977 Jun;16(6):565-8. doi: 10.1177/000992287701600615.,,,,,,,
266426,NLM,MEDLINE,19770723,20190705,0092-8674 (Print) 0092-8674 (Linking),10,4,1977 Apr,Surface changes in differentiating Friend erythroleukemic cells in culture.,689-95,"['Eisen, H', 'Nasi, S', 'Georgopoulos, C P', 'Arndt-Jovin, D', 'Ostertag, W']","['Eisen H', 'Nasi S', 'Georgopoulos CP', 'Arndt-Jovin D', 'Ostertag W']",['eng'],['Journal Article'],United States,Cell,Cell,0413066,IM,"['*Agglutination/drug effects', 'Binding Sites, Antibody', '*Cell Differentiation', 'Cell Line', 'Cell Transformation, Neoplastic', 'Concanavalin A', 'Dimethyl Sulfoxide/pharmacology', 'Friend murine leukemia virus', 'Lectins', 'Leukemia, Erythroblastic, Acute', 'Receptors, Concanavalin A']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']","['0092-8674(77)90102-7 [pii]', '10.1016/0092-8674(77)90102-7 [doi]']",ppublish,Cell. 1977 Apr;10(4):689-95. doi: 10.1016/0092-8674(77)90102-7.,"['0 (Lectins)', '0 (Receptors, Concanavalin A)', '11028-71-0 (Concanavalin A)', 'YOW8V9698H (Dimethyl Sulfoxide)']","The sensitivity to agglutination by several plant lectins has been studied during the induced erythroid differentiation of Friend erythroleukemic cells in culture. In addition, the number of lectin receptors on the cell has been measured. It is shown that early during the differentiation, there is an increase in agglutinability while the receptor density remains constant. In the later phase of the differentiation process, the cells lose their sensitivity to agglutination while the receptor number and density increases. These changes were not observed on nonerythroid mastocytoma culture cells. Two nondifferentiating variants of the FL cells were shown to have altered sensitivities to agglutination by ConA.",,,,,
266418,NLM,MEDLINE,19770718,20131121,0361-5960 (Print) 0361-5960 (Linking),61,1,1977 Jan-Feb,Treatment of chronic myeloid leukemia with repeated single doses of busulfan.,43-5,"['Sullivan, J R', 'Hurley, T H', 'Bolton, J H']","['Sullivan JR', 'Hurley TH', 'Bolton JH']",['eng'],['Journal Article'],United States,Cancer Treat Rep,Cancer treatment reports,7607107,IM,"['Adult', 'Aged', 'Busulfan/administration & dosage/*therapeutic use', 'Dose-Response Relationship, Drug', 'Drug Administration Schedule', 'Drug Evaluation', 'Follow-Up Studies', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Cancer Treat Rep. 1977 Jan-Feb;61(1):43-5.,['G1LN9045DK (Busulfan)'],Repeated single doses of busulfan (50-200 mg) were given over 1--2 days to 17 patients with chronic myeloid leukemia. The mean survival time was 137 weeks. In this small trial the drug was shown to be safe in most but not all patients and as effective as continous busulfan.,,,,,
266416,NLM,MEDLINE,19770729,20131121,0008-5472 (Print) 0008-5472 (Linking),37,7 Pt 1,1977 Jul,Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.,2138-46,"['Burke, P J', 'Karp, J E', 'Braine, H G', 'Vaughan, W P']","['Burke PJ', 'Karp JE', 'Braine HG', 'Vaughan WP']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/*administration & dosage', 'Bone Marrow/drug effects/pathology', 'Bone Marrow Cells', 'Cell Division/drug effects', 'Child', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Drug Administration Schedule', 'Drug Therapy, Combination', 'Female', 'Growth Substances/*blood', 'Humans', 'Leukemia, Myeloid/blood/*drug therapy/metabolism/pathology', 'Male', 'Middle Aged', 'Remission, Spontaneous', 'Thymidine/metabolism']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Jul;37(7 Pt 1):2138-46.,"['0 (Antineoplastic Agents)', '0 (Growth Substances)', '04079A1RDZ (Cytarabine)', '8N3DW7272P (Cyclophosphamide)', 'VC2W18DGKR (Thymidine)', 'ZS7284E0ZP (Daunorubicin)']",,,,,,
266415,NLM,MEDLINE,19770729,20131121,0008-5472 (Print) 0008-5472 (Linking),37,7 Pt 1,1977 Jul,Levels of serum ribonuclease as an indicator of renal insufficiency in patients with leukemia.,2015-22,"['Humphrey, R L', 'Karpetsky, T P', 'Neuwelt, E A', 'Levy, C C']","['Humphrey RL', 'Karpetsky TP', 'Neuwelt EA', 'Levy CC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Creatinine/blood', 'Humans', 'Isoenzymes/immunology', 'Kidney Failure, Chronic/complications/*enzymology/etiology', 'Leukemia/*complications/enzymology/therapy', 'Leukemia, Lymphoid/enzymology', 'Leukemia, Myeloid/enzymology', 'Leukemia, Myeloid, Acute/enzymology', 'Multiple Myeloma/enzymology', 'Ribonucleases/*blood/immunology', 'Time Factors']",1977/07/01 00:00,1977/07/01 00:01,['1977/07/01 00:00'],"['1977/07/01 00:00 [pubmed]', '1977/07/01 00:01 [medline]', '1977/07/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Jul;37(7 Pt 1):2015-22.,"['0 (Isoenzymes)', 'AYI8EX34EU (Creatinine)', 'EC 3.1.- (Ribonucleases)']",,,,,,
266414,NLM,MEDLINE,19770729,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6072,1977 May 21,Conception of normal child during chemotherapy of acute lymphoblastic leukaemia in the father.,1322-3,"['Kroner, T H', 'Tachumi, A']","['Kroner TH', 'Tachumi A']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Adolescent', 'Antineoplastic Agents/*therapeutic use', 'Female', 'Fetus/*drug effects', 'Humans', 'Infant, Low Birth Weight', 'Infant, Newborn', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Pregnancy', 'Spermatogenesis/*drug effects']",1977/05/21 00:00,1977/05/21 00:01,['1977/05/21 00:00'],"['1977/05/21 00:00 [pubmed]', '1977/05/21 00:01 [medline]', '1977/05/21 00:00 [entrez]']",['10.1136/bmj.1.6072.1322-a [doi]'],ppublish,Br Med J. 1977 May 21;1(6072):1322-3. doi: 10.1136/bmj.1.6072.1322-a.,['0 (Antineoplastic Agents)'],,,PMC1607223,,,
266413,NLM,MEDLINE,19770718,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6071,1977 May 14,Effect of splenic irradiation on circulating colony-forming cells in chronic granulocytic leukaemia.,1259,"['Barrett, A J', 'Longhurst, P', 'Humble, J G', 'Newton, K A']","['Barrett AJ', 'Longhurst P', 'Humble JG', 'Newton KA']",['eng'],"['Case Reports', 'Journal Article']",England,Br Med J,British medical journal,0372673,IM,"['Aged', 'Cobalt Radioisotopes', 'Humans', 'Leukemia, Myeloid/*radiotherapy', 'Leukocyte Count', 'Leukocytes/radiation effects', 'Male', 'Spleen/*radiation effects']",1977/05/14 00:00,1977/05/14 00:01,['1977/05/14 00:00'],"['1977/05/14 00:00 [pubmed]', '1977/05/14 00:01 [medline]', '1977/05/14 00:00 [entrez]']",['10.1136/bmj.1.6071.1259 [doi]'],ppublish,Br Med J. 1977 May 14;1(6071):1259. doi: 10.1136/bmj.1.6071.1259.,['0 (Cobalt Radioisotopes)'],,,PMC1607066,,,
266409,NLM,MEDLINE,19770729,20210216,0006-4971 (Print) 0006-4971 (Linking),49,6,1977 Jun,Chronic myeloid leukemia: physical and functional similarities to acute leukemia.,913-23,"['Senn, J S', 'Price, G B']","['Senn JS', 'Price GB']",['eng'],"['Comparative Study', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['*Acute Disease', 'Adult', 'Aged', 'Bone Marrow/*pathology', '*Bone Marrow Cells', 'Cell Separation', 'Cells, Cultured', 'Computers', 'Female', 'Granulocytes/pathology', 'Humans', 'Leukemia, Myeloid/*pathology', 'Male', 'Middle Aged']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['S0006-4971(20)70126-6 [pii]'],ppublish,Blood. 1977 Jun;49(6):913-23.,,"Blast crisis, closely resembling acute leukemia, is the usual terminal event in chronic myeloid leukemia. Using physical (""fingerprint"") and cultural (colony-forming) methods, we have demonstrated distinctive patterns in the stable phase of chronic myeloid leukemia and in blast crisis. An unusual fingerprint alteration preceding the onset of the terminal phase is noted, and cell culture perturbation is evident at different stages of the disease. Our findings indicate that the application of these methods to the study of hemopoietic disorders is valid, and suggest that the use of such techniques may allow a better understanding of the complex cellular events occurring in the course of chronic myeloid leukemia.",,,,,
266408,NLM,MEDLINE,19770729,20210216,0006-4971 (Print) 0006-4971 (Linking),49,6,1977 Jun,Marrow culture studies in adult acute leukemia at presentation and during remission.,903-12,"['Vincent, P C', 'Sutherland, R', 'Bradley, M', 'Lind, D', 'Gunz, F W']","['Vincent PC', 'Sutherland R', 'Bradley M', 'Lind D', 'Gunz FW']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Adolescent', 'Adult', 'Aged', 'Bone Marrow/*pathology', '*Bone Marrow Cells', 'Bone Marrow Examination', 'Cells, Cultured', 'Female', 'Follow-Up Studies', 'Humans', 'Leukemia, Erythroblastic, Acute/drug therapy/*pathology', 'Leukemia, Myeloid, Acute/drug therapy/*pathology', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1977/06/01 00:00,1977/06/01 00:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '1977/06/01 00:01 [medline]', '1977/06/01 00:00 [entrez]']",['S0006-4971(20)70125-4 [pii]'],ppublish,Blood. 1977 Jun;49(6):903-12.,,"Culture of bone marrow and/or blood cells in a semisolid agar system from 43 adults with acute nonlymphoblastic leukemia at first presentation showed two distinct growth patterns at 14 days. In 53% of patients cells failed to grow (type O), while in the remainder an abnormal growth pattern (type B) with small numbers of diffuse colonies and excessive numbers of cell clusters was seen. The response following chemotherapy was significantly better in the patients whose cells failed to grow. Serial culture studies, performed in 9 patients throughout remissions of 100-1112 days, which had been maintained by intermittent chemotherapy, showed wide fluctuations in proliferative activity. These ranged from no growth to marked proliferation with predominance of clusters and small numbers of diffuse colonies, indistinguishable from the type B pattern seen in 47% of patients at first presentation. The possibility is discussed that the periods of failure to grow, and/or those in which a type B pattern emerged, represented sporadic reactivation of leukemic cells.",,,,,
266407,NLM,MEDLINE,19770723,20071115,0300-0893 (Print) 0300-0893 (Linking),26,1,1977 Feb,Follow-up of the first (1962) pilot study of active immunotherapy of acute lymphoid leukaemia: a critical discussion.,29-35,"['Mathe, G', 'Amiel, J L', 'Schwarzenberg, L', 'Schneider, M', 'Cattan, A', 'Schlumberger, J R', 'Hayat, M', 'De Vassal, F']","['Mathe G', 'Amiel JL', 'Schwarzenberg L', 'Schneider M', 'Cattan A', 'Schlumberger JR', 'Hayat M', 'De Vassal F']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial']",France,Biomedicine,Biomedicine / [publiee pour l'A.A.I.C.I.G.],0361342,IM,"['BCG Vaccine/therapeutic use', 'Follow-Up Studies', 'Humans', '*Immunotherapy', 'Leukemia, Lymphoid/*therapy', 'Pilot Projects', 'Remission, Spontaneous', 'Time Factors']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Biomedicine. 1977 Feb;26(1):29-35.,['0 (BCG Vaccine)'],"The follow-up of the first active immunotherapy (AI) controlled pilot study on acute lymphoid leukaemia (ALL), started in 1962, is reported: seven patients out of 20 are still in first remission and eight of the AI group are still alive between 10 and 13 years later, while all ten controls have relapsed and died. The methodology of this pilot study is discussed, as well as the results of the later AI trials conducted on ALL. In the light of a critical discussion and of the further trials conducted by the authors or published in the literature, the authors conclude that A1 is efficient in ALL and that its use is indicated as, in several trials, it has been as active as maintenance chemotherapy, as it has induced no deaths in 300 patients contrary to maintenance chemotherapy, which has been responsible for 4 to 28% of deaths in patients in complete remission, and as the authors have registered no late relapses after three years in the AI trials, while such relapses appear in most maintenance chemotherapy trials.",,,,,
266406,NLM,MEDLINE,19770729,20190515,0007-0920 (Print) 0007-0920 (Linking),35,5,1977 May,Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice.,697-700,"['Franks, C R', 'Bishop, D', 'Balkwill, F R', 'Oliver, R T', 'Spector, W G']","['Franks CR', 'Bishop D', 'Balkwill FR', 'Oliver RT', 'Spector WG']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Animals', 'Female', 'Humans', 'Leukemia, Experimental/pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Mice', 'Mice, Inbred CBA', 'Neoplasm Transplantation', 'Radiation Effects', 'Thymectomy', '*Transplantation, Heterologous']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1038/bjc.1977.107 [doi]'],ppublish,Br J Cancer. 1977 May;35(5):697-700. doi: 10.1038/bjc.1977.107.,,,,PMC2025502,,,
266405,NLM,MEDLINE,19770729,20190515,0007-0920 (Print) 0007-0920 (Linking),35,5,1977 May,Isoferritins in acute leukaemia.,635-42,"['Cragg, S J', 'Jacobs, A', 'Parry, D H', 'Wagstaff, M', 'Worwood, M']","['Cragg SJ', 'Jacobs A', 'Parry DH', 'Wagstaff M', 'Worwood M']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Chromatography, Ion Exchange', 'Female', 'Ferritins/*analysis/isolation & purification', 'Humans', 'Iron/analysis', 'Isoelectric Focusing', 'Leukemia, Myeloid, Acute/*blood', 'Leukocytes/*analysis', 'Male']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1038/bjc.1977.99 [doi]'],ppublish,Br J Cancer. 1977 May;35(5):635-42. doi: 10.1038/bjc.1977.99.,"['9007-73-2 (Ferritins)', 'E1UOL152H7 (Iron)']","Leucocytes containing a high proportion of blast cells were obtained from 11 patients with acute myeloid leukaemia, and leucocytes were also obtained from 2 normal subjects. Ferritin was partially purified from leucocyte extracts and subjected to anion-exchange chromatography and isoelectric focusing. The Fe content of leucocyte ferritin was low, and in all but one case the preparations contained isoferritins corresponding to those found in normal tissues or serum. Only some of the preparations contained the relatively acidic isoferritins which have been described as ""carcinofoetal"", but which are also present in normal heart and kidney. Ferritin from one patient contained isoferritins of lower isoelectric point than heart ferritin. These results show that there does not appear to be any specific isoelectric focusing pattern for leukaemic cells, and that assays for acidic isoferritins are unlikely to be of use in the diagnosis of leukaemia and in monitoring treatment. However, the very acidic protein found in one preparation suggests that the search for abnormal subunits of ferritin may be fruitful in acute leukaemia.",,PMC2025487,,,
266398,NLM,MEDLINE,19770622,20041117,0003-9926 (Print) 0003-9926 (Linking),137,5,1977 May,Partial long arm deletion of a chromosome 17 in acute promyelocytic leukemia.,697,"['Engel, E']",['Engel E'],['eng'],['Journal Article'],United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Chromosome Aberrations', '*Chromosomes, Human, 16-18', 'Humans', 'Leukemia, Myeloid/*genetics']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1977 May;137(5):697.,,,,,,,
266396,NLM,MEDLINE,19770611,20190503,0003-4967 (Print) 0003-4967 (Linking),36,2,1977 Apr,Sucessful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukaemia by cytosine arabinoside.,192-3,"['Douer, D', 'Weinberger, A', 'Djaldetti, M', 'Pinkhas, J', 'De Vries']","['Douer D', 'Weinberger A', 'Djaldetti M', 'Pinkhas J', 'De Vries']",['eng'],"['Case Reports', 'Journal Article']",England,Ann Rheum Dis,Annals of the rheumatic diseases,0372355,IM,"['Arthritis/*drug therapy/etiology', 'Cytarabine/*therapeutic use', 'Humans', 'Leukemia, Myeloid/*complications/drug therapy', 'Male', 'Middle Aged', 'Pain/*drug therapy/etiology']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1136/ard.36.2.192 [doi]'],ppublish,Ann Rheum Dis. 1977 Apr;36(2):192-3. doi: 10.1136/ard.36.2.192.,['04079A1RDZ (Cytarabine)'],"An elderly patient with chronic myelomonocytic leukaemia developed severe bone pains and acute gonarthritis. Intravenously administered cytosine arabinoside brought dramatic relief of the bone pains and led to a rapid subsidence of the arthritis, without achieving haematological remission.",,PMC1006659,,,
266361,NLM,MEDLINE,19770622,20190509,0002-9173 (Print) 0002-9173 (Linking),67,5,1977 May,Simultaneous demonstration of peroxidase and lysozyme activities in leukemic cells.,481-4,"['Kageoka, T', 'Nakashima, K', 'Miwa, S']","['Kageoka T', 'Nakashima K', 'Miwa S']",['eng'],['Journal Article'],England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Bone Marrow/enzymology', 'Bone Marrow Cells', 'Histocytochemistry', 'Humans', 'Leukemia/*enzymology/pathology', 'Leukemia, Lymphoid/enzymology/pathology', 'Leukemia, Myeloid/enzymology/pathology', 'Leukemia, Myeloid, Acute/enzymology/pathology', 'Muramidase/blood/*metabolism', 'Peroxidases/blood/*metabolism']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1093/ajcp/67.5.481 [doi]'],ppublish,Am J Clin Pathol. 1977 May;67(5):481-4. doi: 10.1093/ajcp/67.5.481.,"['EC 1.11.1.- (Peroxidases)', 'EC 3.2.1.17 (Muramidase)']","A simple cytochemical and cytobacterial method for the simultaneous demonstration of peroxidase and lysozyme (muramidase) activities in individual cells was devised. In characterization of myeloid and monocyte series, the combination of these myeloid- and monocyte-specific enzymes not only was more informative than a single enzyme but made it easier to differentiate acute myelomonocytic leukemia, with higher lysozyme activity, from acute myeloid leukemia, with higher peroxidase activity. Acute lymphocytic leukemia had no lysozyme or peroxidase activity.",,,,,
266359,NLM,MEDLINE,19770622,20190509,0002-9173 (Print) 0002-9173 (Linking),67,5,1977 May,Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia.,415-26,"['Nanba, K', 'Soban, E J', 'Bowling, M C', 'Berard, C W']","['Nanba K', 'Soban EJ', 'Bowling MC', 'Berard CW']",['eng'],['Journal Article'],England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Biopsy', 'Endothelium/cytology/enzymology', 'Hemangioma/pathology', 'Histocytochemistry', 'Humans', 'Leukemia/*pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid/pathology', 'Liver Neoplasms/*pathology', 'Lymphatic Diseases/*pathology', 'Morphogenesis', 'Naphthol AS D Esterase/metabolism', 'Splenic Diseases/pathology', 'Splenic Vein/*pathology', 'Vascular Diseases/pathology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1093/ajcp/67.5.415 [doi]'],ppublish,Am J Clin Pathol. 1977 May;67(5):415-26. doi: 10.1093/ajcp/67.5.415.,['EC 3.1.- (Naphthol AS D Esterase)'],"In 14 cases of hairy cell leukemia unique vascular lesions not previously reported were observed in surgically resected spleens and hepatic biopsies. In all 14 spleens there were variably prominent distended spaces filled with erythrocytes and resembling dilated sinuses. These structures appeared to be lined by hairy cells,and studies utilizing histochemical and enzymatic methods confirmed that they were in fact pseudosinuses lacking the endothelial cells and ring fibers of normal splenic sinuses. These changes were not present in normal spleens or in spleens involved by other types of chronic leukemia, and appear to be qualitatively specific for hairy cell leukemia. In three of five hepatic biopsies similar angiomatous lesions were present in multifocal clusters resembling hemangiomas. Their pathogenesis may be related to possible adherence of hairy cells to reticulum fibers in involved tissues.",,,,,
266358,NLM,MEDLINE,19770622,20190622,0065-2598 (Print) 0065-2598 (Linking),76A,,1977,Stability of the azaguanine resistant phenotype in vivo.,181-5,"['Reem, G H', 'Friend, C']","['Reem GH', 'Friend C']",['eng'],['Journal Article'],United States,Adv Exp Med Biol,Advances in experimental medicine and biology,0121103,IM,"['Adenine Phosphoribosyltransferase/metabolism', 'Animals', 'Azaguanine/*pharmacology', 'Cell Line', 'Drug Resistance', 'Hypoxanthine Phosphoribosyltransferase/deficiency/*metabolism', 'Leukemia, Erythroblastic, Acute/*enzymology', 'Mice', 'Mice, Inbred DBA', 'Neoplasm Transplantation', 'Neoplasms, Experimental/enzymology', 'Phenotype']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1007/978-1-4613-4223-6_23 [doi]'],ppublish,Adv Exp Med Biol. 1977;76A:181-5. doi: 10.1007/978-1-4613-4223-6_23.,"['EC 2.4.2.7 (Adenine Phosphoribosyltransferase)', 'EC 2.4.2.8 (Hypoxanthine Phosphoribosyltransferase)', 'Q150359I72 (Azaguanine)']",,,,,,
266357,NLM,MEDLINE,19770630,20190902,0001-6632 (Print) 0001-6632 (Linking),27,2,1977 Mar,Varied pulmonary lesions with intraalveolar large lamellar bodies in an autopsy case with busulfan therapy.,239-49,"['Miyashita, T', 'Ojima, A', 'Tuji, T', 'Tajima, T', 'Watanabe, K']","['Miyashita T', 'Ojima A', 'Tuji T', 'Tajima T', 'Watanabe K']",['eng'],"['Case Reports', 'Journal Article']",Australia,Acta Pathol Jpn,Acta pathologica japonica,0372637,IM,"['Busulfan/*adverse effects', 'Female', 'Humans', 'Leukemia, Myeloid/drug therapy', 'Lung Diseases/*chemically induced/pathology', 'Middle Aged', 'Pulmonary Alveoli/*pathology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1111/j.1440-1827.1977.tb01873.x [doi]'],ppublish,Acta Pathol Jpn. 1977 Mar;27(2):239-49. doi: 10.1111/j.1440-1827.1977.tb01873.x.,['G1LN9045DK (Busulfan)'],"Characteristic pulmonary findings in an autopsy case of a 46-year-old female who presented heavy dyspnea as her chief complaint after 3 months of busulfan therapy for chronic myeloid leukemia were reported. The pulmonary findings were classified into four types: I. alveolar proteinosis type, II. intra alveolar fibrosis type, III. interstitial fibrosis type, and IV. lipid pneumonia type with cholesterol granuloma. No other case with various findings like this case has been previously reported. It was considered that type I is the basic type, type II is a type that developed from type I, type III is a type with interstitial cell infiltration and fibrosis and type IV is a lipidrich variant of type I. A large lamellar body was first found in the granular material of type I. It is supposed that such a body consists of osmiophilic body which originated from type B alveolar epithelial cells and blood plasma.",,,,,
266356,NLM,MEDLINE,19770630,20190902,0001-6632 (Print) 0001-6632 (Linking),27,2,1977 Mar,Pathology of neoplasms and other lesions induced in rats with Moloney murine sarcoma virus.,145-64,"['Hirano, T', 'Miyajima, H', 'Kaziwara, K', 'Watanabe, T']","['Hirano T', 'Miyajima H', 'Kaziwara K', 'Watanabe T']",['eng'],['Journal Article'],Australia,Acta Pathol Jpn,Acta pathologica japonica,0372637,IM,"['Animals', 'Back', 'Bone and Bones/abnormalities', 'Extremities', 'Female', 'Fetus', 'Mesenchymoma/pathology', 'Moloney murine leukemia virus/ultrastructure', 'Osteosarcoma/pathology', 'Pregnancy', 'Rats', 'Rhabdomyosarcoma/pathology', 'Sarcoma, Experimental/*pathology', 'Tumor Virus Infections/*pathology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1111/j.1440-1827.1977.tb01866.x [doi]'],ppublish,Acta Pathol Jpn. 1977 Mar;27(2):145-64. doi: 10.1111/j.1440-1827.1977.tb01866.x.,,"Moloney murine sarcoma virus (M-MSV) was injected directly into the fetuses of Sprague-Dawley rats during the late stage of gestation and into the neonates within 24 hours after birth. Ninety rats developed 188 neoplastic lesions during the 8-week period of observation. Nearly all of the neoplasms were of mesenchymal derivation. Sixty percent of these neoplasms revealed more complex histologic features than those previously reported for neoplasms induced in rodents with M-MSV and were designated ""malignant mesenchymoma"" which developed preferentially in the proximal parts of the extremities, distant from the inoculation site. Rhabdomyosarcoma and osteosarcoma which developed in a pure form at the various sites were the next most common tumor type. Osteosarcoma developing in a pure form and as a component of malignant mesenchymoma in the humerus and femur was comparable to that of juxtacortical osteosarcoma of man; The development of excessive bones were observed in the forelimb and/or hind leg, suggesting a type of skeletal malformation. The reaction to M-MSV merits attention as a model for the study of an osteosarcoma and malignant mesenchymoma as well as rhabdomyosarcoma and also for the study of viral teratogenesis in man, as ""rubella syndrome"".",,,,,
266314,NLM,MEDLINE,19770611,20181113,0093-0415 (Print) 0093-0415 (Linking),126,4,1977 Apr,Acute nonlymphoblastic leukemia in adults. Where do we go from here.,306-7,"['Bert, J R']",['Bert JR'],['eng'],['Editorial'],United States,West J Med,The Western journal of medicine,0410504,IM,"['Aged', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,West J Med. 1977 Apr;126(4):306-7.,,,,PMC1237559,,,
266313,NLM,MEDLINE,19770611,20181113,0093-0415 (Print) 0093-0415 (Linking),126,4,1977 Apr,Remission maintenance therapy in acute myelogenous leukemia.,267-72,"['Embury, S H', 'Elias, L', 'Heller, P H', 'Hood, C E', 'Greenberg, P L', 'Schrier, S L']","['Embury SH', 'Elias L', 'Heller PH', 'Hood CE', 'Greenberg PL', 'Schrier SL']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,West J Med,The Western journal of medicine,0410504,IM,"['Adolescent', 'Adult', 'Aged', 'Cytarabine/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Middle Aged', 'Remission, Spontaneous', 'Thioguanine/therapeutic use']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,West J Med. 1977 Apr;126(4):267-72.,"['04079A1RDZ (Cytarabine)', 'FTK8U1GZNX (Thioguanine)']","Because no conclusive evidence as to the efficacy of maintenance chemotherapy in acute myelogenous leukemia (AML) existed, a study to obtain such information was done. Twenty-six adult patients with AML in whom complete remission had been achieved following induction chemotherapy were randomly assigned to receive either maintenance chemotherapy consisting of cytarabine and 6-thioguanine for two days each month or to receive no maintenance therapy. The data showed a significant difference in remission duration between the two groups, with median remission lengths for the maintained and unmaintained groups being 10.3 and 6.7 months, respectively (p<.05). In 46 percent of the maintained patients there were remissions lasting longer than 11 months, whereas in none of the unmaintained patients was there such a prolonged remission. No significant drug-induced toxicity was observed. That the prolonged exposure to these chemotherapeutic agents, which were also used in our induction program, did not adversely affect the rate of successful reinduction therapy was shown by identical 50 percent complete remission rates for second inductions in both groups. In patients with palpable splenomegaly at the time of diagnosis, there was no prolongation of remission with maintenance therapy. These data indicate the potential utility of maintenance chemotherapy for prolonging remission duration in acute myelogenous leukemia.",,PMC1237541,,,
266307,NLM,MEDLINE,19770622,20071115,0042-8809 (Print) 0042-8809 (Linking),,1,1977 Jan-Feb,[Serum immunoglobulin levels in patients with hemoblastoses].,40-4,"['Loginskii, V E']",['Loginskii VE'],['rus'],"['Comparative Study', 'English Abstract', 'Journal Article']",Russia (Federation),Vopr Med Khim,Voprosy meditsinskoi khimii,0416601,IM,"['Acute Disease', 'Animals', 'Hodgkin Disease/blood', 'Immunoglobulin A/analysis', 'Immunoglobulin D/analysis', 'Immunoglobulin G/analysis', 'Immunoglobulin M/analysis', 'Immunoglobulins/*analysis', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Lymphoma/*blood', 'Paraproteinemias/*blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Vopr Med Khim. 1977 Jan-Feb;(1):40-4.,"['0 (Immunoglobulin A)', '0 (Immunoglobulin D)', '0 (Immunoglobulin G)', '0 (Immunoglobulin M)', '0 (Immunoglobulins)']",Content of serum immunoglobulins (Ig) was estimated in patients with various types of hemoblastoses by radial immunodiffusion. Reactive alterations in content of Ig were observed in several patients with acute leukosis and chronic myeloleukosis. In patients with chronic lympholeukosis the decrease in concentration of serum Ig was manifested as a syndrom of the antibodies insufficiency. Monoclonic type of IgM or the reactive increase in Ig content was found only in several cases of chronic lympholeukosis. Lymphogranulomatosis and other malignant lymphomas were inhirent in the distinct increase of Ig and primarily of IgG. Content of normal Ig was distinctly decreased and monoclonic Ig (paraprotein) was found in paraproteinemic hemoblastoses. The observed alterations in the Ig content under hemoblastoses are of diagnostic and prognostic importance.,Uroven' syvorotochnykh immunoglobulinov u bol'nykh gemoblastozami,,,,
266295,NLM,MEDLINE,19770622,20131121,0039-2073 (Print) 0039-2073 (Linking),153,4,1977 Apr,[Meningosis-prophylaxis in the treatment of acute lymphoblastic leukemia and of non-Hodgkin's lymphomas (author's transl)].,236-40,"['Wehinger, H']",['Wehinger H'],['ger'],"['English Abstract', 'Journal Article']",Germany,Strahlentherapie,Strahlentherapie,1260024,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/drug therapy/*radiotherapy', 'Lymphoma, Non-Hodgkin/drug therapy/*radiotherapy', '*Meninges', 'Methotrexate/therapeutic use', 'Neoplasm Metastasis', 'Remission, Spontaneous']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Strahlentherapie. 1977 Apr;153(4):236-40.,['YL5FZ2Y5U1 (Methotrexate)'],"In ALL the first complete remission would be terminated by CNS-relapse in two thirds of the patients if they received a modern chemotherapeutic treatment without meningosis-prophylaxis. The incidence of meningosis is reduced to 10% by prophylactic irradiation of the cranium (60Co, 2400 rd) and intrathecal methotrexate shortly after hematological remission has been achieved. Non-Hodgkin's lymphomas may be complicated by CNS disease, especially if the risk of spread to the bone marrow is high. Therefore, meningosis-prophylaxis should be included into treatment programs for malignant lymphomas of the lymphocytic poorly differentiated type beyond stage I, especially if the mediastinum is involved. CNS-prophylaxis cannot be recommended for patients with malignant lymphomas in pathological stage I. For the rest of the patients with malignant lymphomas guidelines cannot be given at the present time, because sufficient empirical data are lacking.",Die Meningosisprophylaxe in der Behandlung der akuten lymphoblastischen Leukose (ALL) und der Non-Hodgkin-Lymphome,,,,
266290,NLM,MEDLINE,19770630,20061115,0040-3660 (Print) 0040-3660 (Linking),49,2,1977,[Clinical significance of determining adenosine deaminase activity].,147-51,"['Puni, I N']",['Puni IN'],['rus'],['Journal Article'],Russia (Federation),Ter Arkh,Terapevticheskii arkhiv,2984818R,IM,"['Adenosine Deaminase/*blood', 'Arthritis, Rheumatoid/enzymology', 'Cholestasis/enzymology', 'Diagnosis, Differential', 'Hepatitis, Viral, Human/*enzymology', 'Humans', 'Infectious Mononucleosis/enzymology', 'Leukemia, Myeloid/enzymology', 'Liver Cirrhosis/enzymology', 'Liver Neoplasms/enzymology', 'Lung Neoplasms/enzymology', 'Lymphoma/enzymology', 'Myocardial Infarction/enzymology', 'Neoplasms/*enzymology', 'Nucleoside Deaminases/*blood', 'Stomach Neoplasms/enzymology', 'Tuberculosis, Pulmonary/enzymology', 'Urinary Bladder Neoplasms/enzymology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ter Arkh. 1977;49(2):147-51.,"['EC 3.5.4.- (Nucleoside Deaminases)', 'EC 3.5.4.4 (Adenosine Deaminase)']",,Klinicheskoe znachenie opredeleniia aktivnosti adenozindezaminazy,,,,
266289,NLM,MEDLINE,19770611,20131121,0036-4355 (Print) 0036-4355 (Linking),22,2,1977,[Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].,243-51,"['Morales Polanco, M R', 'Butron, L', 'Echegoyen, G', 'Pizzuto Chavez, J']","['Morales Polanco MR', 'Butron L', 'Echegoyen G', 'Pizzuto Chavez J']",['spa'],"['English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Adult', 'Busulfan/*adverse effects/therapeutic use', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Salivary Gland Diseases/*chemically induced', 'Sialadenitis/*chemically induced']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(2):243-51.,['G1LN9045DK (Busulfan)'],,Sialoadenitis cronica. Manifestacion toxica del empleo prolongado de busulfan en el tratamiento de la leucemia granulocitica cronica,,,,
266272,NLM,MEDLINE,19770622,20190907,0036-553X (Print) 0036-553X (Linking),18,4,1977 Apr,Chronic monocytic leukaemia--a prolonged survival.,337-42,"['Amir, J', 'Djaldetti, M']","['Amir J', 'Djaldetti M']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Aged', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', 'Cell Nucleus/ultrastructure', 'Cytoplasm/ultrastructure', 'Endoplasmic Reticulum/ultrastructure', 'Follow-Up Studies', 'Humans', 'Leukemia, Myeloid/immunology/*mortality/pathology', 'Male', 'Monocytes/ultrastructure', 'Prognosis', 'Time Factors']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01205.x [doi]'],ppublish,Scand J Haematol. 1977 Apr;18(4):337-42. doi: 10.1111/j.1600-0609.1977.tb01205.x.,,This is a report of a patient with chronic monocytic leukaemia with a survival of more than ten years. He was not prone to bacterial infections and his cellular and humoral immunological systems were found to be intact. Ultrastructural study confirmed the monocytic cell type in the bone marrow and peripheral smear.,,,,,
266271,NLM,MEDLINE,19770622,20190907,0036-553X (Print) 0036-553X (Linking),18,4,1977 Apr,"Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapy.",292-300,"['Pedersen-Bjergaard, J', 'Worm, A M', 'Hainau, B']","['Pedersen-Bjergaard J', 'Worm AM', 'Hainau B']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Anemia', 'Fatigue', 'Humans', '*Leukemia, Myeloid', '*Leukemia, Myeloid, Acute/drug therapy/mortality/pathology', 'Leukocyte Count', 'Lymphocytes', 'Prognosis', 'Quality of Life', 'Remission, Spontaneous', 'Splenomegaly']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01199.x [doi]'],ppublish,Scand J Haematol. 1977 Apr;18(4):292-300. doi: 10.1111/j.1600-0609.1977.tb01199.x.,,"21 patients with chronic myelocytic leukaemia (CML) have been followed closely during and after development of blastic transformation (BT). Severe fatigue in previously asymptomatic patients was the most frequently observed prodrome of transformation. Most significant clinical findings were anaemia, rapidly increasing WBC and increasing size of the spleen in patients with previously well-controlled CML. 11 out of 24 patients responded to chemotherapy and had a median survival of 3 months, 6 obtained a complete remission (CR). Median survival time for all patients was 2 months from BT. Quality of life after BT was in most cases inferior. Thus, only 5 patients spent more than 1 month outside hospital. Cytomorphological classification of blasts in marrow as granular or agranular showed no correlation to the results of chemotherapy or to survival.",,,,,
266270,NLM,MEDLINE,19770622,20190907,0036-553X (Print) 0036-553X (Linking),18,4,1977 Apr,Chronic myelocytic leukaemia presenting in blastic transformation. Two cases primarily diagnosed as acute myelocytic leukaemia.,288-91,"['Worm, A M', 'Pedersen-Bjergaard, J']","['Worm AM', 'Pedersen-Bjergaard J']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis', 'Leukemia, Myeloid, Acute/*diagnosis', 'Male', 'Middle Aged', 'Translocation, Genetic']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01198.x [doi]'],ppublish,Scand J Haematol. 1977 Apr;18(4):288-91. doi: 10.1111/j.1600-0609.1977.tb01198.x.,,"The interval from diagnosis of chronic myelocytic leukaemia (CML) to onset of blastic transformation (BT) can vary from days to several years. This blastic phase of CML is indistinguishable from acute myelocytic leukaemia (AML), both clinically and morphologically. The Ph1 chromosome has occasionally been demonstrated in acute leukaemia and it has been suggested that these cases may represent CML presenting in BT. 2 such patients are reported, in 1 of whom the characteristics after treatment further confirmed the diagnosis of CML. Differentiation between CML presenting in BT and AML has both prognostic and therapeutic value. For this reason it is recommended that cytogenetic screening for the Ph1 chromosome should be included in the initial examination of patients with acute leukaemia.",,,,,
266223,NLM,MEDLINE,19770630,20041117,0014-2565 (Print) 0014-2565 (Linking),145,1,1977 Apr 15,[Di Gugliemo's syndrome (erythroleukemia)].,55-60,"['Urbano Jimenez, F J', 'Perez Galvez, M N', 'Pelaez Redondo, J']","['Urbano Jimenez FJ', 'Perez Galvez MN', 'Pelaez Redondo J']",['spa'],"['Case Reports', 'Journal Article']",Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Adult', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Diagnosis, Differential', 'Erythrocytes/pathology', 'Humans', 'Leukemia, Erythroblastic, Acute/*pathology', 'Male']",1977/04/15 00:00,1977/04/15 00:01,['1977/04/15 00:00'],"['1977/04/15 00:00 [pubmed]', '1977/04/15 00:01 [medline]', '1977/04/15 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1977 Apr 15;145(1):55-60.,,,Sindrome de Di Guglielmo (eritroleucemia),,,,
266203,NLM,MEDLINE,19770630,20191210,0027-8424 (Print) 0027-8424 (Linking),74,4,1977 Apr,Extinction of hemoglobin inducibility in Friend erythroleukemia cells by fusion with cytoplasm of enucleated mouse neuroblastoma or fibroblast cells.,1642-6,"['Gopalakrishnan, T V', 'Thompson, E B', 'Anderson, W F']","['Gopalakrishnan TV', 'Thompson EB', 'Anderson WF']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', '*Cell Fusion', 'Cell Line', 'Cell Nucleus/physiology', 'Chromosomes', 'Friend murine leukemia virus', '*Hybrid Cells', 'L Cells/physiology', 'Leukemia, Experimental/*physiopathology', 'Neuroblastoma/*physiopathology']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1073/pnas.74.4.1642 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Apr;74(4):1642-6. doi: 10.1073/pnas.74.4.1642.,,"Friend mouse erythroleukemia cells (T3c1-2 and its subline 5000) can be induced to synthesize hemoglobin after treatment with 1.5% (vol/vol) dimethylsulfoxide. When these cells are fused with nonerythroid cells (namely, mouse neuroblastoma or L cells) hemoglobin induction is extinguished. In order to determine if the nucleus of the nonerythroid cell is necessary for this extinction, fusions were performed between mouse erythroleukemia cells and enucleated neuroblastoma or L cells. Hemoglobin induction was reduced or eliminated in clones of these hybrids even after 6 months of continuous culture. These results suggest that the cytoplasm of nonerythroid cells contains factor(s) that extinguish hemoglobin inducibility in erythroleukemic cells and that this new phenotype can be inherited.",,PMC430848,,,
266170,NLM,MEDLINE,19770630,20190501,0032-5473 (Print) 0032-5473 (Linking),53,617,1977 Mar,Acute leukaemia during azathioprine therapy.,173-4,"['Gilmore, I T', 'Holden, G', 'Rodan, K S']","['Gilmore IT', 'Holden G', 'Rodan KS']",['eng'],"['Case Reports', 'Journal Article']",England,Postgrad Med J,Postgraduate medical journal,0234135,IM,"['Aged', 'Arthritis, Rheumatoid/drug therapy', 'Azathioprine/*adverse effects/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*chemically induced']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1136/pgmj.53.617.173 [doi]'],ppublish,Postgrad Med J. 1977 Mar;53(617):173-4. doi: 10.1136/pgmj.53.617.173.,['MRK240IY2L (Azathioprine)'],"Various tumours, in particular lymphomas, have been reported in association with azathioprine treatment, both after renal transplantation and in other conditions. A case is reported here of acute myeloid leukaemia associated with azathioprine therapy for rheumatoid arthritis, and this is now the third case reported in the world literature of leukaemia arising during azathioprine therapy for a non-malignant condition.",,PMC2496469,,,
266168,NLM,MEDLINE,19770611,20080620,0032-3756 (Print) 0032-3756 (Linking),32,14,1977 Apr 4,[Preleukemia].,517-9,"['Sroczynski, J', 'Pigon-Wegiel, A']","['Sroczynski J', 'Pigon-Wegiel A']",['pol'],"['Case Reports', 'English Abstract', 'Journal Article']",Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Adult', 'Aged', 'Anemia, Megaloblastic/diagnosis', 'Anemia, Sideroblastic/diagnosis', 'Diagnostic Errors', 'Female', 'Hemoglobinuria, Paroxysmal/diagnosis', 'Humans', 'Leukemia, Myeloid, Acute/diagnosis', 'Leukopenia/diagnosis', 'Male', 'Middle Aged', '*Preleukemia']",1977/04/04 00:00,1977/04/04 00:01,['1977/04/04 00:00'],"['1977/04/04 00:00 [pubmed]', '1977/04/04 00:01 [medline]', '1977/04/04 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1977 Apr 4;32(14):517-9.,,,Stany przedbialaczkowe -- preleukemia,,,,
266161,NLM,MEDLINE,19770611,20061115,0031-3114 (Print) 0031-3114 (Linking),28,1,1977 Jan-Feb,[Transplantable hamster sarcoma induced by cells from human culture].,61-74,"['Harlozinska, A', 'Kotlarek-Haus, S', 'Richter, R', 'Albert, Z', 'Skriabin, A', 'Brodzka, W', 'Gasiorowski, K']","['Harlozinska A', 'Kotlarek-Haus S', 'Richter R', 'Albert Z', 'Skriabin A', 'Brodzka W', 'Gasiorowski K']",['pol'],"['English Abstract', 'Journal Article']",Poland,Patol Pol,Patologia polska,0404244,IM,"['Animals', 'Animals, Newborn', 'Cell Line', 'Cricetinae', 'Leukemia, Myeloid/*pathology', 'Mesocricetus', 'Neoplasm Transplantation', 'Sarcoma/*pathology', '*Transplantation, Heterologous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Patol Pol. 1977 Jan-Feb;28(1):61-74.,,,Przesczepialny miesak chomiczy indukowany komorkami hodowli ludzkiej,,,,
266117,NLM,MEDLINE,19770630,20190617,0028-0836 (Print) 0028-0836 (Linking),266,5600,1977 Mar 24,Tumours and viruses in mice injected with plutonium.,355-7,"['Loutit, J F', 'Lloyd, E L']","['Loutit JF', 'Lloyd EL']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",England,Nature,Nature,0410462,IM,"['Animals', 'Carcinoma, Squamous Cell/etiology', 'Dose-Response Relationship, Radiation', 'Female', 'Leukemia, Experimental/etiology', 'Male', 'Mice', 'Neoplasms, Radiation-Induced/*microbiology', 'Osteosarcoma/etiology/*microbiology', 'Plutonium/*toxicity', 'Radiation Chimera', 'Radium/toxicity', 'Sarcoma, Experimental/etiology', 'Sex Factors', 'Viruses/*isolation & purification']",1977/03/24 00:00,1977/03/24 00:01,['1977/03/24 00:00'],"['1977/03/24 00:00 [pubmed]', '1977/03/24 00:01 [medline]', '1977/03/24 00:00 [entrez]']",['10.1038/266355a0 [doi]'],ppublish,Nature. 1977 Mar 24;266(5600):355-7. doi: 10.1038/266355a0.,"['53023GN24M (Plutonium)', 'W90AYD6R3Q (Radium)']",,,,,,
266116,NLM,MEDLINE,19770611,20041117,0027-7622 (Print) 0027-7622 (Linking),39,1-2,1977 Jan,A case of clinically undiagnosed chronic leukaemia: unexpected sudden death of a patient with whiplash injury.,33-5,"['Oya, M']",['Oya M'],['eng'],"['Case Reports', 'Journal Article']",Japan,Nagoya J Med Sci,Nagoya journal of medical science,0412011,IM,"['Adult', '*Death, Sudden', 'Humans', 'Leukemia, Myeloid/complications/*pathology', 'Male', 'Whiplash Injuries/*complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Nagoya J Med Sci. 1977 Jan;39(1-2):33-5.,,,,,,,
266114,NLM,MEDLINE,19770630,20041117,0028-4793 (Print) 0028-4793 (Linking),296,22,1977 Jun 2,Chromosome banding patterns of 49 cases of chronic myelocytic leukemia.,1295,"['Engel, E', 'McGee, B J', 'Myers, B J', 'Flexner, J M', 'Krantz, S B']","['Engel E', 'McGee BJ', 'Myers BJ', 'Flexner JM', 'Krantz SB']",['eng'],['Letter'],United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Aged', '*Chromosomes, Human, 21-22 and Y', 'Chronic Disease', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid/*genetics', 'Male', 'Middle Aged', 'Translocation, Genetic']",1977/06/02 00:00,1977/06/02 00:01,['1977/06/02 00:00'],"['1977/06/02 00:00 [pubmed]', '1977/06/02 00:01 [medline]', '1977/06/02 00:00 [entrez]']",['10.1056/NEJM197706022962216 [doi]'],ppublish,N Engl J Med. 1977 Jun 2;296(22):1295. doi: 10.1056/NEJM197706022962216.,,,,,,,
266113,NLM,MEDLINE,19770622,20131121,0025-8474 (Print) 0025-8474 (Linking),31,4,1977 Apr,[Clinical aspects and therapy of chronic myelosis].,148-53,"['Cohnen, G']",['Cohnen G'],['ger'],['Journal Article'],Germany,Med Monatsschr,Medizinische Monatsschrift,0375265,IM,"['Busulfan/therapeutic use', 'Humans', 'Leukemia, Myeloid/*diagnosis/drug therapy', 'Remission, Spontaneous']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Med Monatsschr. 1977 Apr;31(4):148-53.,['G1LN9045DK (Busulfan)'],,Klinik und Therapie der chronischen Myelose,,,,
266112,NLM,MEDLINE,19770622,20131121,0025-8458 (Print) 0025-8458 (Linking),72,15,1977 Apr 15,[Septicaemia in leukaemia (author's transl)].,650-3,"['Hennemann, H H']",['Hennemann HH'],['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Med Klin,Medizinische Klinik,0376637,IM,"['Adult', 'Amikacin/therapeutic use', 'Ampicillin/therapeutic use', 'Chloramphenicol/therapeutic use', 'Female', 'Gentamicins/therapeutic use', 'Humans', 'Immunity, Cellular', 'Immunologic Deficiency Syndromes/complications', 'Leukemia/*complications', 'Leukemia, Lymphoid/complications', 'Mycoses/complications', 'Sepsis/*complications/diagnosis/drug therapy', 'Staphylococcal Infections/complications', 'Streptococcal Infections/complications']",1977/04/15 00:00,2000/03/22 09:00,['1977/04/15 00:00'],"['1977/04/15 00:00 [pubmed]', '2000/03/22 09:00 [medline]', '1977/04/15 00:00 [entrez]']",,ppublish,Med Klin. 1977 Apr 15;72(15):650-3.,"['0 (Gentamicins)', '66974FR9Q1 (Chloramphenicol)', '7C782967RD (Ampicillin)', '84319SGC3C (Amikacin)']","From 244 patients with leukaemia 34 (13,9%) suffered from septicaemia. Although all forms of leukaemia had been concerned, lymphocytic leukaemias (acute and chronic) predominated. Besides other factors, the most important one is the cellular and humoral immuno-deficiency state in this disease. Gram-negative bacteria occur most frequently, followed by staphylococci, streptococci and fungi. The site of origin of infection is rarely known, presumably in most cases the skin, intestinal and genital mucous membranes and the lungs. The clinical picture of septicaemia in leukaemia is not a typical septicaemic one, as the symptoms of the underlying disease predominate. Diagnosis therefore is only based on blood cultures. As therapy is necessary previous to the knowledge of the bacteriological result, it may be initiated by the application of gentamycin (or, in case of resistance, amikacin) combined with ampicillin or chloramphenicol, corrected later in accordance with the antibiogram. High doses of corticosteroids are used specially in shock states. The prevention of septicaemic complications in leukaemia is most important with regard to better results in cytostatic therapy of leukaemias.",Septikamien bei Leukamien,,,,
266111,NLM,MEDLINE,19770622,20171116,0025-8458 (Print) 0025-8458 (Linking),72,15,1977 Apr 15,[Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy (author's transl)].,642-9,"['Fulle, H H']",['Fulle HH'],['ger'],['Journal Article'],Germany,Med Klin,Medizinische Klinik,0376637,IM,"['Adult', 'Aged', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Daunorubicin/therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Middle Aged', 'Prednisone/therapeutic use', 'Remission, Spontaneous', 'Thioguanine/therapeutic use', 'Time Factors', 'Vincristine/therapeutic use']",1977/04/15 00:00,2000/03/22 09:00,['1977/04/15 00:00'],"['1977/04/15 00:00 [pubmed]', '2000/03/22 09:00 [medline]', '1977/04/15 00:00 [entrez]']",,ppublish,Med Klin. 1977 Apr 15;72(15):642-9.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'FTK8U1GZNX (Thioguanine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)', 'ZS7284E0ZP (Daunorubicin)']","The therapeutic regimens for acute myelogenous leukemia in 2 different periods of time will be described with comparison of their results. A. 28 adults were treated with cytosine arabinoside and 6-thioguanine only. Thereby, 28% complete and 16% partial remissions were achieved. The mean duration of the complete remissions was 23 weeks. The mean survival time of the patients with complete remission amounted to 53 weeks B. 46% complete and 12% partial remissions were obtained in 37 patients treated with cytosine arabinoside and 6-thioguanine doubling the dosage of the above mentioned regimen followed by 3 cycles of TRAP (and COAP). Using a maintenance therapy with modified TRAP, COAP, and POMP cycles the complete remissions lasted 47 weeks at an average. The mean survival time of patients with complete remission was 87 weeks after start of treatment.",Induktions- und Erhaltungstherapie der akuten myeloischen Leukamie des Erwachsenen durch sequentielle Anwendung zytostatischer Chemotherapiekombinationen,,,,
266090,NLM,MEDLINE,19770630,20131121,0485-1439 (Print) 0485-1439 (Linking),18,2,1977 Feb,[Preventive therapy of central nervous system leukemia in children. Effects of cranial irradiation plus intrathecal methotrexate and hydrocortisone (author's transl)].,137-44,"['Fujimoto, T', 'Shin, H', 'Kishida, K', 'Take, H', 'Miyazaki, S']","['Fujimoto T', 'Shin H', 'Kishida K', 'Take H', 'Miyazaki S']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Acute Disease', 'Adolescent', 'Brain Neoplasms/*prevention & control', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Hydrocortisone/*administration & dosage', 'Injections, Spinal', 'Leukemia, Myeloid, Acute/drug therapy/radiotherapy/*therapy', 'Male', 'Methotrexate/*administration & dosage']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Feb;18(2):137-44.,"['WI4X0X7BPJ (Hydrocortisone)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
266089,NLM,MEDLINE,19770630,20151119,0485-1439 (Print) 0485-1439 (Linking),18,2,1977 Feb,[Treatment of acute childhood leukemia--4 years' results of protocol 721 and 745 studies (author's transl)].,118-30,"['Fujimoto, T', 'Hasegawa, K', 'Goya, N', 'Miyazaki, S', 'Take, H']","['Fujimoto T', 'Hasegawa K', 'Goya N', 'Miyazaki S', 'Take H']",['jpn'],"['Comparative Study', 'English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Methotrexate/*administration & dosage', 'Prednisolone/*administration & dosage', 'Remission, Spontaneous', 'Vincristine/*administration & dosage']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Feb;18(2):118-30.,"['5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
266087,NLM,MEDLINE,19770630,20161017,0098-7484 (Print) 0098-7484 (Linking),237,24,1977 Jun 13,Lead-contaminated health food. Association with lead poisoning and leukemia.,2627-9,"['Crosby, W H']",['Crosby WH'],['eng'],"['Case Reports', 'Journal Article']",United States,JAMA,JAMA,7501160,IM,"['Acute Disease', 'Anemia/etiology', 'Animals', 'Bone and Bones', 'Calcium/adverse effects', 'California', 'Diagnostic Errors', 'Female', '*Food Contamination', 'Horses', 'Humans', 'Lead Poisoning/complications/diagnosis/*etiology', 'Legislation, Drug', 'Leukemia, Myeloid, Acute/*etiology', 'Middle Aged', 'Powders', 'United States', 'United States Food and Drug Administration']",1977/06/13 00:00,1977/06/13 00:01,['1977/06/13 00:00'],"['1977/06/13 00:00 [pubmed]', '1977/06/13 00:01 [medline]', '1977/06/13 00:00 [entrez]']",,ppublish,JAMA. 1977 Jun 13;237(24):2627-9.,"['0 (Powders)', 'SY7Q814VUP (Calcium)']","A doctor prescribed a dietary supplement prepared from powdered animal bone for a young woman with dysmenorrhea. Severe lead poisoning developed while she was taking the powder, which was shown to be contaminated with lead. The diagnosis eluded more than 20 physicians and was finally made by the patient herself. The Food and Drug Administration, informed of the contamination, declined to take action, stating that a food supplement is neither a food nor a drug and, besides, there are no maximal limits for heavy-metal contamination of foods and drugs.",,,,,
266085,NLM,MEDLINE,19770622,20190509,0027-8874 (Print) 0027-8874 (Linking),58,5,1977 May,Chromosome studies of the transplantable Shay chloroleukemia in rats.,1437-42,"['Alt, B']",['Alt B'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', '*Chromosome Aberrations', 'Chromosome Deletion', 'Fluorescent Dyes', 'Leukemia, Experimental/genetics', 'Leukemia, Myeloid/*genetics', 'Male', 'Neoplasm Transplantation', 'Quinacrine', 'Rats', 'Transplantation, Homologous', 'Trisomy']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1093/jnci/58.5.1437 [doi]'],ppublish,J Natl Cancer Inst. 1977 May;58(5):1437-42. doi: 10.1093/jnci/58.5.1437.,"['0 (Fluorescent Dyes)', 'H0C805XYDE (Quinacrine)']","Chromosomes obtained from tumors in male Long-Evans rats with transplantable Shay chloroleukemia were counted and analyzed with Giemsa staining and quinacrine fluorescence. Several consistent abnormalities were noted in the 43 cells in metaphase. An interstitial deletion of the distal portion of chromosome No 2 was noted in all cells. Trisomy for No 2 was found in 27 of 43 metaphases; the third No 2 had a terminal deletion, resulting in a chromosome shorter than the other deleted No 2. All cells were missing a No 11 chromosome. Most cells contained a large acrocentric chromosome that appeared to be a No 10 with a terminal addition (10q+). Several markers were also consistently noted. These chromosome abnormalities were compared to previous cytogenic analyses on the transplantable Shay chloroleukemia, in which new fluorescent banding techniques were not utilized. Since all the studies ultimately derived from the original Shay chloroleukemia, karyotypic differences and changes could be viewed over an extended period of time. This study corroborated previous reports on the specificity of involvement of chromosome No 2 in chemically induced tumors and supported the idea that chromosome No 2 may be important in oncogenesis in the rat and in the host response to different etiologic agents.",,,,,
266071,NLM,MEDLINE,19770630,20190630,0022-3476 (Print) 0022-3476 (Linking),90,6,1977 Jun,Disseminated Herpesvirus hominis infection in a child with acute leukemia.,951-3,"['Faden, H S', 'Bybee, B L', 'Overall, J C Jr', 'lahey, M E']","['Faden HS', 'Bybee BL', 'Overall JC Jr', 'lahey ME']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Child', 'Female', 'Herpes Simplex/drug therapy/*etiology', 'Humans', 'Leukemia, Lymphoid/*complications', 'Vidarabine/therapeutic use']",1977/06/01 00:00,2001/03/28 10:01,['1977/06/01 00:00'],"['1977/06/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/06/01 00:00 [entrez]']","['S0022-3476(77)80566-0 [pii]', '10.1016/s0022-3476(77)80566-0 [doi]']",ppublish,J Pediatr. 1977 Jun;90(6):951-3. doi: 10.1016/s0022-3476(77)80566-0.,['FA2DM6879K (Vidarabine)'],,,,,,
266045,NLM,MEDLINE,19770622,20091111,0022-3247 (Print) 0022-3247 (Linking),32,2,1977 Apr-Jun,"Early diagnosis and treatment of patients with leukemia, a dental problem.",46-50,"['Sela, M N', 'Pisanti, S']","['Sela MN', 'Pisanti S']",['eng'],"['Case Reports', 'Journal Article']",United States,J Oral Med,Journal of oral medicine,0045507,IM,"['Adolescent', 'Adult', 'Female', 'Gingivitis/pathology', 'Humans', 'Leukemia/diagnosis/*pathology/therapy', 'Male', 'Middle Aged', 'Mouth/*pathology', 'Mouth Mucosa/pathology', 'Toothache/pathology']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,J Oral Med. 1977 Apr-Jun;32(2):46-50.,,,,,,,
265945,NLM,MEDLINE,19770611,20181113,0021-9738 (Print) 0021-9738 (Linking),59,5,1977 May,Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells.,889-99,"['Greenwood, M F', 'Coleman, M S', 'Hutton, J J', 'Lampkin, B', 'Krill, C', 'Bolium, F J', 'Holland, P']","['Greenwood MF', 'Coleman MS', 'Hutton JJ', 'Lampkin B', 'Krill C', 'Bolium FJ', 'Holland P']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Clin Invest,The Journal of clinical investigation,7802877,IM,"['Adolescent', 'Anemia, Aplastic/enzymology', 'Bone Marrow/*enzymology', '*Bone Marrow Cells', 'Child', 'Child, Preschool', 'DNA Nucleotidyltransferases/*analysis/blood', 'Humans', 'Leukemia, Lymphoid/*enzymology', 'Leukemia, Myeloid, Acute/enzymology', 'Lymphocytes/*enzymology', 'Lymphoma/enzymology', 'Neoplasms/*enzymology', 'Neuroblastoma/enzymology', 'Oligonucleotides', 'Purpura, Thrombocytopenic/enzymology', 'Recurrence', 'Remission, Spontaneous', 'Rhabdomyosarcoma/enzymology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1172/JCI108711 [doi]'],ppublish,J Clin Invest. 1977 May;59(5):889-99. doi: 10.1172/JCI108711.,"['0 (Oligonucleotides)', 'EC 2.7.7.- (DNA Nucleotidyltransferases)']","In the present study, terminal deoxynucleotidyltransferase was examined in the peripheral blood and (or) bone marrow of 115 children with a variety of neoplastic, hematologic, and other unrelated disorders. Terminal deoxynucleotidyltransferase activity was present at 4.08+/-0.74 U/108 cells in 23 morphologicall normal bone marrow samples from childhood controls. Terminal transferase was present at greater than 23 U/108 nucleated cells and at greater than31 U/108 blasts in the bone marrow of all children with acute lymphoblastic leukemia studied at initial diagnosis and at disease relapse. Terminal deoxynucleotidyltransferase was detectable at low levels, less than 7.5 U/108 cells, in all remission marrow smaples. Bone marrow terminal transferase activity was markedly elevated in all untreated acute lymphoblastic leukemia patients, whereas low levels which were difficult to interpret were present in the peripheral blood samples of two patients at diagnosis and six patients at relapse who had low absolute lymphoblast counts. Because of greater variation in the lymphoblast content of peripheral blood, bone marrow assays are more reliable in detecting disease activity. Marrow terminal deoxynucleotidyltransferase values obtained during the active phase of acute lymphoblastic leukemia were significantly greater than those found in other types of leukemia, bone marrow malignancies, and hematologic disorders. Terminal transferase determinations in blast cells of two patients with leukemic conversion of non-Hodgkin's lymphoma and in tumor cells from one patient with Burkitt's lymphoma were within the control range. These dat further define the usefulness of terminal deoxynucleotidyltrnasferase assay in the differentiation and classication of hematologic malignancies.",,PMC372297,,,
265944,NLM,MEDLINE,19770611,20131121,0021-9541 (Print) 0021-9541 (Linking),90,3,1977 Mar,Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells.,423-37,"['Loritz, F', 'Bernstein, A', 'Miller, R G']","['Loritz F', 'Bernstein A', 'Miller RG']",['eng'],['Journal Article'],United States,J Cell Physiol,Journal of cellular physiology,0050222,IM,"['Animals', 'Cell Differentiation/drug effects', 'Cell Division/drug effects', 'Cell Line', 'Colchicine/pharmacology', 'Dimethyl Sulfoxide/pharmacology', 'Erythroblasts/*cytology/drug effects', 'Erythrocytes/*cytology', 'Friend murine leukemia virus', 'Leukemia, Erythroblastic, Acute', 'Mice', 'Mutation', 'Temperature']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1002/jcp.1040900306 [doi]'],ppublish,J Cell Physiol. 1977 Mar;90(3):423-37. doi: 10.1002/jcp.1040900306.,"['SML2Y3J35T (Colchicine)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Friend erythroleukemic cells (FLC) can be induced to differentiate in vitro by addition of dimethylsulfoxide (DMSO). We have studied the kinetics of induction by measuring cell volume, volume coefficient of variation and cell doubling time. Two distinct volume changes (early and late) are observed after the addition of the inducing agent. The early change occurs after ten hours and consist of a 10-20% decrease in volume compared to an untreated control population. This shift persists for two days and its magnitude is proportional to both the concentration of DMSO and the number of differentiated cells seen on day 5. FLC lines which induce weakly or not all with DMSO exhibit a reduced or absent early volume shift. Inclusion of a local anaesthetic in the culture prevents the appearance of differentiated cells and also counteracts the early volume shift. The exact time of the early volume change is a function of cell growth rate and appears to be cell cycle related. Synchronized cell populations exposed to DMSO during G2 and S phase undergo one round of mitosis before expression of the volume change whereas cells in G2-M express the change only after a second mitosis. A later, more gradual decrease in volume is observed in those cultures which begin to produce hemoglobin. It occurs after approximately five doubling times and coincides with the first appearance of hemoglobin-containing cells. Volume distribution parameters indicate that only a proportion of the population becomes smaller in size.",,,,,
265943,NLM,MEDLINE,19770611,20181130,0018-022X (Print) 0018-022X (Linking),31,6,1977 Apr,Endocrine function after antineoplastic therapy in 22 children with acute lymphoblastic leukaemia.,463-71,"['Muhlendahl, K E', 'Gadner, H', 'Riehm, H', 'Helge, H', 'Weber, B', 'Muller-Hess, R']","['Muhlendahl KE', 'Gadner H', 'Riehm H', 'Helge H', 'Weber B', 'Muller-Hess R']",['eng'],['Journal Article'],Switzerland,Helv Paediatr Acta,Helvetica paediatrica acta,0373005,IM,"['Adolescent', 'Antineoplastic Agents/*adverse effects/therapeutic use', 'Child', 'Child, Preschool', '*Endocrine Glands/drug effects/radiation effects', 'Female', 'Follicle Stimulating Hormone/metabolism', 'Growth Hormone/metabolism', 'Hormones/*metabolism', 'Humans', 'Hydrocortisone/metabolism', 'Leukemia, Lymphoid/*drug therapy/radiotherapy', 'Luteinizing Hormone/metabolism', 'Male', 'Radiotherapy/*adverse effects', 'Remission, Spontaneous', 'Thyrotropin/metabolism', 'Thyroxine/metabolism']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Helv Paediatr Acta. 1977 Apr;31(6):463-71.,"['0 (Antineoplastic Agents)', '0 (Hormones)', '9002-67-9 (Luteinizing Hormone)', '9002-68-0 (Follicle Stimulating Hormone)', '9002-71-5 (Thyrotropin)', '9002-72-6 (Growth Hormone)', 'Q51BO43MG4 (Thyroxine)', 'WI4X0X7BPJ (Hydrocortisone)']","In 22 children who were in complete remission after acute lymphoblastic leukaemia endocrinological investigations were performed 5-12 weeks after cessation of therapy. The children had received central nervous system irradiation (tele-Co60, 850-1800 rad), and long term, aggressive cytostatic drug therapy during 21 to 36 months. Growth hormone, TSH, thyroxine, LH, FSH, cortisol secretion, and urinary concentrating capacity were found to be normal, with a few exceptions where borderline results were obtained.",,,,,
265926,NLM,MEDLINE,19770622,20171116,0015-8178 (Print) 0015-8178 (Linking),95,16,1977 Apr 28,"[The myelogenous nature of the so-called juvenile ""acute paraleukoblastic leukosis""].",1105-7,"['Panoff, A']",['Panoff A'],['ger'],"['Case Reports', 'Journal Article']",Germany,Fortschr Med,Fortschritte der Medizin,2984763R,IM,"['Bone Marrow/*pathology', '*Bone Marrow Cells', 'Child', 'Child, Preschool', 'Cyclophosphamide/therapeutic use', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy/*pathology', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Prednisone/therapeutic use']",1977/04/28 00:00,1977/04/28 00:01,['1977/04/28 00:00'],"['1977/04/28 00:00 [pubmed]', '1977/04/28 00:01 [medline]', '1977/04/28 00:00 [entrez]']",,ppublish,Fortschr Med. 1977 Apr 28;95(16):1105-7.,"['8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']","Following a critical review of todays predominating opinion on the morphological definition of leukosis cells in severe paraleukoblastic leukosis three cases of the so-called aleukemic from of severe leukosis are described. Such rare cases, in which -- as it is known -- the peripheral blood remains normal while bone marrow shows a paraleukoblastic metaplasia seem to be good evidence for the myelogenic nature of the cells during severe paraleukoblastic leukosis.","Zur myelogenen Natur der sog. ""akuten Paraleukoblasten-Leukose"" im Kindesalter",,,,
265895,NLM,MEDLINE,19770611,20190907,0014-2964 (Print) 0014-2964 (Linking),13,2,1977 Feb,A late clonal evolution of a human leukemic line: sequential cytogenetic studies.,123-30,"['Venuat, A M', 'Dutrillaux, B', 'Rosenfeld, C']","['Venuat AM', 'Dutrillaux B', 'Rosenfeld C']",['eng'],['Journal Article'],England,Eur J Cancer,European journal of cancer,0074126,IM,"['Cell Line', '*Chromosome Aberrations', 'Clone Cells', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid, Acute/*genetics', 'Ploidies', 'Time Factors']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1016/0014-2964(77)90190-6 [doi]'],ppublish,Eur J Cancer. 1977 Feb;13(2):123-30. doi: 10.1016/0014-2964(77)90190-6.,,,,,,,
265894,NLM,MEDLINE,19770630,20170302,0423-104X (Print) 0423-104X (Linking),28,2,1977 Mar-Apr,[Effect of testosterone on the activity of alkaline phosphatase in neutrophils in patients with chronic granulocytic leukemia].,139-43,"['Janicki, K', 'Ronikier, A', 'Sliwczynska, B', 'Lisiewicz, J', 'Moszczynski, P', 'Kwiatkowski, A']","['Janicki K', 'Ronikier A', 'Sliwczynska B', 'Lisiewicz J', 'Moszczynski P', 'Kwiatkowski A']",['pol'],"['English Abstract', 'Journal Article']",Poland,Endokrynol Pol,Endokrynologia Polska,0370674,IM,"['Adult', 'Alkaline Phosphatase/*blood', 'Female', 'Humans', 'Leukemia, Myeloid/*drug therapy', 'Male', 'Middle Aged', 'Neutrophils/*enzymology', 'Stimulation, Chemical', 'Testosterone/*pharmacology/therapeutic use']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Endokrynol Pol. 1977 Mar-Apr;28(2):139-43.,"['3XMK78S47O (Testosterone)', 'EC 3.1.3.1 (Alkaline Phosphatase)']",,Wplyw testosteronu na aktywnosc fosfatazy alkalicznej w granulocytach obojetnochlonnych u chorych z bialaczka granulocytowa przewlekla,,,,
265888,NLM,MEDLINE,19770622,20041117,0012-7183 (Print) 0012-7183 (Linking),93,7,1977,[Clinico-pathological conference XLII. Hematological abnormalities and prolonged fever in a patient with scleroderma].,441-9,"['Leirisalo, M']",['Leirisalo M'],['fin'],"['Case Reports', 'Journal Article']",Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,IM,"['Blood Sedimentation', 'Diagnosis, Differential', 'Female', 'Fever/etiology', 'Hematocrit', 'Humans', 'Leukemia, Myeloid/*pathology', 'Leukocyte Count', 'Middle Aged', 'Scleroderma, Systemic/*pathology', 'Time Factors', 'Tuberculosis, Miliary/*pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Duodecim. 1977;93(7):441-9.,,,Kliinis-patologinen kokousselostus XLII. Verimuutokset ja pitkaaikainen kuumeilu sklerodermapotilaalla,,,,
265886,NLM,MEDLINE,19770622,20131121,0012-0472 (Print) 0012-0472 (Linking),102,16,1977 Apr 22,[Therapy of acute myelosis using D-penicillamine].,628-9,"['Hennig, A']",['Hennig A'],['ger'],['Letter'],Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Penicillamine/*therapeutic use', 'Remission, Spontaneous', 'Time Factors']",1977/04/22 00:00,1977/04/22 00:01,['1977/04/22 00:00'],"['1977/04/22 00:00 [pubmed]', '1977/04/22 00:01 [medline]', '1977/04/22 00:00 [entrez]']",,ppublish,Dtsch Med Wochenschr. 1977 Apr 22;102(16):628-9.,['GNN1DV99GX (Penicillamine)'],,Therapie der akuten Myelose mit D-penicillamin,,,,
265754,NLM,MEDLINE,19770622,20031114,0008-5472 (Print) 0008-5472 (Linking),37,5,1977 May,External surface membrane proteins in normal and neoplastic murine erythroid cells.,1497-501,"['Glass, J', 'Fischer, S', 'Lavidor, L M', 'Nunez, T']","['Glass J', 'Fischer S', 'Lavidor LM', 'Nunez T']",['eng'],['Journal Article'],United States,Cancer Res,Cancer research,2984705R,IM,"['Animals', 'Cell Differentiation', 'Cell Separation', 'Erythrocyte Membrane/*metabolism', 'Erythrocytes/*metabolism', 'Lactoperoxidase', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Membrane Proteins/*metabolism', 'Mice', 'Molecular Weight', 'Spleen/cytology']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 May;37(5):1497-501.,"['0 (Membrane Proteins)', 'EC 1.11.1.- (Lactoperoxidase)']","The development pattern of one class of plasma membrane proteins, the external surface proteins, was examined in neoplastic and nonneoplastic differentiating murine erythroid cells. Neoplastic erythroid precusor cells were obtained from spleens of CD-1 mice after infection with Friend erythroleukemia virus while the nonneoplastic ellls were obtained from spleens of mice with phenylhydrazine-stimulated erythroid hyperplasia. Erythroid precursors at different stages of development were isolated from these erythroid cell populations by sedimentation at unit gravity. The surface proteins were labeled by lactoperoxidase-catalyzed iodination, solubilized in sodium dodecyl sulfate, and separated by sodium dodecyl sulfate gradient gel electrophoresis. Multiple labeled bands were found at all stages of neoplastic and nonneoplastic erythroid differentiation examined. The pattern of external membrane proteins labeled in nonneoplastic erythrocytes and in reticulocytes from peripheral blood were qualitatively similar and not altered by infection with Friend virus. The nucleated precursor cells from noninfected mice exhibited distinct differences from erythrocytes, and with increaseing differentiation an evolutionary pattern of several minor proteins was seen. Clear-cut differences in lactoperoxidast-reactive proteins were also observed between neoplastic and nonneoplastic precursors. The most marked differences were observed between the most immature cells. The youngest neoplastic cells from CD-1 mice possessed a protein with a molecular weight of 8000 not seen in normal erythroid cells. Additionally, there was an absence of a normally occurring protein with a molecular weight of 13,000 and increased amounts of a protein with a molecular weight of 140,000. With increasing maturation of the neoplastic cells, labeling of the protein with a molecular weight of 8,000 decreased while the protein with a molecular weight of 13,000 became apparent, so that a labeling pattern similar to that of nonneoplastic cells was obtained. These studies deomnstrate both distinct alterations of lactoperoxidase-reactive surface membrane proteins in nonneoplastic erythroid cells druring cell maturation in neoplastic erythroid cells as compared with nonneoplastic erythroid cells at similar stages of development.",,,,,
265753,NLM,MEDLINE,19770622,20131121,0008-5472 (Print) 0008-5472 (Linking),37,5,1977 May,Utilization of long-chain free fatty acids and glucose by human leukemic blast cells.,1323-7,"['Burns, C P', 'Welshman, I R', 'Spector, A A']","['Burns CP', 'Welshman IR', 'Spector AA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Carbon Dioxide/metabolism', 'Cholesterol Esters/metabolism', 'Fatty Acids/*metabolism', 'Fatty Acids, Nonesterified/metabolism', 'Glucose/*metabolism', 'Humans', 'Leukemia, Lymphoid/*metabolism', 'Palmitic Acids/metabolism', 'Phospholipids/metabolism', 'Time Factors', 'Triglycerides/metabolism']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 May;37(5):1323-7.,"['0 (Cholesterol Esters)', '0 (Fatty Acids)', '0 (Fatty Acids, Nonesterified)', '0 (Palmitic Acids)', '0 (Phospholipids)', '0 (Triglycerides)', '142M471B3J (Carbon Dioxide)', 'IY9XDZ35W2 (Glucose)']","We have studied the utilization of free fatty acid and glucose by human leukemic blast cells. Palmitate was both incorporated into complex cellular lipids, primarily phospholipids and triglycerides, and oxidized to CO2. The predominant phospholipid synthesized was phosphatidylcholine. Only a small proportion of the incoming fatty acid was modified structurally before incorporation into lipid esters. After incubation with [1-14 C]palmitate, 91% of the radioactivity recovered in cell lipids remained in fatty acids containing 16 carbon atoms. Studies with labeled glucose revealed little de novo synthesis of fatty acid, and the majority of the radioactivity from glucose was located in the water-soluble fraction after saponification of the esters. We conclude that the free fatty acids contained in the extracellular fluid provide much of the fatty acid for required cellular lipid synthesis in human leukemic blast cells. Since there is little elongation of incoming palmitate before incorporation into cellular lipids, it may be possible to alter the fatty acid composition of membrane phospholipids by changing the proportion of the various free fatty acids available to the leukemic cells.",,,,,
265752,NLM,MEDLINE,19770630,20190619,0008-543X (Print) 0008-543X (Linking),39,5,1977 May,Cardiac arrest due to hyperkalemia following therapy for acute lymphoblastic leukemia.,2290-3,"['Wilson, D', 'Stewart, A', 'Szwed, J', 'Einhorn, L H']","['Wilson D', 'Stewart A', 'Szwed J', 'Einhorn LH']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Adolescent', 'Allopurinol/therapeutic use', 'Daunorubicin/adverse effects/therapeutic use', 'Drug Therapy, Combination', 'Heart Arrest/blood/*etiology', 'Humans', 'Hyperkalemia/blood/*complications/etiology', 'Leukemia, Lymphoid/blood/*complications/drug therapy', 'Male', 'Prednisone/adverse effects/therapeutic use', 'Uric Acid/blood', 'Vinblastine/therapeutic use', 'Vincristine/adverse effects']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1002/1097-0142(197705)39:5<2290::aid-cncr2820390550>3.0.co;2-p [doi]'],ppublish,Cancer. 1977 May;39(5):2290-3. doi: 10.1002/1097-0142(197705)39:5<2290::aid-cncr2820390550>3.0.co;2-p.,"['268B43MJ25 (Uric Acid)', '5J49Q6B70F (Vincristine)', '5V9KLZ54CY (Vinblastine)', '63CZ7GJN5I (Allopurinol)', 'VB0R961HZT (Prednisone)', 'ZS7284E0ZP (Daunorubicin)']","A patient with acute lymphoblastic leukemia with a large tumor burden is presented. Following successful chemotherapy, the patient experienced a cardiac arrest presumably due to hyperkalemia in association with hyperuricemia. The implication of these findings for patients with responsive hematological malignancies is discussed.",,,,,
265749,NLM,MEDLINE,19770630,20190619,0008-543X (Print) 0008-543X (Linking),39,5,1977 May,Cytogenetics of juvenile type chronic granulocytic leukemia.,2017-24,"['Inoue, S', 'Ravindranath, Y', 'Thompson, R I', 'Zuelzer, W W', 'Ottenbreit, M J']","['Inoue S', 'Ravindranath Y', 'Thompson RI', 'Zuelzer WW', 'Ottenbreit MJ']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Bone Marrow/ultrastructure', 'Bone Marrow Cells', 'Child, Preschool', '*Chromosome Aberrations', 'Chromosome Deletion', 'Chromosomes/radiation effects', 'Chromosomes, Human, 1-3', 'Chromosomes, Human, 16-18', 'Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Leukemia, Lymphoid/genetics', 'Leukemia, Myeloid/blood/*genetics', 'Male', 'Neoplasms, Radiation-Induced/genetics', 'Translocation, Genetic', 'Trisomy']",1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1002/1097-0142(197705)39:5<2017::aid-cncr2820390518>3.0.co;2-z [doi]'],ppublish,Cancer. 1977 May;39(5):2017-24. doi: 10.1002/1097-0142(197705)39:5<2017::aid-cncr2820390518>3.0.co;2-z.,,"Cytogenetic examination of bone marrow cells from three patients with juvenile chronic granulocytic leukemia (CGL) showed 46,XX,3p-,11p+ ,t(11p:3p) in one case, 45XY,-E in another, and 45X(X),-C/47,XX,+G in the third. The case with the translocated chromosome originally presented like an acute lymphocytic leukemia (ALL). TAn overt clinical picture of juvenile CGL emerged two and a half years later. Serial study of this case revealed no cytogenetic abnormalities until two years after the diagnosis of ALL, when the translocated chromosome was first observed. Unlike the Ph1 chromosome in adult type CGL, chromosomal abnormalities in juvenile CGL lack specificity, resembling ALL in this respect.",,,,,
265748,NLM,MEDLINE,19770611,20191210,0008-543X (Print) 0008-543X (Linking),39,4,1977 Apr,Early deaths in acute myelogenous leukemia.,1710-4,"['Smith, I E', 'Powles, R', 'Clink, H M', 'Jameson, B', 'Kay, H E', 'McElwain, T J']","['Smith IE', 'Powles R', 'Clink HM', 'Jameson B', 'Kay HE', 'McElwain TJ']",['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adult', 'Anti-Bacterial Agents/administration & dosage/therapeutic use', 'Antineoplastic Agents/therapeutic use', 'Blood Transfusion', 'Female', 'Granulocytes/transplantation', 'Humans', 'Infections/complications/drug therapy', 'Leukemia, Myeloid, Acute/complications/*mortality/therapy', 'Male', 'Platelet Transfusion', 'Sepsis/complications/drug therapy', 'Time Factors']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1002/1097-0142(197704)39:4<1710::aid-cncr2820390448>3.0.co;2-3 [doi]'],ppublish,Cancer. 1977 Apr;39(4):1710-4. doi: 10.1002/1097-0142(197704)39:4<1710::aid-cncr2820390448>3.0.co;2-3.,"['0 (Anti-Bacterial Agents)', '0 (Antineoplastic Agents)']","In a series of 84 patients with acute myelogenous leukemia, 24 died within 6 weeks of starting treatment. Twenty of the 24 patients had failed to achieve remission at the time of death. Death was due to infection in 20 patients and in 17 of these to septicemia; but whereas severe local infection with septicemia accounted for 12 deaths, only five patients died of septicemia without local infection. Bleeding was the direct cause of death in only four patients and an associated terminal event in another three; of these four patients three had disseminated intravascular coagulopathy. Surprisingly, in this group of patients age and overall clinical status at the time of admission were of no prognostic value in the first 6-week period. The importance of drug resistent disease associated with intractable local infection as a major cause of early death is emphasized.",,,,,
265747,NLM,MEDLINE,19770611,20190619,0008-543X (Print) 0008-543X (Linking),39,4,1977 Apr,Leukocytic fibrinolysis in myelomonocytic leukemia.,1618-24,"['Talarico, L', 'Weintraub, L R']","['Talarico L', 'Weintraub LR']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Animals', 'Blood Coagulation', 'Cats', '*Fibrinolysis', 'Hemorrhage/complications', 'Humans', 'Leukemia, Myeloid/*blood/complications/physiopathology', 'Leukocytes/enzymology/*physiology', 'Male', 'Peptide Hydrolases/metabolism']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1002/1097-0142(197704)39:4<1618::aid-cncr2820390436>3.0.co;2-q [doi]'],ppublish,Cancer. 1977 Apr;39(4):1618-24. doi: 10.1002/1097-0142(197704)39:4<1618::aid-cncr2820390436>3.0.co;2-q.,['EC 3.4.- (Peptide Hydrolases)'],"A case of myelomonocytic leukemia is described in which an increase in primary fibrinolytic activity produced a severe hemorrhagic diathesis. The leukemic cells were demonstrated to be the source of the fibrinolytic activity. Utilizing a fibrin coated slide technique, the intact leukemic cells were shown to release their fibrinolytic activity and to induce local lysis. Intact leukocytes from normal subjects and other patients with acute leukemia of varied cell types were unable to release fibrinolytic activity although in some of the leukemic preparations, increased fibrinolytic activity was demonstrated after in vitro disruption of the cells.",,,,,
265746,NLM,MEDLINE,19770611,20190619,0008-543X (Print) 0008-543X (Linking),39,4,1977 Apr,Prognotic significance of pretreatment proliferative activity in adult acute leukemia.,1603-17,"['Hart, J S', 'George, S L', 'Frei, E 3rd', 'Bodey, G P', 'Nickerson, R C', 'Freireich, E J']","['Hart JS', 'George SL', 'Frei E 3rd', 'Bodey GP', 'Nickerson RC', 'Freireich EJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Adult', 'Age Factors', 'Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Cell Division', 'Female', 'Humans', 'Leukemia, Lymphoid/blood/drug therapy/*pathology', 'Leukemia, Myeloid, Acute/blood/drug therapy/*pathology', 'Leukocyte Count', 'Male', 'Middle Aged', 'Prognosis', 'Remission, Spontaneous', 'Statistics as Topic', 'Time Factors']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1002/1097-0142(197704)39:4<1603::aid-cncr2820390435>3.0.co;2-8 [doi]'],ppublish,Cancer. 1977 Apr;39(4):1603-17. doi: 10.1002/1097-0142(197704)39:4<1603::aid-cncr2820390435>3.0.co;2-8.,['0 (Antineoplastic Agents)'],"A statistical analysis of the prognostic significance of eight pretreatment variables was undertaken for 71 previously untreated adult patients with acute leukemia seen at M.D. Anderson Hospital over a 5 1/2-year period. None of the patients had received any prior therapy. Nearly all of the patients (68 of the 71) were treated with 4- or 5-day courses of arabinosyl-cytosine alone or in combination with cyclophosphamide, vincristine (oncovin) and prednisone (COAP). The pretreatment variables studied were age at diagnosis, the percent labeling index of the bone marrow leukemic cells, diagnosis, the highest temperature prior to start of treatment, the marrow clot section cellularity and smear differential percent of blasts, percent absolute marrow leukemic cell infiltrate and absolute number of blasts X 10(3)/mm3 in the peripheral blood. Fifty-one patients had acute myeloblastic leukemia (AML) and 20 patients had acute lymphoblastic leukemia (ALL). Using a statistical regression model approach, the only variables found to be of significant prognostic importance with respect to the probability of complete remission for AML patients were the pretreatment percent labeling index, the age of the patient and the highest temperature prior to start of treatment. Unlike AML, the initial percent labeling index did not appear to be of prognostic significance for ALL patients. AML patients with high labeling indices (larger than or equal to 9%) and young patients in general (especially those less than 40 years old) had the best remission rates. With respect to the length of complete remission and survival for all patients, the only important variables were the pretreatment percent labeling index and the age of the patient, respectively. Once in complete remission, an initially high labeling index was an unfavorable sign with respect to length of remission, regardless of the patient's diagnosis. The results of this study are supportive of studies in experimental systems demonstrating the importance of cytokinetic factors in the administration of chemotherapy and suggest that such factors may be of clinical importance in selecting approaches to therapy.",,,,,
265745,NLM,MEDLINE,19770611,20190619,0008-543X (Print) 0008-543X (Linking),39,4,1977 Apr,Granulocytic sarcoma of the brain.,1542-6,"['Krishnamurthy, M', 'Nusbacher, N', 'Elguezabal, A', 'Seligman, B R']","['Krishnamurthy M', 'Nusbacher N', 'Elguezabal A', 'Seligman BR']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Brain Neoplasms/diagnosis/*pathology', 'Female', 'Humans', 'Leukemia, Myeloid/diagnosis/*pathology', 'Middle Aged', 'Radionuclide Imaging']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1002/1097-0142(197704)39:4<1542::aid-cncr2820390427>3.0.co;2-5 [doi]'],ppublish,Cancer. 1977 Apr;39(4):1542-6. doi: 10.1002/1097-0142(197704)39:4<1542::aid-cncr2820390427>3.0.co;2-5.,,An unusual case of granulocytic sarcoma (chloroma) of the parenchyma of the brain occurring in a patient with acute myelocytic leukemia in remission is described and the literature reviewed. The patient presented with an intracranial mass without clinical evidence of meningeal involvement. The value of 99mTc scan in CNS leukemia is shown.,,,,,
265744,NLM,MEDLINE,19770630,20181113,0008-4409 (Print) 0008-4409 (Linking),116,9,1977 May 7,Chronic myelogenous leukemia simulating chronic granulomatous disease.,1029-30,"[""O'Regan, S"", 'Melhorn, D K', 'Newman, A J', 'Graham, R C']","[""O'Regan S"", 'Melhorn DK', 'Newman AJ', 'Graham RC']",['eng'],"['Case Reports', 'Journal Article']",Canada,Can Med Assoc J,Canadian Medical Association journal,0414110,IM,"['Adult', 'Diagnosis, Differential', 'Female', 'Follow-Up Studies', 'Granulomatous Disease, Chronic/*diagnosis', 'Humans', 'Leukemia, Myeloid/*diagnosis/metabolism', 'Leukocyte Count', 'Leukocytes/metabolism', 'Nitroblue Tetrazolium', 'Phagocyte Bactericidal Dysfunction/*diagnosis']",1977/05/07 00:00,1977/05/07 00:01,['1977/05/07 00:00'],"['1977/05/07 00:00 [pubmed]', '1977/05/07 00:01 [medline]', '1977/05/07 00:00 [entrez]']",,ppublish,Can Med Assoc J. 1977 May 7;116(9):1029-30.,['298-83-9 (Nitroblue Tetrazolium)'],"A 5-year illness of a child, characterized by recurrent bacterial infections and abnormal results of nitroblue tetrazolium dye reduction tests, was suggestive of chronic granulomatous disease but the illness terminated in overt myeloid leukemia. During this progression studies of leukocyte structure and metabolic activity revealed abnormalities that suggested the existence of a ""preleukemic"" state.",,PMC1879049,,,
265741,NLM,MEDLINE,19770622,20190501,0007-1447 (Print) 0007-1447 (Linking),1,6064,1977 Mar 26,Anthracycline cardiotoxicity and acute myelogenous leukaemia.,815,"['Al-Ismail, S A', 'Parry, D H', 'Whittaker, J A']","['Al-Ismail SA', 'Parry DH', 'Whittaker JA']",['eng'],['Journal Article'],England,Br Med J,British medical journal,0372673,IM,"['Adult', 'Daunorubicin/*adverse effects/therapeutic use', 'Doxorubicin/*adverse effects/therapeutic use', 'Heart Failure/*chemically induced', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy']",1977/03/26 00:00,1977/03/26 00:01,['1977/03/26 00:00'],"['1977/03/26 00:00 [pubmed]', '1977/03/26 00:01 [medline]', '1977/03/26 00:00 [entrez]']",['10.1136/bmj.1.6064.815 [doi]'],ppublish,Br Med J. 1977 Mar 26;1(6064):815. doi: 10.1136/bmj.1.6064.815.,"['80168379AG (Doxorubicin)', 'ZS7284E0ZP (Daunorubicin)']",,,PMC1606143,,,
265740,NLM,MEDLINE,19770622,20181113,0007-1447 (Print) 0007-1447 (Linking),1,6064,1977 Mar 26,Difficulties in leukaemia diagnosis.,791-2,,,['eng'],['Editorial'],England,Br Med J,British medical journal,0372673,IM,"['Diagnosis, Differential', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/diagnosis', 'Leukemia, Myeloid/diagnosis']",1977/03/26 00:00,1977/03/26 00:01,['1977/03/26 00:00'],"['1977/03/26 00:00 [pubmed]', '1977/03/26 00:01 [medline]', '1977/03/26 00:00 [entrez]']",,ppublish,Br Med J. 1977 Mar 26;1(6064):791-2.,,,,PMC1606209,,,
265737,NLM,MEDLINE,19770611,20210216,0006-4971 (Print) 0006-4971 (Linking),49,5,1977 May,Characteristics of blast crisis in chronic granulocytic leukemia.,705-14,"['Rosenthal, S', 'Canellos, G P', 'DeVita, V T Jr', 'Gralnick, H R']","['Rosenthal S', 'Canellos GP', 'DeVita VT Jr', 'Gralnick HR']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Blood Cell Count', 'Bone Marrow/*pathology', '*Bone Marrow Cells', 'Bone Marrow Examination', '*Cell Transformation, Neoplastic', 'Chromosome Aberrations', 'Chromosomes, Human, 21-22 and Y', 'Erythroblasts/pathology', 'Female', 'Hemoglobins', 'Humans', 'Leukemia, Myeloid/*pathology', 'Lymphocytes/*pathology', 'Male', 'Remission, Spontaneous', 'Retrospective Studies']",1977/05/01 00:00,2001/03/28 10:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/05/01 00:00 [entrez]']",['S0006-4971(20)70148-5 [pii]'],ppublish,Blood. 1977 May;49(5):705-14.,['0 (Hemoglobins)'],"The terminal phase of most patients with Ph1-positive chronic granulocytic leukemia (i.e., blast crisis) resembles acute leukemia. The clinical and hematologic features of blast crisis in 73 patients with chronic granulocytic leukemia have been reviewed. Two major morphological subgroups, lymphoblastic and myeloblastic, were identified. The lymphoblastic group in general had more profound thrombocytopenia and a greater number of blasts, while the myeloblastic group had more severa anemia. Extramedullary leukemia was documented in 27 patients. In 12 patients extramedullary leukemia preceded or occurred simultaneously with blast crisis in the bone marrow and peripheral blood. On the basis of this study we present hematologic criteria for the diagnosis of blast crisis and emphasize the importance of extramedullary leukemia in heralding the onset of blast crisis.",,,,,
265735,NLM,MEDLINE,19770630,20190609,0006-3002 (Print) 0006-3002 (Linking),481,2,1977 Apr 12,Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients.,481-92,"['Cheng, Y C', 'Domin, B', 'Lee, L S']","['Cheng YC', 'Domin B', 'Lee LS']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Biochim Biophys Acta,Biochimica et biophysica acta,0217513,IM,"['Chromatography, Affinity', 'Cytoplasm/enzymology', 'Deoxycytidine', 'Enzyme Activation', 'Humans', 'Kinetics', 'Leukemia, Myeloid, Acute/*enzymology', 'Magnesium/pharmacology', 'Mitochondria/enzymology', 'Molecular Weight', '*Phosphotransferases/isolation & purification/metabolism', 'Ribonucleosides/pharmacology', 'Structure-Activity Relationship', 'Thermodynamics']",1977/04/12 00:00,1977/04/12 00:01,['1977/04/12 00:00'],"['1977/04/12 00:00 [pubmed]', '1977/04/12 00:01 [medline]', '1977/04/12 00:00 [entrez]']","['0005-2744(77)90281-9 [pii]', '10.1016/0005-2744(77)90281-9 [doi]']",ppublish,Biochim Biophys Acta. 1977 Apr 12;481(2):481-92. doi: 10.1016/0005-2744(77)90281-9.,"['0 (Ribonucleosides)', '0W860991D6 (Deoxycytidine)', 'EC 2.7.- (Phosphotransferases)', 'I38ZP9992A (Magnesium)']","A procedure for purifying human cytoplasmic and mitochondrial deoxycytidine kinase (NTP:deoxycytidine 5'-phosphotransferase, EC 2.7.1.74) was developed. Both purified isozymes have a similar molecular weight, activation energy and catalyze the reaction by a sequential mechanism. These two isozymes differ with respect to their substrate specificities. With cytoplasmic deoxycytidine kinase, ATP, GTP and TTP have the highest reaction velocity. Pyrimidine nucleoside triphosphates have higher affinity but lower V than purine nucleoside triphosphates. Cytidine and arabinosylcytidine can serve as substrates. With mitochondrial isozyme only ATP gives the highest reaction velocity. ATP and dATP have the same Km but different V values. Besides deoxycytidine, also deoxythymidine but not cytidine or arabinosylcytidine can serve as substrates. There are also differences between these two isozymes with respect to their sensitivity to inhibition. For cytoplasmic enzyme, Br5dCyd and Iodo5dCyd are not inhibitory. Both dCTP and UTP are competitive inhibitors (Ki 0.25 and 0.5 micronM, respectively) with respect to ATP. For mitochondrial isozyme both Br5dCyd and Iodo5dCyd are inhibitory and dCTP and TTP are competitive inhibitors (Ki 2 and 10 micronM, respectively) with respect to ATP.",,,,,
265734,NLM,MEDLINE,19770630,20190704,0007-1048 (Print) 0007-1048 (Linking),35,3,1977 Mar,The early detection of remission in acute myelogenous leukaemia by in vitro cultures.,411-8,"['Spitzer, G', 'Dicke, K A', 'McCredie, K B', 'Barlogie, B']","['Spitzer G', 'Dicke KA', 'McCredie KB', 'Barlogie B']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Br J Haematol,British journal of haematology,0372544,IM,"['Bone Marrow Cells', 'Cell Division', 'Cells, Cultured', 'Clone Cells', 'Humans', 'Leukemia, Myeloid, Acute/*pathology', 'Remission, Spontaneous', 'Time Factors']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00601.x [doi]'],ppublish,Br J Haematol. 1977 Mar;35(3):411-8. doi: 10.1111/j.1365-2141.1977.tb00601.x.,,Twenty-eight cases of acute myeloid leukaemia without normal myeloid colony growth in vitro were serially cultured by an in vitro agar culture method during remission induction therapy. Colony formation frequently returned before morphological evidence of remission. Without early return of colony formation drug induced aplasia was prolonged and fatal. Analysis of the pattern of return of in vitro colony forming cells may be of value in designing the chemotherapy schedule.,,,,,
265733,NLM,MEDLINE,19770630,20190704,0007-1048 (Print) 0007-1048 (Linking),35,2,1977 Feb,Bone marrow culture studies in refractory cytopenia and 'smouldering leukaemia'.,251-61,"['Milner, G R', 'Testa, N G', 'Geary, C G', 'Dexter, T M', 'Muldal, S', 'MacIver, J E', 'Lajtha, L G']","['Milner GR', 'Testa NG', 'Geary CG', 'Dexter TM', 'Muldal S', 'MacIver JE', 'Lajtha LG']",['eng'],['Journal Article'],England,Br J Haematol,British journal of haematology,0372544,IM,"['Blood Platelets', '*Bone Marrow', '*Bone Marrow Cells', 'Cells, Cultured', 'Humans', 'Leukemia, Myeloid/*pathology', 'Leukocytes', 'Monocytes', 'Neutrophils', 'Pancytopenia/*pathology', 'Preleukemia/*pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00582.x [doi]'],ppublish,Br J Haematol. 1977 Feb;35(2):251-61. doi: 10.1111/j.1365-2141.1977.tb00582.x.,,"As an adjunct to conventional haematological and cytogenetic data, 22 cases of refractory cytopenia, and five with chronic myelomonocytic leukaemia, (CMML) were studied by bone marrow culture. Cultures from II such patients without an excess of marrow myeloblasts usually showed low, or undetectable, numbers of cells capable of giving rise to colonies of granulocytes and/or macrophages (CFUc) but near-normal numbers of cluster-forming cells and cells capable of forming erythroid colonies (CFUE). Those with similar blood pictures, but in whom the marrow contained a slight excess of myeloblasts (II cases), showed a more profound defect in growth patterns: low or undetectable numbers of CFUC, clusters and CFUE, results similar to those found in acute myeloblastic leukaemia, into which three of this group evolved. The patients with CMML gave comparatively normal CFUC, cluster and CFUE growth patterns.",,,,,
265732,NLM,MEDLINE,19770630,20190704,0007-1048 (Print) 0007-1048 (Linking),35,2,1977 Feb,Biochemical abnormalities in chronic erythraemic myelosis.,169-75,"['Kass, L']",['Kass L'],['eng'],['Journal Article'],England,Br J Haematol,British journal of haematology,0372544,IM,"['Anemia, Aplastic/classification', 'Anemia, Sideroblastic/classification', 'Arginine/metabolism', 'Chronic Disease', 'Erythroblasts/metabolism', 'Esterases/metabolism', 'Glycogen/metabolism', 'Histones/metabolism', 'Humans', 'Iron/metabolism', 'Leukemia, Erythroblastic, Acute/classification/*metabolism/pathology', 'Methyltransferases/metabolism', 'Vitamin B 12/metabolism']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1111/j.1365-2141.1977.tb00574.x [doi]'],ppublish,Br J Haematol. 1977 Feb;35(2):169-75. doi: 10.1111/j.1365-2141.1977.tb00574.x.,"['0 (Histones)', '9005-79-2 (Glycogen)', '94ZLA3W45F (Arginine)', 'E1UOL152H7 (Iron)', 'EC 2.1.1.- (Methyltransferases)', 'EC 3.1.- (Esterases)', 'P6YC3EG204 (Vitamin B 12)']",,,,,,
265731,NLM,MEDLINE,19770630,20190515,0007-0920 (Print) 0007-0920 (Linking),35,4,1977 Apr,Early central nervous system involvement in adults with acute non-myelogenous leukaemia.,479-83,"['Lister, T A', 'Whitehouse, J M', 'Beard, M E', 'Paxton, A', 'Brearley, R L', 'Brown, L', 'Wrigley, P F', 'Crowther, D']","['Lister TA', 'Whitehouse JM', 'Beard ME', 'Paxton A', 'Brearley RL', 'Brown L', 'Wrigley PF', 'Crowther D']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['Adolescent', 'Adult', 'Asparaginase/therapeutic use', '*Central Nervous System Diseases', 'Humans', '*Leukemia, Lymphoid/cerebrospinal fluid/drug therapy', 'Middle Aged', 'Neoplasm Metastasis', 'Prednisolone/therapeutic use', 'Remission, Spontaneous']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1038/bjc.1977.71 [doi]'],ppublish,Br J Cancer. 1977 Apr;35(4):479-83. doi: 10.1038/bjc.1977.71.,"['9PHQ9Y1OLM (Prednisolone)', 'EC 3.5.1.1 (Asparaginase)']","Of 47 consecutive patients aged 15-60 years with acute non-myelogenous leukaemia (ANML) (40 acute lymphoblastic leukaemia (ALL); 5 acute Burkitt-like leukaemia (ABLL), 2 acute undifferentiated leukaemia (AUL) treated with a standard chemotherapy protocol (OPAL), 31 achieved complete remission (28/40(70%) of patients with ALL). CNS leukaemia occurred in 4/16 non-remitters, and in 6 patients who achieved complete remission (CR). CNS leukaemia occurred in all 5 patients with acute Burkitt-like leukaemia. 4/28 patients with ALL achieving CR had evidence of CSF involvement on cytocentrifuge examination shortly after CR. The apparent risk of early CNS disease suggests that prophylactic CNS therapy should be given early in the treatment of acute non-myelogenous leukaemia.",,PMC2025338,,,
265730,NLM,MEDLINE,19770622,20190515,0007-0920 (Print) 0007-0920 (Linking),35,3,1977 Mar,Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity.,280-7,"['Gale, D G', 'MacLennan, I C']","['Gale DG', 'MacLennan IC']",['eng'],['Journal Article'],England,Br J Cancer,British journal of cancer,0370635,IM,"['*Antibodies, Neoplasm', 'Antibody Specificity', 'Bone Marrow/immunology', 'Bone Marrow Cells', 'Cytotoxicity Tests, Immunologic', 'Humans', 'Immunotherapy', 'Leukemia, Myeloid, Acute/*immunology/therapy', 'Tissue Preservation']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1038/bjc.1977.40 [doi]'],ppublish,Br J Cancer. 1977 Mar;35(3):280-7. doi: 10.1038/bjc.1977.40.,"['0 (Antibodies, Neoplasm)']","Cytotoxic antibodies to antigens specific for leukaemic myeloblasts have been sought in the serum of patients with acute myeloblastic leukaemia treated by immunotherapy with irradiated allogeneic myeloblasts and BCG. Assays of complement- and K-cell-mediated activity were used. Cytotoxicity to allogeneic myeloblasts was detected in both assays. When sera from 15 patients, taken at various times during immunotherapy, were systematically tested against a panel of 5 myeloblasts, the following patterns emerged: 1. No antibody was cytotoxic against all myeloblasts of the panel in either the K-cell or complement-dependent assay. However, all myeloblasts of the panel were lysed by a number of sera. 2. Cytotoxic antibody was detected as often against a panel of lymphocytes from healthy donors as against the panel of allogeneic myeloblasts. 3. Fresh and cryopreserved myeloblasts were equally susceptible to lysis in both assays. 4. Experiments failed to demonstrate any deterioration of cytotoxic antibody on storage. 5. The number of K-cell-revealed cytotoxic antisera increased with length of immunotherapy. This pattern was not apparent for antibodies revealed by complement. 6. No instance of cytotoxicity in either assay was seen when serum was tested against 12 autologous myeloblasts. It is considered that cytotoxic antibody detected with allogeneic myeloblasts is probably directed against HLA antigens common to immunizing and test target myeloblasts and target lymphocytes.",,PMC2025282,,,
265696,NLM,MEDLINE,19770520,20071115,0003-9985 (Print) 0003-9985 (Linking),101,4,1977 Apr,Pathogenesis of central nervous system infiltration in acute leukemia.,203-5,"['Azzarelli, V', 'Roessmann, U']","['Azzarelli V', 'Roessmann U']",['eng'],['Journal Article'],United States,Arch Pathol Lab Med,Archives of pathology & laboratory medicine,7607091,IM,"['Brain/pathology', 'Humans', 'Leukemia, Lymphoid/*pathology', 'Leukemia, Myeloid, Acute/*pathology', 'Meninges/*pathology', 'Neoplasm Metastasis']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Arch Pathol Lab Med. 1977 Apr;101(4):203-5.,,"The distribution pattern of leukemic infiltrates was studied in 31 cases of acute leukemia with CNS involvement. Dura mater involvement was found in 93% (29/31) of the cases; arachnoid, 71% (22/31); perivascular cuffing, 37% (17/31); parenchymatous, 16% (5/31). Dura matter infiltrates were the sole manifestation in nine cases; Infiltration of the arachnoid in the absence of dural infiltration was rare (9%). The anatomic evidence supports the concept that leukemic cells infiltrate by way of perivenous adventitial tissue connecting the dura mater and subarachnoid space. It is likely that this pathway leads directly from the bones of the skull into the brain parenchyma.",,,,,
265695,NLM,MEDLINE,19770525,20071115,0300-4910 (Print) 0300-4910 (Linking),128,1-2,1977 Jan-Mar,[Cytotoxic antibodies to leukemia cells in normal human sera].,155-7,"['Dore, J F', 'Bertoglio, J', 'Guibout, C']","['Dore JF', 'Bertoglio J', 'Guibout C']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Immunol (Paris),Annales d'immunologie,0353045,IM,"['*Antibodies, Neoplasm', 'Cytotoxicity Tests, Immunologic', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Leukemia, Myeloid, Acute/*immunology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ann Immunol (Paris). 1977 Jan-Mar;128(1-2):155-7.,"['0 (Antibodies, Neoplasm)']","Antibodies cytotoxic for human leukemia cells were demonstrated in 7 parents of leukemia children and in 2 normal donors whose blood had induced a partial remission in leukemia and lymphoma patients. None of these sera were cytotoxic to remission cells nor to normal lymphocytes. These sera appear to be relatively specific for acute lymphoblastic leukemia cells; however, several antigenic specificities appear to be detected by these sera.",Anticorps cytotoxiques pour des cellules leucemiques humaines dans des serums humains normaux,,,,
265694,NLM,MEDLINE,19770527,20161123,0003-4185 (Print) 0003-4185 (Linking),20,1,1977 Jan-Feb,Giant cell pneumonia complicating acute lymphoblastic leukemia in remission.,79-86,"['Shah, K J', 'Lewis, M J', 'Cameron, A H', 'Purdham, D R', 'Mann, J R']","['Shah KJ', 'Lewis MJ', 'Cameron AH', 'Purdham DR', 'Mann JR']","['eng', 'fre']",['Journal Article'],France,Ann Radiol (Paris),Annales de radiologie,0372331,IM,"['Child', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Pulmonary Fibrosis/diagnostic imaging/*etiology', 'Radiography', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Ann Radiol (Paris). 1977 Jan-Feb;20(1):79-86.,,,,,,,
265690,NLM,MEDLINE,19770527,20181113,0002-9440 (Print) 0002-9440 (Linking),87,1,1977 Apr,Animal model: feline acute lymphoblastic leukemia and aplastic anemia.,265-8,"['Cotter, S M', 'Essex, M']","['Cotter SM', 'Essex M']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Pathol,The American journal of pathology,0370502,IM,"['*Anemia, Aplastic/blood', 'Animals', 'Cat Diseases/epidemiology', '*Cats', '*Disease Models, Animal', '*Leukemia, Lymphoid/blood/veterinary']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Am J Pathol. 1977 Apr;87(1):265-8.,,,,PMC2032060,,,
265682,NLM,MEDLINE,19770527,20190626,0002-9343 (Print) 0002-9343 (Linking),62,4,1977 Apr,Renal failure secondary to leukemic infiltration of the kidneys.,636-42,"['Lundberg, W B', 'Cadman, E D', 'Finch, S C', 'Capizzi, R L']","['Lundberg WB', 'Cadman ED', 'Finch SC', 'Capizzi RL']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Med,The American journal of medicine,0267200,IM,"['Calcium/blood', 'Creatinine/blood', 'Female', 'Humans', 'Kidney Failure, Chronic/blood/*etiology', 'Kidney Neoplasms/*complications/radiotherapy', 'Leukemia, Lymphoid/*complications/drug therapy', 'Methotrexate/administration & dosage', 'Middle Aged', 'Neoplasm Metastasis', 'Phosphates/blood', 'Radiotherapy Dosage', 'Uric Acid/blood', 'Urography']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']","['0002-9343(77)90427-2 [pii]', '10.1016/0002-9343(77)90427-2 [doi]']",ppublish,Am J Med. 1977 Apr;62(4):636-42. doi: 10.1016/0002-9343(77)90427-2.,"['0 (Phosphates)', '268B43MJ25 (Uric Acid)', 'AYI8EX34EU (Creatinine)', 'SY7Q814VUP (Calcium)', 'YL5FZ2Y5U1 (Methotrexate)']","Leukemic infiltration of the kidneys is a very rare cause of renal failure. A woman with acute lymphoblastic leukemia presented with nonliguric renal failure and was found to have massively enlarged kidneys. The size of the kidneys was dramatically reduced through the combined effects of local radiation therapy and systemic chemotherapy. Because this rapid shrinkage of the kidneys was associated with improvement in renal function, the uremia was ascribed to leukemic infiltration. As a consequence of rapid tumor lysis in the presence of renal failure, marked hyperphosphatemia and hypocalcemia developed. The literature experience with renal failure secondary to leukemic infiltration of the kidneys is reviewed.",,,,,
265681,NLM,MEDLINE,19770527,20190509,0002-9173 (Print) 0002-9173 (Linking),67,4,1977 Apr,Periodic acid-schiff-positive megaloblasts in pernicious anemia.,371-3,"['Kass, L']",['Kass L'],['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Anemia, Pernicious/metabolism/*pathology', 'Bone Marrow/pathology', 'Bone Marrow Cells', 'Erythrocytes, Abnormal/*pathology', 'Glycogen/*metabolism', 'Humans', 'Leukemia, Erythroblastic, Acute/pathology', 'Megaloblasts/metabolism/*pathology', 'Periodic Acid-Schiff Reaction']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1093/ajcp/67.4.371 [doi]'],ppublish,Am J Clin Pathol. 1977 Apr;67(4):371-3. doi: 10.1093/ajcp/67.4.371.,['9005-79-2 (Glycogen)'],"Periodic acid-Schiff-positive material representing glycogen was found in bone marrow megaloblasts at all stages of maturation from 11 patients with severe untreated pernicious anemia. This accumulation of glycogen in megaloblasts, which are known to have disordered biosynthesis of DNA, RNA, and histones, suggests that carbohydrate metabolism may also be abnormal in vitamin B12 deficiency, perhaps as a result of an abnormality in the enzyme amylophosphorylase.",,,,,
265680,NLM,MEDLINE,19770527,20190509,0002-9173 (Print) 0002-9173 (Linking),67,4,1977 Apr,Esterase activity in erythroleukemia.,368-70,"['Kass, L']",['Kass L'],['eng'],['Journal Article'],England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Erythroblasts/*enzymology/pathology', 'Erythrocytes/*enzymology', 'Esterases/*metabolism', 'Hematopoietic Stem Cells/*enzymology', 'Leukemia, Erythroblastic, Acute/diagnosis/*enzymology/pathology', 'Periodic Acid-Schiff Reaction']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1093/ajcp/67.4.368 [doi]'],ppublish,Am J Clin Pathol. 1977 Apr;67(4):368-70. doi: 10.1093/ajcp/67.4.368.,['EC 3.1.- (Esterases)'],"Specific esterase activity, a property generally ascribed to cells of granulocytic origin, was found in abnormal erythroid precursors obtained from the bone marrows of six patients with untreated erythroleukemia. These erythroblasts also showed nonspecific esterase activity. Neither specific nor nonspecific esterase activity was detected in erythroid precursors obtained from the bone marrows of ten presumed normal individuals. The implications of finding specific esterase activity in the erythroblasts of erythroleukemia are discussed.",,,,,
265679,NLM,MEDLINE,19770527,20190509,0002-9173 (Print) 0002-9173 (Linking),67,4,1977 Apr,Chronic myelomonocytic leukemia: an ultrastructural study by transmission and scanning electron microscopy.,339-46,"['Skinnider, L F', 'Card, R T', 'Padmanabh, S']","['Skinnider LF', 'Card RT', 'Padmanabh S']",['eng'],"['Case Reports', 'Journal Article']",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Aged', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', 'Cell Transformation, Neoplastic', 'Humans', 'Leukemia, Myeloid/*blood/diagnosis/pathology', 'Male', 'Microscopy, Electron, Scanning', 'Middle Aged', 'Thrombocytopenia/complications']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1093/ajcp/67.4.339 [doi]'],ppublish,Am J Clin Pathol. 1977 Apr;67(4):339-46. doi: 10.1093/ajcp/67.4.339.,,"The hematologic findings in three cases of chronic myelomonocytic leukemia are presented, with results of ultrastructural studies by transmission and scanning electron microscopy on two of the cases. In the peripheral blood there was a dual, non-lymphocytic, markedly increased population of granulocytes and monocytes. The granulocytes showed marked nuclear abnormality and nuclear cytoplasmic organelle asynchrony. In the marrow the majority of the cells appeared granulocytic but atypical forms and intermediate difficult to distinguish from monocyte precursors were evident by electron microscopy. The ultrastructural findings lend some support to the concept that the neoplastic granulocytes and monocytes having a common precursor.",,,,,
265678,NLM,MEDLINE,19770527,20190812,0001-6101 (Print) 0001-6101 (Linking),201,4,1977,Amoeboid movement configuration in tumour cells of bone marrow smears from patients with leukaemia. Incidence and significance.,381-6,"['Sjogren, U', 'Norberg, B', 'Rydgren, L']","['Sjogren U', 'Norberg B', 'Rydgren L']",['eng'],['Journal Article'],Sweden,Acta Med Scand,Acta medica Scandinavica,0370330,IM,"['Adolescent', 'Adult', 'Aged', 'Aminopterin/therapeutic use', 'Bone Marrow/*pathology', 'Cell Line', '*Cell Movement', 'Child, Preschool', 'Female', 'Humans', 'Leukemia, Lymphoid/drug therapy/*pathology', 'Leukemia, Myeloid/drug therapy/*pathology', 'Leukemia, Myeloid, Acute/drug therapy/*pathology', 'Male', 'Mercaptopurine/therapeutic use', 'Middle Aged', 'Prednisolone/therapeutic use', 'Prognosis', 'Vincristine/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1111/j.0954-6820.1977.tb15716.x [doi]'],ppublish,Acta Med Scand. 1977;201(4):381-6. doi: 10.1111/j.0954-6820.1977.tb15716.x.,"['5J49Q6B70F (Vincristine)', '9PHQ9Y1OLM (Prednisolone)', 'E7WED276I5 (Mercaptopurine)', 'JYB41CTM2Q (Aminopterin)']","The incidence of amoeboid movement configuration (AMC), a cell shape suggestive of cell locomotion at the moment of fixation, has been studied in the tumour cells of bone marrow smears from leukaemia patients at the time of diagnosis. The groups of patients with CML (n = 8), ALL (n = 5) and CLL (n = 9) were small, and the incidences of AMC were close to those found in the corresponding cell lines from healthy probands. In 39 patients with AML, the incidence of AMC was higher than in the other cell lines investigated. A positive skew distribution of AMC values and a positive significant correlation between incidence of AMC were found at the time of diagnosis and subsequent survival of the patients with AML, in spite of differences in treatment. It is suggested that this positive correlation may be due to an immune reaction of the patients against their tumour cells.",,,,,
265677,NLM,MEDLINE,19770525,20091109,0375-8338 (Print) 0375-8338 (Linking),31,1,1977,"[Clinical, hematological and pathological studies of 5 patients with erythremic myelosis (Di Guglielmo's syndrome)].",71-96,"['Jelic, S', 'Dragovic, M', 'Bojic, P', 'Vidakovic, B', 'Plecas, V']","['Jelic S', 'Dragovic M', 'Bojic P', 'Vidakovic B', 'Plecas V']",['hrv'],"['Case Reports', 'English Abstract', 'Journal Article']",Croatia,Acta Med Iugosl,Acta medica Iugoslavica,0370324,IM,"['Aged', 'Female', 'Hemoglobins/analysis', 'Humans', 'Leukemia, Erythroblastic, Acute/blood/*diagnosis/pathology', 'Male', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Acta Med Iugosl. 1977;31(1):71-96.,['0 (Hemoglobins)'],,"Klinicka, hematoloska i patohistoloska ispitivanja u pet bolesnika s eritremijskom mijelozom (di Guglielmov sindrom)",,,,
265662,NLM,MEDLINE,19770512,20151119,0001-5814 (Print) 0001-5814 (Linking),8,1,1977 Jan-Mar,[Sucrose test in leukemias].,35-8,"['Wnuk-Wojnar, A M', 'Holowiecki, J', 'Wojnar, J', 'Wnuk, R']","['Wnuk-Wojnar AM', 'Holowiecki J', 'Wojnar J', 'Wnuk R']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['ABO Blood-Group System', '*Hemolysis', 'Humans', 'Leukemia/*diagnosis', 'Leukemia, Lymphoid/diagnosis', 'Leukemia, Myeloid/diagnosis', 'Leukemia, Myeloid, Acute/diagnosis', '*Sucrose']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1977 Jan-Mar;8(1):35-8.,"['0 (ABO Blood-Group System)', '57-50-1 (Sucrose)']","In 29 patients with blood diseases, in 40 with other diseases and 22 healthy blood donors sucrose test for presence of plasma haemolytic factor was performed by the method of Hartmann et al. in the modification of Hansen. The percent index of haemolysis of erythrocytes after incubation with serum in 10% sucrose solution was calculated. The results were evaluated in 4 variants: 1) positive sucrose test for presence of SHF against own erythrocytes, 2) positive sucrose test for presence of SHF against foreign erythrocytes, 3) authohaemolysis in 10% sucrose and 0.9% NaCl solution, 4) haemolysis of foreign erythrocytes in 10% sucrose and 0.9% NaCl. The test was usually negative in healthy controls and patients with non-haematological diseases and in patients with leukemia it was positive in 17%.",Zastosowanie testu cukrozowego w bialaczkach,,,,
265661,NLM,MEDLINE,19770512,20071115,0001-5814 (Print) 0001-5814 (Linking),8,1,1977 Jan-Mar,[Free amino acids in leukemic leukocytes].,15-20,"['Maj, S', 'Sitarska, E', 'Szczygiel, M']","['Maj S', 'Sitarska E', 'Szczygiel M']",['pol'],"['English Abstract', 'Journal Article']",Poland,Acta Haematol Pol,Acta haematologica Polonica,0262610,IM,"['Adult', 'Amino Acids/*blood', 'DNA, Neoplasm/blood', 'Female', 'Humans', 'Leukemia/*blood', 'Leukemia, Lymphoid/blood', 'Leukemia, Myeloid/blood', 'Leukemia, Myeloid, Acute/blood', 'Male']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Acta Haematol Pol. 1977 Jan-Mar;8(1):15-20.,"['0 (Amino Acids)', '0 (DNA, Neoplasm)']",Using the method of ion-exchange chromatography in automatic analyser the level of free amino acids was determined in peripheral blood leucocytes of 14 healthy blood donors and 36 patients with various types of leukaemia. In comparison with granulocytes the concentration of free amino acids in lymphocytes was reduced. The concentration of free amino acids in lymphocytes of chronic lymphatic leukemia was not essentially changed. The leucocytes in chronic myeloid leukemia showed a rise in the concentration of most free amino acids. In the blast cells of patients with acute myeloid the concentration of free amino acids was reduced in relation to DNA contents while in relation to proteins this concentration was raised.,Wolne aminokwasy leukocytow bialaczkowych,,,,
265650,NLM,MEDLINE,19770512,20181113,0093-0415 (Print) 0093-0415 (Linking),126,2,1977 Feb,Phagocytosis of hematopoietic cells by blast cells in blast crisis of chronic myelocytic leukemia.,139-41,"['Shanley, J D', 'Cline, M J']","['Shanley JD', 'Cline MJ']",['eng'],"['Case Reports', 'Journal Article']",United States,West J Med,The Western journal of medicine,0410504,IM,"['Adult', 'Female', '*Hematopoietic Stem Cells', 'Humans', 'Leukemia, Myeloid/*physiopathology', '*Phagocytosis']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,West J Med. 1977 Feb;126(2):139-41.,,,,PMC1237481,,,
265647,NLM,MEDLINE,19770527,20191028,0091-0279 (Print) 0091-0279 (Linking),7,1,1977 Feb,Diagnosis and treatment of canine hematopoietic neoplasms.,105-18,"['MacEwen, E G', 'Patnaik, A K', 'Wilkins, R J']","['MacEwen EG', 'Patnaik AK', 'Wilkins RJ']",['eng'],['Journal Article'],United States,Vet Clin North Am,The Veterinary clinics of North America,1247712,IM,"['Animals', 'Chlorambucil/therapeutic use', '*Dog Diseases/diagnosis/drug therapy', 'Dogs', 'Leukemia/*veterinary', 'Leukemia, Lymphoid/diagnosis/drug therapy/veterinary', 'Leukemia, Myeloid/veterinary', 'Lymphoma/*veterinary', 'Lymphoma, Non-Hodgkin/diagnosis/drug therapy/veterinary', 'Prognosis', 'Vincristine/therapeutic use']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1016/s0091-0279(77)50009-3 [doi]'],ppublish,Vet Clin North Am. 1977 Feb;7(1):105-18. doi: 10.1016/s0091-0279(77)50009-3.,"['18D0SL7309 (Chlorambucil)', '5J49Q6B70F (Vincristine)']",,,,,,
265645,NLM,MEDLINE,19770520,20071115,0041-5782 (Print) 0041-5782 (Linking),139,15,1977 Apr 11,"[Immune stimulation as oncologic therapy, especially in acute leukemia].",876-9,"['Olsson, L']",['Olsson L'],['dan'],"['English Abstract', 'Journal Article']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,IM,"['Animals', 'Humans', 'Immunotherapy/*methods', 'Leukemia, Lymphoid/immunology/*therapy', 'Leukemia, Myeloid, Acute/immunology/*therapy']",1977/04/11 00:00,1977/04/11 00:01,['1977/04/11 00:00'],"['1977/04/11 00:00 [pubmed]', '1977/04/11 00:01 [medline]', '1977/04/11 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1977 Apr 11;139(15):876-9.,,,Immunstimulation som onkologisk terapeutikum specielt ved akutte leukaemier,,,,
265635,NLM,MEDLINE,19770525,20151119,0029-2001 (Print) 0029-2001 (Linking),97,1,1977 Jan 10,[Discontinuation of therapy among children with leukemia].,10-2,"['Moe, P J', 'Finne, P H']","['Moe PJ', 'Finne PH']",['nor'],"['English Abstract', 'Journal Article']",Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Prednisone/therapeutic use', 'Prognosis', 'Remission, Spontaneous', 'Time Factors', 'Vincristine/therapeutic use']",1977/01/10 00:00,1977/01/10 00:01,['1977/01/10 00:00'],"['1977/01/10 00:00 [pubmed]', '1977/01/10 00:01 [medline]', '1977/01/10 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1977 Jan 10;97(1):10-2.,"['5J49Q6B70F (Vincristine)', 'VB0R961HZT (Prednisone)']",,Seponering av terapi hos barn med leukemi,,,,
265630,NLM,MEDLINE,19770512,20190702,0038-4348 (Print) 0038-4348 (Linking),70,3,1977 Mar,Granulocyte transfusion therapy in children.,320-4,"['Maybee, D A', 'Millan, A P', 'Ruymann, F B']","['Maybee DA', 'Millan AP', 'Ruymann FB']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,South Med J,Southern medical journal,0404522,IM,"['Bacterial Infections/therapy', '*Blood Transfusion', 'Centrifugation', 'Child', 'Child, Preschool', 'Female', 'Granulocytes/*transplantation', 'Granulomatous Disease, Chronic/complications', 'Humans', 'Infant', 'Leukemia, Lymphoid/complications', '*Leukocyte Transfusion', 'Leukopenia/therapy', 'Male', 'Nocardia Infections/complications/therapy', 'Pneumonia/complications/microbiology/therapy', 'Prospective Studies', 'Pseudomonas Infections/complications/therapy', 'Sepsis/therapy']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1097/00007611-197703000-00017 [doi]'],ppublish,South Med J. 1977 Mar;70(3):320-4. doi: 10.1097/00007611-197703000-00017.,,"A prospective study of 45 granulocyte transfusions in children using continuous flow centrifugation is reported. During 13 episodes of proven or presumed infection, only two children failed to show a favorable response to granulocyte transfusion. The neutropenic child shows a significantly increased absolute granulocyte count one hour after transfusion. The granulocyte counts at one hour after transfusion are inversely proportional to the child's size. A child with chronic granulomatous disease who had documented Nocardia asteroides sepsis and pneumonia exhibited complete recovery following granulocyte transfusion. Dramatic responses to the nonrandom use of granulocyte transfusion have been observed in children with major gram-negative bacterial infections. Endorsement of granulocyte transfusion for instances of presumed, but unproven, infection in the neutropenic child will require randomization to control the variables of antibiotic therapy and bone marrow remission.",,,,,
265629,NLM,MEDLINE,19770520,20071115,0038-0814 (Print) 0038-0814 (Linking),22,5,1977 Mar 5,[Myeloid leukemia].,3-12,"['Vandervaere, M']",['Vandervaere M'],['fre'],['Journal Article'],France,Soins,Soins; la revue de reference infirmiere,20910580R,,"['Humans', '*Leukemia, Myeloid', '*Leukemia, Myeloid, Acute/classification/therapy']",1977/03/05 00:00,1977/03/05 00:01,['1977/03/05 00:00'],"['1977/03/05 00:00 [pubmed]', '1977/03/05 00:01 [medline]', '1977/03/05 00:00 [entrez]']",,ppublish,Soins. 1977 Mar 5;22(5):3-12.,,,Les leucemies myeloides,,,,
265613,NLM,MEDLINE,19770512,20190907,0036-553X (Print) 0036-553X (Linking),18,3,1977 Mar,The incidence and characteristics of acute myeloid leukaemia arising in Hodgkin's disease.,197-206,"['Larsen, J', 'Brincker, H']","['Larsen J', 'Brincker H']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Antineoplastic Agents/therapeutic use', 'Child', 'Female', 'Hodgkin Disease/*complications/drug therapy/radiotherapy', 'Humans', 'Leukemia, Myeloid, Acute/*epidemiology/etiology', 'Male', 'Middle Aged', 'Neoplasms, Multiple Primary/*epidemiology', 'Risk', 'Sex Factors']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb02330.x [doi]'],ppublish,Scand J Haematol. 1977 Mar;18(3):197-206. doi: 10.1111/j.1600-0609.1977.tb02330.x.,['0 (Antineoplastic Agents)'],"In 201 consecutive patients with Hodgkin's disease treated from 1964 through 1975 with intensive irradiation and/or combination chemotherapy 3 cases of acute myeloid leukaemia were observed. The observed number of cases was 75 times over the expected (P less than 0.01). An analysis of 47 reported cases of acute myeloid leukaemia arising in Hodgkin's disease shows that these cases differ considerably from 'spontaneous' cases of acute myeloid leukaemia by appearing in a much younger age group, by a very poor response to anti-leukaemic chemotherapy, and by a relatively low male/female ratio (0.84). The intensification of radiotherapy and cytostatic therapy of Hodgkin's disease during the last decade is considered the explanation of the increased incidence of acute myeloid leukaemia in these patients.",,,,,
265587,NLM,MEDLINE,19770512,20190501,0027-8424 (Print) 0027-8424 (Linking),74,3,1977 Mar,Regulation of cholesterol biosynthesis by normal and leukemic (L2C) guinea pig lymphocytes.,956-60,"['Philippot, J R', 'Cooper, A G', 'Wallach, D F']","['Philippot JR', 'Cooper AG', 'Wallach DF']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Androstanes/pharmacology', 'Animals', 'Cell Membrane/physiology', 'Cholesterol/*biosynthesis', 'Fatty Acids/biosynthesis', 'Guinea Pigs', 'Hydroxycholesterols/pharmacology', 'Hydroxymethylglutaryl CoA Reductases/metabolism', 'Leukemia, Experimental/enzymology/*metabolism', 'Liposomes/metabolism', 'Lymphocytes/enzymology/*metabolism', 'Phosphatidylcholines/metabolism', 'Protein Biosynthesis', 'Temperature']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1073/pnas.74.3.956 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Mar;74(3):956-60. doi: 10.1073/pnas.74.3.956.,"['0 (Androstanes)', '0 (Fatty Acids)', '0 (Hydroxycholesterols)', '0 (Liposomes)', '0 (Phosphatidylcholines)', '97C5T2UQ7J (Cholesterol)', 'EC 1.1.1.- (Hydroxymethylglutaryl CoA Reductases)']","The cholesterol production of guinea pig leukemic (L2C) lymphocytes preceeds at greater than 30 times the rate found in normal cells. Fatty acid biosynthesis is also enhanced in L2C cells. Exposure of L2C cells to cholesterol/lecithin liposomes does not depress their sterol biosynthesis, in contrast to the behavior of normal lymphocytes [Philippot, J.R., Cooper, A.G. & Wallach, D. F. H. (1975) Biochim. Biophys. Acta 406, 161-166]. However, 25-hydroxycholesterol, an inhibitor of hydroxymethylglutaryl-CoA reductase (NADPH) [mevalonate: NADP+ oxidoreductase (CoA-acylating), EC 1.1.1.34], the rate limiting enzyme in cholesterogenesis, and 25-hydroxycholecalciferol, a biologically potent form of vitamin D3, block sterol biosynthesis of both normal and L2C lymphocytes [Philippot, j.r., cooper, A.G. & Wallach, D.F.H. (1976) Biochem. Biophys. Res. Commun. 72, 1035-1041]. Moreover, both cell types exchange cholesterol equivalently with cholesterol/lecithin liposomes. The only difference in sterol biosynthesis observed between the two cell types is in the temperature response of the enzyme. Arrhenius plots of this enzyme activity exhibit a prominent discontinuity at about 24 degrees in the case of normal cells, but none in the case of L2C. The activation energies for L2C cells and normal cells, above the normal cell transition temperature, were not significantly different. All of the data suggest that the regulatory defect in L2C lymphocytes arises from a deficiency in these cells' internal membranes.",,PMC430546,,,
265555,NLM,MEDLINE,19770512,20191210,0027-8424 (Print) 0027-8424 (Linking),74,3,1977 Mar,Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.,1100-4,"['Nudel, U', 'Salmon, J E', 'Terada, M', 'Bank, A', 'Rifkind, R A', 'Marks, P A']","['Nudel U', 'Salmon JE', 'Terada M', 'Bank A', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Acetamides/pharmacology', 'Butyrates/pharmacology', 'Cell Differentiation/*drug effects', 'Cell Line', 'Cell-Free System', 'Dimethyl Sulfoxide/pharmacology', '*Genes', 'Globins/*biosynthesis', 'Leukemia, Erythroblastic, Acute/*metabolism/pathology', 'Neoplasms, Experimental/metabolism/pathology', 'Propionates/pharmacology', 'RNA, Messenger/metabolism']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1073/pnas.74.3.1100 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Mar;74(3):1100-4. doi: 10.1073/pnas.74.3.1100.,"['0 (Acetamides)', '0 (Butyrates)', '0 (Propionates)', '0 (RNA, Messenger)', '9004-22-2 (Globins)', 'LA133J59VU (hexamethylene bisacetamide)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Murine erythroleukemia cells are induced to erythrodifferentiate by polar compounds such as dimethyl sulfoxide and hexamethylene bisacetamide as well as by fatty acids such as butyric acid and propionic acid. The effect of these inducers on the expression of two beta globin genes, betamaj and betamin, during the course of differentiation of the cells has been examined. After 4 days of culture with hexamethylene bisacetamide or dimethyl sulfoxide, the betamaj-containing hemoglobin (Hbmaj) predominates. By contrast, in the presence of butyric acid or propionic acid, after 4 days of culture, relatively equal amounts of Hbmaj and Hbmin are found. When cultured with dimethyl sulfoxide or hexamethylene bisacetamide, murine erythroleukemia cells synthesize more betamaj than betamin, while about equal amounts of the two globins are synthesized in the presence of butyric acid. When poly(A)-containing RNA from the cells exposed to different inducers is translated in a wheat germ cell-free system, the ratio of betamaj to betamin synthesized reflects that in whole cells. In a strain of murine erythroleukemia cells resistant to dimethyl sulfoxide (DR-10), the preferential stimulation of betamaj synthesis by hexamethylene bisacetamide of the betamin synthesis by butyric acid is more pronounced than with the dimethyl sulfoxide-sensitive cells (DS-19). These data suggest that polar compounds and fatty acids cause different expression of the betamaj and betamin genes in murine erythroleukemia cells.",,PMC430606,,,
265529,NLM,MEDLINE,19770520,20190501,0027-8424 (Print) 0027-8424 (Linking),74,2,1977 Feb,Appearance of a chromatin protein during the erythroid differentiation of Friend virus-transformed cells.,653-6,"['Keppel, F', 'Allet, B', 'Eisen, H']","['Keppel F', 'Allet B', 'Eisen H']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['*Cell Differentiation', 'Cell Line', '*Cell Transformation, Neoplastic', 'Chromatin/*metabolism', 'Chromosomal Proteins, Non-Histone/*biosynthesis', 'Electrophoresis, Polyacrylamide Gel', 'Friend murine leukemia virus/*metabolism', 'Molecular Weight']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1073/pnas.74.2.653 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Feb;74(2):653-6. doi: 10.1073/pnas.74.2.653.,"['0 (Chromatin)', '0 (Chromosomal Proteins, Non-Histone)']","Chromatin proteins from erythroleukemia cells transformed by Friend virus were analyzed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. A new chromosomal protein, apparent molecular weight 25,000, was shown to appear during erythroid differentiation of the cells induced by dimethyl sulfoxide or hexamethylenebisacetamide. This protein is tightly bound to the chromatin and does not appear to be related to any of the known histones. It is also demonstrated that this protein is not induced in a dimethyl sulfoxide-resistant variant of these cells.",,PMC392350,,,
265509,NLM,MEDLINE,19770512,20170306,,57,2,1977 Feb,[Results of treatment of acute myeloid leukemia].,131-5,"['Piotrowska-Sowinska, J A', 'Hellmann, A', 'Tyrankiewicz, Z', 'Muszkowska-Penson, J', 'Jablonska-Kaszewska, I']","['Piotrowska-Sowinska JA', 'Hellmann A', 'Tyrankiewicz Z', 'Muszkowska-Penson J', 'Jablonska-Kaszewska I']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Arch Med Wewn,Polskie Archiwum Medycyny Wewnetrznej,0401225,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Antineoplastic Agents/*administration & dosage', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Male', 'Middle Aged', 'Prednisone/*administration & dosage', 'Remission, Spontaneous']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Pol Arch Med Wewn. 1977 Feb;57(2):131-5.,"['0 (Antineoplastic Agents)', 'VB0R961HZT (Prednisone)']",,Wyniki leczenia chorych z ostra bialaczka szpikowa,,,,
265508,NLM,MEDLINE,19770512,20071115,0143-2524 (Print),144,8,1977 Feb 24,Acute lymphoblastic leukaemia.,49-50,"['Siew, L K']",['Siew LK'],['eng'],"['Case Reports', 'Journal Article']",England,Nurs Mirror Midwives J,Nursing mirror and midwives journal,7708428,,"['Child', 'Female', 'Humans', 'Leukemia, Lymphoid/*nursing/therapy']",1977/02/24 00:00,1977/02/24 00:01,['1977/02/24 00:00'],"['1977/02/24 00:00 [pubmed]', '1977/02/24 00:01 [medline]', '1977/02/24 00:00 [entrez]']",,ppublish,Nurs Mirror Midwives J. 1977 Feb 24;144(8):49-50.,,,,,,,
265507,NLM,MEDLINE,19770527,20071115,0301-1518 (Print) 0301-1518 (Linking),6,12,1977 Mar 26,[Recurrence with gonadic localization of acute leukemia. 113 cases].,1029-32,"['Schaison, G', 'Jacquillat, C l', 'Weil, M', 'Auclerc, M J', 'Curely, J P', 'Bernard, J']","['Schaison G', 'Jacquillat Cl', 'Weil M', 'Auclerc MJ', 'Curely JP', 'Bernard J']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Biopsy, Needle', 'Female', 'Humans', 'Leukemia, Lymphoid/diagnosis/*epidemiology', 'Lymphography', 'Male', 'Neoplasm Recurrence, Local', 'Ovarian Neoplasms/diagnosis/*epidemiology', 'Prognosis', 'Testicular Neoplasms/diagnosis/*epidemiology']",1977/03/26 00:00,1977/03/26 00:01,['1977/03/26 00:00'],"['1977/03/26 00:00 [pubmed]', '1977/03/26 00:01 [medline]', '1977/03/26 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Mar 26;6(12):1029-32.,,"Amongst 1500 cases of acute lymphoblastic leukaemia, affecting both sexes, the authors noted 111 testicular recurrences and 2 ovarian recurrences, i.e. an incidence of 16 percent. Clinical diagnosis is easy and testicular needle biopsy was reserved for doubtful cases only. Amongst 12 lymphographies, only one showed lumbar node involvement. Testicular involvement may exist before, after or in association with a bone marrow or a meningeal relapse. In 47 cases the first signal recurrence was a testicular tumour. The majority of these recurrences occured during the first two years of the disease, but late recurrences affecting the gonads are possible. Mean survival after an isolated testicular recurrence was 14 months, identical with meningeal recurrences. General chemotherapy and local radiotherapy were in general followed by an in situ or contralateral recurrence. Bilateral irradiation at a dose of 2400 rads is the best local treatment. However, in the light of the frequency of bone marrow recurrences a short time after, intensification of general treatment is necessary.",Rechute a localisation gonadique au cours des leucemies aigues. 113 cas,,,,
265417,NLM,MEDLINE,19770525,20071115,0485-1439 (Print) 0485-1439 (Linking),18,1,1977 Jan,"[Three-year follow-up of ""total therapy"" of childhood acute leukemia (author's transl)].",8-13,"['Koizumi, S', 'Kobayashi, F']","['Koizumi S', 'Kobayashi F']",['jpn'],"['English Abstract', 'Journal Article']",Japan,Rinsho Ketsueki,[Rinsho ketsueki] The Japanese journal of clinical hematology,2984782R,IM,"['Child', 'Child, Preschool', 'Female', 'Follow-Up Studies', 'Humans', 'Leukemia, Lymphoid/*therapy', 'Leukemia, Myeloid, Acute/*therapy', 'Male']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Rinsho Ketsueki. 1977 Jan;18(1):8-13.,,,,,,,
265415,NLM,MEDLINE,19770520,20190509,0027-8874 (Print) 0027-8874 (Linking),58,4,1977 Apr,Central nervous system (CNS) relapse following chemotherapy of WF rat acute myelogenous leukemia: a model for human CNS leukemia.,1139-46,"['Greenberger, J S', 'Muse, M B', 'Bocaccino, C A', 'Moloney, W C']","['Greenberger JS', 'Muse MB', 'Bocaccino CA', 'Moloney WC']",['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', 'Antineoplastic Agents/*therapeutic use', 'Brain Neoplasms/*pathology/therapy', 'Central Nervous System/*pathology', 'Humans', 'Leukemia, Experimental/drug therapy/pathology', 'Leukemia, Myeloid, Acute/*drug therapy/pathology', 'Rats', 'Rats, Inbred WF', 'Recurrence']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['10.1093/jnci/58.4.1139 [doi]'],ppublish,J Natl Cancer Inst. 1977 Apr;58(4):1139-46. doi: 10.1093/jnci/58.4.1139.,['0 (Antineoplastic Agents)'],"The treatment of central nervous system (CNS) involvement in human acute myelogenous leukemia (AML) presents a serious therapeutic dilemma. In an attempt to study the pathophysiology of this diseases in an animal model, the incidence and sites of detection of CNS leukemia were evaluated in inbred rats receiving chemotherapy for the transplantable WF AML. Eight of 100 rats with untreated WF AML demonstrated CNS leukemia at death with concomitant widespread visceral infiltrates, ascites, bone marrow involvement, and peripheral blood leukemia. Similarly, 6 of 120 rats (5%) failing to attain a complete remission following adriamycin. Cytoxan, or cytosine arabinoside chemotherapy demonstrated CNS leukemia in addition to systemic disease at death. In contrast, 70 of 75 rats (93.3%) achieving a complete remission subsequently relapsed in the CNS, either in combination with widespread systemic disease in 48 (64.0%) or with minimal evidence of systemic relapse in 22 (29.3%). There was a greater frequency of detectable cerebral compared to spinal cord infiltrates in relapsing rats. The WF AML appears to be a valuable model for study of the mechanism and ultimately the prevention of CNS relapse following chemotherapy in human AML.",,,,,
265307,NLM,MEDLINE,19770525,20190501,0021-9746 (Print) 0021-9746 (Linking),30,3,1977 Mar,Megakaryoblastic transformation of chronic granulocytic leukaemia. An electron microscopy and cytochemial study.,235-42,"['Bain, B', 'Catovsky, D', ""O'Brien, M"", 'Spiers, A S', 'Richards, G H']","['Bain B', 'Catovsky D', ""O'Brien M"", 'Spiers AS', 'Richards GH']",['eng'],"['Case Reports', 'Journal Article']",England,J Clin Pathol,Journal of clinical pathology,0376601,IM,"['Adult', 'Cell Transformation, Neoplastic', 'Female', 'Humans', 'Leukemia, Myeloid/metabolism/*ultrastructure', 'Megakaryocytes/analysis/*ultrastructure', 'Microscopy, Electron']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1136/jcp.30.3.235 [doi]'],ppublish,J Clin Pathol. 1977 Mar;30(3):235-42. doi: 10.1136/jcp.30.3.235.,,"Morphological, cytochemical, and ultrastructural electron microscopic (EM) studies were performed on blood and bone-marrow cells of case of Ph1-positive chronic ganulocytic leukaemia in megakaryocytic acute transformation. The entire leukaemic cell population was found to consist and of megakaryoblasts and megakaryocytes. Intermediate stages of maturation between blasts and micromegakaryocytes were observed at EM level.",,PMC476365,,,
265293,NLM,MEDLINE,19770525,20061115,0017-7768 (Print) 0017-7768 (Linking),92,2,1977 Jan 16,[Chloroma in acute monoblastic leukemia].,61-2,"['Michalevicz, R', 'Gur, H', 'Many, A', 'Ramot, B']","['Michalevicz R', 'Gur H', 'Many A', 'Ramot B']",['heb'],"['Case Reports', 'English Abstract', 'Journal Article']",Israel,Harefuah,Harefuah,0034351,IM,"['Eye Neoplasms/complications', 'Female', 'Humans', 'Leukemia, Monocytic, Acute/*complications', 'Leukemia, Myeloid/*complications', '*Neoplasms, Multiple Primary', 'Uterine Neoplasms/complications', 'Vaginal Neoplasms/complications']",1977/01/16 00:00,1977/01/16 00:01,['1977/01/16 00:00'],"['1977/01/16 00:00 [pubmed]', '1977/01/16 00:01 [medline]', '1977/01/16 00:00 [entrez]']",,ppublish,Harefuah. 1977 Jan 16;92(2):61-2.,,,,,,,
265274,NLM,MEDLINE,19770512,20071115,0301-472X (Print) 0301-472X (Linking),5,2,1977 Mar,Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils.,87-102,"['Broxmeyer, H E', 'Moore, M A', 'Ralph, P']","['Broxmeyer HE', 'Moore MA', 'Ralph P']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",Netherlands,Exp Hematol,Experimental hematology,0402313,IM,"['Animals', 'Bone Marrow/*physiology', '*Bone Marrow Cells', 'Cell Division', 'Cell Separation', 'Cells, Cultured', 'Clone Cells', 'Culture Media', 'Granulocytes/*physiology', 'Hematopoiesis', 'Humans', 'Leukemia, Lymphoid', 'Leukemia, Myeloid', 'Leukemia, Myeloid, Acute', 'Leukocytes/*physiology', 'Mice', 'Neutrophils/*physiology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Exp Hematol. 1977 Mar;5(2):87-102.,['0 (Culture Media)'],"Human PMN (non-adherent: density greater than 1.070 g/cm3) were used to prepare cell-free colony inhibiting activity (CIA). Intact PMN, PMN conditioned media (serum-free or serum-containing) and supernatant from immediately lysed PMN equally reduced the numbers of spontaneous bone marrow (density less than 1.070 g/cm3; depleted of PMN) colonies and clusters. Addition of CIA reproducibly reduced colony and/or cluster numbers by 35-70%. CIA was heat labile being inactivated at 37 degrees C. Daily additions of CIA reduced colony numbers even further; inhibition was dependent on [PMN] used to prepare CIA and on the potency of stimulation produced by colony stimulating cells (CSC). PMN from some patients with leukemia were inactive as inhibitors and did not condition media with CIA. All experiments were thereafter controlled by parallel assessment of supernatant of lysed PMN not demonstrating any CIA. CIA appears to be not only stored in PMN but released from viable, as well as degranulating PMN. Although not species-specific, CIA was specific in its nontoxic action on CSC; colony forming cells and cell-free colony stimulating activity were not affected. The influence of CIA on CSC could be reversed within 10 minutes, but not within 35 minutes of incubation. CIA may have possible physiological relevance.",,,,,
265197,NLM,MEDLINE,19770512,20190706,0009-8981 (Print) 0009-8981 (Linking),75,1,1977 Feb 15,Electrophoresis of lysozyme into Microscoccus-containing agarose gel: quantitative and analytical applications.,107-15,"['Virella, G']",['Virella G'],['eng'],['Journal Article'],Netherlands,Clin Chim Acta,Clinica chimica acta; international journal of clinical chemistry,1302422,IM,"['Body Fluids/enzymology', 'Electrophoresis, Agar Gel', 'Humans', 'Leukemia, Myeloid/enzymology', 'Micrococcus/*drug effects', 'Muramidase/*analysis/isolation & purification/pharmacology', 'Saliva/enzymology']",1977/02/15 00:00,1977/02/15 00:01,['1977/02/15 00:00'],"['1977/02/15 00:00 [pubmed]', '1977/02/15 00:01 [medline]', '1977/02/15 00:00 [entrez]']","['0009-8981(77)90505-8 [pii]', '10.1016/0009-8981(77)90505-8 [doi]']",ppublish,Clin Chim Acta. 1977 Feb 15;75(1):107-15. doi: 10.1016/0009-8981(77)90505-8.,['EC 3.2.1.17 (Muramidase)'],"Electrophoresis of lysozyme into agarose gel containing Micrococcus lysodeikticus causes lysis of the microorganism, allowing the development of two methods, one for quantitation (""lyso-rocket electrophoresis"") and the other for electrophoretic characterization (""crossed lyso-electrophoresis"") of lysozyme. The lyso-rocket technique provides an alternative to the method currently used for quantitative assay. By the use of crossed lyso-electrophoresis we have provided evidence, for the first time, of the electrophoretic heterogeneity of urinary lysozyme from patients with monocytic leukemia. We halve also documented the influence of concentration on the electrophoretic mobility of lysozyme.",,,,,
265185,NLM,MEDLINE,19770520,20091119,0008-5472 (Print) 0008-5472 (Linking),37,4,1977 Apr,Clearance of phenylalanine ammonia-lyase from normal and tumor-bearing mice.,1051-6,"['Shen, R S', 'Fritz, R R', 'Abell, C W']","['Shen RS', 'Fritz RR', 'Abell CW']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adenocarcinoma/blood', 'Ammonia-Lyases/*blood', 'Animals', 'Antibody Formation', 'Antigens', 'Carcinoma/blood', 'Dose-Response Relationship, Drug', 'Drug Administration Schedule', 'Female', 'Half-Life', 'Injections, Intraperitoneal', 'Leukemia, Lymphoid/blood', 'Male', 'Melanoma/blood', 'Metabolic Clearance Rate', 'Mice', 'Mice, Inbred A', 'Mice, Inbred C57BL', 'Mice, Inbred DBA', 'Neoplasms, Experimental/*blood/immunology', 'Phenylalanine Ammonia-Lyase/administration & dosage/*blood/immunology']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Apr;37(4):1051-6.,"['0 (Antigens)', 'EC 4.3.1.- (Ammonia-Lyases)', 'EC 4.3.1.24 (Phenylalanine Ammonia-Lyase)']","Yeast phenylalanine ammonia-lyase was administered i.p. to normal and tumor-bearing mice, and its clearance from plasma was studied. Single and multiple weekly injections at dosages of 10,20,50 and 100 units/kg were administered to C57BL female, C57BL X DBA/2F1 male, and A/J female mice. L5178Y murine lymphoblastic leukemia, B16 melanoma, BW10232 adenocarcinoma, and 15091A anaplastic carcinoma were implanted 7 to 11 days prior to enzyme injection in the appropriate host. After a single injection, the average plasma half-lives of phenylalanine ammonia-lyase were 18 to 24 hr in all groups studied. While the other tumors had no effect on the plasma level of phenylalanine ammonia-lyase after a single injection, L5178Y murine lymphoblastic leukemia and 15091A anaplastic carcinoma significantly depressed the maximal level of phenylalanine ammonia-lyase attained in the plasma. After repeated injections of phenylalanine ammonia-lyase, the initial plasma enzyme level was significantly reduced when 20 units/kg were administered, and the clearance of the enzyme from the plasma was greatly accelerated regardless of the amount administered. Furthermore, in tumor-bearing mice, the rate of clearance was significantly more rapid than in the appropriate non-tumor-bearing control.",,,,,
265178,NLM,MEDLINE,19770520,20210216,0006-4971 (Print) 0006-4971 (Linking),49,4,1977 Apr,Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine.,559-62,"['Lilleyman, J S', 'Harrison, J F', 'Black, J A']","['Lilleyman JS', 'Harrison JF', 'Black JA']",['eng'],"['Case Reports', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['Administration, Oral', 'Cytarabine/administration & dosage/*therapeutic use', 'Female', 'Humans', 'Infant', 'Injections, Subcutaneous', 'Leukemia, Myeloid/*drug therapy', 'Life Expectancy', 'Mercaptopurine/administration & dosage/*therapeutic use', 'Quality of Life']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['S0006-4971(20)68027-2 [pii]'],ppublish,Blood. 1977 Apr;49(4):559-62.,"['04079A1RDZ (Cytarabine)', 'E7WED276I5 (Mercaptopurine)']","Three cases of the juvenile type of chronic myeloid leukemia are described, all of which have shown a clinical and hematologic response to repeated cycles of sequential subcutaneous cytarabine and oral mercaptopurine. It appears that this regime, as described, may afford some control of a disease process previously supposed to be unresponsive to chemotherapy. This control, however, is likely to be reflected in an improvement in well-being, rather than overall survival time. Patient 1 survived 26 mo from diagnosis, and patients 2 and 3 are alive and well 12 and 9 mo from diagnosis, respectively.",,,,,
265177,NLM,MEDLINE,19770520,20210216,0006-4971 (Print) 0006-4971 (Linking),49,4,1977 Apr,Ph1-positive childhood leukemias: spectrum of lymphoid-myeloid expressions.,549-58,"['Forman, E N', 'Padre-Mendoza, T', 'Smith, P S', 'Barker, B E', 'Farnes, P']","['Forman EN', 'Padre-Mendoza T', 'Smith PS', 'Barker BE', 'Farnes P']",['eng'],"['Case Reports', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['Bone Marrow/enzymology', 'Bone Marrow Cells', 'Cell Differentiation', 'Child', 'Child, Preschool', '*Chromosome Aberrations', 'Female', 'Histocytochemistry', 'Humans', 'Leukemia, Myeloid/blood/*genetics', 'Lymphocytes', 'Male', 'Nucleotidyltransferases/blood']",1977/04/01 00:00,1977/04/01 00:01,['1977/04/01 00:00'],"['1977/04/01 00:00 [pubmed]', '1977/04/01 00:01 [medline]', '1977/04/01 00:00 [entrez]']",['S0006-4971(20)68026-0 [pii]'],ppublish,Blood. 1977 Apr;49(4):549-58.,['EC 2.7.7.- (Nucleotidyltransferases)'],"Two children presented with Ph1-positive leukemia, confirmed by Giemsa banding as 22q-. One child showed an initial presentation characteristic of acute lymphoblastic leukemia, followed by development of chronic myelocytic leukemia 2 yr later. A second child presented in blast crisis. Both patients showed blast cells possessing both lymphoid and myeloid characteristics, as demonstrated by histochemical, biochemical, or surface receptor properties of each cell series. The evidence provided supports the assumption of mixed lymphoid-myeloid properties of blast cells in chronic myelocytic leukemia in children. Detailed study of the leukemic cells may aid in the understanding of complex stem cell relationships and suggest more effective therapeutic approaches.",,,,,
265145,NLM,MEDLINE,19770415,20190628,0003-9861 (Print) 0003-9861 (Linking),179,1,1977 Feb,Increase in globin chains and globin mRNA in erythroleukemia cells in response to hemin.,106-12,"['Dabney, B J', 'Beaudet, A L']","['Dabney BJ', 'Beaudet AL']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Arch Biochem Biophys,Archives of biochemistry and biophysics,0372430,IM,"['Animals', 'Cell Line', 'Globins/*biosynthesis', 'Heme/*analogs & derivatives', 'Hemin/*pharmacology', 'Leukemia, Erythroblastic, Acute/*metabolism', 'Mice', 'Nucleic Acid Hybridization', 'Protein Biosynthesis/*drug effects', 'RNA, Messenger/*metabolism', 'Reticulocytes/metabolism']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']","['0003-9861(77)90092-3 [pii]', '10.1016/0003-9861(77)90092-3 [doi]']",ppublish,Arch Biochem Biophys. 1977 Feb;179(1):106-12. doi: 10.1016/0003-9861(77)90092-3.,"['0 (RNA, Messenger)', '42VZT0U6YR (Heme)', '743LRP9S7N (Hemin)', '9004-22-2 (Globins)']",,,,,,
265144,NLM,MEDLINE,19770425,20190619,0003-4819 (Print) 0003-4819 (Linking),86,3,1977 Mar,Hypokalemia in leukemia.,363-4,"['Fisher, J R']",['Fisher JR'],['eng'],"['Case Reports', 'Letter']",United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Adolescent', 'Female', 'Humans', 'Hypokalemia/*etiology', 'Leukemia, Lymphoid/*complications', 'Male']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.7326/0003-4819-86-3-363 [doi]'],ppublish,Ann Intern Med. 1977 Mar;86(3):363-4. doi: 10.7326/0003-4819-86-3-363.,,,,,,,
265136,NLM,MEDLINE,19770425,20190716,0002-922X (Print) 0002-922X (Linking),131,3,1977 Mar,Radiological case of the month: acute lymphoblastic leukemia.,351-2,"['Gwinn, J L', 'Lee, F A', 'Murthy, J M', 'Doedhar, S D']","['Gwinn JL', 'Lee FA', 'Murthy JM', 'Doedhar SD']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Bone and Bones/*diagnostic imaging', 'Child', 'Elbow/diagnostic imaging', 'Humans', 'Knee/diagnostic imaging', 'Leukemia, Lymphoid/*diagnostic imaging', 'Male', 'Radiography', 'Radius/diagnostic imaging', 'Skull/diagnostic imaging', 'Ulna/diagnostic imaging']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1001/archpedi.1977.02120160105017 [doi]'],ppublish,Am J Dis Child. 1977 Mar;131(3):351-2. doi: 10.1001/archpedi.1977.02120160105017.,,,,,,,
265135,NLM,MEDLINE,19770430,20190509,0002-9173 (Print) 0002-9173 (Linking),67,3,1977 Mar,Hemoglobin A2 levels in health and various hematologic disorders.,219-26,"['Alperin, J B', 'Dow, P A', 'Petteway, M B']","['Alperin JB', 'Dow PA', 'Petteway MB']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['Adolescent', 'Adult', 'Aged', 'Anemia/*blood', 'Anemia, Hemolytic/blood', 'Anemia, Hypochromic/blood', 'Anemia, Megaloblastic/blood', 'Child', 'Child, Preschool', 'Female', 'Folic Acid Deficiency/blood', 'Hemoglobin A/*analysis', 'Hemoglobins/*analysis', 'Humans', 'Leukemia, Erythroblastic, Acute/blood', 'Male', 'Middle Aged', 'Pregnancy', 'Thalassemia/blood', 'Vitamin B Deficiency/blood']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1093/ajcp/67.3.219 [doi]'],ppublish,Am J Clin Pathol. 1977 Mar;67(3):219-26. doi: 10.1093/ajcp/67.3.219.,"['0 (Hemoglobins)', '9034-51-9 (Hemoglobin A)']","Using a method involving elution of hemoglobin bands from cellulose acetate strips following electrophoresis of hemolysates, hemoglobin A2 (Ab A2) was quantitated in bloods from 300 healthy individuals and 904 patients. The percentage of Hb A2 was elevated in beta-thalassemia heterozygotes and some patients who had megaloblastic anemia. In the latter, the highest Hb A2 levels were observed in patients with the most severe anemia. Low Hb A2 percentages were found in iron-deficiency anemia, hereditary persistance of fetal hemoglobin, and Hb H disease. In iron-deficiency anemia, the lowest levels of Hb A2 were observed in association with the most severe anemia. Iron and folate deficiency each suppressed Hb A2 levels in beta-thalassemia heterozygotes; however, vitamin B12 deficiency did not alter the percentage of Hb A2 in thalassemia. Malignant tumors, renal and hepatic insufficiency, chronic infections and inflammation, hemolytic disease, lead poisoning, aplastic anemia, leukemia, myelofibrosis, and hypothyroidism did not change Hb A2 levels. The pathogenesis of altered Hb A2 levels and their clinical significance in various diseases are discussed.",,,,,
265134,NLM,MEDLINE,19770425,20151119,0002-838X (Print) 0002-838X (Linking),15,3,1977 Mar,Cancer chemotherapy.,186-90,"['Einhorn, L H']",['Einhorn LH'],['eng'],['Journal Article'],United States,Am Fam Physician,American family physician,1272646,IM,"['Chlorambucil/therapeutic use', 'Choriocarcinoma/drug therapy', 'Cyclophosphamide/therapeutic use', 'Dactinomycin/therapeutic use', 'Female', 'Hodgkin Disease/drug therapy', 'Humans', 'Leukemia, Lymphoid/drug therapy', 'Male', 'Methotrexate/therapeutic use', 'Neoplasms/*drug therapy', 'Neuroblastoma/drug therapy', 'Prednisone/therapeutic use', 'Pregnancy', 'Procarbazine/therapeutic use', 'Remission, Spontaneous', 'Testicular Neoplasms/drug therapy', 'Uterine Neoplasms/drug therapy', 'Vincristine/therapeutic use']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Am Fam Physician. 1977 Mar;15(3):186-90.,"['18D0SL7309 (Chlorambucil)', '1CC1JFE158 (Dactinomycin)', '35S93Y190K (Procarbazine)', '5J49Q6B70F (Vincristine)', '8N3DW7272P (Cyclophosphamide)', 'VB0R961HZT (Prednisone)', 'YL5FZ2Y5U1 (Methotrexate)']",,,,,,
265133,NLM,MEDLINE,19770428,20190819,0001-656X (Print) 0001-656X (Linking),66,2,1977 Mar,Insulin and growth hormone secretion in a leukaemic girl with hypothalamic syndrome.,261-3,"['Schiliro, G', 'Russo, A', 'Sciotto, A', 'Vigo, R']","['Schiliro G', 'Russo A', 'Sciotto A', 'Vigo R']",['eng'],"['Case Reports', 'Journal Article']",Sweden,Acta Paediatr Scand,Acta paediatrica Scandinavica,0000211,IM,"['Arginine', 'Child', 'Female', 'Growth Hormone/*metabolism', 'Humans', 'Insulin/*metabolism', 'Insulin Secretion', 'Leukemia, Lymphoid/complications/drug therapy/*physiopathology', 'Methotrexate/therapeutic use', 'Obesity/drug therapy/etiology', 'Triamcinolone/therapeutic use', 'Vincristine/therapeutic use']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1111/j.1651-2227.1977.tb07846.x [doi]'],ppublish,Acta Paediatr Scand. 1977 Mar;66(2):261-3. doi: 10.1111/j.1651-2227.1977.tb07846.x.,"['0 (Insulin)', '1ZK20VI6TY (Triamcinolone)', '5J49Q6B70F (Vincristine)', '9002-72-6 (Growth Hormone)', '94ZLA3W45F (Arginine)', 'YL5FZ2Y5U1 (Methotrexate)']","The authors report a girl with acute lymphoblastic leukaemia presenting hypothalamic syndrome characterized by meningeal leukaemia, hyperphagia and obesity. Insulin and growth hormone secretion, studied with arginine and insulin stimulation tests, showed a high peak of serum insulin and no response of growth hormone. Insulin and growth hormone responses to these tests reverted to normal after intrathecal methotrexate.",,,,,
265102,NLM,MEDLINE,19770428,20131121,0029-2001 (Print) 0029-2001 (Linking),97,4,1977 Feb 10,[Acute myelogenous leukemia in myelomatosis].,175-7,,,['nor'],"['Case Reports', 'English Abstract', 'Journal Article']",Norway,Tidsskr Nor Laegeforen,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",0413423,IM,"['Bone Neoplasms/*drug therapy', 'Cyclophosphamide/*adverse effects/therapeutic use', 'Humans', 'Leukemia, Myeloid, Acute/*chemically induced', 'Male', 'Melphalan/*adverse effects/therapeutic use', 'Middle Aged', 'Multiple Myeloma/*drug therapy', 'Time Factors']",1977/02/10 00:00,1977/02/10 00:01,['1977/02/10 00:00'],"['1977/02/10 00:00 [pubmed]', '1977/02/10 00:01 [medline]', '1977/02/10 00:00 [entrez]']",,ppublish,Tidsskr Nor Laegeforen. 1977 Feb 10;97(4):175-7.,"['8N3DW7272P (Cyclophosphamide)', 'Q41OR9510P (Melphalan)']",,Akutt myelogen leukemi ved myelomatose,,,,
265101,NLM,MEDLINE,19770415,20140912,0256-9574 (Print),51,4,1977 Jan 22,Acute leukaemia.,87-91,"['Jacobs, P', 'Dubovsky, D', 'Kernoff, L']","['Jacobs P', 'Dubovsky D', 'Kernoff L']",['eng'],['Journal Article'],South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,IM,"['Acute Disease', 'Adolescent', 'Adult', 'Aged', 'Antineoplastic Agents/therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Humans', '*Leukemia/epidemiology/etiology/therapy', 'Leukemia, Lymphoid/drug therapy', 'Middle Aged', 'Remission, Spontaneous']",1977/01/22 00:00,1977/01/22 00:01,['1977/01/22 00:00'],"['1977/01/22 00:00 [pubmed]', '1977/01/22 00:01 [medline]', '1977/01/22 00:00 [entrez]']",,ppublish,S Afr Med J. 1977 Jan 22;51(4):87-91.,['0 (Antineoplastic Agents)'],Current concepts underlying the treatment of the acute leukaemias are presented. Improved drug regimens and ancillary services have been developed and their role in the management of acute leukaemia is reviewed.,,,,,
265100,NLM,MEDLINE,19770430,20061115,0093-7754 (Print) 0093-7754 (Linking),4,1,1977 Mar,Adjuvant chemotherapy in cancer.,109-15,"['Block, J B', 'Isacoff, W H']","['Block JB', 'Isacoff WH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Semin Oncol,Seminars in oncology,0420432,IM,"['Antineoplastic Agents/*therapeutic use', 'Breast Neoplasms/drug therapy', 'Humans', 'Leukemia/drug therapy', 'Lung Neoplasms/drug therapy', 'Mastectomy', 'Neoplasm Metastasis/*therapy', 'Neoplasm Recurrence, Local/drug therapy', 'Neoplasm Seeding', 'Neoplasms/*therapy', 'Neoplasms, Experimental', 'Osteosarcoma/drug therapy', 'Postoperative Care', 'Prognosis']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,Semin Oncol. 1977 Mar;4(1):109-15.,['0 (Antineoplastic Agents)'],,,,,,
265094,NLM,MEDLINE,19770428,20071115,0036-553X (Print) 0036-553X (Linking),18,2,1977 Feb,Trisomy 8 in acute myeloid leukaemia: A non-random event. Lack of correlation with prognosis and cytokinetic parameters.,163-69,"['Philip, P', 'Wantzin, G L', 'Jensen, M K', 'Drivsholm, A']","['Philip P', 'Wantzin GL', 'Jensen MK', 'Drivsholm A']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Aged', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Myeloid, Acute/*genetics', 'Male', 'Middle Aged', 'Prognosis', '*Trisomy']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Scand J Haematol. 1977 Feb;18(2):163-69.,,6 cases of AML with a supernumerary chromosome 8 as the only aberration in practically all bone marrow mitoses and 10 cases with a normal chromosome composition of the marrow cells were investigated in order to evaluate the possible influence of trisomy 8 on some clinical and cytokinetic parameters. No significant differences between the groups were found. In our laboratory a supernumerary chromosome 8 is present in 36% of AML cases with chromosomal aberrations.,,,,,
265093,NLM,MEDLINE,19770428,20041117,0036-553X (Print) 0036-553X (Linking),18,1,1977 Jan,The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases.,25-38,"['Spiers, A S', 'Bain, B J', 'Turner, J E']","['Spiers AS', 'Bain BJ', 'Turner JE']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Basophils', 'Blood Cell Count', 'Blood Platelets', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Eosinophils', 'Female', 'Hemoglobins/analysis', 'Humans', 'Leukemia, Myeloid/*blood/genetics', 'Leukocyte Count', 'Lymphocytes', 'Male', 'Monocytes', 'Neutrophils', 'Sex Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Scand J Haematol. 1977 Jan;18(1):25-38.,['0 (Hemoglobins)'],"The haematological findings in the peripheral blood of 50 patients in whom the diagnosis of chronic granulocytic leukaemia (CGL) had been made in the haematology laboratory, and who were subsequently shown to be Philadelphia-chromosome-positive, have been reviewed. The differential leucocyte counts were performed by 3 observers, examining a total of 1,500 cells in each patient. The degree of anaemia at diagnosis was unrelated to sex and correlated poorly with leucocyte count; thrombocytopenia seemed unrelated to leucocytosis. A differential luecocyte count which included a complete spectrum of granulocytic cells, with prominent peaks in the percentages of myelocytes and neutrophils, was an invariable finding. Absolute basophilia occurred in all patients and absolute eosinophilia in 92%. In 54% of the patients there was an absolute lymphocytosis. Unlike the finding in normal subjects, there was no linear relationship between the numbers of circulating neutrophils and monocytes. Application of these findings should improve the accuracy of the haematological diagnosis of CGL, while study of the rare cases which possess the above features but are Ph1-negative may throw further light on the role of the Philadelphia chromosome in the natural history of CGL.",,,,,
265092,NLM,MEDLINE,19770428,20190907,0036-553X (Print) 0036-553X (Linking),18,1,1977 Jan,Syndrome of Shwachman and leukaemia.,20-4,"['Huijgens, P C', 'van der Veen, E A', 'Meijer, S', 'Muntinghe, O G']","['Huijgens PC', 'van der Veen EA', 'Meijer S', 'Muntinghe OG']",['eng'],"['Case Reports', 'Journal Article']",Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adult', 'Anemia, Sideroblastic/complications/pathology', 'Bone Marrow Diseases/*complications/pathology', 'Humans', 'Leukemia, Myeloid, Acute/*etiology/pathology', 'Male', 'Neutropenia', 'Pancreas/pathology', 'Pancreatic Diseases/*complications/pathology', 'Syndrome']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01473.x [doi]'],ppublish,Scand J Haematol. 1977 Jan;18(1):20-4. doi: 10.1111/j.1600-0609.1977.tb01473.x.,,"The syndrome of Shwachman is characterized by pancreatic insufficiency and bone marrow dysfunction, usually manifesting itself as neutropenia. The pancreas shows replacement of the exocrine glands by adipose tissue; sweat electrolytes are normal. A 23-year-old male who was known to suffer from neutropenia and pancreatic dysfunction from early childhood, presented with fever, acquired Pelger-Huet anomaly (of the polymorphonuclear granulocytes) and sideroblastic anaemia, a combination of symptoms suggestive of preleukaemia. A few months later he died of acute myeloblastic leukaemia and autopsy showed a dystrophic pancreas. Considering this case history it seems possible that the haematological anomalies of Shwachman's syndrome are signs of preleukaemia. Careful follow-up of patients suffering from Shwachman's syndrome seems warranted.",,,,,
265091,NLM,MEDLINE,19770428,20190907,0036-553X (Print) 0036-553X (Linking),18,1,1977 Jan,Leukaemia-associated antigen (LAA) in proliferative blood disorders.,13-9,"['Stavem, P', 'Berg, K', 'Noer, G']","['Stavem P', 'Berg K', 'Noer G']",['eng'],['Journal Article'],Denmark,Scand J Haematol,Scandinavian journal of haematology,0404507,IM,"['Adolescent', 'Adult', 'Antigens, Neoplasm/*analysis', 'Female', 'Humans', 'Leukemia, Lymphoid/*immunology', 'Leukemia, Myeloid/*immunology', 'Leukemia, Myeloid, Acute/*immunology', 'Leukocyte Count', 'Male', 'Middle Aged', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1111/j.1600-0609.1977.tb01472.x [doi]'],ppublish,Scand J Haematol. 1977 Jan;18(1):13-9. doi: 10.1111/j.1600-0609.1977.tb01472.x.,"['0 (Antigens, Neoplasm)']","Serum leukaemia associated antigen (LAA) was found in 41-75% of patients with acute leukaemia or chronic myelogenous leukaemia, but in only 12% of persons suffering from chronic lymphocytic leukaemia. LAA was present in detectable amounts in 1% of healthy blood donors. Thus LAA is truly leukaemia associated rather than leukaemia specific. Occurrence of LAA in the serum of a leukaemia patient may signal a serious turn of the disease.",,,,,
265077,NLM,MEDLINE,19770430,20041117,0377-1202 (Print) 0377-1202 (Linking),15,1,1977 Jan-Mar,Ph1-positive polycythemia vera.,57-62,"['Nicoara, S', 'Butoianu, E', 'Gingold, N']","['Nicoara S', 'Butoianu E', 'Gingold N']",['eng'],"['Case Reports', 'Journal Article']",Romania,Med Interne,Medecine interne,7506353,IM,"['Adult', '*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Female', 'Humans', 'Leukemia, Myeloid/genetics', 'Middle Aged', 'Polycythemia Vera/*genetics']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Med Interne. 1977 Jan-Mar;15(1):57-62.,,"The rare presence of the ph1 chromosome in chronic myeloproliferative disorders other than chronic granulocytic leukemia (CGL), i.e. polycythemia vera (PV), myeloid metaplasia with myelofibrosis (MMM) and hemorrhagic thrombocytopenia (HT) raised the question whether or not the Ph1 chromosome is peculiar to CGL. In an attempt to answer this question, the authors reports six cases of positive-Ph1 of which two are from their personal experience and four from the literature. Three of these six cases converted to CGL. The authors conclude that the cases of Ph1-positive PV and HT are transition forms to CGL, and the cases of Ph1-positive MMM are in fact secondary forms derived from CGL.",,,,,
265073,NLM,MEDLINE,19770430,20071115,0014-2565 (Print) 0014-2565 (Linking),144,2,1977 Jan 31,[Acute myeloid leukemia and multiple neoplasms in the same patient].,151-3,"['Del Palacio Perez-Medel, A', 'Fernandez-Ranada, J M', 'Montero Castillo, J', 'Pozuelo Gonzalez, A', 'Schuller Perez, A']","['Del Palacio Perez-Medel A', 'Fernandez-Ranada JM', 'Montero Castillo J', 'Pozuelo Gonzalez A', 'Schuller Perez A']",['spa'],"['Case Reports', 'Journal Article']",Spain,Rev Clin Esp,Revista clinica espanola,8608576,IM,"['Aged', 'Biopsy', 'Diagnosis, Differential', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications', '*Neoplasms, Multiple Primary/diagnosis']",1977/01/31 00:00,1977/01/31 00:01,['1977/01/31 00:00'],"['1977/01/31 00:00 [pubmed]', '1977/01/31 00:01 [medline]', '1977/01/31 00:00 [entrez]']",,ppublish,Rev Clin Esp. 1977 Jan 31;144(2):151-3.,,,Leucemia aguda mieloide y neoplasias multiples en el mismo paciente,,,,
265072,NLM,MEDLINE,19770428,20190726,0031-9155 (Print) 0031-9155 (Linking),22,1,1977 Jan,Aspects of the dosimetry of alpha-emitting radionuclides in bone with particular emphasis on 226Ra and 239Pu.,36-46,"['Thorne, M C']",['Thorne MC'],['eng'],['Journal Article'],England,Phys Med Biol,Physics in medicine and biology,0401220,IM,"['Animals', 'Bone Marrow/*radiation effects', '*Bone Marrow Cells', 'Bone Neoplasms/etiology', 'Bone and Bones/*radiation effects', 'Humans', 'Leukemia/etiology', 'Mathematics', '*Neoplasms, Radiation-Induced', 'Osteosarcoma/etiology', '*Plutonium/adverse effects', '*Radiation Monitoring', '*Radium/adverse effects']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1088/0031-9155/22/1/005 [doi]'],ppublish,Phys Med Biol. 1977 Jan;22(1):36-46. doi: 10.1088/0031-9155/22/1/005.,"['53023GN24M (Plutonium)', 'W90AYD6R3Q (Radium)']",The dosimetry of alpha-emitting radionuclides in bone is discussed. Results are presented for average dose rates to tissues close to endosteal surfaces and to haematopoietic bone marrow from thin plane sources of radionuclides buried to different depths in bone and emitting alpha-particles with energies in the range 3-8 MeV. These results are used to demonstrate that on an activity basis 239Pu is unlikely to be more than fifteen times as toxic as 226Ra with respect to osteosarcoma and leukaemia induction in man.,,,,,
265071,NLM,MEDLINE,19770425,20200930,0037-9727 (Print) 0037-9727 (Linking),154,2,1977 Feb,Toxicity of 5-bromo-2'-deoxyuridine to malignant lymphoid cell lines.,160-3,"['Brent, J A', 'Bojko, C H', 'Hollander, V P']","['Brent JA', 'Bojko CH', 'Hollander VP']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Soc Exp Biol Med,"Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)",7505892,IM,"['Antineoplastic Agents/*pharmacology', 'Bromodeoxyuridine/antagonists & inhibitors/*pharmacology/therapeutic use', 'Cell Division/drug effects', 'Cell Line', 'Leukemia, Lymphoid/*drug therapy', 'Lymphocytes/drug effects', 'Lymphoma/*drug therapy', 'Multiple Myeloma/drug therapy', 'Neoplasms, Experimental/drug therapy', 'Thymidine/pharmacology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.3181/00379727-154-39627 [doi]'],ppublish,Proc Soc Exp Biol Med. 1977 Feb;154(2):160-3. doi: 10.3181/00379727-154-39627.,"['0 (Antineoplastic Agents)', 'G34N38R2N1 (Bromodeoxyuridine)', 'VC2W18DGKR (Thymidine)']",,,,,,
265069,NLM,MEDLINE,19770415,20071115,0032-6518 (Print) 0032-6518 (Linking),218,1304,1977 Feb,Acute leukaemia in adolescents.,250-2,"['Cotter, K P']",['Cotter KP'],['eng'],['Journal Article'],England,Practitioner,The Practitioner,0404245,IM,"['Adolescent', 'Humans', '*Leukemia/therapy', 'Leukemia, Lymphoid/drug therapy', 'Leukemia, Myeloid, Acute/therapy']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Practitioner. 1977 Feb;218(1304):250-2.,,,,,,,
265068,NLM,MEDLINE,19770415,20131121,0032-3756 (Print) 0032-3756 (Linking),32,6,1977 Feb 7,[Serum iron and copper levels in acute lymphoblastic leukemia in children].,225-8,"['Legutko, L']",['Legutko L'],['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Acute Disease', 'Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Copper/*blood', 'Female', 'Humans', 'Iron/*blood', 'Leukemia, Lymphoid/*blood', 'Male']",1977/02/07 00:00,1977/02/07 00:01,['1977/02/07 00:00'],"['1977/02/07 00:00 [pubmed]', '1977/02/07 00:01 [medline]', '1977/02/07 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1977 Feb 7;32(6):225-8.,"['789U1901C5 (Copper)', 'E1UOL152H7 (Iron)']",,Zelazo i miedz surowicy krwi w ostrej bialaczce limfoblastycznej u dzieci,,,,
265067,NLM,MEDLINE,19770430,20071115,0301-1518 (Print) 0301-1518 (Linking),6,7,1977 Feb 19,[Changes in the level of various amino acids in leukemia].,539-43,"['Loeper, J', 'Debray, J', 'Cottet, J', 'Loeper, J']","['Loeper J', 'Debray J', 'Cottet J', 'Loeper J']",['fre'],"['English Abstract', 'Journal Article']",France,Nouv Presse Med,La Nouvelle presse medicale,0312552,IM,"['Amino Acids/*blood', 'Bone Marrow Cells', 'Gout/etiology', 'Humans', 'Leukemia, Myeloid/*blood', 'Leukemia, Myeloid, Acute/*blood', 'Uremia/etiology']",1977/02/19 00:00,1977/02/19 00:01,['1977/02/19 00:00'],"['1977/02/19 00:00 [pubmed]', '1977/02/19 00:01 [medline]', '1977/02/19 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1977 Feb 19;6(7):539-43.,['0 (Amino Acids)'],"The determination of blood amino-acids by column chromatography has been carried out on 53 patients, 17 with acute myeloid leukemia, 22 with chronic myeloid leukemia. A comparison was made with 25 normal subjects. These determination has shown a significant increase in glycin, cystin and a non significant increase of tryptophan. A positive relationship may exist between uricemia and content of glycin and glutamin, both amino-acids which are messengers of uric acid. A positive correlation has been found between glycin tryptophan and the number of myeloblasts.",Variations du taux de certains acides amines au cours des leucemies,,,,
265058,NLM,MEDLINE,19770428,20201209,0031-3939 (Print) 0031-3939 (Linking),52,2,1977 Feb,[Humoral and cellular immunity in acute lymphoblastic leukemia in children].,225-8,"['Zajaczkowski, J']",['Zajaczkowski J'],['pol'],['Journal Article'],Poland,Pediatr Pol,Pediatria polska,2985039R,IM,"['Acute Disease', 'Age Factors', 'Child', 'Dinitrochlorobenzene', 'Humans', '*Immunity, Cellular', 'Immunoglobulins/analysis', 'Immunosuppressive Agents/immunology/therapeutic use', 'Leukemia, Lymphoid/drug therapy/*immunology', 'Lymphocyte Activation', 'Phagocytosis', 'Remission, Spontaneous']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Pediatr Pol. 1977 Feb;52(2):225-8.,"['0 (Dinitrochlorobenzene)', '0 (Immunoglobulins)', '0 (Immunosuppressive Agents)']",,Niektore zagadnienia odpornosci humoralnej i komorkowej w ostrej bialaczce limfoblastycznej,,,,
265001,NLM,MEDLINE,19770425,20190902,0098-1532 (Print) 0098-1532 (Linking),3,1,1977,Intermittent chemotherapy and BCG in continuation therapy of children with acute lymphocytic leukemia.,85-91,"['Ekert, H', 'Jose, D G', 'Walters, K D', 'Smith, P J', 'Matthews, R N']","['Ekert H', 'Jose DG', 'Walters KD', 'Smith PJ', 'Matthews RN']",['eng'],['Journal Article'],United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['BCG Vaccine/*therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Humans', 'Infant', 'Leukemia, Lymphoid/*therapy', 'Mercaptopurine/*administration & dosage/therapeutic use', 'Methotrexate/*administration & dosage/therapeutic use', 'Remission, Spontaneous', 'Vincristine/*administration & dosage/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/mpo.2950030112 [doi]'],ppublish,Med Pediatr Oncol. 1977;3(1):85-91. doi: 10.1002/mpo.2950030112.,"['0 (BCG Vaccine)', '5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']","Continuation therapy using intermittent chemotherapy and BCG inoculation was commenced in 28 children with acute lymphocytic leukemia (ALL) immediately after remission induction and ""CNS prophylaxis."" At a median followup time of 17 months, 71% remain in total remission and 86% in bone marrow remission. Complications of the therapy were minimal. Major infections occurred on two occasions and there were no deaths in remission. Neutropenia, ""minor"" infections and postponement of chemotherapy occurred most often during the first three courses of treatment. There were no local or systemic BCG infections. Tuberculin sensitivity was tested in 25 patients. It was positive in 17 of 18 patients in total remission and all four patients with only CNS relapse, and was negative prior to relapse in three patients who developed bone marrow disease.",,,,,
265000,NLM,MEDLINE,19770425,20190902,0098-1532 (Print) 0098-1532 (Linking),3,1,1977,Variable duration of vincristine-induced metaphase block in leukemic and nornal bone marrow cells of children.,75-83,"['Wagner, H P', 'Swidzinska, P M', 'Hirt, A']","['Wagner HP', 'Swidzinska PM', 'Hirt A']",['eng'],['Journal Article'],United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Acute Disease', 'Bone Marrow/drug effects/*physiopathology', '*Bone Marrow Cells', 'Child, Preschool', 'Female', 'Humans', 'Leukemia/*physiopathology', 'Leukemia, Myeloid/physiopathology', 'Male', 'Mitosis/*drug effects', 'Mitotic Index', 'Prednisone/pharmacology', 'Vincristine/*pharmacology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/mpo.2950030111 [doi]'],ppublish,Med Pediatr Oncol. 1977;3(1):75-83. doi: 10.1002/mpo.2950030111.,"['5J49Q6B70F (Vincristine)', 'VB0R961HZT (Prednisone)']","In four children with previously untreated acute leukemia the stathmokinetic effect of a single IV dose of vincristine (in two children with AML), or of a single IV dose of vincristine combined with daily prednisone (in one child with AMMoL and one with ALL), were investigated. The kinetics of bone marrow blast cells from all patients, and of red cell precursors from the patient with ALL, were studied by conventional methods (determinations of mitotic index and pro-+metaphase/ana-+telophase ratios). In two of the four patients (one AML and one AMMoL) the progression of cells through S, the incorporation pattern of tritiated thymidine, and the nuclear projection area changes during S were analyzed by a combination of autoradiographic and cytophotometric techniques. The results suggest that the doses of vincristine used (0.05 and 0.075mg/kg body weight) did not influence the progression of cells from G0/G1 into S nor from S into G2, and had no effect on the incorporation pattern of tritiated thymidine or on the nuclear projection area changes during S. The results suggests, however, that the duration of the metaphase block induced by vincristine varied from one cell system to another. Differences in the time course of regeneration processes in neoplastic and normal cell systems might be one of the mechanisms responsible for the anti-neoplastic effect of vincristine in man.",,,,,
264999,NLM,MEDLINE,19770425,20190902,0098-1532 (Print) 0098-1532 (Linking),3,1,1977,Remission maintenance of adult acute lymphoblastic leukemia.,53-8,"['Armitage, J O', 'Burns, C P']","['Armitage JO', 'Burns CP']",['eng'],['Journal Article'],United States,Med Pediatr Oncol,Medical and pediatric oncology,7506654,IM,"['Adolescent', 'Adult', 'Brain Neoplasms/prevention & control', 'Cyclophosphamide/therapeutic use', 'Female', 'Head', 'Humans', 'Leukemia, Lymphoid/drug therapy/radiotherapy/*therapy', 'Male', 'Mercaptopurine/therapeutic use', 'Methotrexate/therapeutic use', 'Middle Aged', 'Remission, Spontaneous', 'Spinal Cord Neoplasms/prevention & control']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/mpo.2950030108 [doi]'],ppublish,Med Pediatr Oncol. 1977;3(1):53-8. doi: 10.1002/mpo.2950030108.,"['8N3DW7272P (Cyclophosphamide)', 'E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']","This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradiation and intrathecal methotrexate for CNS prophylaxis followed by continuation systemic chemotherapy with oral methotrexate, 6-mercaptopurine and cyclophosphamide. There were no CNS relapses following treatment. One-half of the patients relapsed within 11 months, with 5 patients remaining in remission for 27+ to 31+ months. The toxicity was acceptable with no treatment-related deaths. This regimen is capable of producing long remissions in a significant proportion of adults with acute lymphoblastic leukemia and appears to be effective in reducing the incidence of CNS relapse. It has the additional advantage of ease of administration and can be largely administered in the community.",,,,,
264997,NLM,MEDLINE,19770428,20141120,0090-0702 (Print) 0090-0702 (Linking),6,1,1977 Spring,An adolescent boy's adjustment to leukemia.,37-49,"['Kikuchi, J']",['Kikuchi J'],['eng'],"['Case Reports', 'Journal Article']",United States,Matern Child Nurs J,Maternal-child nursing journal,0350761,,"['*Adaptation, Psychological', 'Adolescent', 'Humans', '*Leukemia, Lymphoid', 'Male', 'Psychology, Adolescent']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Matern Child Nurs J. 1977 Spring;6(1):37-49.,,,,,,,
264993,NLM,MEDLINE,19770425,20041117,0040-3318 (Print) 0040-3318 (Linking),70,3,1977 Mar,Chronic granulocytic leukemia.,175-9,"['Flexner, J M']",['Flexner JM'],['eng'],['Journal Article'],United States,J Tenn Med Assoc,Journal of the Tennessee Medical Association,7505629,IM,"['Chronic Disease', 'Humans', '*Leukemia, Myeloid/diagnosis/therapy', 'Prognosis']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",,ppublish,J Tenn Med Assoc. 1977 Mar;70(3):175-9.,,,,,,,
264992,NLM,MEDLINE,19770415,20041117,0023-2149 (Print) 0023-2149 (Linking),55,1,1977,[Variations in the terminal stage of chronic myeloleukemia].,121-4,"['Volkova, M A']",['Volkova MA'],['rus'],"['Case Reports', 'Journal Article']",Russia (Federation),Klin Med (Mosk),Klinicheskaia meditsina,2985204R,IM,"['*Chromosomes', 'Female', 'Humans', 'Leukemia, Myeloid/*diagnosis/genetics', 'Middle Aged']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Med (Mosk). 1977;55(1):121-4.,,,O raznovidnosti terminal'noi stadii khronicheskogo mieloleikoza,,,,
264991,NLM,MEDLINE,19770430,20131121,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Therapy of childhood acute lymphoblastic leukemia. Treatment results 1971-75 in 78 patients (author's transl)].,74-88,"['Winkler, K', 'Gaedicke, G', 'Grosch-Worner, I', 'Marsmann, G', 'Lndbeck, G']","['Winkler K', 'Gaedicke G', 'Grosch-Worner I', 'Marsmann G', 'Lndbeck G']",['ger'],"['Clinical Trial', 'English Abstract', 'Journal Article', 'Randomized Controlled Trial']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Central Nervous System', 'Child', 'Cytarabine/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/complications/*drug therapy', 'Lymphoma, Non-Hodgkin/complications', 'Methods', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):74-88.,['04079A1RDZ (Cytarabine)'],"From December 1971 until July 1973 44 children with ALL have been treated according to branch A of the randomised DAL study series of June 3rd 1972 (1/71), which is a slight modification of study VII of Memphis. Afterwards until July 1975 34 patients received a somewhat intensified initial therapy (11/73). The results of 1/71 with a 3-year-remission rate of 39% and an expected 5-year-remission rate of 32% are comparable to those of study VII. The results of 11/73 with an expected 3-year-remission rate of 54% seems clearly superior and unterline the importance of an intensive initial therapy, like it is introduced now in a still more aggressive manner in our running protocol III/75. Therapy mortality was found to be about 5% and seemed to be dependant on the staff's experience. Cytosin-arabinoside orally proved effective as a prophylactic measure during incubation as well as a therapeutic agent in manifest varicalla/zoster infections.",Zur Behandlung der akuten lymphoblastischen Leukamie im Kindesalter - Erfahrungsbericht,,,,
264990,NLM,MEDLINE,19770430,20071115,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Treatment and results of the first relapse of acute lymphatic leukemia in childhood (author's transl)].,47-9,"['Grobe, H', 'Schellong, G']","['Grobe H', 'Schellong G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Bone Marrow Diseases/drug therapy', 'Central Nervous System Diseases/drug therapy', 'Child', 'Drug Therapy, Combination', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Male', 'Prognosis', 'Recurrence', 'Testicular Neoplasms/complications']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):47-9.,,"In our experience the prognosis of hematological relapse in patients with acute lymphatic leukemia treated according to the Pinkel programme is very bad. It may be a little better for patients in whom relapse occurred after the end of therapy and who were submitted to intensified cytostatic treatment. The chances for achieving a second long-term remission, if the relapse is confined to the CNS, are also better. This is true particularly for those patients who in addition were given radiotherapy. In recurrence in the testes radiotherapy alone will not suffice and additional intensified cytosatic treatment should be considered.",Behandlung und Behandlungsergebnisse des 1. Rezidivs bei akuter lymphatischer Leukamie im Kindesalter,,,,
264989,NLM,MEDLINE,19770430,20071115,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Conservative induction treamtment at bone marrow relapse (author's transl)(proceedings)].,45-6,"['Wehinger, H']",['Wehinger H'],['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):45-6.,,"5 patients with ALL under protocol Freiburg 71 suffered bone marrow relapse. They received a conservative reinduction treatment with vincristine-prednisone +/- daunorubicin, followed in one case by L-asparaginase. Complete remission was achieved in 4, partial remission in 1. The duration of complete remissions was 1 to 11+ months.",Konservative Induktionstherapie bei hamatologischem Relaps,,,,
264988,NLM,MEDLINE,19770430,20071115,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Experiences in therapy of first hematologic recurrence of acute lymphatic leukemia (proceedings)].,44,"['Wundisch, G F']",['Wundisch GF'],['ger'],['Journal Article'],Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Child', 'Humans', 'Leukemia, Lymphoid/*drug therapy', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):44.,,,Erfahrungen in der Therapie des 1. hamatologischen Rezidivs bei ALL,,,,
264987,NLM,MEDLINE,19770430,20131121,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Concepts in therapy of the first relapse in acute lymphoblastic leukaemia: experience with 28 children (author's transl)].,41-3,"['Marsmann, G', 'Winkler, K', 'Gaedicke, G', 'Landbeck, G']","['Marsmann G', 'Winkler K', 'Gaedicke G', 'Landbeck G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Adolescent', 'Asparaginase/therapeutic use', 'Child', 'Child, Preschool', 'Doxorubicin/therapeutic use', 'Drug Therapy, Combination', 'Humans', 'Infant', 'Leukemia, Lymphoid/*drug therapy', 'Methylprednisolone/therapeutic use', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):41-3.,"['80168379AG (Doxorubicin)', 'EC 3.5.1.1 (Asparaginase)', 'X4W7ZR7023 (Methylprednisolone)']",In 10 out of 15 children with first relapse of ALL complete remission could be achieved by a combination of Adriamycin + Methylprednisolon followed by Asparaginase + Methylprednisolon. Median remission duration was 24 weeks. The results of this regimen proved superior to other regimens tested.,Behandlungswege fur das 1. Rezidiv der akuten lymphoblastischen Leukamie (ALL): Erfahrungen an 28 Kindern,,,,
264986,NLM,MEDLINE,19770430,20161123,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Necrosis of the caput femoris in complete remission of lymphoblastic leukaemia (author's transl)].,37-40,"['Kaufmann, U', 'Lampert, F']","['Kaufmann U', 'Lampert F']",['ger'],"['Case Reports', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Adult', 'Age Factors', 'Child', 'Femur Head Necrosis/diagnostic imaging/*etiology', 'Follow-Up Studies', 'Humans', 'Leukemia, Lymphoid/*complications/drug therapy', 'Male', 'Prednisone/therapeutic use', 'Radiography', 'Remission, Spontaneous', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):37-40.,['VB0R961HZT (Prednisone)'],"Two cases of necrosis of caput femoris in children are reported. In both of them the lesion developed three years after diagnosis of acute lymphoblastic leukaemia, but during complete remission. Possible relations of the necrosis to ALL, Prednisone-therapy or constitutional factors are discussed.",Huftkopfnekrose bei Langzeitremission der akuten lymphoblastischn Leukamie,,,,
264985,NLM,MEDLINE,19770430,20131121,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Clinical significance of cytochemical findings of childhood acute lymphoblastic leukaemia (author's transl)].,22-30,"['Winkler, K', 'Stuhrk, H', 'Gaedicke, G', 'Marsmann, G', 'Landbeck, G']","['Winkler K', 'Stuhrk H', 'Gaedicke G', 'Marsmann G', 'Landbeck G']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Acid Phosphatase/metabolism', 'Age Factors', 'Aminosalicylic Acid', 'Bone Marrow/enzymology', 'Bone Marrow Cells', 'Central Nervous System', 'Child', 'Child, Preschool', 'Esterases/metabolism', 'Female', 'Histocytochemistry', 'Humans', 'Leukemia, Lymphoid/*metabolism', 'Male', 'Mediastinal Neoplasms/complications', 'Peroxidases/metabolism', 'Sex Factors', 'Time Factors']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):22-30.,"['5B2658E0N2 (Aminosalicylic Acid)', 'EC 1.11.1.- (Peroxidases)', 'EC 3.1.- (Esterases)', 'EC 3.1.3.2 (Acid Phosphatase)']","The initial bone marrow smeasrs of 821 children with ALL have been cytochemically analysed. (PAS-, acid phosphatase-(SPH), peroxydase-(POX), alpha-N-esterase-(EST)reaction) with regard to presenting clinical data and course of disease. Granular reactions of PAS and SPH were not meaningful in this respect. The paranuclear SPH-reaction was associated with high incidence of mediastinal mass, high peripheral blas count and male preponderance. All 5 patients with histories of more than 12 weeks duration belongs to the PAS-type of ALL (cloddy reaction). The PAS-type showed a higher incidence of CNS-leukaemia and generally a less favorable prognosis as compared to the UND-type. Thereby a high proportion of PAS positive cells, independently of other risk factors, indicates a better prognosis. The highterto neglected weak EST-reaction (Grad I and II according to Loffler) seems to signalise a clincally distinct subtype of ALL with a younger age distribution maximum as compared to the UND-type, low incidence of risk factors, high rate of remissions lasting more than 2 years but unfavorable endprognosis.",Klinische Bedeutung cytochemischer Befunde bei akuten lymphoblastischen Leukamien im Kindesalter,,,,
264984,NLM,MEDLINE,19770430,20071115,0300-8630 (Print) 0300-8630 (Linking),189,8,1977 Jan,[Cytological classification and nomenclature of leukaemias in childhood. Present situation of the cytomorphological and cytochemical differentiation (author's transl)].,14-21,"['Landbeck, G', 'Winkler, K']","['Landbeck G', 'Winkler K']",['ger'],"['English Abstract', 'Journal Article']",Germany,Klin Padiatr,Klinische Padiatrie,0326144,IM,"['Acute Disease', 'Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Histocytochemistry', 'Humans', 'Infant', 'Leukemia/*classification/pathology', 'Leukemia, Lymphoid/pathology', 'Leukemia, Myeloid/pathology', 'Leukemia, Myeloid, Acute/pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Klin Padiatr. 1977 Jan;189(8):14-21.,,"The classification and nomenclature of leukaemias in childhood under cytomorphological and cytochemical criteria is presented base on our own longstanding studies as well as on literature. Particular consideration is given to clinically relevant subtypes of acute lymphoblastic leukaemias (ALL), acute myeloid leukaemias (AML) and chronic myeloid leukaemias (CML). The more subtle differentiation leads to a more reliable diagnosis, a better estimation of the individual prognosis and is of immediate importance for the therapeutical decisions. We show the necessity of diagnosis centralisation in cooperative prospective therapy studies and in a risk dependant therapeutical approach.",Zytologische Klassifizierung und Nomenklatur der Leukamien des Kindes. Derzeitiger Stand der zytomorphologischen und zytochemischen Differenzierung,,,,
264981,NLM,MEDLINE,19770415,20161017,0098-7484 (Print) 0098-7484 (Linking),237,11,1977 Mar 14,Disseminated candidiasis in a patient with acute leukemia. Successful treatment with miconazole.,1124-5,"['Katz, M E', 'Cassileth, P A']","['Katz ME', 'Cassileth PA']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,JAMA,JAMA,7501160,IM,"['Acute Disease', 'Candida/isolation & purification', 'Candidiasis/*complications/drug therapy', 'Feces/microbiology', 'Female', 'Humans', 'Imidazoles/*therapeutic use', 'Leukemia, Myeloid, Acute/*complications', 'Miconazole/*therapeutic use', 'Middle Aged', 'Remission, Spontaneous', 'Sputum/microbiology']",1977/03/14 00:00,1977/03/14 00:01,['1977/03/14 00:00'],"['1977/03/14 00:00 [pubmed]', '1977/03/14 00:01 [medline]', '1977/03/14 00:00 [entrez]']",,ppublish,JAMA. 1977 Mar 14;237(11):1124-5.,"['0 (Imidazoles)', '7NNO0D7S5M (Miconazole)']",,,,,,
264958,NLM,MEDLINE,19770425,20190630,0022-3476 (Print) 0022-3476 (Linking),90,3,1977 Mar,Cerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia.,496-7,"['Garwicz, S', 'Mortensson, W']","['Garwicz S', 'Mortensson W']",['eng'],['Letter'],United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Brain Diseases/*chemically induced', 'Calcinosis/*chemically induced', 'Humans', 'Injections, Spinal', 'Leukemia, Lymphoid/*drug therapy', 'Methotrexate/administration & dosage/*adverse effects']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']","['S0022-3476(77)80733-6 [pii]', '10.1016/s0022-3476(77)80733-6 [doi]']",ppublish,J Pediatr. 1977 Mar;90(3):496-7. doi: 10.1016/s0022-3476(77)80733-6.,['YL5FZ2Y5U1 (Methotrexate)'],,,,,,
264857,NLM,MEDLINE,19770430,20190902,0018-2214 (Print) 0018-2214 (Linking),9,2,1977 Mar,Cytochemical detection of histamine in the human granulopoietic series of healthy subjects and of patients affected by chronic myeloid leukaemia. A spectrophotofluorimetric test for checking OPT-induced fluorescence in isolated cells.,141-51,"['Catini, C', 'Gheri, G', 'Miliani, A']","['Catini C', 'Gheri G', 'Miliani A']",['eng'],"['Comparative Study', 'Journal Article']",Netherlands,Histochem J,The Histochemical journal,0163161,IM,"['Adult', '*Aldehydes', 'Basophils/analysis', 'Bone Marrow/*analysis', '*Bone Marrow Cells', 'Eosinophils/analysis', 'Granulocytes/*analysis', 'Histamine/*analysis', 'Histocytochemistry', 'Humans', 'Leukemia, Myeloid/*metabolism', 'Leukocytes/*analysis', 'Middle Aged', 'Neutrophils/analysis', 'Remission, Spontaneous', 'Spectrometry, Fluorescence', '*o-Phthalaldehyde']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['10.1007/BF01003626 [doi]'],ppublish,Histochem J. 1977 Mar;9(2):141-51. doi: 10.1007/BF01003626.,"['0 (Aldehydes)', '643-79-8 (o-Phthalaldehyde)', '820484N8I3 (Histamine)']","Cellular histamine in blood and bone marrow has been identified histochemically using an o-phthaldialdehyde fluorescence reaction. The specificity of the reaction was tested by a spectrofluorometric analysis of cell extracts. In normal blood, the basophils emit a bright yellow fluorescence, whereas neutrophils, eosinophils and platelets react less consistently and when they do, they give off a less intense yellow or blue emission. In normal marrow, basophils react strongly whereas the metamyelocytes and later granular cells show only a weak yellow or blue fluorescence. In chronic myeloid leukaemia, cells of the granular series emit a strong yellow fluorescence at all stages of development, although still less intense than the basophils. During remission, the fluorescence pattern of cells from leukaemic subjects reverts to that of normal cells.",,,,,
264856,NLM,MEDLINE,19770425,20190606,0018-0661 (Print) 0018-0661 (Linking),84,2,1977 Feb 3,Brief reports.,231-2,"['Philip, P', 'Muller-Berat, N', 'Killmann, S']","['Philip P', 'Muller-Berat N', 'Killmann S']",['eng'],['Journal Article'],England,Hereditas,Hereditas,0374654,IM,"['*Chromosome Aberrations', '*Chromosomes, Human, 21-22 and Y', 'Humans', 'Leukemia, Lymphoid/*genetics']",1977/02/03 00:00,1977/02/03 00:01,['1977/02/03 00:00'],"['1977/02/03 00:00 [pubmed]', '1977/02/03 00:01 [medline]', '1977/02/03 00:00 [entrez]']",['10.1111/j.1601-5223.1977.tb01399.x [doi]'],ppublish,Hereditas. 1977 Feb 3;84(2):231-2. doi: 10.1111/j.1601-5223.1977.tb01399.x.,,,,,,,
264846,NLM,MEDLINE,19770425,20190708,0020-7136 (Print) 0020-7136 (Linking),19,2,1977 Feb 15,[Altered platelet surface glycoproteins in chronic myeloid leukemia (author's transl)].,143-9,"['Vainer, H', 'Bussel, A']","['Vainer H', 'Bussel A']",['fre'],"['English Abstract', 'Journal Article']",United States,Int J Cancer,International journal of cancer,0042124,IM,"['Adult', 'Blood Platelets/*metabolism/ultrastructure', 'Cell Membrane/metabolism', 'Female', 'Glucosyltransferases/blood', 'Glycolipids/blood', 'Glycoproteins/*blood', 'Humans', 'Leukemia, Myeloid/*blood', 'Male', 'Membrane Proteins/blood', 'Middle Aged', 'Molecular Weight', 'Uridine Diphosphate Galactose/blood', 'Uridine Diphosphate N-Acetylgalactosamine/blood']",1977/02/15 00:00,1977/02/15 00:01,['1977/02/15 00:00'],"['1977/02/15 00:00 [pubmed]', '1977/02/15 00:01 [medline]', '1977/02/15 00:00 [entrez]']",['10.1002/ijc.2910190202 [doi]'],ppublish,Int J Cancer. 1977 Feb 15;19(2):143-9. doi: 10.1002/ijc.2910190202.,"['0 (Glycolipids)', '0 (Glycoproteins)', '0 (Membrane Proteins)', '2956-16-3 (Uridine Diphosphate Galactose)', '7277-98-7 (Uridine Diphosphate N-Acetylgalactosamine)', 'EC 2.4.1.- (Glucosyltransferases)']","The present status of knowledge about the platelet membrane components suggests that glycoproteins (GP) are involved in the intercellular platelet specific reactions, such as adhesion and aggregation. Normal human platelets and platelet membranes solubilized under dissociating conditions produce characteristic polypeptide and GP electrophoretic patterns (PAGE). Platelets and isolated platelet membranes from patients with chronic myeloid leukemia (CML) presented dissimilarities of their glycoconjugates as compared to the normal platelets. The modification of the electrophoretic banding visualized by the periodic acid-Schiff's reagent (PAS) consisted in the decrease of the 155,000 GP L, the presence of two PAS positive bands in the area of the 135,000 normal PAS positive GP LL and a variable decrease of the 100,000 GP LLL (Apparent mol. wt. are indicated). In addition, preliminary data showed an increased catalytic transfer of the labelled galactosyl and N acetygalactosaminyl residues from exogenous nucleotide 14C-sugar precursors onto the CML-platelet endogenous sugar acceptors. These firstly reported data on molecular abnormalities of the platelet membrane GP in CML, suggested their possible relationship with the impaired platelet adhesion and aggregation occurring in this disease or the ability of leukemic platelets to express modified surface membrane components.",Glycoproteines de surface alterees des plaquettes de leucemie myeloide chronique,,,,
264845,NLM,MEDLINE,19770425,20190721,0012-1606 (Print) 0012-1606 (Linking),56,1,1977 Mar,Teratocarcinoma X friend erythroleukemia cell hybrids resemble their pluripotent embryonal carcinoma parent.,157-73,"['Miller, R A', 'Ruddle, F H']","['Miller RA', 'Ruddle FH']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Dev Biol,Developmental biology,0372762,IM,"['Acetylcholinesterase/metabolism', 'Alkaline Phosphatase/metabolism', 'Animals', 'Cell Differentiation', 'Cell Fusion', 'Clone Cells', 'Friend murine leukemia virus', 'Genotype', '*Hybrid Cells/cytology/physiology', 'Isoenzymes', 'L-Lactate Dehydrogenase/metabolism', '*Leukemia, Erythroblastic, Acute/pathology', 'Leukemia, Experimental', 'Mice', '*Teratoma/embryology/ultrastructure']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']","['0012-1606(77)90159-2 [pii]', '10.1016/0012-1606(77)90159-2 [doi]']",ppublish,Dev Biol. 1977 Mar;56(1):157-73. doi: 10.1016/0012-1606(77)90159-2.,"['0 (Isoenzymes)', 'EC 1.1.1.27 (L-Lactate Dehydrogenase)', 'EC 3.1.1.7 (Acetylcholinesterase)', 'EC 3.1.3.1 (Alkaline Phosphatase)']",,,,,,
264799,NLM,MEDLINE,19770425,20190619,0008-543X (Print) 0008-543X (Linking),39,2 Suppl,1977 Feb,Role of radiation therapy in management of adult leukemia.,852-5,"['Johnson, R E']",['Johnson RE'],['eng'],['Journal Article'],United States,Cancer,Cancer,0374236,IM,"['Adult', 'Humans', 'Leukemia, Lymphoid/*radiotherapy', 'Leukemia, Myeloid/*radiotherapy', 'Leukocyte Count', 'Lymphocytosis/radiotherapy', 'Middle Aged', 'Radiotherapy Dosage', 'Remission, Spontaneous', 'Spleen/radiation effects']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1002/1097-0142(197702)39:2+<852::aid-cncr2820390721>3.0.co;2-e [doi]'],ppublish,Cancer. 1977 Feb;39(2 Suppl):852-5. doi: 10.1002/1097-0142(197702)39:2+<852::aid-cncr2820390721>3.0.co;2-e.,,"There are both defined and evolving roles for radiation therapy in the management of adult leukemias. For the acute leukemias, emphasis presently is on adjuvant irradiation of local manifestations including CNS ""prophylaxis"" for subclinical meningeal involvement. In chronic myelocytic leukemia, local palliative radiotherapy is complemented by the use of splenic irradiation for its systemic effect. Recently, total body irradiation has been shown to influence the natural history of chronic lymphocytic leukemia. For the first time, it has been possible to achieve remissions that prolong survival as well as improve the quality of life. Future exploitation or radiotherapy in adults with leukemia will be dependent upon improved communication and cooperation between the various medical specialists concerned with patient care in these diseases.",,,,,
264798,NLM,MEDLINE,19770425,20190619,0008-543X (Print) 0008-543X (Linking),39,2 Suppl,1977 Feb,Radiotherapy in leukemia and lymphoma of children.,817-24,"['Pinkel, D', 'Hustu, H O', 'Aur, R J', 'Smith, K', 'Borella, L D', 'Simone, J']","['Pinkel D', 'Hustu HO', 'Aur RJ', 'Smith K', 'Borella LD', 'Simone J']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer,Cancer,0374236,IM,"['Antineoplastic Agents/therapeutic use', 'Bone Marrow/pathology', 'Child', 'Female', 'Hodgkin Disease/drug therapy/*radiotherapy', 'Humans', 'Leukemia, Lymphoid/drug therapy/*radiotherapy', 'Leukemia, Myeloid/radiotherapy', 'Lymphoma/pathology/*radiotherapy', 'Male', 'Meninges/pathology', 'Recurrence', 'Remission, Spontaneous', 'Time Factors']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1002/1097-0142(197702)39:2+<817::aid-cncr2820390716>3.0.co;2-q [doi]'],ppublish,Cancer. 1977 Feb;39(2 Suppl):817-24. doi: 10.1002/1097-0142(197702)39:2+<817::aid-cncr2820390716>3.0.co;2-q.,['0 (Antineoplastic Agents)'],"Radiotherapy is important in the treatment of leukemia and lymphoma of children. In acute lymphocytic leukemia administration of cranial irradiation early during chemotherapy-induced remission prevents initial meningeal relapse. When cranial irradiation is combined with a 3-year course of multiple drug systemic chemotherapy approximately one-half of the children remain in complete remission for 5 years or more and are at little risk of relapse. Preventive cranial irradiation is effective in children with acute myelocytic leukemia, also, but this does not affect survival because of the inadequacy of chemotherapy in controlling bone marrow disease. Low dose palliative irradiation can be helpful in caring for some children with obstructive, painful or disabling leukemic lesions. In Hodgkin's disease of children radiotherapy is effective in curing stages IA, IIA, and IIIA disease and contributes to chemotherapy control of stages IIIB and IV disease. The role of radiotherapy in non-Hodgkin's lymphoma is less clear. Children with T-lymphoblastic lymphoma tend to have rapid dissemination to bone marrow and meninges and appear to benefit more from multiple agent chemotherapy and preventive meningeal irradiation. Children with B-lymphoblastic lymphoma usually benefit from cyclophosphamide therapy; the value of irradiation is yet to be established. However, radiotherapy is frequently curative in stage I B-lymphocytic nodular and histiocytic lymphomas. The indications for radiotherapy in children with leukemia and lymphoma are constantly changing. Before each child is treated the multi disciplinary evaluation and treatment team must consider the rationale in relation to the specific child and current knowledge.",,,,,
264793,NLM,MEDLINE,19770430,20210216,0006-4971 (Print) 0006-4971 (Linking),49,3,1977 Mar,IgD myeloma and acute myelomonocytic leukemia.,489-90,"['Goldfarb, S B', 'Bishop, C R']","['Goldfarb SB', 'Bishop CR']",['eng'],"['Case Reports', 'Letter']",United States,Blood,Blood,7603509,IM,"['Female', 'Humans', '*Immunoglobulin D', 'Leukemia, Myeloid/etiology/*immunology', 'Middle Aged', 'Multiple Myeloma/complications/*immunology']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['S0006-4971(20)70890-6 [pii]'],ppublish,Blood. 1977 Mar;49(3):489-90.,['0 (Immunoglobulin D)'],,,,,,
264792,NLM,MEDLINE,19770430,20210216,0006-4971 (Print) 0006-4971 (Linking),49,3,1977 Mar,The Philadelphia chromosome in human macrophages.,367-70,"['Golde, D W', 'Burgaleta, C', 'Sparkes, R S', 'Cline, M J']","['Golde DW', 'Burgaleta C', 'Sparkes RS', 'Cline MJ']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Cell Differentiation', '*Chromosomes, Human, 21-22 and Y', 'Cytogenetics', 'Hematopoietic Stem Cells/cytology', 'Humans', 'Leukemia, Myeloid/*blood', '*Macrophages']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['S0006-4971(20)70874-8 [pii]'],ppublish,Blood. 1977 Mar;49(3):367-70.,,"Three patients with chronic myelocytic leukemia in different phases of the natural history of the disease were studied. Their bone marrow cells were cultured under conditions favoring macrophage proliferation, and parallel cytogenetic and cytochemical studies were performed. All cell metaphases examined contained the Ph1 chromosome at a time when more than 80% of these metaphases were in identifiable macrophages. We conclude that the mononuclear phagocyte cell line contains the abnormal chromosome in Ph1-positive chronic myelocytic leukemia.",,,,,
264791,NLM,MEDLINE,19770430,20210216,0006-4971 (Print) 0006-4971 (Linking),49,3,1977 Mar,Changing erythrocyte populations in juvenile chronic myelocytic leukemia: evidence for disordered regulation.,355-65,"['Dover, G J', 'Boyer, S H', 'Zinkham, W H', 'Kazazian, H H Jr', 'Pinney, D J', 'Sigler, A']","['Dover GJ', 'Boyer SH', 'Zinkham WH', 'Kazazian HH Jr', 'Pinney DJ', 'Sigler A']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Child, Preschool', 'Erythrocytes/*analysis/enzymology', 'Female', 'Fetal Hemoglobin/analysis', 'Hemoglobin A/analysis', 'Hemoglobins/analysis', 'Hemolysis', 'Humans', 'I Blood-Group System', 'Leukemia, Myeloid/*blood']",1977/03/01 00:00,2001/03/28 10:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/03/01 00:00 [entrez]']",['S0006-4971(20)70873-6 [pii]'],ppublish,Blood. 1977 Mar;49(3):355-65.,"['0 (Hemoglobins)', '0 (I Blood-Group System)', '9034-51-9 (Hemoglobin A)', '9034-63-3 (Fetal Hemoglobin)']","Fetal and adult erythrocyte characteristics were studied serially in a 30-mo-old female with juvenile chronic myelocytic leukemia. On presentation the erythrocytes exhibited predominantly fetal characteristics as indicated by 69% hemoglobin F (HbF), 1.1% hemoglobin A2 (HbA2), absent I antigen, and fetal levels of the erythrocyte enzymes, carbonic anhydrase I and II, glucose-6-phosphate dehydrogenase, hexokinase, pyruvate kinase, and lactate dehydrogenase; 100% of the erythrocytes present contained HbF. However, Orskov-Jacobs-Stewart hemolysis demonstrated that at least one adult characteristic was present. Seven months later HbF was 17%; I antigen and carbonic anhydrase I had increased to adult levels. The number of cells containing HbF had decreased to 30%. Further studies indicated that at least three new populations of red cells were present after 7 mo which had not previously been detected. Two of these populations exhibited a mixture of both fetal and adult characteristics. Such findings suggested that an ongoing disturbance of regulatory mechanisms was responsible for the variable expression of fetal versus adult erythrocyte characteristics.",,,,,
264790,NLM,MEDLINE,19770430,20210216,0006-4971 (Print) 0006-4971 (Linking),49,3,1977 Mar,Electrolyte and acid-base disturbances in the management of leukemia.,345-53,"[""O'Regan, S"", 'Carson, S', 'Chesney, R W', 'Drummond, K N']","[""O'Regan S"", 'Carson S', 'Chesney RW', 'Drummond KN']",['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Acid-Base Imbalance/*complications', '*Electrolytes', 'Humans', 'Hypercalcemia/complications', 'Hyperkalemia/complications', 'Hypernatremia/complications', 'Hypocalcemia/complications', 'Hypokalemia/complications', 'Hyponatremia/complications', 'Leukemia/*complications', 'Leukemia, Lymphoid/complications', 'Leukemia, Myeloid/complications', 'Leukemia, Myeloid, Acute/complications', 'Magnesium/blood', 'Phosphates/blood']",1977/03/01 00:00,1977/03/01 00:01,['1977/03/01 00:00'],"['1977/03/01 00:00 [pubmed]', '1977/03/01 00:01 [medline]', '1977/03/01 00:00 [entrez]']",['S0006-4971(20)70872-4 [pii]'],ppublish,Blood. 1977 Mar;49(3):345-53.,"['0 (Electrolytes)', '0 (Phosphates)', 'I38ZP9992A (Magnesium)']","Electrolyte disturbances in leukemia can be the result of the disease process or drug therapy. One group of electrolyte abnormalities is related to the stage of the leukemic process. Included in this group are newly diagnosed patients who may show elevated serum potassium, phosphorus, and magnesium--a result of their release from malignant cells after cytotoxic therapy or their accumulation due to urate nephropathy. Patients in remission usually have normal serum electrolyte concentrations, but acute leukemia patients during relapse may have hypokalemia, hypophosphatemia, and hypomagnesemia. This imbalance may be related to cellular uptake of these electrolytes in the presence of inadequate dietary intake. Other factors contributing to electrolyte derangements, and related to the leukemic process, include hyponatremia and hypochloremia secondary to the SIADH, hypokalemia in acute monocytic or acute myelomonocytic leukemia due to lysozyme-induced tubular damage, hypercalcemia possibly secondary to leukemic infiltration of bone or parathyroid glands (with PTH release), or production of a PTH-like substance by leukemic cells. Nonspecific factors related to the disease process which may aggravate the electrolyte imbalance include gastrointestinal loss through nausea, vomiting, and malnutrition. The drug-related electrolyte abnormalities include cyclophosphamide- and vincristine-induced SIADH; decreased serum sodium, chloride, potassium, and calcium concentrations as a result of polymyxin B nephrotoxicity; hypokalemia and hypomagnesemia secondary to amphotericin B; hypocalcemia, hypophosphatemia, and hyperphosphaturia due to L-asparaginase-induced hypoparathyroidism; hypokalemia due to a nonreabsorbable anion effect of antibiotics in the distal tubule or changes in membrane ionic transport of all cells by large doses of antibiotics. Electrolyte disturbance in leukemia thus have a multifactorial pathogenesis which can best be delineated according to the stage of the leukemic process and the drugs being used. Recognition of the cause or causes in a particular patient is essential for an effective approach to management. This review emphasizes the need for routine measurement of serum electrolytes during all phases of the leukemic process.",,,,,
264785,NLM,MEDLINE,19770321,20190501,1468-2044 (Electronic) 0003-9888 (Linking),52,1,1977 Jan,Myelomonocytic leukaemia with a preleukaemic syndrome and Ph1 chromosome in monozygotic twins.,72-4,"['Svarch, E', 'de la Torre, E']","['Svarch E', 'de la Torre E']",['eng'],"['Case Reports', 'Journal Article']",England,Arch Dis Child,Archives of disease in childhood,0372434,IM,"['Bone Marrow Cells', 'Cell Count', 'Child', 'Chromosome Aberrations/*genetics', 'Chromosome Disorders', '*Chromosomes, Human, 21-22 and Y', '*Diseases in Twins', 'Female', 'Humans', 'Leukemia, Myeloid/blood/*genetics', 'Male', 'Pregnancy', 'Preleukemia/*complications', 'Twins, Monozygotic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1136/adc.52.1.72 [doi]'],ppublish,Arch Dis Child. 1977 Jan;52(1):72-4. doi: 10.1136/adc.52.1.72.,,A case of monozygotic twins with a preleukaemic phase of 3 1/2 years is reported. The final haematological picture was that of myelomonocytic leukaemia. The karyotype investigated in one twin during the final period of the disease showed a Ph1 chromosome.,,PMC1546222,,,
264783,NLM,MEDLINE,19770321,20190619,0003-4819 (Print) 0003-4819 (Linking),86,1,1977 Jan,"Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.",47-51,"['Presant, C A', 'Klahr, C', 'Santala, R']","['Presant CA', 'Klahr C', 'Santala R']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Adult', 'Aged', 'Amphotericin B/adverse effects/*therapeutic use', 'Breast Neoplasms/drug therapy', 'Carmustine/*therapeutic use', 'Cyclophosphamide/*therapeutic use', 'Doxorubicin/*therapeutic use', 'Drug Resistance', 'Drug Therapy, Combination', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/drug therapy', 'Male', 'Middle Aged', 'Multiple Myeloma/drug therapy', 'Neoplasms/*drug therapy']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.7326/0003-4819-86-1-47 [doi]'],ppublish,Ann Intern Med. 1977 Jan;86(1):47-51. doi: 10.7326/0003-4819-86-1-47.,"['7XU7A7DROE (Amphotericin B)', '80168379AG (Doxorubicin)', '8N3DW7272P (Cyclophosphamide)', 'U68WG3173Y (Carmustine)']","Seven patients with metastatic tumors resistant to therapy with adriamycin, BCNU, plus cyclophosphamide received the same chemotherapy combined with amphotericin B. One complete response (acute myelomonocytic leukemia), two partial responses (carcinoma of the breast and multiple myeloma), and one case with objective improvement (carcinoma of the breast) were observed in seven evaluable trials. Myelosuppression was not consistently changed by addition of amphotericin B. Fever and chills were common after amphotericin B. Bronchospasm and hypotension occurred twice. Amphotericin B reverses resistance to adriamycin-containing chemotherapy regimens in some patients.",,,,,
264782,NLM,MEDLINE,19770321,20190619,0003-4819 (Print) 0003-4819 (Linking),86,1,1977 Jan,Hypokalemia in leukemia.,118,"['Prager, D', 'Rule, J', 'Kintzi, H']","['Prager D', 'Rule J', 'Kintzi H']",['eng'],['Letter'],United States,Ann Intern Med,Annals of internal medicine,0372351,IM,"['Adult', 'Humans', 'Leukemia, Myeloid/*blood', 'Male', 'Potassium/*blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.7326/0003-4819-86-1-118_1 [doi]'],ppublish,Ann Intern Med. 1977 Jan;86(1):118. doi: 10.7326/0003-4819-86-1-118_1.,['RWP5GA015D (Potassium)'],,,,,,
264772,NLM,MEDLINE,19770315,20071115,0003-276X (Print) 0003-276X (Linking),187,1,1977 Jan,An electron microscopic study of the spleen of the rat in an acute myelogenous leukemia.,29-46,"['Chen, L T', 'Handler, E E']","['Chen LT', 'Handler EE']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Anat Rec,The Anatomical record,0370540,IM,"['Animals', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', 'Hematopoietic Stem Cells/ultrastructure', 'Leukemia, Experimental/*ultrastructure', 'Leukemia, Myeloid, Acute/*ultrastructure', 'Macrophages/ultrastructure', 'Microscopy, Electron', 'Rats', 'Spleen/*ultrastructure', 'Splenomegaly/pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/ar.1091870104 [doi]'],ppublish,Anat Rec. 1977 Jan;187(1):29-46. doi: 10.1002/ar.1091870104.,,"The spleens of rats were studied by light and electron microscopy during the course of an acute myelogenous leukemia, with special reference to infiltration of leukemic myeloblasts in the spleens and to the correlation of leukemic cell infiltration with splenic hematopoiesis and splenomegaly. Leukemic myeloblasts infiltrated the cordal space of the red pulp. Many of them appeared in groups. Even in spleens which were heavily infiltrated, leukemic myeloblasts did not penetrate the while pulp. Massive infiltration and proliferation of the leukemic myeloblasts in the red pulp resulted in splenomegaly. The spleen increased its hematopoietic activity, while the medullary hematopoiesis diminished due to the invasion of leukemic myeloblasts in the bone marrow. Compensatory splenic hematopoiesis occurred in most of the leukemic spleens, but diminished in spleens which were very heavily infiltrated with leukemic myeloblasts. Thus, the degree of splenomegaly and splenic hematopoiesis did not necessarily correspond to the percentage of leukemic myeloblasts in the bone marrow, but rather related to the number of leukemic myeloblasts present in the spleen. A possible role for the splenic sinus walls in promoting compensatory hematopoiesis in the spleen is discussed. A consistent association of type ""C"" virus particles with leukemic myeloblasts was observed.",,,,,
264765,NLM,MEDLINE,19770331,20071115,0002-9335 (Print) 0002-9335 (Linking),43,2,1977 Feb,Hematology problem.,136-7,"['Sealfon, M S', 'Pickard, N']","['Sealfon MS', 'Pickard N']",['eng'],['Journal Article'],United States,Am J Med Technol,The American journal of medical technology,0370505,IM,"['Blood Cell Count', 'Blood Platelets', 'Child', 'Humans', 'Leukemia, Lymphoid/*blood/drug therapy', 'Leukocyte Count', 'Male']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Am J Med Technol. 1977 Feb;43(2):136-7.,,,,,,,
264764,NLM,MEDLINE,19770331,20191210,0002-922X (Print) 0002-922X (Linking),131,2,1977 Feb,"Neutropenia, fever, and infection in children with acute lymphocytic leukemia.",157-8,"['Wolk, J A', 'Stuart, M J', 'Stockman, J A 3rd', 'Oski, F A']","['Wolk JA', 'Stuart MJ', 'Stockman JA 3rd', 'Oski FA']",['eng'],['Journal Article'],United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Agranulocytosis/*etiology', 'Asparaginase/therapeutic use', 'Child', 'Fever/*etiology', 'Gentamicins/therapeutic use', 'Granulocytes', 'Humans', 'Infections/*etiology', 'Leukemia, Lymphoid/*complications/drug therapy', 'Leukocyte Count', 'Neutropenia/*etiology', 'Remission, Spontaneous', 'Vincristine/therapeutic use']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1001/archpedi.1977.02120150039007 [doi]'],ppublish,Am J Dis Child. 1977 Feb;131(2):157-8. doi: 10.1001/archpedi.1977.02120150039007.,"['0 (Gentamicins)', '5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)']","In an attempt to determine the relationship between neutropenia (absolute granulocyte count less than 1,000/cu mm), infection, and disease status, 20 patients with acute lymphoblastic leukemia were observed for a total of 34 patient-years. Febrile episodes occurred with much greater frequency in patients during the course of treatment induction (0.9/mo), or while in relapse (2.46/mo) than while in remission (0.19/mo). A cause for fever was identified much more frequently in patients in remission, both when neutropenic and nonneutropenic. When absolute granulocyte counts fell below 200/cu mm, a cause for fever was generally identified regardless of disease status. We propose that the majority of febrile episodes in patients at the time of induction of treatment or in relapse with neutrophil counts of more than 200/cu mm are caused by the disease process rather than secondary to a diagnosable infection.",,,,,
264763,NLM,MEDLINE,19770315,20190716,0002-922X (Print) 0002-922X (Linking),131,1,1977 Jan,Rapid correction of anemia with partial exchange transfusion.,60-1,"['Nieburg, P I', 'Stockman, J A']","['Nieburg PI', 'Stockman JA']",['eng'],"['Case Reports', 'Journal Article']",United States,Am J Dis Child,American journal of diseases of children (1960),0370471,IM,"['Adolescent', 'Anemia/complications/*therapy', 'Blood Volume', 'Child', 'Child, Preschool', '*Erythrocyte Transfusion', 'Exchange Transfusion, Whole Blood/*methods', 'Heart Failure/complications', 'Humans', 'Infant', 'Leukemia, Lymphoid/complications/therapy', 'Male', 'Mathematics']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1001/archpedi.1977.02120140062009 [doi]'],ppublish,Am J Dis Child. 1977 Jan;131(1):60-1. doi: 10.1001/archpedi.1977.02120140062009.,,"Six pediatric patients have recently undergone eight partial exchange transfusions for anemias complicated by other clinical conditions. The procedure was well tolerated, and those patients who were in congestive heart failure exhibited good clinical improvement. This technique is particularly useful in situations where the patient is unable to tolerate the increased blood volume produced by other methods of RBC-transfusion therapy. We present a formula for estimation of partial exchange transfusion volume and suggest indications for partial exchange transfusion.",,,,,
264719,NLM,MEDLINE,19770331,20071115,0301-0481 (Print) 0301-0481 (Linking),52,3,1977 Feb 1,[Erythema annulare centrifugum as a symptom in acute myeloid leukemia].,77-80,"['Bonniger, F', 'Happle, R']","['Bonniger F', 'Happle R']",['ger'],"['Case Reports', 'English Abstract', 'Journal Article']",Germany,Z Hautkr,Zeitschrift fur Hautkrankheiten,0367576,IM,"['Aged', 'Erythema/*etiology/pathology', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/*complications']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Z Hautkr. 1977 Feb 1;52(3):77-80.,,"Erythema annulare centrifugum occurred in a 68 year-old women suffering from acute myeloid leukemia. A ""paraneoplastic"" origin of the skin disease was most probable in this case.",Erythema annulare centrifugum als Symptom einer akuten myeloischen Leukamie,,,,
264711,NLM,MEDLINE,19770331,20071115,0039-2073 (Print) 0039-2073 (Linking),153,1,1977 Jan,[Irradiation of the spleen during malign diseases of the blood (author's transl)].,1-8,"['Ermanni, M', 'Straub, P W']","['Ermanni M', 'Straub PW']",['ger'],"['English Abstract', 'Journal Article']",Germany,Strahlentherapie,Strahlentherapie,1260024,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Leukemia/*radiotherapy', 'Leukemia, Lymphoid/radiotherapy', 'Leukemia, Myeloid/radiotherapy', 'Leukemia, Myeloid, Acute/radiotherapy', 'Male', 'Methods', 'Middle Aged', 'Myeloproliferative Disorders/*radiotherapy', 'Pancytopenia/etiology', 'Radiotherapy Dosage', 'Remission, Spontaneous', '*Spleen']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Strahlentherapie. 1977 Jan;153(1):1-8.,,"The results of splenic irradiation in 8 patients with neoplastic hematologic diseases are compared with those previously published. Although only 2 of our 8 cases showed a remission, 7 of the 8 patients showed a decrease in spleen size and a subjective improvement. The regularly observed and often severe pancytopenia after splenic irradiation was in no apparent relation to the dose applied. The indications and the dosage of radiotherapy of the spleen are discussed.",Zur Milzbestrahlung bei malignen hamatologischen Krankheiten,,,,
264707,NLM,MEDLINE,19770331,20071115,0036-4355 (Print) 0036-4355 (Linking),22,1,1977,[Clinical evaluation of specific skin lesions in akute myelogenous leukaemia (author's transl)].,33-42,"['Gil, J L', 'Bunel, C', 'Faura, M V', 'Valero, M I', 'Raichs, A']","['Gil JL', 'Bunel C', 'Faura MV', 'Valero MI', 'Raichs A']",['spa'],"['English Abstract', 'Journal Article']",Spain,Sangre (Barc),Sangre,0404373,IM,"['Adolescent', 'Adult', 'Aged', 'Biopsy', 'Child', 'Female', 'Humans', 'Leukemia, Myeloid, Acute/complications/*diagnosis', 'Male', 'Middle Aged', '*Skin Manifestations']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Sangre (Barc). 1977;22(1):33-42.,,,Significacion clinica de las manifestaciones cutaneas especificas en la leucemia mieloblastica,,,,
264682,NLM,MEDLINE,19770321,20190501,0027-8424 (Print) 0027-8424 (Linking),74,1,1977 Jan,Cleavage map of linear mouse sarcoma virus DNA.,29-33,"['Canaani, E', 'Duesberg, P', 'Dina, D']","['Canaani E', 'Duesberg P', 'Dina D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Chromosome Mapping', 'DNA Restriction Enzymes', 'DNA, Circular/analysis', '*DNA, Viral/analysis', 'Defective Viruses', 'Molecular Weight', '*Moloney murine leukemia virus/analysis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1073/pnas.74.1.29 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Jan;74(1):29-33. doi: 10.1073/pnas.74.1.29.,"['0 (DNA, Circular)', '0 (DNA, Viral)', 'EC 3.1.21.- (DNA Restriction Enzymes)']","Proviral DNA transcribed from the RNA of Moloney murine sarcoma virus was isolated from newly infected cells. Three forms of viral DNA were observed: (i) a linear double-stranded form of 3.4 X 10(6) daltons which constituted the major viral DNA species in the cell, and is thought to be a complete transcript (monomer) of viral RNA; (ii) a fast-sedimenting viral DNA bigger than the monomeric unit which can be either integrated provirls or concatamers; and (iii) covalently closed circles of monomer size representing 5% or less of the total viral DNA in the cell. The linear viral DNA was tested for its susceptibility to restriction endonucleases by electrophoretic analysis of the digestion products and their identification by hybridization with viral RNA or cDNA probes. The linear DNA is not cleaved by endonucleases EcoRI and BamHI. It is cleaved into two fragments by endonucleases HindIII and Hae II, and into three fragments by restriction endonuclease HincII. The fragments of the viral DNA added up to approximately 3.4 X 10(6) daltons; this and the uniform size of the linear DNA indicated that the viral DNA has unique ends and a complexity of 3.4 X 10(6) daltons. The different cleavage fragments were ordered with respect to each other and the 3' end of the viral RNA. It was observed that fragments from both ends of the linear DNA can be hybridized to sequence(s) at the 3' end of murine sarcoma virus RNA; this result suggested the possibility that a short redundant sequence exists at both termini of the genome.",,PMC393190,,,
264678,NLM,MEDLINE,19770321,20190501,0027-8424 (Print) 0027-8424 (Linking),74,1,1977 Jan,Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.,253-7,"['Azumi, J I', 'Sachs, L']","['Azumi JI', 'Sachs L']",['eng'],['Journal Article'],United States,Proc Natl Acad Sci U S A,Proceedings of the National Academy of Sciences of the United States of America,7505876,IM,"['Animals', 'Cell Differentiation/drug effects', 'Cells, Cultured', '*Chromosome Aberrations', 'Chromosome Deletion', 'Chromosome Mapping', 'Chromosomes/ultrastructure', 'Clone Cells', 'Immune Adherence Reaction', 'Karyotyping', 'Leukemia, Experimental/genetics/pathology', 'Leukemia, Lymphoid/genetics', 'Leukemia, Myeloid/*genetics/pathology', 'Mutation', 'Proteins/pharmacology', 'Translocation, Genetic']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1073/pnas.74.1.253 [doi]'],ppublish,Proc Natl Acad Sci U S A. 1977 Jan;74(1):253-7. doi: 10.1073/pnas.74.1.253.,['0 (Proteins)'],"The chromosome banding pattern has been analyzed in clones of mouse myeloid leukemic cells that differ in their ability to be induced to differentiate by the protein inducer MGI (macrophage and granulocyte inducer). None of the clones had a completely normal diploid banding pattern. The clones studied were either MGI+ (that can be induced to form Fc and C3 rosettes), a stage in the differentiation of myeloid cells, or MGI- (that cannot be induced to form these rosettes). All six cultured clones of MGI- cells from myeloid leukemias independently produced in six separate animals showed a loss of a piece of one chromosome 2 and this abnormal chromosome was maintained in leukemias derived from the cultured cells. This loss was not found in MGI+ clones or lymphoid leukemias. Five MGI+ mutants, derived from an MGI- clone with a loss of a piece of one chromosome 2, one normal chromosome 12, and two translocated chromosomes 12, maintained the abnormal chromosome 2 but lost either the one normal or one of these translocated chromosome 12. These results indicate that chromosomes 2 and 12 carry genes that control the differentiation of myeloid leukemic cells and that inducibility by MGI is controlled by the balance between these genes. We suggest that these chromosomes also carry genes that control the malignancy of these cells.",,PMC393237,,,
264661,NLM,MEDLINE,19770331,20071115,0552-2080 (Print) 0552-2080 (Linking),22,1,1977 Jan,[Kinetic analysis of the aggressiveness of acute leukemia].,3-7,"['Vladimirskaia, E B', 'Averbakh, A V']","['Vladimirskaia EB', 'Averbakh AV']",['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adult', '*Bone Marrow', '*Bone Marrow Cells', 'Cell Division', 'Child', 'Humans', 'Kinetics', 'Leukemia, Lymphoid/*pathology', 'Leukemia, Myeloid, Acute/*pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Jan;22(1):3-7.,,,Kineticheskii analiz agressivnosti ostrogo leikoza,,,,
264660,NLM,MEDLINE,19770331,20071115,0552-2080 (Print) 0552-2080 (Linking),22,1,1977 Jan,[Concentration of microelements in the blood and plasma of children with acute leukemia].,15-7,"['Chistiakova, A I']",['Chistiakova AI'],['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Probl Gematol Pereliv Krovi,Problemy gematologii i perelivaniia krovi,0401232,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/*blood', 'Leukemia, Myeloid, Acute/*blood', 'Trace Elements/*blood']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Probl Gematol Pereliv Krovi. 1977 Jan;22(1):15-7.,['0 (Trace Elements)'],,"Soderzhanie mikroelementov v krovi i plazme u detei, bol'nykh ostrym leikozom",,,,
264659,NLM,MEDLINE,19770315,20190713,0032-5481 (Print) 0032-5481 (Linking),61,1,1977 Jan,Current concepts in acute leukemia.,221-4,"['McCredie, K B']",['McCredie KB'],['eng'],['Journal Article'],England,Postgrad Med,Postgraduate medicine,0401147,IM,"['Acute Disease', 'Adult', 'Age Factors', 'BCG Vaccine/therapeutic use', 'Cytarabine/therapeutic use', 'Doxorubicin/therapeutic use', 'Drug Administration Schedule', 'Drug Therapy, Combination', 'Humans', 'Leukemia/*drug therapy', 'Leukemia, Myeloid, Acute/drug therapy', 'Middle Aged', 'Prednisone/therapeutic use', 'Vincristine/therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1080/00325481.1977.11714523 [doi]'],ppublish,Postgrad Med. 1977 Jan;61(1):221-4. doi: 10.1080/00325481.1977.11714523.,"['0 (BCG Vaccine)', '04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', '80168379AG (Doxorubicin)', 'VB0R961HZT (Prednisone)']","Using chemotherapeutic agents in combination instead of separately has significantly improved the outlook for patients with acute leukemia. The rate and duration of complete remission have both increased substantially. Immunotherapy, recently introduced for use with chemotherapy, appears to prolong survival.",,,,,
264658,NLM,MEDLINE,19770321,20080620,0032-3756 (Print) 0032-3756 (Linking),32,1,1977 Jan 3,[C-reactive protein in different clinical stages of acute lymphoblastic leukemia in children].,13-5,"['Zajaczkowski, J', 'Wanicka, A']","['Zajaczkowski J', 'Wanicka A']",['pol'],"['English Abstract', 'Journal Article']",Poland,Pol Tyg Lek,"Polski tygodnik lekarski (Warsaw, Poland : 1960)",9705468,IM,"['Acute Disease', 'Adolescent', 'Age Factors', 'C-Reactive Protein/*analysis', 'Child', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/*blood']",1977/01/03 00:00,1977/01/03 00:01,['1977/01/03 00:00'],"['1977/01/03 00:00 [pubmed]', '1977/01/03 00:01 [medline]', '1977/01/03 00:00 [entrez]']",,ppublish,Pol Tyg Lek. 1977 Jan 3;32(1):13-5.,['9007-41-4 (C-Reactive Protein)'],,Bialko C-reaktywne w roznych stanach klinicznych ostrej bialaczki limfoblastycznej u dzieci,,,,
264657,NLM,MEDLINE,19770321,20211203,0031-4005 (Print) 0031-4005 (Linking),59,2,1977 Feb,Acute measles encephalitis in children with immunosuppression.,232-9,"['Aicardi, J', 'Goutieres, F', 'Arsenio-Nunes, M L', 'Lebon, P']","['Aicardi J', 'Goutieres F', 'Arsenio-Nunes ML', 'Lebon P']",['eng'],"['Case Reports', 'Journal Article']",United States,Pediatrics,Pediatrics,0376422,IM,"['Acute Disease', 'Brain/pathology', 'Child, Preschool', 'Electroencephalography', 'Encephalitis/immunology/*microbiology/pathology', 'Female', 'Humans', 'Immunity, Cellular/drug effects', '*Immunosuppression Therapy', 'Immunosuppressive Agents/therapeutic use', 'Infant', 'Intestinal Neoplasms/drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Lymphoma, Non-Hodgkin/drug therapy', 'Male', 'Measles/immunology/*microbiology/pathology', 'Measles virus/isolation & purification']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Pediatrics. 1977 Feb;59(2):232-9.,['0 (Immunosuppressive Agents)'],"Four cases of encephalitis occurring in children treated for lymphatic malignancies by immunosuppressive drugs are reported. Measles virus was isolated from the brain in one case and identified immunologically in another. Nucleocapsids identical to those seen in subacute sclerosing panencephalitis were demonstrated in three cases. Severe immunosuppression was evidenced in two patients by failure of rosette formation and low phytohemagglutinin tests. Pathologically, the inflammatory reaction was absent in one brain and moderate in two. Clinically, epilepsia partialis continua was a prominent feature in three patients. A history of measles or of contact was elicited in three cases, five weeks to three months before onset. All cases ran an acute fatal course. Measles virus can behave as an opportunistic invader of the central nervous system in children and the diagnosis of measles encephalitis should be considered in immunosuppressed patients.",,,,,
264599,NLM,MEDLINE,19770331,20190617,0028-0836 (Print) 0028-0836 (Linking),265,5590,1977 Jan 13,Defective chemotaxis in monosomy-7.,146-7,"['Ruutu, P', 'Ruutu, T', 'Vuopie, P', 'Kosunen, T U', 'de la Chapelle, A']","['Ruutu P', 'Ruutu T', 'Vuopie P', 'Kosunen TU', 'de la Chapelle A']",['eng'],['Journal Article'],England,Nature,Nature,0410462,IM,"['Adult', 'Aged', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', '*Chemotaxis, Leukocyte', '*Chromosome Aberrations', '*Chromosomes, Human, 6-12 and X', 'Female', 'Haploidy', 'Humans', 'Leukemia/genetics', 'Leukemia, Monocytic, Acute/physiopathology', 'Leukemia, Myeloid, Acute/physiopathology', 'Male', 'Middle Aged', 'Neutrophils/*physiology', 'Preleukemia/genetics/physiopathology']",1977/01/13 00:00,1977/01/13 00:01,['1977/01/13 00:00'],"['1977/01/13 00:00 [pubmed]', '1977/01/13 00:01 [medline]', '1977/01/13 00:00 [entrez]']",['10.1038/265146a0 [doi]'],ppublish,Nature. 1977 Jan 13;265(5590):146-7. doi: 10.1038/265146a0.,,,,,,,
264597,NLM,MEDLINE,19770401,20041117,0028-4793 (Print) 0028-4793 (Linking),296,10,1977 Mar 10,Chronic myelocytic leukemia with a masked Ph1 chromosome.,571-2,"['Tanzer, J', 'Najean, Y', 'Frocrain, C', 'Bernheim, A']","['Tanzer J', 'Najean Y', 'Frocrain C', 'Bernheim A']",['eng'],"['Case Reports', 'Letter']",United States,N Engl J Med,The New England journal of medicine,0255562,IM,"['Adult', '*Chromosome Aberrations', 'Chromosomes, Human, 1-3', '*Chromosomes, Human, 21-22 and Y', 'Chromosomes, Human, 6-12 and X', 'Humans', 'Leukemia, Myeloid/*genetics', 'Male', 'Translocation, Genetic']",1977/03/10 00:00,1977/03/10 00:01,['1977/03/10 00:00'],"['1977/03/10 00:00 [pubmed]', '1977/03/10 00:01 [medline]', '1977/03/10 00:00 [entrez]']",['10.1056/NEJM197703102961015 [doi]'],ppublish,N Engl J Med. 1977 Mar 10;296(10):571-2. doi: 10.1056/NEJM197703102961015.,,,,,,,
264596,NLM,MEDLINE,19770331,20071115,0022-5223 (Print) 0022-5223 (Linking),73,2,1977 Feb,Successful treatment of varicella pneumonia with prolonged extracorporeal membrane oxygenation in a child with leukemia.,297-302,"['Hicks, R E', 'Kinney, T R', 'Raphaely, R C', 'Donaldson, M H', 'Edmunds, L H Jr', 'Naiman, J L']","['Hicks RE', 'Kinney TR', 'Raphaely RC', 'Donaldson MH', 'Edmunds LH Jr', 'Naiman JL']",['eng'],"['Case Reports', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Thorac Cardiovasc Surg,The Journal of thoracic and cardiovascular surgery,0376343,IM,"['Acute Disease', 'Blood Gas Analysis', 'Chickenpox/*complications', 'Child', 'Child, Preschool', '*Extracorporeal Circulation/instrumentation', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', '*Oxygenators, Membrane', 'Pneumonia/complications/*therapy', 'Respiration, Artificial', 'Respiratory Function Tests', 'Respiratory Insufficiency/*therapy']",1977/02/01 00:00,2001/03/28 10:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,J Thorac Cardiovasc Surg. 1977 Feb;73(2):297-302.,,A 5-year-old boy with acute lymphoblastic leukemia in complete continuous remission developed life-threatening varicella pneumonia and acute respiratory insufficiency (ARI). The child recovered after 92 hours of partial venoarterial perfusion with a membrane oxygenator. Functional asplenia developed. Serial pulmonary function tests after perfusion indicate moderately severe restrictive lung disease which has slightly improved during an 18 month period.,,,,,
264594,NLM,MEDLINE,19770331,20190509,0027-8874 (Print) 0027-8874 (Linking),58,2,1977 Feb,Intratibial Moloney sarcoma virus-induced osteosarcoma in the rat: tumor incidence and pathologic evaluation.,433-7,"['Olson, H M', 'Capen, C C']","['Olson HM', 'Capen CC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', 'Animals, Newborn', 'Bone Neoplasms/*etiology/pathology', 'Disease Models, Animal', '*Moloney murine leukemia virus', 'Osteosarcoma/*etiology/pathology', 'Rats', 'Sarcoma, Experimental/etiology/pathology', 'Tibia', '*Tumor Virus Infections']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1093/jnci/58.2.433 [doi]'],ppublish,J Natl Cancer Inst. 1977 Feb;58(2):433-7. doi: 10.1093/jnci/58.2.433.,,"Osteosarcomas were induced in approximately 80% of young New Zealand Black rats by the intratibial inoculation of Moloney murine sarcoma virus from day 1 to day 5 after birth. The neoplasms were composed of a spectrum of well-differentiated to poorly differentiated osteoblasts, osteocytes, and osteoclasts. Budding of C-type viral particles was associated with tumor induction. Compared to rats inoculated on day 1 after birth, rats inoculated at 4 days of age developed consistently more osteoproliferative bone tumors that often were associated with hypercalcemia, increased serum alkaline phosphatase, and elevated urinary hydroxyproline.",,,,,
264593,NLM,MEDLINE,19770331,20190509,0027-8874 (Print) 0027-8874 (Linking),58,2,1977 Feb,Ultrastructural study of liver sinusoids of mice during invasion by leukemic myelocytes.,369-76,"['Campbell, F R']",['Campbell FR'],['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', 'Bone Marrow/ultrastructure', 'Bone Marrow Cells', 'Endothelium/ultrastructure', 'Leukemia, Experimental/ultrastructure', 'Leukemia, Myeloid/*ultrastructure', 'Liver/*ultrastructure', 'Male', 'Mice', 'Neoplasm Invasiveness/*ultrastructure']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['10.1093/jnci/58.2.369 [doi]'],ppublish,J Natl Cancer Inst. 1977 Feb;58(2):369-76. doi: 10.1093/jnci/58.2.369.,,"Results of an ultrastructural study of liver of RF mice during invasion by leukemic myelocytes were reported. In early stages of infiltration, leukemia cells adhered to the endothelial cells of the sinusoidal wall; gaps 1-4 mu in diameter then developed in the endothelium, and leukemia cells passed through the gaps to enter the extravascular space. Other sinusoids became occluded by leukemic myelocytes, the endotheilium disintegrated, and the occluding cells thus became extravascular. In late stages of infiltration, when leukemia cells migrated back into the sinusoids, the endothelium was continuous and leukemia cells passed through temporary pores located within endothelial cells.",,,,,
264591,NLM,MEDLINE,19770331,20190509,0027-8874 (Print) 0027-8874 (Linking),58,1,1977 Jan,"Enhancement of tumor induction in rats with Moloney murine sarcoma virus by a ""new"" method based on direct injection into fetuses.",73-82,"['Hirano, T', 'Miyajima, H', 'Watanabe, T', 'Tsukuda, R', 'Shimamoto, K']","['Hirano T', 'Miyajima H', 'Watanabe T', 'Tsukuda R', 'Shimamoto K']",['eng'],['Journal Article'],United States,J Natl Cancer Inst,Journal of the National Cancer Institute,7503089,IM,"['Animals', 'Animals, Newborn', 'Female', 'Fetus/*microbiology', 'Gestational Age', 'Injections', 'Male', 'Maternal-Fetal Exchange', 'Mesenchymoma/pathology', 'Methods', '*Moloney murine leukemia virus', 'Osteosarcoma/pathology', 'Pregnancy', 'Rats', 'Rhabdomyosarcoma/pathology', 'Sarcoma, Experimental/*etiology/microbiology/pathology', '*Tumor Virus Infections']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1093/jnci/58.1.73 [doi]'],ppublish,J Natl Cancer Inst. 1977 Jan;58(1):73-82. doi: 10.1093/jnci/58.1.73.,,"Undiluted, fivefold-diluted, and 25-fold-diluted doses of a stock of Moloney murine sarcoma virus were injected directly, in a volume of 0.025 ml, into the backs of fetal Sprague-Dawley rats by laparotomy through the uterine wall at 18 days of gestation. During the first 8 weeks after birth the young responded to the virus with remarkably high but dose-dependent incidences of neoplasms. When a one-fifth dilution of the virus preparation was inoculated at fetal ages 16, 18, and 20 days, the incidences of lesions decreased with advancing fetal age. The tumors developed preferentially at the virus inoculation site and/or in the proximal parts of the extremeties; all were considered to be of mesenchymal derivation, i.e., malignant mesenchymoma, rhabdomyosarcoma, osteosarcoma, fibrosarcoma or fibromyxosarcoma, hemangiosarcoma, plasmacytoma, and a giant cell tumor. This injection procedure provided us with a valuable experimental tool for the rapid screening or testing of potential chemical carcinogens and other biologic studies.",,,,,
264567,NLM,MEDLINE,19770315,20190709,0022-2623 (Print) 0022-2623 (Linking),20,1,1977 Jan,Synthesis of mono- and bifunctional alpha-methylene lactone systems as potential tumor inhibitors.,71-6,"['Grieco, P A', 'Noguez, J A', 'Masaki, Y', 'Hiroi, Y', 'Nishizawa, M', 'Rosowsky, A', 'Oppenheim, S', 'Lazarus, H']","['Grieco PA', 'Noguez JA', 'Masaki Y', 'Hiroi Y', 'Nishizawa M', 'Rosowsky A', 'Oppenheim S', 'Lazarus H']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,J Med Chem,Journal of medicinal chemistry,9716531,IM,"['Animals', 'Antineoplastic Agents/*chemical synthesis', 'Chemical Phenomena', 'Chemistry', 'Humans', 'Lactones/*chemical synthesis/therapeutic use', 'Leukemia, Experimental/drug therapy', 'Leukemia, Lymphoid/drug therapy', 'Sesquiterpenes/*chemical synthesis']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1021/jm00211a014 [doi]'],ppublish,J Med Chem. 1977 Jan;20(1):71-6. doi: 10.1021/jm00211a014.,"['0 (Antineoplastic Agents)', '0 (Lactones)', '0 (Sesquiterpenes)']",Synthetic nono- and bifunctional alpha-methylene lactone derivatives including deoxyvernolepin and kihydrodeoxyvernolepin were tested as inhibitors of the growth of CCRF-CEM human lymphoblastic leukemia cells in culture. The range of ID-50 values for compounds 1-7 (ca. 10(-5)-10(-6)M) was roughly comparable to the doses observed earlier in the CCRF-CEM cell system with synthetic alpha-methylene-gamma-butyrolactones. Of significance is that dihydrodeoxyvernolepin and deoxyvernolepin were at least an order of magnitude more active than natural vernolepin.,,,,,
264534,NLM,MEDLINE,19770315,20191210,0022-3263 (Print) 0022-3263 (Linking),42,3,1977 Feb 4,(+/-)-Deoxyvernolepin. A cytotoxic vernolepin prototype.,495-501,"['Grieco, P A', 'Noguez, J A', 'Masaki, Y']","['Grieco PA', 'Noguez JA', 'Masaki Y']",['eng'],['Journal Article'],United States,J Org Chem,The Journal of organic chemistry,2985193R,IM,"['Antineoplastic Agents/*chemical synthesis', 'Cells, Cultured', 'Humans', 'Lactones/chemical synthesis', 'Leukemia, Lymphoid/drug therapy', 'Sesquiterpenes/*chemical synthesis']",1977/02/04 00:00,1977/02/04 00:01,['1977/02/04 00:00'],"['1977/02/04 00:00 [pubmed]', '1977/02/04 00:01 [medline]', '1977/02/04 00:00 [entrez]']",['10.1021/jo00423a022 [doi]'],ppublish,J Org Chem. 1977 Feb 4;42(3):495-501. doi: 10.1021/jo00423a022.,"['0 (Antineoplastic Agents)', '0 (Lactones)', '0 (Sesquiterpenes)', '59076-96-9 (deoxyvernolepin)']",,,,,,
264472,NLM,MEDLINE,19770315,20190708,0020-7136 (Print) 0020-7136 (Linking),19,1,1977 Jan,Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.,136,"['Lozzio, B B', 'Lozzio, C B']","['Lozzio BB', 'Lozzio CB']",['eng'],['Letter'],United States,Int J Cancer,International journal of cancer,0042124,IM,"['Animals', 'Antigens, Neoplasm/analysis', 'Antigens, Viral/*analysis', '*Cell Line', 'Friend murine leukemia virus/immunology', 'Humans', 'Immune Sera', 'Leukemia, Experimental/immunology', 'Leukemia, Myeloid/*immunology', 'Rabbits']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/ijc.2910190119 [doi]'],ppublish,Int J Cancer. 1977 Jan;19(1):136. doi: 10.1002/ijc.2910190119.,"['0 (Antigens, Neoplasm)', '0 (Antigens, Viral)', '0 (Immune Sera)']",,,,,,
264412,NLM,MEDLINE,19770321,20191210,0008-5472 (Print) 0008-5472 (Linking),37,2,1977 Feb,"L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.",535-40,"['Ortega, J A', 'Nesbit, M E Jr', 'Donaldson, M H', 'Hittle, R E', 'Weiner, J', 'Karon, M', 'Hammond, D']","['Ortega JA', 'Nesbit ME Jr', 'Donaldson MH', 'Hittle RE', 'Weiner J', 'Karon M', 'Hammond D']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Adolescent', 'Asparaginase/administration & dosage/adverse effects/*therapeutic use', 'Child', 'Child, Preschool', 'Drug Therapy, Combination', 'Female', 'Humans', 'Hyperglycemia/chemically induced', 'Infections/complications', 'Injections, Intramuscular', 'Leukemia/complications/drug therapy', 'Leukemia, Lymphoid/complications/*drug therapy', 'Male', 'Prednisone/administration & dosage/*therapeutic use', 'Remission, Spontaneous', 'Vincristine/adverse effects/*therapeutic use']",1977/02/01 00:00,2001/03/28 10:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Feb;37(2):535-40.,"['5J49Q6B70F (Vincristine)', 'EC 3.5.1.1 (Asparaginase)', 'VB0R961HZT (Prednisone)']","L-Asparaginase was added to vincristine and prednisone for induction of first remission in 815 children with acute lymphocytic or acute undifferentiated leukemia. This combination resulted in an overall remission rate of 93%. The addition of L-asparaginse to the standard induction regimen using prednisone and vincristine did not significantly increase the morbidity or mortality rate during the induction period. The most common side effect was transient L-asparaginase-induced hyperglycemia. The safe administration of L-asparaginase i.m. and the dose efficacy of 6000 I.U./sq m were confirmed. For these reasons, L-asparaginase should be combined with vincristine and prednisone for the initial induction of children with acute lymphocytic or acute undifferentiated leukemia.",,,,,
264411,NLM,MEDLINE,19770321,20191210,0008-5472 (Print) 0008-5472 (Linking),37,2,1977 Feb,Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.,440-4,"['Fibach, E', 'Reuben, R C', 'Rifkind, R A', 'Marks, P A']","['Fibach E', 'Reuben RC', 'Rifkind RA', 'Marks PA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Cancer Res,Cancer research,2984705R,IM,"['Acetamides/*pharmacology', 'Animals', 'Cell Differentiation/*drug effects', 'Cell Division/drug effects', 'Clone Cells/pathology', 'DNA, Neoplasm/biosynthesis', 'Dimethyl Sulfoxide/pharmacology', 'Dose-Response Relationship, Drug', 'Erythropoiesis/drug effects', 'Hemoglobins/biosynthesis', 'Kinetics', 'Leukemia, Erythroblastic, Acute/metabolism/*pathology', 'Leukemia, Experimental/metabolism/pathology']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",,ppublish,Cancer Res. 1977 Feb;37(2):440-4.,"['0 (Acetamides)', '0 (DNA, Neoplasm)', '0 (Hemoglobins)', 'LA133J59VU (hexamethylene bisacetamide)', 'YOW8V9698H (Dimethyl Sulfoxide)']","Friend virus-transformed murine erythroleukemia cells express the program of erythropoietic differentiation under the influence of the previously described, potent inducing agent, hexamethylene bisacetamide. Commitment to differentiation, defined as the ability to continue the processes of differentiation in the absence of inducer, has been examined at the single-cell level, with a combination of suspension and cell-cloning techniques. Recruitment of committed cells is shown to occur prior to the detectable accumulation of hemoglobin or the appearance of morphological changes characteristic or erythroid maturation. The stability of the commitment of murine erythroleukemia cells to differentiate is found to be dependent upon both the concentration of hexamethylene bisacetamide and the duration of exposure to the inducing agent. Under conditions less than optimal for induction, a single cell can give rise to a colony containing both differentiated and undifferentiated cells. On the basis of these findings, it is suggested that fully stabilized differentiation, in addition to the previously demonstrated requirement for the inducing agent to be present during a cell-cycle S phase, involves subsequent stabilizing event(s) caused by a direct or indirect action of the inducing agent.",,,,,
264409,NLM,MEDLINE,19770315,20190619,0008-543X (Print) 0008-543X (Linking),39,1,1977 Jan,Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy.,58-61,"['Margileth, D A', 'Poplack, D G', 'Pizzo, P A', 'Leventhal, B G']","['Margileth DA', 'Poplack DG', 'Pizzo PA', 'Leventhal BG']",['eng'],"['Case Reports', 'Journal Article']",United States,Cancer,Cancer,0374236,IM,"['Acute Disease', 'Adult', 'Blindness/*complications/etiology', 'Brain/radiation effects', 'Child, Preschool', 'Cytarabine/administration & dosage/adverse effects', 'Drug Therapy, Combination', 'Female', 'Humans', 'Injections, Spinal', 'Leukemia, Lymphoid/*complications/therapy', 'Methotrexate/administration & dosage/adverse effects', 'Optic Nerve/pathology', 'Radiotherapy/adverse effects', 'Remission, Spontaneous']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1002/1097-0142(197701)39:1<58::aid-cncr2820390111>3.0.co;2-5 [doi]'],ppublish,Cancer. 1977 Jan;39(1):58-61. doi: 10.1002/1097-0142(197701)39:1<58::aid-cncr2820390111>3.0.co;2-5.,"['04079A1RDZ (Cytarabine)', 'YL5FZ2Y5U1 (Methotrexate)']","Two patients with acute lymphoblastic leukemia treated on the same protocol became blind during complete remission. Therapy consisted of systemic combination chemotherapy, prophylactic central nervous system irradiation and monthly intrathecal cytosine arabinoside. Eight months after CNS irradiation visual acuity in both patients began to decrease. Meningeal leukemia in the area of the chiasm was suspected but despite additional radiotherapy, steroids and continued intrathecal therapy, both patients were blind within 6 months. Numerous lumbar punctures were negative for leukemic cells. Extensive investigation, including craniotomy in one case, failed to reveal the cause of blindness. Biopsy of the optic nerve in one case was compatible with radiation toxicity. We postulate that potentiation of radiation toxicity to the optic nerves and chiasm by systemic chemotherapy, intrathecal chemotherapy, or both, may have led to blindness. The patients continue in complete hemotologic and CNS remission 12 and 29 months after becoming blind.",,,,,
264404,NLM,MEDLINE,19770315,20041117,0007-1285 (Print) 0007-1285 (Linking),50,589,1977 Jan,Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid.,61-4,"['Bundi, R S', 'Scott, J S', 'Halnan, K E']","['Bundi RS', 'Scott JS', 'Halnan KE']",['eng'],"['Case Reports', 'Journal Article']",England,Br J Radiol,The British journal of radiology,0373125,IM,"['Adenocarcinoma/radiotherapy', 'Adult', 'Humans', 'Iodine Radioisotopes/*adverse effects', 'Leukemia, Myeloid/*etiology', '*Leukemia, Radiation-Induced', 'Male', 'Radiotherapy/*adverse effects', 'Thyroid Neoplasms/radiotherapy']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1259/0007-1285-50-589-61 [doi]'],ppublish,Br J Radiol. 1977 Jan;50(589):61-4. doi: 10.1259/0007-1285-50-589-61.,['0 (Iodine Radioisotopes)'],,,,,,
264384,NLM,MEDLINE,19770321,20210216,0006-4971 (Print) 0006-4971 (Linking),49,2,1977 Feb,Ph1-positive acute lymphocytic leukemia with chromosome 7 abnormalities.,281-7,"['Mandel, E M', 'Shabtai, F', 'Gafter, U', 'Klein, B', 'Halbrecht, I', 'Djaldetti, M']","['Mandel EM', 'Shabtai F', 'Gafter U', 'Klein B', 'Halbrecht I', 'Djaldetti M']",['eng'],"['Case Reports', 'Journal Article']",United States,Blood,Blood,7603509,IM,"['Cell Transformation, Neoplastic', 'Chromosome Aberrations/*blood', 'Chromosome Disorders', '*Chromosomes, Human, 21-22 and Y', '*Chromosomes, Human, 6-12 and X', 'Female', 'Humans', 'Karyotyping', 'Leukemia, Lymphoid/*complications', 'Microscopy, Electron', 'Middle Aged']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['S0006-4971(20)68332-X [pii]'],ppublish,Blood. 1977 Feb;49(2):281-7.,,"A 56-yr-old woman with acute lymphocytic leukemia showed the presence of a Philadelphia chromosome in 90% of the bone marrow metaphases and in 10% of the peripheral blood metaphases. Part of the long arm of a G22 chromsome was translocated to the long arm of a C9 chromosome. A second cytogenetic abnormality was found in chromosome 7. Monosomy 7 was found in 60% of the marrow and in 20% of the peripheral blood metaphases. Chromosome 7q- was also found in a small percentage of the metaphases examined. Three months later, when the patient was in partial remission, only 10% of the marrow cells showed chromosome 7 monosomy and a Ph1 chromosome. During complete remission, no chromosomal abnormalities were found, except for a high breakage rate. The finding of a Ph1 chromosome in acute lymphocytic leukemia indicates that different precursors, both granulocytic and lymphocytic, may be involved in the Ph1 process.",,,,,
264383,NLM,MEDLINE,19770321,20210216,0006-4971 (Print) 0006-4971 (Linking),49,2,1977 Feb,Interacting cell populations in cultures of leukocytes from normal or leukemic peripheral blood.,269-80,,,['eng'],['Journal Article'],United States,Blood,Blood,7603509,IM,"['Cell Differentiation', '*Cell Transformation, Neoplastic/radiation effects', 'Cells, Cultured', 'Dose-Response Relationship, Radiation', 'Humans', 'Kinetics', 'Lectins/pharmacology', 'Leukemia, Myeloid, Acute/*blood', 'Leukocyte Count', 'Leukocytes/*cytology/radiation effects', 'Thymidine/metabolism']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']",['S0006-4971(20)68331-8 [pii]'],ppublish,Blood. 1977 Feb;49(2):269-80.,"['0 (Lectins)', 'VC2W18DGKR (Thymidine)']","Kinetic studies in cultures containing 2 X 10(5) peripheral leukocytes from patients with acute myelobastic leukemia revealed extensive, radiation-sensitive increases in thymidine incorporation without parallel increases in cell number. Modest and variable stimulation of 3HTdR incorporation was seen with the addition of either leukocyte-conditioned medium prepared with phytohemagglutin (PHA) or PHA alone. However, using the method of limiting dilution, stimulation was always observed and ranged from 3- to 20-fold in individual patients. By mixing small numbers of intact cells with larger numbers of irradiated autologous cells, quantitative evidence was obtained for a cellular interaction between irradiated, PHA-stimulated populations capable of 3HTdR incorporation. Similar evidence for cell-cell interaction was obtained for normal leukocytes.",,,,,
264369,NLM,MEDLINE,19770226,20151119,0003-9926 (Print) 0003-9926 (Linking),137,1,1977 Jan,Successful treatment of acute leukemia during pregnancy. Combination therapy in the third trimester.,90-1,"['Durie, B G', 'Giles, H R']","['Durie BG', 'Giles HR']",['eng'],"['Case Reports', 'Journal Article']",United States,Arch Intern Med,Archives of internal medicine,0372440,IM,"['Adult', 'Birth Weight', 'Cytarabine/*therapeutic use', 'Drug Therapy, Combination', 'Female', 'Humans', 'Infant, Newborn', 'Karyotyping', 'Leukemia, Myeloid, Acute/*drug therapy', 'Prednisone/therapeutic use', 'Pregnancy', 'Pregnancy Complications, Hematologic/*drug therapy', 'Pregnancy Trimester, Third', 'Remission, Spontaneous', 'Vincristine/*therapeutic use']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Arch Intern Med. 1977 Jan;137(1):90-1.,"['04079A1RDZ (Cytarabine)', '5J49Q6B70F (Vincristine)', 'VB0R961HZT (Prednisone)']","Aggressive treatment with cytarabine, vincristine sulfate, and prednisone for acute myelogenous leukemia, administered from the 31 st week of pregnancy, resulted in both sustained complete remission of the leukemia and delivery of a normal infant with a normal birthweight and a normal male karyotype. It is concluded that chemotherapy with cytarabine combinations can be administered in the third, and probably the second, trimester of pregnancy without risk of serious damage to the developing fetus.",,,,,
264363,NLM,MEDLINE,19770224,20190509,0002-9173 (Print) 0002-9173 (Linking),67,1,1977 Jan,Cytochemical detection of homocysteine in pernicious anemia and in chronic erythremic myelosis.,53-6,"['Kass, L']",['Kass L'],['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Am J Clin Pathol,American journal of clinical pathology,0370470,IM,"['5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/metabolism', 'Anemia, Pernicious/*metabolism', 'Bone Marrow/metabolism', 'Bone Marrow Cells', 'Erythrocytes/metabolism', 'Histocytochemistry', 'Homocysteine/*metabolism', 'Humans', 'Leukemia, Erythroblastic, Acute/blood/*metabolism', 'Nickel', 'Vitamin B 12 Deficiency/metabolism']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1093/ajcp/67.1.53 [doi]'],ppublish,Am J Clin Pathol. 1977 Jan;67(1):53-6. doi: 10.1093/ajcp/67.1.53.,"['0LVT1QZ0BA (Homocysteine)', '7OV03QG267 (Nickel)', 'EC 2.1.1.13 (5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase)']","Utilizing a unique ability of homocysteine to form a yellow-brown precipitate with nickel chloride, a cytochemical test was developed in an effort to identify this amino acid. Among a variety of types of anemias studied, bright yellow-colored erythrocytes and erythroid precursors were found only in marrows from patients who had untreated pernicious anemia and chronic erythremic myelosis. The results of the study support the ""methyltetrahydrofolate-trap"" hypothesis in vitamin B12 deficiency, in which decreased activity of the methylocobalamin-dependent methyltransferase enzyme is believed to lead to accumulation of methyltetrahydrofolate and homocysteine in the deficient cells. The findings also raise the possibility that similar intracellular accumulations of homocysteine may occur in chronic erythremic myelosis, perhaps as a result of a defect in the methyltransferase enzyme.",,,,,
264341,NLM,MEDLINE,19770226,20190712,0030-4220 (Print) 0030-4220 (Linking),43,1,1977 Jan,An estimation of somatic hazards to the United States population from dental radiography.,152-9,"['White, S C', 'Frey, N W']","['White SC', 'Frey NW']",['eng'],"['Comparative Study', 'Journal Article']",United States,Oral Surg Oral Med Oral Pathol,"Oral surgery, oral medicine, and oral pathology",0376406,IM,"['Dose-Response Relationship, Radiation', 'Humans', 'Leukemia/etiology', 'Neoplasms, Radiation-Induced/etiology', 'Radiation Dosage', '*Radiation Effects', 'Radiography, Dental/*adverse effects', 'Risk', 'Thyroid Neoplasms/etiology', 'United States']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['10.1016/0030-4220(77)90366-8 [doi]'],ppublish,Oral Surg Oral Med Oral Pathol. 1977 Jan;43(1):152-9. doi: 10.1016/0030-4220(77)90366-8.,,"Recently, data have become available pertaining both to the estimated somatic hazard from exposure of populations to low doses of ionizing radiation and to the extent of exposure resulting from dental radiography. This has made possible an estimation of the somatic hazard to the United States population from dental radiography. It is concluded that the greatest risk of lethality would result from induction of leukemia, but that the actual hazard is probably quite low. It is advised that all procedures which will reduce the radiation exposure to the patient consistent with diagnostic requirements should be employed in order to minimize the potential risk.",,,,,
264319,NLM,MEDLINE,19770224,20190630,0022-3476 (Print) 0022-3476 (Linking),90,2,1977 Feb,Chorea associated with a subdural hematoma in a child with leukemia.,255-6,"['Bean, S C', 'Ladisch, S']","['Bean SC', 'Ladisch S']",['eng'],"['Case Reports', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,IM,"['Child', 'Chorea/*etiology', 'Hematoma, Subdural/*complications/surgery', 'Humans', 'Leukemia, Lymphoid/*complications', 'Male', 'Meninges', 'Neoplasm Metastasis']",1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']","['S0022-3476(77)80644-6 [pii]', '10.1016/s0022-3476(77)80644-6 [doi]']",ppublish,J Pediatr. 1977 Feb;90(2):255-6. doi: 10.1016/s0022-3476(77)80644-6.,,,,,,,
264284,NLM,MEDLINE,19770224,20151119,0012-0472 (Print) 0012-0472 (Linking),102,2,1977 Jan 14,[Combination chemotherapy of acute lymphoid leukaemia in children combined with prophylactic cranial irradiation (author's transl)].,49-54,"['Grobe, H', 'Schellong, G', 'Wannenmacher']","['Grobe H', 'Schellong G', 'Wannenmacher']",['ger'],"['English Abstract', 'Journal Article']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Adrenal Cortex Hormones/therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Injections, Spinal', 'Leukemia, Lymphoid/diagnosis/*drug therapy/radiotherapy', 'Male', 'Methotrexate/administration & dosage/therapeutic use', 'Prognosis', 'Remission, Spontaneous', 'Skull/radiation effects', 'Vincristine/therapeutic use']",1977/01/14 00:00,1977/01/14 00:01,['1977/01/14 00:00'],"['1977/01/14 00:00 [pubmed]', '1977/01/14 00:01 [medline]', '1977/01/14 00:00 [entrez]']",['10.1055/s-0028-1104840 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Jan 14;102(2):49-54. doi: 10.1055/s-0028-1104840.,"['0 (Adrenal Cortex Hormones)', '5J49Q6B70F (Vincristine)', 'YL5FZ2Y5U1 (Methotrexate)']","From June 1971 to May 1974, 41 children, aged four months to eleven years, with acute lymphoid leukaemia were treated by a schedule which included prophylactic cranial irradiation and intrathecal methotrexate injection after remission (phase II) and combination cytostatic treatment for 2 1/2 years (phase III). Induction of remission (phase I) was usually achieved with vincristine and a corticosteroid. Complete remission, now lasting 18 to 54 months, was obtained in 18 patients (44%), in nine of them without treatment for up to 24 months. Twelve patients (29%) had bone-marrow recurrence, five (12%) CNS and three (7%) testicular recurrence. One child died of liver failure in complete remission. Another nine patients, who had been pretreated according to a different schedule and were in their first remission for six to twelve months, were added to the programme from phase II onwards. Three of them now are in complete remission for 60 to 88 months, seven to 30 months after treatment had been stopped. The results indicate a significantly improved prognosis of acute lymphoid leukaemia in children.",Polychemotherapie der akuten lymphatischen Leukamie im Kindesalter in Kombination mit prophylaktischer Schadelbestrahlung,,,,
264283,NLM,MEDLINE,19770224,20071115,0012-0472 (Print) 0012-0472 (Linking),102,2,1977 Jan 14,"[""Prophylactic"" intrathecal radiogold (198au) in leukaemia in children (author's transl)].",43-6,"['Metz, O', 'Stoll, W', 'Plenert, W']","['Metz O', 'Stoll W', 'Plenert W']",['ger'],"['English Abstract', 'Journal Article']",Germany,Dtsch Med Wochenschr,Deutsche medizinische Wochenschrift (1946),0006723,IM,"['Child', 'Electroencephalography', 'Gold Colloid, Radioactive/*therapeutic use', 'Humans', 'Injections, Spinal', 'Leukemia/complications/*radiotherapy', 'Leukemia, Lymphoid/radiotherapy', 'Leukemia, Myeloid, Acute/radiotherapy', 'Meningitis/*prevention & control', 'Time Factors']",1977/01/14 00:00,1977/01/14 00:01,['1977/01/14 00:00'],"['1977/01/14 00:00 [pubmed]', '1977/01/14 00:01 [medline]', '1977/01/14 00:00 [entrez]']",['10.1055/s-0028-1104839 [doi]'],ppublish,Dtsch Med Wochenschr. 1977 Jan 14;102(2):43-6. doi: 10.1055/s-0028-1104839.,"['0 (Gold Colloid, Radioactive)']","198Au radiogold-colloid (Behring) was injected as ""prophylactic"" therapy against central nervous system leukaemia in 26 children with acute leukaemia (22 acute lymphatic and 4 myeloid). During the period of observation (1.3. 1972 to 1.9.1975), 23 children remained free of central nervous system recurrences: 16 children are alive 3 to 39 1/2 months later, seven died after 4 1/2 to 29 1/2 months from the underlying disease. In one child CNS leukaemia developed after about five months, in another one during a second haematological recurrence, while the third one developed retrobulbar infiltration in the optic nerve. In general, 2 mCi 198Au gold-colloid was injected intrathecally via a lumbar puncture. The method was well tolerated.","Meningosis- ""Prophylaxe"" mit Radiogold (198Au) bei der Leukamie im Kindesalter",,,,
264273,NLM,MEDLINE,19770224,20210216,0006-4971 (Print) 0006-4971 (Linking),49,1,1977 Jan,"Bone marrow cellularity determination: comparison of the biopsy, aspirate, and buffy coat.",29-31,"['Gruppo, R A', 'Lampkin, B C', 'Granger, S']","['Gruppo RA', 'Lampkin BC', 'Granger S']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Blood,Blood,7603509,IM,"['Anemia, Aplastic/pathology', 'Biopsy, Needle', '*Bone Marrow Cells', 'Cell Differentiation', 'Child', 'Child, Preschool', 'Humans', 'Leukemia, Lymphoid/pathology', 'Leukemia, Monocytic, Acute/pathology', 'Leukemia, Myeloid/pathology']",1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",['S0006-4971(20)68050-8 [pii]'],ppublish,Blood. 1977 Jan;49(1):29-31.,,"Bone marrow biopsies (244) performed with a Jamshidi needle were evaluated in 53 children with leukemia or aplastic anemia. Adequate specimens were obtained in 85%. Results of cellularity estimated by biopsy were compared to the cellularity of the aspirate versus volumetric determination of the myeloid-erythroid layer (buffy coat). A wide discrepancy was noted between marrow cellularity confirmed by biopsy versus the aspirate or buffy coat. The greatest variance was seen in the hypercellular or normocellular marrows, as estimated by biopsy, in which 39% were misinterpreted as moderately or severely hypocellular by aspirate. Volumetric measurement of buffy coat was least acceptable for estimating cellularity. Thus the biopsy has proved to be an important and reliable indicator of bone marrow cellularity.",,,,,
264088,NLM,MEDLINE,19870423,20190816,0301-2115 (Print) 0301-2115 (Linking),9,2,1979 Apr,Spontaneous abortions in sibship of children with congenital malformation or malignant disease.,89-95,"['Spira, A', 'Lazar, P']","['Spira A', 'Lazar P']",['eng'],['Journal Article'],Ireland,Eur J Obstet Gynecol Reprod Biol,"European journal of obstetrics, gynecology, and reproductive biology",0375672,IM,"['Abortion, Spontaneous/*genetics', 'Adult', 'Female', 'Heart Defects, Congenital/*genetics', 'Hemangioma/*genetics', 'Humans', 'Intellectual Disability/*genetics', 'Leukemia/*genetics', 'Maternal Age', 'Neoplasms/*genetics', 'Parity', 'Pregnancy', 'Risk']",1979/04/01 00:00,1979/04/01 00:01,['1979/04/01 00:00'],"['1979/04/01 00:00 [pubmed]', '1979/04/01 00:01 [medline]', '1979/04/01 00:00 [entrez]']","['0028-2243(79)90004-2 [pii]', '10.1016/0028-2243(79)90004-2 [doi]']",ppublish,Eur J Obstet Gynecol Reprod Biol. 1979 Apr;9(2):89-95. doi: 10.1016/0028-2243(79)90004-2.,,"Parents of 751 children affected by cancer/leukemia, congenital heart disease, strawberry nevus or mental retardation have been investigated with respect to their reproductive history and their exposure to risk factors for spontaneous abortion. Differences between the four groups were established for the number of children in the sibship, the proportion of multigravidae and the spontaneous abortion rate among these women. The greatest differences were observed in the two groups of malformed children compared with the other two groups, being as marked in those with a severe malformation (heart defect) as in those with a benign one (strawberry nevus). Taking known risk factors for spontaneous abortion into account did not explain the observed differences. An etiological hypothesis is put forward which takes account of the high proportion of quantitative abnormalities of the karyotype associated with congenital heart disease and spontaneous abortion.",,,,,
263624,NLM,MEDLINE,19810820,20171117,0350-2023 (Print) 0350-2023 (Linking),7,2-3,1979,[Liver injury during combined chemotherapy of acute leukemias].,175-9,"['Stefanovic, N', 'Dzambas, D', 'Pejin, D', 'Uzurov, V']","['Stefanovic N', 'Dzambas D', 'Pejin D', 'Uzurov V']",['hrv'],['Journal Article'],Serbia,Bilt Hematol Transfuz,Bilten za hematologiju i transfuziju,7601504,IM,"['Acute Disease', '*Chemical and Drug Induced Liver Injury', 'Drug Therapy, Combination', 'Humans', 'Leukemia/*drug therapy', 'Mercaptopurine/administration & dosage/*adverse effects', 'Methotrexate/administration & dosage/*adverse effects', 'Vincristine/administration & dosage/*adverse effects']",1979/01/01 00:00,1979/01/01 00:01,['1979/01/01 00:00'],"['1979/01/01 00:00 [pubmed]', '1979/01/01 00:01 [medline]', '1979/01/01 00:00 [entrez]']",,ppublish,Bilt Hematol Transfuz. 1979;7(2-3):175-9.,"['5J49Q6B70F (Vincristine)', 'E7WED276I5 (Mercaptopurine)', 'YL5FZ2Y5U1 (Methotrexate)']","The authors observed 70 patients with acute leukemia treated by polychemotherapy. In 2 patients the signs of severe liver damage were found. The occurrence, course and results of laboratory tests suggested Purinethol predominantly as the cause of development of these alterations. The complication did not occur frequently in our patients. The changes regressed in a satisfactory way after the withdrawal of the hepatotoxic cytostatic from the therapy.",Ostecenje jetre u toku polihemioterapije akutnih leukemija.,,,,
262446,NLM,MEDLINE,19811025,20181113,0006-3495 (Print) 0006-3495 (Linking),28,1,1979 Oct,Effect of low dose rate radiation on cell growth kinetics.,81-91,"['Gregg, E C', 'Yau, T M', 'Kim, S C']","['Gregg EC', 'Yau TM', 'Kim SC']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Biophys J,Biophysical journal,0370626,IM,"['Animals', 'Cell Division/*radiation effects', 'Cell Line', 'Dose-Response Relationship, Radiation', 'Kinetics', 'Leukemia L5178/*physiopathology', 'Leukemia, Experimental/*physiopathology', 'Mathematics', 'Mice', 'Models, Biological']",1979/10/01 00:00,1979/10/01 00:01,['1979/10/01 00:00'],"['1979/10/01 00:00 [pubmed]', '1979/10/01 00:01 [medline]', '1979/10/01 00:00 [entrez]']","['S0006-3495(79)85160-7 [pii]', '10.1016/S0006-3495(79)85160-7 [doi]']",ppublish,Biophys J. 1979 Oct;28(1):81-91. doi: 10.1016/S0006-3495(79)85160-7.,,"Experimental determinations were made of cell number as a function of time for two strains of L5178Y mammalian cells maintained continuously in various environments of radiation. One strain possessed a shoulder in its dose response curve whereas the other did not. Neither strain showed any significant difference in growth rate for interdivision doses on the order of the median lethal dose or less delivered continuously at a low dose rate or pulsed every 4 h at a high instantaneous dose rate. It was also shown that large numbers of dead cells have little effect on growth rate and that these dead cells last as discrete entities for many days. A simple theory of growth rate in the presence of radiation is presented, and the agreement with the observations implies that there is no effect of any sublethal low dose rate radiation received in one generation on the growth rate or radiation sensitivity of the succeeding generation. Further analysis of the data also showed that for the no-shoulder cells at 37 degrees C, tritiated water had a relative biological effect close to unity for cell sterilization.",,PMC1328611,,,"['CA15901/CA/NCI NIH HHS/United States', 'CA19283/CA/NCI NIH HHS/United States']"
262192,NLM,MEDLINE,19810922,20190722,0009-9147 (Print) 0009-9147 (Linking),25,3,1979 Mar,Improved lysozyme assay in biological fluids.,484-5,"['Grossowicz, N', 'Ariel, M', 'Weber, T']","['Grossowicz N', 'Ariel M', 'Weber T']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Clin Chem,Clinical chemistry,9421549,IM,"['Biological Assay', 'Humans', 'Kinetics', 'Leukemia/enzymology', 'Meningitis/enzymology', 'Meningitis, Viral/enzymology', 'Micrococcus/drug effects', 'Muramidase/*blood/cerebrospinal fluid/pharmacology']",1979/03/01 00:00,1979/03/01 00:01,['1979/03/01 00:00'],"['1979/03/01 00:00 [pubmed]', '1979/03/01 00:01 [medline]', '1979/03/01 00:00 [entrez]']",,ppublish,Clin Chem. 1979 Mar;25(3):484-5.,['EC 3.2.1.17 (Muramidase)'],"We describe a simple, rapid, sensitive, and highly reproducible assay for lysozyme, with use of concentrated cell suspensions of Micrococcus lysodeikticus in Tris-buffered glycerol/water (40/60 by vol), pH 7.5. Stored at -20 degrees C, the cells' susceptibility to lysozyme remains unaltered over long periods. Almost identical concentration curves were obtained with different aliquots of the same preparation during eight months. Lysozyme activity was reflected in the decrease in absorbance of the reaction mixture after incubation for 15 min at 37 degrees C. Concentrations of egg-white lysozyme as low as 0.02 mg/L can be accurately assayed.",,,,,
260942,NLM,MEDLINE,19800417,20161116,0368-2781 (Print) 0368-2781 (Linking),32,12,1979 Dec,[Treatment of severe infections complicated with blood diseases. Clinical experience with minocycline for intravenous drip for infections caused by glucose non-fermenting Gram-negative rods (author's transl)].,1385-9,"['Yoshida, H', 'Nakamura, Y', 'Hiraguri, M', 'Suzuki, T', 'Igarashi, T', 'Takezawa, M', 'Takabatake, H', 'Kimura, H', 'Tanaka, T', 'Matsuda, S', 'Akizuki, T', 'Uchida, T', 'Kariyone, S']","['Yoshida H', 'Nakamura Y', 'Hiraguri M', 'Suzuki T', 'Igarashi T', 'Takezawa M', 'Takabatake H', 'Kimura H', 'Tanaka T', 'Matsuda S', 'Akizuki T', 'Uchida T', 'Kariyone S']",['jpn'],"['Case Reports', 'Journal Article']",Japan,Jpn J Antibiot,The Japanese journal of antibiotics,0154402,IM,"['Acute Disease', 'Adult', 'Aged', 'Anemia, Aplastic/complications', 'Bacterial Infections/*drug therapy/etiology/microbiology', 'Carbenicillin/administration & dosage/therapeutic use', 'Cefazolin/administration & dosage/therapeutic use', 'Female', 'Humans', 'Infusions, Parenteral', 'Leukemia/*complications', 'Male', 'Middle Aged', 'Minocycline/*administration & dosage/therapeutic use', 'Multiple Myeloma/complications', 'Penicillin Resistance', 'Sulbenicillin/administration & dosage/therapeutic use', 'Tetracyclines/*administration & dosage']",1979/12/01 00:00,1979/12/01 00:01,['1979/12/01 00:00'],"['1979/12/01 00:00 [pubmed]', '1979/12/01 00:01 [medline]', '1979/12/01 00:00 [entrez]']",,ppublish,Jpn J Antibiot. 1979 Dec;32(12):1385-9.,"['0 (Tetracyclines)', 'FYY3R43WGO (Minocycline)', 'G42ZU72N5G (Carbenicillin)', 'IHS69L0Y4T (Cefazolin)', 'Q2VYF0562D (Sulbenicillin)']",,,,,,
260666,NLM,MEDLINE,19800215,20131111,0045-0758 (Print) 0045-0758 (Linking),9,3,1979 Sep,The nursing role in paediatric haematology and oncology.,37-40,"['Holmes, D']",['Holmes D'],['eng'],['Journal Article'],Australia,Aust Nurses J,The Australian nurses' journal. Royal Australian Nursing Federation,0370074,,"['Child', 'Humans', 'Leukemia/nursing', 'Neoplasms/*nursing', 'Patient Care Team', 'Patient Isolators', '*Pediatric Nursing']",1979/09/01 00:00,1979/09/01 00:01,['1979/09/01 00:00'],"['1979/09/01 00:00 [pubmed]', '1979/09/01 00:01 [medline]', '1979/09/01 00:00 [entrez]']",,ppublish,Aust Nurses J. 1979 Sep;9(3):37-40.,,,,,,,
258496,NLM,MEDLINE,19791129,20131121,0033-7021 (Print) 0033-7021 (Linking),42,10,1979 Oct,"Heparin lock: how, what, why.",36-41,"['Huxley, V D']",['Huxley VD'],['eng'],"['Case Reports', 'Journal Article']",United States,RN,RN,20010080R,,"['Adult', 'Cyclophosphamide/therapeutic use', 'Cytarabine/therapeutic use', 'Heparin/*administration & dosage', 'Humans', 'Infusions, Parenteral/instrumentation/*methods', 'Leukemia/drug therapy', 'Male']",1979/10/01 00:00,1979/10/01 00:01,['1979/10/01 00:00'],"['1979/10/01 00:00 [pubmed]', '1979/10/01 00:01 [medline]', '1979/10/01 00:00 [entrez]']",,ppublish,RN. 1979 Oct;42(10):36-41.,"['04079A1RDZ (Cytarabine)', '8N3DW7272P (Cyclophosphamide)', '9005-49-6 (Heparin)']",,,,,,
258177,NLM,MEDLINE,19791129,20190902,0300-5208 (Print) 0300-5208 (Linking),,66,1979 Jun 27-29,DNA repair defects and chromosome instability disorders.,81-131,"['Polani, P E']",['Polani PE'],['eng'],['Journal Article'],Netherlands,Ciba Found Symp,Ciba Foundation symposium,0356636,IM,"['Abnormalities, Multiple/physiopathology', 'Ataxia Telangiectasia/physiopathology', 'Chromatids/physiology', 'Chromosome Aberrations/*genetics', 'Chromosome Disorders', '*Chromosomes, Human', 'Crossing Over, Genetic', '*DNA Repair', 'DNA Replication', 'Dwarfism', 'Humans', 'Syndrome', 'Telangiectasis/*physiopathology', 'Translocation, Genetic', 'Xeroderma Pigmentosum/physiopathology']",1979/06/27 00:00,1979/06/27 00:01,['1979/06/27 00:00'],"['1979/06/27 00:00 [pubmed]', '1979/06/27 00:01 [medline]', '1979/06/27 00:00 [entrez]']",['10.1002/9780470720486.ch6 [doi]'],ppublish,Ciba Found Symp. 1979 Jun 27-29;(66):81-131. doi: 10.1002/9780470720486.ch6.,,"Xeroderma pigmentosum (XP), Fanconi anaemia (FA), ataxia telangiectasia (AT) and Bloom disease (BS) are four rare autosomal recessive disorders in which there is defective DNA repair and/or chromosome instability and proneness to malignancy. Between 80 and 90% of patients with XP have a defect, demonstrable at cell level, of excision of DNA lesions induced by ultraviolet rays, while the remainder have a cellular error of post-replication repair. XP cells are also deficient in repairing DNA damage caused by a variety of chemical mutagens. There are at least five different complementation groups of the first, or classical, type of XP (A to D, etc.) Apparently group C patients, as well as those with defective post-replication repair, do not show the progressive neurological illness found in a proportion of the other patients. AT is heterogeneous clinically and genetically. Clinically it presents with a progressive neurological illness, progressive telangiectases and a developmental disorder of the thymus. AT is characterized by sensitivity to X-rays and AT cells are unable to repair gamma-ray-induced damage to bases in the DNA. It appears that in many cases of the disorder a chromosomally marked cellular clone is found. In BS the main defect, which results in growth retardation, sun-induced lesions of the face and susceptibility to infection, appears to be a slow DNA chain maturation during DNA synthesis. An increase of sister chromatid exchanges is characteristically seen in the chromosomes of cultured BS cells. In FA, in which there is progressive pancytopenia with eventual bone marrow exhaustion and a tendency to haemorrhage and infection, the cellular defect seems to consist of faulty removal of repair of cross-links in the DNA. In this condition, as in BS and AT, various structural chromosome changes are detected in cultured cells. Patients with XP develop skin cancers in early life and often maligant melanomas. In the other three disorders, in which an immune deficiency is often present, leukaemia and related proliferative disorders are a frequent cause of death while other malignancies also occur. There is some evidence that points to an increased risk of malignancy in heterozygotes who carry the FA and AT genes.",,,,,
